Clustering O 0 2.288666962613206e-07
of O 0 1.4969057104963213e-08
missense O 0 1.3994081200507935e-06
mutations O 0 3.2232765789785844e-08
in O 0 9.085042718126601e-10
the O 0 3.269424837526458e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 5.2693895469246854e-08
in O 0 4.780001727766603e-09
a O 0 8.840348009186982e-09
sporadic B-Disease 0 2.0279437649151077e-06
T I-Disease 0 2.0513714844128117e-05
- I-Disease 0 1.0527635822654702e-05
cell I-Disease 0 1.1112851098005194e-05
leukaemia I-Disease 0 0.07441455870866776
. O 0 1.2678106031671632e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0008670625975355506
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.057634003101773e-12
is O 0 1.8846683653810092e-13
a O 0 4.652126774085108e-12
recessive B-Disease 0 6.353236159384323e-08
multi I-Disease 0 0.0005907920422032475
- I-Disease 1 0.9999998807907104
system I-Disease 1 0.9998527765274048
disorder I-Disease 1 0.9999998807907104
caused O 0 2.9160406711525866e-07
by O 0 1.4498975631216382e-10
mutations O 0 1.849473907356014e-10
in O 0 9.310564819120515e-11
the O 0 7.001000890127784e-10
ATM O 0 4.077814352854148e-08
gene O 0 3.273633031319889e-10
at O 0 3.632232514760858e-09
11q22 O 0 3.029739161775069e-07
- O 0 1.5202472525288613e-07
q23 O 0 1.534494344923587e-06
( O 0 3.760992350887449e-10
ref O 0 5.068208963621146e-08
. O 0 1.177154346221343e-10
3 O 0 7.320509087804794e-09
) O 0 2.8470999863250412e-11
. O 0 1.4510825874225475e-09

The O 0 2.3462884257696714e-07
risk O 0 3.869773536280263e-06
of O 0 2.4513030894013355e-07
cancer B-Disease 1 0.8147265911102295
, O 0 3.8020100956437375e-10
especially O 0 3.5280209309540567e-10
lymphoid B-Disease 0 6.945318773432518e-07
neoplasias I-Disease 0 0.00013358167780097574
, O 0 5.033347003080557e-11
is O 0 3.5186428423705784e-12
substantially O 0 7.568078802533407e-11
elevated O 0 7.331617979389193e-09
in O 0 1.6645377298729613e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.856615128303929e-08
and O 0 3.1995775386789438e-12
has O 0 9.45070193977826e-13
long O 0 1.3425829458596494e-12
been O 0 6.430292496389933e-13
associated O 0 8.633687514914001e-12
with O 0 9.622416752286256e-11
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.8685590475797653e-05

By O 0 6.757901349629947e-09
analysing O 0 2.5243710410904896e-07
tumour B-Disease 1 1.0
DNA O 0 2.7727086404638612e-08
from O 0 2.712436109053584e-10
patients O 0 6.6330491446664475e-12
with O 0 2.658077208859966e-13
sporadic B-Disease 0 4.401429976041982e-08
T I-Disease 0 4.304948504341155e-07
- I-Disease 0 4.319296635912906e-07
cell I-Disease 0 1.9865916556227603e-07
prolymphocytic I-Disease 0 6.189659870869946e-06
leukaemia I-Disease 0 0.009906445629894733
( O 0 5.376225575837168e-10
T B-Disease 0 4.3339692723520784e-08
- I-Disease 0 5.577380335353155e-08
PLL I-Disease 0 4.9154536441164964e-08
) O 0 4.055846804240648e-12
, O 0 2.2532717879053532e-12
a O 0 8.44531389265768e-11
rare O 0 1.2103984481370844e-09
clonal B-Disease 0 1.1814995559689123e-07
malignancy I-Disease 0 7.392548582174641e-07
with O 0 6.200419518098688e-12
similarities O 0 9.97126547996885e-11
to O 0 1.7976946597997312e-09
a O 0 9.040708626173455e-09
mature B-Disease 0 6.694055798561749e-08
T I-Disease 0 2.6897353677668434e-07
- I-Disease 0 2.1935755967206205e-07
cell I-Disease 0 1.2887880984635558e-07
leukaemia I-Disease 0 1.3695349480258301e-05
seen O 0 9.912373144516096e-10
in O 0 5.184930262913667e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.59809201930139e-10
we O 0 1.5467080741182748e-11
demonstrate O 0 2.152721360546006e-12
a O 0 5.921426977223421e-12
high O 0 7.974738230887013e-11
frequency O 0 4.3660575155257675e-10
of O 0 3.1767774522073466e-10
ATM O 0 1.5386663108074572e-06
mutations O 0 6.477677771954404e-08
in O 0 1.3896841899452284e-08
T B-Disease 0 9.393838809046429e-06
- I-Disease 0 4.8367364797741175e-06
PLL I-Disease 0 8.375357538170647e-06
. O 0 3.2158094853684815e-08

In O 0 1.2757007894492745e-08
marked O 0 1.9379666760244163e-09
contrast O 0 7.499965232193873e-11
to O 0 1.4627703492919863e-09
the O 0 5.686565107687613e-10
ATM O 0 1.4367491019129375e-07
mutation O 0 4.776517514848422e-10
pattern O 0 7.282403013952887e-10
in O 0 4.747706672247887e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 9.438430037533863e-10
the O 0 8.011800944895953e-11
most O 0 7.337268813356612e-13
frequent O 0 1.3291147696326e-12
nucleotide O 0 6.800457766353851e-12
changes O 0 3.2396218953983924e-12
in O 0 6.501355877264192e-12
this O 0 2.036463359056384e-10
leukaemia B-Disease 0 2.780854856609949e-06
were O 0 4.429615785284113e-09
missense O 0 4.209076394090516e-07
mutations O 0 2.856008904927876e-07
. O 0 3.966966843904629e-08

These O 0 1.8491679298904273e-09
clustered O 0 6.439892619169996e-09
in O 0 6.84836146125356e-11
the O 0 2.149814354313051e-10
region O 0 8.216031743835117e-10
corresponding O 0 1.509353420026116e-09
to O 0 1.8555743608317243e-08
the O 0 8.274002816222037e-09
kinase O 0 8.326486522491905e-08
domain O 0 2.2402360855267034e-08
, O 0 9.164675095207908e-12
which O 0 3.3287986082874976e-12
is O 0 7.86746709446895e-12
highly O 0 1.1720366864531595e-11
conserved O 0 1.6794544921427956e-11
in O 0 2.6046154816272704e-11
ATM O 0 6.193044299607209e-08
- O 0 8.035176968235191e-09
related O 0 1.6174291905812765e-09
proteins O 0 3.148627409146898e-12
in O 0 4.880169619109198e-12
mouse O 0 5.906359429319608e-11
, O 0 1.783243865072226e-11
yeast O 0 1.2433659657418161e-09
and O 0 4.5857148633920986e-10
Drosophila O 0 1.552944617344565e-08
. O 0 2.2374548880321754e-09

The O 0 3.085758919496584e-07
resulting O 0 1.3060258652330958e-07
amino O 0 1.19987660696097e-07
- O 0 1.0986870968565654e-08
acid O 0 5.096424615658179e-09
substitutions O 0 1.0277764750377116e-10
are O 0 7.865516397920214e-12
predicted O 0 9.165352921058911e-09
to O 0 2.027882972654993e-09
interfere O 0 2.7526414481116035e-09
with O 0 1.9712448687259077e-11
ATP O 0 1.8166990400914074e-07
binding O 0 1.3264658704770227e-08
or O 0 9.844938198000364e-10
substrate O 0 4.014172816368955e-08
recognition O 0 1.1898205753979596e-09
. O 0 5.115434298375021e-09

Two O 0 8.35135871568582e-09
of O 0 6.858253698283079e-08
seventeen O 0 2.6222110705020896e-07
mutated O 0 5.044974926704526e-08
T B-Disease 0 1.1072306449477765e-07
- I-Disease 0 5.450799989148436e-08
PLL I-Disease 0 5.9332982971227466e-08
samples O 0 3.737534587378022e-11
had O 0 1.503020277682232e-11
a O 0 1.2330208035149504e-11
previously O 0 9.651348470418597e-11
reported O 0 5.177086315200086e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
allele O 0 1.5102979205039446e-06
. O 0 5.250849000049129e-08

In O 0 9.836364611714998e-09
contrast O 0 4.427040067866983e-09
, O 0 1.5913027562319826e-09
no O 0 4.850333024108977e-09
mutations O 0 2.228455642239169e-09
were O 0 7.351428354951395e-10
detected O 0 2.307361191000723e-09
in O 0 1.1636620139698906e-10
the O 0 2.3012871608329988e-09
p53 O 0 3.8742573593708585e-09
gene O 0 2.283068040176417e-10
, O 0 5.84968315106571e-12
suggesting O 0 9.874232681506001e-11
that O 0 1.2949975293496951e-11
this O 0 1.944939542752877e-09
tumour B-Disease 1 1.0
suppressor O 0 1.4102752174949273e-05
is O 0 1.2418201189579037e-10
not O 0 1.9783072749413044e-11
frequently O 0 3.0292413542853946e-12
altered O 0 2.201075779972861e-11
in O 0 1.7249838710209353e-11
this O 0 8.703037179813577e-10
leukaemia B-Disease 0 0.00010237948299618438
. O 0 8.104846216383521e-08

Occasional O 0 1.1043260883525363e-06
missense O 0 1.5578208376609837e-06
mutations O 0 1.6066408647930075e-08
in O 0 1.216643230605996e-09
ATM O 0 1.0304568149877014e-06
were O 0 1.8520022182499929e-09
also O 0 1.8166437104616406e-11
found O 0 9.218638005736857e-12
in O 0 5.175748371555322e-11
tumour B-Disease 1 0.9999997615814209
DNA O 0 5.09156627970242e-09
from O 0 9.392237682037674e-11
patients O 0 1.2124253424145026e-12
with O 0 8.143111158249658e-14
B B-Disease 0 3.865726583285323e-08
- I-Disease 0 1.6870981056626988e-08
cell I-Disease 0 4.803465003533347e-07
non I-Disease 0 4.780074596055783e-05
- I-Disease 0 2.463981945766136e-05
Hodgkins I-Disease 0 0.0009344425052404404
lymphomas I-Disease 0 1.7708243760239384e-08
( O 0 1.552920660986834e-12
B B-Disease 0 2.291572043233714e-09
- I-Disease 0 2.566334922349256e-10
NHL I-Disease 0 2.407141819205094e-09
) O 0 2.325222805098226e-13
and O 0 1.5808091597888096e-12
a O 0 5.326517560355626e-10
B B-Disease 0 7.852894867710347e-08
- I-Disease 0 1.67329226030688e-08
NHL I-Disease 0 1.2927061732170841e-07
cell O 0 3.3356570838805055e-08
line O 0 1.741994850590345e-07
. O 0 1.942875371696573e-08

The O 0 6.834302013203342e-09
evidence O 0 2.3407115135043455e-10
of O 0 3.446457008671189e-11
a O 0 3.597479605876863e-11
significant O 0 2.1775591052541898e-10
proportion O 0 3.386522173798312e-10
of O 0 2.1307665354353134e-10
loss O 0 2.266282023155597e-10
- O 0 2.786884722993932e-09
of O 0 1.774560409728565e-08
- O 0 4.578733836524407e-09
function O 0 1.0781426446060394e-10
mutations O 0 7.437591124578868e-13
and O 0 9.162568842752475e-14
a O 0 6.173102393841612e-12
complete O 0 6.071644853555824e-10
absence O 0 8.671096729528927e-09
of O 0 5.873715402948676e-10
the O 0 9.247929505518115e-11
normal O 0 2.7643731748128175e-10
copy O 0 5.958591259291879e-11
of O 0 3.7337460900843666e-10
ATM O 0 1.989097242471871e-08
in O 0 2.9061019216070072e-11
the O 0 1.1286345469319059e-10
majority O 0 6.287443482522193e-11
of O 0 6.210060243816429e-10
mutated O 0 1.1726124427013929e-07
tumours B-Disease 1 1.0
establishes O 0 2.0636878872437592e-08
somatic O 0 2.2596200466296068e-08
inactivation O 0 2.987652578667621e-07
of O 0 1.9242061277680023e-09
this O 0 3.065529427526137e-11
gene O 0 8.42327162881018e-12
in O 0 1.0578376716252613e-11
the O 0 1.519781245296059e-10
pathogenesis O 0 5.519767043438151e-08
of O 0 2.1641293201923872e-08
sporadic B-Disease 0 0.00031200781813822687
T I-Disease 0 0.008646155707538128
- I-Disease 0 0.0011733125429600477
PLL I-Disease 0 2.345828079342027e-06
and O 0 4.7556163867978896e-11
suggests O 0 2.1427436214249695e-11
that O 0 1.1907996290416722e-12
ATM O 0 2.4108406382339354e-09
acts O 0 2.2701496238397567e-10
as O 0 4.308075424175328e-11
a O 0 7.680788449704323e-09
tumour B-Disease 1 1.0
suppressor O 0 3.4362477890681475e-05
. O 0 6.523777074107784e-08

As O 0 1.176856834206319e-08
constitutional O 0 1.245739724708983e-07
DNA O 0 2.948819410875103e-09
was O 0 4.903797160005219e-11
not O 0 3.129030509089331e-13
available O 0 1.7356890664316227e-12
, O 0 1.984224199877427e-12
a O 0 6.463231616571363e-10
putative O 0 6.4257383201038465e-06
hereditary O 1 0.9999997615814209
predisposition O 1 0.9999945163726807
to O 1 0.6558493375778198
T B-Disease 0 0.00011100964911747724
- I-Disease 0 1.9473109205137007e-06
PLL I-Disease 0 1.0002709416312427e-07
will O 0 1.1217347883896167e-10
require O 0 1.6440456634958522e-11
further O 0 8.119409311557746e-11
investigation O 0 4.100076667068464e-10
. O 0 4.139789205881428e-11
. O 0 9.19943121679978e-10

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 8.137159602483734e-05
kinase O 0 5.861298859599628e-07
is O 0 5.192515688257071e-12
involved O 0 2.5732568202999073e-13
in O 0 1.250262371930988e-13
the O 0 1.1972972526613779e-12
modulation O 0 1.7440552040753898e-12
of O 0 2.5610721876567766e-11
the O 0 4.1383840798658866e-11
Ca2 O 0 6.054667878174769e-10
+ O 0 7.354265196823917e-09
homeostasis O 0 5.118147683447205e-09
in O 0 1.254569559350216e-09
skeletal O 0 4.4519288167066406e-07
muscle O 0 2.9812375146320846e-07
cells O 0 7.742981438241259e-07
. O 0 1.0608745526496932e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.123511527926894e-06
DM B-Disease 1 1.0
) O 0 1.0214471490854748e-09
, O 0 1.56070711909706e-11
the O 0 2.6948811238103332e-11
most O 0 3.423702293892106e-11
prevalent O 0 1.8521958509154501e-06
muscular B-Disease 1 0.9996678829193115
disorder I-Disease 1 0.8592305779457092
in O 0 1.3774362761509451e-09
adults O 0 1.310299513335167e-08
, O 0 2.6571725722512873e-11
is O 0 2.2908968125290308e-11
caused O 0 8.207808321891719e-10
by O 0 2.354457739883742e-10
( O 0 2.5086139832097842e-09
CTG O 0 1.9930094197206927e-07
) O 0 4.295038283363972e-11
n O 0 5.41890754490737e-10
- O 0 9.225330499518236e-10
repeat O 0 6.70364541655033e-10
expansion O 0 1.6365346577895679e-10
in O 0 1.2449736554176472e-11
a O 0 1.7211919389747976e-10
gene O 0 7.011778744431263e-12
encoding O 0 1.0666230398914678e-10
a O 0 3.1402411782011086e-09
protein O 0 4.765511718574089e-08
kinase O 0 3.685805154418631e-07
( O 0 1.339428790103625e-09
DM B-Disease 1 0.9999593496322632
protein O 0 1.0479626944004394e-08
kinase O 0 2.664605425195532e-09
; O 0 4.9056466354391315e-12
DMPK O 0 1.4680040294479113e-07
) O 0 3.7288724083310576e-13
and O 0 3.3986236134403436e-13
involves O 0 3.3386991088457663e-12
changes O 0 9.463207127635709e-12
in O 0 4.173531659157348e-11
cytoarchitecture O 0 5.510457157242854e-08
and O 0 3.4353886402271883e-09
ion O 0 1.963958084161277e-06
homeostasis O 0 4.411373026869114e-07
. O 0 3.985981678056305e-08

To O 0 1.8146660352158506e-07
obtain O 0 9.161651348676969e-08
clues O 0 5.133490432740473e-08
to O 0 1.398455351520056e-09
the O 0 6.616339698339857e-10
normal O 0 7.927353884440436e-09
biological O 0 4.037683520863311e-09
role O 0 1.5433962441413485e-10
of O 0 1.0496826741146492e-09
DMPK O 0 7.812139665475115e-05
in O 0 4.230989958386999e-08
cellular O 0 4.536359199391882e-08
ion O 0 7.137290594982915e-06
homeostasis O 0 5.030537977290805e-07
, O 0 3.55862922463146e-10
we O 0 7.08407707494807e-11
have O 0 1.8645926816440728e-12
compared O 0 4.0902638914763756e-11
the O 0 5.712870801422021e-11
resting O 0 3.3445154978828384e-10
[ O 0 2.8640171831351147e-11
Ca2 O 0 8.330812428791745e-11
+ O 0 7.299006399286156e-10
] O 0 5.336422415069819e-10
i O 0 1.8562379411335428e-10
, O 0 4.254018578370156e-12
the O 0 6.393534139614854e-12
amplitude O 0 1.5612669143627578e-11
and O 0 8.328880662412941e-13
shape O 0 7.15523751360081e-10
of O 0 7.990287320680522e-10
depolarization O 0 2.563210310668751e-09
- O 0 5.531884283982436e-09
induced O 0 4.674639697554994e-08
Ca2 O 0 1.2439441143818897e-10
+ O 0 1.177401232066444e-10
transients O 0 2.749061811524456e-10
, O 0 1.5838414293197628e-13
and O 0 1.1980573596994532e-13
the O 0 2.1253253063707733e-12
content O 0 5.475024947299012e-12
of O 0 5.864253527221308e-11
ATP O 0 8.603092460646167e-09
- O 0 7.05229152853093e-10
driven O 0 1.1201767291524334e-09
ion O 0 4.030112243924577e-09
pumps O 0 3.71903369211779e-10
in O 0 3.565455569676246e-11
cultured O 0 4.12953315986897e-09
skeletal O 0 1.357753642849957e-08
muscle O 0 2.017989997327163e-09
cells O 0 4.332694203412757e-09
of O 0 1.1734605509516882e-09
wild O 0 6.73175404308779e-11
- O 0 7.529847405318701e-12
type O 0 3.59445494202415e-11
and O 0 7.577984247053582e-12
DMPK O 0 8.092757184385846e-07
[ O 0 6.053204604228313e-09
- O 0 1.885448597249706e-07
/ O 0 7.680995395276113e-07
- O 0 1.8780149275698932e-06
] O 0 1.756722838308633e-07
knockout O 0 1.557859286549501e-05
mice O 0 6.02676806238378e-08
. O 0 6.551294617906933e-09

In O 0 4.7575195338822596e-08
vitro O 0 2.3018442618649715e-07
- O 0 4.540956055620882e-08
differentiated O 0 1.167068308660646e-08
DMPK O 0 4.9994923756457865e-06
[ O 0 2.616265248889249e-08
- O 0 3.0785662374910316e-07
/ O 0 6.483870720330742e-07
- O 0 4.2286259827051254e-07
] O 0 5.488981713597241e-09
myotubes O 0 1.8142502611340205e-08
exhibit O 0 4.126597934889231e-12
a O 0 5.1010293211639635e-11
higher O 0 1.6651569012537948e-09
resting O 0 2.4026740597093976e-09
[ O 0 2.489342065814526e-10
Ca2 O 0 6.145324804585073e-10
+ O 0 6.450071143859759e-09
] O 0 4.701731448619739e-09
i O 0 1.7833715615367396e-09
than O 0 6.020971499154371e-10
do O 0 1.0579537246258042e-09
wild O 0 3.697404882263555e-10
- O 0 4.873213985123748e-11
type O 0 3.5850969415385237e-10
myotubes O 0 7.214087105467115e-08
because O 0 4.767359076951472e-11
of O 0 3.625819436359201e-11
an O 0 2.954715031672217e-12
altered O 0 6.119285633765514e-11
open O 0 1.0156540053429808e-09
probability O 0 3.1870597272387613e-09
of O 0 4.78830308736633e-10
voltage O 0 2.331050836801296e-07
- O 0 1.1262701882230886e-08
dependent O 0 1.1644996078530312e-09
l O 0 9.196890211199404e-13
- O 0 5.074814700412045e-12
type O 0 1.2931858708875588e-11
Ca2 O 0 3.4474480561930143e-12
+ O 0 4.95953625390122e-12
and O 0 9.117321481122431e-12
Na O 0 6.698031712604191e-11
+ O 0 2.171949946283558e-11
channels O 0 3.9040684574054296e-10
. O 0 7.026311199531676e-10

The O 0 5.29080580236041e-07
mutant O 0 3.5545599530451e-07
myotubes O 0 1.179803234663268e-06
exhibit O 0 3.022307126787638e-10
smaller O 0 2.066939813749613e-10
and O 0 3.5572311762877007e-10
slower O 0 2.5536472492149187e-08
Ca2 O 0 1.5104650863406732e-09
+ O 0 3.3875233174107677e-10
responses O 0 7.625773276731529e-12
upon O 0 2.0465787051171525e-11
triggering O 0 2.9147520508310265e-10
by O 0 2.6018199747457338e-11
acetylcholine O 0 7.711232541396384e-09
or O 0 1.055218912249245e-09
high O 0 8.874811996406606e-09
external O 0 2.3455227093904796e-08
K O 0 4.97796044385268e-08
+ O 0 3.758728439606784e-09
. O 0 1.2924152859028482e-09

In O 0 1.1780067588063048e-08
addition O 0 4.5863882136565337e-10
, O 0 6.046589340336084e-10
we O 0 2.9947180846257027e-10
observed O 0 9.579620430244518e-11
that O 0 1.747654863708259e-12
these O 0 3.0218258451064628e-12
Ca2 O 0 1.6807154556985893e-09
+ O 0 1.2298424501011596e-08
transients O 0 1.5392144447901046e-08
partially O 0 7.341899865842549e-10
result O 0 1.8746677821201985e-11
from O 0 1.7210597530459282e-11
an O 0 2.20530213014547e-12
influx O 0 5.169448311255487e-13
of O 0 9.382832184823275e-12
extracellular O 0 3.737620282717735e-11
Ca2 O 0 3.14126849532137e-11
+ O 0 1.979885179415053e-11
through O 0 6.859047292813447e-13
the O 0 7.502823015648197e-12
l O 0 2.2235908860718245e-12
- O 0 7.73319689534313e-12
type O 0 3.111097490737791e-11
Ca2 O 0 8.070804441429047e-11
+ O 0 1.8923328182207655e-10
channel O 0 4.027806976836246e-09
. O 0 9.012692259169341e-10

Neither O 0 8.701684350853611e-08
the O 0 1.1889268458631364e-09
content O 0 1.4387790958636515e-10
nor O 0 1.0336453915016364e-09
the O 0 1.229714385875269e-10
activity O 0 2.8000865515132034e-10
of O 0 2.916414887366159e-10
Na O 0 5.268660507873335e-10
+ O 0 1.431820217945301e-10
/ O 0 1.3111088881245792e-09
K O 0 1.4774155232544217e-09
+ O 0 4.4799629284053566e-11
ATPase O 0 4.167327247173169e-11
and O 0 1.1848394661229111e-11
sarcoplasmic O 0 4.751531612612325e-09
reticulum O 0 3.810550097682608e-09
Ca2 O 0 4.41902292536156e-10
+ O 0 9.570251535695462e-11
- O 0 9.859195404526844e-11
ATPase O 0 1.183995124165449e-10
are O 0 1.787849924529683e-13
affected O 0 2.0285760918281603e-12
by O 0 2.6260753988038843e-11
DMPK O 0 0.00015546502254437655
absence O 0 7.140403681660246e-07
. O 0 3.3468030125050063e-08

In O 0 1.2747271682655992e-07
conclusion O 0 5.389751436268853e-07
, O 0 1.044920483472822e-09
our O 0 2.495622042353318e-10
data O 0 6.543782876677895e-11
suggest O 0 1.132261159830783e-10
that O 0 1.5034501421595792e-11
DMPK O 0 1.0288630619470496e-05
is O 0 2.4914736940218063e-11
involved O 0 9.974641555429709e-13
in O 0 8.637998085911369e-13
modulating O 0 1.0450529330796599e-11
the O 0 2.21512148901315e-11
initial O 0 4.1518719018363015e-11
events O 0 5.270241166220602e-13
of O 0 3.000502624139756e-11
excitation O 0 1.1377647268773217e-07
- O 0 2.2860021999804303e-06
contraction O 0 5.219535026412814e-08
coupling O 0 7.792697043207397e-10
in O 0 5.511712752870324e-10
skeletal O 0 2.340758520347208e-08
muscle O 0 2.0315957804939444e-09
. O 0 1.0152704232879728e-09
. O 0 8.68112515206576e-09

Constitutional O 0 2.888575181714259e-05
RB1 O 0 0.0005493456264957786
- O 0 1.265942682948662e-05
gene O 0 4.920910789962818e-09
mutations O 0 3.3183695791194623e-09
in O 0 6.493155318976207e-11
patients O 0 5.546426859459608e-11
with O 0 5.292818700680657e-12
isolated O 0 1.4702288808621233e-07
unilateral B-Disease 1 0.886588454246521
retinoblastoma I-Disease 1 0.9999997615814209
. O 0 3.019245014002081e-05

In O 0 2.818371669377484e-08
most O 0 3.1567362612783256e-10
patients O 0 1.0082417539747368e-10
with O 0 3.5336607771829787e-12
isolated O 0 9.444976001304894e-08
unilateral B-Disease 1 0.9970061182975769
retinoblastoma I-Disease 1 0.9999998807907104
, O 0 8.910112825333272e-08
tumor B-Disease 0 0.006300357170403004
development O 0 3.884735644277271e-09
is O 0 5.983141065923903e-12
initiated O 0 1.167837770932323e-10
by O 0 1.1298488186706201e-11
somatic O 0 7.979200078445103e-10
inactivation O 0 3.683569715917656e-08
of O 0 1.0172276909692357e-10
both O 0 7.899690450396957e-12
alleles O 0 3.0017734825582565e-11
of O 0 4.119453667073003e-10
the O 0 2.0127313149487236e-09
RB1 O 0 2.0146237602602923e-06
gene O 0 1.0639441327953136e-08
. O 0 1.9524671657222825e-08

However O 0 8.058771783225893e-08
, O 0 2.3254304037934048e-10
some O 0 9.515078829014367e-12
of O 0 1.734813820375436e-10
these O 0 1.8307171750775453e-11
patients O 0 4.217351121105217e-11
can O 0 1.6492726628847265e-10
transmit O 0 5.978110806381665e-08
retinoblastoma B-Disease 0 8.346117829205468e-05
predisposition O 0 4.63297801616136e-05
to O 0 3.3284760547758196e-07
their O 0 2.637403717642428e-08
offspring O 0 7.276300806324798e-08
. O 0 1.65359601567161e-08

To O 0 9.914155718604434e-09
determine O 0 8.736400491926588e-10
the O 0 2.7087847589979397e-11
frequency O 0 2.0865070782249973e-10
and O 0 1.967352496190511e-12
nature O 0 1.2654677306045414e-10
of O 0 1.5589733670662298e-10
constitutional O 0 3.034753319752781e-07
RB1 O 0 3.4531619803601643e-06
- O 0 1.266645597297611e-07
gene O 0 4.578137868804788e-10
mutations O 0 6.197777291383488e-10
in O 0 2.2876306751684616e-11
patients O 0 2.982552052555043e-11
with O 0 5.224853535934493e-12
isolated O 0 2.3821327488349198e-07
unilateral B-Disease 1 0.9989491105079651
retinoblastoma I-Disease 1 0.9998877048492432
, O 0 1.2025544116056608e-08
we O 0 2.3871342680337193e-09
analyzed O 0 2.773816731860279e-10
DNA O 0 4.424724198148766e-10
from O 0 2.3404111981761844e-11
peripheral O 0 4.372926909468333e-09
blood O 0 3.0476345891372603e-09
and O 0 1.7896267801020826e-10
from O 0 4.156670119215278e-09
tumor B-Disease 0 2.3329419036599575e-06
tissue O 0 4.7013935500217485e-07
. O 0 3.204408827173211e-08

The O 0 1.8172009674799483e-08
analysis O 0 3.44968964505199e-09
of O 0 6.383359618666873e-08
tumors B-Disease 1 1.0
from O 0 4.068398595791223e-08
54 O 0 1.6501301658422562e-08
( O 0 5.561806223908228e-12
71 O 0 2.757517991724967e-09
% O 0 5.5037155388681924e-11
) O 0 6.965148401615051e-13
of O 0 5.239396416722997e-11
76 O 0 1.0963258745277926e-08
informative O 0 9.354786945081628e-10
patients O 0 4.312541712625517e-10
showed O 0 3.2012760498023596e-11
loss O 0 2.168498713928102e-10
of O 0 8.911004711897874e-10
constitutional O 0 2.5290703433711315e-06
heterozygosity O 0 3.8011719880159944e-05
( O 0 1.8193858863924106e-08
LOH O 0 0.027056684717535973
) O 0 5.0422929720461696e-11
at O 0 2.471050031260802e-09
intragenic O 0 1.0055850907519925e-07
loci O 0 4.68905270167852e-08
. O 0 9.276133638991269e-09

Three O 0 1.7847266775561366e-08
of O 0 2.0868434091880772e-08
13 O 0 3.181019110343186e-07
uninformative O 0 5.794078606413677e-05
patients O 0 8.148584917933022e-09
had O 0 4.198670300326057e-09
constitutional O 0 2.578255475782498e-07
deletions O 0 7.787635922795744e-07
. O 0 1.6729994456454733e-07

For O 0 2.6619197512900428e-08
39 O 0 3.092797271619929e-07
randomly O 0 4.305623857447927e-09
selected O 0 1.9278404650435732e-08
tumors B-Disease 1 1.0
, O 0 2.8258750006671107e-08
SSCP O 0 0.030034609138965607
, O 0 1.733852883489817e-08
hetero O 0 2.5658088986801886e-08
- O 0 9.117052668372594e-10
duplex O 0 4.808117237686815e-10
analysis O 0 3.7582655737500303e-11
, O 0 2.0897630414323798e-12
sequencing O 0 3.508355932158036e-12
, O 0 2.612724489883811e-12
and O 0 9.156742204752266e-12
Southern O 0 1.361658674703392e-09
blot O 0 3.935165437951582e-08
analysis O 0 4.508017917292939e-11
were O 0 2.550487815736191e-12
used O 0 2.1122075442858712e-12
to O 0 4.6351084082019156e-10
identify O 0 1.9840606935161986e-09
mutations O 0 3.7786197282230205e-08
. O 0 4.813361087485646e-08

Mutations O 0 7.671376920370676e-07
were O 0 5.405945024961056e-09
detected O 0 2.96898394758216e-09
in O 0 5.594920360341149e-11
21 O 0 2.0066441841493088e-09
( O 0 1.0083450567577312e-11
91 O 0 3.647353086222438e-09
% O 0 1.2170280061507555e-10
) O 0 5.077990545415689e-12
of O 0 1.0078807788360677e-09
23 O 0 3.910678060492501e-05
tumors B-Disease 1 1.0
with O 0 2.3864757281444327e-07
LOH O 1 1.0
. O 0 1.4700453903060406e-06

In O 0 1.5376153683632765e-08
6 O 0 1.4585816643375438e-07
( O 0 5.081665990780415e-11
38 O 0 6.544437880506848e-09
% O 0 6.71101091365145e-11
) O 0 1.807911242587834e-12
of O 0 3.615235055764998e-10
16 O 0 2.240318735857727e-06
tumors B-Disease 1 1.0
without O 0 5.2575910558516625e-06
LOH O 1 0.9993643164634705
, O 0 3.494435019124609e-10
one O 0 3.9639964921622806e-11
mutation O 0 2.2986482509090855e-11
was O 0 1.3227983985952818e-10
detected O 0 7.105986632449657e-11
, O 0 3.871021884115089e-13
and O 0 6.948813811684385e-13
in O 0 7.116349176605752e-11
9 O 0 4.43597620858327e-08
( O 0 1.0745233869347004e-10
56 O 0 8.604257750732813e-09
% O 0 1.0093615526729494e-10
) O 0 2.8881250689616333e-12
of O 0 1.967864898810845e-10
the O 0 7.671216906146583e-08
tumors B-Disease 1 1.0
without O 0 1.6244770449702628e-05
LOH O 1 0.9741244316101074
, O 0 4.942505849037104e-10
both O 0 9.058495620273277e-11
mutations O 0 2.801812115649227e-10
were O 0 1.2953761674427966e-10
found O 0 1.2628685597260159e-10
. O 0 7.609652907802911e-10

Thus O 0 1.1364424068460721e-08
, O 0 6.787800183039039e-11
a O 0 2.9192590011994923e-10
total O 0 1.3397678799709212e-10
of O 0 8.112567562168493e-11
45 O 0 3.3854066217031686e-09
mutations O 0 2.6509777706351656e-10
were O 0 2.4723206121235464e-11
identified O 0 7.377189414903285e-10
in O 0 3.1877285255887955e-09
tumors B-Disease 1 1.0
of O 0 1.0212907000095583e-05
36 O 0 7.099572485458339e-06
patients O 0 2.1300495589571256e-08
. O 0 4.249105245435203e-08

Thirty O 0 5.549704837903846e-07
- O 0 8.395983464026813e-09
nine O 0 6.13490147571838e-10
of O 0 7.938422141862134e-11
the O 0 7.167595683643668e-11
mutations O 0 2.6357601864979152e-11
- O 0 2.4221316619055244e-10
including O 0 4.477520090806486e-11
34 O 0 2.5365499922713752e-08
small O 0 1.1088211460119624e-09
mutations O 0 1.5103966077845143e-08
, O 0 1.4626085897972985e-09
2 O 0 9.688541240393533e-07
large O 0 7.506986143823724e-09
structural O 0 7.332809559557063e-07
alterations O 0 4.624384075668786e-07
, O 0 2.162675816208548e-09
and O 0 1.807438310130749e-09
hypermethylation O 0 2.747818871284835e-05
in O 0 2.476548957019986e-07
3 O 0 0.00011961135169258341
tumors O 1 1.0
- O 0 1.9232604842045475e-08
were O 0 3.295597406083317e-10
not O 0 2.22717122522198e-10
detected O 0 1.871621191362749e-10
in O 0 1.998726488136593e-12
the O 0 1.0526729661564094e-11
corresponding O 0 2.644180707722654e-10
peripheral O 0 2.7604242447409888e-08
blood O 0 1.5277345610797965e-08
DNA O 0 1.269351912469574e-07
. O 0 1.6597260454886964e-08

In O 0 1.9344778223739922e-08
6 O 0 1.249706969019826e-07
( O 0 4.0373555193484734e-11
17 O 0 3.6501508482444933e-09
% O 0 3.116175026351975e-11
) O 0 2.1515872850735862e-13
of O 0 2.0719596177665167e-11
the O 0 2.432594958801104e-10
36 O 0 7.463526685569377e-09
patients O 0 5.927396073968083e-11
, O 0 1.0310018463965953e-11
a O 0 1.8905803589319703e-09
mutation O 0 2.6865030200440287e-09
was O 0 8.749311497524559e-09
detected O 0 4.889323390599998e-10
in O 0 1.3179397677365312e-11
constitutional O 0 1.198158550153039e-08
DNA O 0 1.3599456005763955e-09
, O 0 4.725729790128197e-12
and O 0 7.73253336361357e-12
1 O 0 4.709785272893896e-08
of O 0 9.09915920388471e-10
these O 0 4.753394206025163e-11
mutations O 0 1.3442095214699634e-09
is O 0 4.641287354445467e-12
known O 0 3.5720630012919807e-12
to O 0 3.1814689771536564e-11
be O 0 2.667195977967829e-11
associated O 0 5.527364677071489e-11
with O 0 2.464212427860657e-12
reduced O 0 6.469649260765209e-09
expressivity O 0 4.5981875018696883e-07
. O 0 3.50419639971733e-08

The O 0 5.115346812800681e-09
presence O 0 4.6546145410220063e-11
of O 0 1.5848834744591755e-10
a O 0 1.603018273677037e-10
constitutional O 0 1.6821530834931764e-08
mutation O 0 2.543494859175155e-10
was O 0 4.132909639520399e-11
not O 0 6.393384628135268e-13
associated O 0 2.65559926479475e-13
with O 0 1.7677411590739586e-14
an O 0 2.0101309939485335e-12
early O 0 2.8902069626468574e-09
age O 0 1.259650272977808e-09
at O 0 6.644148564660668e-10
treatment O 0 3.613837229465844e-09
. O 0 5.107001488369178e-09

In O 0 3.201354203952178e-08
1 O 0 1.6138395949383266e-05
patient O 0 4.3617754386104934e-07
, O 0 3.166609641169771e-09
somatic O 0 1.3460685295285657e-06
mosaicism O 0 2.062017665593885e-05
was O 0 3.673982895691097e-09
demonstrated O 0 9.658340099916174e-12
by O 0 2.485193257781293e-12
molecular O 0 3.286863836660103e-11
analysis O 0 1.2030567514420554e-12
of O 0 7.75482109083292e-12
DNA O 0 1.1010349749984716e-11
and O 0 2.5301811427264065e-12
RNA O 0 6.287014797656809e-10
from O 0 1.4668487258173712e-10
peripheral O 0 4.6759598859580365e-08
blood O 0 8.086424685416205e-08
. O 0 2.610010341186353e-08

In O 0 2.0537795819564053e-07
2 O 0 9.093091648537666e-06
patients O 0 1.3484259264728848e-09
without O 0 1.3873713289314082e-09
a O 0 5.865143481997848e-09
detectable O 0 6.423076683859108e-07
mutation O 0 3.816478244544896e-09
in O 0 8.831389092245345e-11
peripheral O 0 4.133546482876227e-08
blood O 0 5.702830918608015e-08
, O 0 1.822829803765913e-10
mosaicism O 0 3.731308311216708e-07
was O 0 7.967064230562926e-10
suggested O 0 3.608963822232525e-11
because O 0 6.798226478282876e-12
1 O 0 7.979355842735458e-09
of O 0 4.1017796797993e-11
the O 0 3.2945021710695244e-11
patients O 0 3.931993272643375e-11
showed O 0 6.615708536550358e-10
multifocal O 1 0.999996542930603
tumors B-Disease 1 1.0
and O 0 8.469585033310523e-09
the O 0 2.93410895579882e-09
other O 0 1.2464468693296205e-11
later O 0 3.698998884971161e-10
developed O 0 3.675214577114616e-10
bilateral B-Disease 0 1.1910008652193937e-05
retinoblastoma I-Disease 0 0.0008206425700336695
. O 0 9.241979341823026e-07

In O 0 1.4208091592138317e-08
conclusion O 0 5.018342719154134e-08
, O 0 3.720466712486825e-10
our O 0 7.730251161408574e-11
results O 0 4.478963727683194e-11
emphasize O 0 3.197492617901254e-11
that O 0 1.0478187328216704e-12
the O 0 9.888230859123048e-12
manifestation O 0 4.91025775595233e-10
and O 0 1.508750242795731e-11
transmissibility O 0 1.692570883449207e-08
of O 0 1.2123409220965442e-10
retinoblastoma B-Disease 0 1.7169245580817005e-08
depend O 0 4.723922919502854e-10
on O 0 2.324065828673838e-09
the O 0 2.0630011587918773e-10
nature O 0 2.106187307893137e-10
of O 0 1.5245309181732836e-10
the O 0 5.4644590935515325e-11
first O 0 3.6308941964158237e-10
mutation O 0 9.739538342490306e-11
, O 0 2.5231210350196154e-12
its O 0 5.755050516004223e-12
time O 0 1.7151162434725364e-10
in O 0 5.353199480917503e-11
development O 0 1.8973647097908497e-09
, O 0 1.0861924554239621e-10
and O 0 4.686524085473209e-11
the O 0 2.030773188499424e-10
number O 0 6.4103843760987544e-12
and O 0 2.6723224327840356e-12
types O 0 4.574452275307728e-11
of O 0 2.1546871231681308e-10
cells O 0 5.892946547403355e-11
that O 0 8.772090692721335e-12
are O 0 3.736577887381021e-12
affected O 0 1.058855503277556e-10
. O 0 4.694220567813545e-10
. O 0 1.4577103968349547e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 0 0.3845478892326355
the I-Disease 0 3.1747654247737955e-06
fifth I-Disease 0 1.2769233137532865e-07
component I-Disease 0 7.488519804255134e-10
of I-Disease 0 5.078296672067495e-10
complement I-Disease 0 2.758467412822263e-11
in O 0 5.300009320308163e-09
man O 0 4.657659076201526e-07
. O 0 4.7017518767233923e-08

I O 0 0.00924388412386179
. O 0 4.403014372655889e-06

Clinical O 0 9.453603524889331e-06
, O 0 2.388035769129715e-09
immunochemical O 0 1.652306855248753e-05
, O 0 2.6960560450817184e-09
and O 0 2.336831839144793e-09
family O 0 5.4585584940980425e-09
studies O 0 6.0398384071902456e-09
. O 0 7.194983719926995e-09

The O 0 2.2355268747276114e-09
first O 0 1.3119437480835217e-10
recognized O 0 8.811871371472435e-11
human O 0 2.666291909481089e-10
kindred O 0 7.528641532417168e-08
with O 0 7.168132754031831e-10
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999924898147583
the I-Disease 0 2.1999134332872927e-05
fifth I-Disease 0 9.615971663379241e-08
component I-Disease 0 1.2823845318976623e-09
of I-Disease 0 2.2850341618863013e-09
complement I-Disease 0 4.76597927789868e-10
( O 0 4.704223122153905e-10
C5 O 0 0.0004310167860239744
) O 0 9.055386301914936e-11
is O 0 8.544474155991466e-11
described O 0 4.466512937284506e-09
. O 0 2.731450798876267e-08

The O 0 7.611576791077823e-08
proband O 0 3.4465656426618807e-06
, O 0 1.3913031837731182e-10
a O 0 1.0147201134902417e-10
20 O 0 2.2747874417472502e-10
- O 0 1.1534831249881972e-11
year O 0 2.3190508541270916e-11
- O 0 1.140393127152528e-10
old O 0 2.718838210125085e-10
black O 0 2.570084553163432e-12
female O 0 3.0279283854545147e-13
with O 0 2.419095739697452e-12
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9778969287872314
age O 0 0.0004981397651135921
11 O 0 1.028872418373794e-07
, O 0 3.5844112400429395e-11
lacked O 0 1.8991279659985594e-09
serum O 0 1.3092371631273636e-09
hemolytic O 0 6.915116301797752e-08
complement O 0 1.2353094935857456e-10
activity O 0 3.022009309461282e-09
, O 0 1.220991450306963e-11
even O 0 7.934818774257835e-11
during O 0 1.3354855887826034e-08
remission O 0 8.45382004399653e-08
. O 0 2.2320842951728537e-09

C5 O 0 0.0006834358791820705
was O 0 1.380165576847503e-05
undetectable O 0 1.885470197748873e-07
in O 0 2.640894447569764e-10
her O 0 3.1344038475822344e-11
serum O 0 3.145999433185054e-11
by O 0 1.7333865462779152e-12
both O 0 4.8561595716867245e-11
immunodiffusion O 0 1.3202561603975482e-06
and O 0 1.7005508112788448e-08
hemolytic O 0 0.0005393940373323858
assays O 0 5.6020844567683525e-06
. O 0 6.839297839178471e-07

Other O 0 1.6347190268106715e-10
complement O 0 2.7187229897918108e-11
components O 0 6.535400692841975e-11
were O 0 2.30644808807412e-11
normal O 0 3.7667211016945146e-10
during O 0 2.698812562318409e-10
remission O 0 2.0299957270708546e-09
of O 0 1.5919911222628258e-10
lupus O 0 1.628009016485521e-08
, O 0 7.410919794503812e-11
but O 0 4.3639925006999647e-10
C1 O 0 2.413243862520176e-07
, O 0 8.1270874474626e-09
C4 O 0 1.3023893643548945e-06
, O 0 7.893868891883926e-10
C2 O 0 4.411128529113739e-08
, O 0 4.937493192080922e-10
and O 0 4.3448094011466765e-09
C3 O 0 8.414242620347068e-05
levels O 0 8.187612934307253e-07
fell O 0 2.9127962989150546e-05
during O 0 4.847875345603825e-08
exacerbations O 0 5.839467121404596e-06
. O 0 1.7099374360896036e-08

A O 0 6.402003123184841e-07
younger O 0 3.5911624785001095e-09
half O 0 2.228697892903142e-09
- O 0 2.203081495011361e-09
sister O 0 2.9238909071693797e-09
, O 0 9.812238521700323e-11
who O 0 5.863932117655679e-10
had O 0 1.4070096199247928e-08
no O 0 2.104727592211475e-08
underlying O 1 0.9982498288154602
disease O 1 0.9999562501907349
, O 0 1.2302282803577924e-10
was O 0 2.7263187263315558e-08
also O 0 3.9018108188848544e-11
found O 0 4.394142688601832e-11
to O 0 3.2299400931634636e-09
lack O 0 6.581493749990841e-08
immunochemically O 0 2.6138517569052055e-05
detectable O 0 0.0013380552409216762
C5 O 0 0.0013660624390468001
. O 0 8.307782195515756e-07

By O 0 4.854712898350044e-08
hemolytic O 0 0.01786525547504425
assay O 0 1.4822931007074658e-06
, O 0 8.231749171194735e-10
she O 0 2.1346339626471256e-11
exhibited O 0 4.44552988171365e-12
1 O 0 1.0164833419423758e-09
- O 0 2.1691937135415174e-10
2 O 0 6.781660122356925e-09
% O 0 7.656938971756233e-11
of O 0 2.2149483636102474e-11
the O 0 1.5404140463193272e-10
normal O 0 3.020199867975748e-09
serum O 0 7.117832434566651e-10
C5 O 0 3.0378629389815615e-08
level O 0 2.3007693528143136e-09
and O 0 1.1943872973985137e-11
normal O 0 1.5413730292124228e-09
concentrations O 0 2.849568081497722e-10
of O 0 5.8617568264585085e-12
other O 0 4.594979995456439e-13
complement O 0 1.148771269082749e-11
components O 0 1.5805282638226004e-09
. O 0 7.372466637178832e-09

C5 O 0 0.00020199418941047043
levels O 0 3.886331114699715e-07
of O 0 1.999209908731814e-09
other O 0 7.870514136254503e-12
family O 0 1.722498185752208e-11
members O 0 6.86517303508799e-13
were O 0 4.0525989682127506e-12
either O 0 1.7276780006625359e-10
normal O 0 5.963895155502996e-09
or O 0 2.3798454873436015e-10
approximately O 0 2.0177810811095043e-10
half O 0 5.290532456569963e-10
- O 0 2.4560702360787445e-09
normal O 0 8.571497289722174e-09
, O 0 1.0555057695926795e-11
consistent O 0 9.62151747163631e-11
with O 0 4.805627683984737e-12
autosomal O 0 2.9671096513084194e-07
codominant O 0 2.1323832299913192e-07
inheritance O 0 1.6949487147144282e-08
of O 0 1.6540021574584785e-09
the O 0 6.020489662361683e-10
gene O 0 2.704910295747709e-09
determining O 0 8.629383955849335e-06
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.2959471607464366e-05

Normal O 0 0.0005291568231768906
hemolytic O 0 0.022704949602484703
titers O 0 5.997892003506422e-06
were O 0 1.587377007616908e-09
restored O 0 2.6679720654954053e-09
to O 0 1.5556266275140729e-09
both O 0 2.333214177419052e-10
homozygous O 0 2.1298144758929993e-07
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.9819063368231582e-07
C5D B-Disease 1 1.0
) O 0 6.529696783275085e-10
sera O 0 1.1076458639180942e-09
by O 0 2.0256367384233892e-13
addition O 0 1.0238877887897013e-12
of O 0 1.0922714122063581e-10
highly O 0 4.168139999816134e-10
purified O 0 1.233860214000515e-08
human O 0 3.0784068627554007e-08
C5 O 0 3.791021299548447e-05
. O 0 2.8631046689042705e-07

In O 0 2.4360193862094093e-08
specific O 0 3.653175539852782e-08
C5 O 0 8.721724043425638e-06
titrations O 0 2.599453523544071e-07
, O 0 6.318691680995414e-10
however O 0 5.394961699600742e-10
, O 0 2.069337062815535e-11
it O 0 2.2320180426138592e-11
was O 0 1.7799868246015649e-09
noted O 0 3.350483432362772e-11
that O 0 6.773153002001542e-13
when O 0 3.830664084547575e-12
limited O 0 8.694732434033625e-12
amounts O 0 1.7382884021088785e-10
of O 0 1.796666260212021e-09
C5 O 0 2.14808110854392e-07
were O 0 9.906174769369613e-10
assayed O 0 3.661747127736703e-09
in O 0 2.7072817945783534e-11
the O 0 1.7731774382134802e-11
presence O 0 5.86209249545111e-12
of O 0 4.411021201078391e-11
low O 0 3.0802964623433127e-09
dilutions O 0 1.7745469094165855e-08
of O 0 3.166620021755051e-10
either O 0 2.2993271286964045e-08
C5D B-Disease 1 1.0
serum O 0 2.873754283427843e-07
, O 0 6.008945424573753e-11
curving O 0 3.092382128144777e-09
rather O 0 3.276336146829095e-11
than O 0 2.2611688563212162e-11
linear O 0 8.373881144052575e-09
dose O 0 1.059204013387216e-08
- O 0 1.2251866188250915e-10
response O 0 1.4563270728240596e-11
plots O 0 8.762183201227458e-10
were O 0 2.4805249868031787e-11
consistently O 0 4.4789720543558786e-11
obtained O 0 1.7748998451527775e-11
, O 0 8.377447173468777e-12
suggesting O 0 6.741351921135674e-11
some O 0 8.434009567126477e-12
inhibitory O 0 3.4087259681570004e-09
effect O 0 9.371045450734528e-08
. O 0 7.997045692320626e-09

Further O 0 8.454126287915642e-08
studies O 0 9.389824473515773e-10
suggested O 0 3.414157290215769e-10
that O 0 1.3831028336519502e-11
low O 0 7.914165323086308e-09
dilutions O 0 1.6531615187886928e-07
of O 0 1.4044544194291575e-08
C5D B-Disease 1 1.0
serum O 0 1.290310081003554e-08
contain O 0 3.380318941426097e-11
a O 0 5.5749578564689983e-11
factor O 0 2.465774633086948e-11
( O 0 1.0476608729853565e-12
or O 0 3.8702083204888993e-10
factors O 0 1.020084239300445e-09
) O 0 4.059824525171063e-12
interfering O 0 7.810583291245621e-10
at O 0 1.8890844444285904e-09
some O 0 4.076670858527143e-12
step O 0 1.7727971313163948e-09
in O 0 1.9334494075207154e-11
the O 0 4.050184354564834e-10
hemolytic O 0 3.535745349836361e-07
assay O 0 3.240969448370379e-08
of O 0 3.1612945150527594e-08
C5 O 0 5.059611794422381e-06
, O 0 2.691521484854409e-11
rather O 0 1.431469786455919e-11
than O 0 8.774215728979406e-12
a O 0 3.727491648675141e-10
true O 0 3.5564802214338442e-09
C5 O 0 2.5902826905621623e-07
inhibitor O 0 1.8553903302631625e-08
or O 0 1.2934213700077635e-09
inactivator O 0 1.2428697573341196e-06
. O 0 3.0937698625166377e-08

Of O 0 1.1667166290862951e-06
clinical O 0 1.4232197145247483e-06
interest O 0 2.8587930245294046e-08
are O 0 5.59851782988563e-11
( O 0 2.6303362266055785e-11
a O 0 3.061119691061265e-10
) O 0 1.334031734905039e-12
the O 0 3.045787797320565e-12
documentation O 0 8.16844855644483e-11
of O 0 1.045196984517105e-10
membranous O 0 0.00016350428631994873
glomerulonephritis B-Disease 1 1.0
, O 0 2.9470889728600014e-08
vasculitis B-Disease 1 1.0
, O 0 1.78391665883737e-08
and O 0 2.5529880076646805e-07
arthritis B-Disease 1 1.0
in O 0 1.945512480006073e-07
an O 0 2.8808999630314247e-09
individual O 0 1.20208301646052e-10
lacking O 0 2.3171472207650368e-07
C5 O 0 2.078045508824289e-05
( O 0 7.445419281104648e-11
and O 0 3.470891976609103e-11
its O 0 4.518933838237871e-11
biologic O 0 2.2086688034050894e-09
functions O 0 1.6081521964778078e-12
) O 0 8.872775832200613e-14
, O 0 2.6981392922849345e-13
and O 0 1.900291772896634e-12
( O 0 6.365474987390929e-12
b O 0 1.9226570335817428e-10
) O 0 1.673939307479666e-13
a O 0 1.2884021974302051e-11
remarkable O 0 1.3853048048961814e-11
propensity O 0 5.608324027406297e-09
to O 0 2.2060469007101347e-08
bacterial B-Disease 1 1.0
infections I-Disease 1 0.9999867677688599
in O 0 3.1066323125106265e-11
the O 0 6.09549841157353e-11
proband O 0 3.0565645570135302e-09
, O 0 5.011885437916641e-12
even O 0 1.8963317027775872e-11
during O 0 6.038590738555172e-10
periods O 0 1.0383680582037869e-09
of O 0 3.685293042954285e-11
low O 0 3.5889419214285567e-10
- O 0 2.487200376211085e-11
dose O 0 1.8512455457475596e-10
or O 0 8.694832180633494e-12
alternate O 0 4.233816769394494e-11
- O 0 4.86277074163155e-10
day O 0 6.021385057231043e-10
corticosteroid O 0 5.398631230946194e-08
therapy O 0 2.055723591354308e-09
. O 0 4.1427772323743284e-10

Other O 0 1.876301780612266e-08
observations O 0 4.881035309267645e-08
indicate O 0 1.1310056224900222e-09
that O 0 1.7121802239894457e-11
the O 0 7.366067755754102e-10
C5D B-Disease 1 1.0
state O 0 4.6301426581685234e-10
is O 0 5.824555681516186e-12
compatible O 0 1.6574276673342325e-10
with O 0 1.2715957627140728e-11
normal O 0 3.067259513045428e-08
coagulation O 0 3.357357281075224e-09
function O 0 2.3643581537058367e-10
and O 0 4.352948123481637e-12
the O 0 1.7147294001373936e-11
capacity O 0 1.292416521025963e-11
to O 0 7.809447533091429e-11
mount O 0 9.181839288885385e-08
a O 0 4.7516703460814824e-08
neutrophilic O 0 0.0002105786552419886
leukocytosis O 0 5.6394783314317465e-06
during O 0 1.3572234536241012e-07
pyogenic B-Disease 0 4.865243681706488e-06
infection I-Disease 0 5.368360689317342e-08
. O 0 1.4810994097835817e-10
. O 0 2.6483915060993013e-09

Susceptibility O 0 8.964129665400833e-05
to O 0 1.8395183360553347e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 2.229614665338886e-06
twins O 0 4.5807279747123175e-08
: O 0 7.698064733406562e-13
the O 0 2.463380627953926e-12
role O 0 2.5935789974007584e-12
of O 0 2.0665169228606395e-11
genes O 0 1.1363475264924983e-11
, O 0 1.3026325677845119e-11
HLA O 0 2.0973461190010312e-08
, O 0 4.963418565040456e-11
and O 0 1.9307933030177082e-10
the O 0 1.1884830009023517e-08
environment O 0 4.858187097056543e-08
. O 0 4.831121813708705e-08

OBJECTIVE O 0 6.430507710319944e-06
To O 0 2.0491508490039223e-09
determine O 0 5.563350335968664e-10
the O 0 4.880115755945269e-11
relative O 0 2.721111780346064e-09
effects O 0 7.141334190663429e-09
of O 0 9.774940856743797e-10
genetic O 0 7.611206664925874e-10
and O 0 1.4697186176415578e-11
environmental O 0 1.4126477765330492e-09
factors O 0 3.723290425972081e-11
in O 0 2.226383357187278e-12
susceptibility O 0 4.3505171021251954e-08
to O 0 1.4022322147866362e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 3.6135847381046915e-07
AS B-Disease 1 1.0
) O 0 4.569675471355339e-10
. O 0 1.5710784895262009e-09

METHODS O 0 5.901677923247917e-06
Twins O 0 1.9460314248931354e-08
with O 0 4.595332794843365e-12
AS B-Disease 1 0.999998927116394
were O 0 5.327406484706421e-12
identified O 0 5.55668195918041e-13
from O 0 1.3689578442187267e-13
the O 0 2.480276726189723e-13
Royal O 0 6.380355965784901e-11
National O 0 6.286834386415308e-10
Hospital O 0 1.5361767680133198e-07
for O 0 3.650993285475579e-09
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 2.1283078410760936e-07
. O 0 1.4152867322536622e-07

Clinical O 0 1.0562927172941272e-06
and O 0 6.947459829653724e-10
radiographic O 0 9.156390312625717e-09
examinations O 0 1.7025206133780557e-08
were O 0 2.961503958731626e-11
performed O 0 4.395806364309446e-13
to O 0 4.1733305179703084e-12
establish O 0 1.4628644129377477e-10
diagnoses O 0 6.46550688543357e-08
, O 0 2.536232890371082e-10
and O 0 2.0101158071383907e-08
disease O 1 0.9999986886978149
severity O 0 0.02291029877960682
was O 0 5.8891997944954255e-09
assessed O 0 9.021807745313026e-10
using O 0 3.2969081024264435e-12
a O 0 1.641814462161051e-11
combination O 0 4.3789988996012497e-11
of O 0 3.156465089304561e-10
validated O 0 1.397053028817652e-09
scoring O 0 1.0060792199340085e-09
systems O 0 1.6108785416690807e-08
. O 0 3.286542948899296e-08

HLA O 0 2.105548446706962e-06
typing O 0 1.7130703522383328e-09
for O 0 5.696878524474869e-10
HLA O 0 3.1668591304878646e-08
- O 0 1.1815171063744856e-08
B27 O 0 7.229128584640421e-08
, O 0 2.607965926548772e-11
HLA O 0 3.241201196324539e-10
- O 0 3.032597506447132e-10
B60 O 0 8.504776438655881e-09
, O 0 3.80941762509468e-12
and O 0 2.844125802925479e-11
HLA O 0 2.4931887665502472e-08
- O 0 1.9208997059649846e-08
DR1 O 0 1.1075386282755062e-05
was O 0 2.828731915371918e-09
performed O 0 3.4162644501484207e-12
by O 0 1.6291861523048956e-12
polymerase O 0 6.477139935512355e-10
chain O 0 8.640923393476996e-11
reaction O 0 3.1972838005628335e-12
with O 0 2.123614326922374e-13
sequence O 0 1.7155234481244785e-12
- O 0 1.8634657619059913e-12
specific O 0 1.398389325342475e-12
primers O 0 6.921110212720905e-11
, O 0 1.276228688701364e-12
and O 0 8.155056491210289e-12
zygosity O 0 2.759771611238193e-08
was O 0 1.274907179826812e-09
assessed O 0 7.072146201991814e-10
using O 0 5.826113896878482e-11
microsatellite O 0 6.548248876470097e-08
markers O 0 1.124456439072219e-08
. O 0 6.9258705437391654e-09

Genetic O 0 9.342862199446245e-07
and O 0 1.6741789066188062e-09
environmental O 0 9.1821510395107e-09
variance O 0 1.1151712886459109e-09
components O 0 9.276567014548931e-11
were O 0 1.4437320262905562e-11
assessed O 0 3.840720241843343e-10
with O 0 6.804709790433905e-13
the O 0 1.7974126353959008e-10
program O 0 3.094993358820908e-11
Mx O 0 1.2046337261040208e-09
, O 0 8.180882729059979e-13
using O 0 7.213368357489314e-13
data O 0 1.5307997924818295e-12
from O 0 1.6648527174922823e-12
this O 0 9.919886093112673e-13
and O 0 4.0532616325805737e-13
previous O 0 3.424081157499259e-11
studies O 0 9.867186061274236e-12
of O 0 8.640771258228153e-12
twins O 0 5.293186999821842e-10
with O 0 1.8272567486876667e-11
AS B-Disease 1 1.0
. O 0 1.3343097293727624e-07

RESULTS O 0 4.396169970277697e-07
Six O 0 1.935381988005247e-08
of O 0 3.7660763396729635e-09
8 O 0 3.1568211511512345e-07
monozygotic O 0 2.4011481514207844e-07
( O 0 3.3148206401989455e-09
MZ O 0 2.14153897104552e-06
) O 0 5.01477574743614e-11
twin O 0 9.117822941107079e-09
pairs O 0 5.979471084938126e-11
were O 0 1.059765275535085e-09
disease O 0 1.8895690345743787e-07
concordant O 0 1.8637881282757007e-07
, O 0 3.048765406798992e-11
compared O 0 2.9853123445500174e-11
with O 0 1.0950863696748692e-12
4 O 0 4.7811347769766144e-08
of O 0 1.0954912532668004e-09
15 O 0 1.9100633963375913e-08
B27 O 0 1.2444324681837315e-07
- O 0 4.465277925191913e-09
positive O 0 1.1835525615122577e-10
dizygotic O 0 2.9719032568209514e-08
( O 0 1.2806045113222808e-10
DZ O 0 1.1778971753528822e-07
) O 0 1.6157246981313156e-12
twin O 0 1.293632978516257e-10
pairs O 0 3.731519216884638e-13
( O 0 1.0341959493648245e-12
27 O 0 2.6011079956589356e-09
% O 0 6.020726972533197e-11
) O 0 3.123842601693988e-13
and O 0 1.31909413947362e-11
4 O 0 1.5746493886581447e-08
of O 0 8.453860389501244e-10
32 O 0 1.7611235136882897e-08
DZ O 0 4.552472603336355e-07
twin O 0 2.6349886717014215e-09
pairs O 0 1.2967673809760605e-11
overall O 0 1.0757721796705866e-10
( O 0 1.277179056957678e-11
12 O 0 3.0863953615067885e-09
. O 0 5.467211405818517e-11
5 O 0 5.66947822022712e-09
% O 0 3.403533288537375e-10
) O 0 5.38410357964203e-11
. O 0 5.912046407985372e-09

Nonsignificant O 0 9.221363143296912e-05
increases O 0 1.601479482360446e-08
in O 0 4.639475609247157e-11
similarity O 0 6.861262426272052e-12
with O 0 9.967828157927267e-14
regard O 0 6.243072725453658e-11
to O 0 2.3556079309372535e-10
age O 0 6.544400577013221e-09
at O 0 2.8483195801953798e-09
disease O 0 1.5992458202163107e-07
onset O 0 3.920044662208966e-07
and O 0 1.071777909478211e-11
all O 0 7.541993071735753e-12
of O 0 1.2700572538104637e-10
the O 0 5.778517664367655e-10
disease O 0 7.198857332468833e-08
severity O 0 1.7080012071346573e-08
scores O 0 5.444660694520209e-11
assessed O 0 4.312453505406211e-09
were O 0 1.181752473655706e-10
noted O 0 1.4014667204520492e-10
in O 0 6.035758004507841e-10
disease O 0 7.339554031204898e-07
- O 0 6.426115817248501e-08
concordant O 0 1.191605315398192e-05
MZ O 0 1.5399185940623283e-05
twins O 0 2.4753428196078175e-09
compared O 0 1.2578563191034675e-10
with O 0 4.0762608566335956e-11
concordant O 0 4.472574801184237e-05
DZ O 0 0.002990227658301592
twins O 0 1.803532768462901e-06
. O 0 1.474885635843748e-07

HLA O 0 2.934742724391981e-06
- O 0 1.0639303127391031e-07
B27 O 0 2.7272920988252736e-07
and O 0 4.32118507642798e-11
B60 O 0 1.4492052002879063e-08
were O 0 5.2690777088693075e-12
associated O 0 3.3734833503051842e-12
with O 0 2.7721835244021165e-13
the O 0 3.518941527058672e-10
disease O 0 1.966871554515137e-09
in O 0 7.669768466167515e-12
probands O 0 4.0407357460026105e-08
, O 0 1.849719856450438e-11
and O 0 2.543280169797768e-11
the O 0 1.3553932420862225e-09
rate O 0 1.2114018943520932e-07
of O 0 5.030002636630115e-09
disease O 0 4.180668611297733e-07
concordance O 0 2.0830606128896534e-09
was O 0 5.376717404637077e-10
significantly O 0 1.479837224982461e-10
increased O 0 2.822424793880174e-10
among O 0 5.4129346838127645e-11
DZ O 0 4.126756607547577e-07
twin O 0 2.491171935403713e-09
pairs O 0 2.120413870529414e-12
in O 0 9.053132050441948e-13
which O 0 1.1855215160255783e-12
the O 0 7.770874221879609e-11
co O 0 1.0225303936906016e-10
- O 0 4.35046276781037e-10
twin O 0 9.573469794688094e-10
was O 0 2.865996606704613e-10
positive O 0 6.152188133934366e-13
for O 0 1.1283192262456776e-12
both O 0 3.536123477365649e-11
B27 O 0 2.0152424440311734e-06
and O 0 1.170630969937747e-08
DR1 O 0 0.003802613588050008
. O 0 1.8331122930703714e-07

Additive O 0 2.8840604500146583e-06
genetic O 0 7.575484062272153e-08
effects O 0 4.880492898706734e-09
were O 0 2.2872729751877152e-11
estimated O 0 1.5015932941508936e-11
to O 0 1.0330038040240463e-11
contribute O 0 1.5434868660957335e-11
97 O 0 8.479666413485631e-10
% O 0 2.5205922418725102e-11
of O 0 6.1159796845011716e-12
the O 0 2.4072863494262187e-11
population O 0 2.985783278605658e-12
variance O 0 4.076536885833093e-09
. O 0 2.0504733910797768e-08

CONCLUSION O 0 0.00015439870185218751
Susceptibility O 0 3.811807982856408e-05
to O 0 3.01856346140994e-07
AS B-Disease 1 1.0
is O 0 5.68293245795104e-10
largely O 0 1.9736423606531162e-10
genetically O 0 3.3548573641351e-11
determined O 0 4.0185504923684334e-10
, O 0 6.941041925251357e-12
and O 0 9.242669130049563e-12
the O 0 2.7532595647805636e-10
environmental O 0 5.441666228733766e-09
trigger O 0 3.748449017848543e-08
for O 0 3.786848057352188e-10
the O 0 1.4838245476767042e-07
disease O 0 0.0015298196813091636
is O 0 7.88877782542663e-11
probably O 0 9.973057935042107e-10
ubiquitous O 0 2.5656461399847785e-09
. O 0 2.5749230303517834e-08

HLA O 0 2.24496288865339e-05
- O 0 4.526203838395304e-07
B27 O 0 1.8160856996018993e-07
accounts O 0 9.389415243574173e-13
for O 0 1.0165201064791032e-13
a O 0 2.8475492363372323e-12
minority O 0 8.121400145270907e-13
of O 0 1.2318993915239052e-11
the O 0 1.181524877935658e-10
overall O 0 2.8586006894926186e-09
genetic O 0 4.217252680405181e-08
susceptibility O 0 3.500947968859691e-06
to O 0 4.737096787721384e-06
AS B-Disease 1 1.0
. O 0 1.9780025013460545e-06

Cell O 0 3.97307803723379e-06
cycle O 0 4.30677204121821e-07
- O 0 5.230255339938594e-09
dependent O 0 3.530742365143169e-09
colocalization O 0 4.1756557322969456e-08
of O 0 9.588733362875246e-09
BARD1 O 0 2.0376530301291496e-05
and O 0 1.881651501278725e-09
BRCA1 O 0 6.000678842710272e-10
proteins O 0 4.034975045058564e-12
in O 0 3.646846713500906e-12
discrete O 0 1.3388565811567332e-09
nuclear O 0 1.2774827382600051e-06
domains O 0 2.937134979674738e-07
. O 0 4.420662946813536e-08

Germ O 0 2.7035839593736455e-05
- O 0 1.5945050790833193e-07
line O 0 8.522611238959144e-08
mutations O 0 1.5067502801002775e-09
of O 0 3.515956137345455e-10
the O 0 2.6783925077822346e-10
BRCA1 O 0 3.5954644816982295e-10
gene O 0 2.894424283583774e-11
predispose O 0 2.715730085256496e-09
women O 0 5.403995935633621e-13
to O 0 8.31680835311488e-11
early O 0 1.267889501832542e-06
- O 0 5.331197098712437e-05
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 1.237331570536071e-08
compromising O 0 4.840538991857102e-08
the O 0 2.655655251260214e-09
genes O 0 4.5662079672936784e-10
presumptive O 0 2.8403555063505337e-09
function O 0 1.7982836053587192e-10
as O 0 2.6170947353687524e-11
a O 0 1.0978695730301524e-09
tumor B-Disease 0 2.8243932774785208e-06
suppressor O 0 6.843044047855074e-06
. O 0 1.7195472423736646e-07

Although O 0 2.794007514239638e-08
the O 0 8.621901415040156e-09
biochemical O 0 1.5709774814354205e-08
properties O 0 9.243442455897366e-09
of O 0 2.3437161544848095e-08
BRCA1 O 0 6.535033403309853e-09
polypeptides O 0 3.309222063041517e-10
are O 0 1.1481770395560531e-12
not O 0 1.3757964385796573e-11
understood O 0 4.132247669041966e-11
, O 0 1.5264323008704062e-12
their O 0 7.040212054824913e-13
expression O 0 4.128007397713462e-12
pattern O 0 9.81283804213362e-11
and O 0 1.2082751466024888e-11
subcellular O 0 3.11387466922497e-08
localization O 0 3.616004207174228e-08
suggest O 0 1.9550142060786868e-10
a O 0 8.957777575258064e-11
role O 0 6.337178698467838e-11
in O 0 8.448149818596207e-11
cell O 0 1.0868713040679268e-08
- O 0 5.185281537478659e-08
cycle O 0 1.7701059107366746e-07
regulation O 0 4.7660027036044994e-08
. O 0 5.4399640347924105e-09

When O 0 7.776281449878297e-07
resting O 0 2.9284356060088612e-06
cells O 0 3.892530742177769e-09
are O 0 1.1118723997061153e-10
induced O 0 2.5497243427707872e-08
to O 0 2.2227291118781523e-09
proliferate O 0 1.5630979843805903e-09
, O 0 1.1207056116457892e-11
the O 0 6.035594246611709e-11
steady O 0 6.229384785783054e-10
- O 0 2.9627640618645756e-11
state O 0 2.93411718532699e-11
levels O 0 2.6519689222403997e-10
of O 0 1.8114433564253574e-11
BRCA1 O 0 5.2227736024867966e-11
increase O 0 3.5122342534332773e-11
in O 0 1.4382352080122285e-11
late O 0 1.471670856290075e-07
G1 O 0 2.14281103971814e-09
and O 0 1.411261407215092e-12
reach O 0 9.380081433807419e-11
a O 0 2.0378067289161805e-11
maximum O 0 1.6309390504787302e-09
during O 0 2.112239050333642e-09
S O 0 4.0992017602548003e-07
phase O 0 2.061281065834919e-07
. O 0 1.4523680036404585e-08

Moreover O 0 2.7239312316851283e-07
, O 0 1.3168530710316873e-09
in O 0 1.6928478618893905e-09
S O 0 2.45760497818992e-06
phase O 0 7.151655267989554e-07
cells O 0 1.9367991654917205e-09
, O 0 6.206717778622917e-11
BRCA1 O 0 2.7560023707629e-10
polypeptides O 0 2.292008111082211e-10
are O 0 3.496158224036705e-12
hyperphosphorylated O 0 4.6193919800430194e-09
and O 0 5.4016825734581886e-11
accumulate O 0 1.7294848886351133e-10
into O 0 6.855105372238768e-11
discrete O 0 3.812847371165162e-09
subnuclear O 0 9.585186262484058e-07
foci O 0 4.167874578797637e-07
termed O 0 1.5046680346131325e-07
" O 0 3.7401363783828856e-08
BRCA1 O 0 2.997932924131419e-08
nuclear O 0 2.7730848159990273e-06
dots O 0 3.355957574058266e-07
. O 0 1.431677389973629e-07

" O 0 2.0216668417560868e-05
BRCA1 O 0 4.983602593711112e-06
associates O 0 3.459344952716492e-07
in O 0 3.4928178127557885e-09
vivo O 0 7.09189817982292e-09
with O 0 1.2030963031373076e-11
a O 0 1.5029852917791686e-08
structurally O 0 4.770722625835333e-07
related O 0 1.6593072871273762e-07
protein O 0 4.762976459460333e-06
termed O 0 2.9463410555763403e-06
BARD1 O 0 0.06439676880836487
. O 0 4.2045547843372333e-07

Here O 0 1.2081126499197126e-07
we O 0 1.1616422268545534e-09
show O 0 9.575801956929197e-11
that O 0 8.473816808830803e-13
the O 0 1.9758033750760795e-11
steady O 0 4.0965589254149393e-10
- O 0 5.636533254027576e-11
state O 0 9.833203695741588e-11
levels O 0 1.2343537303394214e-09
of O 0 1.9044264776280073e-10
BARD1 O 0 5.876287559658522e-06
, O 0 2.190718266514846e-11
unlike O 0 2.5043373624855647e-11
those O 0 2.3789772235494056e-11
of O 0 2.450678271426199e-10
BRCA1 O 0 1.210562317055519e-09
, O 0 2.4879263579857813e-11
remain O 0 3.1432781377738195e-10
relatively O 0 2.0364779307335823e-11
constant O 0 3.4931224579537457e-10
during O 0 7.668784718362076e-09
cell O 0 3.0370057402251405e-07
cycle O 0 4.647515936540003e-07
progression O 0 1.3858651470854966e-07
. O 0 1.0004213457648348e-08

However O 0 6.122516538198397e-08
, O 0 1.69354530399346e-09
immunostaining O 0 4.967469521943713e-06
revealed O 0 3.557974537216069e-08
that O 0 1.9543952567424583e-10
BARD1 O 0 3.5231580113759264e-05
resides O 0 1.753172940155423e-09
within O 0 1.6879534436853305e-09
BRCA1 O 0 3.3059242010580192e-09
nuclear O 0 2.4006442345125834e-07
dots O 0 1.0919052328972612e-09
during O 0 1.7195981305562213e-09
S O 0 4.953852439371076e-09
phase O 0 1.8952595048915555e-09
of O 0 2.6884789533498932e-11
the O 0 4.593293453925007e-11
cell O 0 2.103044127732545e-10
cycle O 0 3.6154487736972385e-10
, O 0 3.293047800591309e-13
but O 0 1.837432983542442e-12
not O 0 4.831602826160797e-11
during O 0 1.3903064255416098e-09
the O 0 8.755651204062076e-10
G1 O 0 3.5450973712158884e-08
phase O 0 1.6579865302901453e-07
. O 0 1.1115744769085723e-08

Nevertheless O 0 3.6385347357281717e-06
, O 0 1.1403225030903741e-08
BARD1 O 0 2.2036592781660147e-05
polypeptides O 0 5.4486868350522855e-09
are O 0 7.720198612337636e-12
found O 0 7.367082746796705e-13
exclusively O 0 1.9927682008875902e-13
in O 0 2.8292346763991727e-12
the O 0 2.989922198715078e-11
nuclear O 0 2.0066604378143893e-08
fractions O 0 7.840644800083396e-10
of O 0 5.542894962462519e-11
both O 0 2.670367225954262e-11
G1 O 0 1.1909785380126436e-09
- O 0 2.3733404130865665e-10
and O 0 7.332925239245114e-11
S O 0 3.3774753660509305e-08
- O 0 1.9748787050133387e-09
phase O 0 2.3969263907019922e-08
cells O 0 8.974576082287911e-10
. O 0 9.97005367153747e-10

Therefore O 0 6.423909582053966e-08
, O 0 4.090227045949746e-10
progression O 0 2.8546995878286907e-09
to O 0 9.665150901838615e-10
S O 0 1.1471139060859059e-07
phase O 0 5.3697743140901366e-08
is O 0 4.3395191953732315e-12
accompanied O 0 5.138505072832533e-12
by O 0 2.9629996373126133e-12
the O 0 1.6495181609510468e-10
aggregation O 0 3.865560649352062e-10
of O 0 2.126978038141658e-10
nuclear O 0 3.111150022050424e-07
BARD1 O 0 1.4599731912312564e-05
polypeptides O 0 1.0120808191516062e-08
into O 0 6.2021321411975805e-09
BRCA1 O 0 9.825864566437303e-09
nuclear O 0 7.416119274239463e-07
dots O 0 1.4009434323725145e-07
. O 0 1.7223234394236897e-08

This O 0 5.211954601236357e-08
cell O 0 1.1062786597904051e-07
cycle O 0 4.1096953395936e-08
- O 0 1.4472073539550934e-09
dependent O 0 2.655969222331578e-09
colocalization O 0 9.149096058536088e-08
of O 0 4.992067648146303e-09
BARD1 O 0 0.00011765020462917164
and O 0 2.6981445966356432e-09
BRCA1 O 0 4.631010686040327e-09
indicates O 0 1.3279834176760374e-10
a O 0 8.725500356965288e-12
role O 0 1.1176401817913906e-11
for O 0 9.573806157570086e-12
BARD1 O 0 8.49685602588579e-05
in O 0 2.2788546161223167e-08
BRCA1 O 0 3.444468177349336e-07
- O 0 1.3292565199662931e-06
mediated O 0 0.015296963974833488
tumor B-Disease 1 0.9999794960021973
suppression O 0 5.378412424761336e-06
. O 0 2.852279123999324e-08

Ethnic O 0 1.2185672915165924e-07
differences O 0 2.238442142754593e-08
in O 0 1.2395111603780151e-09
the O 0 7.918045774601978e-09
HFE O 0 2.082455694107921e-06
codon O 0 1.3161523781946016e-07
282 O 0 5.7021132704448974e-08
( O 0 1.1934139232394614e-09
Cys O 0 9.81170069280779e-06
/ O 0 6.890185773045232e-07
Tyr O 0 6.73029319386842e-07
) O 0 4.9811058056015156e-11
polymorphism O 0 1.2904552981751749e-08
. O 0 9.774926645889082e-09

Recent O 0 7.83413067750871e-09
studies O 0 5.410436335062663e-11
have O 0 9.211708002290764e-13
shown O 0 6.558586139460143e-12
that O 0 8.063130718660716e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 2.0912568743369775e-07
HH B-Disease 0 0.000624865002464503
) O 0 7.665004742030135e-11
is O 0 1.4270699205676252e-11
likely O 0 2.7392951795768283e-10
to O 0 3.552166616405117e-10
be O 0 3.1832733671244284e-10
caused O 0 1.5405325903827816e-09
by O 0 2.4109070642652775e-11
homozygosity O 0 1.9037857512671508e-08
for O 0 3.8309876104758445e-11
a O 0 1.5750750703702465e-09
Cys282Tyr O 0 1.9731895406494004e-07
mutation O 0 1.6831920301996206e-09
in O 0 1.5526911700813883e-10
the O 0 4.8750599113134285e-09
HFE O 0 8.167591659002937e-06
gene O 0 3.5821323685070183e-09
located O 0 6.827748144644374e-09
4 O 0 1.568909056004486e-06
. O 0 6.121395301761368e-08

5 O 0 7.369921149802394e-06
Mb O 0 4.081412498635473e-06
telomeric O 0 1.7450840914534638e-06
to O 0 1.7412673969374737e-07
HLA O 0 1.2228962305016466e-06
- O 0 3.034289974834792e-08
A O 0 3.339056604545476e-07
. O 0 1.803437754688275e-08

Population O 0 1.7817191055868875e-09
studies O 0 5.931976437834052e-11
of O 0 1.8481540950410213e-11
this O 0 7.280007326138094e-12
polymorphism O 0 5.50078038674684e-10
are O 0 3.4179655633570505e-12
facilitated O 0 3.2304540986682895e-11
by O 0 3.16767402239182e-12
the O 0 2.980106786343306e-11
fact O 0 1.642270846223537e-12
that O 0 9.757229746387708e-13
the O 0 1.2952131034360548e-10
Cys282Tyr O 0 2.803467680223548e-07
mutation O 0 6.6220366967684186e-09
creates O 0 4.489965621523595e-10
a O 0 4.505392059428459e-09
Rsal O 0 3.4598238016769756e-06
restriction O 0 9.113652765790903e-08
site O 0 2.125637799110791e-08
. O 0 4.494594474380165e-09

We O 0 4.611805692888993e-08
have O 0 7.774283994343989e-11
studied O 0 6.863010715285611e-10
the O 0 7.666554197038877e-11
codon O 0 1.6481540576762654e-09
282 O 0 9.20842424534385e-09
( O 0 9.729054228913014e-10
Cys O 0 5.469761617860058e-06
/ O 0 1.434375178632763e-07
Tyr O 0 1.3878379334641977e-08
) O 0 1.612731215933083e-13
polymorphism O 0 7.71062901028241e-13
in O 0 6.232094376147634e-14
different O 0 6.120385638184664e-14
ethnic O 0 1.2091489268173383e-11
groups O 0 1.2540586624698591e-11
. O 0 1.2943097704720685e-09

In O 0 7.883024899513202e-09
agreement O 0 1.0103414638251706e-07
with O 0 1.9661954009375648e-10
previous O 0 1.0787793769395648e-08
observations O 0 3.867834053039587e-09
the O 0 4.17765905202927e-10
Tyr O 0 6.3080620726907455e-09
allele O 0 6.450264211643741e-10
appeared O 0 1.8069547247367979e-10
to O 0 4.6361844918685335e-11
be O 0 4.806537459711713e-11
rare O 0 2.6120494656112214e-10
or O 0 1.274958894015299e-08
absent O 0 6.835960419948606e-08
in O 0 2.19610343799026e-10
Asiatic O 0 1.655946602063807e-09
( O 0 7.574703017598772e-12
Indian O 0 6.55125051429728e-11
, O 0 6.628067018843442e-12
Chinese O 0 5.221077910289029e-12
) O 0 8.809884245730704e-12
populations O 0 8.649812116567901e-11
. O 0 9.891409913365123e-10

The O 0 2.961706258020058e-08
highest O 0 1.5505561279383073e-08
allele O 0 1.038343785952911e-10
frequency O 0 9.544717238796352e-10
( O 0 6.0127714439361934e-12
7 O 0 1.7511477823362043e-09
. O 0 8.015740848854591e-12
5 O 0 1.5255905427835614e-09
% O 0 7.046022099110871e-11
) O 0 1.679777085657197e-12
was O 0 6.825479070826646e-10
found O 0 2.5434645709032644e-11
in O 0 1.0523663884765e-10
Swedes O 0 7.176374339223912e-08
. O 0 5.223698096301632e-08

Saamis O 0 5.382135714171454e-05
( O 0 3.2662252902326827e-09
2 O 0 4.828418127544865e-07
% O 0 1.101851276885668e-09
) O 0 1.6102485013783085e-12
and O 0 2.2729994969550305e-11
Mordvinians O 0 7.234964272129218e-08
( O 0 3.802675535569122e-11
1 O 0 1.2965566398293049e-08
. O 0 4.305487910638561e-11
8 O 0 5.7363958028133766e-09
% O 0 4.267389219769768e-11
) O 0 5.88744710535577e-13
had O 0 2.75538064586911e-11
significantly O 0 2.003551838325457e-11
lower O 0 1.3568876577885192e-10
frequencies O 0 1.2432159468556137e-10
of O 0 6.380648093218255e-11
the O 0 3.988297192503154e-10
Tyr O 0 2.0130208611135458e-07
allele O 0 4.2114731257925087e-08
. O 0 8.669376327929967e-09

Comparisons O 0 8.565205433797018e-09
with O 0 3.6202079528591113e-11
allele O 0 6.090202231412434e-10
frequencies O 0 2.888453087823706e-10
based O 0 4.214255333589989e-11
on O 0 3.386569247254556e-09
prevalence O 0 7.432642945559564e-09
estimates O 0 8.034897747144498e-10
of O 0 1.2973548901840104e-09
HH B-Disease 0 0.000377359741833061
showed O 0 1.5246168771909652e-08
some O 0 1.286767220554097e-10
disagreements O 0 1.5508872408531715e-08
with O 0 1.1471204194868356e-11
the O 0 1.0394162197613355e-09
RFLP O 0 1.1608345396041386e-08
data O 0 7.653112865657619e-11
, O 0 3.8496783885677566e-12
particularly O 0 2.4523041583512928e-11
in O 0 8.549662089407661e-10
Finns O 0 3.806788839710862e-08
. O 0 2.6653998119741118e-08

The O 0 2.29187122613439e-07
newly O 0 5.051628448882184e-08
described O 0 2.8037128174673853e-08
HFE O 0 8.215652087528724e-06
marker O 0 2.1317321241554055e-08
provides O 0 2.3523471365249904e-11
a O 0 4.337137940457758e-11
new O 0 6.414653096892264e-12
approach O 0 3.749315788392771e-11
to O 0 2.225450379533811e-11
the O 0 9.309423891490365e-12
screening O 0 6.476544300859643e-11
of O 0 1.4003391501926643e-10
HH B-Disease 0 2.7313890313962474e-06
as O 0 2.353209849204063e-10
well O 0 2.5325193331315887e-11
as O 0 1.6070828695591288e-11
studies O 0 1.6453003889860263e-11
of O 0 6.0246647080874904e-12
the O 0 3.290469025724052e-12
relationship O 0 2.3410540866963814e-11
between O 0 8.052986610884716e-10
the O 0 1.173841734924963e-08
HFE O 0 6.730390396114672e-06
Tyr O 0 7.327483331209805e-08
allele O 0 1.1426188883945088e-09
and O 0 9.999429236018376e-12
different O 0 1.0459208499291606e-10
disorders O 0 5.862568650627509e-05
including O 0 4.779785456321406e-08
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999754428863525
associated O 0 8.488554747998478e-09
with O 0 1.0868778967110249e-11
a O 0 6.858875689630395e-10
missense O 0 7.525365219862579e-09
mutation O 0 8.008076979315604e-10
encoding O 0 1.9139488605102173e-10
Gly23 O 0 1.672402731855982e-07
- O 0 3.6726959251609514e-08
- O 0 4.2050761095424605e-08
> O 0 5.01285164489218e-08
Val O 0 3.5276523924210323e-09
in O 0 1.7647601435744065e-10
neurophysin O 0 4.240426392243535e-07
II O 0 7.448124961229041e-05
. O 0 2.606776945413003e-07

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 6.56104859331208e-09
ADNDI B-Disease 1 0.9999966621398926
) O 0 1.0254517721075551e-11
is O 0 1.4132123422883058e-11
an O 0 7.073728269801904e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 7.531479695899179e-06
by O 0 4.535705699915127e-10
progressive O 0 0.02689458802342415
degeneration O 1 1.0
of O 0 1.8348995354244835e-06
the O 0 5.1298393088927696e-08
magnocellular O 0 1.52623744753555e-08
neurons O 0 4.899566530269794e-09
of O 0 3.851831209544798e-08
the O 0 1.3936232612365984e-08
hypothalamus O 0 2.574844160108114e-08
leading O 0 6.580235467623652e-09
to O 0 4.479463910911363e-09
decreased O 0 5.281521886502105e-09
ability O 0 3.725364461359959e-11
to O 0 7.552725111992231e-10
produce O 0 2.4825108635440074e-09
the O 0 6.156755105735101e-09
hormone O 0 7.213929453797618e-10
arginine O 0 6.838018151711367e-09
vasopressin O 0 2.6494337390658984e-08
( O 0 1.6516596978988218e-09
AVP O 0 5.067967663308082e-07
) O 0 1.445656233611814e-10
. O 0 1.7325297863024502e-09

Affected O 0 9.71378284475577e-08
individuals O 0 5.539311717650541e-11
are O 0 1.1416721734658353e-11
not O 0 2.967051881963556e-10
symptomatic O 0 9.43151121646224e-08
at O 0 8.465433687376844e-09
birth O 0 2.9128137679634847e-09
, O 0 4.016653763067035e-12
but O 0 1.0059476689139313e-11
usually O 0 3.16193204952242e-09
develop O 0 1.1692757652781438e-05
diabetes B-Disease 1 1.0
insipidus I-Disease 1 0.5163096785545349
at O 0 4.672772320191143e-07
1 O 0 3.991508492617868e-06
- O 0 1.0288797511748271e-06
6 O 0 2.349325086470344e-06
yr O 0 6.499322466879676e-07
of O 0 1.0044570730727287e-09
age O 0 6.232062421673845e-09
. O 0 1.6774808209163439e-09

The O 0 1.0802907013385266e-08
genetic O 0 1.8559486170133255e-09
locus O 0 3.5109450902126582e-09
of O 0 8.659902794860841e-10
the O 0 1.0083619272904798e-08
disease O 0 0.011571983806788921
is O 0 1.0292851293502991e-10
the O 0 4.796202990320353e-09
AVP O 0 2.3267782580660423e-06
- O 0 5.367776338971453e-07
neurophysin O 0 2.5461740733589977e-05
II O 1 0.9717954993247986
( O 0 5.754104304145358e-09
NPII O 0 5.345079262042418e-05
) O 0 1.4618270482991136e-10
gene O 0 2.2914475872326534e-11
, O 0 1.005713654717022e-11
and O 0 6.685867831590642e-11
mutations O 0 6.751482151123867e-10
that O 0 1.4698342543084664e-10
cause O 0 1.0104972716362681e-06
ADNDI B-Disease 0 0.009004811756312847
have O 0 2.4370219176006458e-09
been O 0 1.6221986254283394e-10
found O 0 1.4508035614882453e-12
in O 0 2.895210926470021e-13
both O 0 3.7405050844901977e-13
the O 0 1.1724212746477836e-11
signal O 0 2.0413089274473606e-10
peptide O 0 3.5565528300196547e-10
of O 0 1.4668326553390898e-09
the O 0 1.1282584866378897e-09
prepro O 0 1.6312312709487742e-06
- O 0 2.7840869734063745e-06
AVP O 0 1.681085336713295e-06
- O 0 2.50335734364171e-08
NPII O 0 6.597845185751794e-07
precursor O 0 4.666048103452169e-10
and O 0 5.2393037824893796e-12
within O 0 2.5083543575554756e-10
NPII O 0 1.9332503143232316e-05
itself O 0 3.864581987755855e-09
. O 0 6.588160239573426e-09

An O 0 1.234227386959219e-08
affected O 0 1.512858815999607e-08
girl O 0 1.1832807622624841e-08
who O 0 5.1555110874845766e-11
presented O 0 1.7231948507001604e-11
at O 0 3.3528058107634706e-10
9 O 0 1.758263201701027e-09
months O 0 1.7015353015459311e-10
of O 0 3.41562091110692e-11
age O 0 1.4053801178359748e-10
and O 0 2.1899899428634573e-12
her O 0 3.3861440127541664e-12
similarly O 0 7.260898046007602e-12
affected O 0 1.736154553455549e-10
younger O 0 3.1890767804299003e-10
brother O 0 1.0888258294983189e-08
and O 0 9.316876159459753e-10
father O 0 3.2818260109479525e-08
were O 0 3.998442688057935e-10
all O 0 5.387613966068017e-12
found O 0 7.109870418103847e-13
to O 0 2.2339504378299235e-12
have O 0 4.1952517306452497e-13
a O 0 2.3456890943518438e-11
novel O 0 8.762751635416066e-10
missense O 0 8.877237434035123e-08
mutation O 0 8.233810078195347e-09
( O 0 3.025593317551589e-11
G1758 O 0 7.419614433956667e-08
- O 0 2.79990786111739e-08
- O 0 1.1790895371177612e-07
> O 0 4.009244847225091e-08
T O 0 1.5487463533858659e-09
) O 0 2.557842718013681e-13
encoding O 0 2.202141247131806e-12
the O 0 6.471987529232948e-11
amino O 0 5.632620758699858e-11
acid O 0 9.184992176558548e-12
substitution O 0 9.72731790949144e-12
Gly23 O 0 6.339530678189931e-09
- O 0 2.8471898172455212e-09
- O 0 1.2889007194871738e-08
> O 0 5.001420078087904e-08
Val O 0 7.59256391091867e-09
within O 0 2.4242541307728516e-09
NPII O 0 3.181947977282107e-05
. O 0 2.9364731091163776e-08

The O 0 7.347032919824414e-07
mutation O 0 2.0772173314753672e-08
was O 0 1.6176173733839505e-09
confirmed O 0 2.4035424692203655e-11
by O 0 5.6763400403669895e-12
restriction O 0 1.3018488509430881e-09
endonuclease O 0 1.453976210541441e-07
analysis O 0 3.979590879055195e-09
. O 0 5.916626744095765e-09

A O 0 0.00012017852714052424
T1 O 0 0.0002940479898825288
- O 0 2.3274523641703126e-07
weighted O 0 9.169339953984945e-09
magnetic O 0 3.645934221196967e-09
resonance O 0 4.860758462399417e-10
imaging O 0 7.806044699520953e-09
of O 0 1.9410557605681333e-09
the O 0 1.6209755315799157e-08
fathers O 0 3.285239813521912e-07
pituitary O 0 9.143161150859669e-06
gland O 0 2.675516043382231e-06
demonstrates O 0 8.118225203190832e-09
an O 0 1.4423491290216361e-09
attenuated O 0 2.6925865768134827e-06
posterior O 0 0.00483579421415925
pituitary O 1 0.997856080532074
bright O 0 6.276631029322743e-05
spot O 0 6.1006929172435775e-05
. O 0 2.895343413911178e-07

This O 0 1.3785729890969378e-07
mutation O 0 5.414253934077351e-08
may O 0 9.600445771695831e-09
be O 0 9.886123170099737e-11
valuable O 0 1.3559891924586065e-11
for O 0 1.0341643990816052e-12
developing O 0 2.7062439095226765e-11
models O 0 6.499400323489724e-11
of O 0 3.6939526992796345e-09
dominantly B-Disease 0 3.8073940231697634e-05
inherited I-Disease 0 0.46773862838745117
neurodegeneration I-Disease 1 1.0
, O 0 1.32072103253833e-10
as O 0 2.6120269142060337e-12
the O 0 1.2552641218133154e-12
early O 0 2.668956895768293e-11
age O 0 6.62612326118861e-11
of O 0 1.1091584248279496e-11
onset O 0 0.00021094396652188152
of O 0 6.987786349554881e-08
symptoms O 0 0.0016565195983275771
suggests O 0 3.047900543062809e-10
that O 0 6.079820241006173e-12
this O 0 9.964991332100936e-11
mutation O 0 2.0467991745931613e-09
may O 0 3.0889806268419306e-09
be O 0 4.727636615520225e-10
particularly O 0 1.1448106351785725e-10
deleterious O 0 1.0637354819209577e-07
to O 0 1.5789380469755088e-08
the O 0 1.7501536220265734e-08
magnocellular O 0 3.719917174294096e-07
neuron O 0 2.3759412215440534e-07
. O 0 1.6862230722836102e-08
. O 0 2.983808045087244e-08

Frequent O 0 1.4502427347906632e-07
inactivation O 0 8.650945346744265e-06
of O 0 2.5540668957546586e-07
PTEN O 0 0.03760889545083046
/ O 0 5.102555587654933e-05
MMAC1 O 1 0.9973690509796143
in O 0 1.2968439477845095e-07
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.4461927750962786e-05

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 3.509043835947523e-06
the O 0 1.233756652396778e-08
most O 0 7.912975830137725e-12
common O 0 5.756307652760029e-10
male B-Disease 0 2.1191545740428808e-10
cancer I-Disease 0 5.307978501178923e-10
in O 0 4.5630777802119216e-12
the O 0 1.0365786701216351e-10
Western O 0 3.81750453470886e-09
world O 0 1.980527200573512e-11
, O 0 1.2416460004258112e-12
yet O 0 9.367132070003947e-12
many O 0 2.767101597769134e-13
of O 0 7.906851388905789e-12
the O 0 2.2458415335768755e-11
major O 0 2.626382167303376e-10
genetic O 0 7.532738321991417e-11
events O 0 6.054681495754055e-13
involved O 0 3.1000900631295014e-12
in O 0 1.4244131048279929e-11
the O 0 2.8128641083036143e-10
progression O 0 2.530624154672978e-09
of O 0 3.69013222756287e-11
this O 0 1.7653391248817485e-10
often O 0 1.686682971069331e-08
fatal O 1 0.9129418134689331
cancer B-Disease 1 0.9874420762062073
remain O 0 2.8208022584408354e-08
to O 0 6.318755296774725e-09
be O 0 1.1437271574266106e-08
elucidated O 0 5.611611300082586e-07
. O 0 4.288660093720864e-08

Numerous O 0 4.670771502901516e-08
cytogenetic O 0 8.375340257771313e-06
and O 0 2.5241178036594647e-08
allelotype O 0 1.0496387403691188e-05
studies O 0 2.042739311036712e-09
have O 0 2.9072662680040828e-11
reported O 0 2.522002606752949e-10
frequent O 0 1.0194827620990665e-10
loss O 0 1.5178605594634575e-10
of O 0 5.213440790186041e-10
heterozygosity O 0 3.049142094369017e-08
on O 0 3.113684954314522e-07
chromosomal O 0 1.9806699128821492e-05
arm O 0 2.4115048290695995e-05
10q O 0 0.0019485485972836614
in O 0 1.9544910401236848e-07
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.006401455495506525

Deletion O 0 4.001104116468923e-06
mapping O 0 8.516956029325229e-08
studies O 0 1.4218168864488234e-09
have O 0 2.5624157309889206e-11
unambiguously O 0 7.419777570127906e-10
identified O 0 6.405009855825483e-11
a O 0 4.3540965971589074e-11
region O 0 5.468875574621279e-09
of O 0 2.2705505031694884e-08
chromosome O 0 6.458989446400665e-06
10q23 O 0 3.6334483866085066e-06
to O 0 2.147680033814936e-09
be O 0 8.626086650531661e-11
the O 0 9.099847958493612e-11
minimal O 0 7.318163852687576e-09
area O 0 1.62638276179905e-08
of O 0 3.8698115822910495e-09
loss O 0 8.551888441843403e-08
. O 0 1.3925529174230178e-07

A O 0 4.1580028664611746e-06
new O 0 3.103995638298329e-08
tumor B-Disease 0 3.236417285279458e-07
suppressor O 0 9.307576931405492e-08
gene O 0 6.31731778000244e-10
, O 0 5.2816979956293864e-11
PTEN O 0 2.1161451968509937e-06
/ O 0 1.2078412510163616e-06
MMAC1 O 1 0.9827143549919128
, O 0 2.576680202537318e-09
was O 0 1.0418208518103711e-07
isolated O 0 2.334017601413052e-08
recently O 0 9.004250817179482e-11
at O 0 6.238942695802052e-11
this O 0 1.437153998237739e-12
region O 0 5.942647485213115e-10
of O 0 9.89552328967136e-10
chromosome O 0 2.5419609528398723e-07
10q23 O 0 2.1226373974059243e-06
and O 0 2.1029079866341505e-10
found O 0 1.5082064069860124e-11
to O 0 4.245680196302004e-11
be O 0 5.633316296077551e-12
inactivated O 0 1.282038451094758e-11
by O 0 2.0854069339437675e-12
mutation O 0 4.752545024189203e-10
in O 0 1.4275342019587356e-09
three O 0 1.7852939890872221e-06
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.0005871247849427164
lines O 0 1.592209031286984e-07
. O 0 7.029012039083682e-08

We O 0 4.4766812834495795e-07
screened O 0 1.0028821861851611e-06
80 O 0 1.3968107168693678e-06
prostate B-Disease 0 0.16296081244945526
tumors I-Disease 1 1.0
by O 0 3.006416227080422e-10
microsatellite O 0 4.8726609414018185e-09
analysis O 0 3.411473534220555e-11
and O 0 6.13594852011401e-12
found O 0 2.0820178914249254e-11
chromosome O 0 1.8214832309126905e-08
10q23 O 0 1.1642230646202734e-07
to O 0 2.389120012935564e-09
be O 0 3.8325534412742e-10
deleted O 0 4.818812016083029e-10
in O 0 4.478365595028677e-11
23 O 0 5.095394328691327e-09
cases O 0 1.0371957459565095e-10
. O 0 4.61225235781626e-09

We O 0 3.0723359856210664e-08
then O 0 3.8751721276319984e-10
proceeded O 0 7.203146412670947e-11
with O 0 7.904802843110986e-15
sequence O 0 2.50901079426602e-13
analysis O 0 1.4049277420689205e-13
of O 0 1.7004694093797346e-12
the O 0 6.335535568391393e-11
entire O 0 1.2565649853968353e-08
PTEN O 0 2.9300665119080804e-05
/ O 0 1.6040190757848904e-06
MMAC1 O 0 6.628080882364884e-05
coding O 0 3.97418453701448e-08
region O 0 1.422294992892148e-08
and O 0 4.385802832018726e-11
tested O 0 4.2477372313998174e-11
for O 0 1.0611598405541045e-11
homozygous O 0 6.557401149853703e-11
deletion O 0 7.644159749631285e-10
with O 0 5.072034914462009e-13
new O 0 1.1005547861930864e-10
intragenic O 0 2.8587146516656503e-07
markers O 0 1.8257882983263585e-09
in O 0 8.035782456117246e-11
these O 0 5.095989168840687e-12
23 O 0 4.3197204147027435e-10
cases O 0 1.957691387471927e-12
with O 0 3.1022372171118917e-12
10q23 O 0 1.729492396407295e-05
loss O 0 9.2134165186053e-08
of O 0 2.6915060402643576e-07
heterozygosity O 0 7.4875360951409675e-06
. O 0 4.612984980667534e-07

The O 0 2.2821287082308572e-09
identification O 0 5.923982832056751e-11
of O 0 1.0857885424098157e-10
the O 0 1.242701497261578e-10
second O 0 1.7644379290970846e-09
mutational O 0 2.5713795537285478e-08
event O 0 5.698008731513937e-10
in O 0 2.2258972443012226e-10
10 O 0 7.518406341944228e-09
( O 0 2.6270685626883505e-10
43 O 0 3.8888558151484176e-07
% O 0 6.401428720437252e-08
) O 0 5.488230669925542e-08
tumors B-Disease 1 1.0
establishes O 0 7.072981134115253e-06
PTEN O 0 0.0012181282509118319
/ O 0 1.3149912774679251e-05
MMAC1 O 0 8.520207484252751e-05
as O 0 1.1265397642512553e-10
a O 0 2.8562922860242423e-11
main O 0 1.978296831905979e-10
inactivation O 0 5.19252085773303e-10
target O 0 1.3573017709767043e-10
of O 0 1.205430616435521e-10
10q O 0 6.35025890005636e-06
loss O 0 8.653702110450467e-08
in O 0 3.751725614620227e-07
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0201326833557687e-07
. O 0 6.4537872823677844e-09

Risk O 0 1.6280113413813524e-05
reversals O 0 2.047373044433698e-07
in O 0 7.110392830078638e-11
predictive O 0 3.378543000920331e-09
testing O 0 3.814658811052141e-09
for O 0 4.561057309615535e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 5.260241664473142e-07

The O 0 8.28311375045132e-09
first O 0 9.814316026535153e-11
predictive O 0 3.26220134239108e-10
testing O 0 7.153381775815149e-10
for O 0 2.6951407772202174e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.651625030658522e-10
HD B-Disease 0 1.4738591858076688e-07
) O 0 6.3228688777783315e-12
was O 0 4.0550902913327747e-11
based O 0 3.4865422181284966e-12
on O 0 1.5874762615553095e-10
analysis O 0 5.465248479469276e-12
of O 0 1.4740784981537303e-11
linked O 0 8.595149592061091e-10
polymorphic O 0 3.178607654863441e-10
DNA O 0 6.25036800094847e-10
markers O 0 1.2930403275879243e-11
to O 0 1.7644597588573063e-11
estimate O 0 1.6190981888541955e-10
the O 0 2.5861557687023584e-11
likelihood O 0 7.703422899574264e-10
of O 0 1.0243580428337395e-09
inheriting O 0 2.438813417882102e-08
the O 0 1.0939321448688588e-08
mutation O 0 5.872102248893896e-10
for O 0 1.3199386028617255e-09
HD B-Disease 0 7.380337046924978e-05
. O 0 4.346801176779991e-07

Limits O 0 1.0986330778450792e-07
to O 0 3.271144022320982e-09
accuracy O 0 2.079459937576189e-09
included O 0 4.811423828798844e-12
recombination O 0 1.3257429876123439e-11
between O 0 3.3860378390038193e-10
the O 0 1.0115939197419266e-09
DNA O 0 3.263458669966468e-10
markers O 0 3.0679920409726336e-11
and O 0 9.17488914703446e-12
the O 0 2.0997936722721988e-10
mutation O 0 5.028139571372492e-10
, O 0 2.1856846194046042e-11
pedigree O 0 3.153727001770079e-10
structure O 0 1.7483635372794737e-10
, O 0 5.22062219843189e-11
and O 0 7.964340992261398e-11
whether O 0 3.620493349565379e-10
DNA O 0 1.8075752006296852e-10
samples O 0 9.038655783034921e-13
were O 0 8.164542447067907e-14
available O 0 2.555965150901479e-13
from O 0 3.779716470364569e-11
family O 0 7.622141806606919e-11
members O 0 9.271507173114202e-11
. O 0 3.6462264318970483e-09

With O 0 4.626520694328562e-11
direct O 0 1.6088849141837613e-09
tests O 0 5.8399986235802e-11
for O 0 7.0941603286245325e-12
the O 0 2.2574164759703308e-10
HD B-Disease 0 5.910853815294104e-07
mutation O 0 3.831773565110552e-09
, O 0 5.871293728976212e-11
we O 0 5.4205799571160895e-11
have O 0 7.035705351654542e-12
assessed O 0 1.400932814199507e-09
the O 0 8.778253818286785e-11
accuracy O 0 7.341116048387164e-10
of O 0 6.982874001248973e-11
results O 0 1.593299624180755e-11
obtained O 0 2.359014719677255e-11
by O 0 2.322778254459923e-11
linkage O 0 1.1748602091188332e-09
approaches O 0 5.81724446391263e-10
when O 0 3.827757121682707e-12
requested O 0 4.779358853124194e-11
to O 0 1.7560670972915915e-10
do O 0 1.9770360695781086e-11
so O 0 2.8104035483360323e-13
by O 0 3.043683740374531e-13
the O 0 1.1004954759974428e-11
test O 0 1.082415580777596e-11
individuals O 0 5.615658112134714e-12
. O 0 8.027640774344036e-09

For O 0 1.6289867232899269e-09
six O 0 2.07937972396266e-10
such O 0 1.3531929483195926e-12
individuals O 0 4.871733658845523e-12
, O 0 2.400262280599641e-11
there O 0 2.067538154570947e-11
was O 0 1.4379677448772554e-09
significant O 0 8.91152707183096e-11
disparity O 0 8.117354566294921e-10
between O 0 1.6048056217243811e-09
the O 0 8.227059922205626e-09
tests O 0 2.129150633578547e-09
. O 0 3.0379019300141863e-09

Three O 0 2.4972436563075462e-08
went O 0 1.0914061654432317e-08
from O 0 1.666064647354304e-10
a O 0 7.236047316894201e-10
decreased O 0 1.1193955984367676e-08
risk O 0 1.7233270366290299e-10
to O 0 4.8031554428229484e-11
an O 0 6.656267984711528e-12
increased O 0 2.052459036061549e-10
risk O 0 1.1277442313328834e-09
, O 0 2.1981546357435766e-12
while O 0 2.6855614086718216e-12
in O 0 4.323986047688466e-12
another O 0 3.117114552586564e-11
three O 0 1.589575172877833e-11
the O 0 4.397831751545844e-11
risk O 0 7.573743299182922e-10
was O 0 1.3446871172106967e-08
decreased O 0 2.2248256570378544e-08
. O 0 9.680173107540213e-09

Knowledge O 0 1.03826991448841e-07
of O 0 1.2362158408052437e-08
the O 0 1.2291523354690526e-09
potential O 0 3.7838013278168603e-10
reasons O 0 3.0123899902312345e-11
for O 0 1.036583579389072e-12
these O 0 2.0035575032818081e-13
changes O 0 9.890394709818895e-13
in O 0 1.525192515686169e-12
results O 0 2.0106151119025917e-11
and O 0 1.3736254321494723e-11
impact O 0 2.6652560158879623e-09
of O 0 4.2789813359256357e-10
these O 0 1.0774062197960177e-11
risk O 0 2.1462048804821166e-10
reversals O 0 4.833273226090284e-10
on O 0 7.588332739949522e-10
both O 0 3.0939940279944844e-12
patients O 0 5.0546346622160065e-12
and O 0 9.738432933323327e-13
the O 0 5.738852448811116e-11
counseling O 0 1.8750039715298428e-11
team O 0 5.636997148900612e-14
can O 0 4.0606748649349433e-13
assist O 0 9.89870338474752e-12
in O 0 1.3199623685733464e-11
the O 0 1.2327767973108195e-10
development O 0 9.597690003859682e-11
of O 0 3.370172890759804e-11
strategies O 0 5.193169679007514e-12
for O 0 1.2508283254650254e-12
the O 0 7.106244065413492e-11
prevention O 0 6.603879249000855e-11
and O 0 1.0820572817751492e-13
, O 0 1.7574146077194847e-13
where O 0 1.6074315272937567e-12
necessary O 0 1.8449781979956725e-10
, O 0 6.573179500701798e-11
management O 0 7.356730225005492e-10
of O 0 3.7091935078947813e-10
a O 0 1.1086926932080132e-08
risk O 0 1.89683362350479e-08
reversal O 0 1.5642133144311288e-09
in O 0 1.669636304213462e-11
any O 0 3.196578071684719e-11
predictive O 0 1.324141490899322e-10
testing O 0 2.3448168753881227e-11
program O 0 3.3615300213535315e-12
. O 0 3.127558542009856e-12
. O 0 4.080650262139329e-10

A O 0 8.920467564621504e-08
novel O 0 2.6229041161229816e-09
common O 0 5.437132077901197e-09
missense O 0 5.998545020702295e-07
mutation O 0 4.567013789369412e-08
G301C O 0 2.8235456284164684e-07
in O 0 1.3373449569975548e-10
the O 0 8.240153004379636e-10
N O 0 4.6411290810510764e-08
- O 0 3.363588874094603e-08
acetylgalactosamine O 0 6.215896064531989e-07
- O 0 1.3756468320025306e-07
6 O 0 1.8080534402997728e-07
- O 0 6.600171520432241e-09
sulfate O 0 2.9659783518098948e-09
sulfatase O 0 2.6572615219322415e-09
gene O 0 1.813216590762501e-11
in O 0 7.009321595363716e-11
mucopolysaccharidosis B-Disease 0 5.897250048292335e-06
IVA I-Disease 1 0.9992484450340271
. O 0 1.8459659258951433e-06

Mucopolysaccharidosis B-Disease 1 0.998786985874176
IVA I-Disease 1 1.0
( O 0 4.326084308559075e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.6065799518804056e-10
is O 0 1.731471771515558e-10
an O 0 1.735467591856832e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999963045120239
by O 0 1.4207143017586077e-08
a O 0 0.0003583338111639023
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.189415055335985e-08
N O 0 6.55662262261103e-08
- O 0 9.077460561002226e-09
acetylgalactosamine O 0 4.338021497574118e-08
- O 0 2.0790048793628557e-08
6 O 0 5.807738645557947e-08
- O 0 4.32077751355564e-09
sulfate O 0 3.27270432975979e-09
sulfatase O 0 2.10825525925884e-08
( O 0 2.1321680532260245e-11
GALNS O 0 9.601645842849393e-07
) O 0 1.1527183374493433e-10
. O 0 1.9708183973676796e-09

In O 0 6.134438734761716e-08
previous O 0 6.094170146297984e-08
studies O 0 1.0496225000267145e-09
, O 0 1.5353652377259053e-11
we O 0 2.0934023611807184e-11
have O 0 1.1284052034779557e-12
found O 0 3.2038260933120455e-13
two O 0 1.0725293808459824e-13
common O 0 4.098438602384569e-12
mutations O 0 1.0018920588994451e-11
in O 0 2.4629543196597048e-11
Caucasians O 0 2.2416142553272067e-10
and O 0 1.502326561764189e-11
Japanese O 0 5.551036519335639e-09
, O 0 8.167014980964282e-11
respectively O 0 6.204096347772747e-09
. O 0 1.7762705084578556e-08

To O 0 1.2495151224811707e-07
characterize O 0 1.0043391540648372e-07
the O 0 2.016150801864569e-09
mutational O 0 1.456593157200814e-08
spectrum O 0 1.3185343927801796e-09
in O 0 7.490464954025555e-13
various O 0 1.1340836039361313e-13
ethnic O 0 4.469949150404107e-12
groups O 0 3.5885327370234477e-13
, O 0 2.6668487296960253e-12
mutations O 0 1.1550285901329449e-11
in O 0 1.0495875002458632e-11
the O 0 2.0259102728736877e-10
GALNS O 0 2.0514924017334124e-06
gene O 0 4.166500477964519e-11
in O 0 1.1938094957031353e-10
Colombian O 0 1.3414360182650853e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 2.239526786240731e-08
were O 0 2.2200163929397831e-10
investigated O 0 2.915431673855551e-09
, O 0 6.164927596197245e-11
and O 0 1.5817758214353717e-10
genetic O 0 2.281027811079639e-09
backgrounds O 0 1.7793001794164098e-10
were O 0 8.920267996481712e-11
extensively O 0 7.140587600373838e-12
analyzed O 0 2.2133433974502736e-11
to O 0 2.3964425929778876e-11
identify O 0 1.4222385422146822e-11
racial O 0 1.1490628760990607e-11
origin O 0 1.2279928593081357e-12
, O 0 1.640529346483982e-13
based O 0 3.4511586297081287e-12
on O 0 3.7952090359283375e-09
mitochondrial O 0 5.637363909016813e-10
DNA O 0 7.307085492236354e-10
( O 0 1.2707229365971351e-11
mtDNA O 0 7.280288177868854e-11
) O 0 2.3848834365680638e-11
lineages O 0 3.7949754450039563e-10
. O 0 5.951676373960879e-10

Three O 0 1.669071991727833e-08
novel O 0 1.2091484258291985e-08
missense O 0 2.5206547888956266e-06
mutations O 0 2.549705584442563e-07
never O 0 1.7126531304256787e-08
identified O 0 1.0804611649817275e-09
previously O 0 6.006630609567409e-11
in O 0 2.8044504652574576e-12
other O 0 6.413439115719732e-13
populations O 0 3.1093103352447526e-12
and O 0 1.4084861749141808e-12
found O 0 4.955120515293121e-12
in O 0 6.22979489176001e-12
16 O 0 2.786171293678308e-10
out O 0 2.4117613288410222e-12
of O 0 1.987387684976305e-11
19 O 0 3.327673914199636e-09
Colombian O 0 9.463375363338855e-07
MPS B-Disease 1 0.9999996423721313
IVA I-Disease 1 0.9999998807907104
unrelated O 0 1.853189490752527e-09
alleles O 0 1.1660030579951908e-11
account O 0 1.1260746024879809e-12
for O 0 3.540935600288009e-11
84 O 0 6.046179379382011e-08
. O 0 2.3609267429947067e-08

2 O 0 1.479211732657859e-06
% O 0 2.578602664726759e-09
of O 0 1.7892820558529365e-10
the O 0 2.0907378606160876e-10
alleles O 0 3.179740151737498e-11
in O 0 2.703669579884327e-11
this O 0 1.167445723426752e-10
study O 0 8.42419523028326e-10
. O 0 5.217262621926011e-09

The O 0 2.0238773856817716e-07
G301C O 0 4.7940197873685975e-06
and O 0 3.884416788224598e-09
S162F O 0 2.5859285415208433e-06
mutations O 0 8.70015004483804e-10
account O 0 3.2488990664436557e-11
for O 0 1.3880693816581413e-10
68 O 0 1.4005988191456709e-07
. O 0 1.5279004728085965e-08

4 O 0 3.0975249956100015e-06
% O 0 1.1654534226579472e-08
and O 0 5.185553098030482e-10
10 O 0 3.928341030245974e-08
. O 0 1.712391828334603e-08

5 O 0 8.976506933322526e-07
% O 0 5.668623792587368e-09
of O 0 8.475301016552805e-10
mutations O 0 3.5130534592475726e-10
, O 0 2.278307924263867e-11
respectively O 0 4.195105929305498e-10
, O 0 1.764530188630431e-11
whereas O 0 2.6400984176611075e-10
the O 0 9.866932826341213e-10
remaining O 0 1.8585851080388238e-08
F69V O 0 1.2791005019607837e-06
is O 0 1.6955669507323634e-11
limited O 0 3.0461074201210137e-12
to O 0 5.96621085868776e-11
a O 0 5.327665530963088e-10
single O 0 2.017297218159797e-09
allele O 0 8.201087808856755e-08
. O 0 6.028515286971015e-08

The O 0 7.160404891237704e-08
skewed O 0 6.547474384888119e-08
prevalence O 0 5.276560699485344e-08
of O 0 4.875094772316402e-10
G301C O 0 2.3136163918024977e-07
in O 0 1.747753330949564e-10
only O 0 3.1965308178172336e-10
Colombian O 0 5.943945780018112e-08
patients O 0 2.1008993156268474e-10
and O 0 8.925471473020252e-12
haplotype O 0 1.8629948972392896e-10
analysis O 0 6.992676294774458e-13
by O 0 3.343923445434105e-13
restriction O 0 3.859178948628639e-11
fragment O 0 2.956792588548751e-10
length O 0 4.549733645387022e-10
polymorphisms O 0 9.582951099318393e-10
in O 0 8.351478536505752e-11
the O 0 1.4449981211583918e-09
GALNS O 0 0.00013500692148227245
gene O 0 5.437648109563042e-10
suggest O 0 1.3505462026497383e-10
that O 0 7.542654868741838e-12
G301C O 0 4.934437924930535e-08
originated O 0 4.997080440410917e-12
from O 0 1.7460288857101824e-12
a O 0 2.6587645279851913e-11
common O 0 2.1154918095067643e-10
ancestor O 0 1.315666242618363e-08
. O 0 6.9487358089759255e-09

Investigation O 0 8.221147709264187e-07
of O 0 3.190199748814848e-08
the O 0 5.4256434900423756e-09
genetic O 0 4.273484066619204e-10
background O 0 1.1095852969073006e-12
by O 0 2.2500592968682787e-12
means O 0 2.3680239991108465e-09
of O 0 5.513786760502626e-09
mtDNA O 0 1.341660893494634e-09
lineages O 0 8.530957884556045e-11
indicate O 0 5.0033012455319437e-11
that O 0 3.5198979148054477e-12
all O 0 1.7134411944841332e-11
our O 0 4.7622513571488057e-11
patients O 0 7.699786988557555e-12
are O 0 3.0905949999736337e-13
probably O 0 3.750175725514282e-10
of O 0 3.9629022285936344e-10
native O 0 5.830908533788204e-10
American O 0 2.2338230820651006e-08
descent O 0 7.05272686900571e-05

Low O 0 3.1270525369109237e-07
frequency O 0 9.294534031312196e-09
of O 0 3.6322467256155733e-09
BRCA1 O 0 3.3504630181369066e-08
germline O 0 9.05631409864327e-08
mutations O 0 2.459650538799707e-10
in O 0 3.282670793178233e-12
45 O 0 5.131088887111446e-09
German O 1 0.9999635219573975
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.286631601260524e-07
. O 0 2.851952629612242e-08

In O 0 4.348722715263875e-09
this O 0 8.27004992265401e-11
study O 0 1.6864940000083095e-11
we O 0 2.0012136479202747e-12
investigated O 0 6.632015769891808e-11
45 O 0 8.547840657513461e-09
German O 1 0.9933618307113647
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.943792125151504e-10
for O 0 1.8281953728660483e-10
germline O 0 4.7263792879448374e-08
mutations O 0 1.2043327446420449e-09
in O 0 2.1251572723812728e-10
the O 0 3.3829148371467e-09
BRCA1 O 0 1.1486525508530576e-08
gene O 0 5.230215371909708e-09
. O 0 6.693516851896675e-09

We O 0 1.2370366953007306e-08
identified O 0 4.48248715922972e-10
four O 0 7.448274635946106e-11
germline O 0 1.9306110488059858e-08
mutations O 0 6.166870902823973e-10
in O 0 1.9609146251209353e-10
three O 0 1.1620544526635967e-09
breast B-Disease 0 0.013386258855462074
cancer I-Disease 1 0.8175172805786133
families O 0 2.856348213509108e-10
and O 0 1.217176498480299e-10
in O 0 3.253778402267926e-08
one O 1 0.9998880624771118
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 5.833561544932309e-07
. O 0 4.91850345174516e-11
among O 0 6.390028751360882e-14
these O 0 4.0196768439845765e-14
were O 0 1.760099119403613e-12
one O 0 4.529078934806252e-12
frameshift O 0 4.718369694955982e-09
mutation O 0 1.3180768698717316e-09
, O 0 2.7906746358219436e-11
one O 0 1.7346285519082016e-10
nonsense O 0 3.4399015191866056e-08
mutation O 0 2.8458324585756145e-09
, O 0 1.2234626506346657e-11
one O 0 7.671465893088758e-12
novel O 0 5.486390855513612e-11
splice O 0 1.6675693048640028e-09
site O 0 1.8191063932970764e-10
mutation O 0 5.947826259289357e-11
, O 0 3.3126351054596492e-12
and O 0 5.975366035304575e-11
one O 0 7.037111338092927e-09
missense O 0 2.194758599216584e-05
mutation O 0 3.80860292352736e-05
. O 0 1.0509451158213778e-06

The O 0 2.482134107140155e-07
missense O 0 1.484010226704413e-06
mutation O 0 7.267451707093642e-08
was O 0 1.235376689834311e-08
also O 0 1.67119113686498e-11
found O 0 1.3271547055770938e-11
in O 0 8.77172709468077e-11
2 O 0 4.946056151311495e-07
. O 0 4.1037811371325006e-08

8 O 0 2.3046150090522133e-06
% O 0 1.4390276525944046e-08
of O 0 5.09937814197059e-10
the O 0 2.0681859003168768e-10
general O 0 3.2263502980356407e-09
population O 0 5.944817554892623e-12
, O 0 3.1085691746396416e-12
suggesting O 0 5.337508560132598e-11
that O 0 8.46142925690907e-13
it O 0 2.2283587735455468e-12
is O 0 3.2398767696451e-11
not O 0 7.604869622923616e-09
disease O 0 2.0139993921475252e-06
associated O 0 4.132521524979893e-08
. O 0 1.6346855602478172e-07

The O 0 4.606994341571635e-09
average O 0 4.434408840126025e-09
age O 0 3.385085278750921e-08
of O 0 7.802769985687519e-09
disease O 0 0.01586690917611122
onset O 0 3.694271435961127e-05
in O 0 7.18118411957569e-11
those O 0 7.17466711042114e-11
families O 0 4.7495157112775743e-11
harbouring O 0 1.976424357508222e-08
causative O 0 2.9634563691871563e-09
mutations O 0 1.3712498914131288e-09
was O 0 2.0270398692900926e-09
between O 0 8.316864530399926e-09
32 O 0 3.0148751761771564e-07
. O 0 1.8778914423478454e-08

3 O 0 6.237158231670037e-06
and O 0 9.54242818096418e-09
37 O 0 1.135150000663998e-06
. O 0 2.7630633780972857e-08

4 O 0 1.0008851859311108e-05
years O 0 8.439783094615905e-09
, O 0 3.4701901074907227e-11
whereas O 0 1.7655107931169312e-10
the O 0 1.1429932000872611e-10
family O 0 7.516434696874796e-11
harbouring O 0 5.0198818435376324e-09
the O 0 1.3040160062871564e-09
missense O 0 2.298647316933966e-08
mutation O 0 2.7593911600121146e-09
had O 0 1.6033759042688445e-10
an O 0 1.5294630796233721e-12
average O 0 2.8842124868977415e-11
age O 0 5.341523889867972e-10
of O 0 1.7213207526012297e-09
onset O 0 0.00022394611733034253
of O 0 5.291860247780278e-07
51 O 0 3.6638280107581522e-06
. O 0 1.4819352145423181e-07

2 O 0 7.261034625116736e-05
years O 0 2.768033198208286e-07
. O 0 7.321992967490587e-08

These O 0 3.0622890889731025e-09
findings O 0 2.059770132234462e-09
show O 0 5.950095971485325e-11
that O 0 5.918422869843898e-12
BRCA1 O 0 1.3062870785063296e-08
is O 0 5.152935023122751e-11
implicated O 0 4.1143574658342175e-10
in O 0 7.807149891847498e-12
a O 0 9.200321060554018e-11
small O 0 1.225434476115339e-10
fraction O 0 3.435508233451401e-08
of O 0 0.006553306244313717
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.132093721689102e-10
suggesting O 0 2.0279349380314393e-11
the O 0 3.661602271387565e-12
involvement O 0 1.3400686810216556e-11
of O 0 1.2157349779662319e-11
another O 0 9.53197659692151e-11
susceptibility O 0 1.4594046859883747e-08
gene O 0 1.6479277942238468e-09
( O 0 1.2589154163578087e-09
s O 0 9.477256526224664e-07
) O 0 2.946965338423979e-08

Paternal O 0 2.2463162167696282e-05
transmission O 0 0.0020188388880342245
of O 0 0.0007705445750616491
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.522393524646759

We O 0 9.809108547642609e-08
report O 0 1.4058010311401858e-10
a O 0 1.943836237805474e-11
rare O 0 1.5823876930998182e-11
case O 0 2.3739155086133223e-10
of O 0 1.045825648304799e-09
paternally O 1 0.9998675584793091
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.664089151949156e-06
DM B-Disease 1 1.0
) O 0 4.577607626288227e-09
. O 0 2.103957008614543e-08

The O 0 5.060356045305525e-08
proband O 0 1.5928529819575488e-06
is O 0 5.001632094603359e-11
a O 0 7.714844041384339e-11
23 O 0 1.474420141533983e-09
year O 0 3.618040589348226e-11
old O 0 1.8153363257056299e-09
, O 0 5.126498670016133e-10
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.321305376222881e-06
who O 0 3.3159288648221263e-08
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9807403087615967

He O 0 1.3045490909746604e-08
presented O 0 3.7125433838269828e-09
with O 0 1.14788756278017e-09
respiratory O 1 0.9999502897262573
and O 0 1.0545921469429231e-07
feeding O 0 5.527525672732736e-07
difficulties O 0 4.3068087762776486e-08
at O 0 3.616031563069555e-08
birth O 0 9.441968273904422e-08
. O 0 3.2767971447356103e-08

His O 0 1.3885443195249536e-06
two O 0 1.6501499544574472e-07
sibs O 1 0.999984622001648
suffer O 0 1.5594498108839616e-05
from O 0 1.7786921091555996e-07
childhood O 1 0.9997236132621765
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 1.3177856089896522e-05

Their O 0 1.878478883554635e-08
late O 0 4.672198429034324e-06
father O 0 7.889673803163078e-09
had O 0 1.1621115181270625e-10
the O 0 2.1706401866911085e-12
adult O 0 1.5825076709122254e-12
type O 0 2.4134376788720324e-11
of O 0 1.012727235405464e-09
DM B-Disease 1 1.0
, O 0 5.488172694079196e-10
with O 0 5.4608022964641734e-11
onset O 0 0.00522630475461483
around O 0 2.383930830518466e-09
30 O 0 9.612868723252177e-09
years O 0 1.512275416004627e-09
. O 0 3.582473873109393e-09

Only O 0 2.5410133996928153e-09
six O 0 2.5613408963232054e-11
other O 0 3.432124986231695e-14
cases O 0 2.0339293942649161e-13
of O 0 6.274740709660831e-12
paternal O 0 1.968978224908824e-08
transmission O 0 0.00018490318325348198
of O 0 0.004448296967893839
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 1.597319896973204e-05
been O 0 4.929882280180209e-09
reported O 0 3.1979763281952955e-10
recently O 0 3.797031300489806e-10
. O 0 9.49634149094436e-10

We O 0 1.5152558319186937e-08
review O 0 1.8012711322512587e-09
the O 0 8.711154020346612e-11
sex O 0 5.38712087091997e-12
related O 0 7.329174593617704e-12
effects O 0 2.2480198258456596e-10
on O 0 4.512874518525223e-09
transmission O 0 3.95159247545962e-07
of O 0 1.8855475047985237e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 7.8445220424328e-05

Decreased O 0 4.405971594678704e-06
fertility O 0 1.3009138655206698e-08
of O 0 1.2481501943106821e-11
males O 0 2.7801206974563397e-13
with O 0 1.1103505030837183e-14
adult O 0 2.419435207734466e-10
onset O 0 1.875246198324021e-05
DM B-Disease 1 1.0
and O 0 5.8256417467816846e-09
contraction O 0 1.0458624899456481e-07
of O 0 1.2741535604376963e-09
the O 0 1.0725535043443202e-10
repeat O 0 8.169102200250578e-11
upon O 0 2.2307752867156694e-11
male O 0 1.999653047313199e-12
transmission O 0 1.8189173041013862e-12
contribute O 0 3.0276684479836613e-13
to O 0 2.5599050657021394e-11
the O 0 6.252021816921527e-11
almost O 0 6.460273982433762e-10
absent O 0 3.9618384128914386e-09
occurrence O 0 4.343390369587752e-10
of O 0 9.456391225626248e-11
paternal O 0 6.73121078875738e-08
transmission O 0 1.7070850617528777e-06
of O 0 1.3937793710283586e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 5.222028630669229e-05

Also O 0 7.1570975812562665e-09
the O 0 4.016536880868671e-09
fathers O 0 9.707944670367397e-09
of O 0 7.418292091720957e-10
the O 0 7.653905287341445e-10
reported O 0 2.90267170299785e-08
congenitally O 0 0.00010610389290377498
affected O 0 7.089872156029742e-08
children O 0 7.595921114322834e-10
showed O 0 1.8893790698637503e-10
, O 0 3.5766396788705634e-11
on O 0 2.3308233565444425e-08
average O 0 3.8354071030255454e-09
, O 0 2.437708923608284e-10
shorter O 0 2.9405092050183157e-07
CTG O 0 7.191624717961531e-07
repeat O 0 1.2956394179752806e-08
lengths O 0 5.327803620502891e-08
and O 0 9.063986540491786e-12
hence O 0 2.4585342095484464e-10
less O 0 9.451815996541768e-10
severe O 0 9.1600239102263e-05
clinical O 0 4.516411706845247e-07
symptoms O 0 6.919427697482661e-09
than O 0 1.1848477927955958e-12
the O 0 1.963514940916955e-11
mothers O 0 2.253598349599706e-12
of O 0 7.833427374641377e-13
children O 0 1.434038738451493e-11
with O 0 2.9413410596035305e-10
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.21928369998931885

We O 0 6.8117360640940205e-09
conclude O 0 2.2735060056788825e-08
that O 0 1.075275198741954e-11
paternal O 0 6.69613697823479e-08
transmission O 0 2.913732259912649e-06
of O 0 2.7205198875890346e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 3.57047042598424e-07
rare O 0 1.0725064586436517e-10
and O 0 3.4922260395975346e-12
preferentially O 0 1.3483011582215987e-11
occurs O 0 8.77446227655343e-13
with O 0 6.182451469174954e-14
onset O 0 4.537047288977192e-07
of O 0 8.360156122932949e-09
DM B-Disease 1 1.0
past O 0 5.523041934907269e-08
30 O 0 2.1636494818011442e-09
years O 0 1.852406596170031e-11
in O 0 2.542968439989135e-12
the O 0 2.105849002120852e-11
father O 0 2.6944252384808465e-10
. O 0 1.4352380395266096e-10
. O 0 3.909711221439238e-09

The O 0 3.913082480266894e-07
RB1 O 0 7.0773876359453425e-06
gene O 0 1.1182832437839352e-09
mutation O 0 7.015129588339164e-10
in O 0 2.6538498829054014e-11
a O 0 3.136996662433944e-09
child O 0 3.553051897142723e-07
with O 0 4.153755384095348e-08
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 9.576256707077846e-05

The O 0 9.502462035015924e-07
RB1 O 0 1.1416300367272925e-05
gene O 0 4.348764015560391e-09
mutation O 0 4.000801911985263e-09
was O 0 1.4906340606302138e-09
investigated O 0 3.9466843682056663e-10
in O 0 4.1682331197723244e-11
a O 0 7.631168585930936e-09
child O 0 1.2047060238273843e-07
with O 0 5.4381694702954064e-09
ectopic B-Disease 1 0.9999167919158936
intracranial I-Disease 1 0.9999971389770508
retinoblastoma I-Disease 0 7.295077921298798e-06
using O 0 4.1707245990174613e-10
DNA O 0 7.031111248778643e-10
obtained O 0 2.8943800481351367e-11
from O 0 1.68124281857418e-11
both O 0 3.1636043611171782e-12
the O 0 5.963593507907206e-11
pineal B-Disease 0 3.6016874105371244e-07
and I-Disease 0 3.582740548679908e-09
retinal I-Disease 0 0.002074708929285407
tumours I-Disease 1 1.0
of O 0 0.00014994217781350017
the O 0 9.732362968861707e-07
patient O 0 6.310555704658327e-07
. O 0 2.25400711428847e-08

A O 0 3.3174458167195553e-06
nonsense O 0 9.358922739011177e-07
mutation O 0 1.0153502927323643e-08
in O 0 3.9944178520379126e-10
exon O 0 5.589742002598541e-09
17 O 0 1.6208456798949555e-08
( O 0 2.3727781892080024e-11
codon O 0 5.795994351132094e-09
556 O 0 8.640202997511892e-10
) O 0 7.986256621295151e-12
of O 0 2.3730509224328955e-10
the O 0 2.734285242667056e-09
RB1 O 0 3.550748601810483e-07
gene O 0 5.590218843387618e-10
was O 0 1.2840537522151863e-09
found O 0 5.245993309893615e-12
to O 0 3.0239494935857536e-11
be O 0 2.9723182248808655e-11
present O 0 1.1580114644971218e-10
homozygously O 0 4.325306406371965e-07
in O 0 6.407872565894479e-10
both O 0 3.216842903164263e-10
the O 0 6.0397113976762284e-09
retinal B-Disease 0 2.5163839723063575e-07
and I-Disease 0 4.779548135047662e-08
the I-Disease 0 1.016916257867706e-06
pineal I-Disease 1 0.9993894100189209
tumours I-Disease 1 1.0
. O 0 9.224595487467013e-06

The O 0 6.0670637402893135e-09
same O 0 4.677488951720932e-10
mutation O 0 3.584269547829422e-10
was O 0 1.281054012869376e-10
present O 0 1.1915362793657458e-11
heterozygously O 0 5.576643147264804e-09
in O 0 3.8666569945888796e-11
the O 0 3.894821618000144e-11
DNA O 0 8.721124516997136e-12
from O 0 3.482780470270841e-12
the O 0 7.084722131872612e-12
constitutional O 0 7.258717515945534e-10
cells O 0 1.2372289304174444e-10
of O 0 5.8069209163402746e-11
the O 0 1.0720851983947455e-10
patient O 0 9.287087210374523e-10
, O 0 1.3451519412233104e-11
proving O 0 3.187994312980891e-10
it O 0 1.0707823516753479e-12
to O 0 7.19031154061689e-11
be O 0 2.743352489620321e-10
of O 0 1.893626366822332e-09
germline O 0 5.232623152551241e-07
origin O 0 2.6354124216254604e-08
. O 0 1.9493638703238503e-08

The O 0 4.143650045307368e-08
initial O 0 1.8254549871699055e-08
mutation O 0 1.8416390634712343e-09
was O 0 2.958609190972794e-10
shown O 0 3.7121343325619005e-12
to O 0 7.145155300758432e-11
have O 0 1.608281910425724e-11
occurred O 0 1.4456734698242713e-09
in O 0 5.427405053159973e-12
the O 0 2.9154234582051686e-11
paternally O 0 9.382394861034982e-10
derived O 0 5.333328778611701e-10
RB1 O 0 1.1128174719488015e-06
allele O 0 1.0861670318718097e-07
. O 0 4.942510756222873e-08

The O 0 2.5951875315399775e-08
mutation O 0 1.4158848538059488e-09
is O 0 3.1736067766796605e-12
in O 0 1.0651318152130052e-12
an O 0 1.8807479445354103e-12
area O 0 1.096363000385736e-09
of O 0 1.1736663863004537e-09
the O 0 2.184199043853141e-09
gene O 0 7.231490406489627e-11
that O 0 4.4327215509287754e-11
encodes O 0 1.8249022085137234e-11
the O 0 5.6522508895540113e-11
protein O 0 5.3669808181000533e-11
- O 0 1.0658908478067275e-10
binding O 0 1.4962070338242484e-07
region O 0 2.2924971290194662e-06
known O 0 3.4611771226877863e-09
as O 0 1.3073050975087597e-10
the O 0 1.0533161842740668e-10
pocket O 0 2.1104899587953696e-06
region O 0 3.205466896361031e-07
and O 0 2.4387285524340996e-09
has O 0 2.5137818493448094e-09
been O 0 6.455101453362033e-10
detected O 0 7.867369533620661e-10
in O 0 1.4645381261890744e-12
other O 0 4.990296370577241e-13
cases O 0 9.409338759536201e-12
of O 0 1.063947055457426e-10
retinoblastoma B-Disease 0 2.6766696237245924e-07
. O 0 3.923426916685457e-09
. O 0 2.5590592755975194e-08

Low O 0 6.700546236970695e-06
levels O 0 8.8256060237768e-09
of O 0 6.511638450668045e-10
beta O 0 1.0646976278394504e-07
hexosaminidase O 0 1.393953397155201e-07
A O 0 3.471577247893265e-09
in O 0 3.40850750402133e-11
healthy O 0 5.084814080208444e-12
individuals O 0 1.964224545817836e-13
with O 0 4.780395263664916e-12
apparent O 1 0.9867606163024902
deficiency O 1 0.9999922513961792
of O 0 7.919964991742745e-05
this O 0 2.535092562538921e-07
enzyme O 0 3.35187621658406e-07
. O 0 3.2136387773107344e-08

Appreciable O 0 6.113500603532884e-06
beta O 0 2.5956314857467078e-06
hexosaminidase O 0 1.0463793842063751e-05
A O 0 1.2441976650734432e-05
( O 0 7.339355345692411e-09
hex O 0 1.0539361028349958e-06
A O 0 1.489677742938511e-06
) O 0 3.474669163505695e-10
activity O 0 9.228784847437055e-09
has O 0 3.77337994184046e-10
been O 0 1.009262007301004e-09
detected O 0 7.701149051797529e-09
in O 0 3.4173366914025394e-10
cultured O 0 1.2014017158890056e-07
skin O 0 9.612282383386628e-07
fibroblasts O 0 3.037822438045623e-08
and O 0 4.163748013041868e-09
melanoma B-Disease 0 4.308170173317194e-05
tissue O 0 1.4356391631054066e-08
from O 0 1.2204618426991942e-09
healthy O 0 9.997775524128727e-11
individuals O 0 1.2329659862531095e-12
previously O 0 1.0164092484332699e-10
reported O 0 1.8217974351308897e-10
as O 0 1.703737151359519e-10
having O 0 4.9404156321486425e-09
deficiency B-Disease 0 2.8058022962795803e-06
of I-Disease 0 8.948028380473261e-07
hex I-Disease 0 4.433849198903772e-07
A I-Disease 0 3.76077373687167e-08
activity O 0 9.113784171788097e-10
indistinguishable O 0 3.320898764314073e-11
from O 0 4.2331584201513173e-13
that O 0 2.3935839882404178e-14
of O 0 4.2875693772280454e-13
patients O 0 2.3264261610894676e-12
with O 0 8.769021064836124e-10
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.4196816751405095e-09
TSD B-Disease 0 2.2907312086317688e-05
) O 0 5.923578849653666e-10
. O 0 1.4119858171568467e-08

Identification O 0 9.179104587531128e-09
and O 0 1.7841507160554215e-09
quantitation O 0 1.7393072994309478e-05
of O 0 3.380164343980141e-06
hex O 0 5.810574293718673e-06
A O 0 9.453245866097859e-07
, O 0 9.516572252454836e-11
amounting O 0 9.337922657337572e-10
to O 0 6.047815137577572e-09
3 O 0 1.3317205684870714e-06
. O 0 6.316745526646628e-08

5 O 0 4.147037543589249e-06
% O 0 5.921020829191548e-08
- O 0 1.2835457141591178e-07
6 O 0 1.747637156768178e-06
. O 0 4.216287408098651e-08

9 O 0 1.4868008975099656e-06
% O 0 8.238616899802764e-09
of O 0 3.032760931276357e-09
total O 0 1.5549384002611077e-09
beta O 0 9.694884539612758e-08
hexosaminidase O 0 1.6269154912151862e-07
activity O 0 6.888823289585844e-09
, O 0 4.4980377061909493e-11
has O 0 1.273688186170796e-11
been O 0 2.3716152305897076e-11
obtained O 0 6.644093608620949e-11
by O 0 1.150379097536458e-10
cellulose O 0 8.342698087915323e-09
acetate O 0 4.3584691411524545e-10
gel O 0 2.2572841373857955e-09
electrophoresis O 0 5.623327359316477e-10
, O 0 2.9800044376582235e-11
DEAE O 0 2.8533219165183255e-07
- O 0 9.50522593967662e-09
cellulose O 0 1.3660034881013416e-08
ion O 0 1.1104492436686542e-08
- O 0 6.656731277310257e-10
exchange O 0 4.968612188349653e-10
chromatography O 0 4.0140077373074234e-10
, O 0 4.0383165561541645e-12
radial O 0 4.885538640309051e-10
immunodiffusion O 0 1.8773604892885487e-09
, O 0 5.97600181145852e-12
and O 0 5.736980682180537e-11
radioimmunoassay O 0 1.9637034256447805e-06
. O 0 1.074268638490139e-07

Previous O 0 2.019728344748728e-05
family O 0 1.6811746661460347e-08
studies O 0 2.8327851175902197e-10
suggested O 0 1.6540549485632994e-10
that O 0 1.8854494788361764e-12
these O 0 2.406540136438984e-13
individuals O 0 5.88209277292695e-13
may O 0 4.709546641556983e-10
be O 0 1.2453590936267744e-10
compound O 0 1.7086479453531922e-10
heterozygotes O 0 2.0977830583746027e-11
for O 0 1.1399135758580203e-12
the O 0 2.0181262910812237e-11
common O 0 3.902929368582164e-10
mutant O 0 1.2022539408462762e-08
TSD B-Disease 0 2.057702630509084e-07
gene O 0 4.67515019753062e-11
and O 0 3.667270480345319e-12
a O 0 2.2571712554597667e-10
rare O 0 5.947534686967515e-10
( O 0 1.1256596765818472e-09
allelic O 0 3.80537308330986e-08
) O 0 7.256046319348286e-10
mutant O 0 8.498194148387483e-09
gene O 0 1.938994742545219e-09
. O 0 4.53702275748924e-09

Thus O 0 1.2993743325750984e-07
, O 0 1.4007591753184556e-09
the O 0 6.489670578702089e-09
postulated O 0 1.4775972090319556e-07
rate O 0 8.324787614810703e-08
mutant O 0 1.823300177505871e-09
gene O 0 2.8792548206757473e-11
appears O 0 4.8185132099642924e-12
to O 0 1.9735164023815255e-12
code O 0 5.096424042332071e-13
for O 0 1.828528214259384e-12
the O 0 1.5637345585073348e-11
expression O 0 2.2460941093149778e-11
of O 0 3.176449936415082e-10
low O 0 3.6441474282611352e-09
amounts O 0 6.553015907684312e-10
of O 0 2.2752530970393536e-09
hex O 0 3.1153056170296622e-06
A O 0 4.264891686034389e-06
. O 0 1.882430211708197e-07

Heterozygotes O 0 2.7574044452194357e-06
for O 0 2.3925780467948243e-08
the O 0 1.4289788019539174e-08
rare O 0 2.913958629946478e-09
mutant O 0 5.917122791743168e-09
may O 0 1.404266258830944e-09
be O 0 1.4976810069899926e-10
indistinguishable O 0 4.216010041080409e-10
from O 0 4.497033995187749e-11
heterozygotes O 0 5.46562906045267e-10
for O 0 1.9783674698459208e-11
the O 0 4.761854244250685e-10
common O 0 2.0685153145905133e-08
TSD B-Disease 0 2.3900296582723968e-05
mutant O 0 3.299195725503523e-07
. O 0 2.805135679295745e-08

However O 0 1.2239570246208586e-08
, O 0 4.950598264663597e-11
direct O 0 9.25684640051827e-10
visualization O 0 3.7228393701127516e-09
and O 0 1.0089694635340152e-09
quantitation O 0 6.954459422559012e-06
of O 0 2.368247322692696e-07
hex O 0 3.035372913018364e-07
A O 0 1.0044461262737059e-08
by O 0 8.559819519859957e-12
the O 0 3.157138092624301e-11
methods O 0 3.738975101752473e-11
described O 0 1.2111292871375134e-11
may O 0 1.1703887858871553e-10
prevent O 0 1.3505307983052717e-10
false O 0 1.6006594660833429e-10
- O 0 2.337192883672401e-09
positive O 0 5.782241352392248e-11
prenatal O 0 2.411931987467142e-08
diagnosis O 0 4.082709637032167e-08
of O 0 5.035721284407657e-10
TSD B-Disease 0 4.812736733583733e-07
in O 0 1.7303402044532845e-09
fetuses O 0 1.3988242564266784e-08
having O 0 5.815023115807172e-11
the O 0 2.5632138078712785e-10
incomplete O 0 1.3015666766591494e-08
hex B-Disease 0 8.51759068609681e-06
A I-Disease 0 0.00012151906412327662
deficiency I-Disease 1 0.6878305673599243
of O 0 3.480855639281799e-07
the O 0 8.513768356976925e-09
type O 0 3.35769207993053e-08
described O 0 1.0542010597802687e-09
in O 0 6.338932156957355e-11
the O 0 7.479384334097006e-10
four O 0 3.7688843712579967e-10
healthy O 0 6.407555042109436e-10
individuals O 0 2.368837348498687e-09

The O 0 6.756730499546393e-07
tumor B-Disease 0 5.6204771681223065e-06
suppressor O 0 5.341621545085218e-07
gene O 0 7.876862717637323e-09
Smad4 O 0 4.7638758360335487e-07
/ O 0 4.268258635420352e-08
Dpc4 O 0 1.6992190410292096e-07
is O 0 1.4721734248324125e-11
required O 0 2.996521780707084e-11
for O 0 2.777055148339702e-11
gastrulation O 0 1.8911898713724895e-09
and O 0 1.8081147473356096e-12
later O 0 6.10999029149184e-11
for O 0 4.6517186803873845e-12
anterior O 0 8.014472285822194e-08
development O 0 4.1274463846718845e-09
of O 0 2.3936446158501212e-09
the O 0 1.0293347285639243e-09
mouse O 0 4.809596276800221e-09
embryo O 0 1.7237586291685147e-07
. O 0 2.099695706192506e-08

Mutations O 0 2.4720986857573735e-07
in O 0 1.6848655803869406e-09
the O 0 2.394815190598365e-08
SMAD4 O 1 0.9959996938705444
/ O 0 0.0006374468794092536
DPC4 O 1 0.9550760984420776
tumor B-Disease 0 0.00012737856013700366
suppressor O 0 5.754770313615154e-07
gene O 0 5.682282422370122e-10
, O 0 1.4806383549781366e-11
a O 0 3.8989783623932794e-10
key O 0 2.6010550158162005e-08
signal O 0 5.5433471146670854e-08
transducer O 0 6.848697609029841e-08
in O 0 5.877304865009592e-09
most O 0 1.2069334420772293e-09
TGFbeta O 0 1.3009680515096989e-06
- O 0 6.0391492695544e-08
related O 0 1.8525401657143448e-08
pathways O 0 2.117998970652124e-10
, O 0 7.356691211074518e-13
are O 0 1.9754687049047294e-14
involved O 0 3.8631443421803524e-13
in O 0 2.207372739454483e-12
50 O 0 4.867847236411649e-10
% O 0 1.1382663700487683e-09
of O 0 1.8074391761047082e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.00010805201600305736

Homozygous O 0 4.575402272166684e-06
Smad4 O 0 0.0002304390218341723
mutant O 0 2.36073447013041e-06
mice O 0 2.77558257266719e-07
die O 0 3.9569474097334023e-07
before O 0 3.850961771689754e-09
day O 0 1.3018869537972932e-08
7 O 0 3.483279726879118e-07
. O 0 1.8109588495462958e-08

5 O 0 1.891821921162773e-05
of O 0 3.8985029959803796e-07
embryogenesis O 0 4.981065103493165e-06
. O 0 4.62047836435886e-07

Mutant O 0 9.119214610109339e-07
embryos O 0 1.5488771154537062e-08
have O 0 3.45135135748631e-11
reduced O 0 2.875557014725416e-10
size O 0 7.890282871514387e-11
, O 0 1.924303424938323e-11
fail O 0 8.170840892773867e-09
to O 0 2.912869501159321e-09
gastrulate O 0 2.616707490687986e-07
or O 0 1.6285797155290993e-09
express O 0 1.458162202094826e-10
a O 0 3.085287025861305e-10
mesodermal O 0 4.147934440368317e-09
marker O 0 1.9095414138803335e-09
, O 0 1.9868533901457042e-11
and O 0 8.379656690760129e-11
show O 0 8.397712747409969e-09
abnormal O 0 2.251584305668075e-07
visceral O 0 1.3668005749423173e-06
endoderm O 0 0.00012662686640396714
development O 0 5.2969471653341316e-06
. O 0 2.370294538422968e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.226090823067352e-05
the O 0 2.094385308737401e-06
Smad4 O 0 0.00013450131518766284
- O 0 3.4866141049860744e-06
deficient O 0 7.494814013853102e-08
embryos O 0 6.356418169595202e-10
results O 0 5.1549601393086064e-11
from O 0 1.5622954319116644e-10
reduced O 0 7.610528207635525e-09
cell O 0 1.275466510186618e-09
proliferation O 0 2.640442309242985e-09
rather O 0 9.89696605918633e-12
than O 0 2.6665244665102783e-11
increased O 0 3.236588108634919e-09
apoptosis O 0 1.0196610844559473e-07
. O 0 1.4160908001770167e-08

Aggregation O 0 2.8227540838088316e-07
of O 0 1.5046689227915522e-08
mutant O 0 3.8916937228350434e-08
Smad4 O 0 3.89539582101861e-06
ES O 0 7.06343030287826e-07
cells O 0 5.984342882348059e-11
with O 0 2.869876103255009e-13
wild O 0 3.083879679399715e-11
- O 0 2.971201756851727e-11
type O 0 8.654238436989203e-10
tetraploid O 0 5.908937623644306e-07
morulae O 0 2.2688720946462126e-06
rescues O 0 8.915059623859634e-08
the O 0 7.3569443870269424e-09
gastrulation B-Disease 0 4.692784841608955e-06
defect I-Disease 0 4.811387952941004e-06
. O 0 8.944405038846526e-08

These O 0 3.504328605075102e-09
results O 0 6.85261181132546e-10
indicate O 0 4.4126555187595784e-10
that O 0 6.9243812073072064e-12
Smad4 O 0 7.597360074385051e-09
is O 0 6.682571163096895e-13
initially O 0 1.7433401727426356e-12
required O 0 8.291679517470618e-13
for O 0 4.286253155790648e-13
the O 0 1.4802995634832783e-11
differentiation O 0 3.690357394670052e-11
of O 0 8.953866120764431e-11
the O 0 1.1243909275870934e-10
visceral O 0 1.5845849077322782e-09
endoderm O 0 2.264746079561064e-08
and O 0 3.010201463093942e-11
that O 0 5.43764252375345e-12
the O 0 9.064008571479931e-11
gastrulation B-Disease 0 2.317449343536282e-08
defect I-Disease 0 4.444053125496339e-09
in O 0 2.2737539281947328e-11
the O 0 1.5033936595632014e-10
epiblast O 0 2.0384396393069437e-08
is O 0 1.0766912535153939e-11
secondary O 0 3.647657176308883e-10
and O 0 2.400912454958437e-11
non O 0 7.57901048586973e-08
- O 0 4.6964194666543335e-07
cell O 0 2.77522781289008e-06
autonomous O 0 4.205511686450336e-06
. O 0 1.7687155207113392e-07

Rescued O 0 4.839874236495234e-06
embryos O 0 3.391826552956445e-08
show O 0 6.4228777851838e-09
severe O 0 2.3381091978080804e-06
anterior O 0 0.0004576735373120755
truncations O 0 0.0007625172729603946
, O 0 1.0507447356644661e-08
indicating O 0 2.3103041257854784e-08
a O 0 2.6713991019278183e-09
second O 0 3.817905103176145e-09
important O 0 3.104979814927411e-11
role O 0 1.2173546025395776e-11
for O 0 2.2872556279529555e-11
Smad4 O 0 6.357903430398437e-07
in O 0 6.119385442815428e-09
anterior O 0 6.73273389111273e-05
patterning O 0 6.0577243857551366e-05
during O 0 3.426646799198352e-05
embryogenesis O 0 5.372355076360691e-07
. O 0 2.549831457088203e-08

Prevalence O 0 3.124634167761542e-05
of O 0 3.737825693406194e-08
p16 O 0 2.2115285958079767e-07
and O 0 1.8849931393560837e-08
CDK4 O 1 0.9987000226974487
germline O 0 0.00022154160251375288
mutations O 0 1.3640227791711368e-07
in O 0 1.5530711161559907e-09
48 O 0 1.4397463701243396e-06
melanoma B-Disease 1 0.5826776027679443
- O 0 1.2633761059532844e-07
prone O 0 2.381483170665888e-07
families O 0 1.0446010723086374e-10
in O 0 9.187892668904851e-10
France O 0 1.7967774113003543e-07
. O 0 4.962693083143677e-07

The O 0 1.2285556749702664e-07
French O 0 5.711468929803232e-06
Familial B-Disease 1 0.9998972415924072
Melanoma I-Disease 1 0.9999998807907104
Study O 0 2.415476885175849e-08
Group O 0 1.501668372982934e-10
. O 0 6.489109805052351e-10

Germline O 0 2.777389090624638e-05
mutations O 0 1.5744548420570936e-07
in O 0 2.0466353056747266e-09
the O 0 4.324446134518212e-09
p16 O 0 1.5259347563301162e-08
and O 0 2.041699254107243e-09
CDK4 O 0 0.0006090172682888806
genes O 0 7.88534126883178e-09
have O 0 5.028251773286918e-11
been O 0 3.112349614142751e-11
reported O 0 3.2778176006775794e-11
in O 0 1.0304922063233968e-12
a O 0 4.5943974319451186e-11
subset O 0 3.21505333467087e-09
of O 0 5.223266708043184e-09
melanoma B-Disease 0 1.7497935914434493e-05
pedigrees O 0 8.026721509679646e-09
, O 0 3.8541544955528195e-11
but O 0 3.150383079408847e-11
their O 0 1.0892754753744072e-10
prevalence O 0 4.471592873755981e-09
is O 0 7.133178596407941e-13
not O 0 3.088394470718292e-11
well O 0 1.269786081836699e-10
known O 0 1.3885659733148259e-08
. O 0 1.4947094939543604e-07

We O 0 1.2927785064675845e-08
searched O 0 1.1863375837251056e-09
for O 0 1.565172817741267e-11
such O 0 8.313874588772308e-11
germline O 0 5.844196948601166e-07
mutations O 0 1.267512583780217e-08
in O 0 6.050753786901453e-10
48 O 0 8.186911770735605e-08
French O 0 3.049485712836031e-07
melanoma B-Disease 1 0.811383843421936
- O 0 1.1705443370146895e-07
prone O 0 5.343047604355888e-08
families O 0 7.634723582505831e-12
selected O 0 8.139528005594865e-13
according O 0 1.5692882106635442e-12
to O 0 2.9774308019092643e-11
two O 0 3.0925839146489498e-12
major O 0 3.8922687295439573e-10
criteria O 0 1.2909444624398247e-09
families O 0 3.4952761713592795e-13
with O 0 6.066990714068826e-14
at O 0 4.2839709557540573e-10
least O 0 7.07629857488179e-11
three O 0 1.6193784160845048e-11
affected O 0 6.072104624665897e-11
members O 0 2.8211625743845836e-12
( O 0 3.028439998775667e-11
n O 0 3.2583913345263227e-09
= O 0 1.7637783455981548e-09
20 O 0 1.679356764761053e-09
) O 0 4.1125937833182136e-13
or O 0 5.632145357731266e-12
families O 0 5.173709767894441e-13
with O 0 7.98518288167363e-14
two O 0 9.28674151468023e-12
affected O 0 8.131249840115373e-11
members O 0 2.123254913902195e-12
, O 0 5.021118937298397e-12
one O 0 1.0461677531214963e-11
of O 0 9.639108955461495e-12
them O 0 1.4058794005258196e-13
affected O 0 2.4636672910083313e-12
before O 0 3.0835150405250644e-11
the O 0 1.913856746693643e-11
age O 0 3.058271691447345e-10
of O 0 4.725696223228937e-11
50 O 0 1.8443588323258098e-10
( O 0 8.78726171688049e-12
n O 0 1.8329341378020558e-09
= O 0 1.3319946257084325e-09
28 O 0 4.168109857261015e-09
) O 0 1.3168210011987869e-12
, O 0 1.1393875209639304e-12
and O 0 6.617250150608989e-13
one O 0 1.2544695100411007e-12
additional O 0 7.780287698821997e-12
minor O 0 4.2945678124794995e-09
criterion O 0 4.40621079178527e-06
. O 0 6.05760703820124e-08

Sixteen O 0 3.7764010585306096e-07
different O 0 2.6899180660677757e-09
p16 O 0 1.888084710799376e-07
germline O 0 5.184975293559546e-07
mutations O 0 4.670662523409419e-09
were O 0 1.715030201188128e-11
found O 0 2.4074768871160113e-13
in O 0 4.229171537712545e-13
21 O 0 1.0006779432858437e-10
families O 0 1.008444521465035e-12
, O 0 2.077225110669323e-12
while O 0 3.849827401314343e-11
one O 0 9.037962600544347e-10
germline O 0 1.7197670842961088e-07
mutation O 0 4.4566860424311017e-08
, O 0 3.110754986934694e-10
Arg24His O 0 1.0843471045518527e-06
, O 0 7.342907948348909e-10
was O 0 3.038239526631514e-08
detected O 0 1.6070906827536646e-09
in O 0 6.159239090974822e-11
the O 0 1.6147660986121082e-09
CDK4 O 0 6.889060023240745e-05
gene O 0 4.01528303939358e-08
. O 0 4.8486523240853785e-08

The O 0 1.6081216358543315e-08
frequency O 0 1.9406012796707728e-08
of O 0 8.907712789607558e-09
p16 O 0 1.0728963495409971e-08
gene O 0 8.209370683243122e-11
mutation O 0 4.774720896438822e-11
in O 0 3.896669879127623e-12
our O 0 7.236329591098212e-12
sample O 0 1.369575026305414e-12
( O 0 1.4517724045495783e-12
44 O 0 3.4258598735625867e-10
% O 0 3.404011794660988e-11
) O 0 1.2868928199547686e-13
is O 0 5.476568092251111e-13
among O 0 5.1986643749600894e-14
the O 0 7.13214860434408e-12
highest O 0 1.8298847992426204e-09
rates O 0 1.6639147004671173e-10
yet O 0 5.6473905413190195e-11
reported O 0 2.241909435873879e-10
and O 0 1.1632065102795686e-11
the O 0 4.146935572713062e-10
CDK4 O 0 1.5637391470590956e-06
mutation O 0 3.5140923504428656e-10
is O 0 7.62260393694092e-12
the O 0 5.148151002720702e-11
second O 0 4.297222577775983e-09
mutation O 0 2.9166109527523076e-09
detected O 0 8.044178656518852e-09
in O 0 4.0978540005731645e-11
this O 0 2.701124601767191e-10
gene O 0 1.8324448625151035e-09
worldwide O 0 2.1203119260349013e-09
. O 0 3.304866780240445e-08

In O 0 4.716119939018881e-09
summary O 0 3.093409972620975e-08
, O 0 1.3414325206184685e-10
our O 0 6.730443979918732e-11
results O 0 2.8208787736239138e-11
show O 0 1.0643342110427945e-11
frequent O 0 6.315721383376438e-12
involvement O 0 1.6745932418515963e-10
of O 0 5.529392499425967e-10
the O 0 1.6570965710727137e-09
p16 O 0 1.5112719964349708e-09
gene O 0 2.557074517406388e-11
in O 0 2.270132415382875e-10
familial B-Disease 0 5.89016281082877e-06
melanoma I-Disease 1 0.7400823831558228
and O 0 2.464440596039452e-10
confirm O 0 5.255412216520483e-10
the O 0 2.5597254871279063e-10
role O 0 4.190377558832559e-11
of O 0 1.554249784430084e-10
the O 0 5.487869048081961e-10
CDK4 O 0 2.6901332603301853e-05
gene O 0 1.6823503701246523e-10
as O 0 1.2315641562121726e-10
a O 0 1.0858911103639457e-08
melanoma B-Disease 0 9.435727406525984e-05
- O 0 1.7146949176094495e-06
predisposing O 0 4.235095332205674e-07
gene O 0 7.73398622921917e-10
. O 0 1.0269697314768678e-09
. O 0 9.30397003884309e-09

Progression O 0 0.0001483680389355868
of O 0 2.5188141989929136e-06
somatic O 0 3.592966095311567e-05
CTG O 0 4.415756120579317e-05
repeat O 0 2.7297321736341473e-08
length O 0 1.5829719757221028e-09
heterogeneity O 0 9.69657798499668e-10
in O 0 7.944537389059647e-12
the O 0 2.4494153233467486e-11
blood O 0 2.690628449208976e-11
cells O 0 2.633274154284493e-10
of O 0 1.0686844742480162e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.00044144809362478554
. O 0 4.5202597220850294e-07

The O 0 1.8609076501974187e-09
genetic O 0 8.522358929674567e-10
basis O 0 1.9222987646116962e-09
of O 0 8.17361556215701e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.751668024662649e-08
DM B-Disease 1 1.0
) O 0 8.43986772830485e-12
is O 0 6.979977034728135e-13
the O 0 5.621927836457763e-12
expansion O 0 1.8120352440753607e-10
of O 0 7.975547999805599e-10
an O 0 2.7931323920427076e-09
unstable O 0 7.731601363047957e-05
CTG O 0 5.238712674326962e-06
repeat O 0 7.892789533059386e-09
in O 0 1.2155872142205482e-10
the O 0 1.2081817768461178e-09
34 O 0 7.710673877170393e-09
UTR O 0 6.298422476902488e-07
of O 0 1.343732680680887e-09
the O 0 8.117853944611397e-09
DM B-Disease 1 0.9999997615814209
protein O 0 3.005444426662507e-08
kinase O 0 2.5756239363516897e-09
gene O 0 2.1321030010956754e-11
on O 0 1.538465244088627e-09
chromosome O 0 1.8756475128611783e-07
19 O 0 3.5477427218211233e-07
. O 0 1.2869378451796365e-08

One O 0 4.956631105557108e-09
of O 0 5.71641567415071e-10
the O 0 7.03282362901625e-11
principal O 0 3.503210499467002e-10
features O 0 1.1028126111964354e-12
of O 0 4.0079714547225365e-10
the O 0 1.728187370986234e-08
DM B-Disease 1 1.0
mutation O 0 1.8735235585154442e-07
is O 0 3.30561203409907e-11
an O 0 9.533208424061801e-12
extraordinarily O 0 9.745360074475684e-10
high O 0 2.0356033303414733e-08
level O 0 1.3569041357186507e-06
of O 0 7.042390848255309e-07
somatic O 0 3.423638190724887e-05
mosaicism O 0 0.00041112396866083145
, O 0 5.231161059882083e-10
due O 0 1.7518836159524653e-08
to O 0 1.7929543960626404e-10
an O 0 4.78336857970274e-12
extremely O 0 1.604467253502051e-11
high O 0 8.233142639868518e-11
degree O 0 7.920583300347062e-09
of O 0 6.548243058901448e-10
somatic O 0 6.570656552185028e-08
instability O 0 5.125164648234204e-08
both O 0 6.255382496711537e-12
within O 0 4.162703862164996e-11
and O 0 1.6790018811038698e-12
between O 0 2.2548217459839037e-10
different O 0 2.387861297581395e-10
tissues O 0 1.4535762815626185e-08
. O 0 3.2162863483620185e-09

This O 0 5.484432108460169e-08
instability O 0 2.915097184086335e-06
appears O 0 6.727854384713794e-10
to O 0 7.285011482949244e-11
be O 0 1.8616469043414297e-12
biased O 0 1.6564343646718882e-11
towards O 0 8.695495712363055e-12
further O 0 2.7978949452417412e-12
expansion O 0 1.042458914329858e-11
and O 0 3.322639472586042e-12
continuous O 0 3.6419986471081245e-10
throughout O 0 7.708308817633291e-12
the O 0 3.2235301233862756e-11
life O 0 4.0361162328972355e-11
of O 0 1.0400716746183924e-11
an O 0 1.0867156783819776e-12
individual O 0 6.301949522120875e-14
, O 0 1.5672482842760127e-12
features O 0 1.600528791532302e-13
that O 0 8.055340249002452e-13
could O 0 1.2227673734654942e-11
be O 0 2.017201726836615e-12
associated O 0 2.015401951230289e-12
with O 0 4.027827333816236e-14
the O 0 2.4761713512955197e-11
progressive O 0 2.2973850377638882e-08
nature O 0 2.3132218363031143e-09
of O 0 4.501337969031738e-09
the O 0 1.9047304533614806e-07
disease O 0 0.00015939600416459143
. O 0 2.5933369229846903e-08

Although O 0 8.951974717064104e-10
increasing O 0 3.2427593943396005e-10
measured O 0 3.7884084758132985e-10
allele O 0 7.281805158854127e-10
size O 0 4.369620984490119e-11
between O 0 6.283837894471844e-10
patients O 0 8.686768526722233e-10
clearly O 0 2.2585610465197803e-11
correlates O 0 2.444990390704227e-11
with O 0 1.7326509557614653e-14
an O 0 7.14502567354669e-13
increased O 0 8.523671352067552e-11
severity O 0 1.8986693817168998e-07
of O 0 3.3346376770992947e-09
symptoms O 0 1.0569880970479062e-08
and O 0 1.0461253174484653e-12
an O 0 9.635446737363274e-13
earlier O 0 1.2044630570695603e-10
age O 0 7.91949172906925e-10
of O 0 1.335125204837695e-10
onset O 0 2.1979856512643892e-07
, O 0 6.337707702391837e-12
this O 0 4.59624664717051e-11
correlation O 0 3.141018556362951e-10
is O 0 9.39653303083654e-12
not O 0 3.971428047533365e-11
precise O 0 1.2207133082142718e-09
and O 0 4.679476597879706e-11
measured O 0 8.237214799144965e-10
allele O 0 2.2311605896163655e-09
length O 0 4.388451380066272e-09
cannot O 0 5.177587802940309e-10
be O 0 1.639536423292398e-11
used O 0 1.3062868928909177e-12
as O 0 6.20084224852574e-13
an O 0 5.606686447577613e-13
accurate O 0 1.963586931941208e-10
predictor O 0 1.2287971173918777e-07
of O 0 2.9558624992098714e-10
age O 0 1.070423394367026e-07
of O 0 4.410438592117316e-08
onset O 1 0.6219668984413147
. O 0 1.8693937420266593e-07

In O 0 2.8129887308381285e-09
order O 0 6.700590082786562e-10
to O 0 4.4067935411895576e-10
further O 0 2.9332566930939663e-10
characterize O 0 1.0709621633964161e-08
the O 0 1.183988906916511e-09
dynamics O 0 1.1710061365022284e-08
of O 0 1.4590908392619895e-07
DM B-Disease 1 1.0
CTG O 0 7.419118628604338e-05
repeat O 0 2.556625702254678e-07
somatic O 0 1.7164474286346376e-07
instability O 0 7.274190920725232e-07
, O 0 7.596322876279871e-11
we O 0 4.521468616180968e-11
have O 0 1.6470327705853105e-12
studied O 0 1.066166946395164e-11
repeat O 0 1.0863369231950415e-11
length O 0 1.0695412654485037e-12
changes O 0 1.917943885307305e-13
over O 0 8.68461823722716e-13
time O 0 1.163612522309121e-11
in O 0 1.976330904485124e-11
111 O 0 1.493992726864235e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 1.390847548243812e-09
with O 0 4.412017626242992e-13
varying O 0 5.368601674327067e-10
clinical O 0 2.1394511051653353e-08
severity O 0 2.106884267050191e-06
and O 0 1.4542078652368673e-09
CTG O 0 2.7179862627235707e-07
repeat O 0 5.511355261056394e-10
size O 0 3.687585306555441e-11
over O 0 2.7773146629717083e-11
time O 0 4.3405144062313994e-11
intervals O 0 1.7276714781022662e-10
of O 0 1.9635598702549828e-11
1 O 0 2.420447176021412e-09
- O 0 1.8739512164245298e-09
7 O 0 4.793406915837295e-08
years O 0 2.955599098797279e-09
. O 0 3.465034925653754e-09

We O 0 3.0663880323800186e-08
have O 0 2.1866146046600754e-11
found O 0 1.2494023827677725e-12
a O 0 1.3783354882793142e-12
direct O 0 1.3054238245935323e-10
progression O 0 1.4085420607656829e-09
of O 0 3.256561340037045e-11
the O 0 5.493374852227895e-11
size O 0 3.124663860987198e-10
heterogeneity O 0 1.0937902139573907e-08
over O 0 3.2566265240063785e-09
time O 0 8.470844470309657e-09
related O 0 5.549977366570147e-09
to O 0 1.3818657329522921e-08
initial O 0 4.6363425099116284e-08
CTG O 0 1.4706313322676579e-07
repeat O 0 1.6979756489732267e-10
size O 0 1.554079955001786e-11
and O 0 9.708522180629231e-12
the O 0 1.3677019239377586e-10
time O 0 5.107788081382125e-10
interval O 0 4.719284962817483e-10
and O 0 2.3855420677038053e-12
always O 0 6.986867247954498e-12
biased O 0 1.0780274589672345e-10
towards O 0 1.1042449593601233e-10
further O 0 1.8671250656687732e-10
expansion O 0 1.5765547090040855e-08
. O 0 5.757938481565361e-08

Attempts O 0 1.064858068389185e-07
to O 0 8.773158199915088e-09
mathematically O 0 1.1648622511017948e-08
model O 0 7.530242540632059e-10
the O 0 1.1186757076231402e-09
dynamics O 0 1.1923907194955063e-08
have O 0 5.797163304954722e-10
proved O 0 8.503381998536952e-09
only O 0 5.688677653936658e-11
partially O 0 1.6005869962754105e-09
successful O 0 3.638781637116395e-11
suggesting O 0 1.0658130628060647e-11
that O 0 2.659948541809676e-13
individual O 0 1.44022950033032e-13
specific O 0 4.413823473381484e-11
genetic O 0 9.172904102960899e-10
and O 0 9.573811188268166e-11
/ O 0 5.321709863892465e-07
or O 0 1.6831167215514142e-07
environmental O 0 2.1340962064186897e-07
factors O 0 7.218636799422029e-10
also O 0 4.28750378299661e-13
play O 0 4.015681016877881e-12
a O 0 3.986713043024892e-11
role O 0 6.939285257523409e-11
in O 0 1.786860520658351e-10
somatic O 0 1.5990416102340532e-07
mosaicism O 0 4.936527602694696e-06
. O 0 6.658068318898813e-09
. O 0 2.126923526191149e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 7.959170211790934e-09
Palestinian O 0 5.419633907877142e-06
Arabs O 0 8.001642015642574e-08
. O 0 6.4906116037377615e-09

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9999967813491821
AGU B-Disease 1 1.0
) O 0 1.9863779510131963e-09
is O 0 6.970392318894625e-11
a O 0 1.780054770250672e-09
rare O 0 4.925759071738867e-07
disorder B-Disease 1 1.0
of I-Disease 0 0.0014301593182608485
glycoprotein I-Disease 0 0.00019746819452848285
metabolism I-Disease 1 0.9995649456977844
caused O 0 7.072549692566099e-07
by O 0 2.89048118773394e-10
the O 0 5.445687278893274e-08
deficiency B-Disease 0 6.347086582536576e-06
of I-Disease 0 1.3201511706029123e-07
the I-Disease 0 7.739172502851943e-08
lysosomal I-Disease 0 1.1859342521347571e-06
enzyme I-Disease 0 5.292395144351758e-08
aspartylglucosaminidase I-Disease 0 4.1692183572195063e-07
( O 0 4.04662470199213e-10
AGA O 0 1.049768115990446e-06
) O 0 1.4022019656501072e-10
. O 0 2.7900279864212507e-09

AGU B-Disease 1 1.0
is O 0 3.61651132152474e-07
inherited O 0 1.5227502672132687e-06
as O 0 5.992149887390497e-09
an O 0 1.2371782709408308e-08
autosomal O 0 0.04645043611526489
recessive O 0 0.016002604737877846
trait O 0 8.404158791108784e-08
and O 0 4.1431091890586913e-10
occurs O 0 2.042449959160919e-10
with O 0 2.2090731750367548e-13
a O 0 4.7374826284141136e-11
high O 0 7.399708623623269e-10
frequency O 0 1.0468035327448888e-09
in O 0 7.505117360917524e-11
Finland O 0 3.5672398368546965e-10
because O 0 2.438591169273696e-11
of O 0 1.290461348890659e-10
a O 0 1.8236061549714577e-09
founder O 0 1.5974494615988988e-08
effect O 0 7.543921043406954e-08
. O 0 1.402326432753398e-08

While O 0 2.509079877199838e-07
very O 0 3.12116310574595e-09
few O 0 5.1822137692170145e-09
patients O 0 1.4405784343196615e-09
with O 0 2.480862182352439e-10
AGU B-Disease 1 1.0
have O 0 1.4209113885499391e-09
been O 0 4.525135474664488e-11
reported O 0 1.1240708884530104e-11
from O 0 1.8591780892585064e-11
non O 0 1.818683120768938e-10
- O 0 3.5529915815013524e-11
Finnish O 0 7.642585453382367e-10
origin O 0 2.770939866447719e-10
, O 0 5.1528468991701715e-11
we O 0 3.2675584460406526e-09
diagnosed O 1 0.9999924898147583
the O 0 4.1880191758991714e-08
disorder O 0 6.954518539714627e-06
in O 0 2.9562796655113743e-10
8 O 0 1.3474502225108154e-07
patients O 0 1.7513197489438248e-11
originating O 0 9.450003279898311e-12
from O 0 6.437454042051982e-11
3 O 0 3.3017524270206877e-09
unrelated O 0 6.483774628307515e-11
families O 0 2.795471644966019e-13
, O 0 6.213152008941597e-14
all O 0 1.4349839946945636e-13
Palestinian O 0 1.1377951913971174e-09
Arabs O 0 2.3998870599117872e-11
from O 0 4.678376609723589e-12
the O 0 9.10345496901721e-12
region O 0 1.931375337438368e-10
of O 0 3.4895528133738196e-10
Jerusalem O 0 2.6451753001310863e-06
. O 0 3.15470494172132e-08

The O 0 8.013035568410487e-08
clinical O 0 1.486688802287972e-06
diagnosis O 1 0.999775230884552
of O 0 0.00013636673975270241
AGU B-Disease 1 1.0
is O 0 2.0908474951397693e-08
often O 0 4.303829168050832e-11
difficult O 0 4.687528143421105e-10
, O 0 7.898526125683925e-13
in O 0 1.558493243312975e-12
particular O 0 1.1781240046027097e-11
early O 0 3.325641984019967e-10
in O 0 2.4210160785853585e-12
the O 0 4.545626028362726e-12
course O 0 1.921590248032956e-10
of O 0 1.3664185234685267e-11
the O 0 4.751493087873371e-10
disease O 0 1.6633141797228745e-07
, O 0 2.7818513551741697e-12
and O 0 6.525606877777479e-12
most O 0 1.675742704321248e-11
of O 0 4.027912448023585e-10
the O 0 5.67863089884213e-10
patients O 0 1.1327795645943439e-10
are O 0 7.1978274035489065e-12
diagnosed O 0 8.123975447915655e-08
after O 0 1.0287125595809243e-09
the O 0 7.596743373250447e-11
age O 0 2.0400868494530044e-10
of O 0 7.563677462130158e-11
5 O 0 7.047131322934774e-09
years O 0 5.492752030988868e-09
. O 0 9.579794735259384e-09

However O 0 1.504044035982588e-07
, O 0 1.4730034969545613e-09
since O 0 9.451424531903285e-09
these O 0 6.802743784950493e-11
patients O 0 1.2118463177390737e-10
excrete O 0 7.367216559028833e-11
early O 0 6.185751910692261e-11
large O 0 2.513754178770644e-12
amounts O 0 8.021280861747471e-11
of O 0 1.533815408016892e-09
aspartylglucosamine O 0 3.456838442161825e-07
in O 0 1.2811775640386713e-08
urine O 0 7.226709231034079e-10
, O 0 5.4934559505503966e-12
biochemical O 0 6.007043473754692e-11
screening O 0 2.3917176572574306e-10
is O 0 8.681144345046299e-12
easy O 0 1.8085684339030905e-10
by O 0 1.5727448510194364e-10
urine O 0 7.252627942655465e-10
chromatography O 0 4.384987484229441e-09
. O 0 1.1458116677687258e-09
. O 0 1.2267546090072301e-08

Detection O 0 1.5518584461915452e-07
of O 0 2.7618118902950073e-10
heterozygous O 0 1.2742834565315775e-11
carriers O 0 5.5368374815567556e-12
of O 0 9.614271184732459e-11
the O 0 1.6506779942915273e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2124051806949865e-07
ATM O 0 1.3131239938957151e-05
) O 0 5.0391971845309413e-11
gene O 0 1.6585865710364023e-12
by O 0 9.35363505399911e-12
G2 O 0 2.7006072045310248e-08
phase O 0 1.8508383448079258e-07
chromosomal O 0 3.152554199914448e-06
radiosensitivity O 0 6.22565357843996e-06
of O 0 1.6764539623181918e-07
peripheral O 0 2.008497904171236e-05
blood O 0 8.93403648660751e-06
lymphocytes O 0 2.284478028968806e-07
. O 0 6.224652082664761e-08

In O 0 2.531741756683914e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.5507866666885093e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.964295806710652e-10
patients O 0 3.080365684748898e-10
, O 0 4.243378651930252e-12
mutations O 0 3.2332205489316035e-12
in O 0 5.243112367880887e-12
a O 0 9.068470280260144e-11
single O 0 4.5665190379073906e-11
gene O 0 2.3336391413025792e-12
, O 0 2.4597934366460406e-12
ATM O 0 7.229953080667428e-09
, O 0 4.5490260863756404e-12
result O 0 5.1432535314033245e-11
in O 0 5.400995206628068e-10
an O 0 0.05791062116622925
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.1384163371985778e-05
embraces O 0 3.3890892314758503e-09
a O 0 4.205109524479944e-11
variety O 0 8.228616572847347e-12
of O 0 1.63775486228257e-11
clinical O 0 5.55289460246744e-11
features O 0 1.4375371552854954e-13
and O 0 2.7354494537557006e-12
manifests O 0 1.5497414462828374e-10
extreme O 0 2.4500078410483184e-08
radiosensitivity O 0 1.8892139053150458e-07
and O 0 1.1527556686985463e-10
a O 0 1.9218955316091524e-09
strong O 0 6.091084858717011e-10
pre O 0 2.7148385584041534e-07
- O 0 5.046995710245028e-08
disposition O 0 4.1875958345372055e-07
to O 0 4.362507866062515e-07
malignancy B-Disease 0 6.213529559317976e-05
. O 0 1.1507555797152236e-08

Heterozygotes O 0 7.596637630058467e-08
for O 0 1.4133674230976112e-09
the O 0 3.784899949010878e-09
ATM O 0 4.002605749064969e-07
gene O 0 9.479669133005686e-11
have O 0 5.896440020275451e-12
no O 0 6.577791263062682e-12
clinical O 0 2.7991400863847105e-11
expression O 0 3.084585711854437e-11
of O 0 4.488238225519581e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.991582898597244e-09
may O 0 1.1822497647528962e-08
be O 0 5.108463430048005e-09
cancer B-Disease 0 8.599667467024119e-08
prone O 0 2.0872314987485652e-10
with O 0 4.7963552346399346e-14
a O 0 1.6143400505264083e-10
moderate O 0 2.3690290618105792e-07
increase O 0 7.423320624866392e-09
in O 0 3.5301699341516724e-09
in O 0 1.4342897536323562e-08
vitro O 0 6.849036822131893e-07
radiosensitivity O 0 2.6382372197986115e-06
. O 0 9.867505923466524e-08

We O 0 1.077412363770236e-07
performed O 0 5.082676501899641e-10
a O 0 2.1578139275391095e-09
blind O 0 3.566243123032109e-08
chromosomal O 0 5.885777554226479e-08
analysis O 0 6.441817634872393e-10
on O 0 1.4327231845356891e-08
G2 O 0 6.041497524478245e-09
- O 0 3.647211976876008e-10
phase O 0 7.097297860525487e-09
lymphocytes O 0 1.0186095023012598e-11
from O 0 8.352174854509009e-12
7 O 0 2.0256485377956324e-09
unrelated O 0 9.099354159047834e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 6.952762254819334e-10
, O 0 2.233912273913452e-12
13 O 0 2.0455651061901392e-10
obligate O 0 1.2620751554948129e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 3.1306131020869543e-09
( O 0 1.7078446946580672e-12
parents O 0 3.5396778823998387e-12
of O 0 6.58964549593577e-12
the O 0 1.400397159345701e-11
patients O 0 2.0288044248056858e-12
) O 0 1.8668657657087973e-13
, O 0 2.022101670134946e-12
and O 0 5.165235253401512e-11
14 O 0 3.532940340278401e-08
normal O 0 1.2207791222351716e-08
controls O 0 2.4084736427454345e-09
following O 0 3.204063125927803e-10
X O 0 4.403672093644673e-08
- O 0 7.022001202727779e-09
irradiation O 0 6.6318195379722056e-09
with O 0 1.0664190884523972e-11
1 O 0 2.5827388228094605e-08
Gy O 0 6.7580172569137176e-09
in O 0 1.0534999522054944e-12
order O 0 1.7972873623400831e-12
to O 0 2.0609862774745302e-11
evaluate O 0 1.3593685205259831e-11
this O 0 7.134706887790276e-12
cytogenetic O 0 2.5852179064145275e-08
method O 0 1.1754094364491152e-09
as O 0 3.0630205403309185e-12
a O 0 1.6810440192638332e-11
tool O 0 2.4735199999348367e-10
for O 0 1.1167005688206277e-11
detection O 0 2.793249631594108e-09
of O 0 1.0860687904568067e-09
ATM O 0 3.0863670872349758e-06
carriers O 0 9.753006402490882e-09
. O 0 2.1688608242698137e-08

Both O 0 1.6236401734204264e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.8377506876277039e-06
and O 0 3.780180057866289e-10
heterozygotes O 0 1.1360864471399168e-09
showed O 0 9.068966931591316e-12
significantly O 0 1.8050524616675112e-11
increased O 0 2.2656241466245675e-11
levels O 0 1.198344756758729e-10
of O 0 1.7209948743879266e-10
radiation O 0 1.1910099601664115e-05
- O 0 1.0671021755115362e-06
induced O 0 1.1967163118242752e-05
chromatid O 0 1.9671856534841936e-06
damage O 0 6.044611922106924e-08
relative O 0 1.1427693236143455e-09
to O 0 5.779760350876906e-11
that O 0 3.5047177833480436e-12
of O 0 5.20618374799664e-11
normal O 0 1.357981638250294e-08
controls O 0 3.5020118360762353e-08
. O 0 6.624765624962947e-09

These O 0 2.1261394866911587e-09
results O 0 2.4875730364470883e-09
show O 0 2.923788988695719e-10
that O 0 1.1938088538554492e-11
the O 0 1.822586387367764e-10
G2 O 0 1.861199727670737e-08
- O 0 1.1661782650662644e-08
phase O 0 5.094191806165327e-07
chromosomal O 0 7.227639002849173e-07
radiosensitivity O 0 4.927027248413651e-07
assay O 0 2.604424231833491e-09
can O 0 1.1519615990274179e-11
be O 0 6.413194086028751e-13
used O 0 4.57999727010959e-14
for O 0 3.041320586214327e-14
the O 0 1.613438928901173e-13
detection O 0 8.292146830291003e-11
of O 0 3.4711186702729435e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.8111778647144092e-06
. O 0 6.419598008733374e-08

In O 0 2.4723997071873782e-08
combination O 0 1.591513054677307e-08
with O 0 2.0486976559652703e-09
molecular O 0 3.814897695519903e-07
genetic O 0 7.949430447240502e-09
analyses O 0 1.028215776410768e-10
, O 0 7.423474812293107e-13
this O 0 1.1548604954281227e-12
test O 0 3.0582218615154977e-12
may O 0 7.33380283585161e-12
be O 0 1.836781378036778e-12
of O 0 1.9273989956131166e-12
value O 0 1.9006833867213357e-12
in O 0 2.0247492918401555e-12
studies O 0 4.324862690197051e-11
of O 0 1.9273091456106783e-10
familial B-Disease 0 3.899198119938774e-08
and I-Disease 0 3.7539922281837335e-09
sporadic I-Disease 0 1.3401624983089278e-06
cancers I-Disease 0 5.042867087468039e-06
aimed O 0 2.1018382589943485e-09
at O 0 2.609191196434324e-10
determination O 0 6.670913127448941e-11
of O 0 1.1977135429275254e-11
the O 0 8.959977725042645e-12
potential O 0 9.792491470483888e-12
involvement O 0 1.838209445770289e-10
of O 0 5.038296446713275e-10
ATM O 0 2.0176673842797754e-06
mutations O 0 3.431459338898435e-09
in O 0 8.281086927297565e-10
tumor B-Disease 0 0.00017900117381941527
risk O 0 8.211276991687555e-08
or O 0 1.2267492577322514e-09
development O 0 6.016795950358755e-09
. O 0 1.593921217235561e-09
. O 0 7.961796555377987e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 5.673099212621935e-10
identification O 0 4.762442176731163e-11
and O 0 2.466822319330264e-12
detection O 0 1.561548446105121e-09
of O 0 4.1662481797821727e-10
founder O 0 2.9011646418553028e-09
- O 0 9.370506148798086e-09
effect O 0 6.849598435110238e-07
mutations O 0 1.9474677426245535e-09
in O 0 2.094597550961197e-10
the O 0 2.8794551187871775e-09
ATM O 0 1.0149305040840773e-07
gene O 0 7.363395310155951e-11
in O 0 5.994967716693722e-11
ethnic O 0 1.7664684159868216e-09
populations O 0 3.2411021089195913e-10
. O 0 3.983874119484199e-09

To O 0 9.212253182511176e-09
facilitate O 0 7.459979300961095e-10
the O 0 2.4129553910512413e-10
evaluation O 0 4.646828477561371e-10
of O 0 6.283837894471844e-10
ATM O 0 3.4851271379920945e-07
heterozygotes O 0 2.9394526812609456e-09
for O 0 2.3808668925262566e-10
susceptibility O 0 1.0647057990809117e-07
to O 0 1.6142555736564645e-08
other O 0 7.916229893822901e-10
diseases O 0 5.918096235291159e-07
, O 0 2.2049079576036412e-11
such O 0 1.5699784527978267e-10
as O 0 6.24124822934391e-07
breast B-Disease 1 0.9999079704284668
cancer I-Disease 1 0.9999743700027466
, O 0 9.761078612058327e-10
we O 0 2.2125890009050408e-10
have O 0 4.763284818659619e-12
attempted O 0 4.127436448175814e-10
to O 0 6.984286066158418e-11
define O 0 1.5738671477194544e-10
the O 0 9.832298170087128e-12
most O 0 4.877319251597734e-13
common O 0 1.3938523946155357e-11
mutations O 0 1.6067243022166444e-11
and O 0 1.3063442471858422e-12
their O 0 1.938218899613653e-12
frequencies O 0 1.0444979325896497e-09
in O 0 6.7660530511659545e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.4763676290385774e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.4383119695260405e-11
homozygotes O 0 1.7295408161199788e-10
from O 0 8.67960477796137e-12
10 O 0 5.277850725904365e-11
ethnic O 0 3.575166551694764e-11
populations O 0 5.97652899392287e-11
. O 0 7.154555281552177e-10

Both O 0 4.9719918848722955e-08
genomic O 0 1.0383273263414594e-07
mutations O 0 3.367504675111377e-08
and O 0 3.2880381750644005e-10
their O 0 8.023331304896075e-11
effects O 0 1.2996904663609143e-09
on O 0 2.75744960198665e-09
cDNA O 0 1.126548965224572e-09
were O 0 1.0126185306935653e-10
characterized O 0 1.0673134598349066e-09
. O 0 6.4135741162374416e-09

Protein O 0 1.4330538533613435e-08
- O 0 1.2825900341795204e-09
truncation O 0 1.1600796767652355e-08
testing O 0 1.6755485887642863e-10
of O 0 5.25814704277483e-11
the O 0 6.718028910945861e-11
entire O 0 2.2337962590768257e-09
ATM O 0 1.658948036720176e-07
cDNA O 0 2.946802446501806e-08
detected O 0 1.57280339863064e-08
92 O 0 2.637724261234098e-09
( O 0 2.6672263356286585e-11
66 O 0 4.7395296576269175e-09
% O 0 7.378058580753688e-11
) O 0 4.536497046070398e-12
truncating O 0 7.929804368700388e-09
mutations O 0 1.5040045597825014e-10
in O 0 3.0511794479881615e-11
140 O 0 5.533939972934832e-10
mutant O 0 5.083781728920655e-10
alleles O 0 3.390173697326304e-10
screened O 0 8.808284768235808e-09
. O 0 4.652559670859091e-09

The O 0 8.694349844518001e-07
haplotyping O 0 0.0013653654605150223
of O 0 9.576571073921514e-07
patients O 0 2.337323401491176e-08
with O 0 3.397616216149757e-11
identical O 0 4.891884231028598e-08
mutations O 0 5.392085427047277e-07
indicates O 0 1.2444817620860249e-08
that O 0 1.0549483162036744e-11
almost O 0 6.817031661388029e-11
all O 0 1.870116908553321e-12
of O 0 1.1505052553012485e-12
these O 0 4.186033776012142e-14
represent O 0 2.481777804097529e-12
common O 0 4.0085984531756935e-10
ancestry O 0 4.0156999947527083e-10
and O 0 6.239620625736464e-11
that O 0 4.5872170645333554e-11
very O 0 2.6749261139435987e-10
few O 0 2.231913986960876e-09
spontaneously O 0 2.9433813608648052e-08
recurring O 0 1.8460429629385544e-08
ATM O 0 1.023625100060599e-05
mutations O 0 1.4565938499799813e-07
exist O 0 6.249693740301154e-08
. O 0 4.585903212728226e-08

Assays O 0 7.060790352397817e-08
requiring O 0 1.1049833936738196e-08
minimal O 0 6.818849129786031e-08
amounts O 0 2.7421662718296602e-09
of O 0 1.7753688519306365e-09
genomic O 0 3.51851853208629e-10
DNA O 0 1.6272684588702901e-10
were O 0 3.666624837951604e-13
designed O 0 3.638604717005889e-13
to O 0 7.414195993260542e-12
allow O 0 7.151573604147199e-12
rapid O 0 1.0326472316135593e-11
screening O 0 2.177432279620861e-12
for O 0 3.4868863438980435e-13
common O 0 1.6409011649454186e-10
ethnic O 0 1.044827246943214e-08
mutations O 0 1.1397685284464387e-07
. O 0 1.4327094177701838e-08

These O 0 4.3188164156049424e-09
rapid O 0 4.5550869742783107e-08
assays O 0 4.984687151932121e-08
detected O 0 2.3314726149692433e-08
mutations O 0 3.9576956295528376e-11
in O 0 4.621147648570245e-12
76 O 0 1.1983339875953902e-09
% O 0 8.02106644992584e-11
of O 0 9.053313654305839e-11
Costa O 0 2.3527192638539418e-07
Rican O 0 3.0181568035914097e-06
patients O 0 4.239429252095306e-09
( O 0 7.229941905578796e-12
3 O 0 1.8352885877703784e-09
) O 0 3.424678617948429e-13
, O 0 4.306912357136816e-13
50 O 0 2.107090370240261e-11
% O 0 4.383525660511811e-12
of O 0 4.2708558044279865e-12
Norwegian O 0 5.073344411243852e-08
patients O 0 3.6042466233787707e-10
( O 0 3.861408155031443e-12
1 O 0 7.071772500921725e-09
) O 0 7.039808731616748e-13
, O 0 6.858132226179869e-13
25 O 0 6.648873812631351e-11
% O 0 7.953725351950158e-12
of O 0 4.124512797271107e-12
Polish O 0 7.461676609921142e-09
patients O 0 3.590023556210298e-10
( O 0 6.389498739128863e-12
4 O 0 3.6526859314989224e-09
) O 0 8.575748076077028e-13
, O 0 3.144532431751529e-13
and O 0 7.228973279357898e-13
14 O 0 1.9658129291055815e-10
% O 0 8.42462124367449e-12
of O 0 4.6913159121309e-12
Italian O 0 4.899014971471161e-09
patients O 0 1.3695501677180033e-10
( O 0 1.222510894599571e-11
1 O 0 3.702518256432086e-07
) O 0 6.680615088905384e-11
, O 0 3.414494034736926e-11
as O 0 2.8581014291373386e-11
well O 0 1.8104235558619175e-12
as O 0 1.9720223717878405e-12
in O 0 2.259912959892696e-12
patients O 0 2.3112338865677318e-12
of O 0 1.2372235180801994e-11
Amish O 0 1.0958319807130579e-09
/ O 0 3.3503717578042824e-09
Mennonite O 0 1.6332021290921261e-09
and O 0 7.981977925841655e-12
Irish O 0 5.6241615531416045e-11
English O 0 1.810867428231333e-10
backgrounds O 0 7.317685346563962e-10
. O 0 3.2658387105755082e-09

Additional O 0 4.104517756786663e-07
mutations O 0 3.496591816087857e-08
were O 0 1.699064999804989e-09
observed O 0 4.151826382692292e-10
in O 0 2.021238905414169e-11
Japanese O 0 1.0010335893539946e-09
, O 0 2.9659868311382453e-11
Utah O 0 8.323874922666619e-10
Mormon O 0 3.132347853318507e-11
, O 0 3.1055271743941903e-13
and O 0 6.756586392805963e-13
African O 0 1.555993008051093e-11
American O 0 2.8720803513238025e-11
patients O 0 2.656768416375854e-10
. O 0 1.8252171996024913e-09

These O 0 1.248936648545751e-10
assays O 0 4.6471097803202355e-11
should O 0 1.5508426791030483e-12
facilitate O 0 1.441909525806695e-12
screening O 0 2.93045774278633e-12
for O 0 1.7815509484320202e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 8.021671327185231e-09
in O 0 3.53907250727481e-11
the O 0 5.960250348824303e-11
populations O 0 4.827952274077951e-12
studied O 0 7.102544941073319e-11
. O 0 6.842577199295263e-11
. O 0 3.740947551733598e-09

The O 0 1.5138741673581535e-06
von B-Disease 1 1.0
Hippel I-Disease 1 0.9999979734420776
- I-Disease 1 0.9998525381088257
Lindau I-Disease 0 0.08261521905660629
tumor I-Disease 0 4.456825627130456e-05
suppressor O 0 3.1357721752556245e-08
gene O 0 1.0482589622717864e-11
is O 0 5.835872150111721e-13
required O 0 6.246166344564541e-12
for O 0 8.160035147586342e-12
cell O 0 6.1041607324341385e-09
cycle O 0 1.837226371037559e-08
exit O 0 2.044637570364216e-09
upon O 0 2.591915015948132e-10
serum O 0 1.2754470812836871e-09
withdrawal O 0 1.2296951013013313e-07
. O 0 4.5374410007070765e-08

The O 0 2.0092342012389963e-08
inactivation O 0 8.333830919582397e-06
of O 0 2.766865847547706e-08
the O 0 3.032600304209154e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 3.643580157586257e-06
VHL I-Disease 1 0.9997005462646484
) I-Disease 0 5.2151936102973195e-09
tumor I-Disease 0 0.07254274934530258
suppressor O 0 1.864248224592302e-05
gene O 0 5.208890652141918e-09
predisposes O 0 2.3946506999550365e-08
affected O 0 1.8958479230946068e-10
individuals O 0 6.389446805844801e-13
to O 0 1.6886747555844295e-09
the O 0 4.4837310753109705e-08
human O 0 0.0036535351537168026
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 2.0429136160515782e-10
is O 0 1.0933213535901931e-11
associated O 0 1.7784383687935446e-10
with O 0 6.096463611715564e-11
sporadic B-Disease 0 0.1314651370048523
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 1.2790980008503539e-06
RCC B-Disease 0 0.001790510374121368
) O 0 6.592043799713565e-09
and O 0 5.253914281411198e-08
brain B-Disease 1 0.8926962018013
hemangioblastomas I-Disease 0 0.0002817540371324867
. O 0 8.194894007829134e-07

VHL O 0 0.011015970259904861
- O 0 4.187106969766319e-05
negative O 0 3.116072321063257e-06
786 O 0 2.709595491978689e-06
- O 0 9.76834826360573e-07
0 O 0 1.5864070235238614e-07
RCC B-Disease 0 4.903374701825669e-07
cells O 0 2.2011631628515715e-08
are O 0 1.2292923623480334e-10
tumorigenic O 0 1.4101416354606044e-06
in O 0 1.9345774759926826e-08
nude O 0 5.587346763036294e-08
mice O 0 3.7220282411709604e-10
which O 0 1.017019042766354e-12
is O 0 1.7361990751335599e-12
suppressed O 0 7.864136425395074e-12
by O 0 3.942700766562668e-12
the O 0 3.7426872712131853e-10
reintroduction O 0 1.2647529956666403e-07
of O 0 2.1595349952718834e-09
VHL B-Disease 0 5.572495501837693e-05
. O 0 5.048719913247623e-07

Remarkably O 0 4.0182715110859135e-07
, O 0 9.162966913001114e-11
this O 0 1.4676456230877655e-11
occurs O 0 1.077158084950014e-10
without O 0 5.4503547508577554e-11
affecting O 0 6.237954597310136e-11
the O 0 7.590152811820516e-11
growth O 0 9.258924876798247e-11
rate O 0 3.0219038382739427e-10
and O 0 1.9006804810595135e-11
cell O 0 7.670775126200624e-09
cycle O 0 2.0013464219204025e-09
profile O 0 7.50154972861683e-12
of O 0 2.1628469848433696e-11
these O 0 1.7342463186006962e-12
cells O 0 3.806834014685734e-11
in O 0 9.959134211756648e-12
culture O 0 1.701898899586496e-10
. O 0 1.531687221500988e-09

The O 0 4.5065547737976885e-07
786 O 0 4.7549931991852645e-07
- O 0 9.894418440126174e-08
0 O 0 1.4323405572724823e-08
cell O 0 2.8745001934282755e-09
line O 0 5.678677528209164e-09
, O 0 5.615607978626258e-11
like O 0 1.6498948041121508e-11
many O 0 4.823481544735664e-11
cancer B-Disease 0 7.750337260858942e-09
cells O 0 1.4183329510863985e-10
, O 0 5.22623871263006e-12
fails O 0 8.698524123218476e-10
to O 0 5.377394085570586e-10
exit O 0 5.5518620811767505e-09
the O 0 8.345208968307816e-10
cell O 0 1.1786241982392198e-09
cycle O 0 1.3302224877165258e-09
upon O 0 1.191952925250206e-10
serum O 0 1.2696994566852027e-09
withdrawal O 0 6.335411484315046e-08
. O 0 2.8616188529895226e-08

Here O 0 1.4442470330777724e-07
, O 0 1.3095685647002142e-10
it O 0 2.433683029406941e-12
is O 0 3.7197230972479955e-13
shown O 0 1.179278435970918e-13
that O 0 6.971448700439364e-13
reintroduction O 0 2.0322583615950407e-09
of O 0 3.168122708618881e-11
the O 0 1.4343949639172848e-10
wild O 0 1.539627758617712e-09
- O 0 9.479334650563942e-09
type O 0 4.3752655187745404e-07
VHL B-Disease 0 3.3206244552275166e-05
gene O 0 3.3439109259347788e-09
restores O 0 1.8808945512205355e-09
the O 0 5.2873826844601624e-11
ability O 0 3.250808303101316e-11
of O 0 5.480818576764079e-10
VHL O 0 4.578571861202363e-06
- O 0 1.5368683534688898e-06
negative O 0 4.353472320417495e-07
RCC B-Disease 0 5.525598680833355e-06
cancer I-Disease 0 3.8928041590224893e-07
cells O 0 1.9359264191720627e-10
to O 0 5.258400381791262e-10
exit O 0 7.386383726881718e-10
the O 0 8.024034908737931e-11
cell O 0 1.3437218004952456e-10
cycle O 0 3.0378655146989786e-10
and O 0 6.4199531107922425e-12
enter O 0 8.709750254354276e-09
G0 O 0 1.4134122466202825e-05
/ O 0 1.0386121402916615e-06
quiescence O 0 5.151037498762889e-07
in O 0 1.0273517592196413e-09
low O 0 7.408669233655019e-08
serum O 0 5.948717518577951e-09
. O 0 2.4187625236038457e-09

Both O 0 2.6268011765751e-07
VHL O 0 0.0004484846431296319
- O 0 4.547327534965007e-06
positive O 0 2.607948523802861e-09
and O 0 6.452220424613131e-10
VHL O 0 1.8116347746399697e-06
- O 0 5.0115229299763087e-08
negative O 0 1.1066411786941899e-08
RCC B-Disease 0 4.36992770858069e-08
cells O 0 3.063282294490932e-09
exit O 0 4.027929545458164e-09
the O 0 9.70134528266442e-11
cell O 0 9.332219719215828e-11
cycle O 0 1.3319025049529643e-10
by O 0 1.468384008135315e-12
contact O 0 6.1636638015727385e-09
inhibition O 0 1.8244914201659412e-07
. O 0 1.26448156834158e-07

The O 0 2.7224118639423978e-06
cyclin O 0 1.1624661055975594e-06
- O 0 1.2092272072550259e-07
dependent O 0 8.992129352236589e-08
kinase O 0 5.631941846218069e-08
inhibitor O 0 2.506381768796473e-08
, O 0 1.325157067411098e-10
p27 O 0 9.391368571698422e-09
, O 0 1.1071673959583972e-11
accumulates O 0 4.496785235841294e-11
upon O 0 2.0031087899496924e-11
serum O 0 2.3468482365784915e-11
withdrawal O 0 1.8873484997072865e-09
, O 0 4.733199075734884e-12
only O 0 6.661080974995626e-12
in O 0 4.96771590877132e-12
the O 0 2.8246637667761476e-11
presence O 0 4.960314450852543e-11
of O 0 1.7839975052780233e-09
VHL B-Disease 0 1.9358158169779927e-06
, O 0 3.444189725088087e-11
as O 0 3.5332563697726416e-12
a O 0 1.1477770123224929e-11
result O 0 1.9391332289897534e-11
of O 0 1.3622703659565971e-11
the O 0 1.1386884490871552e-11
stabilization O 0 2.308149227303602e-09
of O 0 3.715717289409781e-09
the O 0 1.0708723685581845e-08
protein O 0 6.712876654546562e-08
. O 0 7.989194195090477e-09

We O 0 4.468932779388979e-09
propose O 0 7.34006899705264e-09
that O 0 4.822322749453711e-11
the O 0 5.111647771727235e-10
loss O 0 2.0380965803923345e-09
of O 0 1.8583574679098547e-09
wild O 0 3.082659461028925e-09
- O 0 4.9667758794669226e-09
type O 0 1.326484095898195e-07
VHL B-Disease 0 5.50447657587938e-06
gene O 0 3.091802369681318e-10
results O 0 2.2978209612833922e-10
in O 0 3.481281235506728e-11
a O 0 3.9654654560017377e-10
specific O 0 3.696856598622844e-09
cellular O 0 2.6268407893326184e-08
defect O 0 5.161530580721774e-08
in O 0 9.703811088002112e-10
serum O 0 1.1827414603260422e-08
- O 0 3.8465817198130026e-08
dependent O 0 4.5620776489840864e-08
growth O 0 4.607071113493788e-10
control O 0 2.948221666798645e-10
, O 0 7.089152398789822e-13
which O 0 6.963727554668009e-13
may O 0 5.397380320459888e-10
initiate O 0 8.86378259679077e-09
tumor B-Disease 0 3.2692159379621444e-07
formation O 0 6.486453596465935e-09
. O 0 1.602927923727293e-08

This O 0 9.812679557796855e-09
is O 0 3.677115001377018e-10
corrected O 0 6.292401044660778e-10
by O 0 1.1766957200287642e-11
the O 0 6.382221418022027e-10
reintroduction O 0 2.4837245149456066e-08
of O 0 6.595838875078641e-10
wild O 0 4.741030679156211e-09
- O 0 3.609512688740324e-08
type O 0 1.5897336197667755e-05
VHL B-Disease 1 0.9997426867485046
, O 0 1.3203148796492314e-07
implicating O 0 8.435852942056954e-05
VHL B-Disease 0 0.0009681889205239713
as O 0 1.1539557753792451e-08
the O 0 1.854646547450045e-09
first O 0 2.703067769616041e-10
tumor B-Disease 0 1.7855805722888363e-09
suppressor O 0 1.3423929745570717e-09
involved O 0 1.2608196604813049e-11
in O 0 6.74856568197435e-12
the O 0 1.336878246993578e-10
regulation O 0 5.979896022800801e-10
of O 0 1.5536458786158391e-09
cell O 0 3.189723374319442e-09
cycle O 0 2.037837099067019e-08
exit O 0 2.397738896320334e-09
, O 0 1.8420787898515423e-12
which O 0 1.7226878560802628e-12
is O 0 7.333103742290792e-12
consistent O 0 4.587497395847073e-11
with O 0 5.023674076558293e-13
its O 0 9.776743997713666e-11
gatekeeper O 0 5.063587327214236e-09
function O 0 4.5698042572261954e-11
in O 0 2.0476407028291455e-11
the O 0 1.081747913467268e-09
kidney O 0 1.2016187156405067e-06
. O 0 2.457363423857828e-09
. O 0 1.9428087583150955e-08

Piebaldism B-Disease 1 1.0
with O 1 0.9962320923805237
deafness B-Disease 1 1.0
: O 0 4.206182779853407e-08
molecular O 0 4.375654949484442e-09
evidence O 0 1.4132985580450619e-11
for O 0 6.710453590366705e-13
an O 0 7.311247093855222e-12
expanded O 0 2.007357302602486e-08
syndrome O 1 0.9999997615814209
. O 0 7.614523269694473e-07

In O 0 7.112362920835835e-10
a O 0 5.832075933298597e-10
South O 0 6.695211607343765e-10
African O 0 1.3305161139509636e-10
girl O 0 5.037277817088182e-10
of O 0 6.456403467414162e-11
Xhosa O 0 3.5072575954586682e-09
stock O 0 3.629292699702802e-11
with O 0 2.025675363125784e-13
severe O 0 7.170379831222817e-06
piebaldism B-Disease 0 0.00042690010741353035
and O 0 1.3569541579272482e-07
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.249248427688144e-05
identified O 0 6.253301210179529e-10
a O 0 1.8992201908374362e-11
novel O 0 2.2883856268252067e-11
missense O 0 5.226902244359621e-10
substitution O 0 2.8652752392943626e-10
at O 0 1.3593777214992997e-09
a O 0 2.707887247765939e-10
highly O 0 3.7668720920258636e-10
conserved O 0 3.1573159642306337e-09
residue O 0 8.4898054808491e-08
in O 0 6.979199163037464e-11
the O 0 3.782762159065811e-10
intracellular O 0 8.178351884602364e-10
kinase O 0 2.816227429036644e-08
domain O 0 9.315868076953393e-09
of O 0 8.888496050296624e-10
the O 0 6.72787991984336e-10
KIT O 0 5.8006644820807196e-08
proto O 0 5.253123163129203e-07
- O 0 9.819235202712662e-08
oncogene O 0 1.40322200081755e-07
, O 0 1.4316399454816775e-10
R796G O 0 9.314873068433371e-07
. O 0 8.909887050378984e-09

Though O 0 1.3143239812052343e-06
auditory B-Disease 0 0.0625700056552887
anomalies I-Disease 0 0.2543085217475891
have O 0 1.171821750745039e-08
been O 0 3.632398826169947e-09
observed O 0 2.177368951805647e-09
in O 0 8.812880286646063e-11
mice O 0 1.9556072039517147e-10
with O 0 3.925861372100492e-12
dominant O 0 1.8549515701238306e-08
white O 0 2.6121003138257493e-09
spotting O 0 7.260662471253454e-08
( O 0 8.148472452340627e-10
W O 0 1.2894535075247404e-06
) O 0 1.329470977751157e-10
due O 0 1.4053058805529872e-07
to O 0 2.203860027805149e-08
KIT O 0 6.46769240120193e-06
mutations O 0 4.11790506404941e-06
, O 0 2.8277081582928076e-06
deafness B-Disease 1 1.0
is O 0 6.78925760055904e-09
not O 0 3.5472783044276923e-10
typical O 0 8.74298522468564e-10
in O 0 1.769904223181129e-10
human O 0 1.2672558558080027e-09
piebaldism B-Disease 0 2.8391195883159526e-06
. O 0 6.535858432243913e-08

Thus O 0 3.2994673659914042e-09
, O 0 1.721663957232611e-11
the O 0 5.17154444268364e-11
occurrence O 0 1.9158502340133055e-08
of O 0 6.341565494949464e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.00038506221608258784
this O 0 1.6695629767582432e-07
patient O 0 3.549786242729169e-08
extends O 0 7.428345161208938e-10
considerably O 0 9.96615082127228e-11
the O 0 1.3727349118530796e-11
phenotypic O 0 3.1921318366379126e-10
range O 0 4.280322318805929e-09
of O 0 9.448066773387609e-10
piebaldism B-Disease 0 4.6423551225416304e-07
due O 0 2.793635474063194e-07
to O 0 2.69316888790172e-08
KIT O 0 4.983627945875924e-07
gene O 0 1.0696101782059486e-09
mutation O 0 1.0669409800101448e-09
in O 0 6.554125298041669e-11
humans O 0 2.4668389553283987e-10
and O 0 7.949058078438043e-11
tightens O 0 1.7763611692700465e-09
the O 0 3.2065253230406654e-11
clinical O 0 2.352375239045301e-10
similarity O 0 1.0642204999189442e-11
between O 0 7.36824212754783e-11
piebaldism B-Disease 0 1.6799823754354293e-08
and O 0 1.245452742673625e-12
the O 0 1.0612059191464351e-12
various O 0 1.1267679497772853e-13
forms O 0 8.451985639146287e-11
of O 0 8.058337996885712e-09
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.279170369627991e-08
. O 0 2.739214188807182e-08

Cycloheximide O 0 9.153212090495799e-07
facilitates O 0 2.359863193746037e-09
the O 0 9.651812682420768e-10
identification O 0 2.7976149175046316e-10
of O 0 3.6912901624219785e-09
aberrant O 0 7.126434997672959e-09
transcripts O 0 8.254094296944459e-09
resulting O 0 8.998332079457327e-10
from O 0 2.9620250696638095e-10
a O 0 2.4512158969258735e-10
novel O 0 4.3606893096459487e-10
splice O 0 3.843580120843626e-09
- O 0 2.2798871124329878e-10
site O 0 8.568350889914811e-11
mutation O 0 1.7129577270513785e-11
in O 0 1.1175911758531942e-11
COL17A1 O 0 0.00011477346561150625
in O 0 5.656481394389345e-10
a O 0 2.4037433377088746e-08
patient O 0 4.898924430563056e-07
with O 0 9.252679733506852e-10
generalized O 1 0.9999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999992847442627
bullosa I-Disease 0 0.01304276380687952
. O 0 5.951580419605307e-07

Patients O 0 1.6758270930949948e-06
with O 0 1.7258674489539771e-09
generalized O 1 0.9999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.05148756131529808
often O 0 6.090132287361882e-10
show O 0 5.954216980574856e-11
decreased O 0 3.5447622614981356e-10
expression O 0 1.5327553462562982e-11
of O 0 1.1874734529015996e-10
type O 0 6.200358448893439e-09
XVII O 0 2.258643689856399e-06
collagen O 0 4.258727770434234e-08
, O 0 9.135346923372367e-10
a O 0 7.1904153742252674e-09
transmembrane O 0 2.5919086965586757e-07
hemidesmosomal O 0 1.7722477707593498e-07
protein O 0 3.714156482370612e-10
encoded O 0 3.784331788908579e-12
by O 0 3.8705604693545226e-11
COL17A1 O 0 4.301400622352958e-05
. O 0 1.0403434202999051e-07

This O 0 7.137685109626091e-09
report O 0 3.7554298559783206e-10
documents O 0 6.158323156979506e-11
a O 0 2.995494963187184e-10
novel O 0 9.797600508676396e-10
splice O 0 7.639543220250289e-09
- O 0 4.688421872955928e-10
site O 0 2.3494156620174067e-10
mutation O 0 2.3338183816057345e-11
in O 0 2.4422311395433383e-11
COL17A1 O 0 0.027743661776185036
in O 0 2.4376449747620654e-09
a O 0 7.335943763564501e-08
patient O 0 2.1681739781342912e-06
with O 0 1.8601375995075387e-09
generalized O 1 0.9999988079071045
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9990020394325256
bullosa I-Disease 0 8.186348713934422e-05
, O 0 1.0468668293350802e-10
and O 0 1.1797790175349654e-11
applies O 0 1.387452652767962e-10
a O 0 3.277042179283818e-11
new O 0 5.801935754751186e-12
methodology O 0 1.6218760709452162e-11
to O 0 5.216621232206897e-11
define O 0 2.7709506911222093e-10
and O 0 2.6782581361017854e-11
characterize O 0 5.461974428300209e-09
the O 0 6.889950276978141e-10
resulting O 0 5.191055363340524e-10
mRNA O 0 1.4648036561482058e-08
splice O 0 2.27309833178424e-08
variants O 0 5.564538829716525e-10
. O 0 2.2466748461624775e-09

Mutational O 0 1.2373299796308856e-05
analysis O 0 8.187189592945288e-09
of O 0 3.1595345006962816e-08
COL17A1 O 1 0.9895350337028503
identified O 0 8.379796412327778e-08
a O 0 5.979158057556333e-09
maternally O 0 2.3967068329966423e-08
inherited O 0 7.622517017580321e-08
G O 0 4.0343827834021795e-08
- O 0 1.511745395532671e-08
to O 0 2.161201138051183e-07
- O 0 1.0020828540291404e-06
T O 0 3.5306904067056166e-08
transversion O 0 2.433920087696606e-08
at O 0 4.981298706852044e-10
the O 0 7.570355800567974e-12
- O 0 1.4937433234774034e-11
1 O 0 1.1052990744886415e-09
position O 0 5.233046773689409e-10
of O 0 1.1997444704370253e-10
exon O 0 2.4234820816815272e-09
32 O 0 1.2326863085831974e-08
. O 0 5.546644032961012e-09

This O 0 8.191766376342002e-09
acceptor O 0 2.726655567997227e-09
splice O 0 1.1115257159133307e-08
- O 0 1.3229303208461829e-09
site O 0 7.837595017434751e-10
mutation O 0 4.599535335936267e-11
led O 0 1.1581942002680812e-11
to O 0 1.8598812767667283e-10
the O 0 6.174144528969805e-10
formation O 0 4.322624036490197e-09
of O 0 1.348949325574722e-07
aberrant O 0 1.146901738025008e-07
transcripts O 0 1.1173567315836408e-07
present O 0 1.0059607369328205e-08
at O 0 5.839406114205303e-08
extremely O 0 1.0691539209517487e-08
low O 0 4.4370511886882014e-07
levels O 0 6.594788004576912e-08
. O 0 1.046157382944557e-08

Based O 0 1.169236263365292e-08
on O 0 1.744728308494814e-07
our O 0 2.762149120538737e-10
recent O 0 3.278980559295874e-11
finding O 0 3.831543068932852e-11
that O 0 2.5798629725570787e-12
cycloheximide O 0 3.664327152819169e-08
stabilized O 0 4.083800604348653e-07
mutant O 0 3.3382601571929627e-08
COL17A1 O 0 1.0429674830447766e-06
transcripts O 0 2.381431274400825e-09
in O 0 6.639913618933235e-11
keratinocytes O 0 2.826320955051642e-09
homozygous O 0 2.1884962592144674e-11
for O 0 5.048641626287376e-12
a O 0 1.0508404146847283e-09
frameshift O 0 1.0727846984082134e-06
mutation O 0 4.586996737998561e-08
, O 0 1.3697434853021662e-10
the O 0 4.817287124758707e-10
effects O 0 1.993484133322454e-08
of O 0 1.1034943625531923e-08
the O 0 4.7038484218830945e-09
splice O 0 1.0916476611555481e-08
- O 0 1.3363486983664075e-09
site O 0 6.117281126094554e-10
mutation O 0 3.7828035842624175e-11
on O 0 1.6507872846460714e-09
splicing O 0 3.438415663303829e-10
of O 0 5.130186275792425e-10
COL17A1 O 0 7.320903137042478e-07
transcripts O 0 5.3137751976350955e-09
were O 0 1.2375876712322764e-10
determined O 0 1.119321926812411e-10
using O 0 2.4124757747046033e-11
reverse O 0 1.3232835938126186e-09
transcriptase O 0 1.8236016863237836e-10
polymerase O 0 1.4487973321042347e-10
chain O 0 4.6639012096783006e-11
reaction O 0 3.678913944316076e-12
of O 0 2.7531810165015713e-10
total O 0 5.369264408083829e-11
RNA O 0 4.080118881644168e-11
from O 0 2.7765730686857282e-11
keratinocytes O 0 4.684792553888428e-10
incubated O 0 5.8107654105077344e-11
for O 0 6.501715832385457e-12
2 O 0 2.3118204239835904e-08
. O 0 7.889944697581086e-09

5 O 0 1.9971887468273053e-06
h O 0 3.1825888591185958e-09
in O 0 3.982107699140869e-11
the O 0 6.809286468012488e-11
presence O 0 1.7836385146630107e-11
or O 0 1.1149543510668991e-09
absence O 0 2.917202301944144e-08
of O 0 1.6725703044784268e-09
10 O 0 3.751050581257687e-09
microg O 0 5.2294403474206774e-08
cycloheximide O 0 1.0281740259188155e-07
per O 0 4.102740192024612e-08
ml O 0 2.845633844117401e-07
. O 0 1.1338918248782193e-08

Using O 0 2.564221335266126e-10
this O 0 3.145879390320516e-11
approach O 0 1.7364965021471335e-09
, O 0 1.0573823067128174e-10
an O 0 3.0352881319473113e-10
abnormally O 0 2.522893893797118e-09
spliced O 0 1.4754075738920847e-09
transcript O 0 1.169019991920095e-08
was O 0 5.283607329431561e-09
identified O 0 6.978812666647016e-11
that O 0 5.725693356939399e-13
contains O 0 5.359242238357764e-13
an O 0 9.337751925853066e-12
extra O 0 8.307977916732767e-11
264 O 0 1.4372542045393288e-10
bases O 0 1.185744419318624e-10
upstream O 0 1.1011831446694487e-09
from O 0 3.3001831822865313e-10
exon O 0 6.280446718243127e-10
32 O 0 7.515864597351651e-10
, O 0 2.6039734604688114e-12
resulting O 0 2.0546906190355152e-11
in O 0 3.899326000977865e-11
a O 0 8.850470578636305e-09
premature O 0 2.0071128403742478e-07
termination O 0 6.611046501348028e-07
codon O 0 2.982096134473977e-07
27 O 0 4.141237468502368e-07
bp O 0 5.463373398129079e-08
downstream O 0 1.3835457224331549e-08
from O 0 1.1697889323869504e-09
the O 0 2.751938010803201e-09
cryptic O 0 4.615757021042555e-08
splice O 0 1.7026026455368992e-07
site O 0 1.0875909062235678e-08
. O 0 5.882127673828563e-09

Three O 0 5.067926078794471e-09
other O 0 8.132940848559755e-11
splice O 0 2.3668274007349055e-09
variants O 0 1.4120240567072617e-11
, O 0 7.428078334717481e-13
including O 0 7.005461206792407e-14
one O 0 1.4407796787227478e-12
derived O 0 2.0585219726726445e-12
from O 0 7.157745923747072e-11
the O 0 6.462575613541688e-11
skipping O 0 1.3017513456059504e-10
of O 0 1.3107057106331865e-10
exon O 0 2.0646623299924727e-10
32 O 0 2.063659243489724e-09
, O 0 2.279498811930125e-11
were O 0 1.6731374619105566e-10
also O 0 1.4356567323847713e-10
identified O 0 9.600463535264225e-09
. O 0 1.4946119009096037e-08

These O 0 1.5351471205349299e-09
results O 0 5.899168931122745e-10
indicate O 0 3.898242284527953e-10
the O 0 1.5409343245842422e-10
usefulness O 0 5.382935763798002e-10
of O 0 1.8947697577598177e-11
cycloheximide O 0 1.5353528226569324e-08
treatment O 0 5.718182594094401e-10
in O 0 8.09261251760729e-12
evaluating O 0 3.2923164194897936e-11
the O 0 5.954662873897121e-10
abnormal O 0 8.143627994172675e-09
processing O 0 1.2650805736313941e-08
of O 0 1.673174310212744e-08
mRNA O 0 2.712418378791881e-08
due O 0 2.922343469435873e-07
to O 0 8.753768376834614e-09
splice O 0 1.7272975938453783e-08
- O 0 2.321956626971655e-09
site O 0 4.52625964486586e-10
mutations O 0 1.2755704825728742e-10
, O 0 1.0620568660635321e-11
because O 0 3.0626964853119887e-10
( O 0 1.225456069953168e-09
i O 0 2.379853043521507e-07
) O 0 8.911429372204793e-10
aberrant O 0 6.403099384044708e-09
splicing O 0 1.0552089202420234e-09
often O 0 6.0747661241589146e-12
generates O 0 3.528771025385069e-12
a O 0 7.109281219275232e-11
premature O 0 1.717373443455017e-08
termination O 0 2.7273591385323925e-08
codon O 0 8.144995788939013e-09
, O 0 1.4605895659602908e-10
( O 0 5.6205051029989406e-11
ii O 0 2.76283138589406e-08
) O 0 1.0243751680238944e-10
transcripts O 0 7.381538713602254e-10
with O 0 1.733251910052136e-11
premature O 0 3.0936931239011756e-08
termination O 0 7.713575200796186e-08
codons O 0 1.5825440513594913e-08
can O 0 5.066473907078262e-10
occur O 0 1.5142093134912216e-09
at O 0 2.2696053925130855e-09
low O 0 1.530295001828108e-08
or O 0 4.058096969572489e-09
undetectable O 0 2.5223563682175154e-08
levels O 0 4.1355141533472306e-10
due O 0 2.9035560622503453e-09
to O 0 5.540561898165208e-10
nonsense O 0 6.8748540194008e-10
- O 0 1.752526873621818e-10
mediated O 0 5.195277541503174e-09
mRNA O 0 1.9654613492292583e-09
decay O 0 1.1076569883528009e-08
, O 0 6.376772482448445e-13
and O 0 5.503038346191258e-13
( O 0 1.0856244722634578e-11
iii O 0 2.1561280760806767e-08
) O 0 1.521553438799117e-10
the O 0 2.5013513482718963e-09
levels O 0 1.561751061807115e-09
of O 0 1.2102709112671306e-10
these O 0 5.138309482760617e-12
transcripts O 0 7.65860361240378e-11
can O 0 4.030152513795349e-12
be O 0 7.59220551010964e-12
increased O 0 7.063174264215766e-12
by O 0 4.965672317780445e-11
cycloheximide O 0 1.7631322180022835e-06
. O 0 3.1364418617840784e-08

A O 0 1.951190370164113e-06
deletion O 0 7.428344019899669e-07
mutation O 0 2.907756924130922e-09
in O 0 3.691188327215045e-11
COL17A1 O 0 3.416569143155357e-06
in O 0 3.4075978150305275e-11
five O 0 7.001946245033253e-11
Austrian O 0 5.645909961771167e-09
families O 0 1.9897051020678624e-11
with O 0 4.825653418527587e-11
generalized O 1 0.9999892711639404
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999934434890747
bullosa I-Disease 0 6.780632247682661e-05
represents O 0 5.555926829714508e-10
propagation O 0 9.263367850564919e-09
of O 0 3.429104111773995e-09
an O 0 2.2899455942582136e-10
ancestral O 0 2.062515314094071e-08
allele O 0 1.1219397322292934e-07
. O 0 4.233960382293844e-08

Patients O 0 2.1258097149257082e-06
with O 0 1.2039491625870369e-09
generalized O 1 0.9997410178184509
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 0 0.08537852764129639
, O 0 4.451270185779066e-10
a O 0 1.760497025937724e-10
usually O 0 3.5937489095694275e-11
nonlethal O 0 6.395544094317529e-09
form O 0 3.038272744504411e-09
of O 0 8.605178436482674e-07
junctional B-Disease 1 0.9997629523277283
epidermolysis I-Disease 1 0.9858596920967102
bullosa I-Disease 0 0.00022300434648059309
, O 0 2.4593035941045116e-10
have O 0 1.9862585534657917e-11
generalized O 0 2.5641393452957573e-09
blistering B-Disease 0 3.2222570212070423e-07
, O 0 1.6056007912101933e-10
nail B-Disease 0 0.0007508110138587654
dystrophy I-Disease 1 0.9997774958610535
, O 0 2.4584510356362443e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 2.9066661682009e-06
and O 1 0.9101322293281555
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 1.0

Skin B-Disease 1 1.0
fragility I-Disease 0 0.000604306987952441
in O 0 1.2345916511335986e-09
most O 0 1.430132661600636e-11
cases O 0 6.0687206128451354e-12
is O 0 1.8883323724128154e-12
due O 0 2.5584334650829987e-09
to O 0 2.6498012672959703e-09
mutations O 0 7.174861815784084e-10
in O 0 1.0041117937120703e-10
the O 0 2.940937215978323e-10
gene O 0 1.6349770495804883e-11
encoding O 0 2.189862735590964e-10
type O 0 4.149534404973565e-08
XVII O 0 7.186851235019276e-06
collagen O 0 1.1088157947369837e-07
( O 0 1.87064785883706e-09
COL17A1 O 0 1.0104537068400532e-05
) O 0 2.824449563121334e-10
. O 0 2.1239388026117467e-09

Recently O 0 1.320186413522606e-07
, O 0 1.5029177902192714e-10
we O 0 1.6464399288373954e-11
reported O 0 8.071384706431761e-12
five O 0 7.691474410501109e-13
Austrian O 0 1.354477641157814e-10
families O 0 1.0803029477923776e-12
with O 0 5.30234666937246e-12
generalized O 1 0.9991058707237244
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.510726273059845
who O 0 3.945008320016541e-09
share O 0 2.3228281798015615e-10
the O 0 3.362854439359353e-10
same O 0 2.014551636619899e-09
COL17A1 O 0 0.0004409850516822189
mutation O 0 1.0130098644367536e-06
. O 0 6.203897839895944e-08

Affected O 0 1.5167108813329833e-07
individuals O 0 1.548881439772387e-10
in O 0 8.966222209139119e-11
three O 0 3.878941612356357e-11
families O 0 3.964160597003108e-12
are O 0 3.356358160150341e-13
homozygous O 0 1.0442016175338242e-12
for O 0 1.2701268856107895e-11
4003delTC O 0 1.5334263858690633e-09
, O 0 3.223855904455064e-11
whereas O 0 1.036017313604809e-10
those O 0 1.3580469214458102e-11
in O 0 2.5490594010579848e-11
two O 0 2.5676946679986656e-11
others O 0 2.5182233034937163e-11
are O 0 1.5240090005946838e-12
compound O 0 1.5933437902404535e-09
heterozygotes O 0 8.89597995268332e-09
. O 0 1.0801279870520375e-08

To O 0 2.957450107032855e-08
determine O 0 8.268875362205108e-09
if O 0 2.624874761991691e-10
the O 0 9.880015555685517e-11
occurrence O 0 4.766306793690944e-10
of O 0 9.47907238812995e-11
4003delTC O 0 1.4517415047876625e-09
in O 0 4.789796163862103e-12
these O 0 5.189948405932843e-13
unrelated O 0 6.443448552495568e-11
families O 0 1.7076589708259204e-12
signifies O 0 4.895750471689553e-11
propagation O 0 9.330147321406912e-09
of O 0 5.623713716929046e-10
an O 0 2.60140936569897e-10
ancestral O 0 3.600194586894645e-09
allele O 0 5.2256283744611665e-09
or O 0 2.2028125989947966e-09
a O 0 2.9774524179515538e-08
mutational O 0 6.639861112489598e-06
hot O 0 1.1238452316320036e-05
spot O 0 1.0861090515845717e-07
, O 0 5.3725524029601956e-11
haplotypes O 0 1.9164109188452016e-10
were O 0 1.472909294530922e-11
determined O 0 7.913433103245993e-11
for O 0 1.341145163674673e-11
polymorphisms O 0 1.1411291911400667e-09
both O 0 2.246386687776436e-10
within O 0 7.119356659757159e-09
and O 0 4.570076539422985e-10
flanking O 0 9.78268644757918e-07
COL17A1 O 1 0.8626248836517334
. O 0 2.961235736620438e-07

Five O 0 1.211249411880999e-07
intragenic O 0 3.9482702618443e-07
polymorphisms O 0 4.897688921090548e-09
were O 0 2.162476725464657e-10
chosen O 0 6.325682339047844e-11
based O 0 1.7545796412998804e-11
on O 0 4.497355821087012e-09
their O 0 6.360331705757005e-11
informativeness O 0 2.243328083295637e-07
. O 0 3.438327311755529e-08

One O 0 4.260336794459363e-08
of O 0 3.812614224329991e-09
these O 0 1.6649456119344208e-11
, O 0 1.3243529536910437e-11
not O 0 1.1813310052399828e-10
previously O 0 2.5377330792331065e-10
reported O 0 2.4790269836927337e-10
, O 0 7.81767012236756e-12
was O 0 1.5953325327444645e-09
2988 O 0 3.395742709244587e-08
A O 0 1.5817660425909708e-07
or O 0 1.1659003540387403e-08
C O 0 1.175990632873436e-06
that O 0 1.2454415970752919e-11
introduces O 0 3.174993254417835e-12
a O 0 2.1197223663838027e-12
new O 0 2.3062051400513095e-12
restriction O 0 4.90540594255684e-11
site O 0 4.093690317286125e-11
for O 0 1.5269631045700116e-11
Eco0109 O 0 6.797513833589619e-06
I O 0 8.994152267405298e-06
. O 0 1.9463401201846864e-07

All O 0 6.129968976864575e-09
the O 0 5.286457938069589e-10
4003delTC O 0 8.594498446257148e-09
alleles O 0 9.23939605379509e-11
showed O 0 3.3054545212074515e-11
the O 0 4.8178331983617095e-12
same O 0 8.172028158337508e-12
haplotype O 0 9.380766163857857e-10
for O 0 9.642828202593989e-11
these O 0 5.2068592493181853e-11
five O 0 5.322739471402826e-10
polymorphic O 0 2.3130995785436426e-08
markers O 0 6.55097167623353e-08
. O 0 5.7216254845116055e-08

Fourteen O 0 6.96824784540695e-08
microsatellite O 0 7.904151999582609e-08
polymorphisms O 0 6.295765686559207e-09
were O 0 8.86876266870118e-11
selected O 0 3.6851698450614256e-13
based O 0 6.245019150245834e-13
on O 0 7.15654813188138e-10
their O 0 6.740101098773321e-12
high O 0 6.544859099122391e-10
heterozygosity O 0 2.3647428459838693e-09
and O 0 1.851018643916902e-11
their O 0 1.445484443945988e-11
location O 0 1.8478456542680988e-09
within O 0 3.5096798800537954e-09
10q23 O 0 1.893268063213327e-06
- O 0 2.5595386432542e-07
q25 O 0 2.296444563398836e-06
near O 0 2.5241280354748596e-07
COL17A1 O 0 0.0001056290275300853
. O 0 4.361492145221746e-08

Three O 0 2.1598727251159744e-09
families O 0 6.29296198484397e-11
shared O 0 8.90252316310125e-11
microsatellite O 0 2.476400027262571e-07
polymorphisms O 0 1.8429196302349737e-07
covering O 0 1.9209733181924094e-07
at O 0 2.7250244727383688e-08
most O 0 3.680446225562406e-11
19 O 0 1.5687818821774613e-09
cM O 0 1.8934935397396657e-08
, O 0 3.471638341384642e-12
whereas O 0 2.8004910890278012e-11
the O 0 2.675125121420763e-10
others O 0 4.260525265920023e-11
shared O 0 7.129904305847035e-12
smaller O 0 2.2363434021288597e-11
regions O 0 6.840101818283983e-10
consistent O 0 1.6819107218069007e-10
with O 0 6.0096952371122e-13
cross O 0 7.167394455720455e-10
- O 0 1.1089205109726663e-09
over O 0 2.0501114694759792e-10
events O 0 2.682500272258026e-12
during O 0 2.4921387870024958e-11
passage O 0 1.0188640729713594e-11
of O 0 1.1458078409687378e-12
this O 0 1.3372721983581637e-12
mutation O 0 7.345086344701102e-12
through O 0 8.502152974709798e-12
several O 0 3.427341743744705e-11
generations O 0 6.258432105887834e-10
. O 0 6.8640741979209e-09

These O 0 2.1235904146266193e-09
results O 0 2.7908424460321157e-09
indicate O 0 4.392535779551565e-10
that O 0 5.706235397390236e-12
4003delTC O 0 1.044657360615986e-09
occurs O 0 3.5568971379351666e-11
on O 0 5.2423350382913014e-11
a O 0 3.336269108200618e-11
single O 0 4.8041449290936455e-11
ancestral O 0 4.349018922766845e-10
allele O 0 1.6514769551889685e-09
. O 0 1.34233157922381e-09
. O 0 1.8146689484410672e-08

The O 0 2.9591666361739044e-07
haptoglobin O 0 1.5474132624149206e-06
- O 0 2.5892791910564483e-08
gene O 0 4.749877921539358e-11
deletion O 0 1.911429237111406e-09
responsible O 0 7.432667259443804e-10
for O 0 1.3811686516707056e-10
anhaptoglobinemia B-Disease 0 5.3792009566677734e-05
. O 0 1.6915789728955133e-06

We O 0 2.9554200864367886e-08
have O 0 7.432507387328258e-11
found O 0 3.945604259980584e-12
an O 0 2.036469083643855e-12
allelic O 0 7.056812911798716e-10
deletion O 0 6.145492115194884e-09
of O 0 7.821291170273525e-09
the O 0 1.0199971534063934e-08
haptoglobin O 0 1.5638286186003825e-06
( O 0 1.8630561537946733e-09
Hp O 0 2.7473281427603524e-09
) O 0 1.285194260042255e-11
gene O 0 1.3153600387713626e-12
from O 0 7.273927987716533e-12
an O 0 9.730225522877611e-13
individual O 0 7.505935705875294e-14
with O 0 7.094295637055659e-12
anhaptoglobinemia B-Disease 0 5.60055450478103e-05
. O 0 1.4091092452872545e-06

The O 0 7.564885606825555e-08
Hp O 0 6.618235737221312e-09
gene O 0 1.5487774257527676e-11
cluster O 0 2.0930358834991836e-10
consists O 0 3.9097427552425845e-12
of O 0 6.867000718058236e-11
coding O 0 9.375869858274655e-09
regions O 0 1.6589577001013822e-07
of O 0 3.1045348691804975e-07
the O 0 1.0103376268943975e-07
alpha O 0 5.013559700728365e-08
chain O 0 1.9709112120125383e-10
and O 0 4.765583760946157e-12
beta O 0 3.0722346888722996e-09
chain O 0 9.551377744276834e-11
of O 0 2.3641135923901935e-11
the O 0 5.3520562981468345e-11
haptoglobin O 0 5.706744854450108e-09
gene O 0 1.3828443598540296e-11
( O 0 2.7901836657101553e-12
Hp O 0 1.3132949588934295e-11
) O 0 1.8748266556855436e-13
and O 0 4.148814104765197e-12
of O 0 1.286298567659827e-10
the O 0 9.465381811679663e-10
alpha O 0 6.189582180127218e-09
chain O 0 1.609065103380658e-10
and O 0 7.668260991466891e-12
beta O 0 1.1152484269416618e-08
chain O 0 3.2317254428093634e-10
of O 0 1.7185962722376935e-11
the O 0 9.639647413628438e-11
haptoglobin O 0 1.7019591069811213e-08
- O 0 3.0170446141397633e-09
related O 0 2.7012807546356044e-09
gene O 0 7.403135743322409e-11
( O 0 8.880539532907239e-12
Hpr O 0 1.245587744058696e-09
) O 0 2.994966254166176e-12
, O 0 1.5506268144505064e-12
in O 0 2.4439738427473046e-11
tandem O 0 8.077830626618265e-10
from O 0 4.158398514420014e-09
the O 0 5.938344482814273e-09
5 O 0 5.615948239778845e-08
side O 0 3.042368490469016e-08
. O 0 6.34960173329091e-08

Southern O 0 1.014082499750657e-06
blot O 0 5.271498139336472e-06
and O 0 2.1863164612057062e-09
PCR O 0 2.4398962850114003e-09
analyses O 0 3.2793451287815856e-10
have O 0 2.0229581898512095e-12
indicated O 0 1.562157694867672e-11
that O 0 1.2979165810687865e-13
the O 0 4.08630621744413e-13
individual O 0 2.323074890480249e-15
with O 0 1.7104575066972764e-14
anhaptoglobinemia B-Disease 0 6.392617102335407e-09
was O 0 1.1514926789857327e-09
homozygous O 0 5.442353165352465e-12
for O 0 6.269967184335812e-12
the O 0 5.513034820325835e-11
gene O 0 1.0111684059510573e-11
deletion O 0 3.2703126318089915e-10
and O 0 1.9659093797308458e-11
that O 0 1.9340726936656338e-11
the O 0 5.435294436750837e-10
gene O 0 4.014809665275898e-11
deletion O 0 1.1231504615238919e-09
was O 0 2.360577566751232e-10
included O 0 1.1235666260225874e-12
at O 0 2.153260382498079e-11
least O 0 3.232498903965597e-12
from O 0 1.7168466301398233e-11
the O 0 2.3257541725829611e-10
promoter O 0 4.171866407887137e-08
region O 0 2.5890175336940047e-08
of O 0 1.7958448950139427e-08
Hp O 0 6.66652788527955e-10
to O 0 5.896303445496187e-09
Hpr O 0 2.180262725914872e-08
alpha O 0 5.398453684080096e-09
but O 0 1.78781087156743e-11
not O 0 4.2562689483993665e-11
to O 0 6.844473876554957e-10
Hpr O 0 3.613880394937041e-08
beta O 0 1.5485410642668285e-07
( O 0 5.845953165994899e-10
Hpdel O 0 7.925012255327601e-07
) O 0 3.832465733655255e-10
. O 0 6.723342771408625e-09

In O 0 4.456012447917601e-09
addition O 0 1.4688421312580857e-10
, O 0 1.1159175666852761e-10
we O 0 5.802027608359239e-11
found O 0 2.9755046083296266e-12
seven O 0 8.563130131193641e-13
individuals O 0 1.7709100787362264e-14
with O 0 1.0486438648850405e-13
hypohaptoglobinemia B-Disease 0 2.7035550687060095e-08
in O 0 4.2424095486603974e-11
three O 0 1.2640848437439622e-11
families O 0 5.298775198996075e-13
, O 0 5.063567837595984e-13
and O 0 8.924087597367292e-13
the O 0 9.203111883682169e-11
genotypes O 0 1.5619922022480637e-09
of O 0 1.9091772607282564e-09
six O 0 3.0914959481265214e-10
of O 0 2.488962091984348e-10
the O 0 8.254762845494312e-11
seven O 0 1.1524406429153089e-11
individuals O 0 3.5977915525259307e-13
were O 0 6.789522416505989e-11
found O 0 7.688105360670328e-12
to O 0 1.5970183508962066e-10
be O 0 2.2782928876807773e-09
Hp2 O 0 1.5748913938296027e-05
/ O 0 1.1483903108455706e-05
Hpdel O 0 7.500713400077075e-05
. O 0 1.9376615512101125e-07

The O 0 3.611758003785326e-08
phenotypes O 0 3.1856375315442165e-09
and O 0 6.479224795574723e-11
genotypes O 0 1.359738099893093e-09
in O 0 1.60495401690941e-11
one O 0 8.952494995329019e-12
of O 0 5.254464831988548e-12
these O 0 1.036840088070555e-13
three O 0 1.376969176701548e-12
families O 0 1.6899802954620236e-12
showed O 0 1.8386188405106196e-11
the O 0 1.24821750158155e-10
father O 0 6.503694249815339e-10
to O 0 1.471765043170592e-09
be O 0 1.6856337436976787e-09
hypohaptoglobinemic B-Disease 0 4.800493229595304e-07
( O 0 6.103528793488522e-10
Hp2 O 0 3.221205986392306e-07
) O 0 3.029549180966207e-11
and O 0 8.474035362304733e-11
Hp2 O 0 7.94012692040269e-07
/ O 0 8.322469824406653e-08
Hpdel O 0 1.088402200366545e-06
, O 0 1.4512643864428298e-10
the O 0 3.2925062676270045e-10
mother O 0 6.680449943230471e-11
to O 0 1.13053483241643e-10
be O 0 4.523677266110582e-11
Hp2 O 0 1.2229092405391384e-08
- O 0 9.594179894989452e-10
1 O 0 2.548474853369953e-08
and O 0 7.768147930464764e-11
Hp1 O 0 1.5918553231131227e-07
/ O 0 1.8691507008838926e-08
Hp2 O 0 1.0852372867020676e-07
, O 0 3.700568931147563e-12
one O 0 4.805581280131754e-12
of O 0 3.0700410963424574e-11
the O 0 1.2090797113506468e-11
two O 0 5.0684014277213585e-12
children O 0 8.931051970022252e-13
to O 0 3.9143934621455045e-11
be O 0 1.5892734905875727e-09
hypohaptoglobinemic B-Disease 0 1.1745884194169776e-06
( O 0 1.1085758977458227e-09
Hp2 O 0 7.904406515990559e-07
) O 0 1.576828945193398e-11
and O 0 7.238058763459065e-11
Hp2 O 0 1.7864473988993268e-07
/ O 0 1.950022010532848e-08
Hpdel O 0 3.1765537755745754e-07
, O 0 3.2163566948684164e-11
and O 0 9.112106034991907e-12
the O 0 8.43893843693877e-11
other O 0 2.670136681204305e-12
child O 0 4.1399075140224895e-11
to O 0 3.5985228685753157e-11
be O 0 2.1232976488150257e-10
Hp1 O 0 1.2779686642261368e-07
and O 0 7.793499734454201e-10
Hp1 O 0 8.822007657727227e-06
/ O 0 1.5706710883023334e-06
Hpdel O 0 5.530517228180543e-06
, O 0 5.213656936731148e-11
showing O 0 4.683200355293238e-11
an O 0 4.877668408065361e-11
anomalous O 0 3.702041624364938e-07
inheritance O 0 7.920017992546491e-07
of O 0 3.055532147300255e-07
Hp O 0 1.045144149003363e-08
phenotypes O 0 3.2269148464436626e-10
in O 0 3.047195482053233e-11
the O 0 1.5568013544964288e-10
child O 0 1.2623531386868336e-10
with O 0 7.712147760685628e-12
Hp1 O 0 1.3142678653821349e-05
. O 0 3.3723648584782495e-07

The O 0 3.65310654615314e-07
Hp2 O 0 4.910412826575339e-05
/ O 0 6.414790732378606e-06
Hpdel O 0 1.1585931133595295e-05
individuals O 0 2.1604443234402027e-10
had O 0 1.2391471182482405e-09
an O 0 2.2539218755279755e-11
extremely O 0 3.542423854252519e-10
low O 0 1.748185241012834e-08
level O 0 2.579076330277985e-08
of O 0 1.850971043104721e-09
Hp O 0 7.58409335332999e-10
( O 0 6.06239641820494e-11
mean O 0 1.0103351932855276e-08
+ O 0 8.181924582295608e-10
/ O 0 2.4827380151748457e-09
- O 0 4.362671113256056e-09
SD O 0 3.1185106053044365e-08
= O 0 5.676443759483618e-10
0 O 0 9.731813271907086e-11
. O 0 3.138242920738832e-12
049 O 0 1.6361018095878421e-09
+ O 0 9.709453380191135e-11
/ O 0 6.449021316967674e-10
- O 0 5.924110091370949e-10
0 O 0 2.682375155327321e-10
. O 0 5.336152093110558e-12
043 O 0 5.731438657008425e-10
mg O 0 6.475633362867939e-10
/ O 0 7.590023054504513e-11
ml O 0 3.7082295567536505e-11
; O 0 6.655299141650195e-13
n O 0 4.00803834565977e-11
= O 0 3.813781582207021e-11
6 O 0 2.0337385941981978e-10
) O 0 5.0922628066314354e-14
, O 0 4.596406331176979e-14
compared O 0 6.510212833231444e-13
with O 0 5.607507188622185e-14
the O 0 1.0203678874054489e-10
level O 0 1.5483180293429655e-09
( O 0 5.70273255701137e-12
1 O 0 5.605703901068182e-09
. O 0 1.6843658412479812e-11
64 O 0 2.4649529639653167e-10
+ O 0 2.5500901737474102e-11
/ O 0 2.4679591703602455e-10
- O 0 7.039887006676793e-10
1 O 0 5.1970907577469916e-09
. O 0 2.385661633519387e-11
07 O 0 1.082407774521954e-10
mg O 0 3.760088629345404e-10
/ O 0 4.513283149987224e-11
ml O 0 1.0383809263825317e-11
) O 0 1.0406216497229129e-14
obtained O 0 8.297279963792592e-13
from O 0 2.2672841035187297e-11
52 O 0 1.7431964760561414e-09
healthy O 0 2.0087789071032702e-11
volunteers O 0 1.0307220571839637e-12
having O 0 1.6874947619816005e-11
phenotype O 0 1.1041806580180946e-08
Hp2 O 0 2.1650299686371e-07
, O 0 4.300481498686892e-11
whereas O 0 2.439955737454369e-10
the O 0 4.174823264868621e-10
serum O 0 7.596340778626143e-10
Hp O 0 6.139674879612755e-11
level O 0 1.9093911174383749e-10
of O 0 7.005054522557508e-12
an O 0 1.5562772424926319e-12
individual O 0 2.2932903406130967e-13
with O 0 8.664553449722057e-12
Hp1 O 0 1.2248417988303117e-05
/ O 0 4.620659638021607e-06
Hpdel O 0 6.376329565682681e-06
was O 0 8.972341447588406e-08
0 O 0 3.058076458728465e-08
. O 0 3.2713376452164766e-09

50 O 0 1.0460514658916509e-06
mg O 0 3.4862375741795404e-07
/ O 0 2.521019304424499e-08
ml O 0 7.803067525458118e-09
, O 0 4.462827243173484e-12
which O 0 4.3694832908142134e-13
was O 0 2.6676027706229455e-11
approximately O 0 1.7919714106681695e-12
half O 0 5.729268622023387e-12
the O 0 6.0583929366309075e-12
level O 0 1.3804450915699817e-09
of O 0 2.834211754176863e-10
Hp O 0 2.4761162564779227e-10
in O 0 1.8620818775794135e-10
control O 0 1.6940761682349148e-08
sera O 0 6.405102670470342e-09
from O 0 1.7312134364955156e-11
the O 0 3.159800893159925e-11
Hp1 O 0 7.517316547023256e-09
phenotype O 0 2.9482780106171447e-10
( O 0 8.005011042054588e-13
1 O 0 2.173228264013005e-09
. O 0 2.6442702194540146e-11
26 O 0 2.7611126718340984e-09
+ O 0 1.148386385985134e-10
/ O 0 6.645491379408952e-10
- O 0 2.028880841109526e-09
0 O 0 3.7438865896355367e-10
. O 0 7.30267582516042e-12
33 O 0 8.960374803246296e-11
mg O 0 1.3335345327991632e-10
/ O 0 4.3787733855493727e-11
ml O 0 2.898529159744978e-11
; O 0 1.4263833170158335e-12
n O 0 1.4109183266164393e-10
= O 0 1.5951126530744375e-10
9 O 0 1.289138462645667e-09
) O 0 1.0852719547690959e-12
, O 0 2.0550893885945554e-12
showing O 0 2.480983994634922e-11
a O 0 6.845936040278389e-10
gene O 0 1.145109840283709e-10
- O 0 1.0542432482552044e-09
dosage O 0 2.591522374473243e-08
effect O 0 1.9483303859146872e-08
. O 0 5.186644003174479e-09

The O 0 3.440734630544284e-08
other O 0 1.0623552038069306e-10
allele O 0 1.5859396018669258e-09
( O 0 3.5038770496154115e-11
Hp2 O 0 4.31761613128856e-08
) O 0 1.4045667840606457e-12
of O 0 2.5415053742094962e-11
individuals O 0 3.131569873207618e-12
with O 0 4.953469232016339e-11
Hp2 O 0 4.188720777165145e-05
/ O 0 3.3442368021496804e-06
Hpdel O 0 3.250173676860868e-06
was O 0 7.07984249004312e-09
found O 0 3.3489485056631407e-12
to O 0 1.0174560846620828e-11
have O 0 3.57298825942598e-13
, O 0 3.614491789639268e-13
in O 0 4.902766127107272e-12
all O 0 2.621861235063694e-11
exons O 0 1.5395484886937538e-09
, O 0 3.886302391009622e-11
no O 0 1.7744335167879655e-10
mutation O 0 5.0511102245298645e-11
, O 0 2.4828479116417723e-12
by O 0 1.20591522878577e-11
DNA O 0 1.6136268987665403e-09
sequencing O 0 2.946210830856444e-09
. O 0 4.095451533459027e-09

On O 0 5.9571682697878714e-08
the O 0 2.3727703135634215e-10
basis O 0 9.943693646263796e-10
of O 0 2.5156645863666505e-11
the O 0 8.915076142590461e-12
present O 0 6.354484646808878e-12
study O 0 8.755675871829904e-12
, O 0 6.501997833370521e-13
the O 0 9.592816992143316e-12
mechanism O 0 1.793577092401577e-10
of O 0 8.465361051035458e-11
anhaptoglobinemia B-Disease 0 2.6260892127538682e-08
and O 0 3.075033977451014e-11
the O 0 2.0737278561000494e-10
mechanism O 0 9.12965147925604e-10
of O 0 3.49630158158476e-10
anomalous O 0 2.181209453055999e-07
inheritance O 0 2.3792561876234686e-07
of O 0 5.1550273383327294e-08
Hp O 0 3.705179274504644e-09
phenotypes O 0 1.3202909876497415e-09
were O 0 1.6041926120813343e-10
well O 0 1.1578348696472673e-10
explained O 0 7.453198946905104e-09
. O 0 4.046611046248927e-09

However O 0 8.426673581141131e-09
, O 0 5.733600746959944e-11
the O 0 1.3075519833538607e-10
mechanism O 0 2.059589387926053e-09
of O 0 9.60597268395702e-10
hypohaptoglobinemia B-Disease 0 6.457865674747154e-05
remains O 0 3.5995242342323763e-07
unknown O 0 1.583445850883436e-06

ATM O 0 9.51543333940208e-05
mutations O 0 3.728753839027377e-08
and O 0 1.6615996079050177e-10
phenotypes O 0 3.1204027806097656e-08
in O 0 1.6332963426179958e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.5842111622532684e-08
in O 0 4.3363607843405205e-11
the O 0 9.365565267760445e-11
British O 0 1.2640727874158042e-11
Isles O 0 3.907338619324463e-10
: O 0 6.562358620919306e-14
expression O 0 3.5788470169155484e-13
of O 0 3.483152568456438e-12
mutant O 0 5.015127202412373e-12
ATM O 0 2.5035984396737376e-10
and O 0 5.715360910235612e-13
the O 0 4.447124526268942e-12
risk O 0 1.8132659262981576e-10
of O 0 5.30152310940224e-10
leukemia B-Disease 1 1.0
, O 0 1.212768665936892e-06
lymphoma B-Disease 1 1.0
, O 0 0.000186665216460824
and O 0 0.0006397353135980666
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.34775036573410034

We O 0 9.62556523376179e-09
report O 0 2.4805818857331907e-11
the O 0 1.5415654863737416e-11
spectrum O 0 1.1101288777126683e-09
of O 0 5.023758631317321e-10
59 O 0 7.043987171329036e-09
ATM O 0 2.968278636217292e-07
mutations O 0 2.7719881945387215e-09
observed O 0 6.735841329152947e-10
in O 0 7.639509580492643e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.989628112321952e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.443365451249463e-11
patients O 0 8.254018128706075e-12
in O 0 1.3072240772488142e-12
the O 0 4.084385954450376e-11
British O 0 3.2777253133886575e-10
Isles O 0 1.4430658268338448e-07
. O 0 2.2757923545668746e-08

Of O 0 1.3348625316211837e-06
51 O 0 1.7369416127621662e-06
ATM O 0 1.479299953643931e-05
mutations O 0 1.8897630127412413e-08
identified O 0 4.4608827742820267e-10
in O 0 1.7940210081390795e-11
families O 0 1.3087139878742438e-11
native O 0 3.237786991641678e-12
to O 0 8.543366708524402e-11
the O 0 9.806794265543317e-11
British O 0 8.306726140272502e-11
Isles O 0 4.768091255158424e-09
, O 0 3.108114113303806e-11
11 O 0 1.300233365419956e-09
were O 0 1.022099488379169e-10
founder O 0 3.6157608018783094e-09
mutations O 0 6.934468971264707e-11
, O 0 4.171794420332331e-12
and O 0 1.5944212963803217e-11
2 O 0 5.877958031419439e-08
of O 0 4.126342600940802e-10
these O 0 3.695567723366322e-12
11 O 0 3.5531833031399174e-10
conferred O 0 1.3652995400903478e-09
a O 0 1.463978244187203e-10
milder O 0 4.055653590739894e-08
clinical O 0 2.9592808759026923e-10
phenotype O 0 2.945246824204162e-11
with O 0 7.459338051754583e-14
respect O 0 1.456343726169429e-11
to O 0 4.860072899681711e-10
both O 0 3.7076184344897456e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 1.5946966414048802e-06
cellular O 0 1.0128613325832703e-07
features O 0 7.373728849735528e-10
. O 0 1.49601522281273e-08

We O 0 3.6169680583952868e-09
report O 0 2.6014728565781908e-11
, O 0 3.5727085352654786e-13
in O 0 5.515395540452162e-13
two O 0 2.1026499985588032e-11
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.7364094884175785e-10
, O 0 8.43576337256069e-12
an O 0 3.226414968526825e-11
ATM O 0 4.0572172110842075e-07
mutation O 0 7.039904215133674e-09
( O 0 2.0183226617787042e-11
7271T O 0 4.5886157096219904e-08
- O 0 8.090031755614291e-09
- O 0 2.8244095062746055e-08
> O 0 2.2974113278451114e-08
G O 0 3.384244662285596e-09
) O 0 1.7793653649036262e-13
that O 0 1.6247664021487584e-13
may O 0 3.772183260197792e-11
be O 0 4.2636770850035255e-12
associated O 0 2.0239576074138066e-12
with O 0 1.1852535419061214e-14
an O 0 5.293533081492108e-13
increased O 0 5.515790602039772e-11
risk O 0 1.0447993581408355e-08
of O 0 1.846289521267863e-08
breast B-Disease 1 0.9999626874923706
cancer I-Disease 0 0.024735277518630028
in O 0 2.921488384544091e-09
both O 0 1.8701553639033364e-09
homozygotes O 0 3.8093961762797335e-08
and O 0 2.0230218888972473e-10
heterozygotes O 0 2.5656754498726286e-09
( O 0 3.320392225059088e-11
relative O 0 1.0694986229964343e-08
risk O 0 1.4373864321015617e-09
12 O 0 2.8574981270068633e-10
. O 0 2.5337306037986895e-12
7 O 0 1.018387152385003e-09
; O 0 3.557786010244257e-11
P O 0 6.823896683272324e-07
= O 0 9.637187714517381e-10
. O 0 6.124060980550183e-11
0025 O 0 8.736288137356496e-09
) O 0 2.8955806394108385e-13
, O 0 1.3617079198165877e-13
although O 0 2.0131802041384317e-13
there O 0 2.655913412374228e-13
is O 0 4.977216555568376e-13
a O 0 2.8622477651896183e-11
less O 0 1.2900590817821467e-08
severe O 1 1.0
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 6.066805946502996e-10
in O 0 1.2147649151774548e-13
terms O 0 2.026797132903546e-12
of O 0 3.821794768675557e-13
the O 0 5.134651926731737e-13
degree O 0 2.2073507466302544e-09
of O 0 1.2642717983624152e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 6.362407475535292e-06

This O 0 2.0945797984950332e-08
mutation O 0 6.7348944199352445e-09
( O 0 1.3720280987727929e-11
7271T O 0 1.1569706970249172e-08
- O 0 2.585275549193966e-09
- O 0 3.888063648815887e-09
> O 0 4.276127896218895e-09
G O 0 6.859817158755277e-10
) O 0 1.2495631631736885e-14
also O 0 4.068422912472704e-15
allows O 0 1.2025782455894925e-14
expression O 0 3.9495024004715384e-13
of O 0 5.060963367137239e-12
full O 0 1.7019174264332193e-11
- O 0 2.029290346872159e-10
length O 0 9.299530590034522e-10
ATM O 0 2.9476060703359508e-08
protein O 0 2.961132727907767e-10
at O 0 8.264798567747533e-11
a O 0 2.3911966157141862e-11
level O 0 4.949023968414679e-10
comparable O 0 5.897207722149744e-11
with O 0 5.276295893252847e-13
that O 0 3.3469366601118766e-12
in O 0 2.8145746150398665e-11
unaffected O 0 4.13791445552647e-09
individuals O 0 4.086661217761467e-11
. O 0 7.2644135151733735e-09

In O 0 3.5199771986071937e-09
addition O 0 1.7726846379684247e-10
, O 0 6.019820059099956e-11
we O 0 2.3999784798389712e-11
have O 0 1.3787115980129494e-12
studied O 0 1.0085263874026751e-10
18 O 0 8.42575786919042e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.8220996933493439e-10
, O 0 5.1489584487361337e-14
in O 0 1.233739401872852e-13
15 O 0 3.3161137030779386e-11
families O 0 1.1088109597157114e-12
, O 0 5.012296567380448e-12
who O 0 1.852778624966689e-10
developed O 0 2.790930011542514e-07
leukemia B-Disease 1 1.0
, O 0 0.00039598418516106904
lymphoma B-Disease 1 1.0
, O 0 1.2195373528811615e-06
preleukemic O 0 0.0007921457872726023
T O 0 9.892547723211464e-07
- O 0 1.4074946363962226e-07
cell O 0 6.046098377510134e-08
proliferation O 0 5.398825919655792e-07
, O 0 3.0651963606187493e-11
or O 0 1.576558474880585e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 9.93420528061506e-08
mostly O 0 1.0522840238058606e-10
in O 0 1.4678654958188986e-09
childhood O 0 1.5782476339154528e-06
. O 0 2.344456646596882e-07

A O 0 2.8179308628750732e-06
wide O 0 6.173043232138298e-08
variety O 0 1.4939928183466122e-09
of O 0 4.1331658096055435e-09
ATM O 0 1.5760592759761494e-06
mutation O 0 7.086029985003961e-09
types O 0 7.085242947901804e-10
, O 0 2.732791423709635e-11
including O 0 6.507375888142874e-11
missense O 0 1.0425279697301448e-06
mutations O 0 3.14259196443345e-08
and O 0 2.881904159757198e-10
in O 0 1.8457771422397684e-10
- O 0 1.0377463333099968e-09
frame O 0 3.389806657594363e-09
deletions O 0 2.395946774313984e-09
, O 0 1.414739575489321e-10
were O 0 7.236015953093755e-11
seen O 0 2.0621748753058e-10
in O 0 9.391373095857247e-12
these O 0 1.7290684509174703e-11
patients O 0 2.9874153151254745e-10
. O 0 7.78614950291967e-09

We O 0 1.019796869172751e-08
also O 0 1.0199821022516264e-11
show O 0 1.455185147727911e-12
that O 0 2.095444484432902e-14
25 O 0 1.6225196533548036e-11
% O 0 7.797357377825609e-12
of O 0 6.5384269179458165e-12
all O 0 4.915561291340964e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 7.002861401872451e-09
carried O 0 6.899437618446136e-12
in O 0 1.7999632817219946e-12
- O 0 3.663042785762016e-11
frame O 0 4.358111649338525e-10
deletions O 0 2.2415898026650893e-09
or O 0 1.3762813999562695e-08
missense O 0 9.894132517729304e-07
mutations O 0 1.1030108026943708e-07
, O 0 9.611350777760652e-12
many O 0 1.297686323632405e-13
of O 0 3.556718938466097e-12
which O 0 2.5295428729074643e-13
were O 0 1.0834808527801498e-12
also O 0 1.5114216031075073e-13
associated O 0 1.996672792381471e-12
with O 0 2.2627152972479192e-13
expression O 0 1.00672366276644e-10
of O 0 3.854805363801006e-09
mutant O 0 4.9547597136267996e-09
ATM O 0 4.732847287414188e-07
protein O 0 7.772545984607859e-08
. O 0 5.549342319000061e-09

The O 0 7.492327114277941e-08
DMPK O 0 0.25895193219184875
gene O 0 4.58322535479283e-09
of O 0 3.942488113750642e-09
severely O 1 0.9998835325241089
affected O 1 0.999995231628418
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998260140419006
is O 0 2.601847404193336e-09
hypermethylated O 0 2.7129755153509905e-07
proximal O 0 2.401952770014759e-06
to O 0 9.36016704145004e-08
the O 0 1.469479737892243e-08
largely O 0 2.2207966576814897e-09
expanded O 0 3.9686760544555e-09
CTG O 0 2.347734834984294e-06
repeat O 0 1.407560432653554e-07
. O 0 6.242832029101919e-08

Using O 0 3.478584886806857e-08
methylation O 0 2.1013987350215757e-07
- O 0 7.789375899847073e-08
sensitive O 0 4.083425864109813e-08
restriction O 0 4.9586548200863945e-09
enzymes O 0 1.8325559125731417e-10
, O 0 1.43930191116165e-12
we O 0 3.2947392644006035e-12
characterized O 0 2.9058913261770236e-11
the O 0 6.11426881347299e-11
methylation O 0 5.206842179639182e-10
pattern O 0 8.128122064299248e-10
on O 0 1.7157256726463288e-09
the O 0 6.941337088450794e-11
5 O 0 2.048814673472066e-09
side O 0 1.6393003621217872e-09
of O 0 4.3780676861615575e-09
the O 0 1.8831640247185533e-08
CTG O 0 1.5447179748662165e-06
repeat O 0 1.3133414356047979e-09
in O 0 4.1109119580662323e-11
the O 0 2.5783603030404834e-10
DMPK O 0 1.4130346244201064e-06
gene O 0 1.001307457088041e-11
of O 0 9.177182451469701e-12
normal O 0 3.9692640840804927e-10
individuals O 0 1.5217722915128462e-12
and O 0 9.906088102584754e-12
of O 0 1.0121015137087852e-09
patients O 0 8.808045404151699e-10
affected O 0 7.035685367640099e-10
with O 0 5.741649822255113e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 2.2029260637879133e-09
showing O 0 3.363046785498369e-10
expansions O 0 2.2424664347653334e-09
of O 0 1.863752929764928e-09
the O 0 2.1440824671259406e-09
repetitive O 0 1.3434412693413833e-08
sequence O 0 1.2073801958223385e-09
. O 0 1.5160558364257781e-09

The O 0 8.873544743437378e-07
gene O 0 1.2783404335081627e-09
segment O 0 4.083751115047107e-09
analyzed O 0 2.614561622760192e-10
corresponds O 0 8.672977336310339e-10
to O 0 1.1140997013825427e-09
the O 0 1.1555409962227259e-09
genomic O 0 4.204953718556226e-09
SacI O 0 8.115767258232154e-08
- O 0 6.341704383849844e-10
HindIII O 0 2.2799924170868735e-09
fragment O 0 5.864782548492542e-10
carrying O 0 4.800032593621495e-11
exons O 0 1.3163257150949903e-09
11 O 0 1.3178481639286588e-09
- O 0 1.5386177887322106e-09
15 O 0 1.578540498314851e-08
. O 0 6.158798804278831e-09

There O 0 6.1029847842064555e-09
is O 0 3.021586869600412e-10
constitutive O 0 3.80890234907838e-08
methylation O 0 1.0322612098434547e-07
in O 0 1.7817267661257574e-08
intron O 0 3.766114957670652e-07
12 O 0 2.9026496761730414e-08
at O 0 4.39738939705947e-10
restriction O 0 1.4766483868999813e-10
sites O 0 4.1239171799656305e-11
of O 0 8.603198708989623e-11
SacII O 0 9.293208336202952e-08
and O 0 7.515320032958073e-10
HhaI O 0 2.2884430563863134e-06
, O 0 5.207348441338411e-10
localized O 0 1.0371022085564618e-07
1 O 0 3.220659436919959e-07
, O 0 8.34030344787351e-11
159 O 0 6.344330061303083e-10
- O 0 1.624218093354557e-09
1 O 0 7.616282005074027e-08
, O 0 2.4891047556430124e-10
232 O 0 9.347830287609327e-10
bp O 0 8.720322242083967e-09
upstream O 0 1.4225499889164439e-08
of O 0 6.874461000450083e-10
the O 0 3.415728588862521e-09
CTG O 0 4.610741655142192e-07
repeat O 0 1.8221086861558433e-08
, O 0 7.711459942827403e-11
whereas O 0 1.422125472938518e-10
most O 0 5.873934151578997e-12
, O 0 1.9226770783115077e-12
if O 0 8.220428678040737e-12
not O 0 3.5054948527291074e-11
all O 0 5.898892485589613e-12
, O 0 5.766554768416032e-12
of O 0 1.2972521494514222e-11
the O 0 1.6729803306581026e-11
other O 0 7.817158921043232e-13
sites O 0 3.81338884081206e-11
of O 0 1.0392472993281388e-10
SacII O 0 2.1950991424546373e-07
, O 0 2.3596730125419185e-10
HhaI O 0 7.586298806927516e-07
, O 0 1.320202280830074e-10
and O 0 1.358063106415841e-10
HpaII O 0 8.122237886709627e-07
in O 0 9.069110046278084e-11
this O 0 1.0894749685741445e-10
region O 0 2.824242351096018e-08
are O 0 6.39619607278874e-11
unmethylated O 0 1.2865844389864378e-08
, O 0 5.860281010461321e-12
in O 0 1.2816815317395758e-11
normal O 0 4.6156580779666e-09
individuals O 0 3.156528424058669e-12
and O 0 9.805816748864604e-12
most O 0 1.732012623600898e-11
of O 0 5.792211155153382e-10
the O 0 1.7389392148459137e-09
patients O 0 6.003976205093409e-10
. O 0 1.2436916385638597e-08

In O 0 2.9007720669937953e-09
a O 0 1.6527910151609149e-09
number O 0 1.439943164704971e-10
of O 0 5.032648742187007e-10
young O 0 3.115004434950386e-11
and O 0 1.5092548044659537e-10
severely O 0 0.44996950030326843
affected O 0 1.0961387033603387e-06
patients O 0 1.7012450115316824e-08
, O 0 1.1884070116874312e-10
however O 0 3.708196250062912e-10
, O 0 4.4782292457634654e-11
complete O 0 1.29312049956809e-09
methylation O 0 4.627302097048869e-09
of O 0 1.615018563327908e-09
these O 0 9.983744733710331e-12
restriction O 0 5.587756368718999e-10
sites O 0 8.003706031267654e-11
was O 0 1.715541597668846e-10
found O 0 6.466033763107004e-13
in O 0 7.640619907600676e-13
the O 0 2.2554442688504928e-11
mutated O 0 2.730875248158071e-10
allele O 0 2.9008285551412882e-08
. O 0 2.2243163755319983e-08

In O 0 6.694308218868628e-09
most O 0 1.0693893687241385e-10
of O 0 6.235278265931399e-11
these O 0 7.262514699866995e-13
patients O 0 1.8928615185681563e-12
, O 0 7.796249133469949e-14
the O 0 5.072405169503913e-12
onset O 0 7.944292974570999e-07
of O 0 1.7456253109671138e-09
the O 0 3.856307984051455e-08
disease O 1 0.9999998807907104
was O 0 0.010064969770610332
congenital O 1 1.0
. O 0 0.0013813864206895232

Preliminary O 0 1.22405599540798e-05
in O 0 9.948441856977297e-07
vivo O 0 3.888543687935453e-06
footprinting O 0 2.192031388403848e-06
data O 0 3.946767357376757e-10
gave O 0 1.0001188766040059e-10
evidence O 0 3.380299165578471e-11
for O 0 9.8559563288525e-12
protein O 0 9.202479750447523e-11
- O 0 1.2146324224193705e-10
DNA O 0 1.4903660250364936e-10
contact O 0 6.986647371753918e-10
in O 0 2.585126279708305e-10
normal O 0 4.556311949954761e-08
genes O 0 2.0401100253586435e-10
at O 0 1.3419083899623985e-10
an O 0 5.6359491726332145e-12
Sp1 O 0 6.927954876445597e-10
consensus O 0 2.7095523602582716e-09
binding O 0 4.546814480477224e-08
site O 0 3.9952983144075915e-08
upstream O 0 4.478816606479086e-08
of O 0 1.0938209227262519e-09
the O 0 1.9211368051941236e-09
CTG O 0 2.399721950041567e-07
repeat O 0 1.8748187724515475e-10
and O 0 3.5005868646506566e-13
for O 0 1.5640521646917427e-13
a O 0 3.1607696061169976e-12
significant O 0 5.915251795329812e-12
reduction O 0 5.041891903978524e-10
of O 0 4.9717376049418505e-11
this O 0 2.1588036913655628e-11
interaction O 0 8.076347923768878e-11
in O 0 1.3897066830637073e-10
cells O 0 7.387915279544188e-11
with O 0 2.2157922198451363e-12
a O 0 3.1661628874246617e-09
hypermethylated O 0 2.1496398403542116e-06
DMPK O 0 2.536533065722324e-05
gene O 0 1.151095219142917e-09
. O 0 5.697737281984416e-10
. O 0 6.148634490443783e-09

The O 0 7.796733552822843e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.7000383323306778e-08
product O 0 4.58850568652025e-10
complexes O 0 1.8471743232217896e-11
with O 0 8.59836670179942e-13
the O 0 1.4629593370063532e-10
transferrin O 0 1.7022252052356635e-08
receptor O 0 1.3495948358865917e-08
and O 0 1.0169153019656818e-10
lowers O 0 2.164490392475571e-10
its O 0 1.9388735408853996e-12
affinity O 0 1.857691951656637e-12
for O 0 2.0826879717356084e-12
ligand O 0 9.511350596014267e-10
binding O 0 5.002917902174886e-08
. O 0 2.492884476623658e-08

We O 0 1.2119218695261225e-07
recently O 0 2.448450775460742e-09
reported O 0 9.824355218235326e-11
the O 0 1.8383242844643988e-11
positional O 0 9.593443400790491e-11
cloning O 0 1.6158303861590895e-11
of O 0 1.5783145190101378e-12
a O 0 4.317212386195646e-12
candidate O 0 1.2052173703480662e-09
gene O 0 2.7975577410188635e-09
for O 0 1.0415028839361185e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 0.9997332692146301
. O 0 1.2742438002533163e-06

The O 0 1.059260590352551e-08
gene O 0 7.496758422376182e-12
product O 0 1.4198479197924385e-11
, O 0 9.116065107644955e-13
a O 0 1.6963053184326782e-10
member O 0 1.1111203068736586e-09
of O 0 3.176445551034135e-09
the O 0 4.306535572595749e-09
major O 0 4.311658230449211e-08
histocompatibility O 0 3.3188084103130677e-07
complex O 0 1.3024158640462247e-08
class O 0 7.220478381864126e-11
I O 0 7.438428983874701e-09
- O 0 6.154943776870425e-10
like O 0 9.376857797172011e-12
family O 0 1.0066308897549447e-11
, O 0 1.0081464742878188e-12
was O 0 8.984505500686524e-11
found O 0 2.4983771561987167e-12
to O 0 1.8559679834662113e-11
have O 0 9.746445837899298e-12
a O 0 6.41920017141473e-10
mutation O 0 2.347736893781871e-09
, O 0 2.3576304797323644e-10
Cys O 0 6.781959882573574e-08
- O 0 2.2807419952641794e-08
282 O 0 5.552518889118119e-09
- O 0 3.559386385632024e-08
- O 0 8.354963654255698e-08
> O 0 4.046057355822086e-08
Tyr O 0 5.0749509483694055e-08
( O 0 2.14169654233487e-12
C282Y O 0 3.204829068792492e-09
) O 0 7.591864149055633e-14
, O 0 7.160137554477336e-14
in O 0 1.6590675231201168e-12
85 O 0 4.781512963347723e-10
% O 0 5.063176961028759e-11
of O 0 2.4295393474815796e-10
patient O 0 6.150302311880296e-08
chromosomes O 0 3.869057820793387e-07
. O 0 2.0852209559052426e-07

This O 0 2.546327237951118e-08
mutation O 0 1.4739457654400212e-08
eliminates O 0 4.400286357508776e-09
the O 0 3.2227875923496185e-10
ability O 0 1.84433787686622e-10
of O 0 1.3535796927754973e-09
HFE O 0 3.913417458534241e-06
to O 0 2.3758884637459232e-08
associate O 0 5.104615841133864e-09
with O 0 3.4781932108790548e-12
beta2 O 0 6.665299565611349e-07
- O 0 4.615246496086911e-07
microglobulin O 0 1.6202789083763491e-06
( O 0 1.2803944016148705e-10
beta2m O 0 1.290145661414499e-07
) O 0 8.13036183516802e-12
and O 0 9.55213772663166e-12
prevents O 0 6.047535250353064e-10
cell O 0 1.7387145945235716e-08
- O 0 4.63328087008108e-09
surface O 0 1.61412543775441e-07
expression O 0 9.545177093173152e-09
. O 0 2.54035086300064e-08

A O 0 9.539377060718834e-06
second O 0 7.262545409503218e-07
mutation O 0 3.7101366423542004e-09
that O 0 6.693085322084791e-12
has O 0 3.1123541244237884e-12
no O 0 3.314480634397654e-12
effect O 0 3.8517536382620676e-10
on O 0 2.333277571153758e-09
beta2m O 0 2.5760880362213356e-07
association O 0 2.312029734330423e-10
, O 0 1.9431031783589958e-10
H63D O 0 7.595160423079506e-05
, O 0 1.880151034860944e-10
was O 0 1.5811915110575114e-09
found O 0 1.5541029834559295e-12
in O 0 6.757114399263964e-13
eight O 0 3.592122693046873e-12
out O 0 8.024026863957812e-13
of O 0 5.891707260952117e-12
nine O 0 1.9015979763059576e-11
patients O 0 7.966809178507062e-13
heterozygous O 0 9.687966574800644e-13
for O 0 1.9698279465907298e-11
the O 0 1.0210034595559137e-08
C282Y O 0 1.3513431440514978e-05
mutant O 0 4.683466272581427e-07
. O 0 4.207105774867159e-08

In O 0 1.3607299287343722e-08
this O 0 1.2031320384409128e-09
report O 0 3.8304051597215505e-10
, O 0 2.3661255246776314e-11
we O 0 7.29015389722143e-11
demonstrate O 0 1.2995658715819758e-10
in O 0 3.3245636799072997e-10
cultured O 0 6.257697293676756e-08
293 O 0 3.841551787786557e-08
cells O 0 2.6637785310867912e-08
overexpressing O 0 8.659399242105792e-08
wild O 0 1.483579814554048e-09
- O 0 4.0026545966576066e-10
type O 0 1.1475701500174296e-09
or O 0 3.1006328615745815e-09
mutant O 0 9.399361289297303e-09
HFE O 0 1.2148356631769275e-07
proteins O 0 4.855360904998385e-12
that O 0 2.541560982938923e-13
both O 0 1.0219211544690299e-12
the O 0 8.310450244630729e-11
wild O 0 3.7415667786255824e-10
- O 0 3.2508346015092116e-10
type O 0 5.274706449398536e-09
and O 0 4.381760287941461e-09
H63D O 0 0.000449459592346102
HFE O 0 5.83076371185598e-06
proteins O 0 1.3542916788011894e-10
form O 0 7.688578246289879e-11
stable O 0 6.896221371732736e-10
complexes O 0 7.020062049029052e-12
with O 0 1.0902970149981317e-12
the O 0 1.3866888748381712e-09
transferrin O 0 1.0580474452126509e-07
receptor O 0 1.242951128688219e-07
( O 0 2.9629237952022436e-10
TfR O 0 1.806556859662578e-08
) O 0 9.525065632065566e-12
. O 0 4.7332665564781e-10

The O 0 1.465195737182512e-06
C282Y O 0 7.793655822752044e-05
mutation O 0 1.71025060780039e-08
nearly O 0 1.236151514483197e-09
completely O 0 2.384097919083672e-10
prevents O 0 5.3980261233155247e-11
the O 0 1.4052133588682292e-11
association O 0 1.6545494141428918e-11
of O 0 5.724271612272958e-10
the O 0 1.342359667866333e-09
mutant O 0 6.58409016196515e-09
HFE O 0 2.3752184574732382e-07
protein O 0 2.3929039305592426e-10
with O 0 1.7440585651021245e-12
the O 0 8.295694131632558e-10
TfR O 0 2.27992913437447e-07
. O 0 6.531768459439036e-09

Studies O 0 2.3135672932994567e-08
on O 0 3.10022656435649e-08
cell O 0 2.6571955746845788e-09
- O 0 2.733230308749057e-10
associated O 0 1.325323878420548e-10
transferrin O 0 2.655444042432009e-08
at O 0 2.8338080770851093e-09
37 O 0 6.634549576389759e-10
degrees O 0 1.8285946978835455e-08
C O 0 2.648857488907197e-08
suggest O 0 8.27599863639783e-11
that O 0 6.1310232064848424e-12
the O 0 4.736743774991226e-10
overexpressed O 0 3.5274803167339996e-07
wild O 0 1.0517914539320827e-08
- O 0 2.395517340048059e-09
type O 0 2.0094642394496987e-08
HFE O 0 2.9953521334391553e-06
protein O 0 8.984068600170758e-09
decreases O 0 3.8314276751272303e-10
the O 0 3.4914668812363603e-12
affinity O 0 4.8246868306067725e-11
of O 0 4.919153417937139e-10
the O 0 1.2265480853201893e-09
TfR O 0 2.7198266749905997e-08
for O 0 1.0802608113591461e-10
transferrin O 0 7.619404414072051e-07
. O 0 6.537142382967431e-08

The O 0 6.552143076987704e-06
overexpressed O 0 5.2807299653068185e-05
H63D O 0 0.006546908523887396
protein O 0 8.779796871749568e-07
does O 0 3.2029023877555574e-10
not O 0 4.214456214568507e-11
have O 0 1.011912775794599e-12
this O 0 1.0071528029967358e-12
effect O 0 1.8784591937492934e-10
, O 0 1.3633146261210483e-12
providing O 0 3.9455567177153206e-13
the O 0 2.854842013830239e-12
first O 0 3.325625799049936e-12
direct O 0 1.1877740978272211e-11
evidence O 0 3.3648400905861298e-12
for O 0 3.2836458704020577e-13
a O 0 3.4030250839478526e-11
functional O 0 4.0670933287856315e-09
consequence O 0 5.908844524782353e-09
of O 0 4.5995027231349184e-10
the O 0 5.200869068744396e-09
H63D O 0 3.963136987295002e-05
mutation O 0 1.3216730110343633e-07
. O 0 1.1606551275633592e-08

Addition O 0 2.597961135109017e-08
of O 0 3.4369773516118585e-07
soluble O 0 6.175720955070574e-06
wild O 0 3.0543866103016626e-08
- O 0 6.70114319589743e-09
type O 0 8.101013548866831e-08
HFE O 0 0.00010193741036346182
/ O 0 2.438665887893876e-06
beta2m O 0 2.0645147742470726e-06
heterodimers O 0 9.148886448429039e-08
to O 0 2.6049175261277924e-08
cultured O 0 2.9234057397076185e-09
cells O 0 4.731019465076258e-10
also O 0 2.8594470541376538e-12
decreased O 0 4.9828068754420585e-11
the O 0 3.715059510023266e-12
apparent O 0 1.2800085991138133e-10
affinity O 0 1.971384999688297e-10
of O 0 9.29406940297639e-10
the O 0 2.3888638289726316e-10
TfR O 0 4.97597130166838e-10
for O 0 5.202228079738414e-13
its O 0 8.241712976149451e-13
ligand O 0 2.895081396836474e-11
under O 0 9.311511006693252e-10
steady O 0 5.664319568943199e-10
- O 0 2.502675497395579e-11
state O 0 3.3556254996902624e-11
conditions O 0 1.2182344910627307e-08
, O 0 3.698839845522883e-12
both O 0 3.640591734327403e-12
in O 0 4.930752334209032e-11
293 O 0 5.5350661554154357e-11
cells O 0 1.822995747413625e-11
and O 0 3.5536559805926515e-11
in O 0 9.772852527234477e-10
HeLa O 0 2.0624058549856272e-07
cells O 0 1.2040599628448945e-08
. O 0 8.639235105079024e-09

Furthermore O 0 3.0204084566776146e-08
, O 0 2.463444170874851e-10
at O 0 2.9988977967576602e-09
4 O 0 1.203993438281259e-08
degrees O 0 6.936528507139883e-07
C O 0 2.936451437562937e-07
, O 0 5.581341291915898e-11
the O 0 5.073958475598772e-10
added O 0 2.85136914079942e-09
soluble O 0 7.87728371420826e-09
complex O 0 5.845841588580925e-10
of O 0 1.0355811763673728e-09
HFE O 0 3.6241251564206323e-06
/ O 0 7.774043098152106e-08
beta2m O 0 4.93894845021714e-08
inhibited O 0 1.7466901536256074e-10
binding O 0 1.241392100226335e-09
of O 0 6.181343770172987e-10
transferrin O 0 6.345267422602774e-08
to O 0 6.696009791085089e-08
HeLa O 0 5.600244890047179e-07
cell O 0 3.836989748151609e-08
TfR O 0 3.433962447729755e-08
in O 0 2.658414460787739e-11
a O 0 6.635043070524205e-10
concentration O 0 3.269704862418621e-08
- O 0 3.079345001211209e-09
dependent O 0 3.304020390615392e-09
manner O 0 4.151060828405662e-09
. O 0 2.6732607238955097e-08

Scatchard O 0 4.105267362319864e-05
plots O 0 1.3115343335812213e-06
of O 0 1.3418974731393973e-07
these O 0 2.1980563202905756e-10
data O 0 4.621619476008476e-10
indicate O 0 3.424370231819296e-10
that O 0 1.3767099439621067e-11
the O 0 8.73679531498972e-11
added O 0 5.734519456512821e-11
heterodimer O 0 4.28245938710603e-10
substantially O 0 2.373204688321806e-10
reduced O 0 1.7525034201604228e-10
the O 0 2.4640820633914373e-11
affinity O 0 1.3406702137341853e-10
of O 0 7.811090108056362e-10
TfR O 0 3.773014345398451e-09
for O 0 5.660871077450835e-11
transferrin O 0 3.084408319864451e-07
. O 0 2.7174518635320055e-08

These O 0 3.5601519510208846e-09
results O 0 1.329050869358639e-09
establish O 0 4.619462590227386e-09
a O 0 2.284842315347646e-09
molecular O 0 2.338543803048765e-09
link O 0 2.1893959978314115e-09
between O 0 5.920713253004806e-09
HFE O 0 5.849667104484979e-06
and O 0 7.089244191682553e-10
a O 0 3.350761446085926e-09
key O 0 2.0207870932154037e-08
protein O 0 4.534425335211978e-10
involved O 0 1.798618892712156e-11
in O 0 6.269600116848295e-11
iron O 0 1.4137158999005806e-08
transport O 0 1.1823821921552735e-09
, O 0 1.6822404580452144e-11
the O 0 2.328959247677176e-10
TfR O 0 1.9453552102532967e-09
, O 0 1.3741644541015452e-12
and O 0 1.1606328962146528e-12
raise O 0 1.501571089690401e-10
the O 0 1.8206962326683396e-10
possibility O 0 6.346472236629097e-10
that O 0 9.46223221304221e-12
alterations O 0 9.061312811198263e-11
in O 0 2.0376929310561565e-12
this O 0 1.9318708958937503e-12
regulatory O 0 4.244840035028119e-10
mechanism O 0 8.284783969969567e-10
may O 0 2.0507998077512468e-10
play O 0 1.2908963828439646e-11
a O 0 1.0275212104782216e-11
role O 0 3.8178262634636084e-12
in O 0 6.431028669665051e-13
the O 0 1.9536414153087378e-11
pathogenesis O 0 7.40705843327305e-08
of O 0 3.614514909600075e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 3.712613306561252e-06
. O 0 3.554644223413561e-08

Genomic O 0 2.1242077252736635e-07
organization O 0 5.239311207105857e-09
of O 0 5.665284241729296e-09
the O 0 1.7773754024119626e-08
UBE3A O 0 5.559554847422987e-05
/ O 0 3.059800064875162e-06
E6 O 0 3.193467819073703e-06
- O 0 7.48821207707806e-07
AP O 0 8.911096074371017e-07
gene O 0 1.2432793509986606e-11
and O 0 3.00443545910023e-12
related O 0 7.50847106711916e-10
pseudogenes O 0 2.2952177403112728e-07
. O 0 4.4053436454305483e-08

The O 0 2.131164592356072e-06
UBE3A O 0 5.241486360318959e-05
gene O 0 4.823716093227404e-09
encodes O 0 3.310313967386236e-10
the O 0 9.49463951904761e-10
E6 O 0 1.1978653446931276e-07
- O 0 3.58590739324427e-08
AP O 0 3.439957936279825e-07
ubiquitin O 0 1.342830846517984e-09
- O 0 8.594657763261182e-10
protein O 0 4.7499955357910295e-11
ligase O 0 1.0492286293267705e-12
and O 0 3.346968752496182e-12
has O 0 1.4198256285957722e-12
recently O 0 4.653254344344493e-12
been O 0 3.338780261378377e-13
shown O 0 7.443320319908825e-14
to O 0 5.879782338097383e-13
be O 0 2.457364390098804e-12
mutated O 0 9.425441538368773e-10
in O 0 1.7231776894277573e-08
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.0002553105296101421
who O 0 3.435794759809596e-09
lack O 0 5.430066707390324e-08
15q11 O 0 6.594920023417217e-07
- O 0 9.199369088719322e-08
q13 O 0 5.066542030363053e-07
deletions O 0 2.2983832614897892e-09
or O 0 3.823537930713883e-09
chromosome O 0 1.7137335817096755e-06
15 O 0 4.541124951629172e-07
paternal O 0 1.0849594218598213e-06
uniparental B-Disease 0 0.00034356798278167844
disomy I-Disease 0 0.0006397194811142981
. O 0 2.9124212233000435e-06

Previous O 0 6.946047506062314e-06
UBE3A O 0 9.080180461751297e-06
cDNA O 0 1.9685614915943006e-08
analysis O 0 9.701567327269345e-11
has O 0 9.594952870423112e-13
shown O 0 2.997605148043897e-13
a O 0 1.3376657420627325e-11
coding O 0 2.6827602361834124e-09
region O 0 9.076837059751597e-09
of O 0 1.3616846539221683e-09
approximately O 0 1.6617081044500992e-09
2 O 0 5.018477509111108e-07
. O 0 3.9006557983611856e-08

6 O 0 0.00011716935114236549
kb O 0 6.114527423051186e-06
and O 0 1.4924832481000294e-09
a O 0 3.070115894843184e-08
3 O 0 4.9451646191300824e-06
- O 0 4.974904186383355e-07
untranslated O 0 2.782277442747727e-05
region O 0 6.642050465188731e-08
( O 0 3.3960564915780367e-10
UTR O 0 8.327446039402275e-07
) O 0 2.2071254546229824e-11
of O 0 9.249327415083997e-10
< O 0 4.162980360433721e-07
50 O 0 1.0382853687929128e-08
bp O 0 3.200803178060596e-09
, O 0 3.6646415069174765e-12
whereas O 0 2.4445426585750774e-11
Northern O 0 5.136158720553397e-10
analysis O 0 1.0811445488867477e-11
has O 0 7.892788527787131e-13
indicated O 0 5.799192289573929e-12
mRNA O 0 6.630064552926029e-12
sizes O 0 3.6255549343972016e-12
of O 0 1.7870880122949906e-11
5 O 0 3.82354548023045e-09
- O 0 8.688082253627272e-09
8 O 0 1.1789084908286895e-07
kb O 0 3.9335674273388577e-07
. O 0 1.8962007075629117e-08

We O 0 4.129339572500612e-07
have O 0 3.389132863240718e-10
analyzed O 0 6.905484517538696e-11
additional O 0 2.2452116554827484e-11
cDNA O 0 1.2557738182650269e-09
clones O 0 4.817194976247663e-10
and O 0 2.5570635019123156e-12
provide O 0 7.534871706606217e-13
evidence O 0 7.198377310890791e-12
for O 0 1.9111964615070587e-12
an O 0 2.4741885623624782e-11
additional O 0 4.5499937151305403e-10
0 O 0 8.365934434095834e-08
. O 0 4.828284616564815e-08

5 O 0 8.382276973861735e-06
kb O 0 2.468009824951878e-06
of O 0 4.5953683525112865e-08
5 O 0 5.136497520652483e-07
- O 0 5.2906290903820263e-08
UTR O 0 3.6695525977847865e-06
and O 0 2.0640243680869474e-10
> O 0 2.3391873327227586e-08
2 O 0 4.3093475454725194e-08
kb O 0 4.525349339701279e-08
of O 0 6.055872248111882e-09
3 O 0 5.369793711906823e-07
- O 0 3.3576893088138604e-07
UTR O 0 2.848374606401194e-05
. O 0 1.256148074446628e-08

We O 0 7.842952065573172e-09
have O 0 9.475199271025136e-12
established O 0 1.8399448631356563e-11
the O 0 5.472122754923703e-12
genomic O 0 2.6899151309156544e-11
organization O 0 2.7806115049378022e-11
of O 0 1.5989934376570147e-10
UBE3A O 0 2.2743870431440882e-07
and O 0 1.0642068476451882e-10
the O 0 2.477235638842501e-10
sequence O 0 1.1562303892098669e-10
of O 0 4.296958067140366e-10
intron O 0 4.5747210464242016e-08
- O 0 9.173506754223126e-08
exon O 0 3.0903375858315485e-08
borders O 0 3.420959515665345e-08
. O 0 1.2169668650585663e-07

We O 0 1.3240160114946775e-06
have O 0 3.472583998131995e-09
also O 0 3.232976941713872e-10
mapped O 0 1.053025933117624e-08
two O 0 3.281541149924294e-10
highly O 0 3.099312750887151e-10
homologous O 0 3.7161124177842453e-10
processed O 0 5.514060763545103e-09
pseudogenes O 0 9.285940016923178e-09
, O 0 2.523393161091292e-10
UBE3AP1 O 0 2.427921799608157e-06
and O 0 3.004709148157758e-09
UBE3AP2 O 0 3.039583498321008e-05
, O 0 2.787398922787787e-10
to O 0 2.9188202965713117e-09
chromosomes O 0 9.284660262842692e-10
2 O 0 4.025203281798895e-09
and O 0 6.8448714578284164e-12
21 O 0 1.3527640119193052e-09
, O 0 3.1911062334244455e-12
respectively O 0 3.246706029025326e-11
, O 0 1.8178004674435089e-12
and O 0 6.561588945797059e-12
determined O 0 5.668372438094593e-10
their O 0 1.5551325852070086e-11
genomic O 0 8.599609913062523e-10
organization O 0 9.115070365162126e-10
. O 0 4.715445367509119e-09

These O 0 4.251054230852702e-10
results O 0 1.5353483762137188e-10
will O 0 1.6176620806773734e-11
form O 0 3.420776249069002e-12
the O 0 1.5684691392903183e-11
basis O 0 2.0315856635866325e-11
for O 0 3.4190787137275414e-13
studies O 0 2.460234706930242e-12
of O 0 3.7181221643201035e-12
mutation O 0 3.14934953116186e-11
and O 0 1.659853331170691e-11
imprinting O 0 1.607395745395479e-07
of O 0 5.642199241151502e-08
UBE3A O 0 0.00020009205036330968
. O 0 2.597104469259648e-07

Mutation O 0 4.25112375523895e-07
spectrum O 0 1.4291387628873053e-07
and O 0 5.729897112338733e-10
genotype O 0 3.063637734612712e-07
- O 0 5.101348321545629e-08
phenotype O 0 5.867000663073441e-09
analyses O 0 8.121748412692753e-11
in O 0 1.9994899833064572e-11
Cowden B-Disease 0 0.0007138337241485715
disease I-Disease 0 2.472339474479668e-06
and O 0 1.1301063418400759e-09
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.388707758844589e-09
two O 0 7.809157764882002e-09
hamartoma B-Disease 1 0.9988289475440979
syndromes I-Disease 0 0.01959008164703846
with O 0 4.3950421968474984e-07
germline O 1 0.9999252557754517
PTEN O 1 0.9998587369918823
mutation O 0 9.184794180328026e-05
. O 0 3.2945959560493066e-07

The O 0 1.0128531357622705e-05
tumour B-Disease 1 1.0
suppressor O 0 0.0008832797757349908
gene O 0 7.45586021366762e-07
PTEN O 0 1.4978395483922213e-05
, O 0 1.1351478784726865e-10
which O 0 4.895561386830671e-12
maps O 0 8.228028258727704e-10
to O 0 4.144835941133351e-08
10q23 O 0 0.00011398165952414274
. O 0 2.403556038643728e-07

3 O 0 1.4369343261932954e-06
and O 0 8.638934012594746e-10
encodes O 0 1.9752090241187403e-10
a O 0 2.0817776391623966e-09
403 O 0 4.345445669962089e-10
amino O 0 2.184907366142852e-09
acid O 0 8.797954031969368e-10
dual O 0 1.1562597546088682e-09
specificity O 0 6.129679519517595e-08
phosphatase O 0 4.165672726230696e-05
( O 0 4.209238291252859e-09
protein O 0 3.887092425713945e-09
tyrosine O 0 4.394851149669421e-09
phosphatase O 0 9.452578275670476e-09
; O 0 6.732482193266831e-12
PTPase O 0 5.68831426406291e-09
) O 0 8.405900758443052e-13
, O 0 1.3650683231350436e-12
was O 0 1.1394191146152366e-10
shown O 0 4.075901074984678e-12
recently O 0 2.5438914863507023e-11
to O 0 3.098714340676878e-11
play O 0 7.077050750980973e-12
a O 0 3.8864952922601503e-11
broad O 0 1.6722768725330184e-09
role O 0 6.437969601869042e-11
in O 0 9.909362219673312e-11
human O 0 1.0007705775194609e-08
malignancy B-Disease 0 4.926200199406594e-05
. O 0 3.0163327835452947e-08

Somatic O 0 0.00014203067985363305
PTEN O 0 7.04175909049809e-05
deletions O 0 1.3141230681412708e-07
and O 0 5.229636723669273e-09
mutations O 0 1.1242156094937172e-09
were O 0 9.768785086405884e-11
observed O 0 4.1849943649419075e-11
in O 0 7.398163678895564e-12
sporadic B-Disease 0 1.1803845723079576e-07
breast I-Disease 1 0.9999899864196777
, I-Disease 0 3.1931344324220845e-07
brain I-Disease 1 1.0
, I-Disease 0 5.3041228966321796e-05
prostate I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.6521145375445485e-05
lines O 0 1.0374657577472135e-08
and O 0 1.166292895593557e-10
in O 0 2.95718623199992e-11
several O 0 4.176525791876884e-11
primary O 0 1.0926436999625366e-07
tumours B-Disease 1 1.0
such O 0 4.5882433963306823e-10
as O 0 6.92482956310414e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999551773071289

In O 0 4.415832144388787e-09
addition O 0 5.947103365322448e-10
, O 0 3.818531268962033e-09
PTEN O 0 0.005432407837361097
was O 0 1.8385483713245776e-07
identified O 0 6.856338274907614e-10
as O 0 1.4927692762456424e-11
the O 0 5.1274248735744266e-11
susceptibility O 0 3.6686051974044176e-09
gene O 0 1.8736311113709547e-11
for O 0 8.040074855886203e-11
two O 0 3.805140735835266e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.0931133775926583e-10
CD B-Disease 0 1.9226888525736285e-07
; O 0 8.39667180230208e-09
MIM O 0 1.9275412341812626e-05
158350 O 0 1.3143375099389232e-07
) O 0 2.388679098269675e-12
and O 0 5.929838564622258e-11
Bannayan B-Disease 0 0.00023521114781033248
- I-Disease 0 0.0009144368232227862
Zonana I-Disease 0 0.00026170231285504997
( I-Disease 0 2.0552570756393607e-09
BZS I-Disease 0 1.8744866565612028e-06
) I-Disease 0 9.265628628934985e-13
or I-Disease 0 1.2456577436203986e-11
Ruvalcaba I-Disease 0 2.760598150075566e-08
- I-Disease 0 6.661739604396644e-09
Riley I-Disease 0 3.978088081169062e-09
- I-Disease 0 3.1276058507501148e-06
Smith I-Disease 0 3.5395275972405216e-06
syndrome I-Disease 1 1.0
( O 0 8.665111295158567e-09
MIM O 0 4.996696225134656e-05
153480 O 0 1.6041750541262445e-06
) O 0 3.9146938468626047e-10
. O 0 1.7430709320365168e-08

Constitutive O 0 5.565648208971652e-08
DNA O 0 8.581033661414494e-09
from O 0 4.5882955768128397e-10
37 O 0 1.2928812465062833e-09
CD B-Disease 0 2.2302542035390616e-09
families O 0 9.428403890954229e-11
and O 0 2.6111227069414156e-10
seven O 0 6.83155221281595e-09
BZS B-Disease 0 9.105136086873244e-06
families O 0 7.815720987069952e-11
was O 0 1.1869306648648603e-09
screened O 0 2.445785574067827e-09
for O 0 1.3435763612790197e-09
germline O 0 6.175156886456534e-05
PTEN O 0 0.001496164477430284
mutations O 0 2.66698452833225e-06
. O 0 1.0639647740617875e-07

PTEN O 0 0.00046376281534321606
mutations O 0 1.3829711065227457e-07
were O 0 2.2067686566984435e-10
identified O 0 1.405736031051541e-11
in O 0 3.636774908999385e-12
30 O 0 4.877345194387317e-10
of O 0 1.0189014909567362e-10
37 O 0 9.53625511890266e-10
( O 0 1.4525653249664039e-11
81 O 0 4.940076347992317e-09
% O 0 4.906313549879471e-11
) O 0 4.122292784902726e-13
CD B-Disease 0 7.675615143476477e-10
families O 0 5.8181071072027635e-11
, O 0 1.827078939531379e-11
including O 0 4.04876861204162e-11
missense O 0 9.267524347933431e-08
and O 0 3.5356348959680872e-09
nonsense O 0 3.2766166668807273e-07
point O 0 4.300365219478408e-07
mutations O 0 4.658817776004298e-10
, O 0 1.4817600271777032e-11
deletions O 0 5.395722757484123e-10
, O 0 1.4486924160284076e-10
insertions O 0 1.035832086770938e-09
, O 0 9.165693898305349e-11
a O 0 3.3380738173605096e-09
deletion O 0 8.053363131921287e-08
/ O 0 7.932076329097981e-08
insertion O 0 3.545875060240178e-08
and O 0 6.203611402355591e-09
splice O 0 5.170172130419814e-07
site O 0 2.9213058638788425e-08
mutations O 0 1.4327286024240493e-08
. O 0 1.062127363837817e-08

These O 0 7.927717149414093e-09
mutations O 0 4.995792224349316e-09
were O 0 1.8609741525565937e-10
scattered O 0 1.0895580271341743e-10
over O 0 1.1612091496693289e-11
the O 0 2.3031467358269886e-11
entire O 0 1.3883792726598898e-10
length O 0 2.5516191937136057e-10
of O 0 2.1483263779042971e-10
PTEN O 0 8.314346189308708e-08
, O 0 3.893764650986231e-12
with O 0 3.021495542914615e-13
the O 0 4.1481516138697216e-11
exception O 0 8.026514869419188e-11
of O 0 6.91010929032565e-11
the O 0 3.125181016749856e-11
first O 0 1.3144108024221168e-10
, O 0 3.15991538490934e-11
fourth O 0 5.929346791333501e-09
and O 0 2.2525520337879357e-10
last O 0 7.7420213528967e-07
exons O 0 4.179072675469797e-06
. O 0 6.684678055535187e-08

A O 0 0.00030114877154119313
hot O 0 0.0001162449989351444
spot O 0 9.445017781217757e-07
for O 0 2.5625306321330754e-09
PTEN O 0 7.610437933180947e-06
mutation O 0 2.677883026436234e-09
in O 0 2.0110685339247425e-10
CD B-Disease 0 2.6162901178850007e-08
was O 0 7.682432823230556e-08
identified O 0 1.67884761648196e-09
in O 0 1.9544399432191994e-10
exon O 0 2.4651751751036954e-09
5 O 0 6.138978214664803e-09
that O 0 2.5477068371637657e-12
contains O 0 2.851642099538365e-12
the O 0 3.735726450404542e-10
PTPase O 0 6.73830129471753e-07
core O 0 1.1127283983114467e-08
motif O 0 2.8327836604225e-11
, O 0 3.2273901433288454e-13
with O 0 1.4823435718919892e-13
13 O 0 1.3229202178166588e-09
of O 0 2.3508323065968284e-10
30 O 0 1.6240322420202347e-09
( O 0 1.2675857759270048e-11
43 O 0 2.6355215787532416e-09
% O 0 3.123399108795333e-11
) O 0 9.958710288707207e-13
CD B-Disease 0 2.1622057477799217e-09
mutations O 0 7.809392021940198e-10
identified O 0 1.658300441409466e-10
in O 0 1.2190624378016768e-11
this O 0 3.5397221265220935e-10
exon O 0 5.9406019659036247e-08
. O 0 3.91266752330921e-08

Seven O 0 1.4399836345546646e-07
of O 0 1.3861394698722052e-08
30 O 0 2.8280641828359876e-08
( O 0 9.309410881064295e-11
23 O 0 2.846387836541453e-08
% O 0 1.4858020369601377e-10
) O 0 3.918049424397191e-13
were O 0 2.7103547271117856e-12
within O 0 5.362519456264536e-11
the O 0 3.2478457423490426e-11
core O 0 6.141501890377654e-11
motif O 0 1.7334525741902196e-12
, O 0 5.951675648629626e-14
the O 0 6.234141891950373e-13
majority O 0 2.869865261233284e-13
( O 0 4.786526643790756e-12
five O 0 1.730002807676101e-10
of O 0 8.810711882301092e-11
seven O 0 4.352618612757375e-11
) O 0 6.487850621322844e-13
of O 0 1.0870582212163526e-11
which O 0 1.4861670921684222e-11
were O 0 6.523348528020279e-10
missense O 0 1.850019657467783e-07
mutations O 0 1.8598653284129796e-08
, O 0 9.285949092996404e-11
possibly O 0 3.537658610497374e-09
pointing O 0 2.726889603010818e-09
to O 0 6.158196730332577e-10
the O 0 1.0436650849099394e-10
functional O 0 2.0749157947363983e-09
significance O 0 1.300999308284645e-10
of O 0 3.683685578792506e-10
this O 0 1.37725164606195e-10
region O 0 1.0363942237745505e-07
. O 0 6.318553147366401e-08

Germline O 0 0.0025039012543857098
PTEN O 0 0.00016037735622376204
mutations O 0 1.3659722242209682e-08
were O 0 4.957382074288752e-11
identified O 0 1.2669540980572713e-12
in O 0 3.0991897416454695e-13
four O 0 2.712939194040448e-13
of O 0 1.5690764659792578e-11
seven O 0 2.6437456390748793e-11
( O 0 9.658266374168445e-12
57 O 0 2.8845249744335888e-08
% O 0 1.837702101603611e-09
) O 0 2.5855603769109337e-10
BZS B-Disease 0 1.8540815290180035e-05
families O 0 2.3280131988823172e-10
studied O 0 1.9820417307414573e-08
. O 0 3.130620385149996e-08

Interestingly O 0 2.412213007119135e-07
, O 0 1.0755880630597403e-09
none O 0 4.743976877996658e-10
of O 0 5.963267102337966e-10
these O 0 7.193055179266494e-11
mutations O 0 1.8014428837531682e-09
was O 0 3.469995180083174e-09
observed O 0 4.5483106170252086e-10
in O 0 6.567777571797606e-11
the O 0 1.2852544584163184e-09
PTPase O 0 1.4336451386043336e-06
core O 0 3.133010579858819e-07
motif O 0 5.1650857813001494e-08
. O 0 2.0226071484330532e-08

It O 0 3.6577244011404275e-10
is O 0 5.514420083757576e-12
also O 0 1.0083291623538826e-12
worthy O 0 3.5981249230099266e-11
of O 0 2.6626721660871766e-11
note O 0 9.631225504624918e-12
that O 0 2.5599231935624633e-12
a O 0 6.530042478969378e-11
single O 0 2.0065168970795355e-10
nonsense O 0 1.9167565312727675e-08
point O 0 8.687853636502041e-08
mutation O 0 7.660214129678877e-10
, O 0 6.407417652010139e-11
R233X O 0 3.2028449936660763e-07
, O 0 2.2045558434324874e-10
was O 0 1.852042075256577e-08
observed O 0 1.1091298990351106e-09
in O 0 2.8665746859557473e-11
the O 0 2.442516744416423e-10
germline O 0 6.721470935389107e-09
DNA O 0 1.4343847221098827e-09
from O 0 3.353891123158981e-11
two O 0 6.231538180433149e-13
unrelated O 0 1.1537427263563771e-11
CD B-Disease 0 1.3320505809488736e-09
families O 0 3.880288451663105e-11
and O 0 1.684141853752763e-10
one O 0 2.4470187653946596e-08
BZS B-Disease 0 0.002841829787939787
family O 0 2.9948239443911007e-08
. O 0 4.728426361566562e-08

Genotype O 0 1.122512685469701e-06
- O 0 1.0333604194556756e-07
phenotype O 0 7.541457236470706e-09
studies O 0 1.1299333690928393e-10
were O 0 1.6595327542723304e-12
not O 0 1.2635562084487018e-12
performed O 0 6.389824108200826e-13
on O 0 1.6179460549103908e-11
this O 0 6.030708701518228e-13
small O 0 9.108631383869525e-12
group O 0 4.1057247879283665e-11
of O 0 5.531779034839701e-09
BZS B-Disease 0 0.004414034076035023
families O 0 2.7170992566993846e-08
. O 0 1.8451265759722446e-07

However O 0 3.4803303350372516e-08
, O 0 5.983079032212402e-10
genotype O 0 2.2006174660305078e-08
- O 0 2.4321276104188883e-09
phenotype O 0 2.2778365860176564e-09
analysis O 0 1.018856804479995e-10
inthe O 0 4.480816073737515e-08
group O 0 3.700738066686471e-12
of O 0 2.87621385042236e-11
CD B-Disease 0 1.3101845830476577e-08
families O 0 9.28240748154785e-11
revealed O 0 2.4680391064180185e-10
two O 0 5.886312487782264e-13
possible O 0 8.9138349479434e-12
associations O 0 2.4579691580706164e-12
worthy O 0 1.6237959588050188e-10
of O 0 2.534027987444176e-10
follow O 0 1.5993716073747777e-10
- O 0 1.103049179773663e-10
up O 0 6.677634140084265e-11
in O 0 1.0031923208808635e-11
independent O 0 1.0980931441917363e-10
analyses O 0 1.345812905562127e-09
. O 0 6.772456817571992e-09

The O 0 1.7173832134176337e-08
first O 0 5.249611856328329e-10
was O 0 1.8010751778874123e-09
an O 0 1.7684118058802767e-11
association O 0 2.547703194244466e-11
noted O 0 1.3436621607021415e-11
in O 0 4.365503618319888e-12
the O 0 4.820087731727263e-11
group O 0 3.8279302687696526e-13
of O 0 3.0436911671594125e-12
CD B-Disease 0 2.1192173349504628e-08
families O 0 1.0898536517700563e-09
with O 0 3.80233302621491e-08
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.400319539854536e-06

A O 0 1.5432675581905642e-06
correlation O 0 4.841868772587077e-08
was O 0 2.817101663055155e-09
observed O 0 2.1130749927600334e-11
between O 0 2.5484760135530138e-11
the O 0 7.941041574310859e-11
presence O 0 1.7653087325264494e-10
/ O 0 1.3699665259991889e-06
absence O 0 9.881744489348421e-08
of O 0 4.585813062618627e-09
a O 0 2.1974424058157638e-08
PTEN O 0 5.708756816602545e-06
mutation O 0 6.570776145409241e-10
and O 0 9.054392435467462e-13
the O 0 2.4438049240488313e-12
type O 0 3.664064884834062e-10
of O 0 1.7727429524327931e-09
breast O 0 5.506631714524701e-05
involvement O 0 1.1181044783370453e-06
( O 0 1.768660595757865e-08
unaffected O 0 5.13862214575056e-05
versus O 0 4.440721022547223e-05
benign O 1 0.999498724937439
versus O 0 4.7037217882461846e-05
malignant O 1 0.9773692488670349
) O 0 4.767061190236177e-10
. O 0 4.56521753733341e-09

Specifically O 0 1.0719957144189607e-09
and O 0 1.4728867431257342e-11
more O 0 2.7426574466388187e-13
directly O 0 1.1361394464115548e-11
, O 0 2.3162472374133047e-12
an O 0 8.709538298901087e-12
association O 0 8.998567863072182e-11
was O 0 1.1421880330431122e-08
also O 0 1.455865983324145e-11
observed O 0 3.4207910809547215e-11
between O 0 3.331506598369671e-11
the O 0 4.291656613419903e-11
presence O 0 7.674992585915419e-12
of O 0 7.113810929215703e-11
a O 0 1.830601270569332e-08
PTEN O 1 0.9998304843902588
mutation O 0 0.00030511029763147235
and O 0 1.394146352140524e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.781480816338444e-06

Secondly O 0 2.3200216674013063e-05
, O 0 1.80136812133469e-08
there O 0 2.866559767333854e-10
appeared O 0 2.535285037463808e-10
to O 0 4.523038540926727e-11
be O 0 2.021562604814786e-11
an O 0 2.6610423933814964e-11
interdependent O 0 4.695953492728222e-08
association O 0 9.045274529384528e-10
between O 0 1.2496931276473333e-06
mutations O 0 2.136655211870675e-06
upstream O 0 1.570693513031074e-07
and O 0 3.457716404864364e-11
within O 0 6.277512953900555e-10
the O 0 5.734674957125208e-10
PTPase O 0 2.4640110041218577e-07
core O 0 7.251871103619578e-09
motif O 0 3.0228319847225293e-10
, O 0 5.732143492503949e-12
the O 0 3.809826412681794e-11
core O 0 2.448197478077674e-10
motif O 0 2.101570436771616e-12
containing O 0 2.238029606202365e-14
the O 0 2.273357148146679e-13
majority O 0 1.2594267263191933e-13
of O 0 4.515504983815255e-11
missense O 0 9.952275448199543e-09
mutations O 0 6.700833221628955e-10
, O 0 8.495858638997433e-13
and O 0 2.3227229059390175e-13
the O 0 7.069468708348348e-12
involvement O 0 4.1174194609361336e-10
of O 0 4.31275598566927e-10
all O 0 8.98237560720272e-12
major O 0 1.0556376883741336e-09
organ O 0 6.339629976537253e-07
systems O 0 1.7280184692936018e-05
( O 0 4.605828252124411e-08
central O 1 0.9999995231628418
nervous O 0 0.011177323758602142
system O 0 1.904344026115723e-05
, O 0 3.270153925427621e-08
thyroid O 1 1.0
, O 0 2.2232310925573984e-07
breast O 1 1.0
, O 0 3.0842277283227304e-06
skin O 1 1.0
and O 0 0.1534574031829834
gastrointestinal O 1 1.0
tract O 1 0.9999933242797852
) O 0 2.0570274728015647e-07
. O 0 7.998587534530088e-07

However O 0 2.3459527653812984e-07
, O 0 2.231050011403113e-09
these O 0 7.592194928296436e-11
observations O 0 2.1564725560807574e-09
would O 0 2.5834306915939464e-10
need O 0 1.3177116342522055e-10
to O 0 1.557615147973479e-10
be O 0 8.699879705531544e-11
confirmed O 0 2.4581016042080073e-11
by O 0 1.1237402067904023e-12
studying O 0 3.5661950822940547e-12
a O 0 2.1620045163872614e-12
larger O 0 3.3930746667215628e-12
number O 0 1.9803410213764527e-12
of O 0 2.0963472277535367e-11
CD B-Disease 0 3.888436239662951e-08
families O 0 5.883046938492953e-09
. O 0 1.5128969721445173e-07

Molecular O 0 0.007277810946106911
defects O 1 0.9998179078102112
leading O 0 1.4147166993438987e-08
to O 0 8.167299614392221e-10
human O 0 2.436792989612968e-10
complement B-Disease 0 4.8764730031791714e-09
component I-Disease 1 0.988556444644928
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.4343676246753034e-10
an O 0 6.359855784371371e-12
African O 0 1.8248395849962407e-11
- O 0 6.95603505351805e-11
American O 0 2.2873078431295824e-11
family O 0 1.0196130745265819e-10
. O 0 1.1155223411662973e-09

Complement B-Disease 0 2.0437094860881189e-07
component I-Disease 0 0.0035255905240774155
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 4.2445891246245537e-10
C6D B-Disease 0 2.7982747269561514e-05
) O 0 5.845370021351215e-11
was O 0 1.6092048582549978e-08
diagnosed O 0 9.363541408902165e-08
in O 0 9.000417598714616e-12
a O 0 5.567317440391406e-11
16 O 0 2.2618254491568734e-10
- O 0 9.184851663956994e-12
year O 0 4.970780037583111e-11
- O 0 6.084509979187303e-11
old O 0 1.7514741046387172e-10
African O 0 6.714460801596212e-13
- O 0 7.44941760187634e-13
American O 0 1.3320553969749238e-13
male O 0 1.7118552127041997e-13
with O 0 2.6426034754542527e-13
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.241828272213752e-06

The O 0 3.319409458413247e-08
patients O 0 3.401049442075532e-09
father O 0 8.46295922229956e-10
and O 0 3.1010381762452965e-11
two O 0 9.951012236442125e-11
brothers O 0 9.516799792663733e-09
also O 0 8.799846268336964e-11
had O 0 5.704601235834161e-09
C6D B-Disease 0 9.312500878877472e-06
, O 0 1.0776775305476605e-11
but O 0 4.70715307010483e-12
gave O 0 2.056882442147412e-11
no O 0 2.322902460660803e-11
history O 0 1.8237642299134826e-11
of O 0 1.482987760370591e-10
meningitis B-Disease 1 1.0
or O 0 2.2031445556791596e-09
other O 0 2.0380955256804612e-10
neisserial B-Disease 0 4.357749639893882e-05
infection I-Disease 0 0.00018087899661622941
. O 0 9.232309849949161e-08

By O 0 5.658218338311372e-10
using O 0 5.52279444399062e-10
exon O 0 1.2124224957332785e-09
- O 0 2.5048640939218103e-10
specific O 0 7.276332314454237e-11
polymerase O 0 9.72729119474991e-10
chain O 0 6.719108602837309e-10
reaction O 0 1.5301000050316205e-11
( O 0 2.027029152168458e-12
PCR O 0 1.5738544148491407e-11
) O 0 3.9869675486428613e-13
/ O 0 1.3071274097831154e-11
single O 0 4.887071650139241e-12
- O 0 2.7370793131975546e-11
strand O 0 5.5580231389518175e-11
conformation O 0 5.894022683111677e-12
polymorphism O 0 2.163869127283502e-12
as O 0 1.1150265145877178e-13
a O 0 2.045250904400553e-12
screening O 0 3.782195476947914e-12
step O 0 4.275683626597804e-11
and O 0 2.2771641343399818e-12
nucleotide O 0 2.2081654213468305e-11
sequencing O 0 1.1827937067276917e-11
of O 0 1.1911301112110806e-10
target O 0 7.551763658852906e-09
exons O 0 4.628802674488952e-09
, O 0 2.3722711295359744e-11
we O 0 1.3186463206082966e-11
determined O 0 1.1426836560302078e-10
that O 0 2.077617375015328e-12
the O 0 4.3218938844402643e-11
proband O 0 3.290174532821766e-08
was O 0 5.629702259923874e-10
a O 0 1.1453107906511661e-10
compound O 0 6.319812451138773e-10
heterozygote O 0 1.2091887213738772e-10
for O 0 7.1758402171717695e-12
two O 0 5.906791167298309e-10
C6 O 0 1.4156381439534016e-05
gene O 0 6.546662945083881e-08
mutations O 0 4.3349035649953294e-07
. O 0 9.774371534376769e-08

The O 0 5.8737892771887346e-08
first O 0 2.611159066745472e-09
, O 0 6.697482152207002e-11
1195delC O 0 8.611432456007151e-09
located O 0 3.3608024696540895e-10
in O 0 4.794307173483503e-10
exon O 0 4.856646640405415e-09
7 O 0 1.3391463937750814e-07
, O 0 9.393505071009223e-12
is O 0 2.288895201846275e-12
a O 0 4.413730839147867e-11
novel O 0 1.9581303245530535e-10
mutation O 0 5.75209047060099e-11
, O 0 1.427014756361089e-12
while O 0 2.662264506070322e-12
the O 0 4.2058315163906457e-11
second O 0 3.2011618356087013e-10
, O 0 7.027014820720767e-12
1936delG O 0 1.156780338185115e-09
in O 0 5.136198133470771e-10
exon O 0 1.6215869758084978e-09
12 O 0 2.7801331015098185e-08
, O 0 1.9944927653892108e-11
has O 0 9.6687545123042e-12
been O 0 1.5136359179934722e-11
described O 0 1.3963003496486603e-11
before O 0 4.7313961776263014e-11
to O 0 1.9907843429312067e-10
cause O 0 1.4352722566002285e-08
C6D B-Disease 0 1.241516656591557e-05
in O 0 4.999066091637694e-11
an O 0 1.4406759639429279e-11
unrelated O 0 2.6938445918389675e-10
African O 0 2.7418758236086305e-11
- O 0 1.345399069929698e-10
American O 0 3.215988586546814e-11
individual O 0 1.2581795848232158e-11
. O 0 6.700478394350284e-09

Both O 0 6.589406353896266e-08
mutations O 0 2.2993839721152654e-08
result O 0 3.7099667782314327e-09
in O 0 2.5565356498447045e-09
premature O 0 6.509272338917071e-07
termination O 0 9.922462140821153e-07
codons O 0 1.7233067239885713e-07
and O 0 3.945760607138027e-09
C6 O 0 3.119663915640558e-06
null O 0 2.44437501351058e-06
alleles O 0 2.4752591087917608e-08
. O 0 1.275871142070173e-08

Allele O 0 6.199885049795739e-09
- O 0 5.130166846889495e-10
specific O 0 2.7788353215707495e-11
PCR O 0 6.373532951409189e-11
indicated O 0 2.9692585196139376e-11
that O 0 7.803539037827198e-14
the O 0 1.876004560030786e-12
probands O 0 4.047892687708554e-09
two O 0 4.37135466713201e-11
brothers O 0 2.1471067146450196e-09
also O 0 5.897388133391246e-11
inherited O 0 3.05543967904498e-09
the O 0 5.079209497438342e-09
1195delC O 0 5.9181837208655e-09
mutation O 0 1.8357708408967e-10
from O 0 1.3667762754909774e-10
their O 0 3.369479001369413e-11
heterozygous O 0 7.556131935426702e-12
mother O 0 5.434469714515888e-12
and O 0 1.3143493455061717e-12
the O 0 2.6745213682621838e-11
1936delG O 0 3.8326411488931456e-10
mutation O 0 1.6541937264413775e-10
from O 0 1.6676893199729648e-10
their O 0 1.2034410967753928e-10
homozygous O 0 2.0783488818842955e-10
father O 0 2.5303152906275272e-09
. O 0 2.922010688966026e-10
. O 0 5.193474095221973e-09

PAX6 O 0 0.003953599836677313
mutations O 0 7.76187971496256e-06
reviewed O 0 9.76868363977701e-07
. O 0 2.096486610980719e-07

Mutations O 0 5.294626816976233e-07
in O 0 3.5750882254603766e-09
PAX6 O 0 1.7018833204929251e-06
are O 0 3.7502171507108883e-11
responsible O 0 3.484790789265446e-10
for O 0 1.605983679375811e-10
human O 0 7.0620835401769e-08
aniridia B-Disease 1 1.0
and O 0 1.9358102676392264e-08
have O 0 1.5138908182610322e-10
also O 0 8.079949036232659e-12
been O 0 5.327050866393845e-12
found O 0 9.30366352534795e-14
in O 0 4.667426994485642e-14
patients O 0 9.35400032171102e-14
with O 0 2.2004272048122692e-13
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.3417721334008093e-07
with O 0 0.008537612855434418
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.00145740807056427
with O 0 9.45386204875831e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999997615814209
keratitis I-Disease 1 0.9999997615814209
, O 0 2.4787727426200945e-09
and O 0 4.3584108544436617e-10
with O 0 1.550135242389672e-09
isolated B-Disease 1 1.0
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9996671676635742

No O 0 8.240287030503168e-08
locus O 0 8.640899551437542e-09
other O 0 5.7081297154260024e-12
than O 0 3.8650423139774404e-11
chromosome O 0 2.6930567287308804e-07
11p13 O 0 5.159526153875049e-06
has O 0 1.205336386256306e-10
been O 0 9.315397064835196e-11
implicated O 0 8.52234283144071e-10
in O 0 3.462192199599201e-10
aniridia B-Disease 1 1.0
, O 0 3.0774425230362112e-09
and O 0 5.09079667310175e-10
PAX6 O 0 9.220250831276644e-06
is O 0 1.2115596026429643e-10
clearly O 0 1.1592712206853761e-10
the O 0 1.3941588161703322e-10
major O 0 6.79098888234364e-10
, O 0 5.508322964420387e-12
if O 0 4.9145087305246804e-11
not O 0 6.304916311261621e-11
only O 0 1.1434424240786001e-10
, O 0 6.587964895832243e-11
gene O 0 4.660746788509584e-10
responsible O 0 5.227804678042958e-08
. O 0 1.0857549170850689e-07

Twenty O 0 6.991892291807744e-07
- O 0 2.6739950698129178e-08
eight O 0 1.8402134260853131e-09
percent O 0 1.7381168726515739e-09
of O 0 1.065968147084817e-10
identified O 0 1.9597266032178595e-09
PAX6 O 0 5.835753427163581e-07
mutations O 0 4.684303611668383e-09
are O 0 1.0590898297246909e-10
C O 0 4.394301413412904e-06
- O 0 2.468739467076375e-06
T O 0 1.8275144952895062e-07
changes O 0 1.0798925087485145e-09
at O 0 6.828282383963824e-09
CpG O 0 2.1926183091380835e-09
dinucleotides O 0 1.9318699973069897e-09
, O 0 1.1111700101706923e-11
20 O 0 2.5181765006543344e-10
% O 0 2.4735281531351738e-11
are O 0 8.169717615087724e-13
splicing O 0 1.5603746073011848e-10
errors O 0 1.7643771998976376e-09
, O 0 2.816613912590138e-12
and O 0 5.914087036935911e-13
more O 0 1.5369721825548438e-13
than O 0 4.137529294873099e-12
30 O 0 5.205501030225435e-10
% O 0 2.2047018724546952e-11
are O 0 4.658677957292134e-13
deletion O 0 1.6307111216917747e-10
or O 0 2.0913201725925035e-10
insertion O 0 2.0346397899828617e-09
events O 0 1.675794780719997e-10
. O 0 3.735428855122791e-09

There O 0 1.1160995683212604e-08
is O 0 2.505303742239562e-10
a O 0 3.2099249924755213e-09
noticeably O 0 5.851313034099803e-08
elevated O 0 5.130465652314342e-08
level O 0 1.8816416869071872e-08
of O 0 6.108349936972957e-10
mutation O 0 2.464962400861026e-10
in O 0 4.480091644887274e-11
the O 0 7.278330715898562e-11
paired O 0 5.743985582312705e-12
domain O 0 9.382192939222378e-11
compared O 0 4.382129641794519e-12
with O 0 8.80708605544879e-14
the O 0 2.8501100785005562e-11
rest O 0 1.9270003648319545e-10
of O 0 1.1681294820320431e-10
the O 0 7.36647520760414e-10
gene O 0 1.4279480931023159e-09
. O 0 5.783229006794954e-09

Increased O 0 2.0593594740603294e-07
mutation O 0 2.898415951690936e-09
in O 0 1.4500911582615572e-10
the O 0 4.5422335337441666e-10
homeodomain O 0 2.3432599860484515e-08
is O 0 1.8378545213471043e-11
accounted O 0 2.831481923926127e-11
for O 0 9.692865000215933e-13
by O 0 3.332612311113259e-11
the O 0 6.982028732949175e-09
hypermutable O 0 5.379737899602333e-07
CpG O 0 7.376999633379455e-08
dinucleotide O 0 2.3641804958174362e-08
in O 0 1.186745035575143e-09
codon O 0 2.0999358696371928e-08
240 O 0 5.065877051180223e-09
. O 0 2.3814494820584287e-09

Very O 0 3.4362290790568295e-08
nearly O 0 5.0307606969113294e-09
all O 0 1.2637793589398427e-10
mutations O 0 2.4828220035466586e-10
appear O 0 6.775838778949606e-10
to O 0 1.885830158698809e-09
cause O 0 3.3423700074308726e-07
loss O 0 1.1963499524370036e-08
of O 0 4.744649118038069e-09
function O 0 3.1814764711590726e-10
of O 0 1.6849323325462962e-10
the O 0 5.543666914409329e-11
mutant O 0 2.5059237671043455e-11
allele O 0 7.209015329134871e-11
, O 0 3.812133985217625e-13
and O 0 1.894869081520839e-13
more O 0 7.988747196315676e-14
than O 0 4.842412928973694e-12
80 O 0 2.2152789325158295e-10
% O 0 5.539248573716016e-11
of O 0 4.5002862547605105e-11
exonic O 0 4.623889893196065e-08
substitutions O 0 2.67204480763894e-10
result O 0 2.0351820229080886e-10
in O 0 2.6661139962413927e-10
nonsense O 0 3.770498935296018e-08
codons O 0 6.980646816145963e-08
. O 0 1.463828969150427e-08

In O 0 6.592801327087727e-08
a O 0 2.379076313729911e-08
gene O 0 7.883799169050576e-11
with O 0 4.440631456298361e-12
such O 0 1.1029041568910714e-10
extraordinarily O 0 2.47149447574202e-08
high O 0 1.31012129145347e-07
sequence O 0 2.9622924113681393e-09
conservation O 0 4.91042595474056e-10
throughout O 0 8.381219329667289e-12
evolution O 0 6.281736936175619e-11
, O 0 1.0571941759518477e-11
there O 0 4.5591651981480297e-11
are O 0 1.635314661463383e-10
presumed O 0 6.270461199164856e-06
undiscovered O 0 1.2646599316212814e-05
missense O 0 4.3881397004952305e-07
mutations O 0 2.0868315075972532e-08
, O 0 5.952774384532233e-11
these O 0 4.540998653490558e-12
are O 0 1.1856012699373863e-11
hypothesized O 0 3.997560060753358e-09
to O 0 1.5798650165876893e-09
exist O 0 9.084297758477078e-10
in O 0 1.1644879505112726e-10
as O 0 1.8840566606836973e-10
- O 0 2.7324187357180563e-09
yet O 0 1.5705872158378043e-09
unidentified O 0 2.4865387526773475e-09
phenotypes O 0 3.255028746540489e-10
. O 0 1.2180473296652394e-10
. O 0 2.033933466094595e-09

Genetic O 0 3.2970961001410615e-06
heterogeneity O 0 4.574974070692406e-07
and O 0 6.402509633574027e-10
penetrance O 0 2.4278463683913287e-08
analysis O 0 6.041502714770886e-11
of O 0 3.750347532527343e-10
the O 0 1.100515456542439e-09
BRCA1 O 0 9.437931325351201e-09
and O 0 1.9389576610961967e-09
BRCA2 O 0 1.0699294961113992e-07
genes O 0 6.142199193703846e-09
in O 0 3.114312363550198e-09
breast B-Disease 1 0.9884507656097412
cancer I-Disease 1 0.9999992847442627
families O 0 2.1249938697565085e-07
. O 0 1.0474200280441437e-06

The O 0 0.0016653821803629398
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 4.775921752298018e-06
Consortium O 0 6.591970702629624e-08
. O 0 1.958501982812777e-08

The O 0 2.2045485437161005e-09
contribution O 0 1.0585330390000536e-09
of O 0 1.1757815832069696e-09
BRCA1 O 0 3.963599670697704e-09
and O 0 6.93073043400716e-10
BRCA2 O 0 4.929386818730563e-07
to O 0 0.0003182852524332702
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.006478581577539444
assessed O 0 1.3577795776598123e-08
by O 0 8.218582064900559e-11
linkage O 0 3.136954918048218e-09
and O 0 7.439868859870913e-11
mutation O 0 3.3135973132036867e-11
analysis O 0 1.4869572587117297e-12
in O 0 1.4836001351048456e-12
237 O 0 6.636137386134555e-12
families O 0 1.0260870928965882e-12
, O 0 5.776877999401353e-13
each O 0 7.936597342869667e-13
with O 0 2.2259235741509814e-13
at O 0 9.085562857613638e-10
least O 0 5.389179033588043e-11
four O 0 4.719613588832772e-12
cases O 0 4.1479934070887126e-11
of O 0 3.2789462256488378e-09
breast B-Disease 0 5.3787392971571535e-05
cancer I-Disease 0 2.2770614123146515e-06
, O 0 2.7904989083338272e-11
collected O 0 1.039504420041748e-11
by O 0 3.3289784123757826e-11
the O 0 5.801228439850092e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 5.043959845352219e-07
Consortium O 0 2.207663385433989e-08
. O 0 1.01423154319491e-08

Families O 0 1.650500847105718e-09
were O 0 4.72053438005382e-11
included O 0 8.005011042054588e-13
without O 0 3.97650627703694e-11
regard O 0 1.6585566253723982e-10
to O 0 8.4816847989444e-11
the O 0 1.282457334772502e-10
occurrence O 0 3.793821079511872e-08
of O 0 6.213003871380351e-07
ovarian B-Disease 1 1.0
or I-Disease 1 0.825412929058075
other I-Disease 0 6.33530507911928e-05
cancers I-Disease 1 1.0
. O 0 3.686739728436805e-05

Overall O 0 0.00010721269063651562
, O 0 1.1506323289722786e-06
disease O 1 0.9999839067459106
was O 0 4.774728381562454e-07
linked O 0 3.1614999329576676e-07
to O 0 9.119495558707058e-08
BRCA1 O 0 4.14908152279736e-09
in O 0 5.35234183363098e-11
an O 0 4.018377644521287e-12
estimated O 0 1.8753472733057386e-11
52 O 0 1.4929409097863555e-10
% O 0 9.667316426542616e-12
of O 0 1.6556860049643518e-11
families O 0 4.993469613495671e-12
, O 0 7.133264465220002e-12
to O 0 2.9792799338679288e-09
BRCA2 O 0 1.0584643161948293e-09
in O 0 6.803548696643347e-11
32 O 0 4.888278670733825e-10
% O 0 9.979917933722326e-12
of O 0 3.397471757052295e-12
families O 0 1.3061598243963024e-12
, O 0 1.6916929012136817e-12
and O 0 2.966652748112586e-12
to O 0 5.948771475416947e-10
neither O 0 5.449546924829463e-10
gene O 0 5.843672767902319e-12
in O 0 9.904500830604235e-12
16 O 0 8.952914520854449e-10
% O 0 4.7657586210725356e-11
( O 0 3.1446900205372996e-12
95 O 0 2.9152926739328677e-09
% O 0 6.70730360141647e-10
confidence O 0 3.702007589367895e-09
interval O 0 4.652269325333691e-08
[ O 0 2.2317914627478785e-08
CI O 0 9.193394134854316e-07
] O 0 4.642974615887141e-10
6 O 0 6.219448289712659e-10
% O 0 9.039487908202304e-12
- O 0 2.3645828350904452e-11
28 O 0 6.854742329309715e-10
% O 0 2.120204706246298e-11
) O 0 2.5514594777231725e-13
, O 0 7.814386073987101e-13
suggesting O 0 1.4142376159043124e-10
other O 0 6.861331641738744e-11
predisposition O 0 9.040037184604444e-06
genes O 0 6.515072925594723e-08
. O 0 1.1303073144119935e-08

The O 0 8.811342766534835e-09
majority O 0 2.2928815096578958e-11
( O 0 1.3460784570318296e-11
81 O 0 4.053872793008395e-09
% O 0 6.63178817417176e-11
) O 0 7.593055416192651e-13
of O 0 1.410676159219193e-10
the O 0 2.3461809917080245e-07
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.755025066558119e-09
were O 0 1.2109704905505225e-10
due O 0 2.4382309504744626e-09
to O 0 3.789470959247865e-10
BRCA1 O 0 9.541490514353157e-11
, O 0 5.490645373258662e-13
with O 0 4.748928504670451e-14
most O 0 3.757360308304092e-12
others O 0 6.990599505513062e-12
( O 0 1.915511152472682e-11
14 O 0 1.7982717537279314e-08
% O 0 2.451767677769112e-10
) O 0 9.632786755753298e-12
due O 0 5.930492008587862e-08
to O 0 3.098654417499347e-07
BRCA2 O 0 3.5711689179152017e-06
. O 0 2.1435565145111468e-07

Conversely O 0 7.621877529118137e-08
, O 0 2.042585371675454e-11
the O 0 8.674821277976363e-12
majority O 0 2.752772510807022e-13
of O 0 3.973107867011327e-12
families O 0 5.766541215888876e-13
with O 0 6.33079363671768e-13
male B-Disease 0 9.096608466485634e-10
and I-Disease 0 9.259741862166493e-10
female I-Disease 0 1.587938136538014e-08
breast I-Disease 0 5.114451778354123e-05
cancer I-Disease 0 0.4803581237792969
were O 0 1.4787693736195706e-08
due O 0 2.422139914415311e-06
to O 0 2.2103289154529193e-07
BRCA2 O 0 2.7302112570737336e-08
( O 0 2.3768423340619904e-10
76 O 0 6.28137470926049e-08
% O 0 1.1274516875658946e-09
) O 0 6.430177224014955e-11
. O 0 4.312601387113091e-09

The O 0 4.698533473401767e-08
largest O 0 8.950545193897597e-09
proportion O 0 2.6449575862841357e-10
( O 0 1.1922888024096245e-11
67 O 0 4.320761082254876e-09
% O 0 5.695756366552729e-11
) O 0 4.315563477321621e-13
of O 0 1.8138877552753563e-11
families O 0 8.730428706360538e-12
due O 0 4.512119389232794e-08
to O 0 7.915237354438887e-09
other O 0 1.0018046808779602e-10
genes O 0 2.372026880470557e-11
was O 0 3.471494272599962e-11
found O 0 3.726936497589449e-14
in O 0 3.7570414037875824e-14
families O 0 1.0028311900778675e-14
with O 0 3.338993501922848e-15
four O 0 1.7747329213863017e-12
or O 0 2.328300746645695e-11
five O 0 2.093354309340434e-11
cases O 0 1.2104087697417665e-11
of O 0 4.475353421184991e-10
female O 0 3.786857050158687e-09
breast B-Disease 0 0.001322102965787053
cancer I-Disease 1 0.9914478063583374
only O 0 5.267199298941705e-07
. O 0 1.5939789363983436e-06

These O 0 7.79180986398842e-09
estimates O 0 1.2017931538821358e-08
were O 0 8.585723798582023e-11
not O 0 2.276001609402556e-11
substantially O 0 1.8747794983120514e-10
affected O 0 2.1008302736325035e-11
either O 0 1.517023312525012e-11
by O 0 1.3246560966184706e-11
changing O 0 4.1230538427861063e-10
the O 0 1.2224182777131887e-10
assumed O 0 3.3865868442894964e-10
penetrance O 0 1.1638905811350853e-10
model O 0 3.753549988189109e-12
for O 0 2.2016805045765864e-11
BRCA1 O 0 4.188414337580326e-10
or O 0 1.2706332513934271e-11
by O 0 4.0164009271204115e-12
including O 0 2.1838542259289273e-12
or O 0 3.3777054486705538e-09
excluding O 0 1.6895905119440613e-08
BRCA1 O 0 7.673440904909512e-08
mutation O 0 2.8423025710822003e-08
data O 0 2.86490497991565e-09
. O 0 7.501174792423626e-09

Among O 0 2.7974655925078196e-10
those O 0 3.171859302986135e-11
families O 0 7.365347914900511e-11
with O 0 9.315574700519136e-11
disease O 0 0.0011698735179379582
due O 0 1.1129958693345543e-05
to O 0 5.987480449221039e-07
BRCA1 O 0 7.849462413389574e-09
that O 0 1.877996924637415e-10
were O 0 2.0169525771773777e-11
tested O 0 1.241025619942715e-12
by O 0 4.0423832900829404e-13
one O 0 5.152107473288536e-12
of O 0 5.765839628663061e-12
the O 0 4.27147510070891e-12
standard O 0 1.6361467736203394e-11
screening O 0 1.9283597288421994e-11
methods O 0 1.605270083526733e-10
, O 0 9.494344199723059e-11
mutations O 0 5.123214630309292e-10
were O 0 5.413474113424854e-10
detected O 0 1.1699584634428106e-09
in O 0 1.0487409551895865e-11
the O 0 7.039789584606382e-11
coding O 0 1.639099550532208e-10
sequence O 0 6.775589811436333e-11
or O 0 3.030075149124123e-11
splice O 0 3.7484595982739677e-10
sites O 0 4.779775533703123e-12
in O 0 3.344771833634075e-13
an O 0 7.949732994290415e-13
estimated O 0 5.828470345248249e-11
63 O 0 5.596214047720593e-10
% O 0 4.155746233247548e-11
( O 0 1.4439826938328348e-11
95 O 0 1.4753126720279397e-08
% O 0 4.744666881606463e-09
CI O 0 2.3054407449762948e-07
51 O 0 2.7144613223839542e-09
% O 0 8.011357549575493e-11
- O 0 1.7141417452126717e-10
77 O 0 6.77176870134133e-10
% O 0 8.559023628729179e-11
) O 0 1.4072141889254208e-11
. O 0 1.8208291541199628e-09

The O 0 1.297618439366488e-07
estimated O 0 8.371965343201282e-09
sensitivity O 0 2.849053437614657e-09
was O 0 5.626814569836824e-10
identical O 0 2.2584178450968384e-12
for O 0 1.9399536230896297e-12
direct O 0 8.844319027145886e-11
sequencing O 0 2.9478548074779454e-11
and O 0 7.057128319221118e-12
other O 0 5.605299644578787e-12
techniques O 0 5.158405369520835e-10
. O 0 1.5617271920120857e-09

The O 0 2.6638807071321935e-07
penetrance O 0 3.5536656923795817e-06
of O 0 4.003732101409696e-07
BRCA2 O 0 2.484170522620843e-07
was O 0 5.905847810794285e-09
estimated O 0 9.599593342457524e-11
by O 0 4.466386462065319e-12
maximizing O 0 1.7619156134074387e-09
the O 0 8.332516343578789e-10
LOD O 0 7.995559826667886e-06
score O 0 1.2464124177213876e-09
in O 0 6.305132804751423e-11
BRCA2 O 0 1.6220077503348307e-09
- O 0 2.815984334603172e-09
mutation O 0 3.325534014830822e-10
families O 0 7.319437590747047e-12
, O 0 7.756620866439246e-13
over O 0 1.395999548597926e-11
all O 0 3.008215551658644e-11
possible O 0 4.120014107655834e-09
penetrance O 0 2.4390280373154383e-07
functions O 0 4.948422116513029e-09
. O 0 1.3974562840246563e-08

The O 0 2.2008439515275313e-08
estimated O 0 9.06835850855714e-09
cumulative O 0 2.5594891539526543e-08
risk O 0 4.489285032605039e-08
of O 0 4.803776576522978e-08
breast B-Disease 0 0.27421143651008606
cancer I-Disease 0 0.0013283694861456752
reached O 0 1.2015124411846045e-05
28 O 0 1.9132033912683255e-07
% O 0 2.294540668579259e-10
( O 0 1.8665533528527956e-12
95 O 0 1.7586354594811837e-09
% O 0 4.094277972210847e-10
CI O 0 2.043180735711303e-08
9 O 0 1.386350367837963e-09
% O 0 1.222923585314506e-11
- O 0 1.2486430292502071e-11
44 O 0 2.0387242241626247e-11
% O 0 2.4422009011447476e-13
) O 0 6.796371610806628e-16
by O 0 2.3242062300362493e-14
age O 0 4.693483449114133e-11
50 O 0 2.6593680382824836e-11
years O 0 3.156353650668464e-12
and O 0 2.2240234827386463e-12
84 O 0 5.288041116102704e-10
% O 0 1.3636272666595062e-11
( O 0 1.6740869758155585e-12
95 O 0 1.7041474897894204e-09
% O 0 4.316096646750367e-10
CI O 0 3.290438144176733e-08
43 O 0 1.844862040911721e-10
% O 0 2.044385060545606e-12
- O 0 1.7335817026689626e-12
95 O 0 1.1402751139144574e-11
% O 0 4.198950215306141e-13
) O 0 2.7718949910989638e-15
by O 0 2.529914754252627e-13
age O 0 8.778393012498498e-10
70 O 0 3.0765254233067196e-10
years O 0 4.516549356736732e-10
. O 0 2.406242094465938e-09

The O 0 2.373719780734973e-06
corresponding O 1 0.9999991655349731
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.013140091672539711
were O 0 1.0407677386581327e-08
0 O 0 2.4278000054778204e-08
. O 0 2.2494790474780757e-09

4 O 0 2.9352411274885526e-06
% O 0 6.474735414485622e-09
( O 0 8.732081724360796e-11
95 O 0 2.4107359664071737e-08
% O 0 3.0440501230799555e-09
CI O 0 1.1775220087884009e-07
0 O 0 5.530457758418095e-10
% O 0 1.666003272837724e-11
- O 0 2.479129575239103e-11
1 O 0 9.7835206602781e-10
% O 0 3.520213417637641e-12
) O 0 3.916416497340815e-15
by O 0 2.1999740083041702e-13
age O 0 1.4685255789181895e-10
50 O 0 2.7396909393906377e-11
years O 0 2.758713179770722e-12
and O 0 1.3318580179694228e-12
27 O 0 8.548602381530657e-10
% O 0 2.226223025370011e-11
( O 0 4.404897887416714e-12
95 O 0 2.547360766769202e-09
% O 0 4.0336478601687986e-10
CI O 0 2.13932462855837e-08
0 O 0 1.6607376585042743e-10
% O 0 3.3545165343401573e-12
- O 0 1.093117003164723e-11
47 O 0 8.470222440104536e-11
% O 0 7.405627760331823e-13
) O 0 4.830634827421906e-15
by O 0 5.13649398622279e-13
age O 0 8.18105139188674e-10
70 O 0 7.590692518988362e-10
years O 0 7.600456930489941e-10
. O 0 2.598529391661941e-09

The O 0 1.780789027350238e-08
lifetime O 0 2.546357222854567e-07
risk O 0 1.228412088494224e-06
of O 0 2.779855094559025e-06
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 5.274475078920204e-09
similar O 0 1.4003597760547937e-11
to O 0 2.541197474670298e-09
the O 0 1.6899345256504716e-09
risk O 0 3.650747759653683e-10
in O 0 2.6169351408089625e-11
BRCA1 O 0 1.3732645576247648e-10
carriers O 0 2.3788684563874618e-11
, O 0 1.615318816206024e-11
but O 0 2.7975762331711174e-11
there O 0 1.1119883659704843e-11
was O 0 1.1613161127188576e-10
some O 0 1.409017623714079e-13
suggestion O 0 7.772416044105057e-11
of O 0 4.6067965414620105e-11
a O 0 1.9195241229841287e-10
lower O 0 4.230521710724133e-08
risk O 0 2.411502775245822e-09
in O 0 6.702290389348775e-10
BRCA2 O 0 7.920930578109164e-09
carriers O 0 2.224148643037438e-10
< O 0 4.122460595112898e-08
50 O 0 5.050159179731395e-10
years O 0 7.69964370039844e-11
of O 0 7.290056752706775e-11
age O 0 9.899964403814465e-09
. O 0 1.2245267910770963e-08

Eye B-Disease 1 0.9999592304229736
movement I-Disease 0 9.440710527996998e-06
abnormalities I-Disease 0 3.6886219731968595e-06
correlate O 0 1.0811043171798929e-09
with O 0 6.78061122874607e-13
genotype O 0 7.291443893109317e-08
in O 0 7.3547137269258656e-09
autosomal O 1 0.999996542930603
dominant O 1 0.9999873638153076
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 2.0296231468819315e-06

We O 0 1.2421534734130546e-07
compared O 0 9.123880317929434e-08
horizontal O 0 5.173874342290219e-06
eye O 0 0.00018572091357782483
movements O 0 5.0272621621161306e-08
( O 0 3.4110003710452474e-10
visually O 0 2.627589534842656e-10
guided O 0 7.112539446296751e-10
saccades O 0 4.990899427070872e-08
, O 0 3.856066507768041e-11
antisaccades O 0 1.814077243977863e-08
, O 0 3.436538553724944e-11
and O 0 4.1101594350223536e-11
smooth O 0 1.6313340678308919e-09
pursuit O 0 1.811977234922324e-09
) O 0 4.435764255905639e-12
in O 0 2.2963608445336625e-11
control O 0 1.1965843871308834e-09
subjects O 0 1.7690265918801629e-10
( O 0 6.010478139500952e-12
n O 0 4.68180938462126e-10
= O 0 6.152972020778691e-10
14 O 0 3.440987217384617e-10
) O 0 1.310496172300321e-13
and O 0 4.67642959946224e-13
patients O 0 3.9904901215012667e-13
with O 0 6.365246346093411e-15
three O 0 1.404306900799901e-12
forms O 0 3.4053124209343366e-10
of O 0 1.9432905062899408e-08
autosomal O 1 0.9999082088470459
dominant O 1 0.6405985951423645
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999741315841675
type I-Disease 1 0.9996814727783203
I I-Disease 0 0.4065861403942108
spinocerebellar B-Disease 0 0.00019996844639535993
ataxias I-Disease 0 6.085573659220245e-06
1 I-Disease 0 1.1274972848696052e-06
and I-Disease 0 3.8636219223953105e-10
2 I-Disease 0 8.071324231195831e-08
( O 0 2.1514633130603755e-10
SCA1 B-Disease 0 6.543569270434091e-06
, O 0 3.7388342422062237e-10
n O 0 9.926979238628064e-10
= O 0 3.27243426800905e-10
11 O 0 6.712022604382639e-11
; O 0 2.719250605937029e-12
SCA2 B-Disease 0 4.179584323082963e-07
, O 0 2.5716991036706105e-11
n O 0 1.9984387755744848e-10
= O 0 9.405520806637924e-11
10 O 0 1.1312811798447342e-10
) O 0 1.008090746296153e-12
and O 0 1.9458588906839935e-10
SCA3 B-Disease 1 1.0
/ O 0 0.00027353985933586955
Machado B-Disease 0 4.275184153357259e-07
- I-Disease 0 4.856454438595392e-08
Joseph I-Disease 0 2.692198961540271e-07
disease I-Disease 0 8.905132062864141e-07
( O 0 7.232593690620348e-11
MJD B-Disease 1 1.0
) O 0 4.5353423794303183e-10
( O 0 1.0418472334849938e-10
n O 0 1.1916403863665437e-08
= O 0 8.281833885348533e-09
16 O 0 1.9207750057148587e-08
) O 0 7.119566741708994e-11
. O 0 3.544791127296776e-09

In O 0 1.2036713314955705e-07
SCA1 B-Disease 0 0.0003896408306900412
, O 0 2.7559825532819104e-09
saccade O 0 7.678272595512681e-08
amplitude O 0 1.7185258771590384e-09
was O 0 1.6377806055789534e-10
significantly O 0 3.2924545034784813e-11
increased O 0 2.4295565559384613e-11
, O 0 3.344288604725798e-12
resulting O 0 6.28520152590184e-11
in O 0 2.0983523252304792e-10
hypermetria B-Disease 0 1.3908979781263042e-06
. O 0 3.023267680646313e-08

The O 0 9.991402549758277e-08
smooth O 0 2.819850131174917e-08
pursuit O 0 2.5428238359381794e-07
gain O 0 4.025674513741251e-07
was O 0 3.790031826156337e-07
decreased O 0 3.419251299874304e-07
. O 0 1.3570184087541293e-08

In O 0 1.654218095836768e-07
SCA2 B-Disease 0 0.00017835409380495548
, O 0 2.822307720862227e-09
saccade O 0 2.066097124497901e-07
velocity O 0 9.65371711458829e-08
was O 0 3.1727822591420818e-09
markedly O 0 1.3973521895138674e-08
decreased O 0 8.798684092425901e-08
. O 0 8.155644160012798e-09

The O 0 3.822118799234886e-07
percentage O 0 6.809464707657753e-07
of O 0 2.1258891536035662e-08
errors O 0 2.286828475916991e-06
in O 0 4.624481064752217e-08
antisaccades O 0 0.00010763482714537531
was O 0 6.209888425701138e-08
greatly O 0 1.346746880681593e-10
increased O 0 3.811970877842796e-11
and O 0 8.205948941186758e-13
was O 0 2.6354484566892822e-11
significantly O 0 2.3055277305339406e-12
correlated O 0 1.547164414812674e-12
with O 0 1.3890525828088446e-13
age O 0 4.631063088567089e-09
at O 0 2.0851725679449373e-08
disease O 0 2.7789405976363923e-06
onset O 0 1.9878129023709334e-05
. O 0 8.348511926214996e-08

In O 0 2.7724851303645437e-09
addition O 0 5.8042411155145857e-11
, O 0 2.9657151734419074e-11
a O 0 1.953709416468996e-10
correlation O 0 1.6615551989840327e-10
between O 0 6.54695686552742e-10
smooth O 0 7.107105570725025e-09
pursuit O 0 3.229465583842739e-09
gain O 0 4.840997824828719e-09
and O 0 1.6714621006719277e-11
the O 0 1.1327926097148833e-10
number O 0 6.360623139300969e-11
of O 0 1.7174018873689079e-09
trinucleotide O 0 3.9773320281710767e-07
repeats O 0 9.920397836538086e-09
was O 0 6.391873696998118e-09
found O 0 1.6254877999166695e-10
. O 0 1.6706031003010935e-09

In O 0 1.3073732816337724e-06
SCA3 B-Disease 1 1.0
, O 0 1.2953128134540748e-06
gaze B-Disease 0 6.80557859595865e-05
- I-Disease 0 4.926491783407982e-07
evoked I-Disease 0 1.9095679704150825e-08
nystagmus I-Disease 0 1.3279941413202323e-07
was O 0 6.754856674007215e-10
often O 0 1.3491494163173079e-12
present O 0 3.3995139602643887e-12
as O 0 2.494339370467946e-12
was O 0 1.408122368706799e-10
saccade O 0 7.996298734269658e-09
hypometria O 0 1.4800589198671332e-08
and O 0 8.557163311273541e-11
smooth O 0 5.200730512910923e-09
pursuit O 0 5.09872215559426e-08
gain O 0 1.7722477707593498e-07
was O 0 6.889167991630529e-08
markedly O 0 1.9973889209268236e-08
decreased O 0 1.7342896896366256e-08
. O 0 2.406040033875456e-09

Three O 0 1.973651819753286e-08
major O 0 2.09589838817692e-08
criteria O 0 1.2341331512288889e-08
, O 0 3.760918659834189e-11
saccade O 0 1.552047379504984e-08
amplitude O 0 1.5229738581368224e-09
, O 0 2.4323989003538493e-11
saccade O 0 1.2486689016100172e-08
velocity O 0 1.3468278048378579e-08
, O 0 1.0069535483214764e-11
and O 0 1.2132748798687754e-11
presence O 0 1.4581733043250722e-10
of O 0 3.6306051498513625e-09
gaze B-Disease 0 7.55003725316783e-07
- I-Disease 0 9.343022355778885e-09
evoked I-Disease 0 6.566704402466428e-10
nystagmus I-Disease 0 1.5707248834928578e-09
, O 0 3.570726071593089e-13
permitted O 0 3.142004018075184e-12
the O 0 1.6362770513533853e-12
correct O 0 3.7012837239558394e-11
assignment O 0 2.1857014462223212e-11
of O 0 1.5768710989738643e-11
90 O 0 2.2296235691054989e-10
% O 0 3.639719081682813e-11
of O 0 2.388971832856246e-11
the O 0 2.96113827902289e-10
SCA1 B-Disease 0 3.3625776723056333e-06
, O 0 1.4754210353462582e-10
90 O 0 2.66884736532802e-09
% O 0 2.7467439780992642e-11
of O 0 8.047865325544468e-12
the O 0 4.002805031877443e-11
SCA2 B-Disease 0 3.0399382922041696e-07
, O 0 8.095560680154712e-12
and O 0 6.601043062853806e-12
93 O 0 2.469258686410569e-10
% O 0 1.3647593471999286e-11
of O 0 1.0045863446661585e-11
the O 0 5.313425394115612e-11
patients O 0 3.533777090392043e-11
with O 0 1.3591041486682442e-11
SCA3 B-Disease 1 1.0
to O 0 5.19015998179384e-07
their O 0 1.452503006760253e-09
genetically O 0 3.614704091603471e-10
confirmed O 0 6.786728956598154e-10
patient O 0 1.3165216694588366e-09
group O 0 4.748462473919135e-12
and O 0 1.7114684669472524e-11
, O 0 6.723271939179654e-11
therefore O 0 6.383381823127365e-09
, O 0 4.3571890540050617e-10
may O 0 1.0921812076958304e-07
help O 0 6.722701950678811e-09
orient O 0 3.933664174837759e-06
diagnoses O 0 8.025990894111601e-08
of O 0 4.898445205014923e-09
SCA1 B-Disease 0 4.137808900850359e-06
, O 0 6.386528805801817e-11
SCA2 B-Disease 0 3.966146323364228e-06
, O 0 6.480127545671621e-11
and O 0 3.8122852097366433e-10
SCA3 B-Disease 1 1.0
at O 0 1.821872785967571e-07
early O 0 7.929668477402174e-09
clinical O 0 3.9300004917031117e-10
stages O 0 1.548894013048141e-09
of O 0 3.5702485412514307e-10
the O 0 1.0478568235328112e-08
diseases O 0 3.2362863748858217e-06
. O 0 2.0738435413392153e-09
. O 0 1.618355938148852e-08

Genetic O 0 2.7962361315303497e-08
basis O 0 3.520594926698095e-09
and O 0 1.0369815249544612e-11
molecular O 0 5.9126292750733e-10
mechanism O 0 5.283960380353392e-09
for O 0 1.511090985673036e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.999920129776001

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 0.03371267765760422
more O 0 2.051226272170581e-10
than O 0 6.923856626928071e-11
300 O 0 7.119919931408702e-11
, O 0 6.561339145616518e-12
000 O 0 3.3277547384358286e-10
sudden O 0 6.131556373745184e-10
deaths O 0 2.0689897711756444e-11
each O 0 1.5540584227466403e-12
year O 0 2.0150887902747883e-10
in O 0 1.2337601773548812e-10
the O 0 2.25266494346954e-09
USA O 0 2.561930934064094e-08
alone O 0 5.120178947493059e-09
. O 0 9.523862587457188e-09

In O 0 9.671278000666916e-09
approximately O 0 1.3582658331401376e-09
5 O 0 1.6241136435724002e-08
- O 0 2.6945397024746853e-09
12 O 0 4.7917407819397795e-09
% O 0 1.2814205252453803e-10
of O 0 4.18406628788226e-12
these O 0 2.8590690470502167e-13
cases O 0 9.884666002379916e-12
, O 0 1.714924751684832e-12
there O 0 2.64964048965477e-12
are O 0 1.1861480764610577e-12
no O 0 2.392484266255934e-10
demonstrable O 0 2.4149967430275865e-06
cardiac O 0 0.0002623938780743629
or O 0 1.1591445314707016e-07
non O 0 0.051369719207286835
- O 1 0.9829859137535095
cardiac O 1 0.9999997615814209
causes O 0 4.269936226819482e-08
to O 0 5.738285957512801e-10
account O 0 3.2342936922419296e-12
for O 0 5.2493365557126914e-12
the O 0 2.5474031217775917e-10
episode O 0 1.2763518020264542e-10
, O 0 1.835830071945585e-14
which O 0 7.098048006564522e-15
is O 0 1.4814617089499438e-13
therefore O 0 3.003651841138044e-11
classified O 0 6.941008878769139e-10
as O 0 6.216228598532325e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 3.18425031764491e-06
IVF B-Disease 1 1.0
) O 0 9.3335417172824e-10
. O 0 6.026914967094399e-09

A O 0 4.3797743387585797e-07
distinct O 0 4.159168121020684e-09
group O 0 1.4873851039709507e-09
of O 0 2.3307106289394142e-07
IVF B-Disease 1 1.0
patients O 0 2.9483142043318367e-06
has O 0 1.896653493982381e-11
been O 0 4.205717371585926e-12
found O 0 1.690708120380413e-13
to O 0 1.5442604877138888e-12
present O 0 9.094217891768286e-13
with O 0 9.456196540863146e-14
a O 0 3.3994715376017837e-10
characteristic O 0 1.1764282881188137e-08
electrocardiographic O 0 7.37994287192123e-06
pattern O 0 2.359588961553527e-06
. O 0 1.3435314372145513e-07

Because O 0 1.7434375365610322e-07
of O 0 1.4236656298294292e-08
the O 0 5.884087661556237e-10
small O 0 1.491972170808431e-11
size O 0 1.8907418686264776e-10
of O 0 3.091012445999297e-10
most O 0 1.935083690507433e-11
pedigrees O 0 5.034047831364852e-11
and O 0 6.658909101203703e-12
the O 0 3.400319609214719e-11
high O 0 6.559634613267917e-09
incidence O 0 3.3593357784411637e-07
of O 0 1.7055002965449262e-09
sudden B-Disease 0 1.322141969239965e-07
death I-Disease 0 2.3027115503282403e-07
, O 0 6.32269167577526e-11
however O 0 2.0019486068889591e-10
, O 0 5.305083594642213e-10
molecular O 0 6.0565077397711775e-09
genetic O 0 8.123240413659971e-10
studies O 0 8.458921063603242e-11
of O 0 1.0057357169301895e-09
IVF B-Disease 1 1.0
have O 0 2.2161441085022382e-11
not O 0 5.54535584118554e-12
yet O 0 1.632011019381263e-11
been O 0 8.440415033561521e-12
done O 0 4.354694729813424e-11
. O 0 1.450183306772601e-09

Because O 0 1.2945723028678913e-05
IVF B-Disease 1 1.0
causes O 1 0.999961256980896
cardiac O 1 1.0
rhythm O 0 0.05076592415571213
disturbance O 0 0.0001658291439525783
, O 0 3.979133411657898e-10
we O 0 2.6972685196469115e-10
investigated O 0 1.1393849197460781e-09
whether O 0 9.044585080886236e-10
malfunction O 0 5.013387749386311e-07
of O 0 3.134022763529032e-10
ion O 0 1.1457052195851247e-08
channels O 0 9.814251633599724e-09
could O 0 2.6318143220294132e-09
cause O 0 9.663536815196494e-08
the O 0 3.5710947532408e-09
disorder O 0 2.2780799469046542e-09
by O 0 4.670798036537915e-12
studying O 0 2.1819786255594664e-10
mutations O 0 4.5014280497523984e-11
in O 0 5.625888643834287e-11
the O 0 2.3391817371987145e-09
cardiac O 0 3.2334057209482125e-08
sodium O 0 7.457166439905905e-09
channel O 0 9.866395345170531e-08
gene O 0 7.3585169069190215e-09
SCN5A O 0 1.752739626681432e-05
. O 0 2.9146884017450247e-08

We O 0 6.064254876037012e-08
have O 0 1.5133998221283917e-10
now O 0 2.3620314038019785e-11
identified O 0 3.086680563924027e-11
a O 0 1.0304401776295435e-10
missense O 0 3.247392399430282e-08
mutation O 0 1.3414894750596318e-09
, O 0 2.181006894183546e-12
a O 0 3.512013249662438e-11
splice O 0 8.797551576122942e-10
- O 0 3.674612003568001e-10
donor O 0 1.0921301640820502e-09
mutation O 0 8.333200240961958e-10
, O 0 4.521535056090098e-12
and O 0 9.450616504647069e-12
a O 0 1.1766609908647752e-09
frameshift O 0 3.0209105261747027e-07
mutation O 0 2.191802739304194e-09
in O 0 3.237467585681664e-11
the O 0 1.004786115421652e-10
coding O 0 3.741402465617938e-10
region O 0 1.4964139927187148e-09
of O 0 1.247304259877069e-09
SCN5A O 0 5.406294803833589e-06
in O 0 5.190797791598811e-10
three O 0 9.688868596313682e-10
IVF B-Disease 1 1.0
families O 0 1.666169563430131e-10
. O 0 9.43880862358526e-10

We O 0 8.40718783479133e-08
show O 0 5.05195107969314e-10
that O 0 5.100306461891524e-12
sodium O 0 3.1022507479550043e-11
channels O 0 3.017858879461599e-11
with O 0 5.547923774031072e-13
the O 0 2.7238730715417603e-10
missense O 0 2.3344969690697326e-07
mutation O 0 3.8050249173693373e-08
recover O 0 2.7162702309624365e-08
from O 0 1.3579498636673293e-09
inactivation O 0 1.1311661296531383e-07
more O 0 8.591567561555546e-12
rapidly O 0 2.1836971467181776e-11
than O 0 1.7137541385991995e-12
normal O 0 2.103385104978983e-10
and O 0 1.2493142371311494e-12
that O 0 2.528531203860318e-12
the O 0 4.59153493004294e-10
frameshift O 0 4.910721713713428e-07
mutation O 0 2.2604433880246688e-08
causes O 0 5.406254111051112e-09
the O 0 4.4000825205614547e-10
sodium O 0 4.684835158696998e-11
channel O 0 3.760705358235583e-10
to O 0 5.2441252729185095e-11
be O 0 1.2330307608277025e-10
non O 0 3.380175428446819e-08
- O 0 1.4401094539095993e-08
functional O 0 8.825475816820472e-08
. O 0 6.4025740265094555e-09

Our O 0 1.1102717678568297e-07
results O 0 3.180058660845475e-09
indicate O 0 3.0407771856033605e-09
that O 0 1.7695901688430382e-10
mutations O 0 5.294297777957979e-10
in O 0 1.832192314532577e-10
cardiac O 0 1.3288867783955993e-08
ion O 0 1.8278798918913708e-08
- O 0 7.530045031955979e-09
channel O 0 5.077514408924344e-09
genes O 0 3.0980448241513248e-12
contribute O 0 4.007606150147752e-13
to O 0 1.4504494610587115e-12
the O 0 4.9814930826175274e-12
risk O 0 3.776927728904589e-11
of O 0 3.506136700415219e-11
developing O 0 5.709042572021872e-09
IVF B-Disease 1 1.0
. O 0 1.5843795164727226e-09
. O 0 3.397490067058584e-09

Molecular O 0 1.7429966874260572e-06
heterogeneity O 0 2.2161903245887515e-07
in O 0 2.392371190040876e-09
mucopolysaccharidosis B-Disease 0 0.0003880443109665066
IVA I-Disease 1 0.9999831914901733
in O 0 3.733441999997922e-09
Australia O 0 9.31263833409135e-12
and O 0 3.250011479556669e-13
Northern O 0 3.8740485819310777e-10
Ireland O 0 8.862675177079282e-11
: O 0 1.276404004192655e-12
nine O 0 3.1075805123625955e-11
novel O 0 2.8842508242865605e-11
mutations O 0 1.6002556918470745e-11
including O 0 1.1402919624162178e-12
T312S O 0 1.6331070185060526e-07
, O 0 1.209884189362631e-12
a O 0 1.0368115220538154e-11
common O 0 5.156356591706768e-11
allele O 0 2.737456650248049e-10
that O 0 1.4526650715662726e-11
confers O 0 6.221916315496401e-10
a O 0 2.1778510106429394e-09
mild O 0 2.5020479370141402e-05
phenotype O 0 5.393243918661028e-05
. O 0 3.401642345579603e-07

Mucopolysaccharidosis B-Disease 1 0.9958629608154297
IVA I-Disease 1 1.0
( O 0 2.9488235213648295e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.2357048157228832e-10
is O 0 2.151126915483914e-10
an O 0 3.004200976874927e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999902248382568
by O 0 1.9161205955242622e-08
a O 0 0.01674758456647396
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 1.0804082073434529e-08
N O 0 8.058710676550618e-08
- O 0 1.0485464940757083e-08
acetylgalactosamine O 0 4.246868812174398e-08
- O 0 1.9660324923620465e-08
6 O 0 5.2430230823574675e-08
- O 0 3.3029556867347765e-09
sulfate O 0 2.7497448762403565e-09
sulfatase O 0 2.8013875663646104e-08
( O 0 1.6333250724143156e-11
GALNS O 0 4.84853671878227e-07
) O 0 5.0907947996003955e-11
. O 0 2.1412545070376154e-09

Previous O 0 2.1144818163065793e-07
studies O 0 5.367618571838761e-10
of O 0 1.0754193369155729e-10
patients O 0 4.1529071848067645e-12
from O 0 1.4824969593943416e-12
a O 0 1.0846475627379615e-11
British O 0 5.458782037504051e-11
- O 0 3.3884217653934456e-10
Irish O 0 2.0941052711331842e-11
population O 0 8.289667509289028e-14
showed O 0 8.086462949990006e-14
that O 0 1.484414533566708e-13
the O 0 3.8274449581932046e-11
I113F O 0 4.2026823621199583e-07
mutation O 0 3.89380083731794e-09
is O 0 6.4793461394818674e-12
the O 0 2.43678579918416e-12
most O 0 2.4288347889997106e-14
common O 0 8.1742067541829e-13
single O 0 9.300798846367808e-12
mutation O 0 1.6196644025967544e-09
among O 0 6.12522088605516e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.3018588163049571e-07
and O 0 8.115120381235741e-11
produces O 0 9.613996404533864e-11
a O 0 1.3512786445346592e-09
severe O 0 4.609568713931367e-05
clinical O 0 6.736617592650873e-07
phenotype O 0 9.618903504815535e-07
. O 0 2.3240227520204826e-08

We O 0 1.1768686647428694e-07
studied O 0 3.266949377689343e-08
mutations O 0 6.755191961360651e-10
in O 0 1.6467256377938888e-11
the O 0 1.1270211847103084e-10
GALNS O 0 4.352243649918819e-07
gene O 0 1.9868835743341862e-11
from O 0 2.91197239932206e-11
23 O 0 3.167834328188235e-10
additional O 0 5.713702289078526e-10
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.6644877476323927e-08
( O 0 1.8177390148643724e-11
15 O 0 1.5194717706279448e-09
from O 0 3.302026360674226e-11
Australia O 0 3.1484333911681317e-13
, O 0 5.388492251142893e-14
8 O 0 3.7494875260168925e-11
from O 0 1.1667061414200042e-11
Northern O 0 1.2179225405972716e-09
Ireland O 0 8.635667875234176e-11
) O 0 1.1641402902426434e-12
, O 0 4.0817338658322155e-13
with O 0 1.2717328275527184e-13
various O 0 5.19354836914232e-11
clinical O 0 1.8302650062196335e-07
phenotypes O 0 9.751317975315033e-08
( O 0 8.885902014199587e-10
severe O 0 0.00027182087069377303
, O 0 1.0784223514193059e-10
16 O 0 3.823623639931384e-10
cases O 0 3.4339813978490064e-12
; O 0 1.7265364485319346e-12
intermediate O 0 5.125455171395288e-09
, O 0 1.0048623391711864e-11
4 O 0 6.765626725524498e-09
cases O 0 9.813268253555663e-11
; O 0 3.17573523034298e-10
mild O 0 2.3698932636762038e-05
, O 0 3.1506321995777853e-09
3 O 0 9.119425214976218e-08
cases O 0 5.314776396758703e-10
) O 0 2.405240451253121e-10
. O 0 1.3704138268622046e-08

We O 0 1.2800812498880987e-07
found O 0 2.5375976320241023e-10
two O 0 1.5523825280805426e-11
common O 0 5.984719664287041e-11
mutations O 0 2.015448918868401e-11
that O 0 1.051155581847929e-12
together O 0 3.7730287102098747e-13
accounted O 0 3.822423714355816e-12
for O 0 9.60447433390188e-13
32 O 0 1.286961759383587e-09
% O 0 7.653112865657619e-11
of O 0 4.342170720206262e-11
the O 0 2.5204927034394586e-10
44 O 0 1.596766385780768e-09
unrelated O 0 2.1386042936555327e-10
alleles O 0 4.5119751684863374e-11
in O 0 2.6405504519044776e-11
these O 0 2.632675154268238e-11
patients O 0 8.355847680441286e-10
. O 0 4.852794166509966e-09

One O 0 2.78947069887181e-08
is O 0 5.076291609285022e-10
the O 0 2.1759576362967437e-09
T312S O 0 3.1966767437552335e-06
mutation O 0 5.585170104183135e-09
, O 0 1.034492370238782e-11
a O 0 4.681780310655803e-11
novel O 0 6.19791939993064e-10
mutation O 0 6.345056147161188e-10
found O 0 5.585928854884292e-12
exclusively O 0 5.210075426642646e-12
in O 0 1.7073537028622354e-11
milder O 0 2.4051796572166495e-05
patients O 0 1.9169765153037588e-07
. O 0 1.6169711614111293e-07

The O 0 2.8229766968479453e-08
other O 0 2.9290233433121315e-11
is O 0 1.1365988879241673e-11
the O 0 3.3481328820528233e-11
previously O 0 4.091387298399418e-11
described O 0 9.649121085475443e-11
I113F O 0 6.75524916005088e-08
that O 0 4.3632224569489786e-12
produces O 0 2.5639507877928125e-11
a O 0 2.1969048802361613e-09
severe O 0 0.00046662113163620234
phenotype O 0 1.6402293113060296e-05
. O 0 3.5344640991752385e-07

The O 0 2.557620462084742e-07
I113F O 0 8.348538358404767e-06
and O 0 7.381556255126043e-09
T312S O 0 2.9031257327005733e-06
mutations O 0 1.4939871562091867e-09
accounted O 0 7.573913024527812e-11
for O 0 3.6124189577158017e-12
8 O 0 1.240712754757567e-09
( O 0 5.2963028927821565e-12
18 O 0 2.030584367318511e-09
% O 0 9.051185148600815e-12
) O 0 8.380794701886435e-14
and O 0 2.3128521667303836e-12
6 O 0 2.9917850419280967e-09
( O 0 7.816029941321023e-12
14 O 0 1.1009982925358486e-09
% O 0 6.569641532172543e-12
) O 0 7.28719588469727e-14
of O 0 2.8078385970464748e-12
44 O 0 4.1480961027184904e-11
unrelated O 0 2.8646507041485414e-11
alleles O 0 1.417683158366767e-11
, O 0 2.1823522156072528e-11
respectively O 0 4.767782169068369e-09
. O 0 1.9239870141518622e-08

The O 0 1.4164318429266132e-07
relatively O 0 9.2580334509762e-09
high O 0 3.8027319959610395e-08
residual O 0 1.6518910342711024e-05
GALNS O 0 0.004567897878587246
activity O 0 6.77132234727651e-08
seen O 0 2.7874258456961343e-10
when O 0 1.9542674770112178e-11
the O 0 3.9089467773756326e-11
T312S O 0 7.096174314824566e-09
mutant O 0 3.681992766235709e-10
cDNA O 0 1.7405519248114842e-09
is O 0 1.0316155915623959e-11
overexpressed O 0 1.7419867770485098e-09
in O 0 7.020721504158445e-11
mutant O 0 3.84774434536439e-10
cells O 0 1.3229012503501725e-11
provides O 0 9.569177861126071e-14
an O 0 2.4906823565401526e-13
explanation O 0 2.519482018847885e-11
for O 0 8.6805484675323e-12
the O 0 4.0613623575325164e-10
mild O 0 3.2372122404922266e-06
phenotype O 0 1.3572855550592067e-07
in O 0 2.954025080104117e-10
patients O 0 6.542805359999182e-12
with O 0 2.0030685281020172e-13
this O 0 2.4429405720560737e-10
mutation O 0 1.9409716500717877e-08
. O 0 3.832191808328389e-08

The O 0 8.433153730891263e-09
distribution O 0 2.7213337139286864e-10
and O 0 6.061583093103229e-12
relative O 0 4.596749092478092e-10
frequencies O 0 1.4214746046903315e-10
of O 0 1.0864079774686175e-10
the O 0 2.0006737933009333e-10
I113F O 0 3.466860931666815e-08
and O 0 3.6661901292589505e-10
T312S O 0 3.2351985623790824e-07
mutations O 0 3.7887049053608735e-10
in O 0 1.9813812049407353e-11
Australia O 0 1.8906992399654599e-13
corresponded O 0 1.4500871206926669e-12
to O 0 2.0536915917857e-11
those O 0 7.4648256326304e-12
observed O 0 1.072254854350696e-10
in O 0 5.459987063166638e-12
Northern O 0 1.2765203338815923e-09
Ireland O 0 9.366601938509689e-11
and O 0 1.3617040654778645e-11
are O 0 4.2455804497021354e-12
unique O 0 2.675867340207194e-12
to O 0 2.0791617039161991e-10
these O 0 4.069670815620707e-12
two O 0 2.3643887195334834e-11
populations O 0 1.3275749423391492e-11
, O 0 6.632341377488249e-12
suggesting O 0 1.986236730644464e-10
that O 0 8.767812864629576e-11
both O 0 5.046028039856765e-10
mutations O 0 4.086805560632456e-09
were O 0 1.3794389241983396e-10
probably O 0 2.048367378493232e-11
introduced O 0 2.442397629628945e-12
to O 0 1.6012266165765787e-11
Australia O 0 1.4018387145542377e-13
by O 0 1.251400377636283e-13
Irish O 0 1.1190229992630307e-10
migrants O 0 4.266347691794792e-11
during O 0 1.3909204517326135e-11
the O 0 8.168600344748977e-12
19th O 0 3.2550662165675703e-10
century O 0 1.920536796262695e-08
. O 0 2.378999219843081e-08

Haplotype O 0 3.0902842809155118e-06
analysis O 0 1.2554247419416242e-08
using O 0 2.160078782509345e-09
6 O 0 5.506778961716918e-07
RFLPs O 0 2.0914025355978083e-07
provides O 0 7.0174244019838294e-12
additional O 0 3.212412757677696e-12
data O 0 4.4991337044830715e-12
that O 0 1.3200700298490742e-12
the O 0 1.388752723929798e-10
I113F O 0 9.154682345524634e-08
mutation O 0 8.585707839126044e-11
originated O 0 2.136673650510179e-12
from O 0 2.821404785149917e-12
a O 0 2.4172613563577805e-11
common O 0 2.153286021711054e-10
ancestor O 0 3.495691913713017e-08
. O 0 2.4504283047122044e-08

The O 0 7.830131210084801e-08
other O 0 1.225803764048905e-10
9 O 0 3.750136912117341e-08
novel O 0 8.535454565361533e-10
mutations O 0 8.146048280366358e-10
identified O 0 1.0033919528584789e-10
in O 0 2.0790931476444285e-11
these O 0 2.3120153361255724e-11
23 O 0 1.4098706202503308e-08
patients O 0 2.273051365186962e-11
were O 0 2.5259041819963857e-12
each O 0 4.553546667333819e-13
limited O 0 1.1350342324009666e-12
to O 0 3.676418891540578e-11
a O 0 6.678554931305314e-10
single O 0 5.912745404401676e-09
family O 0 5.729769547713204e-09
. O 0 6.524026474608036e-08

These O 0 2.8228461790291703e-09
data O 0 2.991731862245217e-10
provide O 0 2.8318855507108998e-12
further O 0 6.256221235512172e-11
evidence O 0 5.046170079014978e-11
for O 0 2.1329316351320626e-12
extensive O 0 4.2898498642252036e-10
allelic O 0 6.384745177001605e-09
heterogeneity O 0 8.08790190376385e-09
in O 0 9.432761238770127e-10
MPS B-Disease 1 0.9999980926513672
IVA I-Disease 1 0.9999997615814209
in O 0 9.701048991894723e-11
British O 0 1.0099315828071553e-10
- O 0 8.236130666361419e-10
Irish O 0 1.6696689864037495e-10
patients O 0 9.90367076542098e-12
and O 0 1.0597595934483395e-12
provide O 0 3.3778485650920453e-12
evidence O 0 1.5266375663625098e-10
for O 0 5.149515883151601e-11
their O 0 5.6681315890871886e-11
transmission O 0 5.2301704633883617e-11
to O 0 7.623098333131573e-12
Australia O 0 2.826511887296158e-15
by O 0 1.1078162652088282e-14
British O 0 6.5417198567840895e-12
- O 0 3.0300245645875634e-10
Irish O 0 1.1158259732857445e-10
migrants O 0 3.6480454074228064e-11
. O 0 3.654436562389174e-12
. O 0 2.317398356543876e-10

Identification O 0 6.2204481565686365e-09
of O 0 2.3568136331419964e-09
constitutional O 0 1.5598961908835918e-06
WT1 O 0 0.00035153375938534737
mutations O 0 1.9032523823625525e-07
, O 0 4.324054309057246e-11
in O 0 2.2298947410792636e-11
patients O 0 4.609292808543941e-11
with O 0 4.109655324380235e-12
isolated O 0 3.4333130315644667e-05
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.331025177910618e-10
and O 0 8.587930713788161e-12
analysis O 0 5.406720210432425e-12
of O 0 1.1582280273758627e-10
genotype O 0 1.1965052060247672e-08
/ O 0 3.039444962382731e-08
phenotype O 0 1.183950493199859e-09
correlations O 0 2.0221037344558823e-10
by O 0 1.4808268543678449e-12
use O 0 4.378673118532461e-11
of O 0 9.655269639363695e-11
a O 0 2.489327910470962e-10
computerized O 0 4.9779482758083304e-09
mutation O 0 7.547270364227643e-09
database O 0 1.6379814171685325e-09
. O 0 5.281844295268456e-09

Constitutional O 0 6.116370059316978e-06
mutations O 0 1.5032782130219857e-07
of O 0 3.414173832538836e-08
the O 0 1.214469058652412e-08
WT1 O 0 5.92020739986765e-07
gene O 0 3.4611360999470264e-10
, O 0 2.047023835161088e-11
encoding O 0 1.6159790172665112e-10
a O 0 2.049824132654976e-08
zinc O 0 1.802557960672857e-07
- O 0 1.2380803582345834e-07
finger O 0 9.537496907796594e-07
transcription O 0 9.808191947513478e-08
factor O 0 3.0472160350569766e-09
involved O 0 4.5510241408752705e-11
in O 0 7.780370236964984e-10
renal O 1 0.9878431558609009
and O 0 9.744550055756918e-08
gonadal O 0 0.00465495977550745
development O 0 8.906166840461083e-06
, O 0 2.638960716616623e-10
are O 0 4.710179728889541e-12
found O 0 8.523765027135255e-12
in O 0 8.624794671854841e-13
most O 0 7.692145396120606e-14
patients O 0 1.1808854946410846e-13
with O 0 1.855927249990591e-13
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.4098269218720816e-07
DDS B-Disease 1 1.0
) O 0 5.143783315952888e-11
, O 0 1.993325123017531e-11
or O 0 2.14582271951258e-07
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 6.256718876329614e-08
DMS B-Disease 0 6.893833983667719e-07
) O 0 4.302150812245803e-13
associated O 0 2.2220179255599826e-12
with O 0 2.169655080597188e-12
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.0690882251983567e-07
/ O 0 1.1488033123896457e-05
or O 0 7.819428446964594e-07
Wilms B-Disease 0 0.006684594321995974
tumor I-Disease 0 0.0002976279938593507
( O 0 2.548779853839278e-09
WT B-Disease 1 0.9989521503448486
) O 0 2.2892118756168145e-10
. O 0 4.94507279569234e-09

Most O 0 3.4504285650882593e-08
mutations O 0 1.233854618476471e-07
in O 0 2.327700343585093e-08
DDS B-Disease 1 1.0
patients O 0 3.0050605346332304e-05
lie O 0 1.1698072057697573e-06
in O 0 9.893277308492543e-10
exon O 0 3.980683782600636e-09
8 O 0 5.20627132516438e-08
or O 0 2.9132971590684065e-09
exon O 0 1.9632445003026078e-08
9 O 0 2.196240274088268e-07
, O 0 9.324840899438414e-10
encoding O 0 2.6618282689128137e-08
zinc O 0 2.6912900921161054e-06
finger O 0 2.5250834369217046e-05
2 O 0 2.158109055017121e-05
or O 0 4.4152031364319555e-07
zinc O 0 5.989033411424316e-07
finger O 0 5.281081598695891e-07
3 O 0 1.1831006219154006e-07
, O 0 2.4379307600463918e-11
respectively O 0 1.9564577735664557e-10
, O 0 4.221453481917381e-12
with O 0 1.2411108382334723e-12
a O 0 7.7947079901719e-09
hot O 0 1.3442610224956297e-06
spot O 0 3.5347806459640196e-08
( O 0 4.6785488677647535e-11
R394W O 0 4.430919631204233e-08
) O 0 4.865299135792256e-12
in O 0 1.4254221414322643e-10
exon O 0 6.158681564727431e-09
9 O 0 1.2311900832173706e-07
. O 0 5.899092769823255e-09

We O 0 3.3799302912029816e-08
analyzed O 0 5.850258610884396e-10
a O 0 8.706370346889258e-11
series O 0 1.627438461770936e-11
of O 0 2.8888537395577174e-11
24 O 0 8.176843202534201e-09
patients O 0 9.058703093201004e-11
, O 0 1.3327149279984685e-11
10 O 0 2.430726953051021e-09
with O 0 3.3968142187923434e-10
isolated B-Disease 1 0.6994330286979675
DMS I-Disease 0 0.4366484582424164
( O 0 2.8990973177656088e-08
IDMS B-Disease 0 7.211402589746285e-06
) O 0 2.4498356468449778e-11
, O 0 3.1626392043432316e-12
10 O 0 3.7554279130880275e-11
with O 0 3.3614016518163092e-12
DDS B-Disease 1 1.0
, O 0 1.9289639330288821e-10
and O 0 2.213233762926592e-11
4 O 0 5.2423003715773575e-09
with O 0 1.0931127530922069e-11
urogenital B-Disease 0 3.576397375582019e-06
abnormalities I-Disease 0 1.8103903130395338e-05
and O 0 4.214108528799443e-08
/ O 0 5.032931312598521e-06
or O 0 2.1308036593836732e-05
WT B-Disease 1 1.0
. O 0 9.072824980194127e-08

We O 0 9.727855143637498e-08
report O 0 3.964764516695141e-09
WT1 O 0 2.171362666558707e-06
heterozygous O 0 3.5502651929419926e-09
mutations O 0 4.4231887597057096e-10
in O 0 4.024378053024691e-11
16 O 0 4.845265966224588e-09
patients O 0 6.749045072806936e-11
, O 0 6.408098877919155e-12
4 O 0 2.2732285387405682e-08
of O 0 5.81786618880642e-10
whom O 0 7.489890929690546e-10
presented O 0 1.316601938583517e-09
with O 0 8.835134845952552e-10
IDMS B-Disease 0 0.00592826446518302
. O 0 4.885869770987483e-07

One O 0 1.819032036110002e-08
male O 0 3.8358516363246054e-10
and O 0 7.897370257747838e-12
two O 0 1.1021406703948244e-10
female O 0 1.7102301796967367e-09
IDMS B-Disease 0 0.0002031108597293496
patients O 0 6.926743179036521e-09
with O 0 8.320208411127794e-10
WT1 O 0 0.0013198427623137832
mutations O 0 0.0002284604706801474
underwent O 0 0.04989825189113617
normal O 0 0.07531333714723587
puberty O 0 0.0003248651628382504
. O 0 2.080837901985433e-08

Two O 0 3.04995978694933e-07
mutations O 0 1.5053943513976265e-07
associated O 0 4.3502326185773654e-09
with O 0 8.243403182284226e-11
IDMS B-Disease 0 0.00041679610149003565
are O 0 3.9399638065984455e-12
different O 0 2.353278162614547e-13
from O 0 8.197349916916341e-12
those O 0 8.770981987579751e-13
described O 0 2.2950516487263428e-11
in O 0 2.709473478912372e-10
DDS B-Disease 1 1.0
patients O 0 1.9829271025173512e-07
. O 0 3.492846190056298e-08

No O 0 2.6333329969929764e-06
WT1 O 0 4.337236168794334e-05
mutations O 0 3.0596521582992864e-07
were O 0 3.4813909532971365e-09
detected O 0 1.729894782975805e-09
in O 0 1.664262998246624e-11
the O 0 2.2217278017322428e-10
six O 0 3.2170208164039593e-10
other O 0 5.89409285267628e-11
IDMS B-Disease 1 0.9999849796295166
patients O 0 1.8901451070973962e-08
, O 0 5.759456800369378e-11
suggesting O 0 2.39323383333101e-09
genetic O 0 2.2046547698550967e-08
heterogeneity O 0 4.26379962448209e-08
of O 0 7.910181842873953e-09
this O 0 5.271038006071649e-08
disease O 0 0.2033713012933731
. O 0 3.3619020456399085e-08

We O 0 3.6818281046180346e-07
analyzed O 0 4.395582564598044e-08
genotype O 0 7.009197702245729e-07
/ O 0 3.3087019346567104e-07
phenotype O 0 7.413542668643913e-09
correlations O 0 2.685734745710988e-09
, O 0 1.6534318402275372e-12
on O 0 4.955737556433526e-11
the O 0 1.8697673617729116e-12
basis O 0 3.217571348246295e-11
of O 0 9.538187297278289e-13
the O 0 8.979390581781432e-13
constitution O 0 1.0007480955032122e-11
of O 0 7.804712431891403e-11
a O 0 1.3612380111993616e-09
WT1 O 0 6.669471304121544e-07
mutation O 0 2.259468168119838e-09
database O 0 1.0223315249913156e-10
of O 0 6.207194203078359e-10
84 O 0 1.2647451086422734e-08
germ O 0 8.879605957190506e-07
- O 0 8.54214050605151e-08
line O 0 2.490523058895633e-07
mutations O 0 1.9575077114808437e-09
, O 0 4.035305509880738e-12
to O 0 3.344647475644891e-11
compare O 0 2.0719516380385272e-11
the O 0 5.799139987661128e-11
distribution O 0 3.994530053952339e-11
and O 0 3.368814992590896e-12
type O 0 1.6042547290595621e-09
of O 0 9.97378624134626e-09
mutations O 0 7.552941050370521e-10
, O 0 1.16492718249539e-11
according O 0 1.5528741487136344e-11
to O 0 3.0166577569268327e-10
the O 0 3.007253335240989e-10
different O 0 3.644652912804247e-10
symptoms O 0 1.0947242117254063e-06
. O 0 3.686170302330538e-08

This O 0 2.435223800389963e-09
demonstrated O 0 6.791831541619331e-10
( O 0 4.8365266652750094e-11
1 O 0 9.607813211687244e-08
) O 0 3.2347748611660787e-12
the O 0 2.3564874010451042e-11
association O 0 7.91169300212724e-12
between O 0 1.3394721998238879e-09
mutations O 0 7.234349785889549e-10
in O 0 2.1067499134108658e-10
exons O 0 1.8278440983010569e-09
8 O 0 2.131523624271381e-09
and O 0 8.13236283869756e-12
9 O 0 8.150885300040045e-09
and O 0 9.531103684068398e-11
DMS B-Disease 0 3.095836120792228e-08
; O 0 4.4998137160856544e-11
( O 0 8.282473318299566e-11
2 O 0 6.644002326083864e-08
) O 0 1.1475493298662709e-11
among O 0 3.2982731129616027e-12
patients O 0 7.175292911915099e-12
with O 0 1.2006200070593942e-12
DMS B-Disease 0 4.772561368326933e-08
, O 0 6.677261608217799e-12
a O 0 2.2966106447142032e-11
higher O 0 6.485135345402071e-11
frequency O 0 5.211012177319674e-11
of O 0 3.72763903078166e-11
exon O 0 1.2172624019868294e-10
8 O 0 3.080520061260472e-09
mutations O 0 2.8524323528178464e-11
among O 0 3.907014468895742e-12
46 O 0 1.2164970142336529e-09
, O 0 2.3515944747032336e-10
XY O 0 2.4381854018429294e-05
patients O 0 7.12652298284766e-11
with O 0 2.1455958483431598e-13
female O 0 1.0136942500682533e-11
phenotype O 0 8.421717490048053e-11
than O 0 1.1977432066989646e-11
among O 0 8.490080166678737e-12
46 O 0 1.580812458712444e-08
, O 0 1.259982007617566e-09
XY O 0 0.12933756411075592
patients O 0 5.018376270093938e-10
with O 0 7.813163636037623e-13
sexual O 0 1.7294583820604004e-10
ambiguity O 0 1.1313593395456678e-09
or O 0 7.233604826240025e-10
male O 0 3.510459631317353e-11
phenotype O 0 2.199440213290771e-10
; O 0 1.0949908514634732e-11
and O 0 2.6624499827043735e-10
( O 0 2.686431521681243e-09
3 O 0 1.1895532452399493e-06
) O 0 2.0523299726349364e-10
statistically O 0 2.169375790117556e-10
significant O 0 9.989344421090784e-12
evidence O 0 7.539609214735066e-11
that O 0 2.0766359118407074e-11
mutations O 0 1.1458461263158526e-10
in O 0 1.218442430284128e-10
exons O 0 7.119139944222752e-09
8 O 0 6.900843452228855e-09
and O 0 3.817522339910617e-11
9 O 0 1.1053944426464568e-08
preferentially O 0 1.3957266453701322e-09
affect O 0 2.10889772311873e-09
amino O 0 4.4227249640371724e-10
acids O 0 6.730325064624454e-12
with O 0 1.2477912549513272e-14
different O 0 1.3643727532312855e-13
functions O 0 5.9391623563609386e-12
. O 0 3.586729524496235e-11
. O 0 1.7592191037252292e-09

The O 0 1.539961118623978e-07
185delAG O 0 8.090279948191892e-07
BRCA1 O 0 5.7189627256093445e-08
mutation O 0 1.0196212762991763e-09
originated O 0 2.0728319234664117e-12
before O 0 1.7842260871883675e-12
the O 0 7.270789330847405e-13
dispersion O 0 1.2875553401237028e-10
of O 0 3.7083287829364764e-11
Jews O 0 1.4961698546755997e-11
in O 0 1.7112096245205932e-12
the O 0 7.517276731650036e-12
diaspora O 0 6.585914105738944e-12
and O 0 1.3573729813753932e-12
is O 0 3.31515067134025e-12
not O 0 4.048019558444693e-11
limited O 0 1.2442598340545175e-10
to O 0 2.3561225859225488e-08
Ashkenazim O 0 2.39005694311345e-05
. O 0 1.5493505145514064e-07

The O 0 8.642436455374991e-08
185delAG O 0 5.513789460565022e-07
mutation O 0 8.360809822249848e-09
in O 0 1.990208220448153e-09
BRCA1 O 0 3.65872629970454e-08
is O 0 2.2815097033834775e-10
detected O 0 7.981604821516441e-10
in O 0 2.2883332381762322e-11
Ashkenazi O 0 4.843380807528774e-09
Jews O 0 1.0072594841536997e-10
both O 0 8.601089675555618e-13
in O 0 7.332645601820786e-11
familial B-Disease 1 0.9998098015785217
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.0478887979559204e-08
in O 0 1.060027621235804e-10
the O 0 1.4614924548350672e-10
general O 0 1.595255594288858e-10
population O 0 1.5258443380322673e-12
. O 0 2.407397614589968e-10

All O 0 1.2353959277788817e-07
tested O 0 2.1223037549589208e-08
Ashkenazi O 0 5.0438107024319834e-08
mutation O 0 3.3632713281050997e-10
carriers O 0 3.4278042643914874e-12
share O 0 5.455968576234538e-12
the O 0 6.099542745885422e-12
same O 0 3.658971736708594e-11
allelic O 0 3.5159177791399543e-09
pattern O 0 4.66130023468736e-09
at O 0 2.7306943373162085e-09
the O 0 4.973902956173504e-10
BRCA1 O 0 6.513132699836888e-09
locus O 0 4.292252597792867e-08
. O 0 7.636367094221441e-09

Our O 0 2.925834792222304e-07
previous O 0 1.357670864621241e-08
study O 0 2.2773401220366196e-10
showed O 0 3.250471940219324e-12
that O 0 5.4476859628156335e-14
this O 0 2.0202291228788027e-11
Ashkenazi O 0 1.0767832847591308e-08
mutation O 0 4.0251477151365123e-10
also O 0 5.138110531661966e-13
occurs O 0 3.5015705612817527e-12
in O 0 1.0671672963716294e-12
Iraqi O 0 4.9201570595514e-10
Jews O 0 2.1532808522350955e-11
with O 0 1.8784839406638804e-14
a O 0 1.9909960832786844e-11
similar O 0 4.258234043152953e-11
allelic O 0 9.348230634032006e-08
pattern O 0 1.4492555067135982e-07
. O 0 2.024521528198875e-08

We O 0 2.5344995435716555e-08
extended O 0 6.832503451903449e-09
our O 0 6.527153817437181e-11
analysis O 0 1.26641785166276e-12
to O 0 9.576327578142418e-12
other O 0 2.778992964566629e-12
non O 0 1.0333063293899158e-09
- O 0 1.0025316132811213e-09
Ashkenazi O 0 1.1669966104577156e-09
subsets O 0 3.194006170659236e-11
354 O 0 4.766256399973967e-12
of O 0 1.1193505974546603e-12
Moroccan O 0 1.2976740793035901e-09
origin O 0 7.563864812265564e-11
, O 0 1.4523908117847206e-11
200 O 0 7.255581985915471e-12
Yemenites O 0 4.2639497488394795e-10
and O 0 2.3456434277563387e-12
150 O 0 3.3606215033010756e-11
Iranian O 0 6.932836082995664e-09
Jews O 0 1.0964052776785138e-08
. O 0 4.361082606152422e-09

Heteroduplex O 0 4.635538516595261e-06
analysis O 0 3.171219675746073e-10
complemented O 0 1.9770397124974082e-11
by O 0 4.341853699491027e-12
direct O 0 3.573143725343897e-10
DNA O 0 8.867548917379509e-10
sequencing O 0 2.010934474494519e-10
of O 0 1.060137311270637e-09
abnormally O 0 3.3890892314758503e-09
migrating O 0 2.593164745434695e-11
bands O 0 7.161295861868311e-11
were O 0 9.735489497897376e-11
employed O 0 1.7830382725847471e-09
. O 0 6.897632687241639e-09

Four O 0 1.4653561697386408e-09
of O 0 1.6493175714060726e-09
Moroccan O 0 1.0423992335972798e-07
origin O 0 4.217771409908977e-10
( O 0 8.49890633130429e-13
1 O 0 6.844160238550501e-10
. O 0 1.123673745197229e-12
1 O 0 7.574740279459036e-10
% O 0 5.330923636553964e-12
) O 0 4.2785236752150915e-14
and O 0 4.935809790398982e-13
none O 0 1.3085144079383326e-11
of O 0 8.197135331622363e-11
the O 0 3.5270386611330196e-10
Yemenites O 0 1.509301572610866e-09
or O 0 2.309005417422405e-11
Iranians O 0 7.669128526677227e-11
was O 0 2.330651123483296e-11
a O 0 1.1769600051503293e-12
carrier O 0 3.653460780433937e-12
of O 0 6.713030305249834e-12
the O 0 6.993563367307942e-11
185delAG O 0 2.3215948274923903e-08
mutation O 0 6.301198141045461e-08
. O 0 2.984024405350283e-08

BRCA1 O 0 4.6291770559037104e-06
allelic O 0 1.9707898957221914e-07
patterns O 0 7.428330173198106e-10
were O 0 1.6272365399583322e-11
determined O 0 4.1170872266960146e-11
for O 0 1.0202928996463911e-12
four O 0 8.447222955842992e-13
of O 0 1.7574758922472844e-12
these O 0 1.6015084020764604e-14
individuals O 0 2.3154894139760553e-14
and O 0 1.1542044446935518e-12
for O 0 9.349175947304111e-12
12 O 0 7.479384334097006e-10
additional O 0 4.7688325510719665e-11
non O 0 1.762763623958108e-08
- O 0 5.749430709300896e-09
Ashkenazi O 0 4.220104821150983e-10
185delAG O 0 3.461827699502429e-11
mutation O 0 2.0806631157582745e-12
carriers O 0 1.1101949437888892e-12
who O 0 6.66482077860131e-11
had O 0 8.821400570013793e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.007160876411944628

Six O 0 1.506771809545171e-07
non O 0 1.6374831091070519e-07
- O 0 7.74832731309516e-09
Ashkenazi O 0 5.355860643874166e-09
individuals O 0 4.669798076874232e-13
shared O 0 1.3838332606555537e-12
the O 0 5.252564008739746e-11
common O 0 5.042026240964503e-10
Ashkenazi O 0 4.608271098049954e-08
haplotype O 0 1.2865555731877976e-07
, O 0 2.715319635804292e-10
four O 0 5.988213397367659e-11
had O 0 6.03808392174443e-10
a O 0 6.828978355022386e-11
closely O 0 3.450291441442488e-11
related O 0 4.501043981974817e-10
pattern O 0 7.5963884071939e-09
, O 0 1.665888954560657e-11
and O 0 3.911728926886404e-11
the O 0 2.870648385666641e-09
rest O 0 8.139855012245789e-09
( O 0 2.5145432958062486e-10
n O 0 8.794540207190948e-08
= O 0 5.099295918853386e-08
6 O 0 2.7479845954303528e-08
) O 0 1.7017121219098374e-12
displayed O 0 2.4941823779933703e-12
a O 0 2.4050939018138706e-10
distinct O 0 5.473140274325772e-10
BRCA1 O 0 8.163787157400293e-08
allelic O 0 1.1439282587843991e-07
pattern O 0 1.3993184211358312e-07
. O 0 2.795521503173859e-08

We O 0 7.504870325192314e-08
conclude O 0 1.5618834936503845e-07
that O 0 3.810378748636545e-11
the O 0 2.974100687946901e-10
185delAG O 0 7.155367143241165e-08
BRCA1 O 0 3.5137404097440594e-08
mutation O 0 6.507097527475025e-09
occurs O 0 7.51752410321771e-11
in O 0 1.7609320035125164e-12
some O 0 1.2595673636039972e-11
non O 0 7.705928339873935e-08
- O 0 3.8043214090066613e-07
Ashkenazi O 0 3.854594865515537e-07
populations O 0 2.111282329519959e-11
at O 0 1.212777447912039e-11
rates O 0 4.249858277793894e-12
comparable O 0 2.9251694382698146e-12
with O 0 2.8455338671289077e-13
that O 0 5.090648735883718e-11
of O 0 2.623044448313294e-09
Ashkenazim O 0 2.2582255496672587e-06
. O 0 3.546131921439155e-08

The O 0 2.9365834208761044e-09
majority O 0 4.514712562131429e-11
of O 0 5.095975308400114e-10
Jewish O 0 1.600096410925289e-08
185delAG O 0 7.58360911845557e-08
mutation O 0 3.805908477261255e-09
carriers O 0 1.469121699293474e-11
have O 0 1.3890082660450442e-12
a O 0 7.603117788135272e-12
common O 0 5.0828580927531064e-11
allelic O 0 9.887524132778935e-10
pattern O 0 6.714676592523006e-10
, O 0 9.824889382961666e-13
supporting O 0 1.1349308645658418e-11
the O 0 1.1344061245921466e-09
founder O 0 2.180635894077909e-09
effect O 0 1.0898667746062074e-08
notion O 0 6.682657760492816e-10
, O 0 4.948971787932521e-12
but O 0 5.873059850947104e-12
dating O 0 3.018503502705272e-11
the O 0 6.83655007605033e-11
mutations O 0 2.18621423048182e-11
origin O 0 4.334191859578507e-12
to O 0 1.2459881217063984e-11
an O 0 2.0713775746722396e-12
earlier O 0 1.4361635491955127e-10
date O 0 6.680048514340342e-09
than O 0 6.377095379539455e-11
currently O 0 1.3497274131690773e-10
estimated O 0 5.8837206218242954e-09
. O 0 3.900871448081489e-08

However O 0 1.2902707346995612e-08
, O 0 7.164820819971496e-11
the O 0 3.914990900910631e-11
different O 0 1.5972299437921889e-12
allelic O 0 3.4203380128161598e-09
pattern O 0 4.673968767576753e-09
at O 0 2.217190653297507e-09
the O 0 2.241836577487888e-10
BRCA1 O 0 1.2430719786848954e-09
locus O 0 1.3348380178968e-09
even O 0 7.119725815851741e-12
in O 0 1.2153750228449667e-12
some O 0 8.574603158582883e-13
Jewish O 0 1.8802621959412846e-10
mutation O 0 5.278938050579107e-11
carriers O 0 1.3349683771618492e-12
, O 0 2.8322257733526257e-12
might O 0 6.277126041176473e-11
suggest O 0 7.459278333898922e-11
that O 0 5.767313709936772e-12
the O 0 1.1711524805502194e-10
mutation O 0 4.79122401475518e-11
arose O 0 1.1173722364032912e-10
independently O 0 2.986851599384721e-10
. O 0 1.7925236295290858e-10
. O 0 9.069534456784822e-09

Crystal O 0 1.8269582824359532e-06
structure O 0 2.2344096350934706e-07
of O 0 9.428356861462817e-06
the O 0 1.6100104403449222e-05
hemochromatosis B-Disease 1 1.0
protein O 0 0.00018046333570964634
HFE O 0 7.723305316176265e-06
and O 0 2.056385478566014e-10
characterization O 0 5.9605294033815426e-09
of O 0 1.8901658016545753e-09
its O 0 6.109838329715345e-11
interaction O 0 3.791153502241684e-11
with O 0 1.695699483605928e-11
transferrin O 0 5.602232135970553e-07
receptor O 0 7.638036549906246e-07
. O 0 2.122907005741581e-08

HFE O 1 0.9964367151260376
is O 0 2.9999807082958796e-08
an O 0 2.6388011775679843e-09
MHC O 0 1.656072754485649e-06
- O 0 4.7814228310016915e-06
related O 0 6.498988227576774e-07
protein O 0 2.9459313211077642e-08
that O 0 3.0990969339395047e-12
is O 0 2.214802505891983e-13
mutated O 0 5.22307728751531e-13
in O 0 1.0551771045461122e-12
the O 0 1.3311964031093027e-10
iron B-Disease 1 0.9921780228614807
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.003989522345364094

HFE O 0 7.956064655445516e-05
binds O 0 2.3825956319001307e-08
to O 0 3.916564850214854e-08
transferrin O 0 4.20295123149117e-07
receptor O 0 8.984466148831416e-08
( O 0 2.3807533722219887e-10
TfR O 0 8.908783044603297e-09
) O 0 8.027088650892911e-13
and O 0 1.737729751760675e-12
reduces O 0 4.157434813079064e-11
its O 0 5.363631847693506e-12
affinity O 0 9.363029102038567e-11
for O 0 1.5163587052668959e-10
iron O 0 2.9156556280440782e-08
- O 0 1.3253802499946232e-09
loaded O 0 2.5876212630948636e-11
transferrin O 0 2.4444237745058217e-09
, O 0 2.560198060497232e-11
implicating O 0 1.919720205023623e-08
HFE O 0 5.5413561312889215e-06
in O 0 6.413209518996155e-08
iron O 0 0.00023135000083129853
metabolism O 0 6.839599518571049e-05
. O 0 2.1780167003271345e-07

The O 0 1.9197241272195242e-06
2 O 0 2.1211066268733703e-05
. O 0 1.1670021393683783e-07

6 O 0 0.00024370569735765457
A O 0 5.883694939257111e-06
crystal O 0 2.504956000848324e-06
structure O 0 2.8583821176653146e-07
of O 0 1.12040254407475e-06
HFE O 0 0.0005798236234113574
reveals O 0 4.3105377045549176e-09
the O 0 1.552356576617342e-10
locations O 0 3.1342262118982944e-10
of O 0 8.146673557973827e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 9.900050827127416e-06
and O 0 1.3542207355499158e-08
a O 0 1.618270175640646e-07
patch O 0 0.11639054119586945
of O 0 2.2763169909012504e-05
histidines O 0 3.8064911223045783e-06
that O 0 7.205293584000572e-10
could O 0 1.5193238889210647e-09
be O 0 3.047214425233591e-10
involved O 0 5.82742534782632e-11
in O 0 2.6624144555675855e-10
pH O 0 6.518772806884954e-06
- O 0 1.4110510164755397e-06
dependent O 0 9.980390132113826e-07
interactions O 0 5.6457729158410075e-08
. O 0 7.702181648028272e-08

We O 0 3.0004903806002403e-07
also O 0 1.4190074670850095e-09
demonstrate O 0 1.586916820173201e-09
that O 0 4.4206668881052735e-10
soluble O 0 1.627634134138134e-07
TfR O 0 5.183106210893129e-08
and O 0 1.1205009142756239e-10
HFE O 0 1.3960048761418875e-07
bind O 0 1.1365459684498092e-09
tightly O 0 2.6153545995555305e-10
at O 0 1.1205864708374591e-10
the O 0 2.16565810423619e-11
basic O 0 1.438716090707004e-10
pH O 0 2.1904206448652985e-08
of O 0 9.132821165991345e-10
the O 0 2.719778402493489e-09
cell O 0 2.362966489144469e-09
surface O 0 1.3129813680734514e-08
, O 0 7.246899608182034e-11
but O 0 1.5692748489559705e-10
not O 0 1.291693196847632e-09
at O 0 9.176127413468294e-09
the O 0 1.8716648231276167e-09
acidic O 0 5.766180493083084e-07
pH O 0 1.2307621091167675e-06
of O 0 6.68235813350293e-08
intracellular O 0 8.402395224038628e-08
vesicles O 0 1.3290092510942486e-06
. O 0 8.5184993281473e-08

TfR O 0 0.00016892104758881032
HFE O 0 7.506315159844235e-05
stoichiometry O 0 5.0855857125498e-07
( O 0 2.137846788485831e-09
2 O 0 4.5137377924220345e-07
1 O 0 1.5617763438058319e-07
) O 0 9.112801659105774e-12
differs O 0 4.482219456702907e-11
from O 0 2.542379362591163e-10
TfR O 0 1.0255706506256956e-08
transferrin O 0 2.8396840434652404e-09
stoichiometry O 0 8.616751201451223e-10
( O 0 2.7541826458366003e-11
2 O 0 1.4320510111076601e-08
2 O 0 8.685695718213537e-09
) O 0 3.1333681309309025e-12
, O 0 2.285701792767436e-12
implying O 0 1.8444424806918214e-11
a O 0 7.223876878625912e-12
different O 0 3.1804826784373463e-13
mode O 0 2.58148363796451e-11
of O 0 1.7121009471265936e-12
binding O 0 1.6304126104760286e-10
for O 0 3.973354145703212e-10
HFE O 0 7.583752221762552e-07
and O 0 8.275686802505788e-10
transferrin O 0 3.643739532321888e-08
to O 0 1.4790007440979025e-08
TfR O 0 4.695245792163405e-08
, O 0 7.227239640084093e-12
consistent O 0 5.879384479268168e-11
with O 0 1.7295283857420712e-13
our O 0 2.7751858103219895e-11
demonstration O 0 1.347574274390695e-10
that O 0 7.801567551701805e-12
HFE O 0 4.788052265780607e-08
, O 0 6.23013099443348e-11
transferrin O 0 1.462335941226911e-08
, O 0 1.0033230496420131e-10
and O 0 1.03252947858401e-10
TfR O 0 8.625158365305197e-09
form O 0 3.773385076621949e-11
a O 0 1.3643285390330107e-09
ternary O 0 7.921931199916799e-08
complex O 0 3.81391885184712e-07
. O 0 7.173377269964476e-08

Identification O 0 4.972396716595995e-09
of O 0 2.018413436388755e-09
three O 0 5.900234467670629e-11
novel O 0 4.877782622259019e-10
mutations O 0 6.430839194493387e-11
and O 0 4.323936608069401e-12
a O 0 8.419098751488718e-11
high O 0 1.4438876760891617e-09
frequency O 0 2.5958595273323226e-09
of O 0 3.4106295565550226e-10
the O 0 5.082366194564258e-10
Arg778Leu O 0 5.848027058164007e-07
mutation O 0 2.2621200468364577e-09
in O 0 1.0905102515446075e-10
Korean O 0 1.0655992532804248e-08
patients O 0 6.108336059185149e-11
with O 0 4.359396090641843e-12
Wilson B-Disease 0 5.932494673288602e-07
disease I-Disease 0 2.2893313143868e-05
. O 0 2.45358044992372e-08

Four O 0 2.9674399826262743e-08
mutations O 0 2.4957949040782523e-09
- O 0 3.732473441431239e-09
- O 0 1.0322312782307108e-08
R778L O 0 3.157128105613083e-07
, O 0 3.222485125964347e-11
A874V O 0 5.149229309608927e-08
, O 0 3.154772276747764e-11
L1083F O 0 2.0079545137718924e-08
, O 0 3.045148768560102e-12
and O 0 4.043673382247981e-12
2304delC O 0 1.4453453989204945e-09
- O 0 1.3417913447000274e-09
- O 0 2.5953741378259565e-09
in O 0 1.0699122698909491e-09
the O 0 3.8284051484538395e-09
copper O 0 6.905570337778499e-09
- O 0 1.0366543179429755e-09
transporting O 0 1.0284373352931198e-10
enzyme O 0 6.578246281030431e-11
, O 0 1.8093197079460666e-11
P O 0 5.3460446736153244e-08
- O 0 1.0506882031080522e-09
type O 0 8.298337017542678e-10
ATPase O 0 2.1629440460912974e-09
( O 0 4.36288982372246e-12
ATP7B O 0 4.364463279671327e-08
) O 0 3.2674400294793737e-13
, O 0 1.4136799641063097e-13
were O 0 8.047630487353907e-13
identified O 0 5.420938871403269e-12
in O 0 1.5419763989971136e-12
Korean O 0 6.918896011676168e-10
Patients O 0 2.343238623969679e-11
with O 0 2.6346429378432124e-12
Wilson B-Disease 0 2.744297717072186e-06
disease I-Disease 0 0.0037831293884664774
. O 0 1.0529420535476675e-07

Arg778Leu O 0 0.0007802400505170226
, O 0 1.4764555800184098e-08
the O 0 3.1401756750426557e-09
most O 0 2.6066234240507136e-11
frequently O 0 1.8070848636919656e-11
reported O 0 1.1916347075757727e-10
mutation O 0 3.338363266380817e-11
of O 0 7.734646256807309e-11
this O 0 2.0583933862949877e-11
enzyme O 0 7.352546349537192e-11
, O 0 7.32647709861256e-12
was O 0 4.869658010164812e-10
found O 0 1.8345019513893446e-12
in O 0 1.32969796198118e-12
six O 0 3.6625050214844634e-11
of O 0 3.8470528845868657e-11
eight O 0 1.5324579105691072e-10
unrelated O 0 3.2330034205330094e-09
patients O 0 6.20883761071056e-11
studied O 0 8.695002357006487e-11
, O 0 3.297623675860284e-13
an O 0 6.920878800609209e-13
allele O 0 4.364589592520396e-11
frequency O 0 5.617948772851378e-09
of O 0 5.61936364107396e-09
37 O 0 1.2249921610418824e-07
. O 0 1.7215121772551356e-08

5 O 0 1.3797154679195955e-05
% O 0 2.8290353171200877e-08
, O 0 1.6600875188399478e-11
which O 0 1.7307369730087951e-12
is O 0 4.153612349899749e-12
considerably O 0 1.089884363314475e-10
higher O 0 5.536100744496508e-11
than O 0 1.3897158163828083e-12
those O 0 3.765666706408155e-13
in O 0 3.335834863546494e-12
other O 0 1.3261981790524402e-11
Asian O 0 1.9996322653259568e-10
populations O 0 3.777237550517398e-11
. O 0 5.296307836744063e-10

The O 0 1.414846195757491e-08
novel O 0 3.1636273600810227e-09
single O 0 5.670124370027452e-10
nucleotide O 0 1.2363307044793714e-09
deletion O 0 3.0007918372376707e-09
, O 0 1.3446953620044333e-11
2304delC O 0 7.346386166062757e-09
, O 0 6.80565048760684e-11
was O 0 7.973057769561365e-09
found O 0 1.9642639945138818e-11
in O 0 1.2836925099291019e-11
one O 0 2.5100485578910536e-10
patient O 0 1.1564609714298513e-08
. O 0 1.7153666931335465e-08

Since O 0 2.5948466486624966e-07
a O 0 1.9441506182715784e-08
mutation O 0 4.5389185743260896e-09
at O 0 4.873200509791786e-09
cDNA O 0 2.6419333387650568e-09
nucleotide O 0 4.22540082922751e-08
2302 O 0 4.892780225418392e-07
( O 0 1.6159506024959747e-11
2302insC O 0 3.89578413972913e-09
) O 0 2.11182599185733e-11
had O 0 3.201296172594681e-10
been O 0 4.806839648541228e-11
previously O 0 1.3794198422401038e-11
described O 0 4.545565313041067e-12
, O 0 1.9284938500719467e-13
this O 0 4.0843505877755093e-13
region O 0 1.144324413004938e-09
of O 0 1.2211371913650737e-09
the O 0 8.113859806258006e-09
ATP7B O 0 0.007456727791577578
gene O 0 1.0082326085125715e-09
may O 0 1.4842372664247705e-08
be O 0 2.9872575524336753e-09
susceptible O 0 2.1004771610932949e-07
to O 0 7.6179823338407e-08
gene O 0 1.0147853402031615e-07
rearrangements O 0 0.012730952352285385
causing O 1 0.9999997615814209
Wilson B-Disease 1 0.9203442931175232
disease I-Disease 1 0.9999995231628418
. O 0 8.218639777624048e-07

Disruption O 0 0.00015756842913106084
of O 0 5.812248105030449e-07
splicing O 0 3.1148590373675233e-09
regulated O 0 6.639520877538274e-11
by O 0 8.895096573376116e-13
a O 0 6.406672414804859e-11
CUG O 0 2.023773220116709e-07
- O 0 6.497544169370428e-10
binding O 0 9.634859132745532e-09
protein O 0 2.36236825656988e-08
in O 0 1.4225872702056108e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.3502944057108834e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 9.165264600596856e-06
DM B-Disease 1 1.0
) O 0 2.4341881843525925e-09
is O 0 1.4890193245076233e-10
caused O 0 1.8617669628184785e-09
by O 0 6.164174726208671e-11
a O 0 6.720342504706878e-09
CTG O 0 2.4467394155180955e-07
expansion O 0 6.520735618131823e-10
in O 0 5.997632945842213e-11
the O 0 3.7290842636039656e-10
3 O 0 3.997867281668732e-08
untranslated O 0 2.107995442202082e-06
region O 0 1.375856228946759e-08
of O 0 1.591254128463504e-09
the O 0 3.3371208019161713e-08
DM B-Disease 1 1.0
gene O 0 1.1945012090563978e-07
. O 0 1.6949130099419563e-08

One O 0 1.016781991936e-09
model O 0 1.0438825359671e-09
of O 0 3.9877992463743794e-08
DM B-Disease 1 1.0
pathogenesis O 0 0.000651781156193465
suggests O 0 2.096713025423469e-09
that O 0 1.6132251784428675e-11
RNAs O 0 1.0746278866768932e-10
from O 0 3.178436333572954e-11
the O 0 8.702830123219485e-12
expanded O 0 1.3110894748341595e-12
allele O 0 8.240490755040408e-12
create O 0 1.6592162756581819e-12
a O 0 2.0820307977675867e-10
gain O 0 8.693319841768243e-09
- O 0 5.032651184677661e-09
of O 0 2.9640219167959003e-09
- O 0 1.890785972236131e-09
function O 0 4.458158842091109e-11
mutation O 0 9.141399659809424e-13
by O 0 9.280215620488877e-14
the O 0 1.9621099450056745e-12
inappropriate O 0 7.633107687587959e-12
binding O 0 1.1976484248776842e-09
of O 0 2.9303450777007356e-09
proteins O 0 8.093322019508964e-12
to O 0 6.612037029007922e-10
the O 0 2.664605425195532e-09
CUG O 0 0.00010723681043600664
repeats O 0 1.2722668998321751e-06
. O 0 4.336962788897836e-08

Data O 0 1.9975109566416904e-08
presented O 0 4.962136035402409e-09
here O 0 3.204419396496405e-09
indicate O 0 9.537400869064072e-10
that O 0 2.416565211826871e-11
the O 0 3.3423155909595437e-10
conserved O 0 1.5125292129880563e-09
heterogeneous O 0 7.877689611746064e-09
nuclear O 0 4.356414137873799e-06
ribonucleoprotein O 0 2.9807168289153196e-07
, O 0 3.244541302294124e-10
CUG O 0 3.7103160366314114e-07
- O 0 5.666015989724826e-10
binding O 0 4.443095669159902e-09
protein O 0 1.2816925298864135e-09
( O 0 1.216773643647473e-12
CUG O 0 1.3290316758229892e-07
- O 0 4.32773861192004e-09
BP O 0 7.38631982244442e-08
) O 0 6.2816501132656466e-12
, O 0 8.752503062592343e-12
may O 0 3.1302904712759982e-09
mediate O 0 1.578116837208654e-07
the O 0 4.527289654276956e-09
trans O 0 8.594302158826395e-09
- O 0 1.8387819045173615e-09
dominant O 0 7.580420180453018e-10
effect O 0 1.886484746194128e-09
of O 0 2.705001778124938e-10
the O 0 4.414255072582307e-10
RNA O 0 1.165844754069667e-08
. O 0 1.2887672040662324e-09

CUG O 0 0.004899241495877504
- O 0 4.3856449337909e-05
BP O 0 0.00010120267688762397
was O 0 4.7963702343167824e-08
found O 0 8.193035659631587e-12
to O 0 4.868835369598035e-12
bind O 0 2.7945350027092086e-12
to O 0 1.8890655706371717e-10
the O 0 8.870526535531553e-10
human O 0 1.5637189321182632e-08
cardiac O 0 5.949703336227685e-05
troponin O 0 9.783800123841502e-06
T O 0 3.0028716082597384e-06
( O 0 3.29191590653366e-10
cTNT O 0 2.404784282816763e-08
) O 0 5.057720735279769e-12
pre O 0 9.483164253865084e-10
- O 0 6.078188646840843e-11
messenger O 0 7.407157352756766e-12
RNA O 0 7.300670484822191e-12
and O 0 2.1365014249950798e-13
regulate O 0 4.521291381651832e-13
its O 0 1.087053515778924e-12
alternative O 0 4.745235315795071e-10
splicing O 0 3.0205455914256163e-09
. O 0 9.43538802644639e-10

Splicing O 0 2.0890020380193164e-08
of O 0 5.4586624109731474e-09
cTNT O 0 1.1329988183206297e-06
was O 0 1.8850531091629819e-07
disrupted O 0 1.6332533903096191e-07
in O 0 3.2784586156964224e-09
DM B-Disease 1 1.0
striated O 0 6.421067411110926e-08
muscle O 0 1.5650915230480678e-08
and O 0 1.5165099176428498e-09
in O 0 3.642986801111192e-09
normal O 0 3.2109434755511757e-07
cells O 0 1.6632746291378453e-09
expressing O 0 1.0329471306080862e-10
transcripts O 0 9.23462584179191e-10
that O 0 2.3108161217866297e-11
contain O 0 9.252186239372406e-10
CUG O 0 1.712348785076756e-05
repeats O 0 5.909371338930214e-07
. O 0 3.790349367704948e-08

Altered O 0 4.2350231410637207e-07
expression O 0 5.289004434416711e-08
of O 0 9.174434723036029e-08
genes O 0 6.747468805912149e-09
regulated O 0 1.6176111561350126e-09
posttranscriptionally O 0 3.521798674910315e-08
by O 0 1.0164484809394025e-09
CUG O 0 0.0008942682761698961
- O 0 1.790052124306385e-06
BP O 0 3.170311856592889e-06
therefore O 0 1.1089438256561834e-09
may O 0 3.6061514885332713e-10
contribute O 0 1.0617252216293949e-10
to O 0 4.2980445869034156e-08
DM B-Disease 1 1.0
pathogenesis O 0 1.4532294017044478e-06
. O 0 7.932673962152137e-10
. O 0 2.9748792318429196e-09

Identification O 0 4.246226925630481e-09
of O 0 1.2236318625014064e-09
a O 0 2.717557845421936e-10
novel O 0 1.285212825052895e-09
nonsense O 0 1.881763722622054e-08
mutation O 0 2.0066201478208257e-10
and O 0 9.064435833872064e-12
a O 0 1.3037765311807448e-10
missense O 0 4.311261125877763e-09
substitution O 0 6.963937204673698e-10
in O 0 1.1567884844465581e-10
the O 0 6.248770390016034e-10
vasopressin O 0 2.5242896661836767e-09
- O 0 1.3381526109412789e-08
neurophysin O 0 3.1397703992297465e-07
II O 0 4.632586296793306e-06
gene O 0 2.6983167436545052e-11
in O 0 3.852110037200207e-12
two O 0 1.3727237662547465e-12
Spanish O 0 3.1808031208946375e-10
kindreds O 0 1.559540230289258e-08
with O 0 1.1981819182660391e-11
familial B-Disease 1 0.9989290833473206
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 2.4856876734702382e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.183544728888819e-08
FNDI B-Disease 1 1.0
) O 0 1.8584902714002816e-11
is O 0 1.0291844633469882e-11
an O 0 1.2762354506534734e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999960660934448
by O 0 8.592682831931597e-08
deficiency O 1 0.9999929666519165
in O 0 3.3052090202545514e-06
the O 0 6.540343747474253e-06
antidiuretic O 0 2.2591595438825607e-07
hormone O 0 1.3379560570569993e-08
arginine O 0 2.9619773300737506e-08
vasopressin O 0 2.9013765612262432e-08
( O 0 2.1893699353459084e-10
AVP O 0 1.5136093267642536e-08
) O 0 4.7485300603720623e-14
encoded O 0 1.9653815589424674e-14
by O 0 7.192554386283023e-13
the O 0 1.6441405181755187e-10
AVP O 0 1.2863384313277493e-07
- O 0 1.884669664775629e-08
neurophysin O 0 7.843042908461939e-07
II O 0 0.00038826317177154124
( O 0 1.1183626469346564e-08
AVP O 0 1.827545588639623e-06
- O 0 2.9631415543462936e-08
NPII O 0 1.7735237634042278e-06
) O 0 1.0715203897782022e-11
gene O 0 1.0495734489857078e-11
on O 0 3.337150999982441e-09
chromosome O 0 2.203540361733758e-06
20p13 O 0 6.236288754735142e-05
. O 0 2.3457201336896105e-07

In O 0 2.236768992247562e-08
this O 0 1.7579881994578272e-09
study O 0 5.763822197302204e-10
, O 0 1.1053822787654433e-11
we O 0 3.162755474184209e-11
analyzed O 0 5.0268709334000405e-11
two O 0 3.3134313435351226e-12
families O 0 6.115198625256113e-12
with O 0 1.609098097821171e-11
FNDI B-Disease 1 1.0
using O 0 1.554446127371989e-09
direct O 0 9.385011878748628e-09
automated O 0 2.5217008481348557e-09
fluorescent O 0 4.033055278629405e-10
, O 0 3.497440531630147e-11
solid O 0 1.9700131803634946e-10
phase O 0 3.5027047928792854e-09
, O 0 6.718076615841451e-12
single O 0 2.3841739346663893e-11
- O 0 4.2055611770841494e-10
stranded O 0 1.5374025663650315e-10
DNA O 0 4.036876301988235e-12
sequencing O 0 4.697374759131401e-13
of O 0 5.14302532853006e-12
PCR O 0 3.4202710108566237e-10
- O 0 5.802675229205079e-09
amplified O 0 4.570758882493919e-09
AVP O 0 9.942791479033986e-08
- O 0 4.738236913937044e-09
NPII O 0 7.216330004666816e-07
DNA O 0 8.123677730509371e-09
. O 0 6.187737544571803e-10

In O 0 1.7457052470248868e-09
one O 0 9.449684090778732e-11
of O 0 5.5407064353252267e-11
the O 0 3.054702324423175e-11
families O 0 2.395842638863721e-12
, O 0 6.999455268857924e-13
affected O 0 1.2561509991904085e-11
individuals O 0 7.711143464213255e-13
presented O 0 2.537254017997981e-10
a O 0 1.3156982170414722e-09
novel O 0 1.08934661291471e-09
nonsense O 0 2.4235053963650444e-09
mutation O 0 7.040635435773268e-11
in O 0 2.2986352404830157e-11
exon O 0 2.2472908256521151e-10
3 O 0 7.264205681423164e-09
of O 0 3.5682468091380315e-10
the O 0 5.475479514238657e-10
gene O 0 3.8290351792036326e-12
, O 0 1.396984307747151e-12
consisting O 0 5.012905780581167e-13
in O 0 2.023360298752941e-11
a O 0 5.534755320724116e-09
G O 0 2.3670934012898215e-07
to O 0 4.1138483197755704e-07
T O 0 6.610277409890841e-07
transition O 0 4.378721385478457e-08
at O 0 1.3359186645800492e-08
nucleotide O 0 1.7146624120556453e-09
2101 O 0 1.8442692706344133e-08
, O 0 6.105615687514165e-13
which O 0 5.4998875869153793e-14
produces O 0 1.295302569630924e-13
a O 0 2.978958746346905e-11
stop O 0 5.010734049903931e-10
signal O 0 1.3151261191168828e-09
in O 0 3.1204472339396716e-10
codon O 0 8.693700870310295e-09
82 O 0 3.2156378892977955e-08
( O 0 4.3949999195547207e-10
Glu O 0 2.3423574191383523e-08
) O 0 1.3347043088807187e-11
of O 0 7.199317808570527e-10
NPII O 0 0.00016811362002044916
. O 0 1.0184831467086042e-07

The O 0 6.166077923808189e-07
premature O 0 4.013432771898806e-06
termination O 0 1.877091222013405e-06
eliminates O 0 8.117981309396782e-08
part O 0 9.98087945625059e-10
of O 0 6.272847574706475e-09
the O 0 2.0574377757043294e-09
C O 0 1.0628269819790148e-07
- O 0 2.84879253520387e-09
terminal O 0 6.037868427455351e-09
domain O 0 6.180648215448059e-10
of O 0 9.788966165436008e-11
NPII O 0 2.7527698875928763e-07
, O 0 8.461772948997748e-12
including O 0 1.7416317953794502e-12
a O 0 2.0825161595183772e-09
cysteine O 0 4.2205072769974095e-10
residue O 0 1.463491106079573e-08
in O 0 8.587034555640471e-11
position O 0 2.2958683842944083e-09
85 O 0 5.61762469875049e-10
, O 0 7.519064581032464e-13
which O 0 6.655273662899142e-13
could O 0 4.479322468498026e-11
be O 0 3.840095602614113e-11
involved O 0 1.748082407992957e-11
in O 0 1.6514123402089353e-11
the O 0 9.464998923514045e-11
correct O 0 5.843592276733034e-09
folding O 0 2.0586312654558014e-09
of O 0 8.400368178840267e-10
the O 0 6.722367995593004e-09
prohormone O 0 1.3605604181066155e-05
. O 0 5.37996456273504e-08

In O 0 6.21578699622205e-09
the O 0 2.8462179280097644e-09
second O 0 1.8783142152756227e-08
family O 0 7.774283994343989e-11
, O 0 5.9797761360613766e-12
a O 0 4.667133901570253e-10
G279A O 0 5.742803210750935e-08
substitution O 0 1.2543901473094365e-09
at O 0 1.4734896636170447e-09
position O 0 3.5189012814740295e-10
- O 0 5.117657408959531e-10
1 O 0 4.993927760210681e-08
of O 0 3.111277069312024e-10
the O 0 8.11790704102755e-11
signal O 0 3.49520828946126e-10
peptide O 0 4.0398667050522974e-11
was O 0 3.7012076736786526e-10
observed O 0 7.085694878061766e-12
in O 0 6.626205118452633e-13
all O 0 4.983372113402662e-13
affected O 0 3.156156586081593e-11
individuals O 0 4.4063794280013724e-11
. O 0 2.9002588775028926e-08

This O 0 4.387005958506052e-08
missense O 0 4.46708736490109e-06
mutation O 0 1.8545135560543713e-07
, O 0 1.617702916067998e-10
which O 0 8.81486411641319e-11
replaces O 0 5.5954306077410365e-08
Ala O 0 1.1963641100010136e-07
with O 0 1.2817726047220646e-10
Thr O 0 2.2601982152536948e-07
, O 0 3.4485678201967573e-11
is O 0 1.4102692104389636e-11
frequent O 0 4.400409758797963e-10
among O 0 3.39049677222647e-10
FNDI B-Disease 1 1.0
patients O 0 1.6859549987202627e-06
and O 0 3.404325432665445e-10
is O 0 3.6812200510105697e-10
thought O 0 2.883102923068037e-10
to O 0 1.0010450246511482e-09
reduce O 0 3.025400374667697e-09
the O 0 2.939440080229616e-10
efficiency O 0 6.052009587920182e-11
of O 0 9.204129819417872e-11
cleavage O 0 3.6915981382890095e-10
by O 0 6.355312109906919e-11
signal O 0 4.082818705342106e-08
peptidases O 0 5.149288639927363e-08
. O 0 6.344341718644841e-10
. O 0 4.90094098637428e-09

Genetic O 0 2.5141655441984767e-06
heterogeneity O 0 8.281093073492229e-07
of O 0 2.069573667995428e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.936311555539305e-09
due O 0 7.324087505367061e-07
to O 0 4.157679001082215e-08
TWIST O 0 5.049541414337e-06
and O 0 1.0070204226053647e-08
FGFR O 0 0.0009330644970759749
mutations O 0 8.241275395448611e-07
. O 0 6.544465236402175e-08

Thirty O 0 7.68908103054855e-06
- O 0 2.6067820613207004e-07
two O 0 2.8116356465268666e-10
unrelated O 0 1.880493627481883e-08
patients O 0 9.663260643055782e-12
with O 0 4.416382776655349e-15
features O 0 3.484173941113028e-13
of O 0 9.760259267466154e-10
Saethre B-Disease 1 0.9999947547912598
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.190775587138319e-11
a O 0 3.334050813208478e-10
common O 0 4.259987349541916e-07
autosomal B-Disease 1 0.999998927116394
dominant I-Disease 1 0.9999997615814209
condition I-Disease 1 1.0
of O 1 0.9999995231628418
craniosynostosis B-Disease 1 1.0
and O 1 0.9999456405639648
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9960452914237976
, O 0 9.148267143821442e-10
were O 0 2.013647859566703e-10
screened O 0 4.135379816361251e-10
for O 0 9.786893517826911e-11
mutations O 0 2.3895152523323304e-10
in O 0 1.1099589997121129e-10
TWIST O 0 1.7907217397805653e-07
, O 0 2.394250908643869e-10
FGFR2 O 0 1.2863428310083691e-05
, O 0 1.6341579478496016e-10
and O 0 1.0619405355072331e-09
FGFR3 O 1 0.6123782396316528
. O 0 4.477189463614195e-07

Nine O 0 1.0974036968036671e-07
novel O 0 1.1716735359712516e-09
and O 0 3.7662542529126597e-10
three O 0 3.220667899039853e-10
recurrent O 0 2.570749870756117e-07
TWIST O 0 1.4493732578557683e-06
mutations O 0 5.3962505575100295e-09
were O 0 3.089396100053321e-11
found O 0 2.193773591604997e-12
in O 0 3.797795845167373e-12
12 O 0 6.190888912627202e-10
families O 0 4.188635896462678e-11
. O 0 7.275492652780713e-09

Seven O 0 2.5431626582417266e-08
families O 0 2.6744004233414387e-10
were O 0 8.519396993422745e-11
found O 0 6.6179479431272e-12
to O 0 4.301375922111106e-11
have O 0 7.43634667732529e-12
the O 0 2.0957845181523993e-10
FGFR3 O 0 1.4504324781228206e-06
P250R O 0 3.228839489111124e-07
mutation O 0 4.891524407746317e-10
, O 0 7.202978231229951e-12
and O 0 2.7005346743547154e-12
one O 0 7.48372891434812e-12
individual O 0 1.0139219108404318e-12
was O 0 1.2063443577403632e-09
found O 0 5.953134686598194e-12
to O 0 4.6374935142035056e-11
have O 0 3.9640396000406586e-12
an O 0 4.083684779221386e-11
FGFR2 O 0 1.982827961910516e-05
VV269 O 0 1.39220651362848e-06
- O 0 8.984157773284096e-08
270 O 0 3.5432044853678235e-08
deletion O 0 4.017098476083447e-08
. O 0 7.303229576649528e-09

To O 0 1.2190253073640633e-07
date O 0 1.866697971308895e-06
, O 0 2.11067135991172e-10
our O 0 1.9250118860059118e-11
detection O 0 3.4033253992760137e-10
rate O 0 1.6957027795805324e-11
for O 0 3.1502174458429566e-13
TWIST O 0 1.4042081275533747e-08
or O 0 7.254873146678165e-09
FGFR O 0 4.5415363274514675e-05
mutations O 0 1.42337441833007e-09
is O 0 4.756412277928668e-12
68 O 0 2.1368469493854292e-10
% O 0 4.4158084307188705e-12
in O 0 1.0965118786912531e-12
our O 0 2.844067759077973e-10
Saethre B-Disease 1 0.9999961853027344
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 2.1708142838861022e-08
, O 0 3.2322215650498753e-12
including O 0 2.8958198686201975e-12
our O 0 9.272467238474746e-10
five O 0 1.7412847552744637e-10
patients O 0 5.816928102392316e-12
elsewhere O 0 1.0957534359035126e-11
reported O 0 9.425923236383582e-11
with O 0 1.8694009881747853e-11
TWIST O 0 1.2037006854370702e-05
mutations O 0 8.20178911453695e-07
. O 0 4.302900080688232e-08

More O 0 3.8018144188356473e-10
than O 0 8.811451568391249e-11
35 O 0 3.4887343014489147e-10
different O 0 2.7509773430599294e-13
TWIST O 0 1.0543342199298422e-08
mutations O 0 8.593149525282229e-10
are O 0 5.658954750110967e-13
now O 0 9.200592761618442e-13
known O 0 4.829312947804421e-13
in O 0 1.1289477382450674e-12
the O 0 8.140323484728818e-12
literature O 0 1.2358279677382455e-10
. O 0 3.0083446844741957e-09

The O 0 7.094783427419316e-08
most O 0 2.570875283491869e-11
common O 0 1.8106315058386002e-11
phenotypic O 0 3.618898236634749e-10
features O 0 1.9171038454640632e-12
, O 0 4.771486591254037e-12
present O 0 4.9562073195508205e-12
in O 0 1.3532935622811992e-12
more O 0 8.732284237063584e-14
than O 0 1.2941475148464665e-12
a O 0 1.5690744537000256e-10
third O 0 6.878214886540945e-09
of O 0 1.0149606710641024e-09
our O 0 2.750031868892222e-10
patients O 0 1.6788747475571242e-11
with O 0 4.0118377370168545e-12
TWIST O 0 4.5512410906667355e-06
mutations O 0 3.8795466394958567e-08
, O 0 9.114578536362217e-11
are O 0 1.8944191701453228e-11
coronal B-Disease 0 2.507374665583484e-05
synostosis I-Disease 0 9.731260433909483e-06
, O 0 2.4326182734846213e-10
brachycephaly B-Disease 0 6.810860782024974e-07
, O 0 4.959333499421348e-10
low B-Disease 0 1.940929541888181e-05
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 6.588916221517138e-07
facial B-Disease 1 0.9997969269752502
asymmetry I-Disease 1 0.9999990463256836
, O 0 8.066707124498862e-08
ptosis B-Disease 1 0.9976298809051514
, O 0 4.2820538226351346e-09
hypertelorism B-Disease 0 3.1430436138180085e-06
, O 0 7.763233944579895e-10
broad B-Disease 0 2.2046178855816834e-05
great I-Disease 0 0.00027066876646131277
toes I-Disease 1 0.708238422870636
, O 0 2.329044734850072e-09
and O 0 7.741826735241375e-09
clinodactyly B-Disease 0 0.0008837477653287351
. O 0 2.9738339435425587e-06

Significant O 0 1.8439828863847652e-06
intra O 0 0.0011205588234588504
- O 0 1.2777142046616063e-06
and O 0 1.2137622018570937e-09
interfamilial O 0 9.888566410154453e-07
phenotypic O 0 8.822782149309205e-08
variability O 0 2.543488335504662e-07
is O 0 1.2196130607169953e-12
present O 0 7.590188785648599e-13
for O 0 4.369651775831818e-12
either O 0 5.98575022880965e-10
TWIST O 0 3.3701571737765335e-06
mutations O 0 6.242569838832424e-08
or O 0 2.1338230737910635e-08
FGFR O 0 0.00032331005786545575
mutations O 0 2.6565135158307385e-07
. O 0 3.053751740367261e-08

The O 0 1.8452052330530933e-08
overlap O 0 3.0612963275444827e-09
in O 0 6.679723441038732e-11
clinical O 0 1.3125620035303598e-10
features O 0 2.0462487769750543e-13
and O 0 4.892751568480458e-12
the O 0 8.687840724608265e-11
presence O 0 6.952808120908038e-12
, O 0 1.6355687420741005e-12
in O 0 2.4433901082976384e-12
the O 0 3.234406492635955e-11
same O 0 4.4929445580654814e-11
genes O 0 6.162549637256376e-12
, O 0 2.4953719646170214e-12
of O 0 6.241811234541927e-11
mutations O 0 5.837248046036692e-11
for O 0 4.113105689373953e-12
more O 0 2.780884517886856e-13
than O 0 3.343614621287294e-11
one O 0 6.710144107024973e-10
craniosynostotic B-Disease 0 7.293654675777361e-07
condition I-Disease 0 9.441640713703237e-07
- O 0 6.7567289541159425e-09
such O 0 2.7967598723033227e-11
as O 0 1.95362753752093e-10
Saethre B-Disease 0 2.520865294286523e-08
- I-Disease 0 1.369974134135532e-09
Chotzen I-Disease 0 2.5891953470136286e-08
, I-Disease 0 1.769376659077615e-11
Crouzon I-Disease 0 1.611985709359942e-07
, I-Disease 0 1.4182870156087546e-10
and I-Disease 0 7.637298793383707e-09
Pfeiffer I-Disease 0 0.0002363759558647871
syndromes I-Disease 0 4.9485847739560995e-06
- O 0 1.6782824729943968e-07
support O 0 1.0171879338827239e-08
the O 0 1.5483904292068473e-07
hypothesis O 0 8.054050759653819e-09
that O 0 7.1334956171231756e-12
TWIST O 0 2.1278963036053256e-09
and O 0 2.0513387863352328e-11
FGFRs O 0 4.632282557537337e-09
are O 0 5.653668180317928e-13
components O 0 2.7109141320647012e-11
of O 0 1.3782476548929168e-10
the O 0 1.9183930832777918e-10
same O 0 1.204655958320089e-10
molecular O 0 9.49697542829142e-10
pathway O 0 1.9269928708265383e-10
involved O 0 4.2126033022137077e-13
in O 0 3.5404730362731396e-13
the O 0 5.116148824035882e-12
modulation O 0 4.191882674309255e-10
of O 0 7.278764257989678e-10
craniofacial O 0 0.00029947725124657154
and O 0 2.02418632966328e-07
limb O 1 1.0
development O 0 1.7575349602338974e-06
in O 0 2.3234552060102942e-08
humans O 0 4.640612782935705e-09
. O 0 6.660909601663434e-10
. O 0 5.5420019684504496e-09

Mutation O 0 1.2829546314208073e-09
analysis O 0 2.1041064723892333e-11
of O 0 3.48864798160875e-10
UBE3A O 1 0.999998927116394
in O 0 0.0009283653344027698
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.20944948494434357
. O 0 3.9433743381778186e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.528052729961928e-06
AS B-Disease 1 1.0
) O 0 1.497306861830694e-10
is O 0 1.125330124224222e-11
caused O 0 4.1964742791833487e-10
by O 0 6.535075952607272e-11
chromosome O 0 2.2175634057930438e-06
15q11 O 0 1.8183563952334225e-05
- O 0 2.569926209616824e-07
q13 O 0 6.243736265787447e-07
deletions O 0 1.325688669950864e-09
of O 0 4.003150866349614e-10
maternal O 0 2.0421899726841275e-09
origin O 0 2.752875011280409e-11
, O 0 1.3944287348063855e-12
by O 0 1.177928588003141e-11
paternal O 0 8.10247911431361e-07
uniparental B-Disease 0 0.00017724637291394174
disomy I-Disease 0 0.0002000973909161985
( O 0 2.117629449571723e-08
UPD B-Disease 1 0.9999996423721313
) O 0 1.1857578807727975e-10
15 O 0 1.574861796527216e-09
, O 0 1.4369949457790354e-12
by O 0 5.2982552373181946e-11
imprinting O 0 2.0958255845471285e-05
defects O 0 0.006451488006860018
, O 0 5.317531484583249e-11
and O 0 1.4689506555587428e-11
by O 0 7.087293946161921e-11
mutations O 0 1.1749499151392229e-09
in O 0 1.0266347771903384e-09
the O 0 3.643092938432346e-08
UBE3A O 0 5.705871899408521e-06
gene O 0 2.11577226849613e-08
. O 0 2.669388443621301e-08

UBE3A O 0 0.0026832560542970896
encodes O 0 8.456706979131923e-08
a O 0 1.7278280139976232e-08
ubiquitin O 0 7.172734228788613e-08
- O 0 9.892191599192302e-08
protein O 0 2.058984538422237e-09
ligase O 0 6.281593301071808e-11
and O 0 6.4134211830158e-11
shows O 0 2.567064616432191e-10
brain O 0 1.3513262331343867e-07
- O 0 2.643410379477018e-09
specific O 0 5.998336050083708e-09
imprinting O 0 6.327006190076645e-07
. O 0 2.0043884774167964e-08

Here O 0 1.373125115833318e-07
we O 0 5.235225586375236e-09
describe O 0 2.104816054782077e-08
UBE3A O 0 2.3740281903883442e-05
coding O 0 2.2105512016423745e-06
- O 0 2.0109036995563656e-06
region O 0 1.5696080026827985e-06
mutations O 0 8.382610161561388e-08
detected O 0 1.713710839901239e-09
by O 0 8.413701159393216e-12
SSCP O 0 2.2766047891309427e-07
analysis O 0 2.5969809636094965e-11
in O 0 2.143908488239088e-11
13 O 0 4.116408103271851e-09
AS B-Disease 1 0.9988610744476318
individuals O 0 4.337987868224813e-12
or O 0 6.005419495025421e-10
families O 0 3.1174846037984594e-10
. O 0 7.651865807645208e-09

Two O 0 2.1276660433500183e-08
identical O 0 6.2499183606234965e-09
de O 0 4.3857215814568917e-07
novo O 0 2.153084778910852e-06
5 O 0 1.3799688076687744e-06
- O 0 3.102480405914321e-08
bp O 0 2.0323367877495002e-08
duplications O 0 1.0391684179822391e-09
in O 0 5.686142112715231e-10
exon O 0 8.739900470011719e-10
16 O 0 3.1286013779663335e-09
were O 0 3.491262140498108e-11
found O 0 6.213646958075358e-11
. O 0 1.8233036191972474e-09

Among O 0 2.4208626214772266e-09
the O 0 6.402277596961881e-10
other O 0 1.693685816595014e-11
11 O 0 7.59064866517889e-10
unique O 0 5.549906020863027e-12
mutations O 0 1.5625904736804586e-10
, O 0 6.259861379254161e-11
8 O 0 3.57078953072687e-08
were O 0 2.292764450517737e-10
small O 0 1.430935647750431e-10
deletions O 0 3.2087312806794444e-09
or O 0 2.528357967435113e-08
insertions O 0 2.4865684622454864e-08
predicted O 0 3.620884285737702e-07
to O 0 6.232266969163902e-08
cause O 0 2.435193891869858e-06
frameshifts O 0 5.126409632794093e-06
, O 0 1.0778141712464162e-09
1 O 0 1.614474882671857e-07
was O 0 4.147254095698827e-09
a O 0 2.439564661393945e-10
mutation O 0 9.441283692346314e-12
to O 0 1.3550927047134564e-10
a O 0 3.3435268442794097e-10
stop O 0 7.177380911826958e-10
codon O 0 5.191174157204159e-10
, O 0 2.739617560587604e-11
1 O 0 1.0494028757079832e-08
was O 0 3.4583329533433016e-09
a O 0 1.0112968240605369e-09
missense O 0 5.730151908522885e-09
mutation O 0 4.136129216902873e-10
, O 0 1.4307847441552557e-11
and O 0 4.2660059512700244e-11
1 O 0 1.3112500596434984e-07
was O 0 2.1297974939216147e-08
predicted O 0 2.461530357322772e-08
to O 0 9.57297685566516e-10
cause O 0 4.840739808997796e-09
insertion O 0 4.221620386601899e-09
of O 0 4.115474183663537e-09
an O 0 5.297298155682029e-10
isoleucine O 0 1.1894336182649567e-07
in O 0 1.8435147852713385e-10
the O 0 1.370282554091773e-09
hect O 0 4.298757971810119e-07
domain O 0 3.48278739181751e-08
of O 0 5.419479531809657e-09
the O 0 3.9903609305724785e-09
UBE3A O 0 9.92982677416876e-07
protein O 0 5.892334176138547e-09
, O 0 1.747394872027297e-12
which O 0 4.920713359349294e-13
functions O 0 7.09370019322253e-12
in O 0 2.5150216978464535e-11
E2 O 0 2.515998076546566e-09
binding O 0 3.261885872518633e-09
and O 0 3.5473868287283494e-10
ubiquitin O 0 3.2816365180821094e-09
transfer O 0 4.5007308813183045e-07
. O 0 3.905956802441324e-08

Eight O 0 9.486211638431996e-08
of O 0 1.940737348604671e-09
the O 0 1.309818503658633e-10
cases O 0 3.718322524881579e-11
were O 0 4.512542770007677e-11
familial O 0 1.9176515930752203e-09
, O 0 8.47607262155492e-11
and O 0 1.7009252339938996e-10
five O 0 6.949474329331906e-10
were O 0 3.9810768570625044e-10
sporadic O 0 3.341923360267174e-08
. O 0 3.2360773616346705e-08

In O 0 1.3049124447661598e-08
two O 0 4.871004710693683e-10
familial O 0 3.575383686893474e-07
cases O 0 3.820592731074157e-09
and O 0 7.857303002678506e-11
one O 0 5.028587615751867e-11
sporadic O 0 1.2026915019447415e-09
case O 0 2.866586967797957e-10
, O 0 3.9441686028318657e-11
mosaicism O 0 1.221963117359337e-07
for O 0 6.962864951276515e-09
UBE3A O 0 8.522100870322902e-06
mutations O 0 1.13096945142388e-08
was O 0 2.873781879131343e-09
detected O 0 6.23808574240492e-11
in O 0 4.731968939949982e-13
the O 0 8.913766426366099e-12
mother O 0 1.2548842173720764e-11
of O 0 2.094696464893797e-11
three O 0 4.342286599734457e-11
AS B-Disease 1 1.0
sons O 0 8.593744382778823e-09
, O 0 1.5891408198034918e-12
in O 0 5.383854386614706e-12
the O 0 9.256629490694834e-11
maternal O 0 5.822442528113925e-09
grandfather O 0 4.491457872290994e-09
of O 0 4.558291522016589e-09
two O 0 1.6734765795334283e-09
AS B-Disease 1 1.0
first O 0 8.486693126030787e-09
cousins O 0 1.4144245774616593e-09
, O 0 3.4871873184211255e-12
and O 0 1.3983946379331202e-12
in O 0 7.360793398414334e-12
the O 0 2.5260898928181064e-10
mother O 0 9.212279550308011e-11
of O 0 1.0383338633346284e-10
an O 0 2.928170206306646e-10
AS B-Disease 1 1.0
daughter O 0 1.1341641766193788e-05
. O 0 2.736348108101083e-07

The O 0 2.2910839447831677e-08
frequencies O 0 6.917814099338671e-10
with O 0 1.336869308830868e-12
which O 0 3.2757237894420754e-11
we O 0 1.6894793897215266e-10
detected O 0 3.2673450056641684e-10
mutations O 0 2.0902503686248686e-11
were O 0 1.1899941101956024e-11
5 O 0 6.498139248911627e-10
( O 0 6.951840145208443e-12
14 O 0 1.713161834615562e-09
% O 0 4.707407033621713e-11
) O 0 1.2818446391144045e-12
of O 0 2.7421792267445788e-11
35 O 0 2.2526724929861075e-10
in O 0 3.689890840791188e-12
sporadic O 0 9.41446365310128e-10
cases O 0 5.256409457005118e-12
and O 0 7.126817799102403e-12
8 O 0 2.8921700589989996e-09
( O 0 1.0574563794052416e-11
80 O 0 2.7786883904923343e-10
% O 0 9.1157567605471e-12
) O 0 2.2828860655153826e-13
of O 0 9.268638807846674e-12
10 O 0 1.3057450953812832e-10
in O 0 1.8149950292700723e-11
familial O 0 1.2223262402244472e-08
cases O 0 5.618685516850519e-10
. O 0 5.242597467258747e-10
. O 0 4.1601833089544016e-09

The O 0 8.97620884643402e-06
hemochromatosis B-Disease 1 1.0
845 O 0 3.5918469620810356e-06
G O 0 6.287032050522612e-08
- O 0 3.013950422570133e-09
- O 0 9.047759208513639e-10
> O 0 8.613826318892848e-10
A O 0 4.729088232124923e-10
and O 0 1.7297799477511422e-12
187 O 0 5.075443971352955e-12
C O 0 3.8437686367132073e-10
- O 0 1.7487303272112342e-10
- O 0 1.1626397622421791e-09
> O 0 1.674722760469649e-08
G O 0 1.7016377640288738e-08
mutations O 0 2.8142216335069747e-10
: O 0 6.446109921884324e-13
prevalence O 0 1.9833709674621502e-10
in O 0 4.392271702596817e-12
non O 0 1.475608168988174e-08
- O 0 2.8654694617102905e-08
Caucasian O 0 1.6419210169260623e-07
populations O 0 5.3012527700957435e-09
. O 0 4.438614809032515e-09

Hemochromatosis B-Disease 0 0.35640937089920044
, O 0 1.0027941144130637e-08
the O 0 2.7995024538540747e-06
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999996423721313
iron I-Disease 1 0.9999998807907104
metabolism I-Disease 1 0.9999624490737915
, O 0 5.909408073989653e-09
leads O 0 5.7210658432893524e-09
, O 0 3.893070865679249e-10
if O 0 8.211156909965212e-07
untreated O 0 0.0020446241833269596
, O 0 4.535770196933964e-12
to O 0 6.383381823127365e-09
progressive O 0 0.003876631846651435
iron B-Disease 1 0.998935878276825
overload I-Disease 0 2.579434476501774e-05
and O 0 4.083503668539379e-08
premature B-Disease 0 1.4609882782679051e-05
death I-Disease 0 2.3334939669439336e-06
. O 0 7.151028569296614e-08

The O 0 6.113581184763461e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.199681264552055e-06
, O 0 3.893238087471218e-08
HFE O 0 0.0023767619859427214
, O 0 1.1310686609533604e-08
recently O 0 5.813099335227889e-09
has O 0 1.693608274455638e-11
been O 0 1.679736384707642e-11
identified O 0 7.978369701011623e-12
, O 0 6.060943847502331e-13
and O 0 9.963023244949354e-13
characterization O 0 7.993000150641194e-10
of O 0 1.5280076093304729e-09
this O 0 4.749228232903135e-10
gene O 0 7.261954232395951e-11
has O 0 6.552021945827047e-12
shown O 0 9.018490706828863e-13
that O 0 3.376101481711302e-13
it O 0 6.096980559311405e-13
contains O 0 7.269208564079921e-13
two O 0 1.213214684964159e-11
mutations O 0 1.4411852267137704e-10
that O 0 4.370595899083618e-11
result O 0 1.2481181643764216e-09
in O 0 3.964733874539661e-09
amino O 0 1.3279062294202504e-08
acid O 0 1.3873713289314082e-09
substitutions O 0 6.391598361688011e-11
- O 0 1.255054671300826e-10
cDNA O 0 1.5482198856275886e-10
nucleotides O 0 1.4950944995928417e-11
845 O 0 6.993536999511107e-11
G O 0 2.7226460669327324e-11
- O 0 3.201300335931023e-11
- O 0 9.231592573710756e-11
> O 0 3.0911714854475747e-10
A O 0 2.5559263594487902e-09
( O 0 3.5693186687529854e-12
C282Y O 0 2.780640606658835e-09
) O 0 2.651963426690638e-14
and O 0 6.098815435963065e-14
187 O 0 1.6359400813181768e-12
C O 0 1.944000238562893e-10
- O 0 1.659312964807924e-10
- O 0 9.977548787176715e-10
> O 0 4.378568618790268e-09
G O 0 4.659558072717118e-09
( O 0 1.970466845246932e-11
H63D O 0 1.947871851371019e-06
) O 0 1.5912231254855413e-10
. O 0 3.551084759578771e-09

Although O 0 3.481749672573642e-06
hemochromatosis B-Disease 1 1.0
is O 0 9.163604985928941e-09
common O 0 2.1526218585421475e-09
in O 0 1.040719510569943e-09
Caucasians O 0 1.496803037071004e-08
, O 0 5.489667054270342e-11
affecting O 0 4.788887619788795e-10
> O 0 1.288209983130173e-08
= O 0 3.4375386981366773e-09
1 O 0 2.9891285890926156e-08
/ O 0 5.849209450126125e-10
300 O 0 1.398437247078499e-12
individuals O 0 1.9798264861304454e-13
of O 0 3.398975762305967e-12
northern O 0 9.850473908779023e-11
European O 0 3.946353244188572e-10
origin O 0 3.050017183259257e-10
, O 0 6.0343821953190435e-12
it O 0 7.116382678452882e-13
has O 0 4.3578308279654254e-13
not O 0 1.1081513311139712e-12
been O 0 7.607058429351388e-13
recognized O 0 2.135740586120538e-12
in O 0 4.597770081327113e-12
other O 0 4.255414597087448e-12
populations O 0 7.128521384291986e-11
. O 0 2.6442474876375854e-09

The O 0 4.6992958857572376e-08
present O 0 8.360024894571438e-10
study O 0 3.1838365277536695e-11
used O 0 1.3427570687285506e-12
PCR O 0 3.5082956505172458e-12
and O 0 4.259897556230241e-12
restriction O 0 1.8522061662196165e-10
- O 0 1.0710917569545231e-10
enzyme O 0 6.706579736004414e-12
digestion O 0 4.04199382297854e-11
to O 0 2.3622477238194328e-11
analyze O 0 1.3579458738033345e-11
the O 0 3.1323583050274495e-12
frequency O 0 6.800123658612378e-11
of O 0 1.4814689405784343e-11
the O 0 2.2407967842363874e-11
845 O 0 4.704007738887128e-10
G O 0 1.3153161892986986e-10
- O 0 9.373606751905683e-11
- O 0 1.1408238936860826e-10
> O 0 5.800633237629249e-11
A O 0 9.55666171198466e-11
and O 0 3.7364474578596707e-13
187 O 0 7.903213131675579e-13
C O 0 2.565178625069109e-11
- O 0 2.3895916495542124e-11
- O 0 1.6840873140466783e-10
> O 0 1.8748700369997096e-09
G O 0 1.2039790275863993e-09
mutations O 0 1.2373744390226094e-11
in O 0 1.5185750226742734e-11
HLA O 0 1.5172266221163966e-10
- O 0 2.695395122376265e-11
typed O 0 8.447018258472827e-12
samples O 0 2.351667309236777e-13
from O 0 6.477785430454575e-13
non O 0 1.0869426886328526e-10
- O 0 4.4201840104785006e-11
Caucasian O 0 1.8418874758729942e-10
populations O 0 3.2983297083150065e-12
, O 0 5.88189910731389e-14
comprising O 0 1.1506999509063726e-13
Australian O 0 1.763372954599607e-11
Aboriginal O 0 1.199496665188482e-11
, O 0 7.396988295320372e-13
Chinese O 0 4.053395206288224e-12
, O 0 5.2963028927821565e-12
and O 0 1.3943796117743545e-10
Pacific O 0 9.22590146501534e-08
Islanders O 0 5.353023979637328e-08
. O 0 1.9500740577882425e-08

Results O 0 2.272000187986123e-07
showed O 0 1.5456684820946975e-09
that O 0 1.3241154700471824e-11
the O 0 1.6820518589089062e-10
845 O 0 1.5324936875060757e-09
G O 0 1.7345599401252798e-09
- O 0 8.368288839655236e-10
- O 0 1.3023182532378996e-09
> O 0 2.4865911552041098e-09
A O 0 4.8935802077210155e-09
mutation O 0 1.683168743271679e-10
was O 0 2.8442234678571765e-11
present O 0 9.296324560842395e-13
in O 0 1.9475575666061395e-12
these O 0 6.247640751098904e-13
populations O 0 1.151144067221277e-12
( O 0 1.2701673480358666e-12
allele O 0 4.4785366387634085e-11
frequency O 0 7.751915220843841e-10
0 O 0 3.0530497574510207e-10
. O 0 2.9858858441311753e-12
32 O 0 1.251684034198064e-10
% O 0 1.998304299810627e-11
) O 0 6.906991797082929e-13
, O 0 4.108573724292963e-12
and O 0 8.917201178848533e-12
, O 0 1.923984235818743e-11
furthermore O 0 1.8576654103874546e-10
, O 0 7.183194143667304e-12
it O 0 6.756344615721499e-12
was O 0 2.6689492838016804e-09
always O 0 1.7925433706822425e-11
seen O 0 1.598221208154449e-11
in O 0 1.5603075472284123e-12
conjunction O 0 3.268714812709739e-11
with O 0 9.056198152501693e-11
HLA O 0 1.315859208261827e-06
haplotypes O 0 5.933578073324952e-09
common O 0 5.16001963379864e-10
in O 0 4.3909945124376293e-10
Caucasians O 0 7.381936395489674e-09
, O 0 2.015326100446302e-11
suggesting O 0 1.3977613511073628e-10
that O 0 3.485885885501361e-11
845 O 0 6.3250982229590136e-09
G O 0 2.4335580661727363e-08
- O 0 2.0569837388961787e-08
- O 0 5.03209705016161e-08
> O 0 4.3765336243950514e-08
A O 0 1.7875414926038502e-07
may O 0 7.486338660100955e-09
have O 0 3.92166247392689e-12
been O 0 5.80514315003805e-13
introduced O 0 7.294260139477371e-14
into O 0 2.018174310395443e-13
these O 0 8.091086564035888e-15
populations O 0 8.221580290483296e-14
by O 0 1.3853543963035508e-12
Caucasian O 0 2.1421053375547672e-08
admixture O 0 3.2521595016987703e-07
. O 0 1.3731067838307354e-07

187 O 0 1.5795647456684492e-08
C O 0 1.9418823882233482e-08
- O 0 2.22826002094223e-09
- O 0 2.386892683503561e-09
> O 0 4.767236383429463e-09
G O 0 2.2483124251237996e-09
was O 0 1.0625417212750676e-10
present O 0 3.2673416923423293e-12
at O 0 4.093729175091987e-11
an O 0 7.024786026314789e-13
allele O 0 1.700684384986495e-11
frequency O 0 3.121722658150361e-09
of O 0 1.3120045050385443e-09
2 O 0 5.499871917891141e-07
. O 0 7.637390098125252e-08

68 O 0 1.3520575521397404e-06
% O 0 2.793249631594108e-09
in O 0 1.6862719554033845e-11
the O 0 1.589190862238965e-10
two O 0 2.1249901144271277e-11
populations O 0 4.0585083037336656e-12
analyzed O 0 3.025420539093382e-11
( O 0 5.172913312978533e-12
Australian O 0 2.2619332795681402e-10
Aboriginal O 0 1.2994635749385974e-11
and O 0 2.3345025999127467e-12
Chinese O 0 1.164211869270071e-11
) O 0 1.717878617135682e-11
. O 0 1.145446848482834e-09

In O 0 1.522295178801869e-08
the O 0 4.277498355520493e-09
Australian O 0 5.249621848335551e-10
Aboriginal O 0 1.209697966797485e-11
samples O 0 3.15563547514941e-13
, O 0 5.236960089758172e-14
187 O 0 4.486930358510444e-12
C O 0 7.752491426593622e-10
- O 0 4.379485663008609e-10
- O 0 4.642312756431011e-09
> O 0 1.200762067554706e-08
G O 0 3.2160591967311802e-09
was O 0 1.0601407945953767e-10
found O 0 4.609296343043023e-13
to O 0 3.2714200272343508e-12
be O 0 7.251735670288362e-12
associated O 0 2.0167498226975056e-10
with O 0 7.84827133837318e-11
HLA O 0 5.678522825292021e-07
haplotypes O 0 5.863667329464306e-09
common O 0 7.778352406617728e-10
in O 0 8.522212380235317e-10
Caucasians O 0 6.4242011710291536e-09
, O 0 2.7154889448155473e-11
suggesting O 0 1.071198060809131e-10
that O 0 3.015084275997948e-12
it O 0 3.0507822830483367e-12
was O 0 2.966337592225088e-11
introduced O 0 7.242885219534145e-13
by O 0 2.2871452995398833e-12
recent O 0 1.1228265539564575e-10
admixture O 0 1.3039768376188476e-08
. O 0 2.1354434664999644e-08

In O 0 7.755486564064995e-08
the O 0 2.986438829566396e-08
Chinese O 0 2.7064159247025543e-10
samples O 0 4.157305576180104e-12
analyzed O 0 4.6498382401394256e-12
, O 0 2.4290630813196545e-13
187 O 0 2.5060086384504077e-12
C O 0 1.235917479469606e-10
- O 0 3.1802917938028585e-11
- O 0 1.3311406144023152e-10
> O 0 5.769761890483949e-10
G O 0 2.423485856439811e-10
was O 0 1.521160974959912e-11
present O 0 1.1515854459256958e-12
in O 0 2.0232359624478002e-12
association O 0 2.3750725778454163e-12
with O 0 3.831421941866142e-13
a O 0 5.785664169977167e-10
wide O 0 4.5258303771333885e-09
variety O 0 3.6327299501870414e-10
of O 0 8.047601696148377e-09
HLA O 0 6.032725252680393e-08
haplotypes O 0 5.416789239376385e-10
, O 0 1.0161837517286276e-11
showing O 0 7.214816417910885e-12
this O 0 1.2493267705082634e-11
mutation O 0 8.632139274211692e-12
to O 0 7.464131396295315e-11
be O 0 7.094258513973273e-11
widespread O 0 4.71333860829759e-10
and O 0 5.213537587756001e-11
likely O 0 1.1180278036704294e-08
to O 0 1.3396157960698929e-08
predate O 0 3.467407623247709e-07
the O 0 1.2118976933095382e-09
more O 0 8.673316405360953e-12
genetically O 0 5.668661373636752e-11
restricted O 0 1.0735666522432297e-10
845 O 0 1.92390170461465e-09
G O 0 3.3834959278777887e-09
- O 0 1.0621253210274517e-08
- O 0 2.557751699328037e-08
> O 0 2.4073541382563235e-08
A O 0 1.4957063854126318e-07
mutation O 0 3.0418579655133726e-08
. O 0 3.2286158191396908e-09

Genotype O 0 5.069116014055908e-06
- O 0 5.92917956510064e-07
phenotype O 0 5.870720087841619e-08
correlations O 0 1.7958009834728728e-07
in O 0 2.6889859228163004e-08
attenuated B-Disease 1 0.9999871253967285
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 2.7877138563781045e-05

Germ O 0 7.595536590088159e-05
- O 0 8.128523063533066e-07
line O 0 1.484016962649548e-07
mutations O 0 3.727784747553642e-09
of O 0 2.3543950122828505e-10
the O 0 1.2177779618038898e-10
tumor B-Disease 0 2.686934941209529e-08
suppressor O 0 1.9258159511537087e-07
APC O 0 8.05961430927482e-09
are O 0 5.216996539630925e-12
implicated O 0 2.326731474155963e-09
in O 0 1.2860250642177107e-08
attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.443524524802342e-06
AAPC B-Disease 1 1.0
) O 0 2.678527755498039e-12
, O 0 1.1747121829962237e-13
a O 0 4.436855830652897e-12
variant O 0 2.011767463727665e-07
of O 0 0.0205666683614254
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.038323784376189e-08
FAP B-Disease 0 2.7531784851930752e-08
) O 0 6.282887404784887e-11
. O 0 1.4968193351450054e-09

AAPC B-Disease 1 1.0
is O 0 3.5204672510502633e-09
recognized O 0 3.483433333451025e-11
by O 0 6.918440213082855e-12
the O 0 2.076747940282786e-10
occurrence O 0 3.5386573671303267e-09
of O 0 5.606409114733424e-09
< O 0 6.7896294240199495e-06
100 O 0 2.304103574601868e-08
colonic B-Disease 0 1.6382966805394972e-06
adenomas I-Disease 0 1.3176281754567754e-07
and O 0 7.381052366528529e-12
a O 0 1.4196969988500285e-10
later O 0 1.631403456769931e-08
onset O 1 0.992782711982727
of O 0 1.6528412743355148e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 6.631197257966903e-10
age O 0 2.555917966162724e-08
> O 0 1.0151295803950688e-08
40 O 0 2.8603188706455285e-09
years O 0 2.428566514556252e-10
) O 0 4.434599215619173e-11
. O 0 2.800568887906252e-09

The O 0 1.205995303621421e-08
aim O 0 3.958698258088589e-08
of O 0 1.9567758524630108e-09
this O 0 9.393957139947062e-11
study O 0 4.719489729576587e-11
was O 0 6.916016370706046e-11
to O 0 6.704498761722633e-11
assess O 0 1.7143909625261244e-09
genotype O 0 6.975376010132095e-08
- O 0 2.929595837031229e-07
phenotype O 0 9.11281858861912e-08
correlations O 0 1.5545246867532114e-07
in O 0 1.7851148115255455e-08
AAPC B-Disease 1 1.0
families O 0 8.981275279040801e-09
. O 0 2.1715720777137903e-08

By O 0 1.4160421279996172e-08
protein O 0 1.1222453188963755e-08
- O 0 3.6482994403286284e-09
truncation O 0 2.2555894929610076e-08
test O 0 6.4409979572133125e-09
( O 0 2.6931342572700245e-11
PTT O 0 2.2045748337973237e-08
) O 0 6.512597535909825e-13
assay O 0 2.2114698960962187e-11
, O 0 1.486930966809047e-13
the O 0 9.675355135130292e-13
entire O 0 5.5608434523790606e-11
coding O 0 6.73541722395754e-10
region O 0 5.892862642298269e-09
of O 0 2.5163580108511496e-09
the O 0 1.1883583006522258e-08
APC B-Disease 0 4.9346517982939986e-09
gene O 0 9.857761308629254e-12
was O 0 4.076820478426946e-11
screened O 0 1.2878223661083599e-11
in O 0 6.119676163388044e-13
affected O 0 5.483940124922926e-12
individuals O 0 2.440036887818575e-12
from O 0 2.6998344893058857e-08
11 O 0 1.9661167243612e-05
AAPC B-Disease 1 1.0
kindreds O 0 6.724300760652113e-07
, O 0 4.1770756992187685e-11
and O 0 1.1102866022405511e-11
their O 0 1.3130645876158198e-11
phenotypic O 0 1.7528052342896672e-09
differences O 0 8.311979549091575e-09
were O 0 2.0481427664975627e-09
examined O 0 3.8517502076729215e-08
. O 0 1.8651016731041636e-08

Five O 0 8.090528069715219e-08
novel O 0 7.703441440298775e-09
germ O 0 3.5032050504923973e-07
- O 0 1.881322297947463e-08
line O 0 3.6440869877196747e-08
APC B-Disease 0 7.366423027121982e-09
mutations O 0 4.5089490474659044e-10
were O 0 3.152414787543911e-11
identified O 0 1.6274476558053586e-11
in O 0 2.2858204912212798e-11
seven O 0 2.3417934258418427e-09
kindreds O 0 1.027716734824935e-06
. O 0 6.018944986863062e-08

Mutations O 0 1.920771950381095e-07
were O 0 3.7063649371837926e-10
located O 0 2.942849089415667e-11
in O 0 7.447939834315243e-13
three O 0 3.0122085381556474e-13
different O 0 1.420195883637676e-13
regions O 0 9.934873063111027e-11
of O 0 8.538694196147389e-10
the O 0 3.4940768056657134e-09
APC B-Disease 0 1.3045458047145075e-09
gene O 0 4.5131370862705467e-11
( O 0 1.0620750806600299e-11
1 O 0 4.732802239004741e-08
) O 0 1.319879275318847e-11
at O 0 1.1292853319133656e-09
the O 0 9.196444300529905e-11
5 O 0 1.1428585855455253e-09
end O 0 4.060651814796756e-09
spanning O 0 3.0352260704802347e-09
exons O 0 2.1979149611439652e-09
4 O 0 1.4251945179566405e-09
and O 0 9.572656035905514e-12
5 O 0 3.681615234896185e-09
, O 0 2.4646838389652537e-11
( O 0 2.1678483660969583e-11
2 O 0 2.786523234377114e-09
) O 0 1.9108538536205533e-12
within O 0 5.726671220562807e-11
exon O 0 5.995481888732002e-11
9 O 0 4.890983174021812e-10
, O 0 1.1585052578713673e-12
and O 0 3.1162984519272907e-12
( O 0 5.447507028799592e-11
3 O 0 2.07963175569148e-08
) O 0 5.595397842977912e-12
at O 0 4.769380446134619e-10
the O 0 6.115505324366666e-11
3 O 0 2.98139446464063e-09
distal O 0 3.8468161989158034e-08
end O 0 2.7570251859287964e-08
of O 0 1.2793185399928575e-09
the O 0 2.6045237078164973e-09
gene O 0 1.917907610504699e-09
. O 0 2.3238099444711224e-08

Variability O 0 1.6473069990752265e-05
in O 0 1.0296902219764092e-09
the O 0 1.2029529594670407e-09
number O 0 4.395896979758618e-10
of O 0 2.515721746476629e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.3557735201175092e-06
most O 0 8.443828102000506e-12
apparent O 0 4.1561287744684705e-10
in O 0 4.07935404206361e-12
individuals O 0 1.0227128388953788e-12
with O 0 3.358364151009874e-12
mutations O 0 6.8877987757787196e-09
in O 0 1.2024075957128844e-08
region O 0 2.025217327172868e-05
1 O 1 0.8685756325721741
, O 0 1.031608798385264e-09
and O 0 1.8406698387707365e-09
upper O 1 0.9048373103141785
- O 0 7.985981937963516e-05
gastrointestinal O 0 5.158263434168475e-07
manifestations O 0 4.042779551127751e-07
were O 0 1.3216837346785582e-10
more O 0 6.417501621260036e-13
severe O 0 3.632683043264251e-09
in O 0 5.276240555573963e-11
them O 0 2.0957674831678652e-11
. O 0 2.3777186886064783e-09

In O 0 6.848992484265182e-10
individuals O 0 8.385568281421563e-12
with O 0 9.080633814328998e-12
mutations O 0 2.0943698164632707e-10
in O 0 8.049772654006304e-11
either O 0 6.834872112726487e-10
region O 0 4.706193124093261e-08
2 O 0 2.5998750174949237e-07
or O 0 6.378890304858942e-09
region O 0 1.7091751658426801e-07
3 O 0 3.6756080135091906e-07
, O 0 8.223097897053222e-11
the O 0 2.2985267855712976e-10
average O 0 6.644313432779825e-10
number O 0 2.024813094969602e-10
of O 0 2.8690498865557856e-09
adenomas B-Disease 0 5.07805964389263e-07
tended O 0 1.6732404350960906e-09
to O 0 3.9078085212196356e-10
be O 0 1.928960324804052e-10
lower O 0 7.097118448484707e-10
than O 0 2.5822113544626824e-12
those O 0 2.442424517842823e-13
in O 0 6.47996034001258e-13
individuals O 0 2.49994415359861e-13
with O 0 9.404094256787454e-13
mutations O 0 1.7660868600888335e-10
in O 0 1.3652753927395622e-10
region O 0 3.005295567959365e-08
1 O 0 2.0145841972407652e-07
, O 0 9.14494348303041e-12
although O 0 3.915498480999702e-11
age O 0 1.91817095540614e-09
at O 0 1.6117382983793505e-09
diagnosis O 0 3.706799489577861e-08
was O 0 1.3796784548159025e-10
similar O 0 6.682093767196307e-11
. O 0 8.135820017685091e-09

In O 0 1.374466620518433e-07
all O 0 5.8455572826687785e-08
AAPC B-Disease 1 1.0
kindreds O 0 4.188257207715651e-06
, O 0 2.4191707664877882e-11
a O 0 1.0698055635804948e-10
predominance O 0 3.1662672483889764e-08
of O 0 7.753178721259246e-08
right O 1 0.9999963045120239
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.939350426197052
rectal B-Disease 1 1.0
polyp I-Disease 0 0.046956274658441544
sparing O 0 4.707814014182077e-07
was O 0 9.951860846513227e-08
observed O 0 9.990083427169338e-09
. O 0 6.368010563306825e-09

No O 0 0.00019247621821705252
desmoid B-Disease 1 0.9999966621398926
tumors I-Disease 1 1.0
were O 0 8.432723319629076e-08
found O 0 1.5753627569115025e-10
in O 0 1.679995899339648e-11
these O 0 6.940065883087598e-11
kindreds O 0 3.8887856135261245e-07
. O 0 3.3079317063311464e-08

Our O 0 3.6056360386282904e-07
data O 0 1.391383563920101e-09
suggest O 0 3.596637432323746e-10
that O 0 3.747705271117674e-12
, O 0 1.1339096328555343e-11
in O 0 3.6182012941310404e-10
AAPC B-Disease 1 1.0
families O 0 9.389675842408352e-11
, O 0 1.931867209606364e-12
the O 0 1.3066587742360802e-11
location O 0 5.254069401772199e-10
of O 0 1.721888964745233e-09
the O 0 1.3671452414598662e-08
APC B-Disease 0 2.709368516207178e-07
mutation O 0 6.01878440420478e-08
may O 0 1.0068978895105829e-07
partially O 0 8.538361129240002e-08
predict O 0 2.9676550994395257e-08
specific O 0 1.3997950576438711e-09
phenotypic O 0 1.310630040052274e-07
expression O 0 2.3784457070519238e-08
. O 0 9.881574669634574e-08

This O 0 8.09674216561973e-10
should O 0 1.6086999787834344e-10
help O 0 8.416911265185512e-12
in O 0 1.0869001011715174e-12
the O 0 6.187361820814141e-13
design O 0 3.664144942322478e-12
of O 0 8.788938327120022e-12
tailored O 0 6.582161898860406e-11
clinical O 0 6.887904024921454e-09
- O 0 2.909632090819514e-09
management O 0 1.2430997897716622e-10
protocols O 0 2.828363376838894e-10
in O 0 2.6265849304568656e-12
this O 0 2.220276696870971e-12
subset O 0 1.721267434140472e-10
of O 0 6.93294796572097e-11
FAP B-Disease 0 2.474139115804519e-09
patients O 0 1.1256119647473639e-10
. O 0 1.8642212773478661e-10
. O 0 9.661652811132626e-09

Wilms B-Disease 1 0.9997860789299011
' I-Disease 0 3.6544413887895644e-05
tumor I-Disease 0 3.865797407343052e-05
1 O 0 1.8606372123031178e-06
and O 0 3.1681621770474067e-09
Dax O 0 8.70017447596183e-06
- O 0 9.028632064200792e-08
1 O 0 9.445063255952846e-07
modulate O 0 5.737128994098839e-09
the O 0 3.633521483692448e-09
orphan O 0 1.4462699482464814e-08
nuclear O 0 1.8297012616130814e-07
receptor O 0 1.4629168276769633e-07
SF O 0 6.432396730815526e-06
- O 0 2.1930041782525223e-08
1 O 0 3.7317544610004916e-09
in O 0 1.3987948169549846e-12
sex O 0 1.3883354101767997e-12
- O 0 1.1327742129724205e-12
specific O 0 1.4387941792842751e-12
gene O 0 3.0388419645227538e-12
expression O 0 1.1629164992088548e-10
. O 0 1.967156659787861e-09

Products O 0 1.3034551216151158e-07
of O 0 3.492279532224529e-08
steroidogenic O 0 3.3673911730147665e-06
factor O 0 1.3154329181475077e-08
1 O 0 3.973290318981526e-08
( O 0 8.258211475764554e-11
SF O 0 2.682069498405326e-05
- O 0 6.405190902114555e-07
1 O 0 9.611512723495252e-07
) O 0 4.833391326064529e-11
and O 0 8.099599879685115e-10
Wilms B-Disease 0 2.6829084163182415e-05
tumor I-Disease 0 1.015045381791424e-05
1 O 0 4.977429171049153e-07
( O 0 2.9088650932429516e-10
WT1 O 0 1.573368137997022e-07
) O 0 2.4729100711606833e-11
genes O 0 9.06839620756772e-12
are O 0 1.9743546532911826e-13
essential O 0 8.337833895533109e-12
for O 0 4.2535723207559606e-12
mammalian O 0 4.3086303413986116e-09
gonadogenesis O 0 2.5490631827551624e-08
prior O 0 1.4745805687610414e-09
to O 0 1.242735359063829e-09
sexual O 0 7.947970614985422e-10
differentiation O 0 9.885605223303173e-09
. O 0 4.424153043913748e-09

In O 0 9.014381241456704e-09
males O 0 1.8032924042898912e-09
, O 0 2.730036474662967e-10
SF O 0 0.00016252782370429486
- O 0 2.881388127207174e-06
1 O 0 1.570215886204096e-06
participates O 0 8.691984632047678e-11
in O 0 3.891032895192437e-12
sexual O 0 4.401127465941679e-12
development O 0 2.340267302863852e-12
by O 0 1.0021725203174237e-12
regulating O 0 5.487178489360645e-10
expression O 0 2.7112813730245655e-11
of O 0 2.711282864886755e-10
the O 0 5.905427813424069e-10
polypeptide O 0 2.6484938686621717e-08
hormone O 0 8.229217307587078e-11
Mullerian O 0 1.267376648073082e-09
inhibiting O 0 2.7022994952830004e-10
substance O 0 6.383755191130547e-10
( O 0 1.283783773731173e-10
MIS O 0 2.3543807401438244e-06
) O 0 1.5445683620995965e-10
. O 0 2.474870752777747e-09

Here O 0 1.0946526174393512e-07
, O 0 7.905712751110627e-10
we O 0 1.575026220557163e-10
show O 0 2.999221010435704e-11
that O 0 1.0920417348181388e-11
WT1 O 0 7.007967610661581e-07
- O 0 5.278594130686542e-07
KTS O 0 3.305348946014419e-05
isoforms O 0 3.2716995779225044e-09
associate O 0 8.724377886792922e-10
and O 0 4.65985279876624e-12
synergize O 0 8.746504076562189e-10
with O 0 6.744975671740816e-12
SF O 0 6.272129667195259e-06
- O 0 4.386964036484642e-08
1 O 0 6.616509296009099e-08
to O 0 5.06455366533487e-09
promote O 0 5.538483005551598e-09
MIS O 0 7.7192189564812e-06
expression O 0 2.3770250212606925e-09
. O 0 7.3231349873026375e-09

In O 0 6.5858105635641095e-09
contrast O 0 5.1001296519359585e-09
, O 0 3.4322775732675836e-09
WT1 O 0 1.4815758731856477e-05
missense O 0 1.154464030150848e-06
mutations O 0 1.0138196060438531e-08
, O 0 2.992037173576989e-12
associated O 0 4.28908471239442e-12
with O 0 7.614767648898846e-13
male B-Disease 0 6.707149835527559e-10
pseudohermaphroditism I-Disease 1 1.0
in O 0 2.1189627830153768e-08
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.7975964655979624e-08
fail O 0 3.755616830858344e-07
to O 0 6.378053285516216e-08
synergize O 0 1.1087861651049025e-07
with O 0 9.728478023163234e-10
SF O 0 0.0058748722076416016
- O 0 4.132430149184074e-06
1 O 0 3.1886993383523077e-06
. O 0 1.3902594631076681e-08

Additionally O 0 6.679375985640945e-08
, O 0 1.2389408943214164e-10
the O 0 2.550101241283187e-10
X O 0 1.7842744455265347e-06
- O 0 5.291764750836592e-07
linked O 0 1.1664946697464984e-07
, O 0 2.4520890526402717e-11
candidate O 0 3.3779098962405385e-10
dosage O 0 6.878008207422681e-08
- O 0 1.1120171450329508e-09
sensitive O 0 1.9432375708561267e-09
sex O 0 8.341098645114897e-11
- O 0 2.2080065553709005e-10
reversal O 0 1.9059718248115587e-09
gene O 0 4.140057741075509e-11
, O 0 2.943809085387272e-11
Dax O 0 1.3754029737356177e-07
- O 0 1.6428726823392026e-08
1 O 0 5.6563192174508e-07
, O 0 3.979404653020602e-11
antagonizes O 0 2.445821600804976e-10
synergy O 0 1.1343984779310645e-11
between O 0 2.2667749621785305e-10
SF O 0 1.377657099510543e-06
- O 0 1.4678634308040728e-08
1 O 0 3.5471263259978514e-08
and O 0 6.1670682449666e-11
WT1 O 0 3.1945106115927047e-08
, O 0 5.1349679716650165e-12
most O 0 5.48634325903824e-13
likely O 0 1.4680713242287702e-11
through O 0 5.906759456553168e-13
a O 0 9.897551528359472e-12
direct O 0 8.051661420926948e-11
interaction O 0 7.101379900786853e-11
with O 0 4.0843235044052406e-11
SF O 0 0.00020619134011212736
- O 0 2.8278702757233987e-06
1 O 0 2.07806920116127e-06
. O 0 1.3094476614128325e-08

We O 0 3.7466051594492455e-08
propose O 0 2.8114778061194556e-08
that O 0 2.5064078590375516e-10
WT1 O 0 1.0696871868276503e-06
and O 0 7.794782597159156e-09
Dax O 0 1.4451718470809283e-06
- O 0 8.52743564649927e-09
1 O 0 3.8332956364683923e-08
functionally O 0 1.2748724298461411e-10
oppose O 0 3.444702509347586e-11
each O 0 1.9492818817412605e-12
other O 0 8.642909521752729e-13
in O 0 2.325557975357828e-11
testis O 0 3.2982905295853016e-09
development O 0 9.219164494311816e-12
by O 0 7.344610163106946e-12
modulating O 0 1.5490535520967796e-09
SF O 0 3.674693516586558e-06
- O 0 3.751689092723609e-08
1 O 0 4.81350781456058e-08
- O 0 1.0091195656869445e-09
mediated O 0 3.614983512534309e-08
transactivation O 0 9.110836884929085e-08
. O 0 2.782363783815356e-10
. O 0 5.030345584522422e-10

A O 0 1.6581060080511634e-08
mouse O 0 1.0717252779679498e-10
model O 0 4.022505245560026e-11
for O 0 1.859953080440846e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9997550845146179
- O 1 0.7615182399749756
centre O 0 8.242674311986775e-07
mutations O 0 6.737312219229352e-08
. O 0 7.57263407535902e-09

Imprinting O 0 1.7682410771158175e-06
in O 0 2.7103017607998936e-09
the O 0 5.411267434141109e-09
15q11 O 0 2.624883336466155e-06
- O 0 1.0870541444774062e-07
q13 O 0 1.416144186805468e-06
region O 0 2.8239122151774154e-09
involves O 0 7.953638442304012e-11
an O 0 2.8413823377482217e-11
imprinting O 0 4.6538048081856687e-08
centre O 0 9.018044089259547e-09
( O 0 3.874874379694582e-11
IC O 0 6.9947212466559e-08
) O 0 3.247511287662874e-11
, O 0 5.6633205069989145e-12
mapping O 0 5.3928188303853375e-11
in O 0 3.17322535435538e-12
part O 0 8.03843016455863e-12
to O 0 1.511571007251078e-10
the O 0 1.1808017064129928e-10
promoter O 0 6.0236167165328425e-09
and O 0 2.4707083601249735e-11
first O 0 7.720367678487605e-10
exon O 0 2.9689444236424833e-09
of O 0 5.85450354861905e-09
SNRPN O 0 0.0008207157952710986
. O 0 3.1841361192164186e-07

Deletion O 0 2.7798100745712873e-06
of O 0 1.1236309660489496e-08
this O 0 1.1259109200523199e-09
IC O 0 3.597304385039024e-06
abolishes O 0 2.5713259788062715e-07
local O 0 7.394826972983992e-10
paternally O 0 7.499969534308093e-10
derived O 0 8.023327661976776e-12
gene O 0 6.796848782582299e-13
expression O 0 1.5177395202171234e-13
and O 0 6.384753430165382e-14
results O 0 2.1276940712772197e-12
in O 0 7.037054272629462e-10
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 8.772540240897797e-07
PWS B-Disease 1 1.0
) O 0 1.8768808729419106e-09
. O 0 2.4810208998360395e-08

We O 0 2.3934816795190272e-08
have O 0 2.6194520511002573e-11
created O 0 5.4313845088138635e-11
two O 0 1.3120338149263944e-10
deletion O 0 1.0947148076922986e-08
mutations O 0 2.763109518966189e-09
in O 0 5.005556524828592e-10
mice O 0 1.2457374021224155e-09
to O 0 5.967195182421392e-09
understand O 0 5.368586286635946e-08
PWS B-Disease 1 1.0
and O 0 1.5767042116365815e-09
the O 0 7.288920023107437e-10
mechanism O 0 9.931335753776693e-10
of O 0 6.173493660721618e-11
this O 0 1.1864410842665762e-10
IC O 0 5.781511390523519e-06
. O 0 1.4062094066957798e-07

Mice O 0 1.61517000378808e-05
harbouring O 0 2.073021960313781e-06
an O 0 5.687402993004298e-09
intragenic O 0 5.229821908869781e-06
deletion O 0 4.4951372046853066e-07
in O 0 7.8752702137308e-09
Snrpn O 0 4.766600250150077e-05
are O 0 2.2127759624623877e-09
phenotypically O 0 3.0740177408006275e-06
normal O 0 2.06046070161392e-06
, O 0 1.0747959466872459e-10
suggesting O 0 1.9475333845608844e-10
that O 0 5.543010841990714e-11
mutations O 0 7.742206875605007e-10
of O 0 2.1863331145510756e-09
SNRPN O 0 3.359663651281153e-06
are O 0 9.684977646251536e-12
not O 0 5.915333500805531e-11
sufficient O 0 5.5750559724288e-10
to O 0 7.105085408909417e-09
induce O 0 1.100197096093325e-05
PWS B-Disease 1 1.0
. O 0 7.069548701110762e-06

Mice O 0 1.2615365108104015e-07
with O 0 4.400069718302202e-12
a O 0 1.709700853114171e-10
larger O 0 1.6595248786277494e-10
deletion O 0 2.362457340865376e-09
involving O 0 2.241963732718677e-11
both O 0 1.8339954555024462e-11
Snrpn O 0 2.4994267278088955e-07
and O 0 1.6980856998305427e-10
the O 0 2.7181239481421926e-09
putative O 0 2.548983957240125e-06
PWS O 1 1.0
- O 0 2.0839734133915044e-06
IC O 0 1.3822368600813206e-06
lack O 0 3.206901855179467e-09
expression O 0 1.0223724644653487e-10
of O 0 2.487063888167995e-10
the O 0 1.397932047897399e-10
imprinted O 0 7.728765960557382e-10
genes O 0 2.347334104868537e-09
Zfp127 O 0 2.1306757957972877e-07
( O 0 1.1385827003440596e-10
mouse O 0 5.420110138487644e-09
homologue O 0 1.4951686466702085e-07
of O 0 2.2065183458153115e-08
ZNF127 O 0 0.00011694721615640447
) O 0 1.3606772375496234e-09
, O 0 1.9968853237628537e-09
Ndn O 0 1.528392317595717e-06
and O 0 4.3735273180800505e-09
Ipw O 0 3.8305255856130316e-08
, O 0 4.993939289876792e-11
and O 0 4.461297303803846e-11
manifest O 0 1.209177757921509e-09
several O 0 8.90909221396008e-12
phenotypes O 0 8.57008686239169e-10
common O 0 7.753408470811962e-10
to O 0 3.129539436486084e-06
PWS B-Disease 1 1.0
infants O 0 0.12061908841133118
. O 0 3.8562421877941233e-07

These O 0 7.115836808679887e-10
data O 0 1.0231977071173404e-10
demonstrate O 0 1.802169698195133e-11
that O 0 3.289450688833545e-13
both O 0 5.925389302482986e-13
the O 0 2.41831277225657e-11
position O 0 3.1763044971988563e-10
of O 0 2.2058374224420696e-11
the O 0 9.438331192990201e-12
IC O 0 4.533338149315114e-09
and O 0 2.988113445914764e-12
its O 0 2.9571562212837854e-12
role O 0 1.2196642350595366e-12
in O 0 4.4818131410967466e-13
the O 0 1.586245783162521e-12
coordinate O 0 3.721018285163247e-11
expression O 0 1.5811395248643834e-10
of O 0 2.379479058234324e-09
genes O 0 1.3596233860990736e-10
is O 0 4.551699295252121e-12
conserved O 0 7.412371931525552e-12
between O 0 3.725215275141025e-11
mouse O 0 3.1369892794508303e-10
and O 0 7.087617992507234e-11
human O 0 1.1076030370649192e-10
, O 0 1.0971232602963177e-11
and O 0 1.3741835794278678e-11
indicate O 0 2.164515233715747e-10
that O 0 2.285644980573598e-12
the O 0 1.7556541290209005e-11
mouse O 0 1.5257141036673083e-11
is O 0 5.287841020086559e-13
a O 0 2.523756377492692e-12
suitable O 0 1.5660246710513803e-10
model O 0 7.045293168306266e-12
system O 0 3.919316954315022e-11
in O 0 1.1970877414335668e-11
which O 0 6.747343135604655e-12
to O 0 4.265893749355598e-10
investigate O 0 1.5636227868043306e-09
the O 0 2.2898800910997608e-10
molecular O 0 2.025374090663945e-09
mechanisms O 0 5.228666943857263e-10
of O 0 7.151931824544988e-11
imprinting O 0 8.260295225603898e-10
in O 0 2.212785293539965e-12
this O 0 1.5171208473524489e-12
region O 0 3.298201156631819e-10
of O 0 1.1647188769003947e-10
the O 0 2.6611249315244834e-10
genome O 0 2.256340531081591e-10
. O 0 3.6758388000102116e-10
. O 0 4.486098603706523e-09

Mutations O 0 2.0034867986851168e-07
of O 0 2.3069311794188252e-08
the O 0 7.0498202831004164e-09
ATM O 0 3.391257268958725e-05
gene O 0 1.892539458481224e-09
detected O 0 4.045900947602377e-09
in O 0 4.2235333286289034e-11
Japanese O 0 0.01233021542429924
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 3.3178573630721075e-06
: O 0 1.1799517526250858e-12
possible O 0 4.791680940918752e-11
preponderance O 0 4.828546451562943e-10
of O 0 6.958459849992771e-12
the O 0 6.5290052010669175e-12
two O 0 4.22473948186175e-12
founder O 0 1.4092246258812224e-09
mutations O 0 8.035633269898312e-10
4612del165 O 0 2.2505879826439923e-07
and O 0 7.062090356946271e-10
7883del5 O 0 4.333688411861658e-05
. O 0 1.8739596896466537e-07

The O 0 2.4707970780468713e-08
ATM O 0 0.00010446256783325225
( O 0 9.895154562400421e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 4.748847981517201e-10
mutated O 0 1.9316763466559195e-11
) O 0 5.982659029638016e-13
gene O 0 7.674475746739795e-13
on O 0 6.972998567444932e-11
human O 0 9.695499958439768e-11
chromosome O 0 9.864961612038314e-07
11q22 O 0 3.494651900837198e-05
. O 0 6.844949496098707e-08

3 O 0 0.00015819165855646133
has O 0 2.608167681827922e-09
recently O 0 5.567606931045077e-10
been O 0 4.121801511214329e-11
identified O 0 7.883253945462076e-12
as O 0 1.9448651673512063e-13
the O 0 2.2513374085993132e-13
gene O 0 4.0310013356761876e-14
responsible O 0 1.4679863227784473e-12
for O 0 7.956361806372991e-13
the O 0 1.2951519856585492e-09
human O 0 0.009069309569895267
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0003452183154877275
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.475632004423801e-09
. O 0 1.2790899006631662e-08

In O 0 1.7139855090775313e-09
order O 0 3.393913206028998e-10
to O 0 1.5542200859641753e-10
define O 0 1.7596822887711028e-09
the O 0 2.010396363272271e-11
types O 0 2.3546059546575293e-10
of O 0 2.4013089294783185e-09
disease O 0 7.184063406384666e-07
- O 0 3.970417328247322e-09
causing O 0 2.0298264402640598e-08
ATM O 0 6.081780838940176e-07
mutations O 0 7.293927128948496e-10
in O 0 7.35282668085091e-11
Japanese O 0 9.095954283111496e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.74958945109438e-08
as O 0 1.338058743666215e-11
well O 0 9.690683585444893e-13
as O 0 6.805462768842696e-13
to O 0 1.0588327957472554e-11
look O 0 1.02370618492581e-12
for O 0 5.842424634361354e-12
possible O 0 5.973276095971869e-09
mutational O 0 3.642791170932469e-07
hotspots O 0 7.958654180129088e-09
, O 0 3.239580131930708e-11
reverse O 0 9.336248441016437e-10
- O 0 1.2010609173884745e-10
transcribed O 0 2.3509206734106947e-11
RNA O 0 2.7543876901514608e-11
derived O 0 1.5284592981470307e-13
from O 0 5.71337736236105e-13
ten O 0 2.6562690848969117e-12
patients O 0 7.151211860092349e-14
belonging O 0 9.681163748269384e-14
to O 0 1.4664536945874218e-11
eight O 0 8.173092758134715e-11
unrelated O 0 1.509762204143783e-09
Japanese O 0 5.856331881659571e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 9.1828994408516e-10
was O 0 7.583109695730172e-10
analyzed O 0 2.0118733068397177e-11
for O 0 7.503781450368674e-12
mutations O 0 3.980085792193444e-12
by O 0 2.2664266297045543e-12
the O 0 7.729233225672871e-11
restriction O 0 1.1191766957630023e-10
endonuclease O 0 9.437404191459109e-10
fingerprinting O 0 4.3036590957612475e-10
method O 0 1.13604736728945e-09
. O 0 1.0867857724861096e-09

As O 0 3.057324349242663e-08
has O 0 1.11478791475772e-10
been O 0 8.875527049423404e-12
reported O 0 1.5865483839888617e-12
by O 0 8.545329157824688e-13
others O 0 1.916592926032301e-11
, O 0 1.2384842283663655e-11
mutations O 0 3.905786805091793e-11
that O 0 5.3447215403457093e-11
lead O 0 3.2792385473712216e-10
to O 0 1.3732764259088981e-08
exon O 0 3.522719183024492e-08
skipping O 0 1.9937812112402753e-07
or O 0 1.1758163509512087e-07
premature O 0 2.1356242996262154e-06
protein O 0 3.118189439987873e-08
truncation O 0 1.223556012064364e-07
were O 0 2.0431241420926227e-10
also O 0 1.4101993010828817e-11
predominant O 0 3.534001424831956e-10
in O 0 1.0109453552065162e-10
our O 0 7.881818531174645e-10
mutants O 0 3.21752580134671e-09
. O 0 2.201384408095919e-09

Six O 0 8.816319230220415e-09
different O 0 1.5058322644367905e-11
mutations O 0 5.1356172786620746e-11
were O 0 8.707312648681409e-12
identified O 0 6.769114348909033e-12
on O 0 1.5268560027426048e-10
12 O 0 3.2615418699144527e-10
of O 0 1.9089277034090024e-11
the O 0 1.7205617486304448e-10
16 O 0 7.559458836681188e-09
alleles O 0 2.0120978216908725e-09
examined O 0 9.56012087272029e-08
. O 0 4.982738488479299e-08

Four O 0 6.036889654836841e-09
were O 0 7.096427334651878e-10
deletions O 0 1.7698307264168989e-09
involving O 0 2.888139172263493e-10
a O 0 1.3889335237493583e-09
loss O 0 6.36699004630259e-09
of O 0 1.8982778016152224e-08
a O 0 6.417122833113353e-09
single O 0 1.8180321692540247e-09
exon O 0 4.3016674666773724e-09
exon O 0 1.0699086949728098e-08
7 O 0 3.3523301112836634e-07
, O 0 2.3177521013550972e-10
exon O 0 3.746846388708036e-09
16 O 0 3.828509420600312e-08
, O 0 2.3138031768343836e-10
exon O 0 4.717631618689211e-09
33 O 0 4.0038347748350134e-08
or O 0 7.341119712123145e-09
exon O 0 9.854847604628958e-08
35 O 0 4.2266182731509616e-07
. O 0 2.0056351246466875e-08

The O 0 7.582437433484301e-08
others O 0 2.229420648092173e-09
were O 0 4.736310232900109e-10
minute O 0 4.028154876323242e-08
deletions O 0 2.6414195275492602e-09
, O 0 1.1156281454205441e-10
4649delA O 0 4.2300354330393475e-09
in O 0 6.300399091330178e-10
exon O 0 6.336980273857762e-09
33 O 0 3.7945305564335285e-08
and O 0 2.53499027325077e-10
7883del5 O 0 7.107940973583027e-07
in O 0 1.1997318694056958e-08
exon O 0 2.329801844780377e-07
55 O 0 7.707146778557217e-07
. O 0 2.593811743167862e-08

The O 0 1.2030382094962988e-06
mutations O 0 2.7822079573525116e-07
4612del165 O 0 2.6056536626128945e-06
and O 0 1.2368708279808516e-09
7883del5 O 0 3.1653059977543307e-06
were O 0 5.099980993072961e-10
found O 0 7.643549963971819e-13
in O 0 3.5047404431734486e-14
more O 0 1.0881306054157515e-15
than O 0 4.82636391789526e-14
two O 0 1.002755143459863e-13
unrelated O 0 3.1163637208980743e-12
families O 0 4.53736644068746e-14
; O 0 7.076372365681649e-13
44 O 0 5.724446472399336e-10
% O 0 4.5550712507447244e-11
( O 0 2.9888945051598226e-12
7 O 0 1.2624025380603143e-08
of O 0 5.48286860357905e-10
16 O 0 1.0205843947730386e-09
) O 0 4.2909236276991725e-13
of O 0 6.914983342876102e-12
the O 0 7.443555320729711e-12
mutant O 0 3.107355345255414e-11
alleles O 0 4.496259701364247e-12
had O 0 1.150143695560768e-11
one O 0 1.1180277623840107e-12
of O 0 7.463116930006564e-12
the O 0 6.384129336289845e-11
two O 0 4.5376352675319254e-10
mutations O 0 8.900209991224983e-08
. O 0 1.1894495344222378e-07

The O 0 5.291305456012196e-07
4612del165 O 0 1.0891625606745947e-05
mutations O 0 8.239948723343105e-10
in O 0 7.319982293918503e-12
three O 0 7.614505814074191e-13
different O 0 9.232194951016778e-14
families O 0 8.888753448565989e-13
were O 0 2.4306353371000844e-12
all O 0 1.547716273718469e-12
ascribed O 0 6.774827226996294e-11
to O 0 9.526632954726111e-11
the O 0 1.1304270020051632e-10
same O 0 2.394803522154376e-10
T O 0 2.3171962126866674e-09
- O 0 2.497833051506859e-09
- O 0 3.0620730395725104e-09
> O 0 1.424335760447093e-09
A O 0 1.6476039421675637e-09
substitution O 0 4.499788389122905e-11
at O 0 4.2910591746547766e-11
the O 0 4.9523900605419335e-12
splice O 0 1.556094836319133e-10
donor O 0 4.101685657786902e-11
site O 0 3.2372099445510116e-10
in O 0 5.750063758469537e-10
intron O 0 1.0874622375922627e-06
33 O 0 1.0856798553504632e-06
. O 0 5.5768484941154384e-08

Microsatellite O 0 1.5720463125035167e-05
genotyping O 0 1.7543855790336238e-07
around O 0 3.6492300847790204e-10
the O 0 5.039315076338369e-10
ATM O 0 1.7971699151075882e-07
locus O 0 7.608583985074802e-09
also O 0 9.227697599090146e-12
indicated O 0 9.462797212478335e-11
that O 0 4.56581766752201e-13
a O 0 1.790380343980047e-11
common O 0 1.6193978102929663e-10
haplotype O 0 7.68846852849947e-09
was O 0 5.936439118059411e-10
shared O 0 4.443493370562962e-13
by O 0 1.8860385258764878e-13
the O 0 2.1848342579566804e-11
mutant O 0 3.3600958820878546e-11
alleles O 0 2.2083675166317818e-11
in O 0 2.836919935078619e-11
both O 0 3.029602679838206e-10
mutations O 0 2.1002327343921934e-07
. O 0 2.1443538855692168e-07

This O 0 5.050845519605218e-09
suggests O 0 6.645491379408952e-10
that O 0 4.345175694947523e-12
these O 0 1.9419897547695575e-12
two O 0 1.8177841176747478e-11
founder O 0 4.984503920724137e-09
mutations O 0 7.66993635270552e-10
may O 0 1.942522365183663e-09
be O 0 3.9234171467228407e-10
predominant O 0 4.188320357201292e-09
among O 0 1.4953960379010534e-12
Japanese O 0 2.2083770923053692e-10
ATM O 0 1.3665761855463643e-07
mutant O 0 8.025145881163098e-09
alleles O 0 1.3966167777823557e-08
. O 0 9.640447551362286e-09

W474C O 0 0.00024639914045110345
amino O 0 7.554575063295488e-07
acid O 0 1.0192271027165134e-08
substitution O 0 5.624679055848958e-10
affects O 0 1.597956766907771e-10
early O 0 3.1519770127275137e-10
processing O 0 4.109234480464963e-11
of O 0 2.7626690865534265e-11
the O 0 1.2488622115613968e-11
alpha O 0 1.265254741256161e-11
- O 0 1.0496409514129668e-12
subunit O 0 1.047305818457911e-11
of O 0 8.635103916632136e-12
beta O 0 1.1019605228312912e-09
- O 0 1.574617797261979e-10
hexosaminidase O 0 2.3430175577487944e-09
A O 0 3.168136308850933e-10
and O 0 9.269606566705835e-13
is O 0 1.6568855662479898e-12
associated O 0 7.060282219972791e-11
with O 0 2.6728386864904863e-11
subacute O 0 0.0009122511255554855
G B-Disease 0 7.40048790248693e-06
( I-Disease 0 7.407744417875506e-10
M2 I-Disease 0 1.2686235777437105e-06
) I-Disease 0 1.0352336765606651e-09
gangliosidosis I-Disease 0 8.141524631355423e-06
. O 0 1.4533718228904036e-07

Mutations O 0 1.2362846746327705e-07
in O 0 1.3107438467940824e-09
the O 0 9.767992636966483e-09
HEXA O 0 1.4707716218254063e-06
gene O 0 3.100943460343508e-11
, O 0 1.3832341305350382e-12
encoding O 0 1.043459047465889e-12
the O 0 6.288390641540076e-11
alpha O 0 3.4339045495990206e-11
- O 0 2.7446005537723472e-12
subunit O 0 2.3614412508754512e-11
of O 0 2.4214144578316166e-11
beta O 0 1.250377024142324e-09
- O 0 4.916480000893841e-10
hexosaminidase O 0 1.4757516986207975e-08
A O 0 1.203401609473076e-07
( O 0 2.3179244634796703e-10
Hex O 0 4.2057337168444064e-08
A O 0 3.639113543840722e-08
) O 0 7.037261832293362e-12
, O 0 4.047994578426639e-12
that O 0 4.0544698674815915e-12
abolish O 0 2.4550224964059453e-08
Hex O 0 2.296154022474184e-08
A O 0 2.718030911452729e-09
enzyme O 0 3.4192598752369463e-10
activity O 0 3.3191038806279494e-09
cause O 1 0.9997850060462952
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.585093971165577e-10
TSD B-Disease 0 1.2481018529797439e-06
) O 0 6.4536171545670484e-12
, O 0 5.2509784714827035e-12
the O 0 2.397623488636924e-10
fatal O 0 1.3934551361671765e-06
infantile B-Disease 0 4.559072408483189e-07
form I-Disease 0 7.764778153784846e-09
of I-Disease 0 1.4207624872142333e-06
G I-Disease 0 5.47136824025074e-06
( I-Disease 0 5.532957980669551e-10
M2 I-Disease 0 2.5431802441744367e-07
) I-Disease 0 7.837411275524175e-11
gangliosidosis I-Disease 0 1.4494297317924065e-07
, I-Disease 0 6.257975387891079e-11
Type I-Disease 0 1.1326164894853719e-08
1 I-Disease 0 2.9803384222759632e-06
. O 0 4.439717571358415e-08

Less O 0 1.7782285794964992e-06
severe O 1 0.9997231364250183
, O 0 5.795695479093865e-09
subacute O 1 0.9579721689224243
( O 0 9.921906629628552e-10
juvenile O 0 3.851666406262666e-05
- O 0 1.818255327634688e-06
onset O 1 1.0
) O 0 1.1920080478233785e-09
and O 0 4.143856102700738e-08
chronic O 1 1.0
( O 0 1.1041043634918424e-09
adult O 0 3.423131374802324e-06
- O 0 1.0938141485894448e-06
onset O 0 0.27074745297431946
) O 0 1.461062520968781e-11
variants O 0 5.871629571441161e-11
are O 0 1.370364108646549e-12
characterized O 0 4.655340349324355e-12
by O 0 8.170185448325151e-13
a O 0 3.1932630151221275e-11
broad O 0 1.2400006577095724e-09
spectrum O 0 8.146704644218516e-09
of O 0 4.859136981671952e-10
clinical O 0 1.8603398821426254e-09
manifestations O 0 1.3656538122575057e-09
and O 0 6.039160924814491e-12
are O 0 5.475565205241562e-13
associated O 0 1.585829037531461e-11
with O 0 6.3274294657966745e-12
residual O 0 1.722108891044627e-06
levels O 0 8.736574841350375e-08
of O 0 8.065934586909407e-09
Hex O 0 1.9164939146776305e-07
A O 0 8.981467658486508e-08
enzyme O 0 1.5508332396052538e-09
activity O 0 3.5615033144864583e-09
. O 0 1.1994338855458864e-09

We O 0 4.5450200047980616e-08
identified O 0 1.3800555143106408e-09
a O 0 1.0888585588730848e-09
1422 O 0 2.613181209198956e-07
G O 0 1.8323198958114517e-08
- O 0 8.829007747124251e-09
- O 0 2.0796752764340454e-08
> O 0 1.5520770446642018e-08
C O 0 5.605642527939381e-08
( O 0 1.927899853648718e-11
amino O 0 2.000387494538458e-10
acid O 0 2.7885195888477377e-11
W474C O 0 1.2160696061247478e-10
) O 0 8.532112055715732e-15
substitution O 0 1.7472407255834238e-13
in O 0 2.2230511160202526e-13
the O 0 2.1318131721709266e-12
first O 0 1.1591291294854589e-11
position O 0 2.457657688470505e-10
of O 0 3.853735733305719e-11
exon O 0 2.277665972494347e-10
13 O 0 1.0057644717065273e-09
of O 0 2.2724111481409182e-10
HEXA O 0 1.116457156058459e-06
of O 0 2.299109930214982e-10
a O 0 1.662304072169718e-09
non O 0 2.618375276597362e-07
- O 0 1.6141993341989291e-07
Jewish O 0 1.046386728376092e-06
proband O 0 0.0001268244523089379
who O 0 3.5697170219783914e-10
manifested O 0 9.813680423853555e-11
a O 0 5.575797462631371e-11
subacute O 0 1.2735787890960637e-07
variant O 0 7.76357911291825e-09
of O 0 3.7129248084966093e-06
G B-Disease 0 5.572607187787071e-05
( I-Disease 0 9.774269171813899e-10
M2 I-Disease 0 2.5851495593087748e-06
) I-Disease 0 1.2748512245863708e-09
gangliosidosis I-Disease 0 1.727741619106382e-05
. O 0 2.936910732387332e-07

On O 0 1.8487863826521789e-06
the O 0 5.602432739948426e-09
second O 0 8.264790629652907e-09
maternally O 0 8.217963198831058e-09
inherited O 0 8.862041767088158e-09
allele O 0 1.1629508023247581e-08
, O 0 4.705853762221324e-11
we O 0 2.6658734247897442e-11
identified O 0 1.3321642400310196e-10
the O 0 1.7140958097350278e-10
common O 0 2.398551032456453e-06
infantile O 1 1.0
disease O 1 1.0
- O 0 1.092829006665852e-05
causing O 0 4.0716080548008904e-05
4 O 0 7.856212505430449e-06
- O 0 4.274784615176941e-08
bp O 0 2.0502778141917588e-08
insertion O 0 4.954513688204543e-09
, O 0 1.0335423489271633e-10
+ O 0 8.190856326528717e-10
TATC O 0 5.828267148899613e-07
1278 O 0 4.534430075864293e-08
, O 0 4.3237573243981586e-11
in O 0 2.1612397982373466e-10
exon O 0 1.2396631277056258e-08
11 O 0 5.763278920767334e-08
. O 0 7.841037152900299e-09

Pulse O 0 1.4499134522338863e-05
- O 0 1.1303487923441935e-07
chase O 0 3.217022426227345e-09
analysis O 0 6.163043166085291e-12
using O 0 3.0571271208978956e-11
proband O 0 1.1945810740598972e-07
fibroblasts O 0 1.156449958017447e-08
revealed O 0 2.8597297863086624e-09
that O 0 1.247793188219326e-11
the O 0 9.56481352454297e-11
W474C O 0 2.4287436506398308e-09
- O 0 5.466283675703565e-11
containing O 0 3.2742853567357955e-12
alpha O 0 5.827870130925561e-11
- O 0 1.2125115148031718e-11
subunit O 0 1.3424435174602678e-10
precursor O 0 5.003437664186094e-10
was O 0 3.8902425725240164e-10
normally O 0 1.2729377447950885e-11
synthesized O 0 8.935077504268474e-12
, O 0 5.583755680049762e-12
but O 0 4.806250449712612e-12
not O 0 2.940167553866502e-11
phosphorylated O 0 9.080157736818251e-10
or O 0 3.2076710732020786e-10
secreted O 0 2.8231986193283376e-11
, O 0 4.772988428103364e-12
and O 0 9.046006999025025e-12
the O 0 3.4513597535479335e-10
mature O 0 5.8612963371729165e-09
lysosomal O 0 2.5812957105131318e-08
alpha O 0 1.956085515786299e-09
- O 0 1.456150061640571e-10
subunit O 0 1.0741714184803186e-09
was O 0 1.747290978570959e-09
not O 0 5.462034158298934e-10
detected O 0 1.1549025735746454e-08
. O 0 2.4176280977172837e-09

When O 0 2.7565096871740025e-08
the O 0 2.782975405679622e-09
W474C O 0 3.74065010078084e-08
- O 0 4.397213426710067e-10
containing O 0 6.5360325658680996e-12
alpha O 0 5.1674824141922926e-11
- O 0 3.543325572188949e-12
subunit O 0 5.859279034181597e-11
was O 0 1.8526584433242732e-10
transiently O 0 1.3231069573294008e-09
co O 0 3.236380954896312e-11
- O 0 2.7549391587444738e-11
expressed O 0 7.242501737225737e-12
with O 0 9.259622148899416e-13
the O 0 1.4311893337115578e-10
beta O 0 1.2444283103985043e-10
- O 0 2.924600448969694e-12
subunit O 0 1.3133100509876705e-11
to O 0 5.280015660802384e-11
produce O 0 5.690956386694701e-11
Hex O 0 1.3465248471788982e-08
A O 0 5.8510451594884216e-08
( O 0 5.022292581813304e-10
alphabeta O 0 1.9058134625993262e-07
) O 0 3.145555690919899e-11
in O 0 4.86471030125557e-10
COS O 0 3.8450602346529195e-07
- O 0 7.178208960567645e-08
7 O 0 7.563486548178844e-08
cells O 0 1.9691451247361158e-10
, O 0 2.8863571688991785e-12
the O 0 1.5480715667703926e-11
mature O 0 2.3314692190745667e-11
alpha O 0 1.7745341654440416e-11
- O 0 1.1883786055905121e-12
subunit O 0 9.916486035099759e-12
was O 0 3.5705254725071356e-11
present O 0 1.5137333660847352e-12
, O 0 1.4600921383403631e-12
but O 0 3.637877976289672e-12
its O 0 2.494930650964733e-11
level O 0 2.1384380932687463e-09
was O 0 1.4457754993202343e-09
much O 0 4.193504224425659e-11
lower O 0 2.0626626795472447e-10
than O 0 5.5909170522394636e-12
that O 0 1.9169574781707777e-12
from O 0 2.0122427335511617e-10
normal O 0 2.8189721668070433e-09
alpha O 0 1.530550408634923e-10
- O 0 1.5091964136737523e-11
subunit O 0 1.1091463164580873e-10
transfections O 0 1.3008535360015117e-09
, O 0 4.5326546335711093e-13
although O 0 5.694457492350091e-13
higher O 0 4.1169539999330595e-11
than O 0 2.7628153671105382e-12
in O 0 1.8927071715468813e-11
those O 0 2.3697658418919687e-11
cells O 0 3.674785128970903e-11
transfected O 0 2.3471124349638828e-11
with O 0 4.4679327783087724e-14
an O 0 1.6245069525688827e-12
alpha O 0 3.147547847359711e-11
- O 0 4.506657633879252e-12
subunit O 0 8.886372193650516e-11
associated O 0 9.218782681674753e-11
with O 0 9.598274952615782e-11
infantile O 0 0.0015375803923234344
TSD B-Disease 0 0.00025757288676686585
. O 0 2.0758794505582046e-07

Furthermore O 0 3.832484196664154e-08
, O 0 1.9392600025813778e-10
the O 0 1.4264148195941573e-10
precursor O 0 6.989460121786806e-10
level O 0 1.4641108769808397e-08
of O 0 5.273083636403442e-10
the O 0 7.654415989932772e-10
W474C O 0 7.376799171510129e-09
alpha O 0 7.48396067340451e-11
- O 0 1.6523473127944e-12
subunit O 0 1.050681069925119e-11
was O 0 3.7124546492517396e-11
found O 0 2.0725343099700644e-13
to O 0 8.10478420487648e-12
accumulate O 0 2.452742653077933e-12
in O 0 4.528938530624915e-13
comparison O 0 1.2176804009556008e-10
to O 0 1.7810736219203704e-09
the O 0 1.934679749737711e-09
normal O 0 2.1581318065955202e-08
alpha O 0 5.608719710892274e-09
- O 0 2.373969909541529e-10
subunit O 0 8.56458015618955e-10
precursor O 0 1.9692214525690588e-09
levels O 0 2.092817474874664e-09
. O 0 5.699171690132232e-10

We O 0 1.3908434937093261e-07
conclude O 0 5.96102097460971e-07
that O 0 8.17455755863783e-11
the O 0 4.009730325549299e-10
1422 O 0 2.1180663622999418e-07
G O 0 2.5996811814366083e-08
- O 0 1.0239893377672615e-08
- O 0 8.362261993966058e-09
> O 0 1.0391372207152472e-08
C O 0 2.987880165505885e-08
mutation O 0 1.9246191446109506e-11
is O 0 7.09851150299326e-14
the O 0 9.558311173801792e-13
cause O 0 8.019387931490485e-10
of O 0 1.3037332102783239e-08
Hex B-Disease 0 0.0001141789834946394
A I-Disease 1 0.999913215637207
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.3998940612557362e-09
the O 0 7.1942154455939544e-09
proband O 0 2.100838855767506e-06
. O 0 6.132520979917899e-08

The O 0 8.593977440796152e-08
resulting O 0 3.585018504281834e-08
W474C O 0 1.682694346527569e-06
substitution O 0 1.5622701354800483e-08
clearly O 0 1.412063244110584e-09
interferes O 0 3.0606642220654123e-10
with O 0 4.178220703449087e-12
alpha O 0 3.358354705440547e-10
- O 0 1.2109467074916669e-11
subunit O 0 3.082386082486899e-11
processing O 0 3.181960597786748e-11
, O 0 2.6066605471330995e-13
but O 0 2.7925299334215226e-13
because O 0 5.448894373899504e-13
the O 0 1.8905849108463713e-12
base O 0 9.726650040953189e-12
substitution O 0 1.7200130209005238e-11
falls O 0 1.3797765152645525e-09
at O 0 9.843299092482383e-11
the O 0 2.2882197872609034e-11
first O 0 1.0963164404076409e-10
position O 0 2.4515864893714934e-09
of O 0 8.233507209354229e-10
exon O 0 9.32738442038783e-10
13 O 0 4.551167887001384e-09
, O 0 7.205990665282158e-11
aberrant O 0 1.1310788972096475e-09
splicing O 0 5.335506481074503e-10
may O 0 4.161610223096801e-10
also O 0 4.094359833811678e-12
contribute O 0 5.681629472453764e-11
to O 0 3.0382512505866544e-08
Hex B-Disease 0 0.00013655683142133057
A I-Disease 0 0.008792626671493053
deficiency I-Disease 0 6.228574875422055e-06
in O 0 3.7671524233395814e-10
this O 0 3.3656843978491224e-10
proband O 0 1.8258907630297472e-07
. O 0 2.1471067146450196e-09
. O 0 7.529671997019705e-09

Two O 0 2.912286189982183e-09
frequent O 0 1.1600333138517271e-08
missense O 0 7.004011877143057e-06
mutations O 0 7.07860226611956e-06
in O 0 2.0997351839469047e-06
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00027482808218337595

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.545254744745762e-07
an O 0 0.0712304338812828
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 6.393802465254339e-08
by O 0 5.241155079382942e-11
early O 0 0.0038310964591801167
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999994039535522
goiter B-Disease 1 1.0
. O 0 0.00037548798718489707

A O 0 2.681836122064851e-07
century O 0 9.595868988299117e-09
after O 0 3.435367268433964e-10
its O 0 1.816888870256883e-12
recognition O 0 6.899147919625648e-12
as O 0 3.3538144483813426e-11
a O 0 8.372204263196181e-09
syndrome O 0 1.4155527878756402e-06
by O 0 2.4273702839416877e-11
Vaughan O 0 6.594307322416171e-09
Pendred O 0 2.1167939223687426e-07
, O 0 3.489411537493936e-11
the O 0 7.124111078837814e-09
disease O 0 8.732976311875973e-06
gene O 0 3.9911220994781615e-09
( O 0 3.450729257892249e-09
PDS O 0 5.98366068516043e-06
) O 0 5.035084849058791e-11
was O 0 1.636229707280279e-09
mapped O 0 1.4984475882329207e-09
to O 0 1.9091892511369224e-08
chromosome O 0 2.7644251531455666e-05
7q22 O 0 0.00021643380750901997
- O 0 2.179971124860458e-05
q31 O 0 8.828767749946564e-05
. O 0 1.4839208972716733e-07

1 O 0 1.6860076357261278e-05
and O 0 4.411126575121216e-09
, O 0 1.1738588989729237e-09
recently O 0 2.50384335487297e-09
, O 0 6.986045075763059e-11
found O 0 2.910828522662001e-11
to O 0 1.7030939158946268e-10
encode O 0 6.663104790138874e-11
a O 0 1.1026144441927954e-09
putative O 0 5.2097082203772516e-08
sulfate O 0 8.587210942323509e-08
transporter O 0 2.42570467889891e-06
. O 0 4.559406718840364e-08

We O 0 1.9912191007165347e-08
performed O 0 4.255863023105988e-11
mutation O 0 8.410716567652798e-12
analysis O 0 1.7328741523311986e-12
of O 0 7.845158550567888e-11
the O 0 1.906859115052839e-09
PDS B-Disease 0 1.0000580004998483e-05
gene O 0 4.9153521530787003e-11
in O 0 1.1591777017427862e-11
patients O 0 4.799343648193011e-12
from O 0 1.8240879293141e-11
14 O 0 5.607379560679249e-10
Pendred B-Disease 0 1.9022383668243492e-09
families O 0 4.1456955598463685e-13
originating O 0 8.616869153973972e-13
from O 0 1.0885937117011135e-11
seven O 0 1.1564349304549193e-11
countries O 0 6.568960870048657e-13
and O 0 7.682622767124503e-12
identified O 0 1.3446351809776047e-09
all O 0 6.142805153430686e-10
mutations O 0 4.979952450412384e-09
. O 0 1.6025795801510867e-08

The O 0 1.462079950442785e-07
mutations O 0 8.475705137733769e-10
include O 0 1.389461982970186e-11
three O 0 3.299885711904871e-11
single O 0 2.3122007780651543e-11
base O 0 8.61044235911379e-10
deletions O 0 1.7634251836540216e-09
, O 0 4.2351516738037276e-10
one O 0 1.0067549016667954e-09
splice O 0 2.7860519224987e-08
site O 0 1.6239517508509493e-09
mutation O 0 5.442732375904313e-10
and O 0 2.844691426862056e-10
10 O 0 9.764923447619367e-08
missense O 0 5.143559064890724e-06
mutations O 0 8.288113349408377e-06
. O 0 6.982849640735367e-07

One O 0 1.1241652941862412e-07
missense O 0 1.4361698958964553e-06
mutation O 0 7.033906967990333e-08
( O 0 1.4342227405705898e-10
L236P O 0 3.010967191130476e-07
) O 0 9.808884607331869e-12
was O 0 3.45487666253419e-10
found O 0 3.3518621905814783e-12
in O 0 2.056163616107054e-12
a O 0 1.3567272305614608e-10
homozygous O 0 6.813950792494694e-11
state O 0 1.1934172400307475e-11
in O 0 2.336444839684537e-12
two O 0 1.2024607871918835e-11
consanguineous O 0 3.0383901616914955e-08
families O 0 1.5168959838218754e-11
and O 0 7.2426127595282e-12
in O 0 4.2999565713630616e-11
a O 0 9.69247349047464e-10
heterozygous O 0 4.6543838227997014e-11
state O 0 3.264407624423149e-12
in O 0 1.5976779361298599e-12
five O 0 2.2895416031815108e-12
additional O 0 1.0967759686564271e-11
non O 0 1.7448339661996215e-08
- O 0 1.2585419995048142e-07
consanguineous O 0 9.051821052707965e-07
families O 0 8.952316665755689e-10
. O 0 1.0069627798259262e-08

Another O 0 1.369753306335042e-07
missense O 0 2.1509952148335287e-06
mutation O 0 3.6519981705396276e-08
( O 0 9.566492042978325e-11
T416P O 0 2.052054668411074e-07
) O 0 4.944122368455428e-12
was O 0 2.8899849180419324e-10
found O 0 1.8132537572129737e-12
in O 0 1.9931643141513078e-12
a O 0 5.484497231367236e-11
homozygous O 0 1.9062534536984366e-11
state O 0 6.840995218221346e-12
in O 0 7.51526965658833e-12
one O 0 2.772027572761626e-11
family O 0 3.2999592641802522e-12
and O 0 6.429483681569259e-13
in O 0 3.976557364643307e-12
a O 0 1.253511738852353e-10
heterozygous O 0 2.212697733372515e-11
state O 0 1.495585079391848e-11
in O 0 9.066579952088372e-12
four O 0 3.0268863804305823e-11
families O 0 4.175522427818379e-11
. O 0 7.502777954471185e-09

Pendred B-Disease 0 0.0026218376588076353
patients O 0 8.462773593009842e-08
in O 0 7.15385972682725e-10
three O 0 5.732346264331056e-10
non O 0 2.8901972370931617e-08
- O 0 1.09467519493478e-08
consanguineous O 0 1.2158440654275182e-07
families O 0 4.6865063912937543e-11
were O 0 1.48002287508886e-11
shown O 0 1.4942384352414906e-12
to O 0 3.30892362121471e-11
be O 0 2.468927839949231e-11
compound O 0 1.879365829626778e-10
heterozygotes O 0 3.7545543063455256e-11
for O 0 4.290257038519485e-11
L236P O 0 4.6408632670136285e-07
and O 0 3.2276799011299317e-09
T416P O 0 2.019986459345091e-05
. O 0 8.274415819187197e-08

In O 0 1.611185673766613e-08
total O 0 1.6563478366649065e-09
, O 0 3.1425750890434756e-11
one O 0 3.2328643234658117e-11
or O 0 1.2789348746711227e-10
both O 0 2.8332430151989385e-11
of O 0 2.8757160541736937e-10
these O 0 6.0522602554624605e-12
mutations O 0 4.271639986175302e-11
were O 0 1.5287698190702415e-11
found O 0 2.893710661713844e-12
in O 0 2.2011082193018616e-12
nine O 0 3.5759097072318724e-11
of O 0 1.3556556051341762e-11
the O 0 5.733359967341478e-11
14 O 0 3.4783311786412696e-09
families O 0 3.9224203746135444e-11
analyzed O 0 6.4638396857219504e-09
. O 0 5.760080767913678e-08

The O 0 1.2684454597788886e-09
identification O 0 1.786271131010153e-10
of O 0 4.585776203214209e-10
two O 0 7.32094870836697e-11
frequent O 0 5.621592968907407e-09
PDS B-Disease 0 1.8448537275617127e-06
mutations O 0 1.1931408083754036e-09
will O 0 4.173651008132495e-11
facilitate O 0 1.6348312981140367e-10
the O 0 1.970678203955245e-10
molecular O 0 3.863205577658846e-08
diagnosis O 0 0.0017123976722359657
of O 0 6.644419840995397e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.99384338784148e-06

Insertional O 0 8.204627192753833e-06
mutation O 0 1.3949069677110515e-09
by O 0 1.8440625762505825e-11
transposable O 0 1.1712340430847235e-08
element O 0 9.256139188451584e-10
, O 0 7.136806423613251e-11
L1 O 0 3.4395677062093455e-07
, O 0 3.79419169693751e-11
in O 0 2.742787386100787e-10
the O 0 8.219017644250926e-08
DMD B-Disease 1 1.0
gene O 0 3.3015006284387027e-09
results O 0 2.875173155114652e-10
in O 0 1.0695076768652001e-10
X B-Disease 1 0.9998465776443481
- I-Disease 1 0.9987673759460449
linked I-Disease 1 0.9999293088912964
dilated I-Disease 1 0.7061008214950562
cardiomyopathy I-Disease 1 1.0
. O 0 3.611690090110642e-06

X B-Disease 1 0.9999904632568359
- I-Disease 1 0.9999991655349731
linked I-Disease 1 1.0
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 0 3.572036533228129e-08
XLDCM B-Disease 1 0.9999260902404785
) O 0 2.1663438404262436e-11
is O 0 1.8842739868407676e-12
a O 0 1.1753663320401841e-10
clinical O 0 1.6859207363495443e-08
phenotype O 0 4.830458522064873e-08
of O 0 7.362209064609715e-09
dystrophinopathy B-Disease 0 4.325067379795655e-07
which O 0 1.1015055187413303e-11
is O 0 1.237973482406951e-12
characterized O 0 1.124023183557421e-12
by O 0 1.6074928931367194e-12
preferential O 0 1.41345708470908e-08
myocardial B-Disease 0 4.866867584496504e-06
involvement I-Disease 0 2.1128112592805337e-09
without O 0 1.7617533820679654e-10
any O 0 1.1054629434070762e-10
overt O 0 2.598331105829743e-09
clinical O 0 2.6042917156132717e-08
signs O 0 5.2988062826386795e-09
of O 0 1.6995301166389254e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.00010399235179647803

To O 0 1.112357139732012e-08
date O 0 7.269406410159718e-08
, O 0 1.2356103987198885e-11
several O 0 5.891359015214315e-12
mutations O 0 1.0096754682331621e-10
in O 0 3.489518049515361e-11
the O 0 2.6937339470123334e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 0.024115918204188347
, O 0 1.4231600289349444e-06
DMD O 1 1.0
, O 0 5.597914576327412e-09
have O 0 5.598539340456732e-11
been O 0 1.1714824423025849e-11
identified O 0 3.1364893321450538e-12
in O 0 7.133886580426574e-13
patients O 0 3.6457390383513866e-13
with O 0 3.103833650600768e-13
XLDCM B-Disease 0 0.02464815229177475
, O 0 7.420070807784285e-11
but O 0 1.1885967904357031e-11
a O 0 6.833578147791286e-11
pathogenic O 0 1.8432300130655221e-10
correlation O 0 6.386970397009861e-10
of O 0 2.7366106603032847e-10
these O 0 2.7650361167363968e-11
cardiospecific O 0 1.6104583266951522e-07
mutations O 0 5.199262798072368e-09
in O 0 7.473494600951369e-10
DMD O 1 1.0
with O 0 1.4567501371853808e-10
the O 0 1.655584114246267e-08
XLDCM B-Disease 0 5.625380435958505e-05
phenotype O 0 1.6616303355476703e-07
has O 0 1.3117736064049978e-10
remained O 0 4.245925000478934e-10
to O 0 9.090689312429845e-11
be O 0 4.675446696467134e-10
elucidated O 0 1.6812717262837396e-07
. O 0 1.8364310960805597e-08

We O 0 3.167426854133737e-08
report O 0 1.3007363242056869e-10
here O 0 9.899401610946601e-12
the O 0 1.9008319224189663e-12
identification O 0 2.5829403720034616e-12
of O 0 7.532159791712179e-12
a O 0 5.509755152122153e-11
unique O 0 4.271338838179872e-11
de O 0 3.4584076047394774e-08
novo O 0 2.826851641657413e-07
L1 O 0 2.2154127066187357e-07
insertion O 0 2.1734605226697568e-09
in O 0 9.097644165789731e-11
the O 0 2.7346122588589594e-10
muscle O 0 3.2164318430893957e-10
exon O 0 4.19190859801688e-09
1 O 0 1.8622156972014636e-07
in O 0 1.3287138056483627e-09
DMD O 1 1.0
in O 0 7.557066084018516e-09
three O 0 2.3095803047823438e-09
XLDCM B-Disease 0 0.0008400160586461425
patients O 0 2.5196564279461597e-10
from O 0 2.46897485095543e-11
two O 0 5.1837384211494975e-12
unrelated O 0 1.330105053876096e-10
Japanese O 0 1.1840860514311657e-09
families O 0 4.311322479577662e-11
. O 0 2.1017820817093025e-09

The O 0 3.2233440805384816e-08
insertion O 0 7.082044284345557e-09
was O 0 2.6530528884904925e-09
a O 0 2.2233682950290046e-10
5 O 0 1.4890512156640057e-09
- O 0 7.736504492594776e-11
truncated O 0 2.4078200544508377e-10
form O 0 5.925678003837476e-11
of O 0 2.4997762193557094e-10
human O 0 1.388336945407076e-10
L1 O 0 1.3462730485969132e-08
inversely O 0 3.495363554151254e-09
integrated O 0 1.546496264381858e-10
in O 0 2.238212393201877e-11
the O 0 1.0486034263124111e-10
5 O 0 8.521355177038004e-09
- O 0 4.711714574057169e-09
untranslated O 0 1.116899056796683e-06
region O 0 4.052396196385644e-09
in O 0 2.1816000395080692e-10
the O 0 8.413580943056331e-10
muscle O 0 2.9251109867622915e-10
exon O 0 6.082981340860272e-10
1 O 0 1.1562073964910269e-08
, O 0 1.1476079418357155e-12
which O 0 7.082894383850236e-13
affected O 0 1.2562324444576056e-11
the O 0 8.361387970889922e-12
transcription O 0 6.7949079522733324e-12
or O 0 5.0321925446072946e-12
the O 0 1.5624437507688604e-11
stability O 0 2.442577251571265e-10
of O 0 8.490489561419068e-11
the O 0 7.130329660043344e-11
muscle O 0 5.74784594919997e-11
form O 0 3.330529740885879e-10
of O 0 4.583627255527745e-09
dystrophin O 0 8.83409012608638e-10
transcripts O 0 1.628827350774742e-10
but O 0 1.680969274366062e-12
not O 0 1.1749055504536865e-12
that O 0 2.632170468998968e-13
of O 0 2.7791534698562437e-11
the O 0 2.850464864145863e-10
brain O 0 1.7508153860035236e-07
or O 0 1.702101926071009e-08
Purkinje O 0 6.691655016766163e-07
cell O 0 1.8799562440108275e-07
form O 0 9.104718756702823e-09
, O 0 7.03614166930322e-10
probably O 0 5.120901480637485e-09
due O 0 1.162705132173869e-07
to O 0 6.714727662782138e-10
its O 0 2.3812018329349982e-11
unique O 0 1.201039159619277e-12
site O 0 9.874439460544338e-11
of O 0 2.0391920096951566e-10
integration O 0 1.4776613710409947e-08
. O 0 4.208726878118796e-08

We O 0 1.6519541645720892e-07
speculate O 0 1.6880830955301462e-08
that O 0 2.2839063539698e-12
this O 0 1.9510263630367897e-12
insertion O 0 8.705390575070027e-11
of O 0 3.057220449020903e-11
an O 0 1.8717416505609208e-11
L1 O 0 7.326811868324512e-08
sequence O 0 1.8720389127757642e-10
in O 0 7.798882650789096e-10
DMD O 1 1.0
is O 0 3.878765642006954e-10
responsible O 0 1.4169970752320182e-10
for O 0 3.3702994822054633e-12
some O 0 1.9467663158606596e-12
of O 0 1.9166074977094993e-11
the O 0 6.1854657680548986e-12
population O 0 1.2752524188551495e-13
of O 0 1.403276149794519e-12
Japanese O 0 5.686163762064211e-10
patients O 0 1.5553520277267197e-11
with O 0 7.822801434409499e-12
XLDCM B-Disease 0 0.00013268036127556115
. O 0 1.4416374760628514e-08
. O 0 2.963362000230063e-08

Severe O 1 0.9999768733978271
early O 1 0.9999330043792725
- O 1 0.9999997615814209
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 3.1411650525114965e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.534301751846215e-06
red O 0 1.987225368793588e-05
hair O 0 0.01594705507159233
pigmentation O 0 0.0003020104777533561
caused O 0 3.933907919417834e-06
by O 0 5.1621409369317917e-08
POMC O 0 0.00038551766192540526
mutations O 0 2.444570270654367e-07
in O 0 1.510350600142374e-08
humans O 0 2.4061513670403656e-08
. O 0 1.4475283194315125e-08

Sequential O 0 6.396907110683969e-07
cleavage O 0 1.4566426216333639e-06
of O 0 3.687408067776232e-08
the O 0 1.2904127766333318e-09
precursor O 0 8.978839338702471e-10
protein O 0 5.618749354674435e-10
pre O 0 8.948619267812319e-08
- O 0 2.6529784591389216e-08
pro O 0 4.560903121841875e-08
- O 0 2.628781317071116e-07
opiomelanocortin O 0 1.3849339666194282e-06
( O 0 5.086400189924234e-10
POMC O 0 1.743101734064112e-07
) O 0 1.919701810709773e-12
generates O 0 6.515495608316879e-12
the O 0 3.764787440130313e-11
melanocortin O 0 4.758109639624308e-08
peptides O 0 8.435016018992769e-10
adrenocorticotrophin O 0 1.6002711333840125e-07
( O 0 1.8360685194451776e-10
ACTH O 0 7.726591633172575e-08
) O 0 1.2071947608216504e-11
, O 0 2.813356318742688e-11
melanocyte O 0 5.047073159403226e-08
- O 0 7.410945102037658e-08
stimulating O 0 1.0802927441488919e-08
hormones O 0 7.065849572107652e-10
( O 0 3.148134964520155e-12
MSH O 0 5.527570845487162e-09
) O 0 1.3787483524665967e-12
alpha O 0 1.8234616941392723e-11
, O 0 3.696101855566597e-13
beta O 0 9.281699020480261e-11
and O 0 1.328877199252565e-11
gamma O 0 1.0065206446085995e-09
as O 0 1.3514345025000818e-11
well O 0 2.7882631099818145e-12
as O 0 9.366275116606815e-12
the O 0 2.476634348991258e-11
opioid O 0 5.068387376461203e-10
- O 0 2.4078980476183176e-10
receptor O 0 9.727174621332324e-11
ligand O 0 4.88302287493525e-10
beta O 0 5.0413582641795074e-08
- O 0 9.934447930959323e-09
endorphin O 0 1.1877798300474751e-07
. O 0 1.0559074725691175e-09

While O 0 8.036817433776378e-09
a O 0 6.496738702566063e-10
few O 0 8.568661058472316e-11
cases O 0 3.4584632380152414e-10
of O 0 9.458673844164878e-09
isolated O 0 0.30336517095565796
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 9.082434360152547e-08
been O 0 8.217148739220193e-09
reported O 0 2.5668895897723587e-09
( O 0 2.0115635546158472e-10
OMIM O 0 9.303278716288332e-07
201400 O 0 1.3970405277063946e-08
) O 0 2.6179423212591146e-12
, O 0 5.2010101954380605e-12
an O 0 8.001420082059951e-10
inherited O 1 0.9999830722808838
POMC O 1 1.0
defect O 1 0.999998927116394
has O 0 2.452186365076159e-08
not O 0 3.330836273462978e-09
been O 0 1.3656556441254963e-10
described O 0 6.423019061063684e-11
so O 0 1.1813958665507496e-11
far O 0 8.208399238096575e-11
. O 0 1.3901420015116628e-09

Recent O 0 1.396684012888727e-07
studies O 0 1.087528067600374e-09
in O 0 1.7002043870006922e-11
animal O 0 2.7310405673053317e-11
models O 0 2.6252628543277368e-12
elucidated O 0 7.256281131517994e-10
a O 0 3.4764108258755755e-11
central O 0 1.013474970612549e-09
role O 0 3.8507105837304323e-10
of O 0 2.305029944693615e-09
alpha O 0 2.2506519314902107e-08
- O 0 1.529685000889458e-08
MSH O 0 9.782297638594173e-08
in O 0 2.532533904808787e-11
the O 0 4.627703428794483e-11
regulation O 0 4.1748451917733576e-11
of O 0 3.2350339854853027e-12
food O 0 1.4130714827420565e-12
intake O 0 6.015724891969207e-14
by O 0 1.451546639775949e-14
activation O 0 1.6120232926297717e-10
of O 0 2.4880426607865047e-09
the O 0 4.334150816021065e-08
brain O 0 4.689922570833005e-05
melanocortin O 0 1.6458041045552818e-06
- O 0 7.403711066444885e-08
4 O 0 4.982434376188394e-08
- O 0 2.2382831144085458e-09
receptor O 0 5.735594221789597e-10
( O 0 3.648947897311183e-12
MC4 O 0 3.8808714464266814e-08
- O 0 4.837681921721071e-10
R O 0 1.1397581489713815e-10
; O 0 1.8036438228369311e-12
refs O 0 6.851967604415421e-11
3 O 0 1.1363134044817258e-10
- O 0 1.6306699046619855e-11
5 O 0 4.180821661092793e-11
) O 0 1.0626042722865301e-14
and O 0 1.5534115335204268e-13
the O 0 1.0988531265465618e-11
linkage O 0 3.999695685763527e-09
of O 0 1.2678311733793635e-09
human O 0 3.4762702938451184e-08
obesity B-Disease 1 1.0
to O 0 2.982363156434076e-08
chromosome O 0 2.316133276281107e-07
2 O 0 1.541130529858492e-07
in O 0 1.1774708985612392e-10
close O 0 1.1942571376266642e-08
proximity O 0 6.626812432131146e-09
to O 0 3.29897664741452e-09
the O 0 6.069494240534823e-09
POMC O 0 5.985116331430618e-07
locus O 0 5.521259005547563e-09
, O 0 1.3180931172918076e-11
led O 0 3.0429426339795285e-12
to O 0 8.250504771566136e-13
the O 0 4.296197729167228e-13
proposal O 0 1.1500385713181238e-11
of O 0 1.0128825729538438e-11
an O 0 4.343062801753783e-12
association O 0 1.523975667883093e-10
of O 0 9.343414930640392e-09
POMC O 0 0.0011274607386440039
with O 0 7.187504480477003e-10
human O 0 7.993890176294371e-05
obesity B-Disease 1 1.0
. O 0 2.295732173251963e-07

The O 0 4.125274344346508e-09
dual O 0 1.1131848332013305e-08
role O 0 1.5658679686225696e-08
of O 0 1.1453069248545944e-07
alpha O 0 1.7526742794871097e-06
- O 0 8.326779266099038e-07
MSH O 0 5.384406449593371e-06
in O 0 1.3787189168112945e-09
regulating O 0 1.902242141582633e-09
food O 0 1.102809440989283e-10
intake O 0 1.3860236743046261e-11
and O 0 2.610353339732585e-12
influencing O 0 1.811076444369064e-08
hair O 0 2.3134673483582446e-06
pigmentation O 0 5.2998075261712074e-06
predicts O 0 8.68672334064513e-09
that O 0 5.043165537954586e-12
the O 0 8.439259707726521e-11
phenotype O 0 1.0822018836620373e-09
associated O 0 1.1574020908344806e-10
with O 0 1.7012999082438585e-12
a O 0 3.0096303227367116e-09
defect O 0 6.891809221087897e-07
in O 0 3.7164897825903154e-09
POMC O 0 3.0108030841802247e-06
function O 0 1.7308848798691656e-09
would O 0 3.713886975731384e-10
include O 0 2.7210704800495478e-09
obesity B-Disease 1 1.0
, O 0 8.801797624080621e-10
alteration O 0 2.807962346196291e-06
in O 0 3.1365021868623444e-07
pigmentation O 1 0.9790925979614258
and O 0 0.00012478847929742187
ACTH B-Disease 1 0.9999969005584717
deficiency I-Disease 1 0.9999157190322876
. O 0 1.3890185073250905e-06

The O 0 6.408001240743033e-08
observation O 0 8.735673304727243e-07
of O 0 2.5735186426345535e-08
these O 0 1.1527013787926421e-09
symptoms O 0 1.425406708221999e-06
in O 0 5.284673254557504e-10
two O 0 2.3278799721193622e-10
probands O 0 9.158664227015834e-08
prompted O 0 1.6816485981507867e-09
us O 0 1.2643773528164814e-10
to O 0 5.764592136969782e-10
search O 0 1.0472063494137984e-10
for O 0 8.813228792592387e-12
mutations O 0 2.522830000462051e-10
within O 0 1.3048991887032457e-09
their O 0 2.4491608741072923e-09
POMC O 0 1.789469570212532e-05
genes O 0 3.51157005695768e-08
. O 0 9.884322693665126e-09

Patient O 0 0.0002182087628170848
1 O 0 1.0628482414176688e-05
was O 0 2.9356328923313413e-08
found O 0 1.7460964965576586e-11
to O 0 3.396119496734684e-11
be O 0 8.363875564354473e-12
a O 0 4.9541686725218526e-11
compound O 0 3.283864014047566e-10
heterozygote O 0 9.143168860914486e-11
for O 0 4.2600844726847775e-12
two O 0 4.240435780289431e-11
mutations O 0 1.3931221454210885e-10
in O 0 3.1107846854006027e-10
exon O 0 3.3234366370038515e-09
3 O 0 3.6318402862889343e-07
( O 0 2.9948779567412487e-10
G7013T O 0 9.742094562170678e-07
, O 0 2.189887993164774e-10
C7133delta O 0 1.2434473006806002e-08
) O 0 7.383724165942185e-13
which O 0 5.998346892972795e-13
interfere O 0 1.6799990218419047e-11
with O 0 9.10299396625347e-14
appropriate O 0 2.6937660435599753e-11
synthesis O 0 1.6099675759218002e-10
of O 0 8.173221544005571e-10
ACTH O 0 7.754525199743512e-08
and O 0 3.160581574235266e-09
alpha O 0 1.5471371739295137e-07
- O 0 1.091344188353105e-07
MSH O 0 4.712323971034493e-06
. O 0 4.0185219596367006e-09

Patient O 0 2.52654317591805e-05
2 O 0 4.605011270086834e-07
was O 0 5.50903545004644e-09
homozygous O 0 1.1389012996576575e-11
for O 0 2.843202236146869e-12
a O 0 1.0475599554471415e-10
mutation O 0 3.065571962945768e-10
in O 0 4.6069567605222517e-10
exon O 0 1.4835749517772001e-08
2 O 0 7.93387471276219e-07
( O 0 4.917286577921232e-10
C3804A O 0 1.0147132343263365e-06
) O 0 1.7215128628178533e-11
which O 0 4.41772313175548e-11
abolishes O 0 4.492733012284589e-07
POMC O 0 2.7712869723472977e-06
translation O 0 4.8169518152008095e-08
. O 0 6.450024159221357e-08

These O 0 6.537061447708936e-10
findings O 0 2.9546282087622444e-10
represent O 0 4.906451980812854e-12
the O 0 1.1220016235546915e-11
first O 0 6.958566101805674e-12
examples O 0 4.620627665208321e-12
of O 0 9.328981337430875e-11
a O 0 3.66864902900943e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 4.131685926722639e-08
the O 0 5.075567965917571e-09
POMC O 0 2.0924917976117285e-07
gene O 0 2.1013791401403026e-11
and O 0 1.1537025675079082e-12
define O 0 8.723441413671651e-11
a O 0 6.851733069801469e-11
new O 0 1.7704384625005787e-09
monogenic B-Disease 1 0.9999997615814209
endocrine I-Disease 1 1.0
disorder I-Disease 0 0.2113591879606247
resulting O 0 7.963539272459741e-10
in O 0 6.785767781014584e-11
early O 0 0.00044461997458711267
- O 0 0.13891281187534332
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 1.4299391750682844e-06
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 4.4894480311086227e-07
red O 0 4.1222767777071567e-07
hair O 0 5.141038855072111e-06
pigmentation O 0 3.039271177840419e-06
. O 0 1.5921902019044865e-08
. O 0 5.3281080880651643e-08

A O 0 3.6797359825868625e-07
European O 0 4.429761801816312e-08
multicenter O 0 6.745605787727982e-06
study O 0 3.3300501911526226e-08
of O 0 9.439084465157066e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 5.289523818952091e-10
classification O 0 5.3902229346647346e-09
of O 0 1.380290459707112e-08
105 O 0 3.1419506996144264e-08
mutations O 0 2.2989433967612882e-10
and O 0 1.0705603070704228e-11
a O 0 1.600061194650948e-10
general O 0 1.6768146593459932e-10
system O 0 8.70777755457297e-12
for O 0 1.2974198538434623e-12
genotype O 0 4.299007261288068e-10
- O 0 1.6522133661212024e-10
based O 0 5.323742141571941e-11
prediction O 0 2.181910119247732e-08
of O 0 3.806452930632531e-09
metabolic O 0 3.843520062218886e-06
phenotype O 0 4.948850005348504e-07
. O 0 3.07513232655765e-08

Phenylketonuria B-Disease 1 0.9830527305603027
( O 0 1.1636036845175113e-07
PKU B-Disease 0 8.003059338079765e-05
) O 0 1.6054292617528887e-10
and O 0 2.425432632513491e-10
mild B-Disease 1 1.0
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.00011660692689474672
MHP B-Disease 1 1.0
) O 0 3.1224056673551104e-10
are O 0 1.754965339717529e-10
allelic B-Disease 0 1.4759517398488242e-05
disorders I-Disease 0 1.6729447452235036e-05
caused O 0 1.1176035208393387e-08
by O 0 5.8131489205637266e-11
mutations O 0 1.1745572570109886e-10
in O 0 6.587210638064889e-11
the O 0 4.977034340214459e-10
gene O 0 8.216278352124462e-11
encoding O 0 2.054539871565453e-09
phenylalanine O 0 3.5988209674542304e-06
hydroxylase O 0 6.4043379097711295e-06
( O 0 4.654583385388378e-09
PAH O 0 9.90718149296299e-07
) O 0 1.6644162437184917e-10
. O 0 2.1529793503560768e-09

Previous O 0 7.745743459963705e-07
studies O 0 1.3050559521943228e-09
have O 0 5.2342197416621605e-12
suggested O 0 2.3727238923632044e-11
that O 0 8.434230961210099e-13
the O 0 5.2785735851768045e-12
highly O 0 3.6234067829488126e-11
variable O 0 4.1453193944107625e-07
metabolic O 1 0.9671632051467896
phenotypes O 0 5.340977440937422e-05
of O 0 0.00044689225615002215
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
correlate O 0 3.6406661365617765e-06
with O 0 1.4693900318718534e-08
PAH O 0 0.004590729717165232
genotypes O 0 6.19646925770212e-06
. O 0 5.968995964167334e-08

We O 0 1.0005018680203648e-07
identified O 0 1.5934896735458892e-09
both O 0 6.980317018845383e-11
causative O 0 2.5764395061855794e-09
mutations O 0 5.442483130835285e-10
in O 0 1.20954163351783e-10
686 O 0 3.545300231166948e-08
patients O 0 2.2797305709865157e-10
from O 0 2.382497810149431e-10
seven O 0 5.384650503259536e-10
European O 0 1.185166076389521e-09
centers O 0 9.133396261518101e-10
. O 0 2.6665323282770714e-09

On O 0 4.413056160501583e-07
the O 0 7.103158061738668e-10
basis O 0 3.370626222576334e-09
of O 0 4.7058180269177186e-11
the O 0 2.0954836824071954e-11
phenotypic O 0 1.736887411674104e-09
characteristics O 0 6.149030173929759e-10
of O 0 1.025018736555694e-09
297 O 0 3.2244309444706687e-09
functionally O 0 6.903242422140465e-08
hemizygous O 0 1.8781189510264085e-06
patients O 0 1.1586571702082438e-09
, O 0 1.4895780789392354e-11
105 O 0 2.1855242060553337e-09
of O 0 2.3484614253277414e-10
the O 0 1.5294938926491142e-10
mutations O 0 1.3440646165485681e-11
were O 0 9.624522533113744e-12
assigned O 0 7.59772453284846e-12
to O 0 6.197262755053279e-12
one O 0 3.068101762232489e-12
of O 0 9.558224871308862e-12
four O 0 7.617342520638282e-12
arbitrary O 0 1.106780000981189e-09
phenotype O 0 1.415769901313979e-07
categories O 0 2.9788894906346286e-08
. O 0 1.1419352574648656e-08

We O 0 2.9558032466070472e-08
proposed O 0 1.3016560274081712e-08
and O 0 2.9627653108654783e-10
tested O 0 5.5873059651156964e-11
a O 0 4.673952631178979e-12
simple O 0 1.0957633455113691e-12
model O 0 9.465079544787591e-13
for O 0 3.276263808860147e-13
correlation O 0 1.4162912162496433e-11
between O 0 5.546649251009228e-11
genotype O 0 4.542564546738959e-09
and O 0 1.511271108256551e-10
phenotypic O 0 5.8847451356314195e-08
outcome O 0 7.141813398447994e-07
. O 0 9.723589045051995e-08

The O 0 9.868691108749772e-08
observed O 0 1.5002786568629745e-08
phenotype O 0 6.108749506239519e-09
matched O 0 6.03503302887276e-10
the O 0 4.1573419706786297e-10
predicted O 0 9.04510688570781e-09
phenotype O 0 3.8304195926208706e-10
in O 0 6.277485475880695e-11
79 O 0 2.5063182640394643e-09
% O 0 9.046046550720277e-11
of O 0 1.3542135295085966e-11
the O 0 1.7188125922551478e-11
cases O 0 1.3373494152368881e-11
, O 0 3.154114990022716e-12
and O 0 2.3253926995786545e-12
in O 0 1.9319785354854346e-11
only O 0 6.763103965745643e-11
5 O 0 4.8417274634005025e-09
of O 0 1.7690704456896356e-10
184 O 0 6.246708705859305e-10
patients O 0 9.217094448787932e-11
was O 0 6.376976724453698e-10
the O 0 6.354269888042552e-11
observed O 0 1.1989347015184393e-10
phenotype O 0 6.459432988492608e-11
more O 0 7.741718507578432e-14
than O 0 1.071270567913618e-12
one O 0 5.008321014854378e-12
category O 0 2.2405115263079978e-10
away O 0 1.241041158728251e-10
from O 0 1.2177819516678845e-11
that O 0 1.6287053303254417e-11
expected O 0 3.935435444191171e-08
. O 0 5.738357700124652e-08

Among O 0 1.6420166337738351e-09
the O 0 2.1963339480457478e-10
seven O 0 4.9920914624301815e-11
contributing O 0 7.945461996672343e-12
centers O 0 3.1182307170390944e-12
, O 0 3.599562596774686e-13
the O 0 2.1599323024590333e-11
proportion O 0 4.542178785871265e-11
of O 0 3.273475240872514e-11
patients O 0 7.240871964520057e-12
for O 0 7.239076525722421e-12
whom O 0 6.132058749663827e-10
the O 0 1.2267094007256674e-09
observed O 0 5.427638338773022e-10
phenotype O 0 1.1314910119963884e-09
did O 0 2.109355329293905e-10
not O 0 1.0258473931434864e-10
match O 0 9.49105349867807e-10
the O 0 1.3452296221405646e-10
predicted O 0 3.5914431428807347e-09
phenotype O 0 6.389029860720541e-10
was O 0 9.047069204903835e-10
4 O 0 1.769125290707052e-09
% O 0 1.1410349748386395e-10
- O 0 9.476238682637472e-10
23 O 0 1.1825609824711592e-08
% O 0 4.0625788844117494e-10
( O 0 6.794626666861703e-11
P O 0 8.410410146098002e-07
< O 0 5.966958127601174e-08
. O 0 2.3332630272321353e-10
0001 O 0 5.0254406858130096e-08
) O 0 7.554543470823794e-13
, O 0 9.67860340483906e-13
suggesting O 0 1.7306883356993374e-11
that O 0 2.049312108898249e-12
differences O 0 5.919510021046293e-11
in O 0 2.0352740326412544e-11
methods O 0 1.516717446081728e-10
used O 0 3.729905707211545e-12
for O 0 1.1898624446837758e-11
mutation O 0 3.275950066772282e-10
detection O 0 3.2192566390421007e-09
or O 0 6.912854177976158e-10
phenotype O 0 1.0345831213953716e-07
classification O 0 6.644405026179356e-09
may O 0 1.9166961073846522e-10
account O 0 1.126381756963446e-12
for O 0 9.16865650242571e-13
a O 0 3.525839342710668e-11
considerable O 0 8.742463003530432e-11
proportion O 0 4.643636516976635e-11
of O 0 8.685786812012708e-11
genotype O 0 1.6747745235079492e-07
- O 0 4.190418621874414e-06
phenotype O 0 1.5386060567834647e-06
inconsistencies O 0 1.7620079972857638e-07
. O 0 2.4335905735028973e-08

Our O 0 2.802042899929802e-07
data O 0 3.056932040834681e-09
indicate O 0 1.3717050828532251e-09
that O 0 2.071493324096174e-11
the O 0 4.921114626910139e-10
PAH O 0 1.0888159351907234e-07
- O 0 8.698195941292397e-09
mutation O 0 4.7982843393024055e-11
genotype O 0 1.0489795837509419e-10
is O 0 1.701337909530004e-13
the O 0 4.409821845793166e-13
main O 0 9.781947474252206e-11
determinant O 0 5.693394200534385e-09
of O 0 5.021028037788255e-10
metabolic O 0 3.769247996388003e-05
phenotype O 0 2.213621854707526e-07
in O 0 8.210689350640621e-10
most O 0 2.872377613538646e-10
patients O 0 1.0266940186909324e-08
with O 0 3.423270200642037e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.3401693397318013e-05

In O 0 4.388166718882758e-09
the O 0 1.1385941078856376e-09
present O 0 1.3393668119032753e-10
study O 0 3.0420565372279995e-11
, O 0 1.1515458725464e-12
the O 0 2.3644563737490465e-11
classification O 0 2.9805418133577177e-09
of O 0 5.272010827894746e-09
105 O 0 9.257416309083055e-07
PAH O 0 6.0494144236145075e-06
mutations O 0 8.119619643309761e-09
may O 0 1.4195785658088766e-09
allow O 0 1.5651080431666742e-10
the O 0 6.886202025269128e-11
prediction O 0 2.493805828507334e-09
of O 0 6.646641570462464e-11
the O 0 3.019781993907067e-11
biochemical O 0 5.863571433950554e-11
phenotype O 0 4.1433775854748944e-10
in O 0 1.68907332565027e-10
> O 0 2.5178042761808683e-08
10 O 0 1.8683772751160177e-08
, O 0 1.7065081292511053e-10
000 O 0 1.499594115550451e-09
genotypes O 0 2.423648615135221e-09
, O 0 3.4731946051830276e-12
which O 0 3.4162252020297768e-12
may O 0 3.991394437186102e-10
be O 0 1.4467146230989769e-11
useful O 0 3.671539634819698e-12
for O 0 2.015217420020532e-12
the O 0 2.3168491430913818e-11
management O 0 8.684030577965629e-11
of O 0 2.4207505444628907e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 1.6366463739814208e-07
newborns O 0 1.3587387570623832e-07
. O 0 1.1203802330328472e-08

Somatic O 0 0.00017895510245580226
instability O 0 0.012121597304940224
of O 0 1.2010220416414086e-05
the O 0 2.3643485747015802e-06
CTG O 0 0.000838587642647326
repeat O 0 5.536616072276956e-07
in O 0 2.510121666077225e-09
mice O 0 5.371223465999719e-10
transgenic O 0 3.776416332423871e-11
for O 0 3.546503368756504e-12
the O 0 4.81887019176952e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 4.08361192967277e-05
is O 0 2.537913434963457e-09
age O 0 9.733587269522559e-09
dependent O 0 2.4239663054537175e-10
but O 0 2.2482402224632825e-12
not O 0 7.1416501185028736e-12
correlated O 0 3.090787001336359e-11
to O 0 1.0169153019656818e-10
the O 0 2.5869661968158653e-10
relative O 0 9.420737967502646e-09
intertissue O 0 2.214504490893887e-07
transcription O 0 1.4765006106642886e-08
levels O 0 6.1644636062396785e-09
and O 0 6.538171670733561e-10
proliferative O 0 2.1028088667662814e-05
capacities O 0 3.4678407700994285e-07
. O 0 7.535594193086581e-08

A O 0 0.0003918984439224005
( O 0 1.2172165497759124e-07
CTG O 0 1.3048015716776717e-05
) O 0 1.1677930844555817e-10
nexpansion O 0 9.860074356993209e-08
in O 0 3.819211960576219e-11
the O 0 4.316549617744414e-10
3 O 0 3.043431036076072e-07
- O 0 1.6575343408931076e-07
untranslated O 0 8.002013782970607e-05
region O 0 1.1066121174962973e-07
( O 0 1.7889680015148457e-10
UTR O 0 1.4752585002497653e-06
) O 0 6.524387367173867e-12
of O 0 2.074522914563559e-10
the O 0 1.0807977623983334e-08
DM O 1 1.0
protein O 0 4.940455937685329e-07
kinase O 0 6.553634079864423e-08
gene O 0 9.91516660442393e-11
( O 0 1.1354607575356224e-12
DMPK O 0 2.5489470090178656e-07
) O 0 1.151347626179161e-13
is O 0 6.301696767489415e-14
responsible O 0 5.353013171616183e-12
for O 0 2.1942517247630633e-11
causing O 1 0.9990276098251343
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.7724235590321769e-07
DM B-Disease 1 1.0
) O 0 1.231978186133631e-09
. O 0 6.4065073246410975e-09

Major O 0 0.0031097251921892166
instability O 1 0.9999877214431763
, O 0 8.751314339860983e-09
with O 0 3.113780761010432e-11
very O 0 2.2181412262511913e-10
large O 0 8.85064729838625e-11
expansions O 0 2.685374700384102e-10
between O 0 7.730269757644237e-10
generations O 0 7.49704812119667e-11
and O 0 1.7305266594713764e-11
high O 0 1.3714958058130833e-09
levels O 0 4.3688563877708475e-10
of O 0 1.6669642055600065e-10
somatic O 0 5.6302237538830013e-08
mosaicism O 0 1.042087660607649e-06
, O 0 4.791343016785632e-11
is O 0 3.574443518949977e-11
observed O 0 8.324828049133259e-10
in O 0 1.6271660407962685e-10
patients O 0 7.791953748892411e-10
. O 0 7.862663409241577e-09

There O 0 1.1549223799534047e-08
is O 0 1.352394446429983e-10
a O 0 2.645290375635767e-10
good O 0 1.6480557196718593e-10
correlation O 0 3.8306680050226305e-10
between O 0 4.719968860200652e-10
repeat O 0 3.1785667431449838e-09
size O 0 7.068612917215944e-10
( O 0 5.4138225152877695e-11
at O 0 1.5171839340410997e-09
least O 0 3.39389211179153e-11
in O 0 1.3510866037069746e-11
leucocytes O 0 5.59190649340735e-09
) O 0 1.5015209128138585e-12
, O 0 9.719227376039918e-13
clinical O 0 8.216999303201078e-11
severity O 0 1.4579905061040677e-09
and O 0 6.43294575594644e-12
age O 0 4.163994038464125e-09
of O 0 3.5086020755414893e-09
onset O 0 5.362473166314885e-05
. O 0 4.668527253670618e-08

The O 0 3.3070235076593235e-05
trinucleotide O 1 0.8863510489463806
repeat O 0 8.495549991494045e-06
instability O 0 2.0882367607555352e-05
mechanisms O 0 2.151465992028534e-07
involved O 0 1.0646703518801814e-09
in O 0 5.664981372888178e-09
DM B-Disease 1 1.0
and O 0 2.4256939568090274e-08
other O 0 5.604720243468364e-09
human O 0 5.231892373558367e-06
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 7.983210446871336e-12
unknown O 0 1.4598882103200594e-09
. O 0 5.599737895600754e-10

We O 0 2.2568467272776616e-07
studied O 0 1.1265477439792448e-07
somatic O 0 7.020402676971571e-07
instability O 0 1.6636758459753764e-07
by O 0 3.3282054889838264e-10
measuring O 0 6.625139690186188e-07
the O 0 9.757342489535858e-09
CTG O 0 2.262678435727139e-07
repeat O 0 9.500255027106164e-10
length O 0 7.70303681951745e-11
at O 0 1.6624672125042927e-11
several O 0 1.9277362638039225e-13
ages O 0 4.7059349472799994e-11
in O 0 5.7128351528545895e-12
various O 0 1.9860576724872736e-11
tissues O 0 4.652329188559179e-09
of O 0 1.644038682968585e-08
transgenic O 0 1.4045991925115686e-08
mice O 0 7.036463633980361e-10
carrying O 0 4.0871913492557255e-11
a O 0 8.285526709173041e-10
( O 0 1.8211347985186421e-09
CTG O 0 9.79914830168127e-07
) O 0 8.967402514992173e-11
55expansion O 0 2.7438471050800217e-08
surrounded O 0 2.7658800597074595e-11
by O 0 1.721666320793347e-12
45 O 0 1.4735008768695934e-09
kb O 0 1.2429397955315835e-08
of O 0 5.34787492068034e-10
the O 0 4.040287215900662e-09
human O 0 2.8125029416514735e-07
DM B-Disease 1 1.0
region O 0 1.9768067431868985e-06
, O 0 4.097119518653436e-11
using O 0 2.2147200740008088e-11
small O 0 2.1365086089186747e-10
- O 0 1.4100366430014333e-09
pool O 0 6.438141686437859e-11
PCR O 0 1.4007992543696446e-09
. O 0 8.656318994937351e-10

These O 0 6.387756457115756e-07
mice O 0 2.7798893853514528e-08
have O 0 5.821870069366852e-11
been O 0 9.633172731726702e-12
shown O 0 4.228445664358066e-13
to O 0 8.429185301139785e-12
reproduce O 0 2.5087739177753754e-11
the O 0 9.484570073770016e-11
intergenerational O 0 2.1548525186432244e-09
and O 0 4.82092699094494e-10
somatic O 0 2.3446539216820383e-06
instability O 0 0.0001312580134253949
of O 0 4.2982577497241437e-07
the O 0 1.2923007375320594e-07
55 O 0 7.263280394909088e-07
CTG O 0 1.593200863680977e-06
repeat O 0 7.202040741560722e-09
suggesting O 0 1.1240586239580352e-10
that O 0 2.8120457351565875e-12
surrounding O 0 2.3585423544747464e-11
sequences O 0 2.2923555414999797e-12
and O 0 1.1928886697876173e-12
the O 0 1.890668697990261e-11
chromatin O 0 1.9079786361952955e-10
environment O 0 1.2955714279172525e-10
are O 0 1.0195594368767047e-12
involved O 0 2.4746416721344033e-11
in O 0 2.467036575026782e-10
instability O 0 1.5562559383397456e-06
mechanisms O 0 5.186755629438267e-07
. O 0 2.8304816268587274e-08

As O 0 2.02711820662671e-08
observed O 0 1.3134993093188996e-09
in O 0 6.4663209682624956e-12
some O 0 1.6266928125688307e-12
of O 0 5.826958360266588e-11
the O 0 4.561600402963606e-11
tissues O 0 1.7661844209371225e-10
of O 0 7.634779919385437e-09
DM B-Disease 1 1.0
patients O 0 1.5033556621801836e-07
, O 0 1.959089314385043e-11
there O 0 1.2277732650001205e-11
is O 0 7.2526485685175945e-12
a O 0 1.4258626224172843e-10
tendency O 0 2.1591425869438297e-10
for O 0 1.2064443194459429e-11
repeat O 0 8.175996546455622e-10
length O 0 1.1123798548950958e-09
and O 0 5.463148822215658e-10
somatic O 0 8.328408540592136e-08
mosaicism O 0 1.6141208902809012e-07
to O 0 1.382526038096188e-10
increase O 0 1.9595417302675777e-11
with O 0 1.542917134117125e-13
the O 0 3.587851890585192e-11
age O 0 1.1259130294760666e-09
of O 0 1.0874487421652645e-10
the O 0 1.6280880810182197e-10
mouse O 0 1.6516983336600788e-08
. O 0 3.7804291252996336e-08

Furthermore O 0 2.5589184815544286e-07
, O 0 2.1629562585445683e-09
we O 0 1.3771157547637358e-09
observed O 0 7.134795532159899e-10
no O 0 4.098760914006405e-11
correlation O 0 5.905401861960868e-11
between O 0 1.5286598376018645e-10
the O 0 1.1413795464321197e-09
somatic O 0 5.3396352228674004e-08
mutation O 0 4.0005673440646206e-08
rate O 0 3.966014006095975e-08
and O 0 1.0517067217108433e-09
tissue O 0 2.860176380181656e-07
proliferation O 0 1.1351294233463705e-05
capacity O 0 8.507084459097314e-08
. O 0 5.7911130113552645e-08

The O 0 1.5953507954691304e-06
somatic O 0 1.6420320889665163e-06
mutation O 0 7.538297097653412e-08
rates O 0 3.2453535414589396e-09
in O 0 1.0966964315850536e-11
different O 0 1.915744039099332e-12
tissues O 0 7.602773272052943e-11
were O 0 2.214061226024633e-11
also O 0 4.940019747434743e-13
not O 0 7.344269506784351e-13
correlated O 0 3.784223368691331e-12
to O 0 5.435654357177633e-11
the O 0 2.3496263268363293e-10
relative O 0 1.3036877533068036e-07
inter O 0 3.62300306733232e-05
- O 0 7.42294048450276e-07
tissue O 0 2.8162112641894055e-08
difference O 0 2.7258323376244675e-10
in O 0 5.369988741871223e-12
transcriptional O 0 4.8218259246501916e-11
levels O 0 2.7116279707750657e-11
of O 0 1.708115094679885e-12
the O 0 4.288242504146833e-12
three O 0 5.268977094907701e-12
genes O 0 4.085474580167725e-12
( O 0 1.5962309599104607e-12
DMAHP O 0 1.0516749853195506e-06
, O 0 1.745950745091207e-10
DMPK O 0 4.230233571433928e-06
and O 0 4.1894127056352204e-10
59 O 0 8.651668714776406e-09
) O 0 3.70812885605587e-12
surrounding O 0 1.0140951273163168e-10
the O 0 2.7361879428866587e-10
repeat O 0 3.0484135216113373e-09
. O 0 4.1196265843090885e-10
. O 0 6.552169473650338e-09

A O 0 4.488805416258401e-07
novel O 0 4.4953942790471046e-08
missense O 0 3.528849902068032e-06
mutation O 0 3.9567353837810515e-08
in O 0 1.5627632521386658e-10
patients O 0 2.4967219958149656e-10
from O 0 1.3921686026208135e-10
a O 0 1.8613265373446097e-09
retinoblastoma B-Disease 0 8.35561968415277e-06
pedigree O 0 1.1105763420005133e-08
showing O 0 1.4865192410340455e-10
only O 0 4.6264148761965274e-11
mild O 0 3.5623961025521567e-07
expression O 0 3.550542748698149e-09
of O 0 9.617013851936917e-09
the O 0 3.300694606522825e-09
tumor B-Disease 0 2.59392635371114e-07
phenotype O 0 7.693562764643502e-08
. O 0 1.0619592316629678e-08

We O 0 3.109144586233015e-08
have O 0 1.3538468089657751e-11
used O 0 3.860509568270887e-12
single O 0 5.351451486806935e-12
strand O 0 2.6320376433908166e-11
conformation O 0 2.5396977923475283e-11
polymorphism O 0 1.963908202728959e-11
analysis O 0 2.342205422667387e-12
to O 0 3.431606734882742e-11
study O 0 1.3604424010937866e-11
the O 0 2.4750004129492353e-11
27 O 0 8.512436977525795e-09
exons O 0 8.15279754817766e-09
of O 0 1.952450284781193e-10
the O 0 1.5764116401140171e-10
RB1 O 0 4.380559559535868e-08
gene O 0 2.19531380921123e-12
in O 0 5.0464537063033e-13
individuals O 0 2.83958051299979e-13
from O 0 6.923922546420158e-11
a O 0 6.254604389965834e-09
family O 0 7.787764322308988e-10
showing O 0 2.293219364402077e-10
mild O 0 7.294489137166238e-07
expression O 0 5.438667738388858e-09
of O 0 3.4209268306995e-08
the O 0 3.0448048526920957e-09
retinoblastoma B-Disease 0 3.5811098086924176e-07
phenotype O 0 4.445861350177438e-07
. O 0 2.087480410750686e-08

In O 0 2.8525766193610025e-09
this O 0 1.3729502257309179e-10
family O 0 1.628382324814215e-11
affected O 0 6.232326286992329e-12
individuals O 0 8.138752258940452e-13
developed O 0 9.141923662525642e-09
unilateral B-Disease 1 1.0
tumors I-Disease 1 1.0
and O 0 1.2789654668665662e-08
, O 0 2.2874866931199556e-11
as O 0 4.348483812616211e-12
a O 0 2.315055785961917e-11
result O 0 1.9879460577687524e-10
of O 0 1.5636346661906941e-09
linkage O 0 8.945510110436317e-09
analysis O 0 7.421079861735791e-10
, O 0 8.055241196291973e-11
unaffected O 0 1.7177229638676295e-09
mutation O 0 2.909546215068559e-11
carriers O 0 9.281832030402781e-13
were O 0 7.779393990971217e-13
also O 0 3.354790132758384e-13
identified O 0 1.0885355117284945e-11
within O 0 1.653972792059477e-10
the O 0 5.535174540938215e-10
pedigree O 0 1.87964364073423e-08
. O 0 1.7428050114176585e-08

A O 0 1.5449904822162353e-06
single O 0 2.3471786292361685e-08
band O 0 8.533700857071835e-09
shift O 0 9.445562110244055e-10
using O 0 4.78317038754561e-11
SSCP O 0 1.05234794318676e-05
was O 0 1.071501642968542e-08
identified O 0 8.546820889909768e-11
in O 0 2.3373554827732512e-11
exon O 0 1.7703025156912133e-10
21 O 0 4.897536820536175e-10
which O 0 1.0142004423785433e-12
resulted O 0 7.328535001072112e-11
in O 0 3.400793188723661e-11
a O 0 4.804516784417956e-09
missense O 0 5.129252258484485e-07
mutation O 0 1.6295871319016442e-08
converting O 0 1.1112098796672853e-08
a O 0 6.716677436457985e-09
cys O 0 1.6578110262344126e-07
- O 0 4.371269568537173e-08
- O 0 3.8561900339573185e-08
> O 0 1.1377914610477546e-08
arg O 0 6.209918135269277e-10
at O 0 2.2606654048740182e-10
nucleotide O 0 2.3760840517361714e-11
position O 0 7.460075612808481e-11
28 O 0 2.885303385102844e-10
in O 0 1.3316731398149706e-11
the O 0 4.3750436606870835e-10
exon O 0 7.749362040954111e-09
. O 0 2.661691134164812e-08

The O 0 3.2057175758382073e-07
mutation O 0 3.4714929597612354e-08
destroyed O 0 3.539645021533033e-08
an O 0 4.908347617238462e-10
NdeI O 0 2.738363491516793e-07
restriction O 0 4.66829561673876e-08
enzyme O 0 6.528654505899567e-09
site O 0 1.3210398996932327e-08
. O 0 6.806488705990432e-09

Analysis O 0 1.0452692045248568e-09
of O 0 2.5028501493551403e-09
all O 0 5.355037593912648e-11
family O 0 1.38905406274481e-11
members O 0 3.0786690471268363e-13
demonstrated O 0 1.2702352190918642e-12
that O 0 2.8793245999275685e-12
the O 0 2.3241089608383447e-10
missense O 0 1.0933818117564442e-07
mutation O 0 3.5186094038408555e-08
co O 0 2.214181726856168e-09
- O 0 1.6232711175234726e-08
segregated O 0 1.384975328866389e-10
with O 0 1.1193292386718623e-12
patients O 0 3.210229304606571e-10
with O 0 7.011116687216656e-10
tumors B-Disease 1 1.0
or O 1 0.9999030828475952
who O 0 7.505457233492052e-08
, O 0 6.827151691202182e-12
as O 0 4.459032535569785e-12
a O 0 2.609548341303558e-11
result O 0 3.529770919996622e-10
of O 0 3.7176171030495198e-09
linkage O 0 3.109931867584237e-09
analysis O 0 8.654205685409977e-10
had O 0 1.8718255834215825e-09
been O 0 6.763748588989316e-11
predicted O 0 4.771582573503963e-10
to O 0 5.036333503016799e-11
carry O 0 3.7923900131353605e-11
the O 0 1.1965838042637955e-10
predisposing O 0 2.6827510879456895e-08
mutation O 0 1.6474130504207096e-08
. O 0 2.1920799397889823e-08

These O 0 3.4382729996451644e-09
observations O 0 1.450026410054761e-08
point O 0 3.97590360634581e-09
to O 0 3.1186605381483545e-11
another O 0 3.282371943691409e-11
region O 0 3.59821061834964e-09
of O 0 1.4693473104898658e-09
the O 0 6.100063565384062e-09
RB1 O 0 2.737757540671737e-07
gene O 0 2.758158423876722e-10
where O 0 2.840386814639828e-10
mutations O 0 2.798858367292212e-10
only O 0 4.3676541550130565e-11
modify O 0 7.045676819750213e-10
the O 0 2.6020000043480707e-10
function O 0 3.954453153820481e-10
of O 0 5.505829125951323e-10
the O 0 3.7524441887093474e-10
gene O 0 2.5930362024251252e-11
and O 0 1.6066660155078516e-11
raise O 0 5.353804621854863e-10
important O 0 5.997129182144789e-11
questions O 0 2.6357011018163234e-10
for O 0 1.9246310101195263e-10
genetic O 0 5.903392441553024e-09
counseling O 0 6.48005329950685e-11
in O 0 3.416588301337342e-13
families O 0 3.5786288212283357e-13
with O 0 7.288280086869756e-14
these O 0 1.572080356518346e-12
distinctive O 0 2.407915360158608e-11
phenotypes O 0 9.00128527270283e-10
. O 0 5.831808924661175e-10
. O 0 5.431648908427178e-09

Maternal B-Disease 0 5.243650957709178e-05
disomy I-Disease 0 0.00038351109833456576
and O 0 1.4112278222455643e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 9.88037527349661e-07
with O 0 9.198790167086468e-12
gamete O 0 2.43758115914261e-08
complementation O 0 7.173541405336437e-08
in O 0 1.805479377114949e-11
a O 0 1.0683802453836933e-10
case O 0 2.108214047780166e-09
of O 0 4.1197547595572814e-09
familial O 0 1.0289137009067417e-07
translocation O 0 1.1033744158339687e-06
( O 0 8.033469028889684e-11
3 O 0 7.82326026183e-09
; O 0 1.5483756637957313e-11
15 O 0 5.637893263354954e-09
) O 0 3.029790177425107e-12
( O 0 7.869898309420531e-12
p25 O 0 4.980075907212722e-09
; O 0 1.1901733938668446e-11
q11 O 0 5.4907747681909314e-08
. O 0 4.9847553168502756e-11
2 O 0 8.768624937260938e-09
) O 0 5.564122079748657e-11
. O 0 3.3580105363029134e-09

Maternal B-Disease 1 0.7084378600120544
uniparental I-Disease 1 0.9588102698326111
disomy I-Disease 0 0.17727920413017273
( I-Disease 0 1.5855418666888e-07
UPD I-Disease 1 0.9999998807907104
) I-Disease 0 5.4979243380159915e-11
for I-Disease 0 7.69955557644586e-11
chromosome I-Disease 0 4.6959266342128103e-07
15 I-Disease 0 3.1129662403373004e-08
is O 0 4.510071569679974e-12
responsible O 0 1.3796277488486997e-11
for O 0 1.268039709692581e-12
an O 0 3.0812733007451465e-12
estimated O 0 1.8762666767480063e-11
30 O 0 8.076609520069056e-11
% O 0 3.4694339415275444e-12
of O 0 4.900416552579279e-13
cases O 0 1.9253496366666845e-11
of O 0 5.0114845606685776e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.7261532409283973e-07
PWS B-Disease 1 1.0
) O 0 8.119367400638566e-10
. O 0 9.7402166332472e-09

We O 0 8.588570210577018e-08
report O 0 1.960619167018507e-10
on O 0 3.717267604841368e-10
an O 0 9.426668430220775e-13
unusual O 0 3.6467634467740595e-12
case O 0 1.4678086524000378e-10
of O 0 2.541283572465858e-10
maternal B-Disease 0 4.625239569122641e-08
disomy I-Disease 0 5.335885362001136e-06
15 I-Disease 0 1.2172168908364256e-06
in O 0 2.4815745902628805e-08
PWS B-Disease 1 1.0
that O 0 2.3769386459093766e-09
is O 0 6.276743014232977e-11
most O 0 1.635325555526812e-12
consistent O 0 7.587124505048504e-12
with O 0 1.2384499892617584e-13
adjacent O 0 6.411099984227064e-10
- O 0 1.0796953553438016e-08
1 O 0 4.240824637236074e-06
segregation O 0 2.4211674887197887e-09
of O 0 1.102989748147376e-11
a O 0 1.8629132958469796e-10
paternal O 0 2.4686395150297358e-08
t O 0 1.9409631679678796e-09
( O 0 1.840502923677878e-11
3 O 0 4.841293588242479e-09
; O 0 2.5962480429408963e-11
15 O 0 8.163098641489341e-09
) O 0 8.582723073913279e-12
( O 0 1.663250613626044e-11
p25 O 0 6.34018393341762e-09
; O 0 4.723882309626282e-12
q11 O 0 1.940730953720049e-08
. O 0 1.38297359675299e-11
2 O 0 2.5854518526102765e-10
) O 0 6.041171116957442e-14
with O 0 7.137013555017294e-14
simultaneous O 0 5.102199218676162e-10
maternal O 0 3.7186186574444946e-08
meiotic O 0 9.532625711017317e-08
nondisjunction O 0 1.786004588666401e-07
for O 0 1.4939756098897305e-09
chromosome O 0 1.2996548548471765e-06
15 O 0 2.0238499018887524e-06
. O 0 3.082437416424e-08

The O 0 1.9744094004181534e-07
patient O 0 7.678404045918796e-08
( O 0 7.31997101821591e-11
J O 0 5.286039694851752e-08
. O 0 8.630728076663985e-11
B O 0 3.976965423646561e-09
. O 0 1.911747019370247e-12
) O 0 3.7497411317470586e-13
, O 0 9.530767017609798e-13
a O 0 1.0353358448345062e-10
17 O 0 6.276866248988711e-10
- O 0 9.682674800837177e-11
year O 0 3.46859735378402e-10
- O 0 1.3558069111851978e-09
old O 0 1.0333239819360074e-09
white O 0 1.0837934716345643e-11
male O 0 6.111091450586303e-13
with O 0 1.9711601871152257e-13
PWS B-Disease 1 1.0
, O 0 2.0250767729379504e-09
was O 0 3.498947265256902e-08
found O 0 7.832510334759846e-11
to O 0 4.0151179603320486e-10
have O 0 6.232531851724232e-11
47 O 0 3.3997460402446222e-09
chromosomes O 0 8.327777356598176e-11
with O 0 9.720376630342753e-13
a O 0 1.7982537681149324e-09
supernumerary O 0 8.088405252237862e-07
, O 0 2.5966007122235624e-10
paternal O 0 1.154192830199463e-07
der O 0 2.392935357420356e-06
( O 0 2.7190340257110535e-11
15 O 0 1.4969849804202795e-09
) O 0 2.0543202555733941e-13
consisting O 0 1.9664699285170534e-13
of O 0 5.026696073273662e-12
the O 0 1.254290681734771e-11
short O 0 4.4969656470827957e-11
arm O 0 6.23418705547607e-10
and O 0 5.8648245981896e-11
the O 0 2.928685516323526e-09
proximal O 0 2.5145347990473965e-06
long O 0 9.289713887028483e-09
arm O 0 1.2571547358675161e-08
of O 0 4.882168891384708e-09
chromosome O 0 2.2899551765931392e-07
15 O 0 4.579487722367048e-07
, O 0 5.109988127083298e-11
and O 0 6.118915374386802e-10
distal O 0 4.606967559084296e-05
chromosome O 0 0.0008595915278419852
arm O 0 0.00038817673339508474
3p O 0 0.001523462706245482
. O 0 1.3621109928863007e-06

The O 0 4.744335058148863e-07
t O 0 8.283397079367205e-09
( O 0 6.421940063061626e-11
3 O 0 6.537601571210416e-09
; O 0 1.58007756184686e-11
15 O 0 1.2229038892641597e-09
) O 0 7.180628704486769e-13
was O 0 5.2369983349898064e-11
present O 0 1.1648533700114871e-12
in O 0 1.6780254486273294e-12
the O 0 4.646354048037926e-12
balanced O 0 1.4353412555734302e-11
state O 0 8.45448103886648e-12
in O 0 1.8681499056039108e-11
the O 0 2.5811258685948246e-10
patients O 0 1.5331508285143514e-10
father O 0 2.19633811138209e-10
and O 0 3.8661261692052307e-11
a O 0 1.5041351275613124e-08
sister O 0 1.4874403859721497e-06
. O 0 2.7636335175884597e-07

Fluorescent O 0 1.9873155565619527e-07
in O 0 3.929824998749609e-08
situ O 0 3.038059759319367e-08
hybridization O 0 1.0659519100730819e-10
analysis O 0 4.984363182608531e-12
demonstrated O 0 7.97821335905835e-13
that O 0 1.8244826764830802e-13
the O 0 8.805151746615891e-11
PWS B-Disease 1 1.0
critical O 0 2.681751709587843e-07
region O 0 5.0497689585427e-08
resided O 0 2.8705843035936596e-08
on O 0 6.40256159201158e-09
the O 0 1.4752295218745104e-10
derivative O 0 8.385508953878684e-11
chromosome O 0 1.9444907906063236e-09
3 O 0 1.9556454233793374e-09
and O 0 5.28405064929155e-13
that O 0 3.3481995388023877e-13
there O 0 1.6100212526029556e-12
was O 0 2.5148311211253827e-10
no O 0 3.1050922250086543e-11
deletion O 0 1.047328779257839e-09
of O 0 1.2901758827954524e-10
the O 0 8.606731438653981e-10
PWS B-Disease 1 1.0
region O 0 2.372927099258959e-07
on O 0 1.8518872479944548e-07
the O 0 6.73269495710116e-10
normal O 0 2.1465293986722145e-09
pair O 0 2.766133329334952e-11
of O 0 4.456228788751737e-11
15s O 0 1.7021799081362587e-08
present O 0 2.4016785782343675e-10
in O 0 1.977128460950439e-09
J O 0 3.510327223921195e-05
. O 0 1.7101029925470357e-07

B O 0 0.0004089494759682566
. O 0 5.514305030374089e-07

Methylation O 0 1.767443933431423e-07
analysis O 0 6.9805636826458795e-09
at O 0 1.4872439280111394e-08
exon O 0 2.305891921849934e-09
alpha O 0 1.2419042683120551e-08
of O 0 3.262189129937809e-10
the O 0 1.3771991880240364e-10
small O 0 1.0416385809453033e-10
nuclear O 0 1.5897282992227701e-06
ribonucleoprotein O 0 1.5448373460458242e-06
- O 0 9.320936555923254e-08
associated O 0 2.3316639286008467e-08
polypeptide O 0 6.959414804441622e-07
N O 0 7.706707094712328e-08
( O 0 1.8865081372054782e-11
SNRPN O 0 3.2009091910367715e-07
) O 0 5.952203573772463e-12
gene O 0 1.125245838347333e-12
showed O 0 7.941261038514613e-13
a O 0 4.793250865664511e-12
pattern O 0 4.890069460472546e-10
characteristic O 0 5.899356697591784e-11
of O 0 3.126301648115337e-11
only O 0 3.403433784798793e-11
the O 0 2.4599977610506585e-10
maternal O 0 1.560176698944815e-08
chromosome O 0 1.9809010609606048e-07
15 O 0 4.848429853154812e-07
in O 0 2.1219546120221366e-09
J O 0 3.7849164073122665e-05
. O 0 1.43220177051262e-07

B O 0 0.0007087180856615305
. O 0 4.366328596461244e-07

Maternal B-Disease 0 0.000845686940010637
disomy I-Disease 0 0.00025409727822989225
was O 0 3.1153572876974067e-07
confirmed O 0 8.045187849248236e-10
by O 0 1.1679061363845111e-11
polymerase O 0 6.395833307415444e-10
chain O 0 1.2697012885531933e-10
reaction O 0 2.3684090712933203e-12
analysis O 0 5.054962524952966e-12
of O 0 7.717036037968583e-11
microsatellite O 0 5.6266782344494e-09
repeats O 0 3.9364320691959165e-09
at O 0 7.344463370806409e-10
the O 0 1.1988705861387672e-10
gamma O 0 8.46648351426893e-09
- O 0 3.0940872086659965e-09
aminobutyric O 0 8.491696235068957e-09
acid O 0 6.481453151963024e-10
receptor O 0 2.766029350009802e-10
beta3 O 0 1.788030834504184e-09
subunit O 0 6.870449764662112e-10
( O 0 7.275343088392061e-12
GABRB3 O 0 1.4879651644150726e-07
) O 0 1.796051155023015e-11
locus O 0 3.4949234617442926e-09
. O 0 1.142431482747952e-09

A O 0 9.126139048021287e-06
niece O 0 1.961790303539601e-06
( O 0 1.9254609018304336e-10
B O 0 1.3814204002926544e-08
. O 0 1.1032211602590714e-11
B O 0 4.164706912668237e-10
. O 0 3.847357003296248e-13
) O 0 1.1733619447156646e-13
with O 0 6.144963552758009e-13
45 O 0 2.9778028931559675e-09
chromosomes O 0 8.838366150065724e-11
and O 0 2.7533934333912047e-12
the O 0 1.3447389902998541e-11
derivative O 0 3.779565549422159e-11
3 O 0 9.273700557477227e-11
but O 0 8.576337339957774e-13
without O 0 7.275554464447609e-11
the O 0 5.860231189203091e-10
der O 0 1.4241919643609435e-06
( O 0 2.1111745684976313e-10
15 O 0 1.0177449105697178e-08
) O 0 5.2731191808874645e-12
demonstrated O 0 1.605927717196476e-11
a O 0 1.1710005187737238e-10
phenotype O 0 1.4858964059172308e-09
consistent O 0 7.427249787417267e-11
with O 0 2.84701461624598e-14
that O 0 7.53741632910504e-13
reported O 0 1.2216718088542411e-11
for O 0 5.036782622924729e-12
haploinsufficiency O 0 4.769203343357731e-08
of O 0 1.2168458241035296e-08
distal O 0 2.7246112949796952e-05
3 O 0 0.00013874708383809775
p O 0 5.082426287117414e-05
. O 0 2.1461585220095003e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999991655349731
associated O 0 8.893540837107139e-08
with O 0 3.1160696245535746e-10
unbalanced O 0 8.209527550206985e-06
segregation O 0 5.244703160656172e-08
of O 0 2.6611008951960002e-09
non O 0 2.1269396910383875e-08
- O 0 2.6935595087707043e-08
Robertsonian O 0 1.708513423182012e-06
translocations O 0 3.26659801430651e-07
has O 0 3.12622705500587e-09
been O 0 3.234043866040537e-10
reported O 0 2.620132999453517e-10
previously O 0 4.53129339605951e-11
but O 0 2.0200046062929244e-12
has O 0 1.8412287753483136e-12
not O 0 5.477741090581523e-12
, O 0 2.4336923535456245e-12
to O 0 2.3311680363846676e-10
our O 0 1.784864478437953e-10
knowledge O 0 2.8407334817792673e-10
, O 0 4.3007111760751116e-11
been O 0 8.542665186350717e-11
observed O 0 4.6803248776594586e-11
in O 0 9.178613815177816e-13
a O 0 4.622983593161045e-11
case O 0 1.8141801394477852e-09
of O 0 8.620125946379176e-09
PWS B-Disease 1 1.0
. O 0 2.0984680304536596e-06

Furthermore O 0 5.988341854390455e-06
, O 0 9.718912785672273e-09
our O 0 1.546615058245493e-09
findings O 0 2.9014343705391354e-10
are O 0 7.927565396671776e-13
best O 0 1.2189361933007126e-12
interpreted O 0 3.0173279239736894e-12
as O 0 3.1975032430825445e-12
true O 0 3.377515281344223e-11
gamete O 0 6.869561808287017e-09
complementation O 0 4.1135141515269424e-08
resulting O 0 1.5686620891131042e-09
in O 0 9.708976955735693e-10
maternal B-Disease 0 9.653050074120983e-05
UPD I-Disease 1 1.0
15 I-Disease 0 0.00012589595280587673
and O 0 6.615309757762589e-07
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 3.797524414039799e-06
2 I-Disease 0 2.1003500023653032e-06
and O 0 1.1204759342575699e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 1.4826532362954836e-11
a O 0 4.048220439423211e-11
case O 0 8.625528069572397e-11
for O 0 3.4502588286411395e-11
" O 0 4.657227381521523e-10
lumping O 0 1.0059602040257687e-09
" O 0 8.206466617366459e-09
. O 0 1.055412734984884e-08

Recent O 0 1.1291265700208442e-08
studies O 0 5.34922162120921e-10
demonstrated O 0 6.965580889861656e-11
the O 0 9.691025065761139e-11
existence O 0 7.44268313646046e-10
of O 0 4.589965560408693e-11
a O 0 4.819988852489132e-10
genetically O 0 7.48861972432735e-10
distinct O 0 6.565557993110094e-12
, O 0 2.7541220714612236e-13
usually O 0 3.8482669199695063e-13
lethal O 0 1.3496751459507461e-11
form O 0 5.563214277269635e-13
of O 0 9.337450083968246e-12
the O 0 4.1913611470434375e-11
Schwartz B-Disease 0 0.09694869071245193
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.5316637957951684e-09
SJS B-Disease 0 3.0671119020553306e-05
) O 0 9.254859031915252e-12
of O 0 2.3864785703153757e-09
myotonia B-Disease 1 0.7617717981338501
and O 0 1.1701150697263074e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.888495203023922e-07
which O 0 4.894366867347344e-08
we O 0 5.275343255561893e-07
called O 0 2.758877371888957e-06
SJS B-Disease 0 0.00011580564751056954
type I-Disease 0 7.156431252042239e-07
2 I-Disease 0 5.282610345602734e-06
. O 0 3.2054906284884055e-08

This O 0 5.299769512134844e-08
disorder O 0 0.494699090719223
is O 0 3.8340722957608264e-11
reminiscent O 0 1.0901988201084123e-09
of O 0 7.786665201514609e-10
another O 0 2.8969607268614084e-10
rare O 0 1.973412822042775e-10
condition O 0 3.153074430883862e-06
, O 0 2.3002141857908498e-11
the O 0 1.4376880796973524e-09
Stuve B-Disease 1 0.9999960660934448
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.8251213873554661e-07
SWS B-Disease 0 0.0005362444208003581
) O 0 7.435609419848e-12
, O 0 7.395097988832644e-13
which O 0 1.5327749919996636e-12
comprises O 0 2.0540116916351048e-12
campomelia B-Disease 0 1.7317087497303874e-07
at O 0 2.712496609547088e-07
birth O 0 1.700220622069537e-07
with O 0 3.5934899500489337e-10
skeletal B-Disease 0 0.00024064791796263307
dysplasia I-Disease 1 0.9994528889656067
, O 0 3.238016077489192e-08
contractures B-Disease 0 1.1170769766977173e-06
, O 0 3.170977647126705e-10
and O 0 9.553126345540619e-11
early B-Disease 0 2.512734454285237e-06
death I-Disease 0 7.368757906078827e-07
. O 0 1.254323755972564e-08

To O 0 7.278351699113728e-09
test O 0 9.225290670267228e-11
for O 0 8.954591083389085e-13
possible O 0 5.211581166619794e-10
nosologic O 0 1.6922180066103465e-06
identity O 0 1.2764862500347363e-09
between O 0 3.705117634922317e-08
these O 0 4.550577692441493e-09
disorders O 0 3.6810837400480523e-07
, O 0 2.0379234758061138e-11
we O 0 2.0639209091788402e-11
reviewed O 0 9.305026194006416e-11
the O 0 6.4367018659527986e-12
literature O 0 3.632433167189558e-13
and O 0 1.295280343486388e-13
obtained O 0 2.3059939374681093e-12
a O 0 1.8408646135226192e-11
follow O 0 2.84985490067724e-11
- O 0 2.75669487237451e-11
up O 0 2.544920350844304e-11
of O 0 6.442499311809513e-12
the O 0 2.1725538035255454e-12
only O 0 2.918593318412821e-12
two O 0 5.224973231854335e-12
surviving O 0 4.159524724656194e-09
patients O 0 1.0125315863529494e-10
, O 0 1.4249838288515893e-11
one O 0 7.288082637391113e-11
with O 0 2.7029940785627815e-11
SJS B-Disease 0 3.990820687249652e-07
type I-Disease 0 1.3812727850393003e-08
2 I-Disease 0 1.1176082637120999e-07
at O 0 1.2939963545122168e-09
age O 0 1.964369916729325e-10
10 O 0 1.8052727715489603e-11
years O 0 2.265657496683393e-12
and O 0 3.3170336052532057e-13
another O 0 2.1483089612805983e-11
with O 0 3.48522738446988e-11
SWS B-Disease 0 4.2109977584914304e-06
at O 0 5.312711159888295e-09
age O 0 2.772294616093518e-09
7 O 0 4.284163424017606e-08
years O 0 6.586840850530962e-09
. O 0 8.034242604537667e-09

Patients O 0 1.846108602876484e-06
reported O 0 8.448609811750885e-09
as O 0 7.564903564682979e-11
having O 0 1.3750232896736492e-10
either O 0 1.933972271217499e-08
neonatal O 1 0.9999996423721313
SJS B-Disease 1 0.9993009567260742
or O 0 4.773326054419158e-07
SWS B-Disease 0 6.053754077584017e-06
presented O 0 9.913762519242475e-12
a O 0 3.574871518599587e-12
combination O 0 8.014761597452402e-12
of O 0 5.0776709226152406e-12
a O 0 8.17276524234245e-11
severe O 0 5.454030542750843e-06
, O 0 7.960502257375879e-10
prenatal O 0 0.009105402044951916
- O 0 0.17287583649158478
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.3615021610124955e-10
with O 0 6.953057685166186e-09
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999991655349731
respiratory O 1 1.0
and O 0 0.389820396900177
feeding O 0 0.00714285671710968
difficulties O 0 1.6291013480440597e-06
, O 0 1.752697292856098e-10
tendency O 0 2.3068684740223944e-09
to O 0 2.369624851894514e-08
hyperthermia B-Disease 0 3.880371150444262e-05
, O 0 2.8283188291400307e-11
and O 0 5.431475148115483e-12
frequent O 0 7.637072224619956e-11
death O 0 5.438615335862096e-09
in O 0 2.701943946359364e-10
infancy O 0 2.6704068289973293e-08
) O 0 8.4437875257342e-14
with O 0 3.6853858045816576e-14
a O 0 1.5051093704698815e-10
distinct O 0 2.7808315650190707e-09
campomelic B-Disease 0 0.0002683702332433313
- I-Disease 0 0.035221610218286514
metaphyseal I-Disease 1 0.9781720638275146
skeletal I-Disease 1 0.999642014503479
dysplasia I-Disease 1 1.0
. O 0 3.654908141470514e-05

The O 0 9.382348764574999e-08
similarity O 0 3.8260420609503853e-08
of O 0 1.4347249610580093e-08
the O 0 2.8106721394749457e-09
clinical O 0 1.744744082543548e-08
and O 0 6.296192039956239e-11
radiographic O 0 6.086933268534267e-08
findings O 0 2.803868071055149e-08
is O 0 2.414709820985905e-10
so O 0 1.098823722983644e-11
extensive O 0 5.397617353075645e-10
that O 0 2.023237966053415e-10
these O 0 5.96350580028826e-10
disorders O 0 2.8666784146480495e-07
appear O 0 1.0710862197171878e-09
to O 0 1.6387929901995335e-10
be O 0 1.5524890401019675e-11
a O 0 4.151428506515842e-11
single O 0 9.674293310890647e-11
entity O 0 7.97849253331151e-08
. O 0 6.621502279813285e-07

The O 0 4.677297482658105e-08
follow O 0 6.353633175137929e-09
- O 0 9.64474611286903e-10
up O 0 9.314544274774406e-11
observation O 0 5.404292569011204e-10
of O 0 2.6267052768980115e-12
an O 0 1.0212931032555633e-13
identical O 0 2.1797333089965815e-13
and O 0 8.700895228917413e-14
unique O 0 4.1052664739860134e-13
pattern O 0 1.4018503691204387e-08
of O 0 1.518948664624986e-07
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 2.3926133962959284e-06
the O 0 1.1469797982499585e-06
two O 0 5.9033364863125826e-09
patients O 0 1.9615431501307512e-10
( O 0 2.400297625590464e-12
one O 0 1.8651521299650753e-11
with O 0 9.564900087244421e-12
SJS B-Disease 0 7.107338717560197e-08
type I-Disease 0 4.71396166545901e-09
2 I-Disease 0 1.2885054445632704e-07
, O 0 2.283811507963751e-11
one O 0 3.0110511306524756e-11
with O 0 3.3750811173627326e-11
SWS B-Disease 0 2.4918206236179685e-06
) O 0 9.918250248874827e-11
surviving O 0 1.5145102949531974e-08
beyond O 0 1.2993297104912926e-07
infancy O 0 7.20487420835525e-08
adds O 0 9.050995196380196e-12
to O 0 4.0221680153162964e-11
the O 0 1.2559927924093994e-11
evidence O 0 1.7411535538011669e-12
in O 0 4.5225162590561974e-13
favor O 0 3.413921229045158e-11
of O 0 5.514265433159693e-11
identity O 0 1.0427582131100621e-09
. O 0 4.011400100978335e-09

The O 0 5.06125843457994e-07
hypothesis O 0 5.741740096709691e-07
that O 0 4.041319723313563e-09
SWS B-Disease 0 0.00018536178686190397
and O 0 5.0022499920032715e-08
SJS B-Disease 0 1.3470352314470802e-05
type I-Disease 0 3.994452058009301e-08
2 I-Disease 0 1.4792976799071766e-07
are O 0 5.169688028355823e-12
the O 0 9.45307374045079e-11
same O 0 1.1427540025366056e-09
disorder O 0 2.7811408287448103e-08
should O 0 5.146550546841766e-11
be O 0 1.1054925030951068e-10
testable O 0 2.0088959384878535e-09
by O 0 3.760825678655877e-11
molecular O 0 4.05985217666327e-10
methods O 0 1.7419093945036934e-10
. O 0 3.090480649170502e-11
. O 0 1.0846693543342667e-09

A O 0 4.0893336716862905e-08
mouse O 0 1.4116585678181082e-10
model O 0 4.6490599564519286e-11
of O 0 7.364363979744937e-11
severe O 1 0.9999996423721313
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 9.751698598847724e-06
defects O 1 0.9999990463256836
in O 0 5.541380119211681e-07
hemostasis O 0 0.03736981749534607
and O 0 7.375450650215498e-07
thrombosis B-Disease 1 0.9999985694885254
. O 0 6.28590423730202e-05

von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9267162084579468
( I-Disease 0 1.853035485055443e-07
vWf I-Disease 1 0.9999996423721313
) I-Disease 0 4.874299975199392e-06
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 1.0
humans O 0 0.48806580901145935
. O 0 7.338769592024619e-07

We O 0 5.274316805525814e-08
generated O 0 4.2216403983719175e-11
a O 0 5.673085265445188e-11
mouse O 0 2.6157721821906676e-11
model O 0 6.382227211998437e-12
for O 0 7.610197194640733e-12
this O 0 1.35092229069933e-10
disease O 0 5.352875920294764e-10
by O 0 1.3062769182309308e-12
using O 0 7.19381013092324e-11
gene O 0 1.062703883225602e-10
targeting O 0 2.472077653692395e-09
. O 0 3.779965673800234e-09

vWf B-Disease 0 0.01344626396894455
- I-Disease 1 0.9991379976272583
deficient I-Disease 0 0.0008826000266708434
mice O 0 2.460775192503206e-07
appeared O 0 2.939863463780057e-08
normal O 0 5.362006305631439e-08
at O 0 2.8649487227028203e-09
birth O 0 7.407726515529234e-11
; O 0 1.2264082978330482e-12
they O 0 1.2393443910019286e-11
were O 0 5.181220383287943e-11
viable O 0 4.3110475189678255e-09
and O 0 3.034882900543323e-10
fertile O 0 1.4273274473453057e-06
. O 0 1.1110661546354095e-07

Neither O 0 3.1868494261289015e-05
vWf O 0 0.0005442057154141366
nor O 0 2.5591245503164828e-05
vWf O 0 0.000335423945216462
propolypeptide O 0 0.00028833362739533186
( O 0 2.0438628567376327e-08
von B-Disease 0 0.0059981802478432655
Willebrand I-Disease 0 1.0924768503173254e-05
antigen O 0 1.5574659073536168e-07
II O 0 0.0005208123475313187
) O 0 8.610672175279888e-10
were O 0 1.3672906140627106e-09
detectable O 0 9.818744928224987e-09
in O 0 1.365692142707431e-10
plasma O 0 5.595043095496521e-09
, O 0 7.656178468984365e-11
platelets O 0 8.266773376952585e-10
, O 0 3.513728544235484e-11
or O 0 7.489962539075634e-10
endothelial O 0 4.054742305803494e-11
cells O 0 6.185150308590792e-11
of O 0 1.656590142840031e-10
the O 0 1.1828964474602799e-09
homozygous O 0 2.477553495694451e-09
mutant O 0 8.801738715646934e-08
mice O 0 5.0260538841939706e-08
. O 0 8.759680980574558e-09

The O 0 5.050528670835774e-06
mutant O 0 7.689205631322693e-06
mice O 0 4.183360715614981e-07
exhibited O 0 1.56606816403837e-08
defects O 0 3.604407902457751e-05
in O 0 1.790045089933301e-08
hemostasis O 0 7.252357363540796e-07
with O 0 3.612758703308572e-11
a O 0 2.65180482017513e-08
highly O 0 3.4039778995520464e-08
prolonged O 1 0.9999910593032837
bleeding O 1 0.9998588562011719
time O 0 7.446309382430627e-07
and O 0 4.285142019000432e-09
spontaneous O 0 1.1076827632905406e-07
bleeding O 0 3.0051467092562234e-07
events O 0 8.122395117604597e-12
in O 0 1.4222648666434301e-12
approximately O 0 4.476142980575082e-12
10 O 0 8.950228752580003e-11
% O 0 9.389049260288829e-11
of O 0 4.1773084991092446e-10
neonates O 0 2.6761031790556444e-07
. O 0 1.4182010943386558e-07

As O 0 4.974616718556035e-09
in O 0 4.514783824571822e-10
the O 0 5.717291529094837e-09
human O 0 1.8351704156316373e-08
disease O 0 6.780641115256003e-08
, O 0 1.7638564220323616e-12
the O 0 2.0576164036500977e-11
factor O 0 6.62244634130893e-11
VIII O 0 1.7011336694849888e-06
level O 0 4.163887751928996e-06
in O 0 1.8539823898322538e-08
these O 0 7.732378626279512e-10
mice O 0 1.2858282216754446e-09
was O 0 3.246175273030616e-10
reduced O 0 6.859996598551632e-11
strongly O 0 4.798199164379735e-12
as O 0 1.0198590019369624e-12
a O 0 1.3762294255592611e-11
result O 0 1.0022423863054186e-10
of O 0 1.1135192767852686e-10
the O 0 2.4398486009324927e-10
lack O 0 6.730768165041923e-10
of O 0 3.944642876230198e-11
protection O 0 5.3385167814168355e-11
provided O 0 3.4091954519838152e-12
by O 0 8.575069820881964e-11
vWf O 0 1.0902451776928501e-06
. O 0 2.6955381926541122e-08

Defective O 0 0.002064716536551714
thrombosis B-Disease 0 0.02156808041036129
in O 0 3.746930815395899e-06
mutant O 0 1.7915397165779723e-06
mice O 0 9.728482908144542e-09
was O 0 4.3411790828784547e-10
also O 0 2.0102574119218453e-12
evident O 0 9.345966708873554e-12
in O 0 2.697389403852335e-12
an O 0 1.2027308402690062e-12
in O 0 6.261625332820708e-12
vivo O 0 1.2354037237649607e-10
model O 0 6.484492109937179e-11
of O 0 1.080523581720172e-08
vascular B-Disease 1 0.99998939037323
injury I-Disease 1 1.0
. O 0 2.345779830648098e-05

In O 0 9.39695543600294e-10
this O 0 1.9402431050696833e-11
model O 0 9.771952691473018e-11
, O 0 2.2356269613332813e-11
the O 0 2.412858801648099e-10
exteriorized O 0 1.2387583581130457e-07
mesentery O 0 1.841169847693891e-07
was O 0 2.3431125484307813e-08
superfused O 0 1.5239284323342872e-07
with O 0 1.4499695888403608e-10
ferric O 0 1.250132442009999e-07
chloride O 0 1.4374521573046195e-09
and O 0 7.959609860108685e-09
the O 0 3.89493877150926e-08
accumulation O 0 1.6720440498829703e-07
of O 0 4.494528482723581e-08
fluorescently O 0 1.7704131494156172e-07
labeled O 0 6.809618202652246e-09
platelets O 0 5.14641840254626e-09
was O 0 2.0580539494829964e-09
observed O 0 1.432191587547038e-10
by O 0 1.5262787561587388e-11
intravital O 0 2.7838527927315226e-08
microscopy O 0 1.0092917079873587e-07
. O 0 9.632290698391444e-08

We O 0 5.167116228221857e-07
conclude O 0 1.1569248272280674e-05
that O 0 8.504902893058386e-10
these O 0 1.4547120452679252e-10
mice O 0 2.4707200729778833e-09
very O 0 1.1368091364094557e-11
closely O 0 1.6793400003933812e-10
mimic O 0 9.124694884121709e-07
severe O 1 0.9999996423721313
human O 1 0.9974184036254883
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 1.321234776696656e-06
will O 0 2.782531005607325e-08
be O 0 6.340192815201817e-10
very O 0 3.729827644655126e-12
useful O 0 2.837514077869141e-12
for O 0 6.119442517819873e-13
investigating O 0 3.048276908668157e-11
the O 0 1.4259815550587973e-11
role O 0 1.8269221205291508e-11
of O 0 4.726110822139695e-11
vWf O 0 1.595692289413364e-08
in O 0 2.761537942763681e-10
normal O 0 8.572454817112884e-07
physiology O 0 6.071300351351283e-09
and O 0 1.6411882269862232e-11
in O 0 1.0438959419101224e-10
disease O 0 7.037782800978221e-09
models O 0 2.7499518287510405e-11
. O 0 2.349572758575391e-10
. O 0 1.4137267356773009e-08

Oral O 0 2.558547976150294e-06
contraceptives O 0 4.618381055365717e-08
and O 0 1.8868571635688447e-11
the O 0 1.5347599580106674e-10
risk O 0 8.230563253164291e-08
of O 0 1.0390499483037274e-06
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9943394064903259

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.711913526058197
Study O 0 9.410810264398606e-08
Group O 0 5.00837427086509e-10
. O 0 1.2298980722746933e-09

BACKGROUND O 0 4.6369967776627163e-07
Women O 0 1.7526839701798025e-10
with O 0 3.2480424599912183e-12
mutations O 0 8.829773023855125e-11
in O 0 1.0227796040651604e-11
either O 0 3.056044028948435e-10
the O 0 2.251281827625462e-09
BRCA1 O 0 6.137760966140604e-09
or O 0 2.6364870286954556e-09
the O 0 6.661739604396644e-09
BRCA2 O 0 5.783052259289434e-09
gene O 0 2.3046847416607896e-11
have O 0 1.8059743154066887e-12
a O 0 9.229228492557695e-12
high O 0 1.0541688633125545e-09
lifetime O 0 1.4265523873291386e-08
risk O 0 3.644661092039314e-06
of O 0 0.4322716295719147
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.541558443335816e-05

Oral O 0 0.0001516208576504141
contraceptives O 0 9.34316631173715e-05
protect O 0 1.635879925743211e-06
against O 1 0.9999998807907104
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 7.713065861025825e-05
general O 0 2.928637456989236e-07
, O 0 1.5006685130658504e-11
but O 0 1.112475779899147e-12
it O 0 1.029920398097628e-12
is O 0 5.262074413356355e-13
not O 0 2.9213389519944233e-12
known O 0 2.0608566936308748e-11
whether O 0 1.8064679960239083e-11
they O 0 1.8352019123119012e-12
also O 0 5.486698877350815e-13
protect O 0 3.4336149375147063e-12
against O 0 1.841933133794882e-10
hereditary B-Disease 1 0.9934549927711487
forms I-Disease 0 0.07666067779064178
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.9275304768816568e-05

METHODS O 0 4.386554053326108e-07
We O 0 5.429460769867944e-10
enrolled O 0 6.599636115378615e-11
207 O 0 2.585495012530359e-11
women O 0 3.8742571433977857e-13
with O 0 4.4669344612113804e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.371822382940536e-08
161 O 0 1.3920790076227263e-09
of O 0 2.766794293673769e-10
their O 0 5.277850725904365e-11
sisters O 0 1.195593624103708e-10
as O 0 1.4285541499736709e-11
controls O 0 3.852032859352761e-10
in O 0 1.3367883189285834e-11
a O 0 3.6261185720753986e-10
case O 0 3.508374701866046e-09
- O 0 2.0835422276377358e-08
control O 0 2.9563333114879242e-08
study O 0 3.337601028885473e-10
. O 0 8.213869029383147e-10

All O 0 1.7591126777460886e-08
the O 0 1.9216315205738965e-09
patients O 0 1.177295153725888e-11
carried O 0 1.7167574870372015e-12
a O 0 9.659169297737691e-12
pathogenic O 0 7.497834991765373e-11
mutation O 0 9.476253115536792e-11
in O 0 2.7387711890036748e-11
either O 0 9.502809650285826e-10
BRCA1 O 0 3.795983527510316e-09
( O 0 1.2238219986027143e-11
179 O 0 1.38864933441063e-10
women O 0 3.025463451815369e-13
) O 0 4.136896175014476e-13
or O 0 2.0813559209464927e-10
BRCA2 O 0 5.268442571093601e-09
( O 0 3.648058938265919e-11
28 O 0 4.551048604639618e-08
women O 0 1.2747308417160319e-11
) O 0 2.4157405242863916e-11
. O 0 3.0426221542256826e-09

The O 0 1.9838838127839153e-08
control O 0 9.616041296567346e-09
women O 0 4.606387428614245e-13
were O 0 5.825418814865702e-13
enrolled O 0 3.3445056620007296e-12
regardless O 0 1.3782652970306675e-11
of O 0 1.8313527777591432e-11
whether O 0 1.1074271707989247e-11
or O 0 4.034540201924841e-10
not O 0 1.4361423161801667e-09
they O 0 7.995222539580737e-11
had O 0 3.6459113506026597e-10
either O 0 1.046909448021438e-09
mutation O 0 1.772967017643623e-08
. O 0 1.753274148086348e-08

Lifetime O 0 6.0318670875858516e-06
histories O 0 4.1600713984735194e-07
of O 0 7.095364367160073e-07
oral O 0 1.2153146826676675e-06
- O 0 2.179318769890415e-08
contraceptive O 0 1.3494164674554554e-09
use O 0 1.7419284764619292e-11
were O 0 7.711305552438041e-13
obtained O 0 7.207138531806212e-13
by O 0 6.061036546788079e-13
interview O 0 2.815422894819619e-11
or O 0 1.4681403879071575e-12
by O 0 8.906211271947351e-14
written O 0 8.861546208199095e-14
questionnaire O 0 8.56351732689449e-14
and O 0 1.0233913055098659e-13
were O 0 4.171187592376391e-13
compared O 0 1.724844551041771e-12
between O 0 1.241318159372895e-10
patients O 0 3.5149484017837906e-11
and O 0 1.2966016281479309e-11
control O 0 3.047303076542107e-09
women O 0 1.376522051725615e-13
, O 0 9.409490466525186e-14
after O 0 8.750216697051005e-12
adjustment O 0 2.8081719241623837e-11
for O 0 4.5331043064221477e-13
year O 0 9.950936602498572e-11
of O 0 2.391858933137314e-10
birth O 0 3.899255585082528e-09
and O 0 3.8291192439032784e-10
parity O 0 1.0446722598089764e-07
. O 0 6.618490999699134e-08

RESULTS O 0 1.8607987612995203e-06
The O 0 1.5356809157651696e-08
adjusted O 0 1.0277873663255832e-08
odds O 0 3.36485967977751e-08
ratio O 0 9.835985359529786e-10
for O 0 8.41756957470352e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 1.5977024148128294e-08
with O 0 3.155998466036758e-12
any O 0 3.4940686455264824e-10
past O 0 2.48359888210814e-10
use O 0 1.7653786418825312e-11
of O 0 3.713566606999841e-11
oral O 0 9.082201657406586e-10
contraceptives O 0 4.258197794371199e-09
was O 0 3.916503565903895e-09
0 O 0 2.6644951134358053e-08
. O 0 7.345503760802785e-09

5 O 0 1.5568139133392833e-06
( O 0 6.38595953894594e-10
95 O 0 5.307255079856077e-08
percent O 0 2.5205382669923893e-08
confidence O 0 1.4930128244827756e-09
interval O 0 3.311010354778432e-09
, O 0 7.466366414021763e-11
0 O 0 1.131173821278253e-09
. O 0 2.7609940375650233e-11
3 O 0 1.2009286898262417e-09
to O 0 5.197564600933902e-10
0 O 0 8.624660430278652e-10
. O 0 2.0545495860169183e-11
8 O 0 1.1874021765834186e-08
) O 0 1.868165205864969e-10
. O 0 2.841666901787221e-09

The O 0 6.845843927294482e-07
risk O 0 2.800405241032422e-07
decreased O 0 1.805136817800701e-09
with O 0 6.702804001938734e-13
increasing O 0 9.779971277268373e-11
duration O 0 9.910827714065817e-09
of O 0 1.3103332308084248e-10
use O 0 9.10462261138889e-11
( O 0 1.6975579275602115e-10
P O 0 6.324810328806052e-07
for O 0 5.023700899720041e-10
trend O 0 9.082743446242603e-09
, O 0 4.9169276289395825e-11
< O 0 1.1650000075746902e-08
0 O 0 4.711712131566514e-10
. O 0 7.318990899451983e-12
001 O 0 9.312976605169165e-12
) O 0 1.8930725585210306e-14
; O 0 3.293479584106501e-14
use O 0 1.0606634927995406e-12
for O 0 2.5732189816440876e-12
six O 0 2.408269243747707e-11
or O 0 6.406461298957833e-12
more O 0 3.6968984731128307e-13
years O 0 3.0483698898464695e-11
was O 0 7.079457159386848e-11
associated O 0 3.73219727692331e-12
with O 0 8.278242728896462e-14
a O 0 1.2139700356073035e-10
60 O 0 6.80080158854679e-10
percent O 0 1.6500718846845785e-10
reduction O 0 6.036702249190284e-10
in O 0 1.4186934960136455e-09
risk O 0 1.3227539739091299e-06
. O 0 4.800296551366046e-07

Oral O 0 2.1123418264323846e-05
- O 0 4.85859516174969e-07
contraceptive O 0 6.385636197592248e-08
use O 0 8.384424821095138e-10
protected O 0 1.7441193733702676e-07
against O 1 0.9082972407341003
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.62563841396868e-11
for O 0 3.4056013217820258e-12
carriers O 0 1.1721814924953167e-12
of O 0 6.269516156232058e-11
the O 0 1.6367875110834262e-10
BRCA1 O 0 1.58357282842303e-09
mutation O 0 6.621035941734021e-10
( O 0 5.5620499525566025e-12
odds O 0 2.910953256218818e-09
ratio O 0 1.874710629790055e-11
, O 0 1.206669313080777e-12
0 O 0 7.478923730319664e-11
. O 0 1.8212293652342115e-12
5 O 0 1.5103432393637206e-10
; O 0 2.616494694518412e-12
95 O 0 1.7992245471276647e-09
percent O 0 1.5464882707760808e-09
confidence O 0 1.2903432489164146e-10
interval O 0 3.6849082118983745e-10
, O 0 1.3740236379233828e-11
0 O 0 1.0035219877302382e-10
. O 0 7.37227293101661e-12
3 O 0 7.344883035109717e-10
to O 0 2.2549120903825326e-10
0 O 0 5.512480472091852e-10
. O 0 1.0107597051001171e-11
9 O 0 1.0991686449912663e-09
) O 0 8.87685514287459e-14
and O 0 8.170118634366272e-14
for O 0 1.1879565256847635e-13
carriers O 0 8.21000439941294e-13
of O 0 1.1377376471499723e-11
the O 0 1.2810906502291886e-10
BRCA2 O 0 2.0755808183281488e-09
mutation O 0 7.481081865101658e-10
( O 0 3.998057093723695e-12
odds O 0 5.327597474291679e-09
ratio O 0 3.945222273871174e-11
, O 0 1.2691212013596354e-12
0 O 0 7.467420432005767e-11
. O 0 5.041222647661492e-12
4 O 0 7.830840420552931e-10
; O 0 5.384983691597567e-12
95 O 0 4.94803531481125e-09
percent O 0 3.559398331631769e-09
confidence O 0 4.0938405443391446e-10
interval O 0 5.845986472685638e-10
, O 0 2.3579083130442768e-11
0 O 0 2.2800958343616173e-10
. O 0 6.945624197313149e-12
2 O 0 9.660063859939783e-10
to O 0 6.03453842451529e-10
1 O 0 2.6541123077095108e-08
. O 0 2.0302737269162208e-10
1 O 0 6.302688859705086e-08
) O 0 2.219982531137532e-10
. O 0 8.696272146835327e-09

CONCLUSIONS O 0 5.31333134858869e-05
Oral O 0 1.8639121890373644e-06
- O 0 1.075488142987524e-08
contraceptive O 0 1.6538254099529581e-09
use O 0 2.4223739333861793e-12
may O 0 2.8651645292421257e-11
reduce O 0 1.196499427313924e-10
the O 0 2.6255443999478878e-11
risk O 0 4.5528807390837756e-08
of O 0 4.258543413016014e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.2928849929826356e-08
women O 0 5.984039761104676e-13
with O 0 3.459525146822656e-14
pathogenic O 0 2.5741037773530095e-11
mutations O 0 2.294902809452104e-11
in O 0 2.5784870766321077e-11
the O 0 8.554458252874042e-10
BRCA1 O 0 2.2732415061454958e-08
or O 0 3.052488466437353e-07
BRCA2 O 0 7.080357136146631e-06
gene O 0 4.388288289192133e-06

A O 0 2.7996145490760682e-06
Japanese O 0 5.194408458919497e-07
family O 0 3.080872668093093e-09
with O 0 4.272294185092562e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.4313861607969685e-11
a O 0 3.101674028727075e-09
codon O 0 2.2462817383939182e-08
291 O 0 1.7962757947742602e-09
deletion O 0 7.545342128878474e-09
: O 0 3.147774575718021e-12
a O 0 1.6265298830031583e-10
clinical O 0 7.0410854924318755e-09
, O 0 1.0007657896826672e-10
biochemical O 0 3.485006772052657e-08
, O 0 3.0877438383924982e-09
pathological O 0 0.0007461008499376476
, O 0 6.06936334524022e-10
and O 0 1.344250488699572e-09
genetic O 0 5.457437168843171e-08
report O 0 1.939146399010383e-09
. O 0 4.248041474141928e-09

We O 0 7.273245117289662e-09
report O 0 2.1342757422493364e-11
a O 0 2.81219214581796e-11
Japanese O 0 1.1396892318771279e-09
family O 0 6.175496225502286e-11
with O 0 1.7566464949325677e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.649957195899333e-06
ALD B-Disease 1 1.0
) O 0 4.968227652196733e-12
with O 0 2.714150247867114e-13
a O 0 6.462599899670352e-11
three O 0 8.141985349818803e-12
base O 0 1.4826229133291235e-10
pair O 0 4.312004919793111e-11
deletion O 0 1.1014099632333796e-09
( O 0 1.028193676033684e-11
delGAG O 0 2.25424336974811e-08
291 O 0 1.522084541738522e-10
) O 0 2.1189261283083294e-12
in O 0 1.442832658904436e-10
the O 0 1.3076808613732283e-07
ALD B-Disease 1 1.0
gene O 0 1.5080239563758369e-06
. O 0 1.6725464035971527e-07

A O 0 6.024676508786797e-07
variety O 0 9.587869387317483e-10
of O 0 1.9628014769068614e-09
phenotypes O 0 9.83410908261817e-10
were O 0 2.6924252757853928e-11
observed O 0 3.5964092814921855e-11
within O 0 1.1678771665024623e-11
this O 0 2.8794633344375598e-11
family O 0 2.6267579777972117e-10
. O 0 5.377930101246875e-09

While O 0 3.209277821270007e-08
the O 0 1.4062798925351672e-08
proband O 0 1.4783860933675896e-05
( O 0 5.604656294622146e-09
patient O 0 1.2847253856307361e-06
1 O 0 6.0584784478123765e-06
) O 0 2.3177432195709002e-10
was O 0 1.640946578618241e-08
classified O 0 4.990361457402059e-10
as O 0 3.1497582320128004e-11
having O 0 2.7967917912152807e-11
a O 0 5.117713544611213e-11
rare O 0 2.8768723514538408e-11
intermediate O 0 6.322742329700759e-10
type O 0 3.8316763650847463e-10
of O 0 6.774313332513771e-10
adult O 0 1.784508896207626e-08
cerebral O 0 0.00012911923113279045
and O 0 6.009664588191299e-08
cerebello O 1 0.9943139553070068
- O 1 0.7105157375335693
brain O 0 0.0037058789748698473
stem O 0 2.5834236083710493e-08
forms O 0 2.489270733985194e-10
, O 0 1.8134923901111377e-12
his O 0 1.246943780869314e-11
younger O 0 3.45550775493475e-11
brother O 0 2.4783036733921904e-10
( O 0 7.90672995826247e-12
patient O 0 1.0125823513007504e-09
2 O 0 3.3383285025223586e-09
) O 0 1.949917657895206e-12
and O 0 5.637156366700147e-11
nephew O 0 2.86466701027166e-07
( O 0 3.618891575296601e-10
patient O 0 1.4772055578760046e-07
3 O 0 1.0341531009316896e-07
) O 0 2.247718330905535e-11
had O 0 2.729480863550293e-09
a O 0 1.4707275397540798e-08
childhood O 0 0.0003060367307625711
ALD B-Disease 1 1.0
type O 0 3.6568817449733615e-05
. O 0 1.1023940942322952e-06

Another O 0 3.305459870261984e-07
nephew O 0 5.437224899651483e-06
( O 0 4.4959751477335885e-09
patient O 0 8.724359190637188e-07
4 O 0 6.01188901327987e-07
) O 0 3.104417070631804e-11
of O 0 3.1732785288340892e-09
patient O 0 1.7606188862373529e-07
1 O 0 1.6608477153567947e-06
was O 0 5.9493785897757334e-08
classified O 0 2.0419087254364143e-10
as O 0 1.3607253344927184e-11
having O 0 1.7453571574121973e-11
an O 0 6.451281869823688e-11
adolescent O 0 2.505300189525883e-09
form O 0 5.273587122545109e-10
. O 0 2.487289485486599e-08

The O 0 4.9879684382858613e-08
tau O 0 2.266245502369202e-08
level O 0 4.054862667857151e-09
in O 0 1.230122670392575e-10
the O 0 1.3498154816105057e-09
cerebrospinal O 0 2.6608992342858073e-08
fluid O 0 3.565624240309262e-08
( O 0 1.3544318999691995e-09
CSF O 0 2.378973249506089e-06
) O 0 1.3743703397572915e-10
in O 0 5.580460538112675e-10
patient O 0 9.153966118446988e-08
1 O 0 3.5282337762509997e-07
was O 0 4.877301229555542e-09
as O 0 3.827048920823639e-12
high O 0 2.4871053133646015e-11
as O 0 2.337504647308142e-13
that O 0 6.652973527990214e-14
of O 0 4.948688594325068e-12
patients O 0 4.4083969114039334e-11
with O 0 3.971392104062943e-10
Alzheimers B-Disease 1 1.0
disease I-Disease 1 0.5554243326187134
( O 0 8.217230715312773e-12
AD B-Disease 0 4.507758077920698e-08
) O 0 3.991919850232506e-10
. O 0 1.1253769471863961e-08

His O 0 8.281235204776749e-05
brain O 0 0.00034432284883223474
magnetic O 0 5.14382918481715e-06
resonance O 0 1.6472850461468624e-07
image O 0 1.6253409285127418e-08
( O 0 1.0513416803803466e-09
MRI O 0 1.206558749800024e-06
) O 0 8.923944222472002e-11
showed O 0 1.7810963814923753e-10
abnormalities B-Disease 0 2.5965825045659585e-09
in I-Disease 0 1.8867563761348904e-11
the I-Disease 0 2.505351481829621e-10
bilateral I-Disease 0 1.0196770745096728e-05
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 1 0.9995669722557068
and O 0 1.450166905669903e-06
brain O 0 0.00023521205002907664
stem O 0 6.685021958219295e-08
, O 0 3.3175669243018513e-12
but O 0 1.0208613468454253e-12
not O 0 1.7795088319561003e-12
in O 0 2.2740999621601032e-12
the O 0 6.448452882779065e-11
cerebral O 0 1.2073667221557116e-06
white O 0 4.516611973315321e-09
matter O 0 7.173401872506702e-09
, O 0 1.1726604930151208e-11
where O 0 5.778611096574071e-12
marked O 0 9.714672642713307e-12
reductions O 0 4.372109785322209e-09
of O 0 9.852902937979025e-10
the O 0 3.559140537845451e-09
cerebral O 0 1.39468684210442e-05
blood O 0 1.426038664931184e-07
flow O 0 3.183938090955962e-08
and O 0 1.2237019175742603e-09
oxygen O 0 5.1044892757090565e-09
metabolism O 0 7.298703863511946e-09
were O 0 8.434686109282108e-12
clearly O 0 5.268112768935795e-12
demonstrated O 0 1.6741380417378826e-12
by O 0 5.5866639439572374e-12
positron O 0 9.489143337759742e-08
emission O 0 6.728893708896067e-07
tomography O 0 2.243868038931396e-06
( O 0 5.563437710520702e-09
PET O 0 4.3461548671075434e-07
) O 0 3.5503583406537587e-10
. O 0 4.409309362074509e-09

In O 0 1.2040926833378762e-07
patients O 0 1.4051832586403634e-08
2 O 0 7.213674280137639e-08
and O 0 1.7577525546208506e-10
3 O 0 1.0396254168654195e-07
, O 0 1.0820321028059965e-10
the O 0 6.057555568261819e-10
autopsy O 0 4.8763335591672785e-09
findings O 0 2.4762530914657077e-10
showed O 0 6.340637043189545e-11
massive O 0 1.1530405075177441e-08
demyelination B-Disease 1 1.0
of I-Disease 0 1.885901269815804e-06
the I-Disease 0 1.3103337437314622e-07
cerebral I-Disease 0 0.0005497529054991901
white I-Disease 0 1.7118357842349496e-09
matter I-Disease 0 5.610963915714251e-10
with O 0 3.718573842945161e-13
sparing O 0 3.428435313423961e-10
of O 0 6.000407282158449e-09
the O 0 5.568214778151059e-09
U O 0 9.762760555531713e-07
- O 0 6.25285352384708e-08
fibers O 0 7.734034745965346e-09
, O 0 2.444137080226394e-11
compatible O 0 9.037320891636114e-11
with O 0 2.298870946035314e-12
the O 0 2.4638813211907973e-10
findings O 0 3.1400304578710347e-10
of O 0 1.1567361513087349e-09
childhood O 0 4.309029100113548e-05
ALD B-Disease 1 1.0
. O 0 2.9921229725005105e-06

Oleic O 0 0.00028130391729064286
and O 0 2.3923373646539403e-06
erucic O 0 0.0006923192413523793
acids O 0 2.304430154254078e-06
( O 0 1.3828432843254745e-09
Lorenzos O 0 2.0716906590223516e-07
Oil O 0 7.250242362033532e-08
) O 0 3.17754373160839e-12
were O 0 2.648463262935885e-12
administered O 0 1.439659589458353e-11
to O 0 1.1023720131175807e-10
patients O 0 9.058697368613533e-12
1 O 0 1.1838421354326556e-09
and O 0 2.2853541975509373e-11
4 O 0 1.0187586774179636e-08
, O 0 9.041316306745983e-12
but O 0 5.88317285513118e-12
sufficient O 0 4.7204351538709943e-11
effectiveness O 0 1.6411195319365746e-11
was O 0 3.890567035202963e-11
not O 0 1.6298644725520894e-11
obtained O 0 8.247543203943053e-10
. O 0 4.827867439161082e-09

The O 0 4.918258014185994e-07
findings O 0 9.590104710355263e-09
in O 0 8.865532613588911e-11
this O 0 6.659115620033518e-11
family O 0 9.221592239816445e-12
suggest O 0 3.2948273016170093e-12
that O 0 1.0398662996218694e-13
delGAG291 O 0 2.46407394488557e-10
is O 0 1.3604208905226844e-12
part O 0 1.67721999483339e-11
of O 0 1.567489055220861e-10
the O 0 6.317655287801927e-10
cause O 0 1.1121093024257789e-07
of O 0 5.889292253868916e-08
Japanese O 0 2.8095159905205946e-06
ALD B-Disease 1 1.0
with O 0 3.3377028918479823e-10
phenotypic O 0 7.622691811093318e-08
variations O 0 2.1508076031295786e-07
. O 0 1.6948581205156188e-08

Moreover O 0 4.5914170243577246e-08
, O 0 4.707236336831677e-11
although O 0 5.746933311179259e-12
the O 0 1.80956135492627e-11
scale O 0 3.0440152620769823e-09
of O 0 3.008067961385308e-10
the O 0 9.521546745494547e-11
study O 0 1.7730726609155312e-11
is O 0 6.691613951316511e-13
limited O 0 8.544551351186147e-12
, O 0 2.8244158747914305e-11
there O 0 6.867223456552551e-11
is O 0 1.637152913236406e-10
a O 0 4.695843713875547e-09
possibility O 0 4.764353036534885e-07
that O 0 9.232869579989256e-09
PET O 0 1.998483821807895e-05
can O 0 1.0959745999628012e-08
detect O 0 1.1154163530591177e-06
an O 0 8.005500262697751e-09
insidious B-Disease 0 1.511269420007011e-05
lesion I-Disease 1 0.948442280292511
which O 0 9.907062947789314e-10
is O 0 1.0004012895858949e-10
undetectable O 0 2.636782181486552e-10
by O 0 3.215091387565039e-12
computed O 0 1.5412796372515913e-08
tomogram O 0 3.2733107673266204e-06
( O 0 2.2973576374596405e-09
CT O 0 5.866500032425392e-06
) O 0 9.957315527664434e-11
or O 0 3.9267114559926597e-10
MRI O 0 1.74921570561537e-08
analysis O 0 7.866866880146262e-12
, O 0 1.5206980368952933e-13
and O 0 3.6349195815842464e-14
that O 0 2.453413991063136e-14
the O 0 4.4004955387054456e-13
higher O 0 2.026353564110739e-11
level O 0 3.103672596704854e-10
of O 0 2.1956500853570482e-11
tau O 0 1.9680714002934252e-10
reflects O 0 1.5120480822278237e-12
the O 0 1.688849364175904e-12
process O 0 1.1361118296138173e-10
of O 0 2.1442531084048255e-10
neuronal B-Disease 0 3.437774694248219e-06
degeneration I-Disease 1 0.9999998807907104
in O 0 1.1501288099680096e-06
ALD B-Disease 1 1.0
. O 0 1.309319827669242e-06

Lorenzos O 0 3.376973472768441e-05
Oil O 0 2.5724543206706585e-07
should O 0 4.075983162099561e-10
be O 0 5.540376317447748e-12
given O 0 8.900510536924422e-13
in O 0 6.943554346945657e-13
the O 0 4.443122519209863e-12
early O 0 4.935722941468157e-10
stage O 0 2.317831621079236e-10
. O 0 4.220634258755851e-11
. O 0 4.62368499043464e-09

Nonsense O 0 5.306371349433903e-06
mutation O 0 1.2858778930535664e-08
in O 0 3.0217828239642586e-10
exon O 0 3.698817252484332e-09
4 O 0 2.5449434559732254e-08
of O 0 1.5895183780312294e-10
human O 0 6.2832114511302e-11
complement O 0 2.72043082505391e-10
C9 O 0 4.066648671141593e-06
gene O 0 2.7272977279335642e-11
is O 0 8.127970410436169e-13
the O 0 2.248943652832791e-12
major O 0 2.2493407136892074e-10
cause O 0 1.1557906631765036e-08
of O 0 2.545501764927849e-08
Japanese O 0 3.291311259090435e-07
complement B-Disease 0 2.5352690613544837e-07
C9 I-Disease 1 0.9999364614486694
deficiency I-Disease 1 0.557861328125
. O 0 4.930148520543298e-07

Deficiency B-Disease 0 0.18188564479351044
of I-Disease 0 9.914269867294934e-07
the I-Disease 0 2.6445621870152536e-07
ninth I-Disease 0 6.643101642112015e-07
component I-Disease 0 7.491009590410158e-09
of I-Disease 0 5.947401682249165e-09
human I-Disease 0 2.52153603552685e-10
complement I-Disease 0 5.849064566021411e-10
( O 0 2.1278950823599985e-10
C9 O 0 4.058659669681219e-06
) O 0 1.2949975293496951e-11
is O 0 1.7812951634554874e-12
the O 0 2.8211087979568283e-12
most O 0 1.534509498635206e-12
common O 0 1.9931722050614553e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.1868407912583052e-09
Japan O 0 3.2338112188057266e-09
but O 0 2.4527579620126083e-11
is O 0 5.593477070409136e-12
rare O 0 4.383300146459934e-12
in O 0 4.006545963053387e-12
other O 0 1.5539072849637958e-12
countries O 0 1.6738492536472194e-10
. O 0 1.6380916179059568e-08

We O 0 1.6525145696277832e-08
studied O 0 1.8712829064071457e-09
the O 0 6.784059425335442e-11
molecular O 0 1.9430475284298865e-10
basis O 0 9.158638292205978e-10
of O 0 1.4668298797815282e-09
C9 B-Disease 1 0.9999991655349731
deficiency I-Disease 0 8.549034828320146e-05
in O 0 3.594710362708753e-10
four O 0 1.3078937932675672e-10
Japanese O 0 1.7649570693833994e-08
C9 B-Disease 0 0.0007353180553764105
- I-Disease 0 5.6684166338527575e-06
deficient I-Disease 0 6.972914547986875e-07
patients O 0 1.3249655816949257e-09
who O 0 9.886293173000382e-11
had O 0 3.889547350865996e-09
suffered O 0 7.246425184348482e-07
from O 0 1.2259379218448885e-06
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.0442893148574512e-06

Direct O 0 6.366457938611347e-08
sequencing O 0 5.0496509196307215e-09
of O 0 8.692755848471734e-09
amplified O 0 7.128977408399351e-09
C9 O 0 1.3921786603532382e-06
cDNA O 0 3.4742799748244124e-09
and O 0 1.41375758322404e-10
DNA O 0 1.1035864444508547e-09
revealed O 0 2.307060792405835e-10
a O 0 4.601860906228161e-11
nonsense O 0 5.208570241777011e-10
substitution O 0 2.3958268702273244e-10
( O 0 1.4317210611514142e-11
CGA O 0 7.439138638432041e-09
- O 0 1.4430818318089678e-08
- O 0 1.2311566877087898e-08
> O 0 3.818582339221166e-09
TGA O 0 1.5453057722325525e-09
) O 0 4.3057628317834384e-13
at O 0 1.7961470852312367e-11
codon O 0 1.0416876562724386e-11
95 O 0 2.4974492959795036e-11
in O 0 2.6294621861822076e-12
exon O 0 5.45089529069287e-11
4 O 0 1.1727400162087065e-09
in O 0 2.0776344186734796e-11
the O 0 2.631672380015715e-10
four O 0 1.2426975004586893e-09
C9 B-Disease 0 9.189086995320395e-05
- I-Disease 0 1.2699879334832076e-06
deficient I-Disease 0 1.042057320432832e-07
individuals O 0 1.6183232531830072e-10
. O 0 1.9979111698376073e-08

An O 0 3.1869991090616168e-09
allele O 0 2.3245798619342395e-09
- O 0 8.969374132306029e-10
specific O 0 3.8819777947729506e-10
polymerase O 0 6.389399231920834e-09
chain O 0 1.5469041603211053e-09
reaction O 0 2.8639295795995778e-11
system O 0 1.801698894243753e-11
designed O 0 1.590724600653015e-11
to O 0 4.0448575044926827e-10
detect O 0 8.101047610509227e-11
exclusively O 0 8.173645137457553e-13
only O 0 1.3354522565914295e-12
one O 0 6.246404869042488e-12
of O 0 1.2937039460536592e-11
the O 0 2.960374653748765e-11
normal O 0 4.429622224577656e-10
and O 0 1.3346533947466988e-11
mutant O 0 1.622009887514153e-10
alleles O 0 2.3106927829474877e-11
indicated O 0 9.353961355484941e-11
that O 0 1.5311649517735226e-12
all O 0 2.576676502372144e-12
the O 0 1.7291541462571836e-11
four O 0 8.925454125785492e-12
patients O 0 6.07281694549322e-13
were O 0 3.5395226246487388e-12
homozygous O 0 1.2776804354103222e-12
for O 0 5.358856587645011e-12
the O 0 1.156122350631783e-10
mutation O 0 1.189731507755809e-10
in O 0 2.5362040245724415e-10
exon O 0 1.498921986531343e-09
4 O 0 2.3179048014299042e-08
and O 0 6.673123859046726e-12
that O 0 2.2867309174695594e-12
the O 0 7.479879216010232e-11
parents O 0 3.9001663010296284e-11
of O 0 2.9097141363010337e-10
patient O 0 2.7140729663699403e-09
2 O 0 4.8089194848444095e-08
were O 0 1.981488972901957e-09
heterozygous O 0 4.020285437889015e-09
. O 0 1.407586758261914e-08

The O 0 6.222657589205483e-08
common O 0 6.019229559228734e-09
mutation O 0 4.932553476777457e-09
at O 0 4.95857888083151e-09
codon O 0 1.4033424422521534e-09
95 O 0 2.0346320184216893e-09
in O 0 7.360263787337118e-11
exon O 0 7.006411562038295e-10
4 O 0 3.7137048991553456e-09
might O 0 4.8162283189379096e-11
be O 0 1.2462281206992998e-11
responsible O 0 1.849352962435269e-11
for O 0 4.16627583127438e-12
most O 0 1.0265050615076987e-10
Japanese O 0 4.3605734845186817e-07
C9 B-Disease 1 0.9888483285903931
deficiency I-Disease 0 1.129824340750929e-05
. O 0 3.2592677445819618e-09
. O 0 1.864970045062364e-08

BRCA1 O 0 1.2948785155231235e-08
required O 0 1.2000791471677985e-09
for O 0 1.4405997228461587e-10
transcription O 0 8.194126266403146e-09
- O 0 2.134718712909489e-08
coupled O 0 2.595132997385008e-08
repair O 0 5.975482963549439e-06
of O 0 6.872938911328674e-07
oxidative O 0 7.677780899939535e-07
DNA O 0 2.60002389040892e-06
damage O 0 0.00247222650796175
. O 0 2.1559189633535425e-07

The O 0 1.341006009170087e-05
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 0 4.5662781644750794e-07
BRCA1 O 0 1.1703478719482518e-07
encodes O 0 1.0707942310617113e-09
a O 0 1.126420068331413e-09
zinc O 0 2.1335624822427235e-08
finger O 0 2.8306924804155642e-08
protein O 0 9.037088410934757e-09
of O 0 1.9944490503576162e-09
unknown O 0 4.190973346140936e-09
function O 0 1.9476904533632933e-09
. O 0 3.6883907039708674e-09

Association O 0 1.1078052608581856e-07
of O 0 7.217955300120593e-08
the O 0 3.7194485713598624e-08
BRCA1 O 0 1.5817285259345226e-09
protein O 0 1.0594494725957304e-10
with O 0 2.3797191430960374e-13
the O 0 7.052409350949418e-11
DNA O 0 8.78981942786794e-10
repair O 0 3.257889602537034e-08
protein O 0 1.3418227418071638e-08
Rad51 O 0 6.485624481911145e-09
and O 0 6.279745386889024e-12
changes O 0 1.5832481159439027e-11
in O 0 1.5865007224613592e-11
the O 0 3.3640205204799045e-11
phosphorylation O 0 5.138311998109657e-11
and O 0 1.5602139025183703e-10
cellular O 0 4.1756992308350505e-10
localization O 0 7.887883235468962e-09
of O 0 4.031972977713849e-09
the O 0 2.0786390386717812e-09
protein O 0 4.823925703334453e-10
after O 0 3.0431326347724053e-09
exposure O 0 8.173688392787426e-10
to O 0 5.728269525384633e-10
DNA O 0 1.8238670573822446e-09
- O 0 7.673813806619023e-10
damaging O 0 2.810795152186074e-09
agents O 0 1.3342714953734625e-11
are O 0 1.4385409909719454e-13
consistent O 0 1.0918953458408098e-12
with O 0 2.880479109222808e-15
a O 0 3.1875353051491473e-12
role O 0 2.687395878747667e-12
for O 0 4.612359539440947e-12
BRCA1 O 0 3.427591821481002e-10
in O 0 3.735586062703078e-09
DNA O 0 5.691925366591022e-07
repair O 0 0.00041851194691844285
. O 0 1.4700315205118386e-06

Here O 0 5.876735897913932e-08
, O 0 9.559670416381394e-11
it O 0 4.897223685601526e-12
is O 0 1.9723007949057347e-12
shown O 0 4.164241867998797e-12
that O 0 8.198522589986101e-12
mouse O 0 1.27996111487505e-08
embryonic O 0 7.205491669992625e-07
stem O 0 8.190111771000375e-07
cells O 0 3.031588136082064e-08
deficient B-Disease 0 2.6694904065038827e-08
in I-Disease 0 1.6557349935553134e-09
BRCA1 I-Disease 0 9.558968727674255e-09
are O 0 8.042574939359781e-11
defective O 0 6.10048278559816e-09
in O 0 2.5970714467860034e-10
the O 0 2.5978194595488446e-10
ability O 0 9.844796852731541e-12
to O 0 1.7783637062951385e-10
carry O 0 9.430239228391812e-11
out O 0 1.9667795170263958e-11
transcription O 0 2.7879148989384817e-10
- O 0 8.452086808219406e-10
coupled O 0 3.033628681592404e-09
repair O 0 9.731276122693089e-07
of O 0 1.423867104222154e-07
oxidative O 0 1.1779016517721175e-07
DNA O 0 1.480082261196003e-07
damage O 0 6.6284223976254e-06
, O 0 1.3555864764036585e-10
and O 0 8.284321839635567e-11
are O 0 4.1431701819361066e-11
hypersensitive O 0 2.795601439231632e-08
to O 0 4.0765630160422006e-07
ionizing O 0 3.856422154058237e-06
radiation O 0 2.4614798803668236e-06
and O 0 3.1372704434318166e-10
hydrogen O 0 1.7207127389617938e-10
peroxide O 0 3.3252884890089263e-09
. O 0 1.9458710198705376e-09

These O 0 4.467194170132416e-09
results O 0 2.0173278603152767e-09
suggest O 0 2.07535499896494e-09
that O 0 8.262245054790895e-11
BRCA1 O 0 3.5395550934680386e-09
participates O 0 1.5211550769000937e-11
, O 0 5.865377628033741e-13
directly O 0 9.829317047793662e-12
or O 0 1.7529380724745636e-10
indirectly O 0 1.7684573805354376e-09
, O 0 5.469057498541652e-11
in O 0 1.791884418622658e-10
transcription O 0 2.3425885675720792e-09
- O 0 8.120889738449932e-09
coupled O 0 2.7944218050635072e-09
repair O 0 5.11869757247041e-07
of O 0 7.309755289952591e-08
oxidative O 0 9.19238800634048e-08
DNA O 0 1.5853542834065593e-07
damage O 0 3.950031896238215e-06
. O 0 4.247636464782545e-09
. O 0 5.160336602472171e-09

Truncation O 0 1.2361622793832794e-05
mutations O 0 3.1472104922158906e-08
in O 0 1.4226490818725068e-10
the O 0 3.9857800393505727e-10
transactivation O 0 3.165126258863893e-07
region O 0 1.5616808468621457e-07
of O 0 1.2253963177499827e-07
PAX6 O 0 3.818932600552216e-05
result O 0 4.304689582568244e-08
in O 0 3.5830478584131242e-09
dominant O 0 6.284442832793502e-08
- O 0 9.538206668935345e-09
negative O 0 9.446901039211753e-09
mutants O 0 4.065565217814537e-09
. O 0 3.6189812258058396e-10

PAX6 O 0 0.0006699056830257177
is O 0 5.719494655664903e-09
a O 0 4.2222163543215174e-09
transcription O 0 2.9813036483972155e-09
factor O 0 4.594064365037731e-11
with O 0 3.148167693873237e-14
two O 0 8.571202558468882e-13
DNA O 0 4.8456124529527855e-11
- O 0 1.4044261587020657e-10
binding O 0 1.7311631239635972e-08
domains O 0 2.2433189528214825e-08
( O 0 2.4271388718299924e-11
paired O 0 4.1727992589057905e-11
box O 0 2.9172439464097977e-10
and O 0 9.646802107132757e-11
homeobox O 0 3.4782714486425448e-09
) O 0 5.9955590839266826e-12
and O 0 2.1211997436321184e-11
a O 0 2.988899128197886e-09
proline O 0 1.7319360168244202e-08
- O 0 3.1271593314841084e-08
serine O 0 1.3838438839286482e-08
- O 0 2.4238950402377668e-08
threonine O 0 4.017895349761602e-08
( O 0 8.071250612307068e-11
PST O 0 4.180349719717924e-07
) O 0 7.050132613123372e-12
- O 0 5.883032949682843e-10
rich O 0 6.212607095434919e-10
transactivation O 0 2.930059395112039e-07
domain O 0 1.2765362100708444e-07
. O 0 1.6432487370821036e-08

PAX6 O 1 0.9985072016716003
regulates O 0 0.00015654573508072644
eye O 0 0.020287582650780678
development O 0 3.2553586493122566e-07
in O 0 6.32955154955539e-09
animals O 0 1.1305305303022095e-10
ranging O 0 8.648567195734813e-09
from O 0 6.083123782474331e-09
jellyfish O 0 2.440556090554935e-10
to O 0 8.825164488079906e-10
Drosophila O 0 6.926554330100032e-10
to O 0 6.264940788369699e-10
humans O 0 1.9675430174004305e-09
. O 0 3.6494756106009163e-09

Heterozygous O 0 9.403453304912546e-08
mutations O 0 4.1706389453111115e-09
in O 0 2.8784421027272522e-11
the O 0 3.093082456828711e-10
human O 0 1.1983591896580492e-09
PAX6 O 0 1.4919082786946092e-06
gene O 0 1.1507982761171931e-10
result O 0 2.634744852847426e-11
in O 0 1.1522357503887526e-12
various O 0 6.98045679418946e-13
phenotypes O 0 6.326334595074812e-11
, O 0 4.219728136790196e-13
including O 0 1.5089797900796897e-12
aniridia B-Disease 1 1.0
, O 0 4.675888121141725e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.296422912413277e-09
autosomal B-Disease 0 1.7934333300217986e-05
dominant I-Disease 0 5.288228567223996e-05
keratitis I-Disease 1 0.9998761415481567
, O 0 1.2238099422745563e-08
and O 0 1.165336058761568e-07
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9999991655349731

It O 0 3.2438993713412856e-09
is O 0 1.0023360613731214e-10
believed O 0 1.8503207299680469e-10
that O 0 9.590470778642057e-13
the O 0 1.4087233983495207e-11
mutated O 0 7.018927106194894e-11
allele O 0 2.8242139737955085e-09
of O 0 1.4393350511454628e-08
PAX6 O 0 1.4508225376630435e-06
produces O 0 5.301967753723602e-10
an O 0 4.0381584187620945e-10
inactive O 0 2.0221124774622012e-09
protein O 0 2.063250015282847e-09
and O 0 2.524977171791676e-10
aniridia B-Disease 1 1.0
is O 0 3.801702419536923e-08
caused O 0 6.034895250195405e-07
due O 0 1.5597238416376058e-06
to O 0 2.654902573340223e-07
genetic O 0 3.288672303369822e-07
haploinsufficiency O 0 1.6251026409008773e-06
. O 0 7.789866174334747e-08

However O 0 3.1697233282557136e-08
, O 0 1.2385062420072757e-10
several O 0 3.2804068489378224e-11
truncation O 0 3.237361312358189e-08
mutations O 0 1.5702248390425666e-09
have O 0 2.9030106443728165e-11
been O 0 1.789110526395632e-11
found O 0 4.863737450983008e-13
to O 0 9.556748621630806e-12
occur O 0 1.859185201624758e-11
in O 0 9.706615719529132e-12
the O 0 1.6697644655838673e-10
C O 0 7.889526898452459e-08
- O 0 1.0097784830520595e-08
terminal O 0 1.8292772097083798e-07
half O 0 2.8942561680622703e-09
of O 0 2.2561208457005932e-10
PAX6 O 0 1.2442912122878624e-07
in O 0 1.2642809021912171e-10
patients O 0 1.9337739742830706e-11
with O 0 7.175073903076257e-12
Aniridia B-Disease 1 1.0
resulting O 0 3.9442426214009174e-08
in O 0 1.8517267719175834e-09
mutant O 0 5.723267415547184e-10
proteins O 0 6.4161336833790106e-12
that O 0 8.982233901978776e-13
retain O 0 1.4848833967961994e-11
the O 0 2.2137151486911755e-11
DNA O 0 5.6180934904226376e-11
- O 0 5.794330293351635e-11
binding O 0 6.759345083651169e-09
domains O 0 4.5459884745469026e-09
but O 0 2.172821228496602e-10
have O 0 9.413956419956904e-11
lost O 0 1.8140349222761643e-09
most O 0 3.4515714396853026e-13
of O 0 6.520232270768034e-12
the O 0 4.17713121037e-11
transactivation O 0 7.389561318404958e-08
domain O 0 1.6151879833614657e-07
. O 0 1.716073505519944e-08

It O 0 1.0336650424491722e-09
is O 0 2.7163955113040927e-11
not O 0 1.5400314704039353e-11
clear O 0 4.5985026897454873e-10
whether O 0 4.911247797334539e-11
such O 0 9.65646729245151e-11
mutants O 0 8.23909189762162e-08
really O 0 1.6915051581634089e-09
behave O 0 2.8104132909767543e-10
as O 0 1.0777026493435926e-10
loss O 0 5.375169198629237e-10
- O 0 1.621297052167847e-08
of O 0 6.417957365556504e-08
- O 0 1.4885131349728908e-07
function O 0 3.379529323055408e-09
mutants O 0 1.297074669892595e-10
as O 0 2.614474175349768e-12
predicted O 0 5.792642476798449e-10
by O 0 5.522559146098338e-11
haploinsufficiency O 0 7.894417649367824e-06
. O 0 2.0906287545585656e-07

Contrary O 0 1.6533884661384946e-07
to O 0 3.948478433102309e-09
this O 0 4.0864137074159146e-10
theory O 0 4.733097469511449e-09
, O 0 3.773622733738158e-11
our O 0 5.947089348756762e-11
data O 0 5.711574269096076e-11
showed O 0 2.0818470211625417e-11
that O 0 3.6370730645968186e-12
these O 0 5.004730570939975e-12
mutants O 0 1.4776824208695416e-10
are O 0 4.572740189973112e-12
dominant O 0 1.5532015673613841e-09
- O 0 1.3444453328403938e-09
negative O 0 1.2751406597288906e-09
in O 0 1.6543955094761031e-10
transient O 0 6.5794574233279945e-09
transfection O 0 4.0576225712740666e-10
assays O 0 3.989938240911428e-11
when O 0 3.9836480468513624e-12
they O 0 1.3810066371716667e-12
are O 0 2.243467185029241e-13
coexpressed O 0 6.210608471945989e-09
with O 0 1.529084844853479e-11
wild O 0 7.807027913031561e-09
- O 0 1.139961547380608e-08
type O 0 2.98533137765844e-07
PAX6 O 0 0.00016159600636456162
. O 0 8.166372822415724e-08

We O 0 3.817746829781754e-08
found O 0 3.358699082744998e-11
that O 0 1.7296842126993117e-12
the O 0 7.292476345011067e-11
dominant O 0 1.170161634256317e-09
- O 0 9.738688744320712e-10
negative O 0 6.223898063595357e-10
effects O 0 1.4909760537307193e-08
result O 0 3.4622782418836096e-10
from O 0 1.7769906379694334e-10
the O 0 2.6841596653670585e-11
enhanced O 0 7.09594666012392e-12
DNA O 0 4.292229766056366e-11
binding O 0 5.488685617116573e-10
ability O 0 1.0701300262594415e-10
of O 0 1.2609237265426287e-10
these O 0 3.898032244209482e-11
mutants O 0 4.05800415492763e-09
. O 0 1.7295912480008724e-09

Kinetic O 0 2.3059068610109534e-07
studies O 0 2.5482842502810854e-09
of O 0 4.2908809838593243e-10
binding O 0 1.0727285726375158e-08
and O 0 1.3949069677110515e-09
dissociation O 0 2.3126409232077094e-08
revealed O 0 1.022094076041924e-09
that O 0 7.244003574075064e-13
various O 0 2.3739992176946556e-12
truncation O 0 4.467858971679561e-09
mutants O 0 1.7761266069005188e-10
have O 0 3.660924861870196e-12
3 O 0 2.229904455530729e-10
- O 0 1.9338966539272917e-10
5 O 0 2.353148120803894e-09
- O 0 2.943703891755689e-10
fold O 0 7.790973421961667e-10
higher O 0 2.63581184656303e-10
affinity O 0 7.349599227823855e-12
to O 0 4.79793670071782e-11
various O 0 5.077803954221805e-13
DNA O 0 3.967890252476458e-12
- O 0 1.0438789589672925e-12
binding O 0 2.5780296300514927e-11
sites O 0 2.979764004984453e-12
when O 0 4.2597406179657737e-13
compared O 0 1.0239658513461203e-12
with O 0 8.751909651638287e-14
the O 0 1.6043212591743128e-10
wild O 0 1.7225721959945872e-09
- O 0 5.845576467322644e-09
type O 0 1.35893301944634e-07
PAX6 O 0 7.311993977054954e-05
. O 0 6.557259979445007e-08

These O 0 7.406486535188606e-10
results O 0 2.586640623913894e-10
provide O 0 7.784385115672254e-12
a O 0 8.976094867385598e-11
new O 0 3.4561669498556213e-11
insight O 0 6.3080647476343454e-12
into O 0 1.6592794846448378e-12
the O 0 1.3295000950847013e-12
role O 0 2.1655617837151864e-12
of O 0 1.302582954693099e-11
mutant O 0 1.885258393841127e-09
PAX6 O 0 9.13855899398186e-07
in O 0 4.891673732743129e-10
causing O 0 2.938412535513635e-07
aniridia B-Disease 1 1.0
. O 0 1.14115088933886e-07
. O 0 4.100362005488023e-08

Reversal O 0 8.080911015895254e-07
of O 0 8.927480621423456e-08
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 3.7828710901521845e-06
excellent O 0 1.6069197528167933e-08
neuropsychologic O 0 6.318115629255772e-05
outcome O 0 0.06758704036474228
in O 0 4.482474480482779e-08
very B-Disease 0 3.4907682078255675e-08
- I-Disease 0 6.788300765947497e-07
long I-Disease 0 4.734616965151872e-08
- I-Disease 0 8.549096541798917e-09
chain I-Disease 0 1.6283435710917615e-09
acyl I-Disease 0 1.397495452692965e-09
- I-Disease 0 1.0441439712849387e-08
coenzyme I-Disease 0 4.161008870795513e-09
A I-Disease 0 3.339602699270472e-06
dehydrogenase I-Disease 0 3.319298411952332e-05
deficiency I-Disease 0 0.010128212161362171
. O 0 4.195918847926805e-07

Very B-Disease 0 1.6875958408490987e-06
- I-Disease 0 4.555496616376331e-06
long I-Disease 0 1.2118432834995474e-07
- I-Disease 0 2.1652359905033336e-08
chain I-Disease 0 1.0818593798589404e-09
acyl I-Disease 0 1.9692091013379098e-10
- I-Disease 0 1.1440640795834511e-10
coenzyme I-Disease 0 3.961698677446002e-11
A I-Disease 0 1.7732130208614194e-09
dehydrogenase I-Disease 0 5.077252840379742e-09
( I-Disease 0 3.5149216870422606e-11
VLCAD I-Disease 0 0.00043556580203585327
) I-Disease 0 8.824675989949071e-10
deficiency I-Disease 0 1.6220990062265628e-07
is O 0 3.74910137657114e-11
a O 0 1.826653139858081e-08
disorder O 1 0.9704050421714783
of O 0 3.6127836210653186e-05
fatty O 0 1.1990879102086183e-05
acid O 0 8.146853360813111e-07
beta O 0 1.2511713975982275e-07
oxidation O 0 1.1770477037487126e-08
that O 0 9.652765392553775e-11
reportedly O 0 4.5334830334198273e-10
has O 0 1.6000839975910397e-12
high O 0 3.817070964862168e-11
rates O 0 2.1361246105300324e-11
of O 0 9.978071320582149e-12
morbidity O 0 4.3357964329970855e-08
and O 0 1.6662784485532711e-09
mortality O 0 9.773901865628432e-07
. O 0 3.1372856312827935e-08

We O 0 2.6146491194367627e-08
describe O 0 1.2051576403493414e-09
the O 0 1.3637060924942546e-10
outcome O 0 2.832197587565588e-09
of O 0 5.503925787353481e-11
a O 0 2.8051101372272846e-11
5 O 0 1.7162615773003154e-10
- O 0 1.542183221403537e-11
year O 0 4.6400949055280805e-11
- O 0 3.61232627144048e-10
old O 0 3.03772806908853e-09
girl O 0 4.1611655787754387e-10
with O 0 2.3032476967332904e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.354074837285225e-07
was O 0 7.365986931517909e-09
first O 0 1.4076524668116264e-10
seen O 0 3.468687836960527e-11
at O 0 1.4675812648468067e-11
5 O 0 5.809480327356731e-11
months O 0 7.833670344348231e-12
of O 0 1.0754797660078586e-12
age O 0 1.8817105859603167e-11
with O 0 7.504193121933567e-13
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 0 0.0009102234616875648
hepatomegaly B-Disease 1 1.0
, O 1 0.9643810987472534
encephalopathy B-Disease 1 0.9999978542327881
, O 0 5.755984489042021e-08
and O 0 3.245912978400156e-07
hypotonia B-Disease 1 0.997262716293335
. O 0 0.0007878536125645041

Biochemical O 0 9.498393183093867e-07
studies O 0 6.357454651606531e-08
indicated O 1 0.8090479373931885
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 7.318255029531429e-06
by O 0 9.383749333125024e-11
a O 0 1.694078433089885e-09
stable O 0 9.331232675435785e-09
yet O 0 4.582936696806428e-09
inactive O 0 1.0558294682994074e-08
enzyme O 0 2.1009494588497546e-08
. O 0 1.5727403379628413e-08

Molecular O 0 1.639437755329709e-06
genetic O 0 1.202059074500994e-08
analysis O 0 3.2069000233114764e-10
of O 0 3.0151807717260226e-09
her O 0 8.96501628488977e-09
VLCAD O 1 0.9917036294937134
gene O 0 9.32639299122684e-09
revealed O 0 1.8656708178355075e-08
a O 0 5.5799311837745336e-09
T1372C O 0 3.760175104616792e-06
( O 0 5.191549967697995e-10
F458L O 0 1.3457822660711827e-06
) O 0 3.64106744754622e-10
missense O 0 1.2526218995390082e-07
mutation O 0 7.6902146872726e-09
and O 0 2.0311023696262254e-10
a O 0 1.6669531532897963e-08
1668 O 0 7.742615707684308e-05
ACAG O 0 0.002201820956543088
1669 O 0 3.2354659197153524e-05
splice O 0 2.0321836018410977e-06
site O 0 4.262124519982535e-08
mutation O 0 1.7586597067520415e-08
. O 0 1.1594006643633747e-08

After O 0 1.5678575948641083e-07
initial O 0 4.9449056405137526e-08
treatment O 0 9.109165866050262e-09
with O 0 4.181970394978585e-11
intravenous O 0 4.061395220134045e-09
glucose O 0 1.485979908011359e-07
and O 0 1.607558947069876e-10
carnitine O 0 1.8149485248031283e-09
, O 0 8.873009271770371e-11
the O 0 1.123911186340365e-09
patient O 0 1.5359212568455405e-08
has O 0 4.0967992886997706e-11
thrived O 0 5.671238478832663e-10
on O 0 2.068356597106913e-09
a O 0 1.921873549193265e-09
low O 0 5.296995482240163e-07
- O 0 6.961818144191056e-08
fat O 0 4.820803312099997e-08
diet O 0 1.556735990115854e-10
supplemented O 0 4.609410726372221e-13
with O 0 1.2196077752314044e-13
medium O 0 5.1339181794674005e-09
- O 0 1.7687248998754512e-08
chain O 0 8.212354352110651e-09
triglyceride O 0 1.9882429036499616e-09
oil O 0 2.1286604479087146e-08
and O 0 4.3752248352069145e-11
carnitine O 0 3.898106143429558e-11
and O 0 6.203849933772432e-12
avoidance O 0 7.130686596745761e-10
of O 0 2.6623800941649733e-09
fasting O 0 2.3350557398771343e-07
. O 0 3.4467104725877107e-09

Her O 0 1.2972413969691843e-06
ventricular O 0 0.0014847979182377458
hypertrophy O 0 0.06755295395851135
resolved O 0 0.0001346374483546242
significantly O 0 4.433396227909725e-08
over O 0 3.965679340467432e-09
1 O 0 5.447141404602007e-08
year O 0 3.2669650318339905e-10
, O 0 5.2007924876418254e-12
and O 0 4.480125645467403e-11
cognitively O 0 5.380826451073517e-08
, O 0 3.292548525490879e-11
she O 0 7.2118170810209214e-12
is O 0 2.1995878968054938e-13
in O 0 3.2827817612705867e-13
the O 0 2.0451962606110596e-12
superior O 0 1.814656896970135e-10
range O 0 9.381142529463204e-10
for O 0 3.22188414836333e-10
age O 0 4.739093810712802e-07
. O 0 1.1364819130221804e-07

Clinical O 0 1.0416097211418673e-06
recognition O 0 1.9617027646745555e-07
of O 1 0.9999995231628418
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 6.611714979953831e-07
important O 0 4.15048051483069e-10
because O 0 1.7930082765738042e-11
it O 0 5.738802445406921e-13
is O 0 4.2447688701659214e-13
one O 0 4.0453759591295435e-13
of O 0 5.197410644225409e-12
the O 0 5.9823196743580276e-12
few O 0 7.367675913805272e-12
directly O 0 2.0274342205084395e-09
treatable O 1 0.9999998807907104
causes O 0 7.94443712948123e-06
of O 0 5.5019995670591015e-06
cardiomyopathy B-Disease 1 1.0
in O 0 1.7719142988426029e-06
children O 0 1.597881382764399e-09
. O 0 1.741304878066785e-10
. O 0 2.9322291261735245e-09

Cloning O 0 2.7516822598272483e-08
of O 0 2.3448046282403823e-10
a O 0 2.5380272536401627e-11
novel O 0 8.465538686719398e-11
member O 0 1.0134802719274916e-10
of O 0 2.094793227769287e-10
the O 0 5.260938351625555e-10
low O 0 1.0907634617751683e-07
- O 0 2.5377309142982085e-08
density O 0 4.694535871152539e-09
lipoprotein O 0 2.3072186650097137e-06
receptor O 0 3.5597742680693045e-05
family O 0 6.285449671850074e-08
. O 0 6.073387481819736e-08

A O 0 1.0477058367541758e-06
gene O 0 2.1760561408346035e-10
encoding O 0 3.251064140119553e-10
a O 0 1.1118114207064878e-09
novel O 0 5.561421989597193e-09
transmembrane O 0 2.8412022956558758e-08
protein O 0 9.863263539244826e-10
was O 0 5.582661416481116e-11
identified O 0 5.022284671474253e-13
by O 0 7.755433665060374e-14
DNA O 0 5.1557642703758955e-12
sequence O 0 4.215223818864605e-13
analysis O 0 3.454647321248644e-13
within O 0 4.163559254311e-12
the O 0 2.960911030247537e-11
insulin B-Disease 1 0.9259876012802124
- I-Disease 1 0.9999932050704956
dependent I-Disease 1 1.0
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 3.1093372321322477e-10
IDDM B-Disease 0 3.509715895688714e-07
) O 0 2.6081636850250334e-12
locus O 0 2.0710676229551694e-10
IDDM4 O 0 1.2552743555716006e-07
on O 0 9.986006688222915e-09
chromosome O 0 1.0004348496295279e-06
11q13 O 0 1.6330011931131594e-05
. O 0 6.332125934704891e-08

Based O 0 6.441698285897246e-09
on O 0 3.0951984086868833e-08
its O 0 3.437943263406851e-10
chromosomal O 0 1.504833022636376e-07
position O 0 1.6230428911967465e-07
, O 0 2.1458640420135566e-11
this O 0 2.0075571413591398e-11
gene O 0 4.294061634046997e-12
is O 0 4.5165940757395384e-13
a O 0 5.82217824299236e-12
candidate O 0 1.4053587460427508e-10
for O 0 1.2040673146029857e-11
conferring O 0 1.846627561974401e-08
susceptibility O 0 2.593085628177505e-05
to O 0 1.1313682989566587e-05
diabetes B-Disease 1 1.0
. O 0 6.69404425934772e-06

The O 0 5.160960085959232e-07
gene O 0 8.536598095076897e-09
, O 0 4.862316660414479e-10
termed O 0 6.901530724690019e-08
low O 0 2.6543507374299224e-06
- O 0 4.2816719059146635e-08
density O 0 1.5060462876803626e-09
lipoprotein O 0 2.5780828138977085e-08
receptor O 0 2.918771713211754e-08
related O 0 1.0029050478976842e-08
protein O 0 3.5662479636044964e-09
5 O 0 2.7254127843434617e-09
( O 0 9.013611905472896e-12
LRP5 O 0 3.249506050906348e-07
) O 0 6.2813625828495034e-12
, O 0 9.086125081492202e-12
encodes O 0 1.161109489805634e-11
a O 0 3.620624355882285e-10
protein O 0 7.201601093242971e-09
of O 0 6.64113652959486e-09
1615 O 0 5.165931725059636e-06
amino O 0 1.7168976285120152e-07
acids O 0 1.3625159889230076e-09
that O 0 2.4663094917026784e-12
contains O 0 1.5331316945144113e-12
conserved O 0 2.365078792532227e-11
modules O 0 3.676718651757227e-12
which O 0 3.109996797850262e-13
are O 0 3.0187652507937535e-13
characteristic O 0 1.9530974060266715e-11
of O 0 7.611388082306991e-12
the O 0 2.9978824978016405e-11
low O 0 4.527576535906519e-08
- O 0 1.4752029819931067e-08
density O 0 4.918677465326482e-09
lipoprotein O 0 5.063542403149768e-07
( O 0 2.1458947951913387e-09
LDL O 0 7.903772711870261e-07
) O 0 2.210880645225899e-10
receptor O 0 7.739969731801466e-08
family O 0 2.7652553580281847e-09
. O 0 7.119410838640761e-09

These O 0 3.907571599626181e-09
modules O 0 4.374929307715547e-09
include O 0 1.7638177030043778e-10
a O 0 6.39894848220024e-09
putative O 0 7.562837112118359e-08
signal O 0 2.36711343859497e-08
peptide O 0 6.630880289293373e-10
for O 0 2.2130405841203071e-10
protein O 0 4.506705009177381e-10
export O 0 1.4662284719690888e-09
, O 0 1.0737750098799292e-11
four O 0 3.43052010409739e-11
epidermal O 0 3.137038628864275e-09
growth O 0 1.8371273391437626e-09
factor O 0 2.3419530204016326e-10
( O 0 5.021312879383011e-11
EGF O 0 1.6256912260814715e-08
) O 0 1.4034989316569213e-11
repeats O 0 1.8206511298579642e-10
with O 0 2.4579773980071273e-13
associated O 0 2.914685437449549e-10
spacer O 0 1.097447288600506e-08
domains O 0 6.423686915724147e-09
, O 0 5.216123366569292e-11
three O 0 4.6066383346810014e-11
LDL O 0 7.119481182371601e-08
- O 0 1.9853827026850013e-08
receptor O 0 1.5698542910058677e-08
( O 0 1.0014684220793768e-10
LDLR O 0 1.2194990404168493e-06
) O 0 1.000003985868192e-11
repeats O 0 1.3221022887588418e-10
, O 0 5.651523086319665e-13
a O 0 2.6703824915208507e-11
single O 0 3.4161634632212667e-10
transmembrane O 0 3.171440710048046e-08
spanning O 0 9.997308758613599e-09
domain O 0 1.667315707720718e-08
, O 0 7.179184330352584e-11
and O 0 5.8386843970748e-11
a O 0 6.786007755721357e-09
cytoplasmic O 0 5.070974680165818e-07
domain O 0 4.2138273670389026e-07
. O 0 1.0586505894139009e-08

The O 0 1.6412901970852545e-07
encoded O 0 3.748390042801475e-09
protein O 0 1.4291286376533208e-08
has O 0 1.2260316459983267e-12
a O 0 1.7707261438376642e-12
unique O 0 1.292610549846751e-12
organization O 0 8.509473681250768e-11
of O 0 2.036099289171034e-09
EGF O 0 6.504959628728102e-07
and O 0 7.840021076788162e-09
LDLR O 0 0.02010698989033699
repeats O 0 5.440102057718832e-08
; O 0 2.632986537132176e-11
therefore O 0 8.810565055306085e-10
, O 0 6.0482244212956e-11
LRP5 O 0 2.691200643312186e-05
likely O 0 7.983980143677627e-10
represents O 0 1.2795265064494132e-12
a O 0 1.699311915140389e-12
new O 0 7.435775628041041e-13
category O 0 3.3470216181941126e-11
of O 0 3.791059480229286e-11
the O 0 6.003071928439851e-10
LDLR O 0 0.014667389914393425
family O 0 1.0451640441999643e-08
. O 0 3.516952062909695e-08

Both O 0 1.4345174292884622e-07
human O 0 4.020072452703971e-08
and O 0 1.3924348341021187e-09
mouse O 0 1.2878444977104664e-07
LRP5 O 0 0.003328380873426795
cDNAs O 0 2.168568789784331e-05
have O 0 1.3103389484570016e-09
been O 0 6.368140459400706e-10
isolated O 0 1.515370717797282e-09
and O 0 5.8378905008760196e-12
the O 0 6.982208561323588e-11
encoded O 0 3.172197921008646e-11
mature O 0 9.834615344317399e-10
proteins O 0 5.844196220711195e-12
are O 0 2.281214767866496e-13
95 O 0 2.0383753018826667e-10
% O 0 3.994644545701753e-11
identical O 0 4.375990455413037e-12
, O 0 5.445842127943523e-12
indicating O 0 9.110129317591031e-11
a O 0 2.6488852777895033e-10
high O 0 6.323831236443311e-09
degree O 0 2.238826937173144e-07
of O 0 2.366529638919701e-09
evolutionary O 0 7.2632913017400824e-09
conservation O 0 4.5730061404292144e-10
. O 0 4.596132849310486e-11
. O 0 1.9845109999749866e-09

The O 0 1.555613380332943e-07
APC B-Disease 0 1.2432955109886734e-08
variants O 0 4.399226816165225e-10
I1307K O 0 2.226124991011602e-07
and O 0 1.198486587750125e-10
E1317Q O 0 5.13689883518964e-07
are O 0 1.5915985543402122e-11
associated O 0 9.526846156404645e-08
with O 0 0.0001526534470031038
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 1.989396913870678e-08
but O 0 8.632749029513498e-12
not O 0 5.611579343561823e-12
always O 0 2.1767377939192756e-13
with O 0 4.81312326827037e-15
a O 0 2.6624638257977118e-11
family O 0 4.5474578963533574e-11
history O 0 8.124448891422276e-10
. O 0 9.311674986633989e-09

Classical O 0 0.002390229608863592
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.7124286816615495e-08
FAP B-Disease 0 5.924191803785561e-09
) O 0 3.1434888871605116e-13
is O 0 1.4491214489226883e-13
a O 0 9.743663514916179e-11
high O 0 0.0001746771886246279
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
that O 0 1.7212781200370841e-09
predisposes O 0 8.766986248076591e-09
to O 0 3.1152096457987e-09
hundreds O 0 2.07586378642155e-11
or O 0 1.8922968747503432e-10
thousands O 0 1.4134772519103223e-10
of O 0 5.037263406393322e-08
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999220371246338
carcinoma I-Disease 1 1.0
and O 0 8.012209917751534e-08
that O 0 5.360794030906391e-10
results O 0 3.038932161469887e-10
from O 0 3.885881894039045e-10
truncating O 0 1.8526744582914034e-08
mutations O 0 1.1618167539140245e-10
in O 0 5.2147109547151516e-11
the O 0 8.37445168766493e-10
APC B-Disease 0 4.346649706832295e-09
gene O 0 7.970803461709863e-10
. O 0 5.648516765432987e-09

A O 0 2.2652040243542615e-08
variant O 0 1.2338224664176778e-08
of O 0 1.939439364662121e-08
FAP B-Disease 0 2.7454103701529675e-07
is O 0 5.045126094671559e-09
attenuated B-Disease 1 0.6933217644691467
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999997615814209
coli I-Disease 1 1.0
, O 0 3.7647532313833665e-10
which O 0 6.2700630278078595e-12
results O 0 2.0818669704825155e-11
from O 0 1.9794028915942619e-10
germ O 0 8.40136920032819e-08
- O 0 1.2435487084516694e-09
line O 0 1.2078178457386457e-09
mutations O 0 1.500697136003204e-11
in O 0 3.155649569777652e-12
the O 0 1.6092974175485608e-11
5 O 0 2.570062773710191e-10
and O 0 2.8787204824770596e-12
3 O 0 5.4285314021740305e-09
regions O 0 4.429945299477822e-09
of O 0 3.2849116760047536e-09
the O 0 1.9217864632992132e-08
APC B-Disease 0 3.768205303344985e-08
gene O 0 5.3644995112733795e-09
. O 0 8.518982852478985e-09

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.21641959249973297
have O 0 9.412924661944544e-09
" O 0 8.833201725622075e-09
multiple O 0 1.0858460797180669e-07
" O 0 0.17104843258857727
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.5799224151180624e-09
typically O 0 2.371395024791667e-10
fewer O 0 5.437393590934647e-12
than O 0 3.696301077715791e-12
100 O 0 7.731633042129538e-12
) O 0 8.847629118062528e-14
without O 0 5.99689698940753e-12
the O 0 2.4245293273050805e-11
florid O 0 3.964212513807297e-09
phenotype O 0 3.663521486174659e-09
of O 0 3.2105906822010866e-10
classical O 0 8.109899418684563e-09
FAP B-Disease 0 5.732166030725239e-08
. O 0 4.010130005838164e-09

Another O 0 4.640199335881334e-08
group O 0 4.969369915563959e-10
of O 0 6.431259413908208e-10
patients O 0 2.198362464289616e-10
with O 0 5.003470728015547e-12
multiple O 0 2.04290856231637e-07
adenomas B-Disease 1 0.9962283372879028
has O 0 1.0638876801749575e-07
no O 0 1.0751107559769935e-08
mutations O 0 1.7439871768942794e-10
in O 0 2.4088767092145247e-10
the O 0 9.335393569287476e-10
APC B-Disease 0 4.444567769379404e-10
gene O 0 9.138753989668125e-12
, O 0 1.7820562733805723e-12
and O 0 2.679963672855279e-12
their O 0 5.3417023408719455e-12
phenotype O 0 9.42312228247033e-10
probably O 0 3.041599472286549e-10
results O 0 1.129314974868123e-10
from O 0 5.132760327875019e-10
variation O 0 8.86305084879524e-10
at O 0 2.1520583926015746e-10
a O 0 1.2360489368146155e-11
locus O 0 7.899633724939292e-11
, O 0 2.066409326637042e-12
or O 0 7.198106000139148e-11
loci O 0 8.72101668658587e-10
, O 0 4.935510333758941e-12
elsewhere O 0 4.9615634517552465e-11
in O 0 3.1384478349494316e-11
the O 0 9.357035146706494e-10
genome O 0 3.191731767770989e-09
. O 0 1.4580302298838888e-08

Recently O 0 1.9918769567084382e-07
, O 0 2.444511260080162e-10
however O 0 7.523921763397112e-11
, O 0 2.0115116169949765e-12
a O 0 2.3830281498105066e-11
missense O 0 2.5004356363211855e-09
variant O 0 5.230823774127202e-09
of O 0 3.314822833999642e-07
APC B-Disease 0 4.393864472262976e-08
( O 0 3.735712295060978e-10
I1307K O 0 3.4239833439642098e-06
) O 0 1.3156893977073203e-11
was O 0 1.403124838539327e-10
described O 0 3.040958110323011e-12
that O 0 1.2298299043641409e-13
confers O 0 6.418201907443244e-12
an O 0 4.315530138104817e-13
increased O 0 2.2273921596038804e-10
risk O 0 1.618274609427317e-06
of O 1 0.9925189018249512
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.5425176630733404e-08
including O 0 6.172937161430525e-12
multiple O 0 2.52696696900756e-10
adenomas B-Disease 0 3.2118930448632454e-07
, O 0 1.1183935028080683e-10
in O 0 3.6668492686686704e-09
Ashkenazim O 0 1.004571640805807e-05
. O 0 2.5139181047961756e-07

We O 0 1.2167789975592314e-07
have O 0 1.6376369704751426e-10
studied O 0 6.034166916135675e-11
a O 0 2.8210777464066084e-11
set O 0 9.515918608649088e-11
of O 0 2.197102742795831e-12
164 O 0 1.4917511670375916e-10
patients O 0 2.4082311665674094e-12
with O 0 1.1657266948614242e-12
multiple O 0 0.003321038093417883
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9967389702796936
/ I-Disease 1 0.999998927116394
or I-Disease 1 0.9998528957366943
carcinoma I-Disease 1 1.0
and O 0 1.6438903003290761e-06
analyzed O 0 4.3590471676679954e-08
codons O 0 6.368377114540635e-08
1263 O 0 1.1585434123162486e-07
- O 0 5.718425288847584e-09
1377 O 0 3.42278028142573e-08
( O 0 1.0191969490591646e-10
exon O 0 7.719591188504182e-09
15G O 0 8.921897176605853e-08
) O 0 1.176022061850912e-12
of O 0 4.787661239680219e-11
the O 0 3.8729258688974255e-10
APC B-Disease 0 1.6118304468903943e-09
gene O 0 2.438767937595898e-11
for O 0 1.0070808770246131e-10
germ O 0 6.820642965976731e-07
- O 0 4.027509348247804e-08
line O 0 2.0117575161293644e-08
variants O 0 7.656011824508369e-09
. O 0 6.9853856032864314e-09

Three O 0 1.69210618850002e-08
patients O 0 2.1519927506652436e-10
with O 0 1.6365516797636759e-12
the O 0 1.1773614305710112e-09
I1307K O 0 8.620606450904233e-08
allele O 0 1.7994511436469907e-09
were O 0 1.430351670439478e-10
detected O 0 1.4263712433404407e-10
, O 0 2.0932005586303537e-13
each O 0 1.4077155240099781e-12
of O 0 2.417668287790775e-10
Ashkenazi O 0 1.2902096102607175e-07
descent O 0 1.3198130091041094e-06
. O 0 4.64324507731817e-08

Four O 0 4.795455765815859e-07
patients O 0 2.868652160259444e-08
had O 0 4.02246325137412e-09
a O 0 2.5456268204493426e-09
germ O 0 8.305373739858624e-07
- O 0 4.7715325024455524e-08
line O 0 3.4031600648631866e-08
E1317Q O 0 1.7067971214146382e-07
missense O 0 7.195011697547216e-09
variant O 0 8.762233716375079e-10
of O 0 1.6764740706776138e-08
APC O 0 4.948259579862224e-10
that O 0 4.279842539395284e-12
was O 0 7.79028577757579e-11
not O 0 3.693383272829198e-12
present O 0 6.074349356843811e-12
in O 0 5.84998499295053e-12
controls O 0 1.3802338438839712e-10
; O 0 5.277989417046269e-12
one O 0 4.696384947600052e-11
of O 0 3.900590614391852e-11
these O 0 4.878956938979273e-13
individuals O 0 3.5392324921473817e-12
had O 0 9.37132371703342e-10
an O 0 5.021360757750948e-11
unusually O 0 4.278508103361389e-10
large O 0 6.409984348865194e-11
number O 0 9.491320229759737e-11
of O 0 4.357374461250174e-09
metaplastic B-Disease 0 9.704339026939124e-05
polyps I-Disease 0 1.3427966223389376e-06
of I-Disease 0 5.540567116213424e-08
the I-Disease 0 4.4385576103422864e-08
colorectum I-Disease 0 1.0652126547938678e-05
. O 0 1.3585960800810426e-07

There O 0 6.624891746298545e-09
is O 0 1.3547825361559518e-10
increasing O 0 8.157113873252797e-11
evidence O 0 5.958022963881149e-11
that O 0 2.1668509000982716e-12
there O 0 5.021540475103059e-12
exist O 0 9.977373094383069e-11
germ O 0 8.260740536059075e-09
- O 0 6.765839277722563e-11
line O 0 9.285594515517914e-11
variants O 0 9.683592469555968e-12
of O 0 6.823653447840528e-11
the O 0 1.0260744337520222e-10
APC B-Disease 0 1.1897542673278139e-10
gene O 0 7.349454161573177e-13
that O 0 2.7044458252717396e-13
predispose O 0 3.129918824118505e-10
to O 0 7.04365732406842e-11
the O 0 6.414620223882395e-11
development O 0 5.152367976712924e-10
of O 0 1.3005186927372847e-09
multiple O 1 0.9999822378158569
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
, O 0 1.6838342942193663e-09
but O 0 2.1160233287798036e-11
without O 0 3.6533092523383104e-11
the O 0 5.257385152224181e-11
florid O 0 6.129217688943811e-10
phenotype O 0 6.067257252162506e-10
of O 0 2.7770247212899335e-10
classical O 0 7.61939844551307e-10
FAP B-Disease 0 4.966868583089479e-10
, O 0 8.008187212318885e-13
and O 0 1.551886603164826e-13
possibly O 0 1.680069625087377e-11
with O 0 2.0589607763969037e-13
importance O 0 2.732783555003948e-09
for O 0 7.380674651358277e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.25329041481018066
in O 0 1.9696823339021563e-10
the O 0 5.827103383149179e-11
general O 0 4.5619834299071016e-11
population O 0 4.931875762816118e-13
. O 0 5.44364033017164e-12
. O 0 1.1536295252412287e-09

Genomic O 0 4.2574264114136895e-09
structure O 0 1.5801121522329709e-09
of O 0 4.669451048044948e-09
the O 0 8.353195113386391e-08
human O 0 0.3003006875514984
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 2.776583824015688e-05
CLD B-Disease 1 0.9985257983207703
) O 0 2.7769306853997477e-09
gene O 0 7.1596919504202106e-09
. O 0 1.44763054876762e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 7.191394979599863e-05
CLD B-Disease 1 0.9999979734420776
) O 0 1.4894596667147653e-10
is O 0 3.47722649285398e-11
caused O 0 9.965909208986545e-10
by O 0 8.352608882322698e-11
mutations O 0 4.375394213607109e-10
in O 0 1.213317224468824e-10
a O 0 2.1899211610776348e-10
gene O 0 3.9418282006542515e-12
which O 0 6.240021954012631e-12
encodes O 0 3.1737352329530566e-11
an O 0 5.4897090345784605e-11
intestinal O 0 4.911171345156617e-07
anion O 0 5.405534579949745e-07
transporter O 0 4.803227056981996e-06
. O 0 7.399941637231677e-08

We O 0 3.1689857848959946e-08
report O 0 1.8707324578315365e-10
here O 0 1.103515803041466e-11
the O 0 4.954279174407272e-12
complete O 0 1.4507488960147086e-11
genomic O 0 5.2925285681793e-11
organization O 0 5.5093242468107206e-11
of O 0 1.1899312091223635e-10
the O 0 1.5890552207409314e-09
human O 0 3.293935435522144e-08
CLD B-Disease 0 0.00017346836102660745
gene O 0 1.9114609894899104e-10
which O 0 7.636195495375198e-12
spans O 0 1.5417839227538366e-10
approximately O 0 2.0358255012342674e-11
39kb O 0 8.826902764269562e-09
, O 0 1.8720736766342227e-11
and O 0 4.951315746293261e-11
comprises O 0 1.0387637278119755e-10
21 O 0 5.002440772727823e-08
exons O 0 2.530920824028726e-07
. O 0 1.9596528844090244e-08

All O 0 1.0764510705030261e-07
exon O 0 4.6659188512876426e-08
/ O 0 2.8630054771383584e-08
intron O 0 4.440409817618729e-09
boundaries O 0 1.7971384103088184e-10
conform O 0 6.181447020914277e-11
to O 0 9.869732114919927e-11
the O 0 3.2350802592340244e-10
GT O 0 2.4479525961851323e-08
/ O 0 4.3558935658438713e-07
AG O 0 2.7108904760098085e-05
rule O 0 6.048649083822966e-07
. O 0 6.81922642797872e-08

An O 0 3.3628413942388136e-10
analysis O 0 1.6011542092186914e-10
of O 0 5.644432143903089e-10
the O 0 1.4410319604252209e-09
putative O 0 4.4848263769381447e-07
promoter O 0 1.0047450587080675e-06
region O 0 4.336052938924695e-08
sequence O 0 4.162580502509172e-09
shows O 0 3.911991841576423e-10
a O 0 6.123354712173068e-09
putative O 0 3.913879936590092e-06
TATA O 0 1.4520443983201403e-05
box O 0 3.7805567565385445e-09
and O 0 3.402942649888274e-10
predicts O 0 1.3549054322936627e-08
multiple O 0 2.325128700686463e-10
transcription O 0 8.957479202820195e-09
factor O 0 2.0566166825108922e-10
binding O 0 3.199289499988822e-09
sites O 0 1.6376635159076613e-08
. O 0 1.0718040677204499e-08

The O 0 5.53978516393272e-08
genomic O 0 1.9508170634452426e-09
structure O 0 6.17621731535678e-10
was O 0 1.0061521615867264e-09
determined O 0 1.2515694036707714e-10
using O 0 2.8260096086168973e-12
DNA O 0 3.698997011469807e-11
from O 0 6.100043213608242e-12
several O 0 4.3431434121853074e-13
sources O 0 7.0945397993849024e-12
including O 0 4.5565764703048295e-14
multiple O 0 6.027906038902353e-12
large O 0 2.0703606884442394e-10
- O 0 2.8507112226350273e-09
insert O 0 2.645089702824066e-09
libaries O 0 7.958642811445316e-08
and O 0 4.877510548229047e-11
genomic O 0 1.0954468582236032e-10
DNA O 0 1.0564554786540725e-09
from O 0 3.710191320838163e-10
Finnish O 0 8.650944209875888e-07
CLD B-Disease 0 0.011519926600158215
patients O 0 1.0854211751620824e-08
and O 0 9.779210774496505e-10
controls O 0 8.527226214027905e-07
. O 0 4.169177358903653e-08

Exon O 0 6.67909532126032e-08
- O 0 6.655097362084916e-09
specific O 0 4.4410344846035343e-10
primers O 0 1.5211942816506507e-09
developed O 0 2.938563975485309e-11
in O 0 4.131835498744074e-12
this O 0 8.233797324508352e-12
study O 0 5.062527220350832e-12
will O 0 3.183944210713441e-12
facilitate O 0 2.7821606130018495e-11
mutation O 0 3.2857792875429226e-11
screening O 0 5.834164401585795e-11
studies O 0 5.340408237158867e-12
of O 0 6.267588444769379e-12
patients O 0 5.798373500093268e-12
with O 0 1.2468076701285802e-12
the O 0 1.605611466004575e-08
disease O 0 0.0001350236707367003
. O 0 3.944851911796832e-08

Genomic O 0 2.186855674324306e-08
sequencing O 0 3.284454264118608e-09
of O 0 1.0411846496083399e-08
a O 0 4.630695116247807e-08
BAC O 0 0.0004694062808994204
clone O 0 6.0563238548638765e-06
H O 1 1.0
_ O 0 4.688800014918115e-09
RG364P16 O 0 4.958364456797426e-07
revealed O 0 5.050274642925956e-10
the O 0 9.768482030214631e-12
presence O 0 8.788062508605088e-13
of O 0 1.4103580282809336e-11
another O 0 6.569369354059162e-11
, O 0 2.2367401333878156e-11
highly O 0 6.661948076525093e-11
homologous O 0 1.7669291030308898e-10
gene O 0 5.911727218865792e-10
3 O 0 1.0329722499591298e-07
of O 0 7.563843773539247e-09
the O 0 6.347253389549223e-08
CLD B-Disease 0 0.00044162871199660003
gene O 0 9.356107000257907e-10
, O 0 7.41405461329725e-12
with O 0 6.368152262025556e-14
a O 0 2.0021538246761672e-11
similar O 0 5.532868000562852e-12
genomic O 0 3.161622907921213e-10
structure O 0 1.0149020512884022e-10
, O 0 2.3048769923900148e-12
recently O 0 1.9052938046715262e-11
identified O 0 2.4019890243476283e-11
as O 0 2.0267004220697604e-12
the O 0 1.6446181083651368e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 3.3022452328168583e-08
( O 0 4.1238956693945283e-10
PDS B-Disease 0 1.4574122531030298e-07
) O 0 1.4572384965383378e-11
. O 0 2.3290969153322294e-10
. O 0 6.357282256175267e-09

The O 0 1.3768675444225664e-07
APCI1307K O 0 0.001549075124785304
allele O 0 1.7396471321262652e-06
and O 0 3.5527122577150294e-08
cancer B-Disease 1 0.9088443517684937
risk O 0 1.6121055068651913e-07
in O 0 4.3087082512993646e-11
a O 0 1.075948635742563e-10
community O 0 1.3228684640764765e-11
- O 0 3.698658393447296e-11
based O 0 1.874156559111828e-11
study O 0 3.2122918908195075e-11
of O 0 4.7167273559134415e-11
Ashkenazi O 0 3.7208942593736083e-09
Jews O 0 6.916797690159626e-10
. O 0 1.6481163100934282e-09

Mutations O 0 6.020058407329998e-08
in O 0 3.826126082628889e-10
APC O 0 1.6383062684255378e-09
are O 0 7.775922375614919e-13
classically O 0 6.472496982823372e-10
associated O 0 3.4917317925931e-09
with O 0 3.573392604039327e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.754638828150746e-08
FAP B-Disease 0 2.1535542238382277e-09
) O 0 1.633675562450615e-13
, O 0 9.618933931700505e-14
a O 0 5.259059854267889e-11
highly O 0 9.959435374184977e-07
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 0.00015830725897103548
by O 0 7.374688859584921e-09
multiple O 0 7.788780180817412e-07
intestinal O 1 0.9999985694885254
polyps B-Disease 0 1.410212917107856e-06
and O 0 1.223715295761707e-10
, O 0 7.925146541624961e-13
without O 0 4.91111448383541e-12
surgical O 0 1.2188520193134877e-09
intervention O 0 3.364601264266298e-09
, O 0 4.23925304582351e-12
the O 0 6.273858516037123e-11
development O 0 9.484113405733297e-08
of O 0 0.00020512461196631193
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.824316874874057e-07
CRC B-Disease 0 5.812674771732418e-06
) O 0 2.980051483358892e-10
. O 0 5.604570585404645e-09

APC B-Disease 0 2.7684500309987925e-06
is O 0 1.4703789297243475e-09
a O 0 2.9759080533153792e-08
tumour O 1 1.0
- O 0 2.6835348307940876e-06
suppressor O 0 1.2894273027086456e-07
gene O 0 5.317259965664789e-10
, O 0 2.659677512950598e-11
and O 0 2.0996174243670396e-10
somatic O 0 4.032758624816779e-06
loss O 0 4.009898020740366e-06
occurs O 0 2.3212508040160174e-06
in O 0 5.717195108445594e-07
tumours B-Disease 1 1.0
. O 0 9.86830400506733e-06

The O 0 4.119845925742993e-06
germline O 0 2.0761299310834147e-06
T O 0 2.4237653661884906e-08
- O 0 5.208679598744936e-10
to O 0 3.207964449636336e-10
- O 0 1.2273783378535796e-10
A O 0 6.366233651355913e-10
transversion O 0 3.427534700506385e-09
responsible O 0 1.689797433923612e-11
for O 0 2.088687079196405e-12
the O 0 3.1287192281403975e-10
APC O 0 2.218409012044731e-09
I1307K O 0 7.271500379602003e-08
allele O 0 2.130308374148626e-09
converts O 0 3.5525529740176864e-10
the O 0 3.0472085965627116e-10
wild O 0 8.563530440319767e-11
- O 0 2.1272853270581926e-11
type O 0 1.715498992860276e-10
sequence O 0 4.291197952532855e-11
to O 0 8.929357947495831e-11
a O 0 1.743775124296576e-09
homopolymer O 0 8.061174412432592e-06
tract O 0 2.916139692388242e-06
( O 0 4.2683705459012344e-09
A8 O 0 8.729726914680214e-07
) O 0 5.860750686842442e-12
that O 0 7.36719799748764e-12
is O 0 1.9747194157648806e-10
genetically O 0 4.452837032431489e-08
unstable O 0 2.3026286726235412e-05
and O 0 9.471871287303202e-09
prone O 0 6.027358722349163e-06
to O 0 1.3533523087971844e-05
somatic O 0 0.00016543730453122407
mutation O 0 3.465939880697988e-05
. O 0 5.48569744296401e-07

The O 0 8.0667376778365e-08
I1307K O 0 1.379425384584465e-06
allele O 0 1.6920802536901647e-08
was O 0 4.89158313854432e-09
found O 0 4.03803310233819e-11
in O 0 5.4450038228237574e-11
6 O 0 3.852419467875734e-07
. O 0 2.3643787372407132e-08

1 O 0 2.3726679501123726e-05
% O 0 5.809765823983071e-08
of O 0 1.1279793099561175e-08
unselected O 0 3.130771801806986e-05
Ashkenazi O 0 3.4223504030705953e-07
Jews O 0 4.1599276801029816e-10
and O 0 1.2770274204418341e-12
higher O 0 8.472807178083741e-11
proportions O 0 1.8397036671835565e-10
of O 0 3.986119767596108e-11
Ashkenazim O 0 4.981405510307013e-09
with O 0 6.020847340658386e-13
family O 0 9.264083250526411e-11
or O 0 4.902106498505532e-10
personal O 0 5.943670444708005e-09
histories O 0 3.9114961936093096e-08
of O 0 4.424410235515097e-06
CRC B-Disease 0 3.640819704742171e-05
( O 0 1.881378830503877e-09
ref O 0 6.180324589877273e-07
. O 0 1.5859940027951325e-09
2 O 0 5.1802796718902755e-08
) O 0 1.1333112920342003e-10
. O 0 6.664153673341389e-09

To O 0 1.4097818912262028e-08
evaluate O 0 2.347105843014674e-09
the O 0 1.0873284217449708e-10
role O 0 6.122180540302224e-11
of O 0 7.660506673445866e-10
I1307K O 0 6.2295139287016355e-06
in O 0 1.3695697909099636e-08
cancer B-Disease 0 1.0982629646605346e-05
, O 0 4.070987158488748e-10
we O 0 1.0211529399839492e-09
genotyped O 0 5.979936190669832e-07
5 O 0 1.0108715997603213e-07
, O 0 1.5235775141508867e-10
081 O 0 2.451784837376181e-07
Ashkenazi O 0 3.278921356653086e-09
volunteers O 0 4.108180267324568e-13
in O 0 2.0284522759400625e-12
a O 0 1.8717175032101352e-10
community O 0 7.139342450557251e-10
survey O 0 1.0329364030781107e-08
. O 0 2.2573455993324387e-08

Risk O 0 5.189395324123325e-06
of O 0 1.3545931665248645e-07
developing O 0 0.0015767434379085898
colorectal B-Disease 1 1.0
, I-Disease 1 0.9729430675506592
breast I-Disease 1 1.0
and I-Disease 0 8.347798029717524e-06
other I-Disease 0 1.6780072087385633e-07
cancers I-Disease 1 0.9973795413970947
were O 0 4.152858057437925e-09
compared O 0 4.083967330981153e-10
between O 0 2.774400043037417e-09
genotyped O 0 8.819971952789274e-08
I1307K O 0 1.7485453085441804e-08
carriers O 0 3.945137619365546e-12
and O 0 5.78867119169213e-12
non O 0 1.0686716789276574e-10
- O 0 3.898610167335503e-12
carriers O 0 2.3253602277235885e-13
and O 0 3.777868046606764e-13
their O 0 3.329495696074297e-13
first O 0 3.5302251573388066e-12
- O 0 1.786464379205377e-11
degree O 0 1.6788636036935145e-09
relatives O 0 2.9043523142036065e-10
. O 0 8.699784781462938e-10

Sperm O 0 2.7571198657483365e-08
DNA O 0 2.5947852755336953e-09
analysis O 0 3.1355158053303356e-11
in O 0 2.1963118823631333e-11
a O 0 1.6947579339898766e-08
Friedreich B-Disease 1 0.9852203130722046
ataxia I-Disease 1 0.9995753169059753
premutation O 0 8.243903721449897e-05
carrier O 0 1.0864363986229364e-07
suggests O 0 5.70463365434648e-09
both O 0 2.1450506648701406e-10
meiotic O 0 3.386028168961275e-08
and O 0 3.975342721673769e-09
mitotic O 0 1.4763232414338745e-08
expansion O 0 9.68501190357074e-09
in O 0 1.038290786681273e-09
the O 0 3.4973708373797763e-09
FRDA B-Disease 0 2.2103315131971613e-05
gene O 0 6.878110525576631e-09
. O 0 9.251432508960988e-09

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 2.8535416731756413e-06
usually O 0 1.2756862233231914e-08
caused O 0 3.0626980951353744e-09
by O 0 1.998558653640292e-12
an O 0 1.8493661463336863e-12
expansion O 0 5.463680619044453e-10
of O 0 6.38328057078752e-10
a O 0 8.150749408741831e-08
GAA O 1 0.5288565158843994
trinucleotide O 0 0.0010238951072096825
repeat O 0 1.53983478412556e-07
in O 0 1.8022332515243988e-09
intron O 0 5.1427122116365354e-08
1 O 0 1.312553763455071e-07
of O 0 1.1175581571265525e-09
the O 0 2.7630040477788498e-09
FRDA B-Disease 0 6.898301944602281e-05
gene O 0 1.4178961116328992e-08
. O 0 1.2781851133070177e-08

Occasionally O 0 4.844621344091138e-07
, O 0 7.752107289427101e-10
a O 0 8.833836995236766e-10
fully O 0 1.563264961923494e-09
expanded O 0 2.930851950022628e-10
allele O 0 4.521594210160629e-09
has O 0 7.79346587265195e-11
been O 0 2.9775557019995347e-11
found O 0 1.9834067114393727e-12
to O 0 2.2627478016290503e-11
arise O 0 3.262151659910728e-10
from O 0 4.548767959522415e-11
a O 0 3.9746958502284713e-10
premutation O 0 8.565601206100837e-08
of O 0 1.6540115943541878e-09
100 O 0 7.21925630386977e-10
or O 0 3.598963904671848e-10
less O 0 1.5048756907276584e-08
triplet O 0 8.950871233537327e-06
repeats O 0 2.161189968319377e-06
. O 0 9.739068218550528e-08

We O 0 9.62490744882416e-08
have O 0 1.5527328034448118e-10
examined O 0 7.245881117334818e-10
the O 0 6.169338651051959e-11
sperm O 0 2.6805885636194127e-11
DNA O 0 1.590627629610708e-11
of O 0 9.526010188998235e-12
a O 0 1.0937953320855343e-10
premutation O 0 2.8046468969478155e-07
carrier O 0 1.359321828431348e-07
. O 0 3.058263473576517e-07

This O 0 2.318983760574156e-08
mans O 0 9.708834340926842e-07
leucocyte O 0 2.2352600126396283e-07
DNA O 0 9.571210490832982e-09
showed O 0 1.312379233064931e-10
one O 0 3.17556246055839e-12
normal O 0 7.287317971282903e-11
allele O 0 1.4294944568338241e-11
and O 0 1.0306709912616396e-12
one O 0 4.359545710541646e-12
allele O 0 1.9898921399530423e-10
of O 0 2.0801255162794519e-10
approximately O 0 7.879202845728628e-10
100 O 0 1.7384682582388677e-09
repeats O 0 5.882758458142234e-08
. O 0 1.5560905453071427e-08

His O 0 1.960428789971047e-06
sperm O 0 2.0895678076726654e-08
showed O 0 3.400249803942046e-10
an O 0 2.2137855784643e-12
expanded O 0 1.7093999826744977e-11
allele O 0 6.797922780243937e-10
in O 0 1.273987720873393e-10
a O 0 5.655340640231543e-09
tight O 0 5.8073286623994136e-08
range O 0 4.4595772408229095e-08
centering O 0 4.633787398233835e-08
on O 0 1.2135631388687784e-09
a O 0 9.130482481189972e-11
size O 0 1.8965713721730282e-10
of O 0 3.7633965388472745e-10
approximately O 0 2.134017407229294e-09
320 O 0 4.567606382011036e-08
trinucleotide O 0 1.9293842342449352e-05
repeats O 0 5.976618240310927e-07
. O 0 8.421199026997783e-08

His O 0 6.756950824637897e-06
affected O 0 5.842297014169162e-06
son O 0 2.9737486784142675e-06
has O 0 4.677720988333078e-10
repeat O 0 8.345272251020219e-10
sizes O 0 5.628306154470408e-10
of O 0 9.196694517044079e-10
1040 O 0 2.5804737902035413e-08
and O 0 2.2029638113707506e-09
540 O 0 1.2012436911845725e-07
. O 0 2.9319622285584046e-08

These O 0 2.3062789455963184e-09
data O 0 4.0342554297190247e-10
suggest O 0 8.663020995003379e-11
that O 0 1.0745898528646824e-12
expansion O 0 1.1661549503827473e-10
occurs O 0 1.1232285934692499e-11
in O 0 1.2060479568157256e-12
two O 0 1.0545574830045368e-12
stages O 0 9.611539342202491e-11
, O 0 1.4203997136461033e-12
the O 0 1.4835528638901252e-11
first O 0 1.0893814322843198e-10
during O 0 3.886608257452906e-10
meiosis O 0 2.1930634391820192e-11
followed O 0 7.648964794881863e-12
by O 0 1.988209510223049e-12
a O 0 3.9150149788724775e-10
second O 0 3.105841583916913e-09
mitotic O 0 8.344878565935687e-09
expansion O 0 4.1666339711809997e-08
. O 0 1.1200944527445245e-07

We O 0 2.7887242026736203e-07
also O 0 7.691486891836519e-10
show O 0 1.8096485421281727e-10
that O 0 7.088475856634191e-13
in O 0 1.2874263287387944e-12
all O 0 3.562963726139179e-13
informative O 0 5.5373652711743215e-12
carrier O 0 3.6769236960720875e-11
father O 0 6.741496250128876e-10
to O 0 1.0074580059082905e-09
affected O 0 4.045932033847066e-09
child O 0 2.8230831006226254e-09
transmissions O 0 8.92170226585165e-10
, O 0 1.934614144230573e-12
with O 0 1.377126087860961e-13
the O 0 2.3622655914712354e-11
notable O 0 5.697306775659383e-12
exception O 0 1.750388722854268e-10
of O 0 1.573657038012044e-10
the O 0 1.3352702277202866e-10
premutation O 0 3.299959772107286e-08
carrier O 0 5.629251509375877e-10
, O 0 2.5009674886611322e-11
the O 0 9.19293668966148e-11
expansion O 0 4.820421284357224e-10
size O 0 9.684452129121723e-10
decreases O 0 4.933183639366234e-09
. O 0 9.695672043008585e-10
. O 0 1.6224664278752243e-08

The O 0 1.3503445472906606e-07
R496H O 0 1.2641065040952526e-05
mutation O 0 1.8984335881100378e-08
of O 0 1.1883758421760149e-09
arylsulfatase O 0 8.29467978746834e-07
A O 0 2.8158092391095124e-07
does O 0 3.7520289652981376e-10
not O 0 1.5599677105626597e-09
cause O 0 6.190085696289316e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 8.970704925559403e-07

Deficiency B-Disease 1 0.9999994039535522
of I-Disease 0 6.293461774475873e-05
arylsulfatase I-Disease 1 0.9999988079071045
A I-Disease 1 0.9999985694885254
( O 0 4.514529550192492e-08
ARSA O 0 0.00016233065980486572
) O 0 4.010003787358052e-11
enzyme O 0 7.910659904908357e-10
activity O 0 3.486048782974649e-09
causes O 0 2.6030706976598594e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.707031600517439e-07
MLD B-Disease 1 1.0
) O 0 1.7446467603932092e-09
. O 0 6.456409629151949e-09

A O 0 1.8971685449287179e-06
number O 0 3.7352791970590715e-09
of O 0 4.710600354229655e-09
ARSA O 0 1.67247089848388e-05
gene O 0 2.4952997446092695e-09
mutations O 0 4.265554576221575e-09
responsible O 0 3.607377507819365e-09
for O 0 1.2365129364866334e-08
MLD B-Disease 1 1.0
have O 0 3.8302623295294325e-08
been O 0 2.9235394105597834e-09
identified O 0 1.9038137732962923e-09
. O 0 1.5631129723914228e-09

Recently O 0 8.914735616372127e-08
, O 0 4.4018957923164237e-10
the O 0 2.072973570577119e-09
R496H O 0 1.357779183308594e-06
mutation O 0 3.868527720385373e-09
of O 0 6.540282981859491e-09
ARSA O 0 1.8447182128511486e-06
was O 0 1.03788488914347e-09
proposed O 0 5.5876789306630315e-11
to O 0 5.273986802833974e-11
be O 0 1.618106343359571e-11
a O 0 3.7843644884461014e-10
cause O 0 1.1442403291539449e-07
of O 0 4.3908318048124784e-07
MLD B-Disease 1 1.0
( O 0 2.555234024370634e-09
Draghia O 0 7.49961827750667e-07
et O 0 1.8779916288735876e-08
al O 0 1.1147571754577257e-08
. O 0 3.1212251533352386e-11
, O 0 1.4658356126129313e-11
1997 O 0 6.613916636588613e-10
) O 0 1.4856009478148025e-10
. O 0 9.969678416155148e-09

We O 0 1.4954652272081148e-07
have O 0 4.357488259110198e-10
investigated O 0 5.683022497038337e-09
the O 0 7.680989733138688e-10
R496H O 0 5.54473231773045e-08
mutation O 0 2.3016942518605532e-10
and O 0 7.558712336597218e-12
found O 0 2.931369123132521e-12
this O 0 1.2634532309263591e-11
mutation O 0 1.692065793035269e-10
at O 0 1.636662749771034e-10
a O 0 2.61077288260525e-11
relatively O 0 2.688197060785047e-11
high O 0 6.924649048611897e-11
frequency O 0 7.989947592434987e-11
in O 0 4.1588919807988844e-12
an O 0 3.284505913775382e-12
African O 0 1.0534843830622975e-11
American O 0 3.763780086207813e-12
population O 0 7.309068172749178e-13
( O 0 3.648892386159952e-12
f O 0 5.356616483709331e-09
= O 0 3.428906047986402e-10
0 O 0 2.4921686936352216e-10
. O 0 4.531861431261719e-12
09 O 0 2.7183041928502405e-10
, O 0 2.2812212188694225e-11
n O 0 1.2241081481789706e-09
= O 0 2.734285242667056e-09
61 O 0 2.1316008957938948e-09
subjects O 0 2.8859198364372673e-10
) O 0 6.33698579721731e-11
. O 0 3.202482501407644e-09

The O 0 1.1181332411069889e-06
ARSA O 0 1.578144838276785e-05
enzyme O 0 3.220141042703517e-09
activity O 0 7.252047296013586e-10
in O 0 6.39987845704737e-12
subjects O 0 6.444760523860449e-12
with O 0 8.025078811115666e-14
and O 0 3.1284892211547177e-12
without O 0 7.36346469909499e-11
the O 0 3.812096194266701e-10
R496H O 0 1.136700333859153e-08
mutation O 0 4.6266972891784164e-11
was O 0 6.36161817668679e-11
determined O 0 4.672101247549243e-11
and O 0 2.4511948460564925e-12
found O 0 5.1023599408062115e-12
to O 0 1.9078368052038996e-10
be O 0 8.231042514239562e-10
normal O 0 1.283242028193854e-07
. O 0 2.8588639011672967e-08

It O 0 2.707377433353031e-09
is O 0 5.644655229342099e-11
therefore O 0 3.8949721226089196e-10
concluded O 0 7.192071382888798e-10
that O 0 6.00474878154067e-12
the O 0 3.5526953601205946e-10
R496H O 0 1.3788611568088527e-06
mutation O 0 4.4378467123351584e-08
of O 0 1.3381321828376258e-08
ARSA O 0 2.2639293092652224e-05
does O 0 2.388157449573214e-10
not O 0 4.857660801382835e-11
negatively O 0 7.756643938261476e-11
influence O 0 1.266665522470234e-10
the O 0 2.716877417485719e-11
activity O 0 1.8774382049002725e-10
of O 0 2.7328538737547703e-11
ARSA O 0 8.269603313237894e-08
and O 0 4.35912981058828e-12
is O 0 3.416668423877889e-12
not O 0 1.521630911549554e-11
a O 0 3.3328189097403538e-09
cause O 0 7.407619705190882e-06
of O 0 5.630901341646677e-06
MLD B-Disease 1 1.0

Down O 0 2.270595359732397e-06
- O 0 2.6845221157145716e-08
regulation O 0 6.877664215920731e-09
of O 0 1.2668425197759348e-09
transmembrane O 0 5.952130663899879e-07
carbonic O 0 7.989410369191319e-05
anhydrases O 0 0.000333243515342474
in O 0 3.0817668630334083e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 1.624797278054757e-06
by O 0 3.155558037093442e-09
wild O 0 8.891636760210986e-09
- O 0 6.053513246229159e-10
type O 0 2.1019916474074307e-08
von B-Disease 1 0.9998875856399536
Hippel I-Disease 0 0.02613275684416294
- I-Disease 0 0.0002798255009111017
Lindau I-Disease 0 0.00023358016915153712
transgenes O 0 1.060597332980251e-05
. O 0 1.6065204988535697e-07

To O 0 3.9382180716529547e-07
discover O 0 1.2324983700295888e-08
genes O 0 1.3908149631980393e-10
involved O 0 5.629312987975865e-11
in O 0 8.280166829965907e-11
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 0.9999997615814209
( O 0 1.2975734264841776e-08
VHL B-Disease 0 1.3692874745174777e-06
) O 0 2.9765450521024306e-11
- O 0 2.984802849326229e-09
mediated O 0 8.489249012200162e-06
carcinogenesis O 1 0.993975818157196
, O 0 2.4522224251199987e-09
we O 0 2.7150566239697582e-09
used O 0 7.811931368451042e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.013879237696528435
stably O 0 2.5448391170357354e-05
transfected O 0 1.0837479180736409e-07
with O 0 4.796563840558932e-11
wild O 0 7.145026792443332e-09
- O 0 2.8259059536850373e-09
type O 0 5.614802134346064e-08
VHL O 0 1.0932251825579442e-05
- O 0 2.2737104643510975e-07
expressing O 0 6.380995287713631e-09
transgenes O 0 5.618015279651445e-07
. O 0 2.2974200319936244e-08

Large O 0 8.673548279602983e-08
- O 0 5.461362562186878e-08
scale O 0 1.0170288078370504e-06
RNA O 0 1.3518005914647802e-07
differential O 0 8.690385300269554e-09
display O 0 4.7472692443761844e-11
technology O 0 3.3116148712153404e-10
applied O 0 1.6987670159451795e-09
to O 0 1.6566123473005234e-10
these O 0 2.865786167399742e-12
cell O 0 1.5125169172680586e-10
lines O 0 1.6893819676511157e-11
identified O 0 9.030217545946684e-12
several O 0 2.7078626884183277e-13
differentially O 0 1.1241705344389175e-09
expressed O 0 3.830585501574113e-11
genes O 0 2.2232018309642498e-11
, O 0 2.0243012995024845e-12
including O 0 2.9295747685370577e-12
an O 0 3.1894784036090584e-10
alpha O 0 9.667666489576732e-08
carbonic O 0 8.276173844024015e-07
anhydrase O 0 7.080560635586153e-07
gene O 0 1.718660214145018e-09
, O 0 1.9452538191355728e-10
termed O 0 4.1195767153112683e-07
CA12 O 0 0.0030590950045734644
. O 0 8.58182090723858e-07

The O 0 5.092938977213635e-07
deduced O 0 1.038210584169974e-07
protein O 0 5.897990096315198e-09
sequence O 0 5.727701091196025e-10
was O 0 3.525821301586518e-10
classified O 0 2.1692422164099057e-11
as O 0 6.493090353582032e-12
a O 0 5.054168195073316e-10
one O 0 1.3552691191520694e-09
- O 0 3.9797680528863566e-07
pass O 0 2.62721232502372e-06
transmembrane O 0 0.00012442476872820407
CA O 0 1.3351183042686898e-05
possessing O 0 4.604394199247963e-09
an O 0 5.4967524976135e-10
apparently O 0 4.31032365355577e-09
intact O 0 8.224105840781704e-10
catalytic O 0 1.2400644955334883e-09
domain O 0 1.8257578560110233e-08
in O 0 1.3634414708363352e-09
the O 0 2.2163758828241953e-08
extracellular O 0 1.3553806184063433e-06
CA O 0 5.1091868954245e-05
module O 0 9.68623112385103e-07
. O 0 2.7673619840129504e-08

Reintroduced O 0 2.431164466543123e-05
wild O 0 5.048709681432229e-07
- O 0 9.629425079538123e-08
type O 0 1.7488297032741684e-07
VHL B-Disease 0 6.3311567828350235e-06
strongly O 0 3.4266980364350275e-09
inhibited O 0 1.8554354719313437e-09
the O 0 3.0765254233067196e-10
overexpression O 0 5.775575573352398e-10
of O 0 1.6746444508886071e-10
the O 0 4.0419731450747065e-10
CA12 O 0 2.2886699753144057e-06
gene O 0 2.1938164826429407e-11
in O 0 1.7173642716250548e-11
the O 0 8.520652516885718e-10
parental O 0 1.545682971482165e-05
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.030885647982358932
. O 0 6.771749212930445e-06

Similar O 0 2.3856503439390053e-09
results O 0 1.3169334511786701e-09
were O 0 4.702623707109055e-11
obtained O 0 2.5609207462973238e-11
with O 0 1.5264672121803602e-12
CA9 O 0 1.43007162023423e-06
, O 0 5.986260792623099e-11
encoding O 0 2.802469367679805e-10
another O 0 1.807946148346673e-08
transmembrane O 0 8.155910222740204e-07
CA O 0 1.6944903791227262e-07
with O 0 1.4034455021738612e-11
an O 0 4.133889619506448e-10
intact O 0 3.6578660100872185e-09
catalytic O 0 9.275903600780566e-09
domain O 0 5.807826255477266e-07
. O 0 3.801528336566662e-08

Although O 0 4.392018748688997e-09
both O 0 4.184677049323682e-10
domains O 0 1.563355134237554e-08
of O 0 5.7427671507070954e-09
the O 0 5.189949359163393e-09
VHL B-Disease 0 8.080935742782458e-08
protein O 0 6.167235611087563e-10
contribute O 0 3.3145201860929063e-11
to O 0 3.4285466132821796e-10
regulation O 0 8.013214980451266e-09
of O 0 1.5822324561654e-09
CA12 O 0 2.6481955501367338e-05
expression O 0 5.819031367870764e-10
, O 0 3.614826493691936e-11
the O 0 6.356015019859385e-11
elongin O 0 3.756513322628052e-09
binding O 0 1.0074852951902358e-08
domain O 0 1.0011467210802039e-08
alone O 0 6.358079618351553e-10
could O 0 4.595197278245422e-10
effectively O 0 2.936062726277555e-09
regulate O 0 1.802247950877245e-08
CA9 O 0 6.114205461926758e-05
expression O 0 4.761486493976008e-08
. O 0 1.0007518369548052e-07

We O 0 7.162781656688821e-08
mapped O 0 4.86924989218096e-07
CA12 O 0 0.00034270549076609313
and O 0 8.68772147555319e-08
CA9 O 0 8.683832857059315e-05
loci O 0 3.0609356826971634e-08
to O 0 1.202231025843048e-08
chromosome O 0 7.68164127862292e-08
bands O 0 1.744873934228508e-08
15q22 O 0 1.0050824812424253e-06
and O 0 3.1641163023010677e-09
17q21 O 0 2.3978007448022254e-05
. O 0 1.020217510472321e-07

2 O 0 3.945875050703762e-06
respectively O 0 6.137130981187511e-08
, O 0 1.1047447401324462e-09
regions O 0 6.072878022678196e-08
prone O 0 9.400978484563893e-08
to O 0 1.8546684188436302e-08
amplification O 0 1.8051309780275915e-08
in O 0 8.853505151229513e-10
some O 0 5.24512822064338e-10
human O 0 6.442560618324933e-08
cancers B-Disease 0 0.0003440645814407617
. O 0 8.7102698387298e-08

Additional O 0 8.625507774695507e-08
experiments O 0 1.3595469638971736e-08
are O 0 9.32026157640653e-12
needed O 0 1.5817518128624641e-10
to O 0 1.4639475742761476e-10
define O 0 1.1848180214713011e-09
the O 0 8.297811049384762e-11
role O 0 1.5932881403113441e-10
of O 0 4.851570811759132e-10
CA O 0 3.328939328639535e-07
IX O 0 6.5101062318717595e-06
and O 0 1.5836281619385773e-08
CA O 0 8.482520001962257e-07
XII O 0 3.308462055429118e-07
enzymes O 0 2.865634465831768e-11
in O 0 1.1739854748060718e-11
the O 0 4.531786404471383e-11
regulation O 0 5.432641003721983e-10
of O 0 2.792118758421225e-10
pH O 0 2.3988745212477625e-08
in O 0 4.499841887994904e-10
the O 0 3.2385949477742315e-09
extracellular O 0 2.7905672439487716e-08
microenvironment O 0 2.0691355473445583e-07
and O 0 4.4014819566839947e-11
its O 0 2.8672527893625066e-11
potential O 0 1.3496088968611986e-10
impact O 0 8.94520368888152e-09
on O 0 4.872059889748925e-06
cancer B-Disease 0 0.00033012943458743393
cell O 0 1.251565663551446e-06
growth O 0 1.4613545040731424e-08
. O 0 1.2281732963970171e-08

A O 0 1.7247616597160231e-06
gene O 0 1.883005085190348e-09
encoding O 0 3.3643188235288335e-09
a O 0 2.1646743064707152e-08
transmembrane O 0 5.710286586690927e-06
protein O 0 1.458103184859283e-07
is O 0 1.323388273966053e-11
mutated O 0 3.160452108352807e-11
in O 0 4.100666854689461e-12
patients O 0 2.583293023938893e-10
with O 0 2.0240485676392694e-10
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.982148289680481
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9950376152992249
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.730948021171912e-10
. O 0 2.853763225729722e-09

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.097821483308508e-07
WFS B-Disease 0 0.0010003633797168732
; O 0 2.284650468808991e-09
OMIM O 0 5.531104397960007e-05
222300 O 0 1.3332616788375162e-07
) O 0 1.2546681358791e-12
is O 0 1.3038680378441025e-11
an O 0 5.144321235661664e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 2.161562484559454e-09
by O 0 5.56371893001284e-11
young O 0 4.0560306224790565e-09
- O 0 2.9751769034191966e-05
onset O 1 1.0
non O 1 1.0
- O 1 0.9999479055404663
immune O 0 0.12756803631782532
insulin B-Disease 1 1.0
- I-Disease 1 0.9999637603759766
dependent I-Disease 1 0.9147911071777344
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 3.578214347044195e-08
progressive O 1 0.6880283951759338
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999696016311646
. O 0 1.1409018043195829e-05

Linkage O 0 1.5229898053803481e-06
to O 0 1.0848481934999654e-07
markers O 0 8.683707974910249e-09
on O 0 3.8926291523466716e-08
chromosome O 0 5.355710186449869e-07
4p O 0 0.0001880401832750067
was O 0 2.8333755341947153e-09
confirmed O 0 1.7359425008578455e-10
in O 0 1.429963612797902e-11
five O 0 1.5677371900668646e-10
families O 0 5.633093644319409e-11
. O 0 4.930851282836102e-09

On O 0 7.720507255726261e-08
the O 0 2.076233074355116e-10
basis O 0 1.2302946439390894e-09
of O 0 1.0929028515516137e-10
meiotic O 0 9.240638064511586e-06
recombinants O 1 0.9828752279281616
and O 0 8.805439506431867e-07
disease O 1 0.889833390712738
- O 0 1.2348277955709364e-08
associated O 0 2.3153507555662145e-08
haplotypes O 0 2.0423197355512457e-08
, O 0 2.718869573925531e-10
the O 0 5.3353668150180056e-09
WFS B-Disease 0 3.1339129691332346e-07
gene O 0 1.5398149422196639e-10
was O 0 9.265183620321693e-10
localized O 0 4.322261215605749e-09
to O 0 3.11011731923827e-08
a O 0 1.9223038805193937e-07
BAC O 0 0.0002475054934620857
/ O 0 1.8591970274428604e-06
P1 O 0 8.901633009372745e-06
contig O 0 1.0384536608398776e-06
of O 0 5.296348359884462e-10
less O 0 3.5261168984668245e-10
than O 0 1.3367737472513852e-10
250 O 0 2.791316067174421e-09
kb O 0 5.279173365124734e-07
. O 0 3.498853473615782e-08

Mutations O 0 5.188962148849896e-08
in O 0 8.582596439099532e-11
a O 0 6.292665277740639e-10
novel O 0 3.974781392912519e-09
gene O 0 5.601789032638749e-10
( O 0 1.1515294273678478e-10
WFS1 O 0 8.483793862978928e-06
) O 0 1.0512709452958902e-10
encoding O 0 7.652095068699794e-10
a O 0 2.7482990105909266e-08
putative O 0 4.13504551488586e-07
transmembrane O 0 3.675478410514188e-07
protein O 0 8.197080347827068e-09
were O 0 2.8253102982156442e-11
found O 0 7.421040236314791e-13
in O 0 4.1935075204002636e-13
all O 0 8.574521843419947e-13
affected O 0 6.904189893408574e-12
individuals O 0 1.2090743987600017e-12
in O 0 1.8043855298799372e-10
six O 0 3.530993453182418e-08
WFS B-Disease 0 5.978914487059228e-06
families O 0 7.502369558931576e-11
, O 0 1.3285096113480055e-11
and O 0 1.6326025600865712e-11
these O 0 6.632884779617099e-12
mutations O 0 2.3255267503352606e-11
were O 0 1.0531348362818882e-11
associated O 0 1.4603018447245653e-11
with O 0 2.0451884543554177e-12
the O 0 7.993583572840635e-09
disease O 0 1.5466431477761944e-06
phenotype O 0 2.0595736316408875e-07
. O 0 1.8131957801870158e-07

WFS1 O 0 0.2302120178937912
appears O 0 7.428067760884005e-08
to O 0 2.2591795101334355e-09
function O 0 2.119130287914217e-10
in O 0 4.0407760470984044e-11
survival O 0 5.924791324218859e-09
of O 0 1.0890599533297518e-09
islet O 0 3.5022861766265123e-07
beta O 0 1.904263285723573e-06
- O 0 3.350079680330964e-08
cells O 0 2.459519254927045e-10
and O 0 2.0762438643351366e-11
neurons O 0 6.1410249108107e-10
. O 0 8.788846872498368e-10
. O 0 7.465661866490336e-09

Stable O 0 1.2871613762399647e-05
interaction O 0 1.3985627766999187e-08
between O 0 1.6913576317278967e-08
the O 0 3.095208755965473e-09
products O 0 2.9959748570895783e-10
of O 0 1.9375297199974995e-10
the O 0 2.1301041486232464e-10
BRCA1 O 0 2.419800804176475e-09
and O 0 4.0399536493929133e-10
BRCA2 O 0 2.4006048704450222e-08
tumor B-Disease 0 3.3625923379076994e-07
suppressor O 0 3.1358077023924125e-08
genes O 0 3.3360608719945617e-10
in O 0 1.403547833511709e-10
mitotic O 0 1.1907020258661305e-08
and O 0 2.2630189278061152e-08
meiotic O 0 3.0875606171321124e-05
cells O 0 1.51341837408836e-05
. O 0 1.150820025941357e-06

BRCA1 O 0 2.3534917090728413e-06
and O 0 1.542868055537383e-08
BRCA2 O 0 1.3192722470023455e-08
account O 0 1.0081488595325983e-11
for O 0 7.169188203162702e-13
most O 0 4.202099009465582e-13
cases O 0 3.2959336215138135e-12
of O 0 2.4257967162766292e-11
familial O 0 3.857357544490014e-09
, O 0 5.111206596852824e-11
early O 0 5.293910021464399e-07
onset O 1 0.9999988079071045
breast B-Disease 1 0.9999388456344604
and I-Disease 0 0.00013179078814573586
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 4.232432182504908e-09
encode O 0 5.564554459575044e-12
products O 0 6.316757446972465e-12
that O 0 2.881251281398184e-13
each O 0 2.655082642459561e-13
interact O 0 3.4145949956432275e-13
with O 0 4.257677381231534e-13
hRAD51 O 0 7.713898497740956e-08
. O 0 2.797585807456926e-08

Results O 0 2.541591470617277e-08
presented O 0 2.2446273728604638e-09
here O 0 9.68203406337409e-10
show O 0 7.357484760328603e-11
that O 0 7.558294268239507e-12
BRCA1 O 0 8.35756963635248e-10
and O 0 4.7381537582325e-10
BRCA2 O 0 9.729154726301203e-08
coexist O 0 5.464183772119213e-09
in O 0 8.157517716878004e-11
a O 0 5.794509871925868e-10
biochemical O 0 3.804137449492373e-09
complex O 0 1.174725761110551e-09
and O 0 1.0838643177413232e-10
colocalize O 0 1.7596083523585548e-07
in O 0 1.318466558153375e-09
subnuclear O 0 6.821001079515554e-07
foci O 0 3.706545115278459e-08
in O 0 3.0500868497540523e-10
somatic O 0 1.3439838131290571e-09
cells O 0 7.323266992820265e-11
and O 0 1.8430242141459496e-12
on O 0 8.067480017359685e-11
the O 0 2.3882235165167964e-12
axial O 0 9.675525138030938e-12
elements O 0 4.716356211825756e-12
of O 0 3.805222109631856e-11
developing O 0 6.722057355190714e-10
synaptonemal O 0 5.676492378370313e-07
complexes O 0 5.422229776286258e-09
. O 0 1.8621548747432826e-08

Like O 0 5.7473396708473956e-08
BRCA1 O 0 1.0908738090620318e-07
and O 0 5.5518620811767505e-09
RAD51 O 0 6.13855809206143e-06
, O 0 2.015247302367129e-09
BRCA2 O 0 1.8480513119811803e-08
relocates O 0 4.626419691788897e-09
to O 0 3.0247657711868214e-09
PCNA O 0 3.580617402576536e-08
+ O 0 3.193106057342021e-10
replication O 0 2.7512582490007986e-11
sites O 0 8.447291477420293e-12
following O 0 2.0942331202533637e-11
exposure O 0 6.797494789267944e-10
of O 0 1.7714449906947038e-09
S O 0 2.0212465301483462e-07
phase O 0 1.3378826224652585e-07
cells O 0 6.638853355944718e-10
to O 0 5.345563103276163e-09
hydroxyurea O 0 4.378270546112617e-08
or O 0 2.75153535511663e-08
UV O 0 4.725307007902302e-05
irradiation O 0 3.203217602276709e-07
. O 0 5.206397535317819e-09

Thus O 0 1.0372169612082871e-07
, O 0 5.799607460943434e-10
BRCA1 O 0 5.470833785992113e-10
and O 0 1.1946796329986853e-10
BRCA2 O 0 6.043534006572315e-10
participate O 0 1.2532391790998076e-10
, O 0 7.585243197438807e-12
together O 0 1.051215755068502e-12
, O 0 3.393417708288937e-12
in O 0 3.976180495968151e-11
a O 0 3.6481044851655042e-09
pathway O 0 2.163101875396478e-08
( O 0 7.139869945271826e-11
s O 0 1.25878563128623e-09
) O 0 7.501302096840634e-13
associated O 0 5.756477326063214e-12
with O 0 7.731787215678465e-14
the O 0 1.939854700483412e-11
activation O 0 4.413301321615215e-11
of O 0 1.0590090609996494e-10
double O 0 9.168346637444813e-12
- O 0 1.3610347571191284e-10
strand O 0 2.5300536665717743e-10
break O 0 7.376570465567056e-10
repair O 0 2.1150690088234114e-09
and O 0 5.0935332340795725e-11
/ O 0 1.3425087708185401e-08
or O 0 1.1286485523953615e-08
homologous O 0 8.105291549043159e-09
recombination O 0 5.408502090631373e-09
. O 0 3.912262513949827e-09

Dysfunction O 0 0.08499500155448914
of O 0 1.8775244825519621e-06
this O 0 2.0466558225962217e-08
pathway O 0 1.6015810899716598e-07
may O 0 1.4416202676059697e-09
be O 0 2.4893122285707392e-11
a O 0 7.116390116079785e-11
general O 0 9.053939820091728e-10
phenomenon O 0 1.414016542744534e-10
in O 0 2.4901077293887353e-13
the O 0 5.668006754049049e-13
majority O 0 5.260416126133538e-14
of O 0 7.622701298296009e-13
cases O 0 5.077855236984563e-12
of O 0 3.6210942577774574e-10
hereditary B-Disease 1 0.9999574422836304
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.841407835483551
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.719410130997858e-07
. O 0 1.519185666154499e-08

A O 0 3.7168925359765126e-07
novel O 0 7.82332065796254e-09
Arg362Ser O 0 6.894359785292181e-07
mutation O 0 3.9577732757756223e-10
in O 0 3.1576984083070414e-11
the O 0 1.3904251361385178e-10
sterol O 0 8.151181063453805e-09
27 O 0 1.5453500168405299e-07
- O 0 4.981845336260449e-08
hydroxylase O 0 7.910606569794254e-08
gene O 0 2.1566288754826246e-09
( O 0 1.2123271830866145e-10
CYP27 O 0 1.8804734281729907e-05
) O 0 4.5023981071201646e-11
: O 0 2.8472942319862637e-12
its O 0 3.079424215624016e-11
effects O 0 1.1265639532354044e-09
on O 0 6.733108737222437e-09
pre O 0 6.7635235190266485e-09
- O 0 4.3314524189597137e-10
mRNA O 0 3.323885333639254e-10
splicing O 0 2.4417374372420753e-11
and O 0 1.955079327597975e-12
enzyme O 0 6.348681563100866e-12
activity O 0 3.411644577955286e-10
. O 0 5.751457088365441e-10

A O 0 3.802427954724408e-07
novel O 0 1.2536062854451302e-08
C O 0 9.196298123015367e-08
to O 0 4.127302666301347e-10
A O 0 1.3831446210588183e-08
mutation O 0 2.336478510667206e-10
in O 0 8.84122809685639e-12
the O 0 1.531601651061365e-10
sterol O 0 6.502804517083405e-09
27 O 0 1.7647660399688903e-07
- O 0 1.1189349891083111e-07
hydroxylase O 0 2.712522757519764e-07
gene O 0 1.6270955693897804e-09
( O 0 6.622737080963503e-11
CYP27 O 0 5.4697406994819175e-06
) O 0 2.498082990465278e-11
was O 0 6.449316636292224e-10
identified O 0 1.2995825769690494e-11
by O 0 1.0107018520721933e-11
sequencing O 0 3.554972982655613e-10
amplified O 0 5.649529732920655e-09
CYP27 O 0 8.282062481157482e-06
gene O 0 1.6198672958545046e-10
products O 0 4.7880904102681754e-11
from O 0 2.094656392781502e-11
a O 0 2.3994853326492205e-10
patient O 0 1.3886208849456239e-09
with O 0 3.239716134251225e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.3850963870586384e-08
CTX B-Disease 0 6.109619334893068e-06
) O 0 3.9607184199041967e-10
. O 0 4.386844665305034e-09

The O 0 4.1876117506944865e-07
mutation O 0 1.2160707996144993e-08
changed O 0 7.402983781545913e-10
the O 0 9.961362290589193e-11
adrenodoxin O 0 4.45234205059819e-09
cofactor O 0 1.7296464260851963e-10
binding O 0 5.8419318271774046e-09
residue O 0 1.614619016265806e-08
362Arg O 0 6.902762250682315e-10
to O 0 1.3013771171799249e-09
362Ser O 0 2.1421995199943922e-07
( O 0 2.915448549245525e-09
CGT O 0 4.341930889495416e-06
362Arg O 0 6.223773141300626e-08
to O 0 2.9549916291671252e-08
AGT O 0 1.7030573928877857e-07
362Ser O 0 4.029435896057976e-09
) O 0 2.7457159809674003e-12
, O 0 6.876705693596719e-13
and O 0 1.418601998023905e-12
was O 0 2.1523551829716325e-09
responsible O 0 5.579835260505206e-09
for O 0 3.961899253113188e-09
deficiency O 0 1.0949269380944315e-05
in O 0 1.3154735256648564e-07
the O 0 2.7847934802593954e-07
sterol O 0 1.330467256366319e-07
27 O 0 6.564154659827182e-07
- O 0 2.881648875074916e-08
hydroxylase O 0 1.106312019771849e-08
activity O 0 1.0959412044542205e-08
, O 0 3.203302423662735e-12
as O 0 1.2007138989675314e-12
confirmed O 0 5.1523919679385966e-12
by O 0 2.0344881649595609e-13
expression O 0 1.4132499857877345e-11
of O 0 1.1193090204697498e-10
mutant O 0 3.165440826125021e-11
cDNA O 0 1.7597787116407915e-10
into O 0 4.779343032446093e-10
COS O 0 4.489010905217583e-07
- O 0 4.585920621025252e-08
1 O 0 3.562596475603641e-07
cells O 0 2.8040536559359452e-09
. O 0 1.7030655774519232e-09

Quantitative O 0 2.990166336758193e-08
analysis O 0 1.3414963584423845e-10
showed O 0 9.124942121352397e-12
that O 0 1.3651302039740382e-13
the O 0 1.5202493127211558e-12
expression O 0 3.327224563573483e-12
of O 0 6.604446156632804e-11
CYP27 O 0 1.1701603597202848e-07
gene O 0 5.711767430555126e-12
mRNA O 0 9.399835770862452e-11
in O 0 2.2456303309936754e-12
the O 0 1.9631104034023572e-11
patient O 0 1.9667466266692912e-10
represented O 0 3.15837439535116e-10
52 O 0 3.731013009655726e-07
. O 0 7.883419783638601e-08

5 O 0 3.658754792468244e-07
% O 0 3.6621663479508015e-09
of O 0 8.401874196373171e-10
the O 0 3.50516438096804e-09
normal O 0 8.839127190185536e-07
level O 0 1.6112708181026392e-06
. O 0 7.095636078702228e-08

As O 0 5.739985375896595e-09
the O 0 1.2346034194976596e-09
mutation O 0 2.9355234909544947e-10
occurred O 0 2.8946369745597167e-09
at O 0 6.147056474947732e-11
the O 0 9.290231778313895e-12
penultimate O 0 7.883502184391489e-10
nucleotide O 0 7.848031946533496e-11
of O 0 1.6201670560711534e-10
exon O 0 2.454458025713535e-10
6 O 0 1.4580747276227157e-08
( O 0 1.090006470499949e-11
- O 0 4.1065746358981414e-09
2 O 0 3.3264697663071274e-08
position O 0 7.910558430523906e-09
of O 0 1.516417325042596e-09
exon O 0 9.299796488448919e-10
6 O 0 1.5182472168362438e-08
- O 0 2.9840230286737324e-09
intron O 0 1.3886375604954537e-08
6 O 0 1.0548492745954263e-08
splice O 0 9.414500290461092e-10
site O 0 6.983766343005016e-11
) O 0 4.970234835678655e-13
of O 0 8.321997257976221e-11
the O 0 1.2597416443327347e-09
gene O 0 1.6962470317238854e-10
, O 0 8.666623668718287e-11
we O 0 5.411945891431458e-10
hypothesized O 0 2.4660782305119255e-09
that O 0 1.2811779415144997e-11
the O 0 1.2594142395627728e-10
mutation O 0 6.820712744604052e-11
may O 0 6.190842283260167e-10
partially O 0 1.2727642273446804e-09
affect O 0 2.2375103991834067e-09
the O 0 1.0494263236182633e-09
normal O 0 7.119777656328097e-09
splicing O 0 3.179000118702646e-11
efficiency O 0 2.414832743491413e-11
in O 0 7.024964377572163e-12
exon O 0 1.1551040679513846e-10
6 O 0 2.2074979622033197e-09
and O 0 4.709434665156609e-12
cause O 0 4.093036742869316e-10
alternative O 0 1.5589950441707856e-09
splicing O 0 8.931231448849886e-11
elsewhere O 0 4.653529298015435e-12
, O 0 1.0597712350691665e-13
which O 0 1.0226009898887597e-13
resulted O 0 1.601513713311853e-11
in O 0 1.7740468816196397e-11
decreased O 0 7.50437600949283e-10
transcript O 0 1.149855433091318e-09
in O 0 6.382230161028346e-11
the O 0 3.9927114392490637e-10
patient O 0 1.0459517696403964e-08
. O 0 1.0882257761579694e-08

Transfection O 0 2.746827249211492e-06
of O 0 2.3372384916342526e-08
constructed O 0 2.6400648334146126e-09
minigenes O 0 1.2728575882192672e-07
, O 0 5.752449731832865e-12
with O 0 9.851661993782665e-14
or O 0 2.468033069580322e-11
without O 0 2.808098475970411e-10
the O 0 4.182251212014876e-10
mutation O 0 5.886004184052496e-11
, O 0 1.0782983880797126e-11
into O 0 6.015427600480905e-10
COS O 0 5.594085337179422e-07
- O 0 1.5477260717489116e-07
1 O 0 1.5392665773106273e-06
cells O 0 2.1573764996674072e-10
confirmed O 0 5.219288196078864e-11
that O 0 3.0409740480949465e-13
the O 0 3.758836991663017e-12
mutant O 0 4.0160198083727394e-11
minigene O 0 2.9720605976280012e-09
was O 0 2.4609411730658337e-10
responsible O 0 4.022451816076966e-11
for O 0 1.3884076180414873e-11
a O 0 2.44516984437837e-09
mRNA O 0 2.001099375092963e-08
species O 0 9.291423186397196e-11
alternatively O 0 1.4963968952841356e-09
spliced O 0 6.090855819707031e-09
at O 0 9.368058329073392e-09
an O 0 8.820048025270921e-10
activated O 0 1.9631065129033232e-07
cryptic O 0 2.553336173605203e-07
5 O 0 5.382631798056536e-07
splice O 0 1.5308955880755093e-07
site O 0 1.9849736077048874e-08
88 O 0 4.8376844752340276e-09
bp O 0 3.530378878124907e-09
upstream O 0 1.6368290056689716e-09
from O 0 5.6860200575714615e-11
the O 0 1.2744202915193625e-10
3 O 0 5.45504086346682e-09
end O 0 1.2577303643013238e-08
of O 0 2.391495224074447e-09
exon O 0 8.170871979018557e-09
6 O 0 1.6965731219897862e-07
. O 0 9.82916326108807e-09

Our O 0 1.87565291298597e-07
data O 0 1.1164354996040515e-09
suggest O 0 1.5100148909041877e-10
that O 0 7.457368056407176e-12
the O 0 3.597809203337299e-11
C O 0 2.5157149696752867e-09
to O 0 5.2342619821788006e-11
A O 0 3.982635998767137e-09
mutation O 0 4.5409492138714924e-11
at O 0 9.951751922532281e-11
the O 0 1.7540207133959207e-11
penultimate O 0 6.260820195613803e-10
nucleotide O 0 8.055317524124916e-11
of O 0 7.98093119369625e-11
exon O 0 1.5697718125373683e-10
6 O 0 6.229138982405402e-09
of O 0 1.1696790758186637e-10
the O 0 2.2757683237895066e-10
CYP27 O 0 5.806237481920107e-07
gene O 0 7.4026236529523e-12
not O 0 9.031372004419946e-12
only O 0 4.469746794910634e-11
causes O 0 2.7463707752417577e-08
the O 0 4.0043826032842844e-09
deficiency B-Disease 0 5.746835185505006e-08
in I-Disease 0 1.5092267435790063e-09
the I-Disease 0 4.522767049763843e-09
sterol I-Disease 0 6.809644848004837e-09
27 I-Disease 0 2.621585082351885e-08
- I-Disease 0 1.0494564106622306e-09
hydroxylase I-Disease 0 7.606954510741559e-10
activity I-Disease 0 2.3626014478139723e-09
, O 0 2.9462287644277385e-12
but O 0 1.774094239570534e-11
also O 0 2.022056307116049e-11
partially O 0 9.864222771938103e-10
leads O 0 1.5867458388885147e-11
to O 0 2.4749438609639185e-11
alternative O 0 1.1902717700351673e-10
pre O 0 8.713850196961914e-10
- O 0 3.9774471910503095e-11
mRNA O 0 5.100776398481166e-11
splicing O 0 5.851423946073853e-12
of O 0 1.1913834719115557e-12
the O 0 1.0481130720274567e-11
gene O 0 4.9939007790156253e-11
. O 0 6.564324639413144e-10

To O 0 1.695876861163015e-08
our O 0 9.168792947100712e-10
knowledge O 0 7.980580779554103e-11
, O 0 1.4557985893171033e-12
this O 0 5.634818241347095e-13
is O 0 2.0304806013643484e-12
the O 0 7.585301310675252e-12
first O 0 2.2819784256666864e-11
report O 0 2.5642345885534823e-11
regarding O 0 1.096906246389473e-10
effects O 0 2.7354327691853086e-09
on O 0 9.164950576234787e-09
pre O 0 5.3979083425304e-09
- O 0 8.931640843590216e-11
mRNA O 0 4.7721077089946107e-11
splicing O 0 6.142552612387053e-12
of O 0 1.305492281118703e-12
a O 0 3.706043284756877e-12
mutation O 0 1.8648889724137696e-11
at O 0 1.6703634309056525e-10
the O 0 3.217092911511621e-11
- O 0 7.698692794377848e-10
2 O 0 6.098797911135989e-08
position O 0 1.896359691500038e-08
of O 0 1.294065521406651e-09
a O 0 1.0723787191579959e-08
5 O 0 4.129615263082087e-07
splice O 0 2.5906680889420386e-07
site O 0 1.5986413970381363e-08
. O 0 6.5349086142418855e-09

ATM O 0 0.000515567313414067
germline O 0 3.625713361543603e-05
mutations O 0 4.287253219104059e-08
in O 0 4.273353892969567e-10
classical O 0 0.02810308337211609
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 3.502972049318487e-06
in O 0 3.262971490225475e-11
the O 0 5.921711732082002e-11
Dutch O 0 3.4288930028658626e-10
population O 0 2.743370417987445e-12
. O 0 1.6452258999599678e-10

Germline O 0 9.32098992052488e-05
mutations O 0 1.914823499760132e-08
in O 0 1.2000464510997233e-10
the O 0 6.546541780894088e-11
ATM O 0 5.829443150418001e-09
gene O 0 1.8895203056281534e-13
are O 0 1.981974087346232e-15
responsible O 0 1.821019870269433e-13
for O 0 1.6067694050270198e-12
the O 0 5.113869974593399e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.4065060390275903e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.830372990483056e-09
. O 0 1.8127284562297064e-08

In O 0 1.517940830808584e-07
our O 0 1.4644935930618885e-08
study O 0 4.47052478369514e-10
, O 0 8.219393048125578e-12
we O 0 9.138927462015722e-12
have O 0 2.069616396663254e-12
determined O 0 7.562594994681149e-11
the O 0 1.900274555766135e-11
ATM O 0 7.299567172935895e-09
mutation O 0 1.0105693365458635e-10
spectrum O 0 7.664877066382303e-10
in O 0 2.468259104049242e-11
19 O 0 6.601581503673515e-09
classical O 0 3.822009375653579e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.3061039300387165e-08
, O 0 1.1411231118016452e-12
including O 0 3.0459535176226293e-14
some O 0 1.6709279359455875e-13
immigrant O 0 6.161283289118913e-11
populations O 0 3.0901899962521018e-12
, O 0 6.177386076625102e-13
as O 0 2.7654302459101388e-12
well O 0 2.322484652511614e-12
as O 0 7.769685068936827e-12
12 O 0 1.14132016337809e-10
of O 0 1.1289074709763813e-11
Dutch O 0 4.76597927789868e-10
ethnic O 0 3.143955651374597e-10
origin O 0 9.661943467520473e-10
. O 0 4.0358045794164354e-09

Both O 0 1.983561936924616e-08
the O 0 1.7975310129259015e-08
protein O 0 3.8817802305857185e-09
truncation O 0 3.935037540259145e-08
test O 0 7.126557122205668e-09
( O 0 1.6773551991811075e-10
PTT O 0 1.2698870932581485e-07
) O 0 2.6749639829570793e-12
and O 0 2.4446720689463852e-12
the O 0 2.269741686267146e-11
restriction O 0 6.90439094785944e-11
endonuclease O 0 2.115186248374812e-09
fingerprinting O 0 3.5425740119165994e-09
( O 0 4.761325014812634e-11
REF O 0 1.767052282275472e-08
) O 0 1.4660976425939776e-12
method O 0 4.263150943373262e-11
were O 0 1.0769947217034725e-12
used O 0 7.533534885327542e-13
and O 0 1.0302504292389325e-12
compared O 0 1.6256048590568284e-11
for O 0 4.4498398021897145e-12
their O 0 1.0335812067330252e-11
detection O 0 1.7175648403533472e-10
efficiency O 0 1.7743717953266902e-11
, O 0 5.46604862067257e-13
identifying O 0 7.933362300427405e-12
76 O 0 2.123459602598743e-10
% O 0 4.353189250044798e-12
and O 0 1.0363858209128107e-12
60 O 0 1.811627375891689e-10
% O 0 5.1370768749947615e-11
of O 0 4.7891773879982225e-11
the O 0 6.581060696397856e-10
mutations O 0 2.137912069599679e-09
, O 0 2.816111788206399e-10
respectively O 0 1.8105929200373794e-08
. O 0 2.07825170406295e-08

Most O 0 1.0851007203882546e-07
patients O 0 4.12514866710012e-09
were O 0 1.2196677001696798e-10
found O 0 5.0998203056373814e-12
to O 0 5.285729146042861e-11
be O 0 1.4331835718195407e-10
compound O 0 5.3804334321228e-09
heterozygote O 0 2.607412952215782e-08
. O 0 7.628767839662487e-09

Seventeen O 0 6.494663580269844e-07
mutations O 0 3.03772806908853e-09
were O 0 4.9527798529069855e-11
distinct O 0 5.98760494310846e-12
, O 0 4.327864022019012e-12
of O 0 2.0497978314715226e-11
which O 0 8.4511434308987e-12
10 O 0 3.527213521259398e-10
were O 0 1.789762435477904e-11
not O 0 2.1340079703335846e-10
reported O 0 2.1074060274628437e-09
previously O 0 5.67791946792795e-09
. O 0 1.0130966288102172e-08

Mutations O 0 1.8953962808154756e-06
are O 0 2.2439328173362583e-10
small O 0 2.557924427826208e-10
deletions O 0 1.847497976825707e-08
or O 0 7.841083515813807e-07
point O 0 2.060891165456269e-05
mutations O 0 2.9550479396789342e-08
frequently O 0 7.629578635537371e-10
affecting O 0 1.1676177802399934e-09
splice O 0 5.317427920203954e-08
sites O 0 3.6767942024340527e-09
. O 0 2.3160826589929684e-09

Moreover O 0 4.666043764700589e-07
, O 0 2.590724967888036e-09
a O 0 2.8071212909708265e-08
16 O 0 1.2613287481144653e-06
. O 0 4.348716586832779e-08

7 O 0 1.625878212507814e-05
- O 0 3.441634817136219e-07
kb O 0 5.115584258419403e-07
genomic O 0 8.84221940111729e-09
deletion O 0 1.8830382586543237e-08
of O 0 3.0864246713946386e-09
the O 0 4.276599074870546e-10
3 O 0 5.9902989235638415e-09
end O 0 1.15732383676459e-08
of O 0 9.217170360287241e-10
the O 0 5.702847083455254e-10
gene O 0 3.320607677714804e-11
, O 0 2.3072433720516816e-12
most O 0 2.1583167111177692e-12
likely O 0 1.782843456199501e-10
a O 0 1.2192072351702166e-10
result O 0 4.391865759956204e-10
of O 0 3.7795025442655117e-10
recombination O 0 9.537536559134363e-12
between O 0 1.4475047549478148e-10
two O 0 1.871866550651191e-11
LINE O 0 2.6765758498470404e-09
elements O 0 3.505000109593759e-11
, O 0 7.279424459050166e-12
was O 0 6.536001739831931e-10
identified O 0 7.573772164981563e-10
. O 0 9.188663718795453e-10

The O 0 4.9656797784791706e-08
most O 0 8.841299914408296e-11
frequently O 0 2.674888609222048e-11
found O 0 1.3243478362567895e-11
mutation O 0 2.1338117037195126e-11
, O 0 7.399754095062383e-13
identified O 0 7.946856714347028e-12
in O 0 1.4333981050718148e-12
three O 0 2.9162228187828987e-12
unrelated O 0 1.2901905932505287e-10
Turkish O 0 4.965670186152238e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 6.600696655922889e-10
, O 0 3.405564025227292e-11
was O 0 4.518685980947623e-10
previously O 0 1.5739744577136783e-11
described O 0 3.8766594643614705e-13
to O 0 2.978080835321778e-13
be O 0 1.5829232456049391e-13
a O 0 3.4155215548198337e-12
Turkish O 0 1.832333929030483e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 3.3686824281176087e-06
mutation O 0 3.609196497222911e-08
. O 0 4.30762803205198e-09

The O 0 9.276027057580905e-09
presence O 0 3.58398949407146e-10
of O 0 1.1948579903275913e-09
a O 0 1.7316915901233187e-08
founder O 0 9.109348866331857e-07
mutation O 0 3.467892639719139e-08
among O 0 1.4439240818633903e-12
relatively O 0 8.4466591707133e-13
small O 0 1.2462744052900432e-13
ethnic O 0 5.1870617176486e-12
population O 0 9.441292826749617e-14
groups O 0 1.7442829204129297e-14
in O 0 4.2128223652626584e-12
Western O 0 2.4394402053928843e-09
Europe O 0 1.371835867125526e-09
could O 0 2.13352491229557e-09
indicate O 0 4.748503812379568e-10
a O 0 1.375978220252705e-10
high O 0 1.1294701285358144e-10
carrier O 0 1.110862270226054e-12
frequency O 0 8.155977976320727e-11
in O 0 9.578989077635436e-13
such O 0 5.892805232492193e-13
communities O 0 2.6131805053175583e-10
. O 0 1.5116935259129605e-08

In O 0 5.440762951280931e-09
patients O 0 5.081561837982917e-10
of O 0 1.0166612690598598e-10
Dutch O 0 1.5156539356908638e-09
ethnic O 0 4.1618244961405537e-10
origin O 0 7.17210874023877e-11
, O 0 1.3548846289693217e-12
however O 0 2.0759428898120547e-11
, O 0 7.249107997903126e-12
no O 0 3.7958421128525544e-11
significant O 0 2.480417815586833e-10
founder O 0 2.86699330942497e-09
effect O 0 9.514040222313724e-09
could O 0 4.145656262721786e-09
be O 0 1.0786821436070682e-09
identified O 0 4.360683369952767e-09
. O 0 5.711373152195165e-09

The O 0 1.9968678088844172e-07
observed O 0 5.723163809534526e-08
genetic O 0 6.775583649698547e-09
heterogeneity O 0 3.842187457081536e-09
including O 0 6.821840835280479e-12
the O 0 5.441258554839123e-10
relative O 0 1.7306447830378602e-08
high O 0 4.796626029701656e-08
percentage O 0 9.443063220260228e-09
of O 0 8.802032436250329e-10
splice O 0 1.8387126488050853e-08
- O 0 1.9752148361362742e-08
site O 0 1.0603076638915354e-08
mutations O 0 1.0443187425934752e-09
had O 0 5.720953710763865e-10
no O 0 4.3612113920232787e-11
reflection O 0 4.5545350824127695e-10
on O 0 1.5175869449990387e-08
the O 0 1.0851844978176928e-09
phenotype O 0 6.275267594446632e-08
. O 0 1.963311824226821e-08

All O 0 2.4369104512089734e-09
patients O 0 1.6522574974864312e-10
manifested O 0 1.3730812320478236e-10
classical O 0 1.8974125381987506e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 9.970509973200592e-10
increased O 0 8.344445134866874e-10
cellular O 0 5.608545849966617e-10
radioresistant O 0 1.3469358073336934e-08
DNA O 0 8.861208433685874e-10
synthesis O 0 5.584783746570565e-10
. O 0 9.970395620229056e-10

Determination O 0 1.8473468799129478e-07
of O 0 5.971988681352514e-09
the O 0 2.551502342740264e-10
genomic O 0 3.0019295382821554e-10
structure O 0 5.113927337152546e-11
of O 0 1.0741278699821777e-10
the O 0 2.762628459329619e-10
COL4A4 O 0 5.967396191408625e-06
gene O 0 9.880086332403337e-12
and O 0 6.872339611448119e-13
of O 0 1.2536927225526018e-11
novel O 0 6.738414715101726e-09
mutations O 0 0.00010940337233478203
causing O 1 0.9998074173927307
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8500133156776428

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.970280827379156e-09
a O 0 9.344180540438174e-09
progressive O 1 0.8840782046318054
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 5.598087955149822e-05
by O 0 1.6261678581486194e-07
glomerular B-Disease 1 0.9991581439971924
basement I-Disease 1 0.9966853260993958
membrane I-Disease 0 3.394790837774053e-05
abnormalities I-Disease 0 5.099179543321952e-05
and O 0 6.394516027796726e-10
associated O 0 1.5492161997698872e-09
with O 0 3.9283201691553415e-11
mutations O 0 5.893668886258752e-10
in O 0 1.5583936918694974e-10
either O 0 2.502271168047798e-10
the O 0 7.466370854913862e-10
COL4A3 O 0 9.175779496217729e-07
or O 0 7.13996861634314e-10
the O 0 3.0686388985401436e-09
COL4A4 O 0 2.8128938538429793e-06
gene O 0 9.926103688995269e-11
, O 0 2.2860636994526118e-12
which O 0 8.916822900710553e-13
encode O 0 3.8004203950503523e-11
the O 0 2.5991972463224045e-10
alpha3 O 0 1.158591942385101e-07
and O 0 3.129602688112243e-10
alpha4 O 0 3.6397563007994904e-07
type O 0 8.546899010752895e-08
IV O 0 0.0001675307867117226
collagen O 0 1.7157175591364648e-07
chains O 0 3.158281458581769e-08
, O 0 2.914863350689245e-10
respectively O 0 9.314215176914331e-09
. O 0 2.500203244437671e-08

To O 0 8.64880149720193e-08
date O 0 6.151886395855399e-07
, O 0 1.384954095851043e-10
mutation O 0 3.137903131777975e-11
screening O 0 5.132102035010355e-11
in O 0 1.2002908215957842e-11
the O 0 1.5051783430752863e-10
two O 0 1.0844639769524989e-10
genes O 0 1.287172313180207e-10
has O 0 3.2654725277969643e-12
been O 0 7.373468155491558e-12
hampered O 0 5.282103643367009e-10
by O 0 3.4121355914351614e-12
the O 0 3.717260665947464e-10
lack O 0 7.03245239819239e-10
of O 0 8.439291626638479e-11
genomic O 0 1.1627035445549438e-10
structure O 0 2.6000984351681744e-11
information O 0 1.1236384739321537e-10
. O 0 2.637291496299099e-09

We O 0 4.123380747955707e-08
report O 0 2.35642561019489e-10
here O 0 2.382737410155933e-11
the O 0 1.4872332532167576e-11
complete O 0 1.7835705135027524e-11
characterization O 0 1.2794278136940562e-10
of O 0 1.1251053561034396e-10
the O 0 8.186978178725823e-11
48 O 0 6.008355590836345e-09
exons O 0 6.1139018292522e-09
of O 0 1.7139594188364526e-09
the O 0 7.358867737394803e-09
COL4A4 O 0 0.00027770883752964437
gene O 0 9.677030288202104e-10
, O 0 3.4722426323074984e-11
a O 0 4.634984895890426e-10
comprehensive O 0 8.03927058257159e-09
gene O 0 1.6991807960664573e-10
screen O 0 1.8419621383714002e-09
, O 0 5.574202904812253e-11
and O 0 1.8149605082729003e-11
the O 0 7.501367582651852e-11
subsequent O 0 6.445624589623833e-11
detection O 0 2.4780533181001374e-10
of O 0 1.4220622075733491e-11
10 O 0 2.773011160972505e-11
novel O 0 7.648162485274224e-12
mutations O 0 2.5311574017305993e-11
in O 0 7.191789698490769e-12
eight O 0 1.080444733680963e-09
patients O 0 1.0209411982486927e-08
diagnosed O 1 0.9998538494110107
with O 0 4.2233546082570683e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.025613080710172653

Furthermore O 0 5.342854478840309e-07
, O 0 5.487819976224273e-09
we O 0 2.597721815433829e-09
identified O 0 1.8859738215581956e-09
a O 0 7.050085515380999e-10
glycine O 0 4.2300918323689984e-09
to O 0 8.296046516420574e-09
alanine O 0 8.348539637381691e-09
substitution O 0 2.8031552634644186e-09
in O 0 3.3217240069660647e-10
the O 0 1.353484102573077e-09
collagenous O 0 3.198864106934707e-08
domain O 0 1.8220868147622582e-09
that O 0 2.623010315894181e-12
is O 0 1.8140147587178412e-12
apparently O 0 4.6889558208418336e-11
silent O 0 1.0270397032829948e-10
in O 0 3.900157106995206e-12
the O 0 1.5065360417509943e-11
heterozygous O 0 4.175073915063665e-12
carriers O 0 1.5668238191254846e-12
, O 0 7.424299890146369e-12
in O 0 2.598285475663431e-10
11 O 0 1.219253107365148e-07
. O 0 5.407164138659937e-08

5 O 0 3.941039778965205e-07
% O 0 1.3218860450692205e-09
of O 0 7.539407986811852e-11
all O 0 3.81951588412921e-12
control O 0 8.671501017243344e-11
individuals O 0 2.436775282423087e-13
, O 0 8.840548735775111e-13
and O 0 1.6723029211407336e-12
in O 0 9.415963668490956e-12
one O 0 5.739451448827371e-12
control O 0 5.33272592750933e-11
individual O 0 6.776290005462357e-14
homozygous O 0 9.636861621198367e-13
for O 0 9.92651056838656e-13
this O 0 1.1275409425581806e-11
glycine O 0 6.949331776695544e-09
substitution O 0 4.4297784995706024e-08
. O 0 2.494006778874791e-08

There O 0 1.0820786044973829e-08
has O 0 9.340002382618451e-11
been O 0 1.3798197827374903e-11
no O 0 7.043868960332489e-12
previous O 0 7.283913749933646e-11
finding O 0 2.212473954044114e-11
of O 0 1.1144089123726886e-11
a O 0 4.8073257180591966e-11
glycine O 0 1.757323592199711e-10
substitution O 0 1.3386210195864834e-10
that O 0 1.1483238405302076e-12
is O 0 8.740371165542882e-13
not O 0 2.3424777742531155e-12
associated O 0 6.451931003348399e-12
with O 0 2.4785739866778345e-13
any O 0 1.6182954976073916e-10
obvious O 0 3.3547697952940325e-10
phenotype O 0 5.471887942753995e-10
in O 0 4.59764969151788e-11
homozygous O 0 4.296546105009291e-11
individuals O 0 5.662393817718048e-11
. O 0 1.695912388299803e-08

Founder O 0 4.454045210877666e-06
BRCA1 O 0 1.4428277950173651e-07
and O 0 2.63120192300903e-09
BRCA2 O 0 6.549158548807554e-09
mutations O 0 8.94599602729862e-11
in O 0 2.13176850304142e-12
French O 0 1.8095976939136449e-09
Canadian O 0 5.94210860072053e-07
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.8378067352387006e-06
. O 0 1.385415799859402e-07

We O 0 2.5854841823047536e-08
have O 0 4.683646873115954e-11
identified O 0 1.4652325186492732e-10
four O 0 2.813467557885585e-12
mutations O 0 2.3019993029838037e-12
in O 0 5.777704161456787e-13
each O 0 6.792990649151509e-12
of O 0 1.416138650789378e-09
the O 0 2.8112586392126104e-07
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999997615814209
- O 0 0.17639116942882538
susceptibility O 0 0.008326292969286442
genes O 0 5.195012775516261e-08
, O 0 8.751271929341442e-11
BRCA1 O 0 8.948151664078807e-10
and O 0 2.2716049874471622e-10
BRCA2 O 0 3.011065841107552e-09
, O 0 7.652506558118721e-13
in O 0 7.455771568708192e-13
French O 0 9.613047025069932e-10
Canadian O 0 2.4898366746128886e-07
breast B-Disease 1 0.9998612403869629
cancer I-Disease 1 0.999996542930603
and O 0 0.002924154279753566
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.749402578354875e-08
from O 0 4.237658224326424e-09
Quebec O 0 3.003599147177738e-08
. O 0 9.533804856687311e-09

To O 0 1.1302781786071137e-06
identify O 0 1.8279342839377932e-06
founder O 0 2.225911430286942e-06
effects O 0 2.1093603209010325e-05
, O 0 1.6380032885621176e-09
we O 0 3.655221125775654e-10
examined O 0 2.4055893388386096e-10
independently O 0 9.19290130130257e-11
ascertained O 0 3.492697686624524e-09
French O 0 5.218553922325952e-10
Canadian O 0 1.0943468353730168e-09
cancer B-Disease 0 7.799600076907609e-09
families O 0 1.5440327781526125e-13
for O 0 1.0136120729645898e-13
the O 0 5.30307525323237e-12
distribution O 0 2.91103946503668e-11
of O 0 2.350723435351476e-11
these O 0 7.0967047342829215e-12
eight O 0 1.1893237505944398e-09
mutations O 0 2.677925081684407e-08
. O 0 9.051650806668476e-08

Mutations O 0 4.268030551202173e-08
were O 0 1.4112414015166053e-10
found O 0 3.941241430438502e-12
in O 0 2.7723858365275023e-12
41 O 0 4.1073008882897e-10
of O 0 7.409026170357436e-11
97 O 0 3.5653231478249836e-09
families O 0 2.735081883198376e-10
. O 0 2.574903135155182e-08

Six O 0 1.4898310496391787e-07
of O 0 3.945694615481443e-08
eight O 0 1.0040246856135582e-08
mutations O 0 1.218756762177975e-09
were O 0 1.033672925032647e-09
observed O 0 1.1289322809915348e-09
at O 0 1.1626508644724254e-09
least O 0 4.369656581015846e-10
twice O 0 2.5263332759095647e-08
. O 0 1.637288882250232e-08

The O 0 1.5267198705259943e-06
BRCA1 O 0 1.9760736904572695e-06
C4446T O 0 1.0188295163970906e-05
mutation O 0 2.9685494951081637e-08
was O 0 1.2353619238680835e-09
the O 0 2.6012147297249655e-11
most O 0 6.324155608916637e-13
common O 0 8.428932551929336e-11
mutation O 0 5.931741764442222e-10
found O 0 9.803422830467756e-12
, O 0 4.785356139125341e-13
followed O 0 9.580305299072833e-13
by O 0 3.4612315184118225e-12
the O 0 1.5220010807226458e-09
BRCA2 O 0 5.1320313332325895e-08
8765delAG O 0 3.1443912007489416e-07
mutation O 0 3.0015092988833203e-07
. O 0 9.182346616398718e-08

Together O 0 3.744924370607805e-09
, O 0 6.28036345151628e-10
these O 0 6.540813030087023e-11
mutations O 0 1.5051093704698815e-10
were O 0 2.027350856637078e-11
found O 0 1.6071371664039269e-12
in O 0 1.1418349989480991e-12
28 O 0 1.0183618393000415e-09
of O 0 1.8767437603983694e-10
41 O 0 1.6391127344306256e-09
families O 0 3.2511042469263174e-12
identified O 0 8.550294500198063e-11
to O 0 1.5288005306146601e-09
have O 0 4.5476250543075025e-10
a O 0 2.2879353522853307e-08
mutation O 0 2.2046258152386145e-07
. O 0 5.1282938784424914e-08

The O 0 6.382555994832728e-08
odds O 0 1.3892977790419536e-07
of O 0 6.363514715168606e-10
detection O 0 1.7019191611566953e-09
of O 0 1.3360014483598803e-10
any O 0 2.1541363137700387e-10
of O 0 9.397528311083647e-10
the O 0 1.7821805142759217e-10
four O 0 4.7402210628932906e-11
BRCA1 O 0 3.3466915350111037e-10
mutations O 0 1.1180207870609138e-09
was O 0 1.2318191799920442e-08
18 O 0 7.141664326582031e-08
. O 0 6.625448190078487e-09

7x O 0 0.0003219437785446644
greater O 0 6.471194069490593e-08
if O 0 1.1530470800380499e-08
one O 0 1.4938267289821283e-10
or O 0 2.1274640035762182e-11
more O 0 1.1807779146805197e-12
cases O 0 1.300242691293363e-10
of O 0 2.1690351559300325e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 6.830314092098888e-09
also O 0 2.6383643533800516e-12
present O 0 1.2317413798992871e-12
in O 0 3.5124670099556665e-12
the O 0 1.4617237975578234e-10
family O 0 1.223759704682692e-10
. O 0 4.909717077339337e-09

The O 0 8.857668376549555e-08
odds O 0 1.749056508515423e-07
of O 0 9.970453351826336e-10
detection O 0 5.001760783329701e-09
of O 0 9.042062237840653e-11
any O 0 1.0729259147801429e-10
of O 0 8.452264443903346e-10
the O 0 4.55391835352259e-10
four O 0 3.7149780474088345e-10
BRCA2 O 0 4.161325950491346e-09
mutations O 0 4.591309998858151e-09
was O 0 2.830012135746074e-08
5 O 0 2.3062499110437784e-07
. O 0 1.8238646148915905e-08

3x O 0 2.5413370167370886e-05
greater O 0 1.6331132712821272e-07
if O 0 1.878443178782163e-08
there O 0 9.020288682659583e-11
were O 0 1.6648947845365747e-11
at O 0 1.3335998104435642e-11
least O 0 6.190478359958951e-13
five O 0 3.468155396115641e-13
cases O 0 6.70266305565631e-13
of O 0 1.5285199495007618e-10
breast B-Disease 0 0.0005444031557999551
cancer I-Disease 0 8.543867443222553e-05
in O 0 6.420918463589942e-09
the O 0 1.7506785354726162e-07
family O 0 1.4768921197116924e-08
. O 0 2.39686226422009e-08

Interestingly O 0 1.4872276210553537e-07
, O 0 2.560355538694381e-10
the O 0 1.186463705060703e-10
presence O 0 4.3858694454002034e-11
of O 0 1.452317488492838e-09
a O 0 3.475913104011852e-07
breast B-Disease 0 0.2450697273015976
cancer I-Disease 0 0.00017841446970123798
case O 0 1.775302820306024e-07
< O 0 1.4156364613882033e-06
36 O 0 1.057536547222071e-08
years O 0 1.229897433896454e-10
of O 0 3.5968141659514785e-11
age O 0 2.902734996812484e-10
was O 0 5.5650452995825717e-11
strongly O 0 2.5784413666685158e-12
predictive O 0 6.482996084411496e-11
of O 0 1.3343962219913852e-11
the O 0 3.398768246010153e-12
presence O 0 5.650930027731316e-13
of O 0 4.286606659908987e-12
any O 0 3.712043866732628e-11
of O 0 1.0921214627090947e-10
the O 0 2.1739073041704415e-10
eight O 0 2.5124721747538104e-10
mutations O 0 1.2052535358630934e-10
screened O 0 6.61675914059856e-09
. O 0 5.737150754470122e-09

Carriers O 0 5.716056517002244e-10
of O 0 4.5920778291019815e-10
the O 0 6.35767619105998e-11
same O 0 1.7166011667679726e-11
mutation O 0 2.330691195595591e-11
, O 0 1.0377699947213687e-13
from O 0 5.545881679239195e-13
different O 0 2.0764000328160614e-13
families O 0 1.18833100911514e-12
, O 0 2.344171731727407e-12
shared O 0 7.143584768859457e-12
similar O 0 4.2769884855964335e-11
haplotypes O 0 2.2800579202453264e-09
, O 0 3.801609374520787e-11
indicating O 0 1.0177477610673336e-10
that O 0 4.7864902145977606e-12
the O 0 7.901020115941293e-11
mutant O 0 2.9335128076679595e-11
alleles O 0 5.734144496033489e-12
were O 0 4.615325049223129e-12
likely O 0 2.946005592252554e-11
to O 0 1.7587375999994492e-11
be O 0 2.8333821833897987e-12
identical O 0 1.0929787890717746e-12
by O 0 3.2589146225364685e-12
descent O 0 1.9502108816737973e-09
for O 0 5.3434244876027215e-12
a O 0 1.1878405203891163e-10
mutation O 0 2.0425630631315528e-10
in O 0 4.2602893435272904e-11
the O 0 5.150540549614391e-10
founder O 0 7.112108679763196e-09
population O 0 7.501482074401267e-11
. O 0 2.3956816530557035e-09

The O 0 1.885948730517839e-09
identification O 0 3.526231528994117e-10
of O 0 2.4354548933125386e-10
common O 0 2.125575937483859e-09
BRCA1 O 0 6.362525084568915e-08
and O 0 1.489409928723262e-08
BRCA2 O 0 5.8688168991238854e-08
mutations O 0 1.540467864380446e-09
will O 0 5.8569629181326466e-12
facilitate O 0 1.938526769662552e-11
carrier O 0 1.0843951604722069e-11
detection O 0 3.2380495507133844e-10
in O 0 3.1772286624570656e-12
French O 0 3.145168570029e-09
Canadian O 0 1.0843599795862247e-07
breast B-Disease 1 0.9577641487121582
cancer I-Disease 1 0.9900370836257935
and O 0 2.6454919861862436e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.2330177646144875e-07
. O 0 4.4269409471553445e-08

Are O 0 3.342897070268691e-09
Dp71 O 0 1.9433371562627144e-05
and O 0 1.2456786713244128e-08
Dp140 O 0 0.0007027555257081985
brain O 0 4.560399702313589e-06
dystrophin O 0 1.3946974242173837e-08
isoforms O 0 4.0469333439929756e-10
related O 0 1.2772527480109375e-10
to O 0 1.7296399035249266e-10
cognitive B-Disease 0 4.4880221139464993e-07
impairment I-Disease 0 0.0027346524875611067
in O 0 1.0621505452945712e-06
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.8386221528053284

Molecular O 0 2.0533557290036697e-06
study O 0 2.418222955213878e-09
and O 0 2.2083381998050378e-11
neuropsychological O 0 3.18812649890976e-11
analysis O 0 1.9970114971401554e-12
were O 0 1.2662970715407451e-12
performed O 0 1.779384812780095e-14
concurrently O 0 1.8472499734283748e-13
on O 0 1.4735527034681617e-11
49 O 0 7.64087959570503e-10
patients O 0 7.372905237723604e-12
with O 0 3.262716138929811e-11
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 6.587228199350648e-06
DMD B-Disease 1 1.0
) O 0 4.166906056313202e-11
in O 0 1.2628027963590416e-11
order O 0 2.809640020640103e-11
to O 0 9.263836225903432e-11
find O 0 2.4452561503407466e-11
a O 0 1.582502531793928e-11
molecular O 0 9.748422208355478e-11
explanation O 0 1.2190275698598096e-11
for O 0 2.256278063689221e-12
the O 0 2.964913592418128e-10
cognitive B-Disease 0 5.598141115115141e-07
impairment I-Disease 0 1.5714052779003396e-06
observed O 0 1.098942803423597e-08
in O 0 3.760662337093379e-10
most O 0 1.2898369039504587e-09
DMD B-Disease 1 1.0
patients O 0 3.128454295620031e-07
. O 0 3.992548158748832e-08

Complete O 0 4.424779476153162e-08
analysis O 0 7.418532455005789e-10
of O 0 4.507816342425031e-09
the O 0 2.6926798568638333e-09
dystrophin O 0 3.2005591510397835e-09
gene O 0 2.501436002777524e-10
was O 0 1.778201919044875e-09
performed O 0 6.632252472910105e-12
to O 0 6.488104498103553e-11
define O 0 1.1293349588825663e-09
the O 0 9.824041580230869e-10
localization O 0 1.3438287282951933e-07
of O 0 6.491676529662982e-09
deletions O 0 5.0601505208192066e-09
and O 0 5.063275909655829e-10
duplications O 0 4.72998396006119e-09
in O 0 1.5544157627722655e-10
relation O 0 9.030191039371971e-10
to O 0 4.3847261932405956e-10
the O 0 3.9796724249363535e-10
different O 0 4.638610884288852e-10
DMD B-Disease 1 1.0
promoters O 0 4.817328772332985e-06
. O 0 6.236297878103869e-08

Qualitative O 0 3.610952248322974e-08
analysis O 0 7.253831979525671e-10
of O 0 2.6055619883891268e-09
the O 0 1.7721919487456717e-09
Dp71 O 0 2.7183848061440585e-08
transcript O 0 3.6765188116127945e-10
and O 0 8.316297303578857e-12
testing O 0 8.834092853939046e-13
for O 0 4.178049304638144e-14
the O 0 1.0492386039867574e-12
specific O 0 5.763662984381579e-12
first O 0 1.0291830582209727e-10
exon O 0 4.0402081680213087e-10
of O 0 2.078373695368896e-09
Dp140 O 0 1.4294754180355085e-07
were O 0 1.9730628242342618e-10
also O 0 1.256115003678282e-11
carried O 0 2.601690911319121e-11
out O 0 1.591186765681485e-10
. O 0 6.235649774311014e-10

Neuropsychological O 0 1.3276576282805763e-06
analysis O 0 1.0306259845549448e-08
assessed O 0 1.0895471547200941e-07
verbal O 0 9.262806344167984e-08
and O 0 6.664738538830761e-09
visuospatial O 0 1.8379839161752898e-07
intelligence O 0 1.6874512898112926e-09
, O 0 1.2222760303881586e-10
verbal O 0 1.4445716622901728e-08
memory O 0 2.2090412699071749e-07
, O 0 1.3760595440892587e-10
and O 0 3.982578850036944e-11
reading O 0 9.365306752329161e-09
skills O 0 6.8282037801736806e-09
. O 0 5.308780970381122e-09

Comparison O 0 8.877201480572694e-07
of O 0 4.51109542609629e-07
molecular O 0 9.919966004190428e-08
and O 0 6.391760454249606e-10
psychometric O 0 1.1101764840759643e-07
findings O 0 2.9037887649963068e-09
demonstrated O 0 3.38594534354808e-11
that O 0 3.743433080877212e-12
deletions O 0 8.951936414369754e-11
and O 0 4.041801268672707e-11
duplications O 0 1.93570492967865e-10
that O 0 2.2246270797721124e-11
were O 0 2.0296221300841744e-11
localized O 0 7.494420639631016e-10
in O 0 1.254449183418771e-10
the O 0 7.309092775464876e-10
distal O 0 8.335351822097437e-07
part O 0 3.409878601701166e-08
of O 0 2.053859134321101e-06
the O 0 5.536256821869756e-07
gene O 0 4.178689394507273e-09
seemed O 0 9.539893319754356e-10
to O 0 2.686341600555142e-11
be O 0 4.806745713265004e-12
preferentially O 0 9.426426306191615e-11
associated O 0 6.079058090247003e-11
with O 0 2.842655971724284e-11
cognitive B-Disease 0 3.5889592254534364e-05
impairment I-Disease 0 0.003659262089058757
. O 0 3.288472953499877e-06

Two O 0 6.871962909826834e-08
altered O 0 6.3494326241198e-08
Dp71 O 0 1.0336241302866256e-06
transcripts O 0 3.246166357939728e-08
and O 0 6.651934003620852e-10
two O 0 9.823193647395811e-11
deleted O 0 3.79164699637613e-10
Dp140 O 0 3.987759011891967e-09
DNA O 0 4.369035081636108e-12
sequences O 0 6.377304961240407e-14
were O 0 5.672568128113967e-14
found O 0 5.067987858802664e-15
in O 0 2.047715702514427e-14
four O 0 1.9934181800899953e-13
patients O 0 1.9458976530800642e-12
with O 0 4.025703815441206e-12
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 0.0004291262594051659

These O 0 1.3327627890191707e-08
findings O 0 6.4561387347339405e-09
suggest O 0 7.469361795742202e-10
that O 0 2.367645576123456e-12
some O 0 7.620187033458015e-13
sequences O 0 8.62584797426541e-13
located O 0 5.032605408794577e-12
in O 0 3.1755199598332284e-12
the O 0 4.864521632730323e-11
distal O 0 7.071572838412976e-08
part O 0 1.7256107653906838e-09
of O 0 1.623048362375812e-08
the O 0 6.215620906857566e-09
gene O 0 9.36061853029635e-11
and O 0 2.5788411336935546e-11
, O 0 8.652085124738473e-12
in O 0 1.0871702843529008e-11
particular O 0 1.6773551991811075e-10
, O 0 1.4468802024547589e-11
some O 0 9.228441621988992e-11
DMD B-Disease 1 1.0
isoforms O 0 9.425896507764264e-09
expressed O 0 3.265563097709645e-10
in O 0 3.673406578919014e-10
the O 0 4.517766605260931e-09
brain O 0 3.2237568348136847e-07
may O 0 3.5772487749774484e-10
be O 0 1.0057999572099519e-11
related O 0 1.7384598968717135e-11
to O 0 1.0050468790545608e-10
the O 0 1.140682409639382e-10
cognitive B-Disease 0 6.572511068725362e-08
impairment I-Disease 0 9.492365649066414e-08
associated O 0 1.8118573308356645e-08
with O 0 9.194729422290493e-10
DMD B-Disease 1 1.0
. O 0 3.9293976072940495e-08
. O 0 6.9847989614402195e-09

I1307K O 0 5.273775241221301e-05
APC O 0 2.2346758044022863e-07
and O 0 9.207312690051594e-10
hMLH1 O 0 1.6139745184773346e-07
mutations O 0 3.6820346771548884e-10
in O 0 1.458082894874313e-12
a O 0 4.292540628503261e-11
non O 0 2.971199064560892e-09
- O 0 4.533362019110143e-10
Jewish O 0 2.7436051208695744e-09
family O 0 2.2704420808705716e-12
with O 0 5.296683773005351e-13
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9999969005584717

We O 0 1.3606565874013654e-09
describe O 0 4.5015224187094915e-11
a O 0 2.6639317488030834e-11
French O 0 1.8211555596892026e-09
Canadian O 0 1.1337214544937524e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.273672746217926e-06
HNPCC B-Disease 1 0.9763121604919434
) O 0 5.563877830683239e-11
kindred O 0 8.073502977268276e-10
which O 0 1.7802183338577748e-12
carries O 0 1.1486305613248038e-12
a O 0 5.2492563247519275e-12
novel O 0 6.650510003813892e-11
truncating O 0 2.469524851278493e-08
mutation O 0 4.01322131082793e-09
in O 0 6.882581726763704e-10
hMLH1 O 0 5.438119501377514e-07
. O 0 2.6685668785830785e-07

Interestingly O 0 4.576693157787304e-08
, O 0 3.8445754912963537e-10
the O 0 7.227605736126463e-10
I1307K O 0 3.987205587918652e-08
APC O 0 7.505263632801018e-10
polymorphism O 0 2.2380086672768584e-10
, O 0 6.1953363446332066e-12
associated O 0 4.3689938819535534e-12
with O 0 3.920320218084826e-14
an O 0 1.0170713013110677e-12
increased O 0 3.767066103499417e-10
risk O 0 9.02755289189372e-07
of O 0 0.20315811038017273
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 6.069632796368296e-09
is O 0 6.202335520177904e-12
also O 0 1.517044953200375e-13
present O 0 1.0295138222829459e-12
in O 0 4.1573849397791296e-12
this O 0 1.1105095315544489e-10
family O 0 7.347895625287038e-10
. O 0 1.0466403743691899e-08

The O 0 4.111926728000981e-07
I1307K O 0 1.2797283488907851e-05
polymorphism O 0 2.500728442100808e-07
has O 0 1.6216417098036118e-10
previously O 0 1.8122069816994824e-11
only O 0 4.702215179730462e-13
been O 0 2.93800059151042e-13
identified O 0 8.235485860971781e-14
in O 0 1.1162494946382814e-14
individuals O 0 2.0392733251291435e-14
of O 0 1.980259012324126e-11
self O 0 3.1689417756552984e-09
- O 0 1.5138517994728318e-08
reported O 0 5.647988743362475e-09
Ashkenazi O 0 1.1162272883780133e-08
Jewish O 0 1.2378761349296497e-09
origins O 0 1.3125249775924885e-09
. O 0 6.004113872748462e-10

In O 0 9.770746434156763e-10
addition O 0 2.4326865175061663e-11
, O 0 1.042653810512384e-11
in O 0 1.0636563678445565e-11
this O 0 5.4278220806835975e-11
family O 0 2.6406613007345925e-11
, O 0 2.670544124380725e-12
there O 0 3.6359287976239774e-12
appears O 0 8.06909140199652e-12
to O 0 3.418188648796061e-11
be O 0 7.578392080542784e-11
no O 0 9.617517893190097e-11
relationship O 0 4.722650395749817e-11
between O 0 4.786997465089371e-10
the O 0 4.850469470518703e-10
I1307K O 0 1.6776727784773016e-09
polymorphism O 0 4.5544110149897676e-11
and O 0 1.9893739433562985e-12
the O 0 1.0120792225121189e-11
presence O 0 6.868608112831076e-12
or O 0 9.290949676277194e-10
absence O 0 4.561781707934642e-08
of O 0 3.46017414720734e-09
cancer B-Disease 0 1.7023690190853813e-07
. O 0 8.716095067917706e-10
. O 0 6.194447621510335e-09

Identification O 0 1.0620497814528562e-09
of O 0 3.5480632321061023e-10
a O 0 1.0108681947063047e-10
novel O 0 6.483443781846177e-10
mutation O 0 1.2416384587154994e-09
of O 0 5.146379322695793e-09
the O 0 1.3760609540725e-08
CPO O 0 9.571773261995986e-06
gene O 0 2.6660363153241384e-11
in O 0 1.0713161260889059e-11
a O 0 1.4542910209414117e-09
Japanese O 0 4.0366114717471646e-07
hereditary B-Disease 1 0.9999940395355225
coproporphyria I-Disease 1 0.9942690134048462
family O 0 1.7401153229457123e-07
. O 0 8.434670206725059e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.2565408269438194e-06
HCP B-Disease 1 0.9999996423721313
) O 0 2.612597360673874e-10
is O 0 2.885303385102844e-10
an O 0 1.346951705727406e-07
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 2.8806432794681314e-08
by O 0 2.2224271034598786e-10
a O 0 9.620759300332793e-08
deficiency B-Disease 0 0.00038977418444119394
of I-Disease 0 0.0002021608524955809
coproporphyrinogen I-Disease 0 1.0233654393232428e-05
oxidase I-Disease 0 3.485250203993928e-07
( O 0 1.8096147913482241e-09
CPO O 0 1.2033182201776071e-06
) O 0 3.015774479100952e-12
caused O 0 6.823510506626107e-11
by O 0 2.6995716859851138e-12
a O 0 3.554593008825435e-10
mutation O 0 3.066794040940124e-10
in O 0 3.7924499651786903e-10
the O 0 1.716256647910086e-08
CPO O 0 1.1446104508650023e-05
gene O 0 8.178543176029507e-09
. O 0 2.0948432322143162e-08

Only O 0 2.0479804163642257e-07
11 O 0 4.224120004892029e-07
mutations O 0 5.498685062832465e-09
of O 0 3.505143952864387e-09
the O 0 2.9690916392155486e-09
gene O 0 1.4509211887503426e-10
have O 0 3.4727790088062704e-11
been O 0 6.617257436447588e-11
reported O 0 1.222674739231877e-10
in O 0 3.986745378270484e-10
HCP B-Disease 1 0.9998924732208252
patients O 0 3.3432817758694e-07
. O 0 2.0550392321183608e-07

We O 0 2.3718270014683185e-08
report O 0 1.8479576202601322e-10
another O 0 8.469284995538118e-11
mutation O 0 2.4666400866291127e-11
in O 0 1.6691896346024415e-12
a O 0 1.2621702294435266e-10
Japanese O 0 1.0917350579120466e-08
family O 0 1.005942995568887e-09
. O 0 6.6439365120629645e-09

Polymerase O 0 1.7169026023111655e-07
chain O 0 5.042307460456641e-09
reaction O 0 3.3926621928470624e-11
- O 0 7.516004485452754e-11
single O 0 7.648045391439595e-12
strand O 0 8.464467841917678e-12
conformational O 0 7.545446038814685e-12
polymorphism O 0 2.600404700597858e-12
and O 0 1.0452437526620173e-12
direct O 0 5.077586961999003e-11
sequence O 0 5.877769798656729e-11
analyses O 0 2.019543386688749e-11
demonstrated O 0 1.1154381238109856e-11
a O 0 2.9519411914868954e-10
C O 0 4.3378310721209346e-08
to O 0 1.2383225556078514e-09
T O 0 5.643162048762917e-10
substitution O 0 6.081606138824691e-12
in O 0 1.2625186486536766e-11
exon O 0 1.50270559884369e-10
1 O 0 1.6090544008307006e-08
of O 0 8.098735015948932e-10
the O 0 5.038068184859412e-09
CPO O 0 1.8297257042831916e-07
gene O 0 6.9870537307281655e-12
at O 0 1.645385910853392e-10
nucleotide O 0 6.216931136560078e-11
position O 0 8.145737417919463e-10
85 O 0 5.084052623338664e-10
, O 0 7.199567548035746e-13
which O 0 1.7146762525468984e-12
lies O 0 8.284799513091912e-10
in O 0 3.6570461936502596e-11
the O 0 5.015917126094394e-10
putative O 0 1.2491596201869015e-08
presequence O 0 1.0378635728613972e-08
for O 0 3.596340586442537e-11
targeting O 0 1.434108498621356e-09
to O 0 1.7049741174446353e-08
mitochondria O 0 2.3085949152346075e-08
. O 0 1.8840765392269532e-08

This O 0 2.7027287075043205e-09
mutation O 0 8.225832237584996e-10
changes O 0 1.0189014909567362e-10
the O 0 1.0523663884765e-10
codon O 0 3.558975614215143e-10
for O 0 5.907238587177233e-11
glutamine O 0 6.68293476113746e-11
to O 0 2.0424383018191605e-10
a O 0 7.956600933667346e-10
termination O 0 6.546612496549642e-08
codon O 0 1.3247996477616653e-08
at O 0 1.4023131100771025e-08
amino O 0 5.151070681108649e-10
acid O 0 1.2692556727866844e-10
position O 0 4.055046298745424e-10
29 O 0 3.6814626014347596e-08
. O 0 6.815712438879018e-09

MaeI O 0 1.5372716006822884e-05
restriction O 0 1.7823589715249e-08
analysis O 0 3.249371605118512e-10
showed O 0 3.648643540077323e-11
two O 0 4.604507422047155e-13
other O 0 7.715744411657469e-14
carriers O 0 2.1006998495321644e-13
in O 0 2.860303357013483e-12
the O 0 1.8910953358819427e-10
family O 0 2.5837312844778637e-10
. O 0 4.192332703212287e-09

The O 0 2.5934909331226663e-07
C O 0 7.808794907759875e-05
- O 0 5.3042243962408975e-05
T O 0 2.937005092462641e-06
mutation O 0 4.156273103461672e-09
is O 0 3.2545476730261313e-12
located O 0 5.0826127161174295e-12
within O 0 5.1369398318401593e-11
a O 0 8.413961888331656e-11
recently O 0 1.8125778655786462e-10
proposed O 0 4.24679180710541e-10
putative O 0 1.4586719609965826e-09
alternative O 0 1.626644652308329e-10
translation O 0 7.579403771273974e-11
initiation O 0 1.774379393415515e-10
codon O 0 2.6005164688314153e-10
( O 0 3.400765563252306e-12
TIC O 0 2.0246045118188505e-10
- O 0 1.0824352525418135e-09
1 O 0 8.334109402596823e-09
) O 0 3.6935011256053474e-13
, O 0 3.5242758689678355e-13
supporting O 0 6.96983052869693e-12
that O 0 1.2100717129703842e-11
TIC O 0 1.324086396081725e-09
- O 0 2.8426372367107433e-09
1 O 0 4.688552124321177e-08
is O 0 2.4862896463861972e-11
the O 0 2.874866178448343e-10
real O 0 3.85516081280457e-08
TIC O 0 2.4798145759064028e-08
rather O 0 4.5863010611491006e-10
than O 0 2.6446445033911914e-10
TIC O 0 5.5171218704686e-09
- O 0 1.3458982373037998e-08
2 O 0 3.717051555440776e-08
. O 0 1.7606785474022502e-10
. O 0 3.2053302234658076e-09

Human B-Disease 0 2.0347405982334976e-09
complement I-Disease 0 1.555710582579195e-08
factor I-Disease 0 5.6640828915988095e-06
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
associated O 0 8.197189345082734e-06
with O 0 5.985863390378654e-05
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999841451644897

This O 0 3.516105406831116e-09
study O 0 7.714608812880996e-11
reports O 0 5.442955548079498e-12
on O 0 1.5818572840498035e-10
six O 0 2.0707347295201295e-11
cases O 0 2.510889933471372e-11
of O 0 6.190901125080472e-10
deficiency B-Disease 0 1.5931643702060683e-06
in I-Disease 0 6.376469130486839e-09
the I-Disease 0 1.2340954924638936e-08
human I-Disease 0 1.362941565163922e-10
complement I-Disease 0 8.25187747993672e-12
regulatory I-Disease 0 2.524126019309847e-09
protein I-Disease 0 1.4949655735563283e-08
Factor I-Disease 0 1.9398529449432544e-09
H I-Disease 0 0.00010316622501704842
( O 0 3.898163909721308e-12
FH O 0 1.9267549777879367e-09
) O 0 4.409077541001755e-15
in O 0 4.033037264068208e-15
the O 0 6.875807313512202e-15
context O 0 3.9281512070887814e-13
of O 0 1.8134163875388465e-12
an O 0 2.998078452165487e-10
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 2.487062829459319e-06

Five O 0 1.1821622081242822e-07
of O 0 1.2092422618792398e-09
the O 0 1.1078354206217611e-10
cases O 0 2.3189446890503618e-11
were O 0 4.2804301769727715e-12
observed O 0 4.201724038144228e-12
in O 0 1.4494613463037626e-13
children O 0 3.462814616213977e-13
presenting O 0 7.1809884427676e-12
with O 0 1.3613107308074746e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 7.851912414480466e-06
HUS B-Disease 1 1.0
) O 0 9.783002852259415e-09
. O 0 1.427185623015248e-07

Two O 0 1.1502589991607692e-09
of O 0 3.064496434390662e-10
the O 0 1.300468344123118e-10
children O 0 5.325333923833497e-12
exhibited O 0 2.857022431135281e-11
a O 0 2.790705444510877e-08
homozygous O 0 3.987627678725403e-06
deficiency O 1 0.9409002065658569
characterized O 0 2.737176041378575e-09
by O 0 2.161899270713974e-10
the O 0 2.7455694606715042e-08
absence O 0 2.584917169201617e-08
of O 0 1.1730666438225512e-09
the O 0 9.17013548429324e-11
150 O 0 1.0942830842852747e-11
- O 0 5.882600830064977e-12
kD O 0 4.214423948711854e-11
form O 0 2.386811668447786e-12
of O 0 1.0538305644791635e-10
Factor O 0 4.286423160859698e-10
H O 0 0.0004779374576173723
and O 0 1.3480800677145854e-11
the O 0 3.1096496905247406e-11
presence O 0 8.776404082644351e-13
, O 0 2.989485557974153e-13
upon O 0 1.5499268535279498e-11
immunoblotting O 0 9.755369845265704e-09
, O 0 8.000374668304389e-12
of O 0 5.757479909496155e-11
the O 0 1.8965207182475297e-10
42 O 0 1.030342366981074e-09
- O 0 7.066685014933682e-10
kD O 0 7.910362143093153e-09
Factor O 0 1.3646174190640181e-09
H O 0 8.617928688181564e-05
- O 0 6.05338934533961e-09
like O 0 7.553772191082331e-11
protein O 0 2.451380654022728e-09
1 O 0 1.0954270379670561e-08
( O 0 6.5149487367410774e-12
FHL O 0 2.1180978748702728e-08
- O 0 2.0451251803166315e-09
1 O 0 1.3209667137914494e-08
) O 0 7.811585037674484e-13
and O 0 3.243176777481538e-12
other O 0 1.7135621047104088e-11
FH O 0 5.2188781296536035e-08
- O 0 1.4609468079740395e-09
related O 0 1.2844090235830663e-09
protein O 0 1.1481854356176768e-09
( O 0 4.086776056455577e-12
FHR O 0 3.493389613140607e-07
) O 0 2.2164782162437113e-11
bands O 0 2.169016966035997e-09
. O 0 3.2920937087510538e-09

Southern O 0 4.830969828617526e-07
blot O 0 1.0893928674704512e-06
and O 0 1.419187961593238e-10
PCR O 0 6.818540176922738e-11
analysis O 0 2.1717746958443973e-12
of O 0 3.24263250799095e-12
DNA O 0 8.146536396858028e-12
of O 0 3.043935329488656e-12
one O 0 2.986911282545912e-12
patient O 0 1.6253545731537145e-10
with O 0 1.2009160159365262e-11
homozygous O 0 2.425060756650055e-07
deficiency O 1 0.9736899733543396
ruled O 0 6.19378124611103e-06
out O 0 3.337690124283199e-10
the O 0 3.513031532342836e-11
presence O 0 9.664767900915971e-13
of O 0 1.0187842756914645e-11
a O 0 1.497565960129066e-11
large O 0 3.5940434656156484e-11
deletion O 0 2.4813460175465707e-09
of O 0 6.0769886900402525e-09
the O 0 7.0679289088104724e-09
FH O 0 3.687865444135241e-07
gene O 0 3.580598664787438e-11
as O 0 4.784591993434173e-12
the O 0 2.262799669860982e-11
underlying O 0 6.727794321648162e-09
defect O 0 1.2054000819716748e-07
for O 0 1.3582607261142243e-09
the O 0 1.0557388350207475e-06
deficiency O 1 0.9999988079071045
. O 0 2.297664286743384e-05

The O 0 1.3192119396876478e-08
other O 0 1.5501929601091646e-11
four O 0 4.17992680398771e-12
children O 0 1.9524846691688913e-13
presented O 0 2.3156376989519334e-12
with O 0 1.751533466876065e-11
heterozygous O 0 6.405044246093894e-07
deficiency O 0 0.24966485798358917
and O 0 6.188008994101324e-10
exhibited O 0 1.5076780102152298e-10
a O 0 4.475185111374458e-09
normal O 0 3.0505154313686944e-07
immunoblotting O 0 6.411325870203655e-08
pattern O 0 2.7306890082456903e-09
of O 0 7.010956259989598e-10
proteins O 0 3.320289139116528e-12
of O 0 9.711750154073329e-11
the O 0 7.047423200567948e-10
FH O 0 1.8723676475929096e-06
family O 0 6.067847335700094e-10
. O 0 7.3933361655065255e-09

Factor B-Disease 1 0.9997527003288269
H I-Disease 1 1.0
deficiency I-Disease 1 0.9978380799293518
is O 0 8.176366528278578e-11
the O 0 1.5463458291620213e-10
only O 0 1.6508031608353235e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.183373019690407e-08
with O 0 2.199458171148194e-09
HUS B-Disease 1 1.0
. O 0 6.067795084163663e-07

These O 0 8.789420746779797e-09
observations O 0 2.8586949696318698e-08
suggest O 0 5.345753839591794e-10
a O 0 7.061413259679128e-11
role O 0 2.8340644067648135e-11
for O 0 8.706714169082197e-12
FH O 0 1.3371402474149363e-07
and O 0 2.762180484339183e-10
/ O 0 9.15361724196373e-08
or O 0 1.103332358809439e-08
FH O 0 3.2991644616231497e-07
receptors O 0 4.337024350764551e-10
in O 0 4.21484808860173e-12
the O 0 2.6652634960155908e-11
pathogenesis O 0 9.349689911175574e-09
of O 0 1.1565199908858403e-09
idiopathic O 0 0.030562927946448326
HUS B-Disease 1 0.9999992847442627
. O 0 3.819130256488279e-08
. O 0 5.4491991363647685e-08

Further O 0 1.2837312546309931e-08
evidence O 0 7.831975623595611e-10
for O 0 4.583751347236875e-12
a O 0 5.988121803968127e-11
major O 0 3.2450361842073505e-10
ancient O 0 2.0739414352544117e-10
mutation O 0 8.669016438034305e-08
underlying O 0 5.00163832839462e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.7347321090710466e-07
linkage O 0 1.1611006556222492e-07
disequilibrium O 0 1.5378712703295605e-07
studies O 0 3.58670246281001e-11
in O 0 9.647307909130265e-13
the O 0 1.1769516784776446e-11
Japanese O 0 1.4183058894001732e-10
population O 0 1.8336660315143583e-12
. O 0 1.4931857139632854e-10

The O 0 1.1243941116845235e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 5.406266154750483e-07
DM B-Disease 1 1.0
) O 0 2.9834068548950654e-10
mutation O 0 3.19656717762129e-10
is O 0 2.1296318875041464e-11
an O 0 1.625946738359474e-10
unstable O 0 2.8511369691841537e-06
( O 0 8.234438908516495e-09
CTG O 0 1.0087103419209598e-06
) O 0 1.560344908835276e-10
n O 0 1.6686383386144144e-09
repeat O 0 1.5717318557761928e-09
, O 0 7.958520994999496e-12
present O 0 1.0854256729531109e-11
at O 0 8.110865451493865e-11
a O 0 4.44705643837251e-12
copy O 0 2.4606018611539326e-11
number O 0 2.429193998731982e-12
of O 0 2.2831670581924257e-11
5 O 0 1.6844157180173625e-09
- O 0 3.9377083815850256e-09
37 O 0 3.950843652233971e-09
repeats O 0 9.962354274861696e-10
on O 0 1.804184357467875e-08
normal O 0 1.086630785351872e-08
chromosomes O 0 1.6929567470125306e-10
but O 0 8.74389362998107e-12
amplified O 0 1.9424239994236814e-11
to O 0 2.542505372904458e-10
50 O 0 9.101241982278907e-10
- O 0 1.7370753446765974e-10
3000 O 0 2.212187204253535e-11
copies O 0 2.899773129949601e-11
on O 0 2.965278689259776e-08
DM B-Disease 1 0.9999991655349731
chromosomes O 0 3.96996142626449e-07
. O 0 1.6442081474110637e-08

Previous O 0 1.5434839895078767e-07
findings O 0 7.663867873652919e-10
in O 0 3.420765060102582e-11
Caucasian O 0 7.632566578763544e-09
populations O 0 1.4406299764235797e-10
of O 0 1.2089695911043918e-10
a O 0 9.268125467087884e-08
DM B-Disease 1 1.0
founder O 0 0.00011135494423797354
chromosome O 0 5.216134468355449e-06
raise O 0 2.9156669967278503e-08
a O 0 1.081397194013789e-09
question O 0 2.1188120147286327e-09
about O 0 2.0719436583105377e-11
the O 0 1.5588863533366748e-11
molecular O 0 1.4311996032745355e-11
events O 0 6.871667270575907e-14
involved O 0 7.602374133865164e-13
in O 0 7.403527443883284e-12
the O 0 2.772372609260998e-10
expansion O 0 1.7628476456366116e-08
mutation O 0 8.933425021950825e-08
. O 0 3.9704342924551383e-08

To O 0 4.1954383078746105e-08
investigate O 0 7.978321114876508e-09
whether O 0 5.170738281989884e-10
a O 0 6.856938905563936e-10
founder O 0 1.4205591147842256e-09
chromosome O 0 1.384305226004301e-09
for O 0 1.333392007918377e-10
the O 0 7.922078992805837e-09
DM B-Disease 1 1.0
mutation O 0 2.698465095818392e-08
exists O 0 4.889115501338637e-11
in O 0 3.5257233330782123e-12
the O 0 1.2440004755476242e-11
Japanese O 0 2.2475737937455165e-10
population O 0 2.6151177577593554e-12
, O 0 2.295186176531905e-12
we O 0 6.902363403060718e-11
genotyped O 0 9.61030579560429e-08
families O 0 8.754177244219008e-11
using O 0 6.68831656724933e-11
polymorphic O 0 1.0609469747180356e-08
markers O 0 1.2711975472257109e-08
near O 0 6.273232600051415e-08
the O 0 6.5050622666262825e-09
( O 0 2.3397708215355806e-09
CTG O 0 1.091962076316122e-06
) O 0 2.2010517020110143e-10
n O 0 4.9540695989946926e-09
repeat O 0 4.709558076854137e-09
region O 0 6.452236522846988e-09
and O 0 1.7683417230518472e-10
constructed O 0 1.9779593074531476e-08
haplotypes O 0 6.178120770528039e-07
. O 0 4.440945389205808e-08

Six O 0 1.2905021051778931e-08
different O 0 6.108006028043844e-12
haplotypes O 0 6.371093097534697e-10
were O 0 3.885191127150911e-11
found O 0 5.746012606694384e-12
and O 0 3.975186846361112e-11
DM B-Disease 1 1.0
alleles O 0 4.4457804104780507e-10
were O 0 7.430197429547647e-11
always O 0 5.430742314183057e-11
haplotype O 0 2.7207606834167564e-08
A O 0 1.1087042821600335e-06
. O 0 2.176830946609698e-07

To O 0 3.2686247042335026e-09
find O 0 2.1696612562127626e-10
an O 0 2.44326434084563e-12
origin O 0 1.4071121871850334e-11
of O 0 1.1728155946411079e-10
the O 0 1.3360855477539957e-10
( O 0 1.4799501901752166e-10
CTG O 0 2.2760968931834213e-07
) O 0 6.800953550323285e-11
n O 0 9.71042135589073e-10
repeat O 0 1.6200011332401232e-09
mutation O 0 2.366058043934416e-11
and O 0 1.197685505459345e-12
to O 0 1.3211462306095267e-11
investigate O 0 3.447666804823335e-11
the O 0 1.5709331405155957e-11
mechanism O 0 9.539070228159474e-11
of O 0 2.7880944081237757e-11
the O 0 1.5660328936406565e-11
expansion O 0 2.2242166441976963e-10
mutation O 0 3.9722385103413416e-11
in O 0 6.1311758621507284e-12
the O 0 1.5137400014020308e-11
Japanese O 0 1.44626019493721e-10
population O 0 1.1013494803646662e-12
we O 0 1.4435441774221514e-12
have O 0 9.150173023789177e-13
studied O 0 6.878300012891359e-11
90 O 0 3.645216073433488e-10
Japanese O 0 1.1086773721302734e-09
DM B-Disease 1 0.9999926090240479
families O 0 1.1743684150133937e-11
comprising O 0 2.4257202149713386e-13
190 O 0 2.9937798767809554e-11
affected O 0 1.9874142262454875e-11
and O 0 1.0500179718764269e-11
130 O 0 1.7703675192493051e-09
unaffected O 0 2.3689786132763402e-08
members O 0 2.1707748099064617e-10
. O 0 6.739635516339604e-09

The O 0 1.2253495640379697e-07
results O 0 3.821197580577973e-09
suggest O 0 1.2045349162548291e-09
that O 0 1.5345717752079935e-11
a O 0 1.7311845013079363e-10
few O 0 5.854787488157598e-11
common O 0 9.697534442132394e-11
ancestral O 0 6.098117566466499e-10
mutations O 0 2.2602643368063724e-10
in O 0 4.621564589357696e-11
both O 0 5.7953915971742376e-11
Caucasian O 0 1.5918196538677876e-08
and O 0 7.609421426302276e-10
Japanese O 0 3.651661861781008e-09
populations O 0 3.6026826053664474e-12
have O 0 9.790444550992344e-14
originated O 0 2.338847160648222e-13
by O 0 8.455326824981235e-14
expansion O 0 1.223075946077401e-10
of O 0 4.278228465937062e-11
an O 0 4.988588708787489e-11
ancestral O 0 5.468966390864693e-10
n O 0 2.812661437090469e-09
= O 0 4.723655244731617e-09
5 O 0 1.1690958423571374e-08
repeat O 0 2.7651549938667586e-09
to O 0 4.5438475204662154e-09
n O 0 7.397454648838675e-09
= O 0 2.6137352282518123e-09
19 O 0 3.112715196706972e-09
- O 0 1.581082931245703e-09
37 O 0 5.232188571291374e-10
copies O 0 6.803392571530509e-11
. O 0 1.4769505618517087e-09

These O 0 9.229783604070008e-10
data O 0 6.628322890556149e-11
support O 0 2.01229918145307e-11
multistep O 0 3.072605636589287e-08
models O 0 3.048727714727306e-09
of O 0 1.865909382559039e-08
triplet O 0 2.348747329961043e-06
repeat O 0 7.647141586630823e-08
expansion O 0 1.907004554269065e-09
that O 0 3.4851329721447e-12
have O 0 3.7103485431635996e-13
been O 0 7.60944923066699e-14
proposed O 0 6.105882943349683e-13
for O 0 1.0140148269666138e-12
both O 0 6.467495289319558e-11
DM B-Disease 1 1.0
and O 0 1.38620821488189e-08
Friedreichs B-Disease 0 6.36854165350087e-05
ataxia I-Disease 0 0.0001323152391705662
. O 0 2.8246734729009404e-08
. O 0 1.0188037435909791e-07

The O 0 3.3073119798388007e-09
molecular O 0 1.2718275321788042e-09
basis O 0 3.6428083660666744e-08
of O 0 4.5630088152393e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2983846220393502e-09
the O 0 1.801792465228047e-10
western O 0 6.869008140064636e-10
Cape O 0 3.319774899424033e-09
, O 0 8.657333530615041e-12
South O 0 1.1107976344293391e-10
Africa O 0 1.98793467798275e-10
. O 0 4.726834479384934e-10

Deficiency B-Disease 0 0.00836106762290001
of I-Disease 0 1.2917698768433183e-06
the I-Disease 0 1.1923548015602137e-07
sixth I-Disease 0 2.0665245870077342e-07
component I-Disease 0 1.055072562650139e-08
of I-Disease 0 8.32730862043718e-09
human I-Disease 0 7.128891921226455e-10
complement I-Disease 0 5.771677580312939e-10
( O 0 3.484710853207673e-10
C6 O 0 3.7219581372482935e-06
) O 0 5.699864538688537e-11
has O 0 1.3003388296684015e-11
been O 0 2.9326888140168705e-12
reported O 0 1.6581185209585403e-12
in O 0 6.941511574527423e-14
a O 0 3.212650143743362e-13
number O 0 3.3380463920328757e-14
of O 0 2.2789490563765447e-13
families O 0 2.1006384904654653e-14
from O 0 7.898726811506052e-12
the O 0 2.264932685847043e-11
western O 0 9.717313620427603e-10
Cape O 0 9.036088322034175e-09
, O 0 1.518459143146078e-11
South O 0 8.16446465989884e-10
Africa O 0 3.8967923332577925e-10
. O 0 1.2873399013457743e-09

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 6.947622477326831e-09
endemic O 0 2.6150104304178967e-10
in O 0 3.463088843469464e-11
the O 0 3.4166586226902496e-10
Cape O 0 3.0685802787644434e-09
and O 0 1.4264052178997177e-12
almost O 0 1.847657096765154e-11
all O 0 2.455485684574321e-12
pedigrees O 0 2.7413962766509314e-10
of O 0 1.1934572219374218e-09
total O 0 4.175587037025252e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 1.5563463762191532e-07
C6Q0 O 0 0.0006659860373474658
) O 0 2.5298013683894283e-11
have O 0 3.0763345430090405e-12
been O 0 4.000269299836434e-12
ascertained O 0 9.653174926071983e-10
because O 0 8.464855552614559e-12
of O 0 1.3863919734458108e-10
recurrent O 0 0.033757731318473816
disease O 1 0.9983489513397217
. O 0 1.0811547923594844e-07

We O 0 3.4151376837598946e-08
have O 0 5.0259314071654515e-11
sequenced O 0 4.45632246381944e-11
the O 0 1.1199790227178763e-11
expressed O 0 1.4001941966990117e-11
exons O 0 1.0270309935833666e-08
of O 0 2.7872357755143184e-09
the O 0 1.8448241823065814e-09
C6 O 0 1.5075593751134875e-07
gene O 0 3.166781767371951e-11
from O 0 3.132957435147965e-11
selected O 0 1.8790843447219485e-12
cases O 0 1.0021553899230984e-12
and O 0 3.076006246591212e-12
have O 0 1.78670966910488e-11
found O 0 7.054144074425395e-11
three O 0 6.655381801223825e-11
molecular O 0 3.752290211878062e-08
defects O 0 3.7506167700485094e-06
leading O 0 3.6309582007731933e-09
to O 0 2.2683428468894817e-08
total O 0 6.524225426574048e-08
deficiency O 0 2.6130319383810274e-06
879delG O 0 1.039641261968427e-07
, O 0 1.3292852929502885e-11
which O 0 2.708277178908869e-12
is O 0 2.6936259212712033e-12
the O 0 3.652027638634259e-11
common O 0 7.973585680609574e-10
defect O 0 3.993081065800652e-08
in O 0 8.334583023739128e-10
the O 0 2.533319110042953e-09
Cape O 0 2.7158558069118044e-08
and O 0 4.5879805510296023e-10
hitherto O 0 3.182608665497355e-08
unreported O 0 4.253076113513998e-09
, O 0 2.0008320087555598e-12
and O 0 6.0978097571329215e-12
1195delC O 0 1.1099933194813616e-09
and O 0 7.167089838278073e-11
1936delG O 0 8.966401843224503e-09
, O 0 1.4659669311800627e-11
which O 0 3.725120906183932e-12
have O 0 4.807479501295342e-12
been O 0 2.4984642826852976e-11
previously O 0 9.936857760239892e-12
reported O 0 4.3451344952649684e-12
in O 0 2.294455207427215e-12
African O 0 3.3309726504837656e-11
- O 0 4.713662793420781e-10
Americans O 0 6.277150327305137e-11
. O 0 3.9567411569407795e-09

We O 0 1.1229544583102324e-07
also O 0 1.2574988272895382e-10
show O 0 1.6967444810278565e-11
that O 0 1.1653571445509325e-13
the O 0 2.439013400967749e-12
879delG O 0 4.920654994577944e-10
and O 0 4.6742224674156674e-11
1195delC O 0 2.3827194581826916e-06
defects O 0 0.0003456328995525837
are O 0 4.1484603946484455e-11
associated O 0 3.002967430276726e-09
with O 0 2.917227015508672e-10
characteristic O 0 6.549656518473057e-06
C6 O 1 0.9999648332595825
/ O 1 0.8373549580574036
C7 O 0 0.00016442094056401402
region O 0 1.2389301673465525e-06
DNA O 0 1.162084402039909e-07
marker O 0 8.80433770333866e-09
haplotypes O 0 2.0323087657203587e-09
, O 0 1.3989075522968797e-11
although O 0 2.2538865305371525e-12
small O 0 2.6046602374929506e-11
variations O 0 5.2701207842176245e-09
were O 0 7.140190216858855e-09
observed O 0 7.504369392563603e-08
. O 0 2.82135115270421e-08

The O 0 1.6671859270900313e-07
1936delG O 0 1.711323079689464e-06
defect O 0 3.1579613732901635e-06
was O 0 9.681838264441467e-08
observed O 0 2.768278939413449e-09
only O 0 6.025747262272674e-11
once O 0 3.897690156740019e-11
in O 0 9.626468025492052e-12
the O 0 5.241815315137899e-11
Cape O 0 3.785795676947146e-09
, O 0 4.449517143623183e-12
but O 0 4.4188836617609084e-12
its O 0 3.363122280664044e-11
associated O 0 7.603792040455915e-10
haplotype O 0 6.167594079897754e-08
could O 0 3.974556150865283e-08
be O 0 8.069027224166803e-09
deduced O 0 8.738825840737263e-08
. O 0 9.377980170199862e-09

The O 0 5.2895092750304684e-08
data O 0 4.063167857726313e-10
from O 0 2.441822577470276e-10
the O 0 3.659602065830825e-10
haplotypes O 0 1.2361538459515486e-09
indicate O 0 1.7188463152795208e-10
that O 0 4.531308054472882e-12
these O 0 5.838536685370821e-12
three O 0 1.5796412788926517e-10
molecular O 0 4.021774913098852e-08
defects O 0 1.9814281415619917e-07
account O 0 2.8511758926041963e-11
for O 0 2.618793792930063e-10
the O 0 1.6110912781641673e-07
defects O 0 0.00018385921430308372
in O 0 2.0652737298121338e-09
all O 0 1.495294860154317e-10
the O 0 1.6707521477421494e-10
38 O 0 6.265084562251388e-10
unrelated O 0 1.2836270935068228e-10
C6Q0 O 0 2.8917366989844595e-07
individuals O 0 1.1932442881001926e-11
we O 0 2.0906101849682557e-10
have O 0 2.7642662464577583e-11
studied O 0 2.084780542643827e-10
from O 0 4.007129003613663e-11
the O 0 1.8521108258173768e-10
Cape O 0 5.908337374904704e-09
. O 0 4.882957926888309e-10

We O 0 6.511445604928667e-08
have O 0 1.0367427749624625e-10
also O 0 7.35624582082206e-12
observed O 0 4.540974887778937e-11
the O 0 9.460391671434198e-12
879delG O 0 5.893030952108802e-09
defect O 0 7.578775829131246e-09
in O 0 1.870125998504335e-10
two O 0 1.551324402271348e-09
Dutch O 0 0.0011154982494190335
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 2.0696249691809498e-07
, O 0 4.935623524465749e-12
but O 0 2.5345619700245514e-12
the O 0 7.655331923928088e-11
879delG O 0 8.738720858048055e-09
defect O 0 1.936341931241259e-08
in O 0 1.1038159275500448e-09
the O 0 8.974238241421517e-09
Cape O 0 5.006812742180955e-08
probably O 0 6.271038688332453e-10
did O 0 3.9690348230259076e-11
not O 0 2.1277641107375622e-11
come O 0 2.1567213293050003e-11
from O 0 3.037203821776302e-11
The O 0 9.900653213934518e-11
Netherlands O 0 4.095965233652521e-10
. O 0 2.798927756231251e-10
. O 0 1.7320944678544947e-08

Complement B-Disease 1 0.9993205070495605
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 2.6586659540583923e-09
seven O 0 1.0452473331312717e-09
further O 0 3.151672256507254e-09
molecular O 0 5.900243422729545e-07
defects O 0 1.1857447134389076e-05
and O 0 3.942087489772206e-10
their O 0 4.454352997562694e-10
associated O 0 3.039188456455122e-09
marker O 0 3.4920066838139974e-08
haplotypes O 0 3.616004562445596e-07
. O 0 4.8717250678009805e-08

Seven O 0 1.7699294474482485e-08
further O 0 7.340527630184113e-10
molecular O 0 8.035039300580138e-09
bases O 0 9.25545595720223e-09
of O 0 7.749150427116547e-06
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 4.8243329331398854e-09
described O 0 1.2531854665098763e-08
. O 0 8.460445677371808e-09

All O 0 6.395324270158653e-09
these O 0 5.3660700882751655e-11
new O 0 8.460490086292793e-10
molecular O 0 5.7975668710241735e-08
defects O 0 2.971087198488931e-08
involve O 0 1.4676099224786299e-10
single O 0 3.278306792697805e-10
- O 0 3.919918611927642e-09
nucleotide O 0 4.252037832941369e-09
events O 0 1.370877855677577e-10
, O 0 2.6490051471816933e-11
deletions O 0 1.5836716660277972e-10
and O 0 1.8471929541519216e-10
substitutions O 0 4.1650724535990946e-10
, O 0 9.967685531131476e-12
some O 0 1.2571162643845724e-12
of O 0 3.055028799381354e-11
which O 0 8.098016181234957e-12
alter O 0 2.1415170081695578e-08
splice O 0 8.568114218121536e-09
sites O 0 1.7516278705276278e-10
, O 0 2.4594980999742555e-12
and O 0 1.5705556646872232e-11
others O 0 5.019189508459476e-10
codons O 0 1.0108618653248413e-07
. O 0 3.000037906986108e-08

They O 0 2.5661794911258085e-09
are O 0 1.873444325020679e-12
distributed O 0 7.543143193400326e-12
along O 0 1.3724109348967062e-10
the O 0 1.2394071324806077e-09
C7 O 0 8.198145451387973e-07
gene O 0 2.6763228785919857e-11
, O 0 6.086290867991784e-13
but O 0 2.5912339765218895e-13
predominantly O 0 7.825990831940299e-13
towards O 0 1.6670968425169796e-11
the O 0 7.625122755428038e-11
3 O 0 2.1532430949378067e-08
end O 0 1.926480877045833e-07
. O 0 6.279170605694162e-08

All O 0 1.199915011795838e-08
were O 0 1.2942229232759672e-10
found O 0 3.819975152169475e-12
in O 0 1.3691830872200605e-12
compound O 0 9.569321030022948e-11
heterozygous O 0 3.6069473796640494e-11
individuals O 0 6.484664888395386e-11
. O 0 1.3709053447996666e-08

The O 0 9.346478691441007e-06
C6 O 0 0.05067257210612297
/ O 0 0.009830979630351067
C7 O 0 0.00024319157819263637
marker O 0 1.9052173172440234e-07
haplotypes O 0 1.1614058159636897e-08
associated O 0 2.5935580350022747e-09
with O 0 1.636341201427527e-10
most O 0 3.9874493040770176e-08
C7 B-Disease 1 0.9999997615814209
defects I-Disease 1 0.9999980926513672
are O 0 5.949500447854916e-09
tabulated O 0 1.1502551799935645e-08
. O 0 1.220720302619327e-09
. O 0 7.86203369074201e-09

A O 0 2.0643315110646654e-06
genome O 0 2.5928061919699985e-09
- O 0 1.1949810030387198e-09
wide O 0 1.945298366834436e-10
search O 0 4.522305099841084e-11
for O 0 1.3197779457838066e-12
chromosomal O 0 1.3662307196682377e-07
loci O 0 1.0379571335761284e-07
linked O 0 2.163741896765714e-07
to O 0 6.40985859945431e-08
mental O 1 0.9999997615814209
health O 0 1.0159053090319503e-05
wellness O 0 9.079071787709836e-07
in O 0 1.9253654226503158e-10
relatives O 0 7.20822179722802e-10
at O 0 1.418522244112097e-10
high O 0 5.893758814323746e-10
risk O 0 6.530061824605582e-09
for O 0 1.0535301520064877e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.3968125267549425e-10
the O 0 1.2507157531871371e-09
Old O 0 4.660340113815664e-09
Order O 0 2.840408186433052e-10
Amish O 0 1.1544042388678122e-09
. O 0 3.390664971014701e-10

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 6.195159585331567e-08
BPAD B-Disease 1 1.0
; O 1 0.9988293051719666
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.0832401642346667e-10
is O 0 6.572147773914461e-12
characterized O 0 8.937259786401253e-12
by O 0 9.306050721691328e-12
episodes O 0 1.423596907024205e-09
of O 0 7.10936587378086e-10
mania B-Disease 0 1.1928547927197997e-08
and O 0 3.292418560008059e-10
/ O 0 5.367044764170714e-07
or O 0 6.664028973091263e-08
hypomania B-Disease 0 3.2376724448113237e-06
interspersed O 0 1.0072845335606928e-10
with O 0 3.8176935029075876e-13
periods O 0 2.1554855678118656e-09
of O 0 8.766612991095712e-10
depression B-Disease 0 3.2103603189170826e-06
. O 0 2.2599476068307922e-08

Compelling O 0 4.4791754305606446e-08
evidence O 0 3.3885592110038942e-09
supports O 0 3.521117009075425e-10
a O 0 8.232392545437506e-10
significant O 0 1.947489947085046e-09
genetic O 0 2.5717654672519075e-09
component O 0 3.551137162105533e-10
in O 0 3.8374522309814196e-11
the O 0 7.542921287573279e-10
susceptibility O 0 1.1970850088971474e-08
to O 0 7.659224365852424e-09
develop O 0 3.5650032259582076e-06
BPAD B-Disease 1 1.0
. O 0 4.9906961066881195e-05

To O 0 1.9162374798042947e-08
date O 0 3.112826902906818e-07
, O 0 1.946983685385817e-10
however O 0 2.8820967834519706e-10
, O 0 2.0567345049293806e-10
linkage O 0 6.337403490874749e-09
studies O 0 1.6050680229362513e-10
have O 0 3.5316326685991273e-12
attempted O 0 1.2736870447227489e-09
only O 0 4.790673500260079e-12
to O 0 7.754351327715625e-11
identify O 0 6.545982644823312e-10
chromosomal O 0 6.971557695578667e-07
loci O 0 1.264581612758775e-07
that O 0 3.990777708295923e-10
cause O 0 5.623934029586053e-08
or O 0 6.465303292735314e-10
increase O 0 8.506605975178161e-10
the O 0 2.6035537614710336e-10
risk O 0 9.13604358832032e-10
of O 0 1.6945146397162603e-09
developing O 0 1.2861522691309801e-06
BPAD B-Disease 1 1.0
. O 0 7.645808182132896e-06

To O 0 1.9011444862826465e-07
determine O 0 3.6197651098746064e-08
whether O 0 8.548602381530657e-10
there O 0 4.1187761534722256e-11
could O 0 7.026589032843589e-11
be O 0 9.401970174627294e-11
protective O 0 2.39201880525286e-10
alleles O 0 4.0679326226977786e-12
that O 0 9.078792947460335e-13
prevent O 0 3.537668422093354e-11
or O 0 6.206410385622974e-11
reduce O 0 5.904192246219964e-09
the O 0 5.438083316988696e-10
risk O 0 8.35636182472399e-09
of O 0 3.162613948504145e-09
developing O 0 1.561902877256216e-06
BPAD B-Disease 1 1.0
, O 0 1.452294534631804e-10
similar O 0 1.4893529118320536e-12
to O 0 3.086062655421884e-11
what O 0 7.463881400958383e-13
is O 0 3.260597900619361e-13
observed O 0 1.1687373291380254e-11
in O 0 8.051288802324308e-12
other O 0 1.4172769624565262e-08
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 8.580321869677832e-11
we O 0 4.811224335599107e-11
used O 0 4.1260198035963924e-10
mental O 0 6.277613283600658e-05
health O 0 2.988750802401796e-09
wellness O 0 9.723065907962791e-09
( O 0 7.908113725495214e-13
absence O 0 2.968291723526306e-10
of O 0 2.0473606143767142e-10
any O 0 1.0488950152875987e-07
psychiatric B-Disease 1 1.0
disorder I-Disease 1 0.9624865055084229
) O 0 1.073815407252876e-12
as O 0 4.212654097085489e-12
the O 0 3.1703414199446556e-11
phenotype O 0 6.82027379017569e-10
in O 0 4.416217391778332e-10
our O 0 1.4767421729899866e-09
genome O 0 1.1989718107230374e-09
- O 0 3.0556279284610355e-08
wide O 0 1.0333742039847493e-07
linkage O 0 2.0698460900803184e-07
scan O 0 6.298290600170731e-07
of O 0 4.661513397508088e-09
several O 0 4.644043830048794e-11
large O 0 1.6652830503449678e-10
multigeneration O 0 1.6784392187219055e-07
Old O 0 6.73644873216972e-09
Order O 0 9.082755658695874e-10
Amish O 0 2.3336337307000576e-09
pedigrees O 0 3.3920427577882606e-10
exhibiting O 0 4.2371935821128304e-11
an O 0 1.612369959769211e-11
extremely O 0 1.1950903600066454e-09
high O 0 4.7342740572275943e-07
incidence O 0 0.0730479508638382
of O 0 1.581914875714574e-05
BPAD B-Disease 1 1.0
. O 0 8.377685298910365e-05

We O 0 3.8774464883317705e-07
have O 0 3.1856725590806434e-10
found O 0 6.945637641420088e-12
strong O 0 5.125738158570647e-13
evidence O 0 1.950055134730677e-12
for O 0 1.8027797950206231e-13
a O 0 2.6376912806713726e-11
locus O 0 6.497829496687757e-10
on O 0 4.0540353296592e-09
chromosome O 0 1.623305934117525e-07
4p O 0 0.0009417124674655497
at O 0 2.85870580540859e-08
D4S2949 O 0 5.879045872347888e-08
( O 0 9.21789901353609e-12
maximum O 0 1.1164551061426664e-08
GENEHUNTER O 0 6.291710974437592e-07
- O 0 5.500614630449263e-09
PLUS O 0 1.1332815796905038e-09
nonparametric O 0 3.05505509778925e-09
linkage O 0 5.197574592941123e-10
score O 0 1.166477470171401e-10
= O 0 4.775531706191494e-11
4 O 0 2.9596702866285796e-10
. O 0 4.5758371050586e-12
05 O 0 2.4881849913782617e-09
, O 0 3.909029003268394e-11
P O 0 1.1803259525322574e-07
= O 0 1.868186577658193e-10
5 O 0 1.514162129012675e-10
. O 0 8.305878229121488e-13
22 O 0 7.675655250283242e-11
x O 0 5.174082828851567e-10
10 O 0 5.211531761695198e-10
( O 0 7.888804193223464e-12
- O 0 2.5619295573875434e-09
4 O 0 4.50826309617014e-09
) O 0 1.1552901647490788e-12
; O 0 9.212064271124643e-12
SIBPAL O 0 9.141174359683646e-07
Pempirical O 0 1.1716696945995864e-08
value O 0 2.9167640525074034e-11
< O 0 1.0449523468736288e-09
3 O 0 5.4097965690447225e-11
x O 0 6.450900924548364e-11
10 O 0 1.3910432528074779e-10
( O 0 1.5579076657196156e-12
- O 0 1.0357253943382716e-09
5 O 0 3.2282958528639938e-09
) O 0 2.1771458334068905e-12
) O 0 8.644755918052471e-13
and O 0 2.5194661894961667e-12
suggestive O 0 4.2457447280153104e-11
evidence O 0 2.8441133996526258e-12
for O 0 2.8332021516190575e-13
a O 0 1.2824230566366168e-10
locus O 0 2.2957107326249115e-09
on O 0 1.9793066741158327e-08
chromosome O 0 2.12602867577516e-06
4q O 0 3.2234845548373414e-06
at O 0 8.56200443877242e-09
D4S397 O 0 1.8291563819161638e-08
( O 0 4.370527377506317e-12
maximum O 0 7.976784566210426e-09
GENEHUNTER O 0 1.987554298921168e-07
- O 0 1.960900775088703e-09
PLUS O 0 5.828784677142096e-10
nonparametric O 0 1.1083644002596316e-09
linkage O 0 2.2101891150594355e-10
score O 0 1.2846018693224437e-10
= O 0 2.3730043971492698e-11
3 O 0 1.2603515453513126e-10
. O 0 1.9016769495922015e-12
29 O 0 1.487033274294447e-09
, O 0 2.9340724294613096e-11
P O 0 5.905636513148238e-08
= O 0 6.466730623211348e-11
2 O 0 1.9368129322572258e-10
. O 0 9.838634898104437e-13
57 O 0 3.20186238633724e-11
x O 0 2.472444471379731e-10
10 O 0 4.4221426520607565e-10
( O 0 8.67346472421815e-12
- O 0 3.543993543075885e-09
3 O 0 5.744640318994243e-09
) O 0 2.0616026247255448e-12
; O 0 1.5193658831069712e-11
SIBPAL O 0 1.6739199963922147e-06
Pempirical O 0 1.9035205411910283e-08
value O 0 3.7495017507493955e-11
< O 0 2.287502187670043e-09
1 O 0 6.091387394491221e-10
x O 0 6.520611828264578e-10
10 O 0 4.4014003552916847e-10
( O 0 6.54255599349951e-12
- O 0 1.7796778495338117e-09
3 O 0 2.311638658269999e-09
) O 0 2.6040614434751086e-13
) O 0 3.7029444587650603e-14
that O 0 5.283251795578335e-14
are O 0 2.4395145192118717e-13
linked O 0 1.0528526939168614e-09
to O 0 1.028006924030933e-08
mental O 0 0.13180972635746002
health O 0 5.851759397046408e-07
wellness O 0 5.992404226162762e-07
. O 0 1.088632650692034e-08

These O 0 3.0948896778681956e-09
findings O 0 2.2334893934328193e-09
are O 0 6.3230254365720384e-12
consistent O 0 5.5022042477759214e-11
with O 0 2.8323648764913556e-13
the O 0 6.878116132202905e-11
hypothesis O 0 2.9183125360709994e-10
that O 0 5.306431834738168e-13
certain O 0 4.481236562381419e-11
alleles O 0 3.1243896359001155e-10
could O 0 6.757176485017169e-10
prevent O 0 3.972363771254095e-09
or O 0 4.417272769785541e-09
modify O 0 5.992449558789303e-08
the O 0 1.0919489756844314e-09
clinical O 0 3.596694275742607e-09
manifestations O 0 1.2434401952532426e-08
of O 0 3.5522766950180085e-09
BPAD B-Disease 1 1.0
and O 0 1.404565491691656e-10
perhaps O 0 9.828310387760553e-11
other O 0 1.819695436000579e-11
related O 0 5.774375495093409e-06
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 7.495323188777547e-06

Segregation O 0 6.2012045418669e-06
distortion O 0 3.686068157549016e-05
in O 0 2.071070355214033e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0003872379311360419

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 2.859753749362426e-07
DM B-Disease 1 1.0
) O 0 4.3398524357529666e-11
is O 0 1.0816065057484003e-11
an O 0 4.424336452757416e-10
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
which O 0 3.823616423481724e-10
, O 0 7.739925887706445e-12
in O 0 5.709087716465611e-12
the O 0 2.604267669570337e-11
typical O 0 2.51575704712792e-10
pedigree O 0 1.4988241203717223e-10
, O 0 1.3277160404098765e-12
shows O 0 2.568692654414395e-12
a O 0 8.685687585829882e-11
three O 0 1.1939506328051408e-10
generation O 0 2.007348509636131e-09
anticipation O 0 5.857831553157666e-09
cascade O 0 4.604024070431478e-06
. O 0 3.987297532148659e-07

This O 0 1.785235570483934e-10
results O 0 1.621759254666344e-10
in O 0 1.0971662467440524e-09
infertility B-Disease 1 1.0
and O 0 5.4995161917759106e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.4910016332692066e-08
CDM B-Disease 0 1.7069272928438295e-07
) O 0 1.8984504723471018e-13
with O 0 9.588051110443613e-14
the O 0 4.317290414057595e-10
disappearance O 0 4.138958331623144e-08
of O 0 3.183044050558692e-09
DM B-Disease 1 1.0
in O 0 1.8925609968079016e-09
that O 0 5.603413288923775e-10
pedigree O 0 2.0573995840322823e-08
. O 0 8.549112529010472e-09

The O 0 2.456266967598708e-09
concept O 0 1.0138268002890527e-09
of O 0 4.313564172520046e-09
segregation O 0 2.749713567951062e-09
distortion O 0 6.203104874202836e-08
, O 0 1.84628683869148e-11
where O 0 4.707000848119813e-12
there O 0 3.223378866341192e-13
is O 0 1.109551469799519e-12
preferential O 0 1.0240259751270742e-09
transmission O 0 1.230414325981144e-09
of O 0 5.648112533229721e-11
the O 0 1.9834456993494953e-11
larger O 0 1.6020667431559943e-11
allele O 0 3.5167610490383083e-10
at O 0 1.32598199087397e-09
the O 0 6.463527491007426e-10
DM B-Disease 1 0.9999949932098389
locus O 0 9.1810825608718e-09
, O 0 7.28853782883121e-12
has O 0 3.0239823232275365e-12
been O 0 4.744035893289311e-12
put O 0 2.5208326745462806e-11
forward O 0 1.31397226432739e-10
to O 0 1.288326667570061e-10
explain O 0 7.102236576628229e-10
partially O 0 9.316059035313629e-10
the O 0 6.392415763389891e-11
maintenance O 0 1.6416282777598212e-09
of O 0 1.00563024574285e-09
DM B-Disease 1 1.0
in O 0 1.5922256846323535e-09
the O 0 2.3778727875622963e-09
population O 0 4.96651539338977e-11
. O 0 9.842591186526306e-10

In O 0 5.102649414112648e-09
a O 0 2.4134398923791878e-09
survey O 0 6.936721752559549e-10
of O 0 2.4468493897700228e-09
DM B-Disease 1 1.0
in O 0 2.6186453006005195e-09
Northern O 0 3.275916071743268e-08
Ireland O 0 1.0356622226481704e-09
, O 0 1.266926563658899e-10
59 O 0 6.448668710135053e-09
pedigrees O 0 7.050919292872493e-10
were O 0 4.675544951204813e-10
ascertained O 0 1.8905585363881983e-07
. O 0 1.1968567470432845e-08

Sibships O 0 6.298894277279032e-06
where O 0 7.259381984425772e-10
the O 0 1.8053426809050421e-10
status O 0 8.834494802378856e-10
of O 0 2.1331737765084569e-10
all O 0 7.036912719193822e-12
the O 0 4.952363866217446e-11
members O 0 4.523277585821717e-12
had O 0 2.4034338408363e-10
been O 0 6.101326388563422e-11
identified O 0 8.921935412686821e-11
were O 0 1.2356669507052054e-11
examined O 0 2.263257116441597e-11
to O 0 2.4566392323177588e-11
determine O 0 9.287029478777242e-11
the O 0 2.5483981244689424e-11
transmission O 0 2.0177232107343457e-10
of O 0 3.243940949193558e-10
the O 0 4.296927702540643e-09
DM B-Disease 1 1.0
expansion O 0 7.332726426056979e-08
from O 0 1.0837351460679656e-08
affected O 0 8.940985729566364e-10
parents O 0 2.8528023693352722e-11
to O 0 2.925161501909912e-10
their O 0 1.2972750651485399e-10
offspring O 0 1.15437348569003e-09
. O 0 3.400978387801956e-09

Where O 0 1.0658675719810162e-08
the O 0 1.7625240156249333e-09
transmitting O 0 1.3252191344292896e-08
parent O 0 2.3371529156435145e-09
was O 0 2.7851646322574197e-08
male O 0 7.144014824156386e-10
, O 0 4.9810964380947453e-11
58 O 0 2.3078948530041998e-08
. O 0 1.1308205927207382e-08

3 O 0 3.2048785669758217e-06
% O 0 1.2165116025641964e-08
of O 0 2.103647034346068e-09
the O 0 3.750356913911901e-09
offspring O 0 3.7936023211671e-09
were O 0 3.3219776929271916e-10
affected O 0 5.080514897670696e-10
, O 0 6.6518257915704204e-12
and O 0 3.6843839611166995e-12
in O 0 5.484797945681796e-12
the O 0 1.9105194856705587e-11
case O 0 2.553360821389017e-11
of O 0 3.7644119592339376e-12
a O 0 2.1309483691500652e-11
female O 0 8.460158788803351e-12
transmitting O 0 7.743979346663821e-10
parent O 0 1.7786055961366287e-09
, O 0 5.8622799947727344e-09
68 O 0 2.2020467440597713e-06
. O 0 1.5597757396790257e-07

7 O 0 1.46815209518536e-05
% O 0 9.538209866377656e-08
were O 0 1.2000150872992776e-09
affected O 0 6.9885839337757716e-09
. O 0 2.8255032091806243e-08

Studies O 0 3.855653218920452e-08
on O 0 6.621988291044545e-08
meiotic O 0 2.5218255927939026e-07
drive O 0 3.2010245121227854e-08
in O 0 8.286036745630554e-09
DM B-Disease 1 1.0
have O 0 2.3514556968251554e-10
shown O 0 3.6074682737557984e-12
increased O 0 1.3557125040641882e-11
transmission O 0 2.7140857269958296e-11
of O 0 6.901948088576526e-13
the O 0 4.65478729779617e-13
larger O 0 1.992624815150279e-12
allele O 0 7.580965716291743e-11
at O 0 1.7357504322745854e-10
the O 0 1.301955071530969e-10
DM B-Disease 1 0.9997559189796448
locus O 0 2.766494811012876e-09
in O 0 1.772708368985576e-10
non O 0 9.115008481330733e-08
- O 0 7.192721795945545e-07
DM O 1 1.0
heterozygotes O 0 1.9215152136098368e-08
for O 0 2.3942142712840564e-10
CTGn O 0 1.4985647567300475e-06
. O 0 8.692126129972166e-09

This O 0 1.1139898781209467e-08
study O 0 3.602589893070274e-10
provides O 0 1.4443785794140962e-12
further O 0 8.50026021792516e-11
evidence O 0 1.0570031655499079e-10
that O 0 5.879314396439739e-12
the O 0 1.8419973324412808e-09
DM B-Disease 1 1.0
expansion O 0 1.7011906550123967e-07
tends O 0 5.2413406947948715e-09
to O 0 6.814370179242246e-10
be O 0 4.1260750371918675e-10
transmitted O 0 1.8514336730390824e-09
preferentially O 0 7.492110043472167e-09
. O 0 4.670413389362693e-09

Diagnosis O 1 0.9999994039535522
of O 0 0.00018268926942255348
hemochromatosis B-Disease 1 1.0
. O 0 0.00141372368671

If O 0 0.0003213865857105702
untreated O 1 0.9999953508377075
, O 0 6.5442384844516255e-09
hemochromatosis B-Disease 1 1.0
can O 0 1.686650108467802e-07
cause O 1 0.9999277591705322
serious O 1 0.9999998807907104
illness O 1 0.9999990463256836
and O 0 1.4750804744334545e-10
early B-Disease 0 3.147744820353182e-08
death I-Disease 0 2.1680077733066128e-09
, O 0 2.8673648199729895e-13
but O 0 4.6805098859181715e-12
the O 0 2.386331687809218e-10
disease O 0 1.9681259288972797e-08
is O 0 1.7220242159304844e-12
still O 0 1.1400598347310886e-11
substantially O 0 7.576286265020826e-10
under O 0 2.2855376755614998e-06
- O 1 0.999934196472168
diagnosed O 1 0.9999662637710571
. O 0 3.9765092196830665e-07

The O 0 5.129995983566005e-08
cornerstone O 0 6.499000448911829e-08
of O 0 1.8789010347575186e-09
screening O 0 1.5869736080809105e-10
and O 0 3.1429930272969253e-12
case O 0 1.1492080204122956e-10
detection O 0 1.930249515780247e-09
is O 0 5.0785044572454474e-12
the O 0 2.8007903288274072e-11
measurement O 0 1.3012531052680743e-09
of O 0 4.0782227594959863e-10
serum O 0 2.9721103356195044e-10
transferrin O 0 1.861599985275575e-09
saturation O 0 1.3697024625614063e-09
and O 0 8.368088340315882e-12
the O 0 7.292629694566344e-11
serum O 0 5.137383296549558e-10
ferritin O 0 1.577237362937467e-08
level O 0 1.6511251033080043e-08
. O 0 5.368173905395679e-09

Once O 0 3.1306120717999875e-07
the O 0 2.9429869652375373e-09
diagnosis O 0 7.368515070993453e-06
is O 0 1.3051648650730385e-10
suspected O 0 3.031362894034828e-08
, O 0 5.7337318920547276e-11
physicians O 0 9.391150079807176e-10
must O 0 4.2207028982943484e-09
use O 0 1.1953510181683669e-08
serum O 0 2.471188622621412e-07
ferritin O 0 2.2691792764817365e-06
levels O 0 4.626616245673176e-08
and O 0 1.4100043355114167e-09
hepatic O 0 0.00019097645417787135
iron O 0 1.8605005607241765e-05
stores O 0 7.661887480026053e-08
on O 0 2.6906536731985398e-06
liver O 0 1.4610390053348965e-06
biopsy O 0 1.638242252965938e-07
specimens O 0 1.3396223019768172e-10
to O 0 1.9536350315263462e-10
assess O 0 1.5913816930890334e-09
patients O 0 1.5865309066498412e-11
for O 0 4.311822166674917e-12
the O 0 2.7167026961372187e-10
presence O 0 2.5252469559866597e-10
of O 0 2.5369130796093486e-08
iron B-Disease 0 1.1553899639693554e-05
overload I-Disease 0 2.6336017526773503e-06
. O 0 3.822519190066487e-08

Liver O 1 0.9991775155067444
biopsy O 0 0.4340396821498871
is O 0 6.3563367902474965e-09
also O 0 1.191625010471542e-11
used O 0 2.8723145823611462e-12
to O 0 4.988151211526848e-11
establish O 0 6.090338650066585e-11
the O 0 1.8818615069027267e-11
presence O 0 1.0859122628881224e-11
or O 0 2.9970166348647354e-09
absence O 0 3.9363331438835303e-07
of O 0 7.450103822748133e-08
cirrhosis B-Disease 1 0.9999922513961792
, O 0 9.256271096824698e-12
which O 0 1.176425927160163e-12
can O 0 5.887856868724839e-11
affect O 0 3.0462473432635306e-08
prognosis O 0 4.234449806972407e-05
and O 0 2.0705828163158913e-09
management O 0 5.7262106167854654e-08
. O 0 1.2747814359670429e-08

A O 0 4.2148283796450414e-07
DNA O 0 3.3361517992602785e-09
- O 0 1.3248385721809086e-10
based O 0 4.922067094181859e-12
test O 0 8.366556579486595e-12
for O 0 1.1717834818777972e-12
the O 0 2.776304464102708e-10
HFE O 0 2.2301624369447381e-07
gene O 0 1.1622534185073974e-10
is O 0 4.16622812637879e-12
commercially O 0 3.258480985035561e-11
available O 0 9.427158706443173e-12
, O 0 6.71669274018849e-12
but O 0 5.2182902096631345e-12
its O 0 3.776104862823759e-12
place O 0 5.146550546841766e-11
in O 0 3.1054872215441343e-12
the O 0 1.0521154086839957e-10
diagnosis O 0 9.269464499084279e-06
of O 0 1.222060497241273e-08
hemochromatosis B-Disease 1 1.0
is O 0 1.1455784765246335e-08
still O 0 1.0155101065612016e-10
being O 0 5.516179873987781e-11
evaluated O 0 1.0861308519238833e-09
. O 0 2.6712616563173697e-09

Currently O 0 7.582089978086515e-08
, O 0 9.833227565536617e-10
the O 0 7.467766405255816e-10
most O 0 1.9551549615415276e-11
useful O 0 4.659464133971447e-11
role O 0 1.2687902811725493e-11
for O 0 8.193171618584016e-13
this O 0 4.604228890509043e-12
test O 0 7.963622816742344e-12
is O 0 1.2827000746284956e-13
in O 0 7.854643042752574e-13
the O 0 1.3245069971357104e-11
detection O 0 5.506209710404164e-09
of O 0 5.0247765948086e-09
hemochromatosis B-Disease 1 1.0
in O 0 2.2944499633581472e-09
the O 0 4.676581344398301e-09
family O 0 6.685981629450666e-11
members O 0 1.679395880173351e-12
of O 0 2.177113697654498e-11
patients O 0 3.042083512178051e-12
with O 0 5.735594155653265e-14
a O 0 1.8743219476480277e-10
proven O 0 1.3513868912795601e-09
case O 0 7.745220020893839e-10
of O 0 1.2904570745320143e-09
the O 0 1.0357930513293923e-08
disease O 0 2.701300445551169e-06
. O 0 1.3164218160000019e-08

It O 0 1.3349348293445473e-09
is O 0 1.7191086054690885e-10
crucial O 0 2.495710305083776e-08
to O 0 1.0689503682215218e-07
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 4.531875106295047e-07
because O 0 1.531135107590842e-09
phlebotomy O 0 3.8819084124952496e-07
therapy O 0 2.9566815662462886e-09
can O 0 6.575336108927132e-11
avert O 0 0.2416839450597763
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 6.899309595853609e-11
can O 0 3.8845312383406494e-11
even O 0 4.84308981807402e-11
lead O 0 9.924584591647356e-12
to O 0 5.5890857914020486e-11
normal O 0 3.0285411956043617e-09
life O 0 5.5587440900284335e-11
expectancy O 0 2.463979853484233e-10
. O 0 3.903232598245765e-11
. O 0 4.9502726362504745e-09

Prevalence O 0 2.0473746189964004e-05
of O 0 1.3145976751616217e-08
the O 0 1.2097551405076956e-08
I1307K O 0 6.311389824986691e-06
APC B-Disease 0 7.119954403833617e-09
gene O 0 1.3789955505619234e-12
variant O 0 3.4328813663248026e-12
in O 0 1.3357731804344852e-12
Israeli O 0 5.756867760275952e-10
Jews O 0 4.096820539062351e-12
of O 0 1.2899253334312105e-13
differing O 0 1.27299470335622e-13
ethnic O 0 7.539687732656397e-13
origin O 0 2.785732798951668e-12
and O 0 4.17499411778377e-12
risk O 0 1.163339113929851e-08
for O 0 8.074355264398037e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00034314164076931775

BACKGROUND O 0 6.189856094351853e-08
& O 0 1.1234509322832764e-08
AIMS O 0 1.4251870794623756e-08
Israeli O 0 8.159086206660504e-08
Jews O 0 2.9774622767320125e-09
of O 0 2.3493887391090595e-10
European O 0 5.52094325811936e-09
birth O 0 1.0470100875181743e-07
, O 0 1.448446501628453e-10
i O 0 1.6135560665375692e-09
. O 0 3.5387616448279147e-11
e O 0 2.4489387948078978e-11
. O 0 1.7151545808613555e-11
, O 0 3.6015235932440604e-11
Ashkenazim O 0 8.74791439287037e-08
, O 0 9.822608004750322e-12
have O 0 1.6162864449609238e-11
the O 0 1.261020621257103e-09
highest O 1 0.9751011729240417
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.00012734091433230788
of O 0 2.622082551084759e-10
any O 0 9.921617000197003e-11
Israeli O 0 5.375471801016829e-08
ethnic O 0 5.043949702354666e-10
group O 0 2.597124772185655e-11
. O 0 5.451480378226847e-10

The O 0 6.138349135653698e-07
I1307K O 0 1.0426162589283194e-05
APC B-Disease 0 1.4605296527747669e-08
gene O 0 1.6698050928076746e-11
variant O 0 4.975800327322588e-10
was O 0 2.3476967037083796e-09
found O 0 2.339014398833328e-11
in O 0 1.2628106893508573e-10
6 O 0 7.13542760877317e-07
. O 0 4.2913601561167525e-08

1 O 0 3.9119817074606544e-07
% O 0 4.0783548760359167e-10
of O 0 3.177957202948889e-11
American O 0 6.790244148208169e-12
Jews O 0 1.3236104053071518e-11
, O 0 5.627761169406387e-13
28 O 0 5.718771567408965e-10
% O 0 5.2224644747633775e-11
of O 0 7.218563941036038e-11
their O 0 1.0981801246146006e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.0773152325782576e-06
, O 0 3.100226022081931e-12
but O 0 5.278409545388107e-13
not O 0 3.991473818132363e-12
in O 0 1.3105599938612045e-11
non O 0 4.231738071069913e-09
- O 0 7.691593140179975e-09
Jews O 0 8.950545193897597e-09
. O 0 5.728939100890784e-09

We O 0 4.1688593910294e-08
assessed O 0 1.498344630590509e-07
the O 0 2.16200368718944e-09
I1307K O 0 1.258572297047067e-06
prevalence O 0 6.994554380135298e-10
in O 0 9.396003669125824e-14
Israeli O 0 2.290793110759637e-10
Jews O 0 6.640125515405826e-12
of O 0 3.970345983949665e-14
differing O 0 9.253543569419376e-14
ethnic O 0 5.039998908669407e-13
origin O 0 9.11331882354205e-13
and O 0 1.7157950407686862e-12
risk O 0 6.913754901916036e-09
for O 0 3.472801495263411e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0006340459804050624

METHODS O 0 1.4873113514113356e-06
DNA O 0 1.1557840906561978e-08
samples O 0 2.211663838180833e-11
from O 0 1.0610667726396183e-11
500 O 0 2.3494223060083197e-12
unrelated O 0 1.146989187655878e-11
Jews O 0 1.4927692762456424e-11
of O 0 1.745051152191035e-11
European O 0 5.003912562084878e-11
or O 0 2.9941410462086537e-10
non O 0 5.048919060612889e-09
- O 0 8.3910607628912e-11
European O 0 8.729666989282237e-11
origin O 0 1.0415446283218444e-11
, O 0 4.955238286754107e-14
with O 0 1.5027074933175798e-15
or O 0 1.4255729843121179e-12
without O 0 3.0551321021643485e-12
a O 0 6.990599505513062e-12
personal O 0 4.743701091658448e-12
and O 0 3.805853895921807e-11
/ O 0 1.284361133002676e-07
or O 0 1.8616931996007224e-08
family O 0 1.355826978466368e-10
history O 0 4.0379793259104346e-11
of O 0 5.525224722191524e-11
neoplasia B-Disease 0 7.228273801729301e-08
, O 0 8.389219874338494e-11
were O 0 4.6933672226412426e-11
examined O 0 1.7477365388263166e-10
for O 0 9.485216431737165e-12
the O 0 1.8970633397508152e-10
I1307K O 0 2.5867554764857914e-09
variant O 0 4.198063337929048e-12
by O 0 2.780737445862158e-12
the O 0 5.0547722257876515e-11
allele O 0 3.29271818144683e-11
- O 0 5.671181579902651e-11
specific O 0 1.109927219578033e-10
oligonucleotide O 0 2.2192862658698687e-08
( O 0 6.77193690012956e-10
ASO O 0 5.424582468549488e-06
) O 0 2.561687667546053e-11
method O 0 2.825485623247914e-09
. O 0 1.615283573563886e-09

RESULTS O 0 3.7111226447450463e-07
In O 0 2.5237891776441757e-09
persons O 0 3.1420790969072243e-10
at O 0 1.3229901896227858e-10
average O 0 5.00366692524068e-10
risk O 0 8.846049226463037e-09
for O 0 3.5741567216973635e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.241564859810751e-07
I1307K O 0 1.245989665221714e-06
was O 0 1.9908916737421123e-09
found O 0 1.1204533828523822e-11
in O 0 1.7143630265392673e-11
5 O 0 2.2172510938389678e-08
. O 0 9.693844837954657e-09

0 O 0 2.736175872541935e-07
% O 0 1.0891596513573631e-09
of O 0 1.0023130936342994e-10
120 O 0 3.384307556419941e-10
European O 0 4.472170689329147e-10
and O 0 1.1422266465999087e-09
1 O 0 6.598243999178521e-06
. O 0 4.8085436077371924e-08

6 O 0 2.109035222019884e-06
% O 0 3.2830138607664594e-09
of O 0 5.692045168537163e-10
188 O 0 9.077421592174062e-10
non O 0 4.6657384622506015e-09
- O 0 1.0312408704749032e-09
European O 0 8.73381811317131e-10
Jews O 0 3.643292778576779e-09
( O 0 8.485712826855618e-11
P O 0 2.920928068306239e-07
= O 0 1.9088522429377974e-10
0 O 0 8.647865062938465e-11
. O 0 2.221361115883891e-12
08 O 0 2.0650915699693684e-10
) O 0 1.2281152657334093e-11
. O 0 1.2415555250555599e-09

It O 0 2.812462929213666e-09
occurred O 0 3.5118176811010926e-08
in O 0 2.783749064594332e-10
15 O 0 4.367228001456169e-08
. O 0 5.603138397702878e-09

4 O 0 7.950151825752982e-07
% O 0 1.2849112884794067e-09
of O 0 2.5356478028371043e-10
52 O 0 1.8418356839688954e-09
Ashkenazi O 0 1.9426780184517156e-09
Israelis O 0 5.8440940975401645e-09
with O 0 2.7346578126974386e-11
familial O 0 0.00018057951820082963
cancer B-Disease 1 0.9998877048492432
( O 0 6.679102271256454e-10
P O 0 1.411053744959645e-06
= O 0 2.5640303769058903e-10
0 O 0 2.159484258079658e-10
. O 0 7.602625126668094e-12
02 O 0 2.4275647464433447e-11
) O 0 8.275800292452395e-13
and O 0 8.06402947889362e-12
was O 0 3.178421303928758e-09
not O 0 6.980160893732545e-10
detected O 0 2.6954491971764583e-09
in O 0 3.0225710823117424e-11
51 O 0 2.5253394930757622e-09
non O 0 5.112517964533936e-09
- O 0 5.481341491808678e-10
European O 0 1.6133960833997207e-09
Jews O 0 3.6322049812298474e-09
at O 0 2.6542881226276904e-09
increased O 0 4.277058263113531e-09
cancer B-Disease 0 4.50369356030933e-07
risk O 0 2.1063824462430603e-08
. O 0 1.1486459783327518e-08

Colorectal B-Disease 1 0.998531699180603
neoplasia I-Disease 0 0.29531803727149963
occurred O 0 0.000818309374153614
personally O 0 4.002992604057454e-09
or O 0 3.1088968205361667e-11
in O 0 4.372361413901293e-12
the O 0 4.316907508544743e-12
families O 0 8.934664531660974e-13
of O 0 1.6170143349314436e-11
13 O 0 7.566264281777535e-10
of O 0 3.327380315720774e-10
20 O 0 8.458542311018391e-09
Ashkenazi O 0 2.8809385987926817e-09
I1307K O 0 2.1143109485421974e-09
carriers O 0 7.11635557339857e-13
, O 0 9.916026333378625e-13
8 O 0 1.0449922038802129e-09
of O 0 7.354707121098869e-11
whom O 0 2.483958871923875e-10
also O 0 2.3043858488058788e-11
had O 0 1.3973294743507836e-10
a O 0 1.2589700115750446e-10
personal O 0 2.1196679134138918e-10
or O 0 3.434995399231866e-09
family O 0 1.7946377717237283e-10
history O 0 1.3730104553300038e-10
of O 0 8.271821005934044e-10
noncolonic O 0 2.5107965484494343e-06
neoplasia B-Disease 0 0.006164480000734329
. O 0 4.392068603920052e-06

CONCLUSIONS O 0 3.860595097648911e-05
The O 0 1.1675564337565447e-07
I1307K O 0 7.260645816131728e-06
APC O 0 9.654321786456421e-09
variant O 0 1.769611346347233e-09
may O 0 3.401192216756499e-09
represent O 0 5.450302709153476e-11
a O 0 4.3431356289147516e-09
susceptibility O 0 1.2576900587646378e-07
gene O 0 6.800257024153211e-10
for O 0 4.71206496044374e-09
colorectal B-Disease 1 1.0
, I-Disease 0 3.1275194487534463e-05
or I-Disease 0 5.2078848966630176e-05
other I-Disease 0 3.807609516570665e-08
, I-Disease 0 3.0132949468963943e-09
cancers I-Disease 0 6.560289421031484e-06
in O 0 2.4872313098001086e-09
Ashkenazi O 0 4.770959662891983e-07
Jews O 0 3.145426585859923e-09
, O 0 8.253704143756924e-12
and O 0 7.934573137413636e-12
partially O 0 1.3920584684967707e-08
explains O 0 5.0394088207950105e-11
the O 0 1.280872543446554e-11
higher O 0 8.346164315220506e-10
incidence O 0 1.2980015526409261e-05
of O 0 1.7298184502578806e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 9.81275416478411e-09
European O 0 8.156561648320348e-09
Israelis O 0 2.1917293224760215e-07
. O 0 7.437975124702234e-09

Systematic O 0 9.267609790697406e-09
analysis O 0 2.512702268475664e-10
of O 0 4.42011038881418e-10
coproporphyrinogen O 0 3.740739884960931e-06
oxidase O 0 2.7936724222854536e-07
gene O 0 2.8610623203917385e-08
defects O 0 3.1663626032241154e-06
in O 0 3.6770817501974307e-09
hereditary B-Disease 1 0.9998724460601807
coproporphyria I-Disease 0 0.0033158338628709316
and O 0 3.7366356764323427e-07
mutation O 0 1.1231772845121668e-07
update O 0 9.474494788719312e-08
. O 0 4.712507717385961e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999998807907104
( O 0 2.55590407505224e-07
HC B-Disease 1 1.0
) O 0 2.708202273549176e-10
is O 0 1.2160139561956385e-10
an O 0 5.38982147801903e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9682797193527222
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999129772186279
caused O 0 0.01726371794939041
by O 0 7.60115304032638e-10
deficient B-Disease 0 6.1274462836991e-08
activity I-Disease 0 1.9453226585142147e-08
of I-Disease 0 8.851162469625251e-09
coproporphyrinogen I-Disease 0 1.3292674339027144e-07
III I-Disease 0 8.602975867688656e-05
oxidase I-Disease 0 3.002723190093093e-07
( O 0 2.3975468277370737e-09
CPO O 0 1.8434801631883602e-06
) O 0 7.620237774119687e-11
. O 0 1.3662061482122567e-09

Clinical O 0 0.0008459557429887354
manifestations O 0 0.0005301150376908481
of O 0 1.5890976783339283e-06
the O 0 3.904236109519843e-06
disease O 1 0.9999934434890747
are O 0 2.548818361230998e-13
characterized O 0 1.3287193611002945e-12
by O 0 1.7964168564157945e-12
acute O 0 0.0005754324374720454
attacks O 0 2.5362911401316524e-05
of O 1 0.7769520282745361
neurological B-Disease 1 1.0
dysfunction I-Disease 1 0.9999997615814209
often O 0 5.337789321657738e-09
precipitated O 0 7.802393731104473e-10
by O 0 7.010361041670521e-12
drugs O 0 8.713031685037009e-11
, O 0 4.105534488763052e-12
fasting O 0 1.4062637276879286e-08
, O 0 1.1210225803193197e-10
cyclical O 0 5.68068344364292e-07
hormonal O 0 1.2818000527659024e-07
changes O 0 5.809485781327339e-09
, O 0 2.5465447528461027e-09
or O 0 0.00015049333160277456
infectious B-Disease 1 0.9856729507446289
diseases I-Disease 0 0.00040665428969077766
. O 0 4.1392112848370743e-08

Skin O 1 1.0
photosensitivity O 1 0.9249130487442017
may O 0 8.374549906875473e-06
also O 0 8.30658763995018e-10
be O 0 2.435352752794273e-10
present O 0 1.0067203737307295e-09
. O 0 7.3700205938109775e-09

The O 0 1.0085700807849207e-07
seven O 0 7.769252796663295e-09
exons O 0 1.7893690085202252e-08
, O 0 1.0424415497478634e-10
the O 0 6.091410154063226e-10
exon O 0 2.4106658891298594e-09
/ O 0 1.0441738140798407e-08
intron O 0 7.291107273488251e-09
boundaries O 0 1.2799945547925518e-09
and O 0 3.9668553164506903e-11
part O 0 6.169800781385959e-10
of O 0 9.254943478254063e-09
3 O 0 2.3135039839417004e-07
noncoding O 0 3.827480199447564e-08
sequence O 0 3.003282511571115e-09
of O 0 3.029737127846488e-09
the O 0 1.5452977564223147e-08
CPO O 0 2.0673853668995434e-06
gene O 0 2.5915147805477545e-10
were O 0 9.619149921036296e-11
systematically O 0 6.945548303161075e-11
analyzed O 0 1.9982498728615683e-12
by O 0 3.834302395987893e-13
an O 0 1.3402399849649083e-11
exon O 0 5.88059601014379e-11
- O 0 2.5391858060608286e-10
by O 0 4.4279835353933095e-10
- O 0 7.5591600534608e-08
exon O 0 1.2563660334308224e-08
denaturing O 0 1.0538697097217664e-06
gradient O 0 3.757013757876848e-07
gel O 0 4.0823202596129704e-08
electrophoresis O 0 4.075277448833958e-09
( O 0 2.1853302153984622e-11
DGGE O 0 2.408264379027969e-07
) O 0 1.2073853201954865e-12
strategy O 0 1.4412723618739687e-11
followed O 0 8.961835722305633e-13
by O 0 7.951275136355504e-14
direct O 0 1.5005968689862925e-11
sequencing O 0 2.2182533587766784e-12
in O 0 1.9503417977850823e-12
seven O 0 8.430535783365833e-12
unrelated O 0 1.3127672560120374e-10
heterozygous O 0 3.137683446396977e-10
HC B-Disease 0 0.0014906638534739614
patients O 0 2.9080287067273503e-09
from O 0 2.2976852365186318e-10
France O 0 2.4815061117067216e-10
, O 0 3.652248642405098e-12
Holland O 0 6.726157825154289e-11
, O 0 2.0142798019817665e-12
and O 0 4.3732539291296835e-12
Czech O 0 6.203944735716505e-08
Republic O 0 7.715471497249382e-07
. O 0 6.017659757162619e-07

Seven O 0 7.401649781968445e-08
novel O 0 5.5588134095785335e-09
mutations O 0 6.223352388978753e-10
and O 0 1.0758824386947197e-11
two O 0 1.9970507886268862e-11
new O 0 1.7633436377728628e-10
polymorphisms O 0 1.8010933189316347e-08
were O 0 3.1688227153381376e-08
detected O 0 4.4824059841630515e-07
. O 0 1.6279841474897694e-08

Among O 0 7.786015387978296e-09
these O 0 1.2320645892405224e-10
mutations O 0 9.653433608036721e-10
two O 0 2.9947620772130534e-11
are O 0 5.95034221548274e-12
missense O 0 2.917435892868525e-08
( O 0 7.336328211593468e-10
G197W O 0 1.6835963378980523e-06
, O 0 3.712768148478318e-10
W427R O 0 1.941447891340431e-07
) O 0 1.7041229538605762e-11
, O 0 4.706731532300168e-12
two O 0 9.316956060823056e-12
are O 0 6.900938154252856e-12
nonsense O 0 9.508743126218633e-09
( O 0 3.225991973554443e-10
Q306X O 0 6.049375542716007e-07
, O 0 1.2139329819138567e-10
Q385X O 0 9.544779544512494e-08
) O 0 6.236428474332145e-12
, O 0 4.919608123654662e-12
two O 0 3.3553676330455584e-12
are O 0 1.3964754916676037e-12
small O 0 3.705111911722625e-11
deletions O 0 5.3189261883801464e-09
( O 0 1.4304997186798118e-09
662de14bp O 0 9.774871614354197e-07
; O 0 1.6670086144809915e-10
1168del3bp O 0 2.317069771606839e-07
removing O 0 2.0439641090774785e-08
a O 0 1.6208757669389229e-09
glycine O 0 7.637488863565522e-09
at O 0 1.0814307671580536e-08
position O 0 1.3431024070698072e-09
390 O 0 6.959843812381905e-11
) O 0 1.004727551157103e-12
, O 0 7.450597213840005e-13
and O 0 8.523289496062403e-13
one O 0 9.16100528769448e-12
is O 0 7.099954305034295e-12
a O 0 3.849550400669699e-10
splicing O 0 1.822239692472749e-09
mutation O 0 9.204538797824569e-10
( O 0 3.261040959837147e-12
IVS1 O 0 2.6287912646694167e-07
- O 0 5.586256346390428e-09
15c O 0 1.6512990441697184e-07
- O 0 2.1491184387656403e-09
- O 0 1.8213015540169408e-09
> O 0 1.732265442200287e-09
g O 0 4.509514289763317e-11
) O 0 5.964175822052026e-14
which O 0 1.8923985913455593e-13
creates O 0 5.379655922121973e-12
a O 0 7.882130365066686e-11
new O 0 2.52964815761203e-10
acceptor O 0 1.978603725305561e-09
splice O 0 2.3828411244153358e-08
site O 0 2.7827418147552407e-09
. O 0 1.6185897067089172e-09

The O 0 7.958991687928574e-08
pathological O 0 5.689928912033793e-06
significance O 0 5.6511573198747556e-09
of O 0 7.451236960775987e-09
the O 0 3.647513180382589e-09
point O 0 3.76450586259125e-08
mutations O 0 2.3596740117426407e-09
G197W O 0 7.00566886280285e-07
, O 0 1.9157239683487148e-10
W427R O 0 1.6498773902640096e-06
, O 0 9.079875740169996e-11
and O 0 4.7684682591420113e-11
the O 0 2.7730498453060193e-10
in O 0 7.711518923425587e-11
- O 0 4.696674715809479e-10
frame O 0 1.5252907825669126e-09
deletion O 0 4.2401646638268176e-09
390delGly O 0 7.701865256670715e-10
were O 0 9.419376736929941e-12
assessed O 0 9.933982803023156e-11
by O 0 5.268451690534914e-13
their O 0 4.2324178016472924e-12
respective O 0 4.145209522854465e-11
expression O 0 1.8781896177211266e-11
in O 0 1.7053879142192585e-11
a O 0 1.573482871775056e-10
prokaryotic O 0 1.2171873751964934e-11
system O 0 2.342514723863154e-11
using O 0 5.588539613715637e-12
site O 0 5.272820027824032e-11
- O 0 2.0312640458541864e-11
directed O 0 1.4890413554957682e-11
mutagenesis O 0 7.896858278400032e-08
. O 0 7.084786979305591e-09

These O 0 1.0022198626558065e-09
mutations O 0 3.950050841972086e-10
resulted O 0 2.912395880017016e-10
in O 0 3.270298962188001e-11
the O 0 8.785930316612678e-10
absence O 0 3.747017807143038e-09
or O 0 3.3565425439086027e-10
a O 0 1.322445930540539e-09
dramatic O 0 1.4237689249796404e-08
decrease O 0 1.7756548231773195e-07
of O 0 9.444165272043392e-08
CPO O 0 7.729485514573753e-05
activity O 0 2.523877640214778e-07
. O 0 3.441069651444195e-08

The O 0 5.501121336237702e-08
two O 0 6.286786646825249e-10
polymorphisms O 0 3.998040565278416e-09
were O 0 6.368153226965489e-10
localized O 0 2.745003868653839e-08
in O 0 8.624709280091736e-10
noncoding O 0 1.579449993016624e-08
part O 0 1.1524858845035624e-09
of O 0 2.085004169316562e-09
the O 0 6.843116073795841e-10
gene O 0 1.188438149973825e-11
1 O 0 3.801729597796566e-09
) O 0 1.4381631736198885e-12
a O 0 4.693450628145968e-10
C O 0 1.0919104198592322e-07
/ O 0 5.54214985015733e-09
G O 0 7.70483343792705e-10
polymorphism O 0 5.0161055864528237e-11
in O 0 1.6202435226819745e-11
the O 0 1.1715881043095067e-10
promotor O 0 2.521673820865544e-07
region O 0 2.0383540189072846e-08
, O 0 1.7424751641570424e-09
142 O 0 7.607393825992403e-09
bp O 0 9.67864011158781e-09
upstream O 0 2.6405329034417946e-09
from O 0 8.627041442332839e-11
the O 0 3.739317189221936e-11
transcriptional O 0 7.252112105282649e-11
initiation O 0 2.5937535105824416e-11
site O 0 4.412861569214055e-12
( O 0 2.670512194626745e-13
- O 0 3.529932735002461e-10
142C O 0 2.745658633784842e-08
/ O 0 2.188811576431249e-09
G O 0 1.342815525440244e-09
) O 0 1.0281029499958905e-12
, O 0 3.754609470552062e-12
and O 0 3.15704788700355e-11
2 O 0 2.5831674577148078e-08
) O 0 1.3569955922831944e-11
a O 0 9.708944759267979e-09
6 O 0 9.558424807210031e-08
bp O 0 2.328485182445661e-09
deletion O 0 1.2683964989435026e-10
polymorphism O 0 4.158275460075522e-11
in O 0 2.1205525183032314e-11
the O 0 1.248748604520955e-10
3 O 0 5.059137109242329e-09
noncoding O 0 1.4803017478470792e-08
part O 0 1.1565199908858403e-09
of O 0 9.834189462765153e-09
the O 0 6.613127823129616e-08
CPO O 0 1.7887870853883214e-05
gene O 0 1.4056248387461778e-09
, O 0 2.764120043963203e-10
574 O 0 1.82913186819178e-08
bp O 0 2.1318825815797027e-08
downstream O 0 6.771759153423318e-09
of O 0 9.361635772142662e-11
the O 0 1.8665151022001503e-11
last O 0 6.52882192753168e-11
base O 0 3.725705507995336e-11
of O 0 6.138476879580246e-12
the O 0 1.2946122472656807e-11
normal O 0 5.464576569025326e-10
termination O 0 3.976767803948178e-09
codon O 0 5.8238529554444085e-09
( O 0 4.825183655410292e-11
+ O 0 1.1107091912876399e-09
574 O 0 2.449123570613665e-09
delATTCTT O 0 2.1840669717221317e-08
) O 0 6.553000503339845e-11
. O 0 2.6681961085017747e-09

Five O 0 1.6055480500654085e-07
intragenic O 0 3.7159074963710736e-06
dimorphisms O 0 6.5188660300918855e-06
are O 0 1.0480376289034865e-10
now O 0 1.7955819123227634e-11
well O 0 1.6177477109649563e-12
characterized O 0 6.169935656136216e-12
and O 0 8.606915093828382e-13
the O 0 1.299510759417144e-11
high O 0 5.7404945380534755e-11
degree O 0 3.5696237077331716e-09
of O 0 1.1763733043235192e-10
allelic O 0 7.57337126344737e-09
heterogeneity O 0 1.3027090517425677e-08
in O 0 8.046108224135651e-10
HC B-Disease 1 0.9998502731323242
is O 0 4.6083453719703016e-10
demonstrated O 0 7.068754002276245e-12
with O 0 1.9105540988249153e-13
seven O 0 5.53383901202853e-12
new O 0 1.4772856332320727e-13
different O 0 2.9354113134346174e-14
mutations O 0 1.7707194217841948e-12
making O 0 8.224438925036326e-13
a O 0 3.805774098641912e-11
total O 0 3.325388020503084e-10
of O 0 1.5813664822061924e-09
nineteen O 0 4.706212166638579e-06
CPO O 0 0.3978513479232788
gene B-Disease 0 4.599630756274564e-06
defects I-Disease 1 0.8103339672088623
reported O 0 4.826102539823296e-08
so O 0 6.602107194275675e-10
far O 0 1.7422857601090413e-09
. O 0 3.605243603654884e-10
. O 0 5.0405670748432385e-09

Coincidence O 0 1.7466940107624396e-06
of O 0 7.977241089918152e-09
two O 0 4.028379019249684e-11
novel O 0 2.7925767254188827e-10
arylsulfatase O 0 4.104384032643793e-08
A O 0 1.6638814770431054e-08
alleles O 0 1.69250474746363e-10
and O 0 1.9902907100188827e-10
mutation O 0 3.0360829406106404e-09
459 O 0 9.078430451836539e-09
+ O 0 1.1553564327471122e-08
1G O 0 3.439055831222504e-07
> O 0 1.0674809480804015e-08
A O 0 4.5171462126347706e-09
within O 0 5.849856710149481e-10
a O 0 6.067847335700094e-10
family O 0 7.824058761984887e-11
with O 0 7.502282822757778e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 6.052032486270065e-11
molecular O 0 1.7986129252633987e-10
basis O 0 9.491157165752995e-11
of O 0 3.267007150919987e-11
phenotypic O 0 5.743077124975571e-08
heterogeneity O 0 1.0925266451522475e-06
. O 0 1.0513526405020457e-07

In O 0 2.1523141047197214e-09
a O 0 8.823211605779591e-10
family O 0 4.133193440281069e-11
with O 0 2.272225647654419e-13
three O 0 3.899564005038769e-11
siblings O 0 3.909262080714626e-10
, O 0 4.786177422270999e-13
one O 0 2.0798683955658426e-13
developed O 0 1.0562629763899434e-11
classical O 0 2.215660321880364e-09
late O 0 0.05654703825712204
infantile O 1 0.9999958276748657
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 6.613478653605398e-09
MLD B-Disease 1 1.0
) O 0 6.47996656333305e-11
, O 0 4.1766531205800206e-11
fatal O 0 5.281464154904825e-08
at O 0 5.00981922613164e-09
age O 0 1.1725080462099413e-08
5 O 0 1.9863032107991785e-08
years O 0 7.687907532805127e-10
, O 0 1.2984576955310523e-11
with O 0 1.7203575369828528e-11
deficient O 0 2.4573913037784223e-07
arylsulfatase O 0 1.3214137197792297e-06
A O 0 1.93190044228686e-06
( O 0 1.0256405724717865e-09
ARSA O 0 8.465502077115161e-08
) O 0 9.12960245597061e-13
activity O 0 8.334781649577128e-12
and O 0 5.19855805538455e-13
increased O 0 1.685221406866333e-10
galactosylsulfatide O 0 1.2867126031324005e-07
( O 0 1.839276508874832e-09
GS O 0 0.00035049172583967447
) O 0 5.939067015958699e-10
excretion O 0 8.595985589998634e-10
. O 0 2.735744408788321e-10

The O 0 3.9939571649938443e-08
two O 0 1.674836103138233e-10
other O 0 3.9601499163266496e-11
siblings O 0 2.8830660081524684e-09
, O 0 9.632222103261867e-11
apparently O 0 6.326053636485085e-08
healthy O 0 2.111441466112751e-09
at O 0 1.2531472748378292e-08
12 O 0 1.004158711737091e-08
( O 0 8.304381488022372e-11
1 O 0 7.634380949639308e-07
/ O 0 1.6508227673739384e-08
2 O 0 1.9444547305624837e-08
) O 0 1.860326562935777e-12
and O 0 1.461753808273958e-11
15 O 0 4.820292498486367e-10
years O 0 7.997403433934736e-11
, O 0 1.767938660052204e-12
respectively O 0 3.562383374400291e-11
, O 0 1.7906662480929314e-12
and O 0 2.9434317396631604e-12
their O 0 9.316067015041618e-12
father O 0 2.349694661063495e-09
, O 0 1.8983373206715726e-10
apparently O 0 4.2819330303700553e-08
healthy O 0 5.471029532189142e-11
as O 0 3.5785074990052346e-12
well O 0 2.971931294809549e-12
, O 0 3.493058923706438e-12
presented O 0 1.1622561801871711e-09
ARSA O 0 2.065828311970108e-06
and O 0 3.6667144320823297e-10
GS O 0 9.273390605812892e-05
values O 0 1.3160030357117769e-11
within O 0 9.52884559451972e-12
the O 0 1.858875900428991e-12
range O 0 7.556384962192908e-10
of O 0 3.1305351644306256e-09
MLD B-Disease 1 1.0
patients O 0 4.5118095926000024e-08
. O 0 1.0854686927075363e-08

Mutation O 0 6.52432241565748e-09
screening O 0 6.799997231965449e-10
and O 0 2.8154267112112663e-12
sequence O 0 2.01467922206211e-12
analysis O 0 8.844900723295468e-13
disclosed O 0 4.6870871767135114e-11
the O 0 6.999045006755855e-12
involvement O 0 3.728200734243181e-11
of O 0 8.334689882705248e-11
three O 0 7.662573700550901e-12
different O 0 2.4922373192959313e-12
ARSA O 0 5.908802336307417e-07
mutations O 0 3.4134409188091297e-10
being O 0 1.1711249157941861e-11
the O 0 1.1706113509091232e-11
molecular O 0 7.149149328089521e-11
basis O 0 8.607125567827723e-10
of O 0 3.5374542184385405e-10
intrafamilial O 0 6.648900807704194e-07
phenotypic O 0 2.895699026339571e-06
heterogeneity O 0 1.38262639666209e-05
. O 0 2.5210030685229867e-07

The O 0 3.3764686602211214e-09
late O 0 7.942687261675019e-06
infantile O 1 0.8387118577957153
patient O 0 4.359635568107478e-06
inherited O 0 7.452988626255319e-08
from O 0 1.8787762456895507e-08
his O 0 1.0842152420309503e-07
mother O 0 1.1520996601177558e-08
the O 0 2.39311526151198e-09
frequent O 0 3.91841448177388e-10
0 O 0 1.7797356921533947e-09
- O 0 1.7920801509418993e-09
type O 0 4.413232446154325e-08
mutation O 0 2.68771405131929e-08
459 O 0 4.416615517754963e-09
+ O 0 4.925735375138629e-10
1G O 0 5.764309030098502e-09
> O 0 4.745769333069916e-10
A O 0 2.1973782793338614e-09
, O 0 1.2501872800885216e-11
and O 0 6.581079431411396e-12
from O 0 1.808658223190207e-10
his O 0 1.392396892230252e-10
father O 0 4.338139222848092e-11
a O 0 5.223030341561241e-12
novel O 0 5.451100508480078e-12
, O 0 3.8360653087203544e-13
single O 0 1.1131555746612953e-11
basepair O 0 3.637656220689678e-08
microdeletion O 0 1.232884301316517e-07
of O 0 7.233842858056505e-09
guanine O 0 2.0211474160980458e-10
at O 0 4.3576400265976645e-09
nucleotide O 0 4.760210559062727e-10
7 O 0 4.4651664588002404e-09
in O 0 6.051778522753182e-11
exon O 0 5.323643192944871e-10
1 O 0 3.3500988649848296e-08
( O 0 1.236794833214816e-10
7delG O 0 4.9584301109462103e-08
) O 0 3.802249348705544e-10
. O 0 8.87293349904894e-09

The O 0 2.862299197659013e-07
two O 0 9.018577884489787e-09
clinically O 0 1.2916151717945468e-05
unaffected O 0 1.2826450301872683e-07
siblings O 0 1.99372651721319e-09
carried O 0 8.899229270165065e-11
the O 0 2.4155111244539285e-10
maternal O 0 5.9798193063898e-09
mutation O 0 3.537321324742493e-09
459 O 0 5.584168683014923e-09
+ O 0 2.988289171668157e-09
1G O 0 8.589422151317194e-08
> O 0 7.50231965440662e-09
A O 0 9.932155542458077e-09
and O 0 5.365271421586826e-11
, O 0 1.315516185568244e-11
on O 0 6.69470145986395e-10
their O 0 8.762491600367017e-12
paternal O 0 1.2398936044544229e-10
allele O 0 1.596202198195229e-10
, O 0 4.075947912518529e-12
a O 0 7.129649648440761e-11
novel O 0 1.254676501583063e-10
cytosine O 0 1.1108145653304646e-10
to O 0 2.0947853174302367e-10
thymidine O 0 2.729680126378753e-08
transition O 0 3.4172877860783046e-08
at O 0 1.3120776465314066e-08
nucleotide O 0 7.546205438302422e-09
2435 O 0 7.102215704435366e-08
in O 0 7.643456007011551e-11
exon O 0 1.4455162622439843e-09
8 O 0 4.0138719015203606e-09
, O 0 2.8059273654568173e-12
resulting O 0 1.1471248430316994e-11
in O 0 1.802664614802829e-11
substitution O 0 2.375269703147609e-10
of O 0 7.491276488025278e-10
alanine O 0 5.7224189831117656e-09
464 O 0 2.017797484654693e-09
by O 0 7.596862583447717e-10
valine O 0 3.971490968979197e-06
( O 0 2.2329442739277283e-09
A464V O 0 2.348008138142177e-06
) O 0 6.272772856696918e-10
. O 0 5.41505684736876e-09

The O 0 6.35013464034273e-08
fathers O 0 5.895875343497892e-09
genotype O 0 3.432323314456198e-09
thus O 0 8.493020731137335e-10
was O 0 5.836942040815529e-09
7delG O 0 4.960587034474884e-07
/ O 0 7.530560196755687e-06
A464V O 0 9.056708950083703e-05
. O 0 2.1747560197127314e-07

Mutation O 0 1.460281282561482e-06
A464V O 0 6.5908293436223175e-06
was O 0 3.3970883883682745e-09
not O 0 1.0710340600517121e-11
found O 0 1.1613924882566962e-12
in O 0 3.1841749289357457e-12
18 O 0 6.255308271363447e-09
unrelated O 0 1.3566281609200814e-07
MLD B-Disease 1 1.0
patients O 0 2.4296806344636934e-08
and O 0 3.662031788920217e-10
50 O 0 1.5009884890559988e-08
controls O 0 3.703464201976203e-08
. O 0 1.9211634949556355e-08

A464V O 0 0.0006489787483587861
, O 0 1.4069847509290412e-09
although O 0 1.1744340222552552e-10
clearly O 0 3.269015613760473e-10
modifying O 0 4.411328191622488e-09
ARSA O 0 2.0424718968570232e-05
and O 0 1.803162597013852e-08
GS O 1 1.0
levels O 0 2.494621185178403e-07
, O 0 5.644031422780138e-11
apparently O 0 2.303179647000775e-09
bears O 0 9.488333729823495e-11
little O 0 3.901020131924504e-12
significance O 0 7.95947682763476e-12
for O 0 2.9867688183804475e-12
clinical O 0 3.5421350297326626e-09
manifestation O 0 9.401785661111717e-08
of O 0 3.572888829239673e-07
MLD B-Disease 1 1.0
, O 0 1.4441824403021997e-09
mimicking O 0 5.557541093992313e-09
the O 0 1.193942167354578e-09
frequent O 0 3.194094544411996e-09
ARSA O 0 1.1393155546102207e-05
pseudodeficiency O 0 3.202770358257112e-06
allele O 0 3.3917169162123173e-07
. O 0 6.152977505280433e-08

Our O 0 7.406493551798121e-08
results O 0 7.021059844625199e-10
demonstrate O 0 2.1325137836147867e-11
that O 0 1.544248778330426e-12
in O 0 3.4871673691011518e-12
certain O 0 2.9942154311513036e-10
genetic O 0 2.081175232149235e-08
conditions O 0 1.0752439720818074e-06
MLD B-Disease 1 1.0
- O 0 2.4991886675707065e-06
like O 0 1.6519590140262608e-09
ARSA O 0 4.1365028664586134e-06
and O 0 8.368863380070479e-10
GS O 0 8.52332086651586e-05
values O 0 6.553550063737035e-11
need O 0 6.239200996127625e-12
not O 0 6.961482714069878e-13
be O 0 6.799286611167132e-13
paralleled O 0 1.6399243074616265e-11
by O 0 2.715643031628301e-12
clinical O 0 1.408661631785435e-07
disease O 0 2.6093781357872103e-08
, O 0 9.037104831827181e-13
a O 0 2.8004699254013943e-11
finding O 0 5.334791289279828e-11
with O 0 5.712211302924541e-13
serious O 0 7.800541368396807e-08
diagnostic O 0 3.1627724439431404e-08
and O 0 3.35720201638523e-10
prognostic O 0 1.1835055374831427e-05
implications O 0 5.425355880106508e-07
. O 0 4.2907053909857495e-08

Moreover O 0 4.748816309074755e-07
, O 0 3.5606613213445826e-09
further O 0 3.45530857259746e-08
ARSA O 0 6.254405161598697e-05
alleles O 0 5.269990221989929e-09
functionally O 0 4.6110446016989215e-10
similar O 0 3.4683753265263295e-12
to O 0 5.298733118941357e-10
A464V O 0 2.4851468083397776e-07
might O 0 4.279462895162567e-10
exist O 0 6.800434521059273e-11
which O 0 3.928557999743898e-12
, O 0 4.0559704032883115e-12
together O 0 8.418833121956459e-13
with O 0 9.264568279210295e-13
0 O 0 5.0096664594434515e-09
- O 0 2.6271249620180015e-09
type O 0 1.9808362949902403e-08
mutations O 0 1.1724812232216664e-08
, O 0 6.724310691597069e-11
may O 0 2.626510031689122e-08
cause O 0 5.690167654393008e-06
pathological O 0 0.0034245650749653578
ARSA O 0 1.5825637092348188e-05
and O 0 1.4508009904545816e-08
GS O 1 0.999927282333374
levels O 0 9.467915340621857e-09
, O 0 5.659127138256392e-13
but O 0 2.0132415970864487e-13
not O 0 5.004424825927334e-12
clinical O 0 3.258669167838235e-10
outbreak O 0 2.931556664087509e-10
of O 0 4.4173102675681974e-11
the O 0 1.4930213732000652e-09
disease O 0 4.97840233038005e-07
. O 0 5.73863623287707e-10
. O 0 2.1576092024133686e-08

Human O 1 0.9102894067764282
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 1.39173198476783e-05
to O 0 4.927144914290693e-07
hematological B-Disease 1 0.9987668991088867
malignancy I-Disease 1 0.9989198446273804
and O 0 2.1881938483403474e-09
neurofibromatosis B-Disease 0 0.0022918873000890017
type I-Disease 0 1.8786506188916974e-05
1 I-Disease 0 0.019203174859285355
. O 0 7.190527639977518e-08

Heterozygous O 0 4.967745326212025e-08
germ O 0 9.098210398406081e-07
- O 0 1.0360439617329575e-08
line O 0 1.9045010901663773e-08
mutations O 0 3.036706996972782e-10
in O 0 1.5131193173423263e-11
the O 0 1.6738907482327647e-10
DNA O 0 7.791854272909404e-09
mismatch O 0 2.700836603253265e-06
repair O 0 1.9957853510277346e-05
genes O 0 1.1626338114467671e-08
lead O 0 1.5983813161923877e-09
to O 0 1.6566550797847412e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9970536231994629

The O 0 7.643553203706688e-07
disease O 0 9.251721166947391e-06
susceptibility O 0 1.2152992212577374e-07
of O 0 2.84901524594261e-09
individuals O 0 3.8330724705382124e-10
who O 0 9.401946954312734e-08
constitutionally O 0 4.821097263629781e-06
lack O 0 2.398129481662181e-07
both O 0 2.3028053075524468e-10
wild O 0 2.5305940676290106e-10
- O 0 4.8170824967774806e-11
type O 0 1.8962456604931788e-10
alleles O 0 8.427854941706059e-11
is O 0 2.129684623097816e-11
unknown O 0 3.86270260221977e-09
. O 0 2.3893158562771077e-09

We O 0 1.0647174697453465e-08
have O 0 2.8838934712505093e-11
identified O 0 2.424260965583347e-11
three O 0 1.367987645904678e-12
offspring O 0 8.887487100428526e-12
in O 0 4.01981697711537e-13
a O 0 1.4470583620251887e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999576807022095
who O 0 6.041278588497789e-09
developed O 0 7.80516717924229e-09
hematological B-Disease 0 4.561511013889685e-05
malignancy I-Disease 0 0.0033038444817066193
at O 0 1.5386158125352267e-08
a O 0 2.4242564553023094e-11
very O 0 1.4496971331712238e-12
early O 0 3.300530959648995e-09
age O 0 1.0705593078697007e-09
, O 0 1.2404789652073478e-12
and O 0 2.196918211586074e-12
at O 0 1.0547113876713254e-10
least O 0 3.5561508598958014e-11
two O 0 4.748770387336121e-12
of O 0 1.7582445915875766e-11
them O 0 6.99385048572726e-13
displayed O 0 4.429028671593116e-11
signs O 0 1.971371066389338e-09
of O 0 1.6657255574870078e-09
neurofibromatosis B-Disease 0 0.000563736364711076
type I-Disease 0 4.2070523704751395e-06
1 I-Disease 0 6.421780562959611e-05
( O 0 2.2214661221653387e-09
NF1 B-Disease 0 2.351248213017243e-06
) O 0 4.341493831105936e-10
. O 0 3.0655558092007595e-09

DNA O 0 9.2156806630328e-09
sequence O 0 1.2753297029544086e-10
analysis O 0 1.979046050301636e-12
and O 0 3.804920788164079e-13
allele O 0 2.4879202430855285e-12
- O 0 2.5927680141757392e-12
specific O 0 1.8737730551193765e-12
amplification O 0 1.7533719268159054e-11
in O 0 9.029597382304022e-12
two O 0 2.7308268493730914e-11
siblings O 0 1.3108713003973094e-09
revealed O 0 2.4277524435234454e-09
a O 0 7.353956554823071e-09
homozygous O 0 2.9061617112802196e-08
MLH1 O 0 9.853389201452956e-06
mutation O 0 3.2337020172690245e-08
( O 0 5.372224887167931e-11
C676T O 0 1.7996687518007093e-07
- O 0 4.980742929205917e-08
- O 0 1.3212242322424572e-07
> O 0 1.1092662788314556e-07
Arg226Stop O 0 3.12265370894238e-07
) O 0 9.255358285331639e-11
. O 0 1.846204078503888e-09

Thus O 0 5.059284546859999e-08
, O 0 6.616704961714959e-10
a O 0 3.3049154524178448e-09
homozygous O 0 2.9387576816475303e-09
germ O 0 1.1256687457716907e-06
- O 0 1.8622756670083618e-08
line O 0 1.3463963277615676e-08
MLH1 O 0 4.374219770397758e-06
mutation O 0 1.1083311157733533e-08
and O 0 3.050122099335084e-10
consequent O 0 8.658019214635715e-05
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 1.7327892010143842e-07
in O 0 8.022815189967503e-10
a O 0 1.5280308129916875e-09
mutator O 0 3.501601781863428e-07
phenotype O 0 4.089035776644323e-09
characterized O 0 2.068867473170588e-11
by O 0 9.00359387739913e-12
leukemia B-Disease 1 0.9268978238105774
and O 0 1.9382973448500707e-07
/ O 1 0.9999622106552124
or O 1 0.9999958276748657
lymphoma B-Disease 1 1.0
associated O 0 5.147872798261233e-06
with O 0 1.7538510921344397e-10
neurofibromatosis B-Disease 0 4.653772703022696e-05
type I-Disease 0 7.719446557530318e-07
1 I-Disease 0 8.177318704838399e-06
. O 0 1.0058374133592451e-09
. O 0 4.002404629943612e-09

Missense O 0 0.0002764133969321847
mutations O 0 1.4618891555073787e-06
in O 0 2.164376011748459e-09
the O 0 1.3611186622242144e-09
most O 0 3.1291830238089346e-11
ancient O 0 6.496565507774221e-10
residues O 0 4.828386224176029e-08
of O 0 1.7827719855922908e-10
the O 0 5.028254479455541e-10
PAX6 O 0 1.5546626173090772e-06
paired O 0 7.63860641406211e-10
domain O 0 4.881870907524899e-09
underlie O 0 3.7169789468549652e-09
a O 0 7.772164162256345e-11
spectrum O 0 5.859538418917509e-07
of O 0 1.5134078523715289e-07
human O 1 0.999997615814209
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.0002038370439549908

Mutations O 0 3.3037073876585055e-07
of O 0 4.879208592711848e-09
the O 0 8.338367218918563e-10
human O 0 1.2027258078362024e-09
PAX6 O 0 1.4651910532847978e-05
gene O 0 6.376410510711139e-08
underlie O 1 0.6790784001350403
aniridia B-Disease 1 1.0
( O 1 1.0
congenital B-Disease 1 1.0
absence I-Disease 1 0.9999997615814209
of I-Disease 0 0.029357606545090675
the I-Disease 0 3.373464778633206e-07
iris I-Disease 0 1.1160766177908954e-07
) O 0 1.122780948076274e-11
, O 0 1.363470642813669e-12
a O 0 1.1054123588705167e-10
rare O 0 1.94327558489249e-08
dominant O 1 0.9999942779541016
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.999948263168335
eye I-Disease 1 0.9999885559082031
. O 0 1.7928114175447263e-06

The O 0 4.862859626086902e-08
spectrum O 0 5.616708449451835e-07
of O 0 1.0488269452935128e-07
PAX6 O 0 0.0010687168687582016
mutations O 0 1.0568388688625419e-06
in O 0 2.175041657892507e-08
aniridia B-Disease 1 1.0
patients O 0 3.232817391563003e-07
is O 0 2.333702675549887e-11
highly O 0 1.7348385098273078e-12
biased O 0 3.085297642368978e-11
, O 0 2.785279602443569e-13
with O 0 1.2146536489295034e-13
92 O 0 1.5762712246569777e-09
% O 0 1.0196013477958843e-10
of O 0 8.497180042921215e-11
all O 0 7.384689387768262e-11
reported O 0 4.587799029565076e-09
mutations O 0 1.2444645314246827e-09
leading O 0 3.3120320375168433e-10
to O 0 9.80829528707261e-10
premature O 0 7.028891246818603e-08
truncation O 0 9.956570323765845e-08
of O 0 1.4174344187267707e-07
the O 0 1.42656597645896e-08
protein O 0 2.326784764861145e-09
( O 0 7.790430626986034e-12
nonsense O 0 6.856259449072866e-10
, O 0 7.871715432261617e-12
splicing O 0 3.1617345460505097e-12
, O 0 3.8296538791733614e-13
insertions O 0 2.199651918943779e-12
and O 0 2.5230921952418273e-12
deletions O 0 1.4215226218361465e-11
) O 0 1.7585891510379925e-12
and O 0 7.347860167539189e-12
just O 0 3.614195609458193e-09
2 O 0 2.1277227091331952e-08
% O 0 1.7827449239060655e-10
leading O 0 1.3963723406729134e-11
to O 0 1.6912710815164544e-11
substitution O 0 6.681392245022622e-11
of O 0 3.3641503471848466e-10
one O 0 1.8777211729936738e-10
amino O 0 2.2450073744462173e-10
acid O 0 5.987993521167079e-12
by O 0 1.0967377180037818e-12
another O 0 7.026994541803333e-10
( O 0 1.9034904763515215e-09
missense O 0 7.059618383209454e-07
) O 0 2.2486081885375597e-09
. O 0 1.3196547854477103e-08

The O 0 6.477082425959679e-09
extraordinary O 0 7.350320907484331e-10
conservation O 0 2.0713608606115486e-09
of O 0 6.555853637735254e-10
the O 0 1.8445182048409947e-09
PAX6 O 0 1.9975001919192437e-07
protein O 0 3.873386056341133e-09
at O 0 3.5216425331441314e-09
the O 0 7.568313753480993e-10
amino O 0 8.493332259718045e-09
acid O 0 1.8782209565415542e-08
level O 0 8.084913361017243e-08
amongst O 0 2.74191919169553e-10
vertebrates O 0 1.2879545430166672e-08
predicts O 0 8.965002962213475e-08
that O 0 2.5739395059787284e-09
pathological O 0 0.0003673930186778307
missense O 0 1.0116271369042806e-05
mutations O 0 2.9170641369091754e-07
should O 0 4.5829606776237597e-10
in O 0 4.628798039307824e-11
fact O 0 1.5308357012577822e-11
be O 0 3.45765673037679e-11
common O 0 1.4603498965648498e-10
even O 0 1.0338454051184165e-11
though O 0 1.833249697880124e-12
they O 0 1.100954613933447e-12
are O 0 2.566257482124884e-13
hardly O 0 2.250550995563927e-10
ever O 0 1.5946441389580457e-10
seen O 0 2.717873981428198e-10
in O 0 1.0171175013340417e-09
aniridia B-Disease 1 1.0
patients O 0 5.298663268149539e-07
. O 0 1.0057500077209625e-07

This O 0 6.56412746380397e-09
indicates O 0 4.646174556199867e-09
that O 0 3.1677163062765468e-12
there O 0 1.125353174362409e-12
is O 0 4.523732733893726e-13
a O 0 2.7699452107010636e-11
heavy O 0 2.697333201240326e-08
ascertainment O 0 7.857988748583011e-08
bias O 0 4.262854069736477e-09
in O 0 1.2165329507651812e-11
the O 0 2.1413626080657444e-11
selection O 0 1.319426165546922e-11
of O 0 3.713927776427539e-11
patients O 0 1.2642077489022352e-11
for O 0 2.7974320776502637e-11
PAX6 O 0 1.0749593570835714e-07
mutation O 0 1.796226778427723e-10
analysis O 0 2.5732237521336465e-12
and O 0 6.139434121678333e-13
that O 0 3.870233994396344e-12
the O 0 6.116161466174219e-10
missing O 0 6.349250725179445e-08
PAX6 O 0 0.00015927675121929497
missense O 0 1.2786425941158086e-05
mutations O 0 5.274689556244994e-07
frequently O 0 3.3469721438805777e-10
may O 0 5.529468882770061e-09
underlie O 0 6.88424250938624e-08
phenotypes O 0 7.3681931667124445e-09
distinct O 0 3.332815620704643e-11
from O 0 1.6274577518959887e-10
textbook O 0 2.1000525407544046e-07
aniridia B-Disease 1 1.0
. O 0 1.6787338097401516e-07

Here O 0 3.073303034284436e-08
we O 0 2.8389024464559043e-10
present O 0 3.955597308036296e-11
four O 0 1.0813610423765496e-11
novel O 0 9.85295955935328e-10
PAX6 O 0 2.5763531539269025e-06
missense O 0 7.818369454071217e-07
mutations O 0 8.013998353817442e-08
, O 0 6.997379758955091e-11
two O 0 1.373808792420883e-11
in O 0 4.0476257762156465e-11
association O 0 2.2680064423741264e-11
with O 0 1.3320644066949772e-11
atypical O 0 3.8167135585354117e-07
phenotypes O 0 9.198158323897587e-08
ectopia B-Disease 0 6.332632551675488e-07
pupillae I-Disease 0 4.4794830955652287e-07
( O 0 1.6887826206901657e-11
displaced B-Disease 0 7.668239931923893e-10
pupils I-Disease 0 1.5834844546702698e-10
) O 0 3.817522339910617e-11
and O 0 8.582593125083804e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.6549429297447205
( O 0 8.317114774669676e-10
searching B-Disease 0 2.1495745627930773e-08
gaze I-Disease 0 1.8254201705758533e-08
) O 0 7.778963562708741e-13
, O 0 4.835322680446508e-13
and O 0 8.591825710092815e-13
two O 0 3.1256741986340764e-12
in O 0 2.1090162602432905e-11
association O 0 2.3010874455886565e-11
with O 0 3.0048305423718835e-12
more O 0 4.9175934158096624e-11
recognizable O 0 6.075194391996774e-08
aniridia B-Disease 1 1.0
phenotypes O 0 2.647787368914578e-06
. O 0 1.1614395134529332e-07

Strikingly O 0 3.648100062036974e-07
, O 0 1.5608904169184257e-09
all O 0 2.425303013975366e-10
four O 0 5.219417606450172e-11
mutations O 0 8.121314731823759e-11
are O 0 6.21701908704031e-13
located O 0 2.5309645004800707e-11
within O 0 4.2839709557540573e-10
the O 0 1.1248098008564966e-09
PAX6 O 0 4.238744111262349e-07
paired O 0 3.6543146286760475e-10
domain O 0 6.6748908622571435e-09
and O 0 5.685567572299988e-10
affect O 0 1.6792006007904092e-08
amino O 0 1.0345649670284729e-08
acids O 0 2.867883153179207e-10
which O 0 2.5373576937465225e-12
are O 0 6.793064374899238e-13
highly O 0 8.56290559292372e-12
conserved O 0 3.433734546698375e-11
in O 0 7.256744684325245e-12
all O 0 1.1601155799900731e-11
known O 0 1.0310299142224366e-10
paired O 0 1.661225601523597e-10
domain O 0 6.754499182193285e-09
proteins O 0 6.723618189985459e-11
. O 0 2.1576564146474908e-10

Our O 0 1.997396559261233e-08
results O 0 1.2062378873523016e-10
support O 0 4.1422535540514005e-11
the O 0 2.173169283414822e-10
hypothesis O 0 7.318742833994918e-11
that O 0 5.154362518939616e-14
the O 0 2.716511911249331e-13
under O 0 3.863360586303655e-12
- O 0 1.2485263690964477e-11
representation O 0 5.860820856407045e-11
of O 0 2.139265292688819e-10
missense O 0 9.388110129293636e-07
mutations O 0 1.555548010401253e-07
is O 0 3.334341830418808e-11
caused O 0 3.076337795615558e-10
by O 0 2.308917466942173e-11
ascertainment O 0 6.860385610707453e-07
bias O 0 6.466271429417247e-08
and O 0 2.6460561172725328e-11
suggest O 0 2.2645612815508365e-11
that O 0 1.2621032149072453e-13
a O 0 1.3850584091104623e-12
substantial O 0 5.94154517252754e-11
burden O 0 1.6367392774441214e-08
of O 0 2.0316198501291183e-08
PAX6 B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999997615814209
related I-Disease 1 1.0
disease I-Disease 1 1.0
remains O 0 1.0920308213258068e-08
to O 0 4.2805811673041205e-10
be O 0 2.142229588164568e-10
uncovered O 0 6.090519200085964e-09
. O 0 8.350697217052172e-11
. O 0 1.9269388307208146e-09

The O 0 2.045348601598107e-08
chromosomal O 0 1.0678880926207057e-06
order O 0 7.385009581639679e-08
of O 0 1.8864251671857346e-07
genes O 0 2.2853795300648017e-08
controlling O 0 6.240878747121315e-07
the O 0 4.087922178541703e-08
major O 0 1.4181699725668295e-07
histocompatibility O 0 1.4568926189895137e-06
complex O 0 7.005335334042684e-08
, O 0 1.694028251009172e-11
properdin O 0 1.8663852685563143e-09
factor O 0 4.006907305953433e-11
B O 0 1.3925836039874184e-09
, O 0 5.437038623143375e-13
and O 0 2.371325705241567e-11
deficiency B-Disease 0 6.12482864426056e-08
of I-Disease 0 1.2516666458850523e-07
the I-Disease 0 3.138823601034346e-08
second I-Disease 0 1.4199800446590416e-08
component I-Disease 0 3.9563768927664e-10
of I-Disease 0 1.1009563261055177e-09
complement I-Disease 0 1.298154361784043e-09
. O 0 1.168057117695298e-08

The O 0 2.001904952919631e-08
relationship O 0 6.918226436170016e-09
of O 0 1.2746355082526861e-08
the O 0 1.0683542939204926e-09
genes O 0 1.1425936585762742e-11
coding O 0 4.959207350330175e-11
for O 0 1.7450842854094262e-11
HLA O 0 1.6981481776312535e-09
to O 0 5.7521230834023385e-11
those O 0 1.8298925742732397e-12
coding O 0 1.4155431167506283e-11
for O 0 1.480016413243912e-12
properdin O 0 1.3483463234820192e-09
Factor O 0 2.4191339903500975e-11
B O 0 1.6315293560609234e-10
allotypes O 0 3.3799077425733515e-10
and O 0 1.7564906777331468e-12
for O 0 1.294721552191902e-10
deficiency B-Disease 0 1.2083867773071688e-07
of I-Disease 0 1.995035958657354e-08
the I-Disease 0 2.9927780254013214e-09
second I-Disease 0 1.925942960667726e-09
component I-Disease 0 2.395059151005796e-10
of I-Disease 0 1.9963625197405577e-10
complement I-Disease 0 4.3992580411877924e-11
( O 0 5.538847158703675e-11
C2 O 0 1.790290937719874e-08
) O 0 2.3171705439833934e-12
was O 0 3.008622864730803e-11
studied O 0 1.8130151243148096e-12
in O 0 3.1022474628224217e-13
families O 0 1.528576635927148e-12
of O 0 3.4683571986660056e-11
patients O 0 1.8789141076336335e-10
with O 0 3.4451902442000915e-10
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 3.317769733257592e-05

Patients O 0 2.352446017539478e-06
were O 0 1.285754613888912e-09
selected O 0 2.1099136326974133e-11
because O 0 4.255276252890239e-12
they O 0 1.5726832813464653e-12
were O 0 1.183578517312267e-12
heterozygous O 0 2.3614623711337712e-12
or O 0 5.779738146416413e-11
homozygous O 0 1.8687720260146534e-09
for O 0 1.2801251614291687e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.5359672033810057e-05

12 O 0 4.5980775098541926e-07
families O 0 2.929130826778703e-10
with O 0 1.5265932615249334e-11
15 O 0 4.6679929255333263e-08
matings O 0 7.600318099321157e-07
informative O 0 1.22274187219773e-07
for O 0 6.477486067524296e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.357093530416023e-08
found O 0 1.1924492504533646e-09
. O 0 1.4469478948342385e-09

Of O 0 1.646381861064583e-06
57 O 0 2.5895613475768187e-07
informative O 0 2.739380056127061e-09
meioses O 0 2.4685246557965e-07
, O 0 4.7670586228454326e-11
two O 0 4.652783366920765e-12
crossovers O 0 3.9073518726118195e-11
were O 0 2.2766006094188107e-11
noted O 0 1.3505713040984357e-11
between O 0 1.010598826844955e-09
the O 0 4.944613465340808e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999947547912598
gene O 0 2.3179012528795617e-11
and O 0 1.8147526884004783e-11
the O 0 2.275616362013011e-10
HLA O 0 1.5253635021750256e-09
- O 0 3.2514442249720332e-09
B O 0 2.5829852035030854e-08
gene O 0 4.3921271242371163e-13
, O 0 3.7166857048617774e-14
with O 0 8.541198178140929e-15
a O 0 2.67593985164849e-11
recombinant O 0 1.569207437601694e-12
fraction O 0 2.3938442894611e-10
of O 0 7.669688217859516e-10
0 O 0 2.7951911008017305e-08
. O 0 1.232157487152108e-08

035 O 0 0.004146113526076078
. O 0 3.948814992327243e-06

A O 0 1.1135574595755315e-06
lod O 0 5.704158411390381e-06
score O 0 4.1967651576158005e-09
of O 0 1.0142538198198991e-10
13 O 0 1.258256970837479e-10
was O 0 1.3967985622309609e-11
calculated O 0 4.64757954343753e-11
for O 0 4.9241140678835116e-12
linkage O 0 1.536169378368868e-07
between O 0 0.1618107110261917
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 5.034427541517061e-09
HLA O 0 4.0101224563215965e-09
- O 0 3.9280523278506507e-10
B O 0 4.793155317095454e-10
at O 0 2.872789625543021e-13
a O 0 1.9316623631583998e-14
maximum O 0 1.2286113966475387e-12
likelihood O 0 2.1522451789518504e-12
value O 0 2.04808500887943e-12
of O 0 8.390191319485041e-12
the O 0 2.4273841617294956e-11
recombinant O 0 1.5162820001315969e-12
fraction O 0 1.1350591994085946e-10
of O 0 1.8038556759414348e-10
0 O 0 1.6900806087960518e-08
. O 0 5.617991405415523e-09

04 O 0 0.0010069550480693579
. O 0 5.2462919484241866e-06

18 O 0 1.8010867961493204e-06
families O 0 3.5043867807615925e-10
with O 0 2.4757937019947995e-11
21 O 0 2.404417287493743e-08
informative O 0 2.9818367219824893e-10
matings O 0 2.072025750976536e-08
for O 0 6.44228143054093e-11
both O 0 2.3421273254164987e-10
properdin O 0 4.027951661100815e-07
Factor O 0 1.7589507628201773e-09
B O 0 4.658260444045936e-09
allotype O 0 4.276519582901983e-09
and O 0 6.220821080482608e-11
HLA O 0 1.686891404339974e-09
- O 0 1.8165381421297866e-09
B O 0 1.9877850476746062e-08
were O 0 5.386650500649459e-11
found O 0 5.007416356561656e-11
. O 0 3.720544705654305e-10

Of O 0 5.500876795849763e-06
72 O 0 1.9432332010183018e-06
informative O 0 1.1228383556272092e-08
meioses O 0 1.3836679499945603e-06
, O 0 3.0765373582042344e-10
three O 0 2.480824434769602e-10
recombinants O 0 1.1128881283184455e-07
were O 0 1.1390676180056403e-09
found O 0 3.031844220124924e-11
, O 0 1.279323977483593e-12
giving O 0 1.2723059368210943e-12
a O 0 6.183924206037972e-11
recombinant O 0 1.9380535370983054e-11
fraction O 0 2.1070682976187527e-09
of O 0 6.116631201535938e-09
0 O 0 1.55197696471987e-07
. O 0 3.976352758172652e-08

042 O 0 0.0035430369898676872
. O 0 7.240475497383159e-06

A O 0 7.877645202825079e-07
lod O 0 3.173097411490744e-06
score O 0 1.5931400643154348e-09
of O 0 3.2344449341081827e-10
16 O 0 5.503130728889971e-10
between O 0 2.361014439511422e-10
HLA O 0 2.57674925840945e-09
- O 0 1.2892933387576022e-09
B O 0 3.544933013799323e-09
and O 0 3.5036413874312e-12
Factor O 0 1.2143583881518705e-11
B O 0 5.780215195372307e-10
allotypes O 0 7.354303277473662e-10
was O 0 4.280522117316998e-11
calculated O 0 8.860917555253423e-11
at O 0 5.878618772325872e-12
a O 0 1.1964434434505455e-12
maximum O 0 4.7456039098392466e-11
likelihood O 0 2.342733645965822e-11
value O 0 1.9028096806539274e-11
of O 0 4.916777748831258e-11
the O 0 5.237647468514517e-11
recombinant O 0 5.141897324589806e-12
fraction O 0 1.8914234067857194e-10
of O 0 2.7013410952569927e-10
0 O 0 2.5192694153020057e-08
. O 0 6.645317629505598e-09

04 O 0 0.0006691096350550652
. O 0 2.6464697384653846e-06

A O 0 1.6891756615677878e-07
crossover O 0 5.769665634147714e-09
was O 0 3.1470588357507268e-09
shown O 0 6.10834429912166e-12
to O 0 4.596658817468402e-11
have O 0 2.3821728010325893e-12
occurred O 0 3.0402305672971863e-10
between O 0 2.410208317649154e-11
genes O 0 6.165085802978254e-13
for O 0 2.8256523097909547e-13
Factor O 0 3.0383607955986047e-12
B O 0 1.0019881452327795e-10
and O 0 4.146361639451035e-12
HLA O 0 2.8345485958425343e-09
- O 0 3.1882878559486016e-09
D O 0 8.814330376694102e-10
, O 0 2.895681741263423e-12
in O 0 4.0822965667597355e-12
which O 0 2.566211305954358e-11
HLA O 0 1.5113209572703568e-09
- O 0 6.439275224146002e-10
D O 0 1.356054435408538e-10
segregared O 0 1.3957639488637597e-09
with O 0 1.7136201312106802e-12
HLA O 0 1.1766901897303228e-09
- O 0 1.2549063177491604e-10
A O 0 2.576493463024576e-09
and O 0 9.453704485906655e-11
B O 0 6.821593956374272e-08
. O 0 5.622083354417384e-10

These O 0 3.927687064475549e-09
studies O 0 4.914033069347568e-10
suggest O 0 8.31384336374974e-11
that O 0 1.325873764078389e-12
the O 0 7.890309065838874e-12
genes O 0 2.729417982860055e-13
for O 0 1.5019726456490246e-13
Factor O 0 3.2688705908778815e-11
B O 0 2.3559432804631797e-07
and O 0 2.126382554479278e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.9712636037394482e-11
located O 0 1.018531786689536e-11
outside O 0 1.0306598456633065e-11
those O 0 2.4072565230244536e-13
for O 0 4.601244298768625e-12
HLA O 0 1.7638893679006173e-09
, O 0 4.59817134455115e-13
that O 0 5.95286827101936e-14
the O 0 5.023587882485581e-13
order O 0 5.027980636007623e-12
of O 0 1.1845185422798554e-11
genese O 0 9.572469927832117e-09
is O 0 3.391730646340463e-11
HLA O 0 1.3557268641051223e-09
- O 0 3.241782120522174e-10
A O 0 1.4702254524934233e-08
, O 0 9.27449176485462e-12
- O 0 1.4584598806433036e-10
B O 0 1.921935721682644e-09
, O 0 1.318612970549471e-12
- O 0 7.393737011529566e-11
D O 0 7.45243797228845e-11
, O 0 3.6537396372327e-12
Factor O 0 6.841415628455749e-11
B O 0 5.332670749425006e-09
allotype O 0 4.1437144204792276e-07
, O 0 1.416480301941192e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 4.2663150789934434e-11
that O 0 4.279940117590808e-12
the O 0 6.244668671051556e-11
genes O 0 1.5845108211620662e-11
coding O 0 2.271017152111199e-09
for O 0 1.4583251051192292e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.402024078586919e-09
Factor O 0 1.3954764011003817e-09
B O 0 3.6795162472458287e-09
allotypes O 0 1.4158362260374702e-09
are O 0 8.06732881452471e-14
approximately O 0 1.1068500716665541e-12
3 O 0 3.1260573990499196e-11
- O 0 2.4160444478393828e-11
- O 0 1.9365986592134732e-10
5 O 0 4.164142919371727e-10
centimorgans O 0 3.158555084148418e-10
from O 0 1.2134692556342586e-11
the O 0 7.331523409204177e-12
HLA O 0 1.4721817515050972e-11
- O 0 4.133853849508373e-12
A O 0 1.517573844367348e-10
and O 0 4.931360875204405e-12
HLA O 0 4.794085267656456e-11
- O 0 4.009055240561388e-11
B O 0 4.851885559986613e-10
loci O 0 6.389071997153772e-12
, O 0 2.5874938856026292e-14
and O 0 2.8760011001405586e-14
that O 0 1.4402595869406065e-13
the O 0 1.0286526838654275e-11
apparent O 0 3.4247902291895116e-09
lack O 0 5.746259024164146e-10
of O 0 4.863937377863614e-11
recombinants O 0 3.2950209227777805e-09
between O 0 3.510521595639915e-10
the O 0 6.847529765430238e-10
Factor O 0 3.2611938149962327e-10
B O 0 2.1083478074501727e-08
gene O 0 1.6934517121924841e-09
and O 0 3.819888547695882e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 2.7574076355563193e-09
suggests O 0 1.2292548923209523e-10
that O 0 1.0130868583271835e-12
these O 0 1.518910214617919e-12
two O 0 2.1770847277724492e-11
genes O 0 1.2140209670885582e-10
lie O 0 3.3228411133734426e-09
in O 0 1.5832873206944598e-11
close O 0 2.675478283364896e-09
proximity O 0 3.6058642738368007e-09
to O 0 2.1295527563580663e-09
one O 0 5.515951584378342e-10
another O 0 3.3879776761835956e-09
. O 0 2.2812900013491344e-08

Distribution O 0 4.0553288727096515e-08
of O 0 8.99845620239148e-09
emerin O 0 4.61840409116121e-06
and O 0 8.426625619506467e-09
lamins O 0 6.627796210523229e-06
in O 0 1.2963136120092145e-09
the O 0 1.407494787386554e-09
heart O 0 2.231224316417979e-09
and O 0 4.723873202328033e-12
implications O 0 6.318824352646857e-10
for O 0 4.8340918074041284e-11
Emery B-Disease 0 0.096674345433712
- I-Disease 1 0.9999841451644897
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 7.914716843515635e-05

Emerin O 0 0.0006734244525432587
is O 0 3.132621628765264e-08
a O 0 2.2450052483691252e-08
nuclear O 0 2.8608169486687984e-06
membrane O 0 2.7149960502015347e-08
protein O 0 1.007354200055488e-09
which O 0 1.5006732835554093e-12
is O 0 8.276878314672498e-12
missing O 0 1.723609865944553e-10
or O 0 1.1837016089533137e-10
defective O 0 1.741100597030254e-08
in O 0 3.1659194710265126e-10
Emery B-Disease 0 0.10733464360237122
- I-Disease 1 0.9999946355819702
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.609638360378085e-07
EDMD B-Disease 1 1.0
) O 0 6.708278821321301e-09
. O 0 2.410492427884492e-08

It O 0 2.9355726183233344e-11
is O 0 2.631830517407785e-12
one O 0 3.486768382701677e-12
member O 0 1.727486209635032e-11
of O 0 3.1258367422237754e-11
a O 0 2.9696578529581075e-09
family O 0 7.83747911015098e-09
of O 0 5.253393453585886e-08
lamina O 1 0.9996310472488403
- O 0 0.00019455011351965368
associated O 0 1.4429626560286124e-07
proteins O 0 1.992979219156421e-11
which O 0 4.5060960171539044e-13
includes O 0 1.0762466357569847e-13
LAP1 O 0 1.3640374163514934e-06
, O 0 1.0273042139186117e-10
LAP2 O 0 1.7032720279530622e-05
and O 0 5.5545101851350864e-09
lamin O 0 6.616965038119815e-06
B O 0 2.3981256163096987e-06
receptor O 0 8.107441544780158e-07
( O 0 2.885601979585317e-09
LBR O 0 1.234976025443757e-06
) O 0 2.2009005729017872e-10
. O 0 3.3145299838110986e-09

A O 0 1.1393785825930536e-05
panel O 0 3.7097356653248426e-07
of O 0 3.2486003220810744e-08
16 O 0 2.0379614440457772e-08
monoclonal O 0 7.159797754674457e-10
antibodies O 0 7.767588794393987e-10
( O 0 1.255940768052355e-10
mAbs O 0 1.34901316783953e-08
) O 0 1.8631185136341877e-11
has O 0 9.758797936409991e-12
been O 0 1.3508933555117508e-11
mapped O 0 1.1130159988104182e-10
to O 0 1.610391542339329e-10
six O 0 4.7301960959256206e-11
specific O 0 1.4787473329169742e-11
sites O 0 6.281138109631712e-11
throughout O 0 1.461806717339975e-11
the O 0 2.413448052518419e-10
emerin O 0 2.1240046166326465e-08
molecule O 0 6.858505430251682e-11
using O 0 2.0681061030369818e-11
phage O 0 3.189427888461438e-11
- O 0 1.5814976064842945e-11
displayed O 0 1.8067599283008717e-12
peptide O 0 3.755585425979646e-11
libraries O 0 1.5559544971899264e-11
and O 0 1.4788574878576988e-11
has O 0 6.676968439950359e-12
been O 0 2.7714130903383483e-12
used O 0 1.0107090945427055e-12
to O 0 8.204987383964024e-11
localize O 0 7.804991497550873e-08
emerin O 0 6.026963887961756e-07
in O 0 3.7075598147140454e-10
human O 0 1.0574170428157004e-09
and O 0 7.312551120186583e-10
rabbit O 0 1.8511472887894342e-07
heart O 0 9.834968750510598e-07
. O 0 2.868795263566426e-07

Several O 0 3.01607379071811e-08
mAbs O 0 1.7260271079067024e-07
against O 0 1.2138317018184352e-09
different O 0 5.975320932494199e-11
emerin O 0 7.996622031214429e-08
epitopes O 0 2.008509980555573e-08
did O 0 1.3147726241058422e-09
not O 0 1.7653795092442692e-10
recognize O 0 5.94397364661603e-10
intercalated O 0 2.664661380435973e-09
discs O 0 2.6496206118054033e-08
in O 0 1.629322343710271e-09
the O 0 1.0747437606539734e-08
heart O 0 3.854094643429562e-08
, O 0 2.966586698516238e-11
though O 0 3.4953314114599676e-12
they O 0 3.056915614738087e-12
recognized O 0 5.493435133868685e-12
cardiomyocyte O 0 5.177204442929906e-09
nuclei O 0 2.090253481412674e-08
strongly O 0 3.3447149494492123e-09
, O 0 5.929940566362646e-11
both O 0 4.4252875669448244e-11
at O 0 1.0841196385058538e-08
the O 0 2.6199681313343604e-10
rim O 0 8.584270516642789e-10
and O 0 7.118666333488788e-12
in O 0 6.270998997859323e-11
intranuclear O 0 9.406269896317099e-08
spots O 0 8.428474806976283e-09
or O 0 4.2703249825137846e-09
channels O 0 1.1810872280193507e-07
. O 0 2.7312216488439844e-08

A O 0 4.751661435875576e-06
polyclonal O 0 1.6947892618190963e-06
rabbit O 0 2.3727634967940503e-08
antiserum O 0 2.7069607000385076e-08
against O 0 8.229837256124028e-09
emerin O 0 5.003901151212631e-07
did O 0 1.9121628724860784e-08
recognize O 0 2.4034394474625742e-09
both O 0 7.055291351143467e-10
nuclear O 0 7.345043400164286e-07
membrane O 0 2.6290598587053182e-09
and O 0 5.2208414674792536e-11
intercalated O 0 8.057253475524107e-11
discs O 0 4.2162590085936813e-10
but O 0 2.766365435336038e-11
, O 0 3.772958508119206e-12
after O 0 3.2653560411155524e-11
affinity O 0 8.78639088569555e-12
purification O 0 3.43569812356892e-12
against O 0 5.818282054065316e-12
a O 0 3.80865686211429e-11
pure O 0 1.9486630364884405e-10
- O 0 7.72757247080591e-10
emerin O 0 1.9922980598607865e-08
band O 0 1.5373029238485714e-10
on O 0 4.2514192166720477e-10
a O 0 7.59845242281898e-11
western O 0 1.980612340801713e-09
blot O 0 6.792820954615308e-07
, O 0 3.7800918645247705e-11
it O 0 2.2438921380707466e-12
stained O 0 9.217258067906187e-10
only O 0 5.662990631982723e-10
the O 0 9.252009713911491e-10
nuclear O 0 1.7789527646527858e-06
membrane O 0 3.0141134743644216e-07
. O 0 3.043331986418707e-08

These O 0 3.3451743597368022e-09
results O 0 3.6501071609684743e-10
would O 0 4.0659742239768093e-10
not O 0 7.523721229363289e-11
be O 0 5.334506100740377e-11
expected O 0 2.6235595917967203e-09
if O 0 1.2988181641304664e-09
immunostaining O 0 2.6378924644632207e-07
at O 0 5.656271184761863e-08
intercalated O 0 3.914755630773925e-09
discs O 0 2.0607064499245098e-08
were O 0 7.95980392709339e-10
due O 0 7.552814373923411e-09
to O 0 2.0090942798312028e-10
a O 0 1.64109531519685e-10
product O 0 1.823483447571661e-10
of O 0 2.664949649844317e-10
the O 0 7.965544335242214e-10
emerin O 0 2.287647902221579e-07
gene O 0 7.434152599072874e-11
and O 0 2.3965477172205318e-11
, O 0 1.59834315921481e-11
therefore O 0 3.2625996349011643e-10
, O 0 3.8988649114779506e-11
cast O 0 9.022456393115164e-11
some O 0 1.4834841254723896e-12
doubt O 0 9.908058401508768e-11
upon O 0 2.2408522953876187e-11
the O 0 1.4396953247619582e-11
hypothesis O 0 1.2902036106154924e-09
that O 0 9.843336562509464e-11
cardiac B-Disease 0 0.3268286883831024
defects I-Disease 0 0.002191547304391861
in O 0 2.70089373088922e-07
EDMD B-Disease 1 1.0
are O 0 3.6427785232717724e-09
caused O 0 5.469566488613964e-08
by O 0 2.4112670193865426e-10
absence O 0 5.912601963586894e-08
of O 0 1.1516206654960115e-08
emerin O 0 8.526437795808306e-07
from O 0 6.692804532804075e-08
intercalated O 0 1.4634916567501932e-07
discs O 0 1.655046503401536e-06
. O 0 1.4455865482432273e-07

Although O 0 2.4681781951585435e-08
emerin O 0 9.16322005650727e-06
was O 0 2.562154008955986e-07
abundant O 0 8.692784825292676e-10
in O 0 4.5886964367136684e-11
the O 0 2.9977353932508777e-10
membranes O 0 5.559255833453847e-10
of O 0 1.075616817836078e-09
cardiomyocyte O 0 7.251528444385258e-08
nuclei O 0 8.871601409055074e-08
, O 0 6.695361626229968e-11
it O 0 3.005640528130904e-11
was O 0 6.359877513517631e-09
absent O 0 7.948364744159164e-10
from O 0 2.331406942501779e-11
many O 0 3.873106696472561e-12
non O 0 4.730002167718794e-09
- O 0 8.961512421024054e-09
myocyte O 0 3.745119059317403e-08
cells O 0 1.202885707707324e-10
in O 0 2.0103196884946328e-11
the O 0 3.462291287004149e-10
heart O 0 1.138234750897027e-07
. O 0 7.024227244301073e-08

This O 0 7.550939318257122e-10
distribution O 0 1.128488746893197e-09
of O 0 7.170484761509499e-10
emerin O 0 3.80583088599451e-07
was O 0 2.2213983985608365e-09
similar O 0 3.3957355156932767e-12
to O 0 1.0858879767594587e-10
that O 0 8.676377324934315e-12
of O 0 3.7596009638818373e-10
lamin O 0 4.3782708303297113e-07
A O 0 2.036131441229827e-08
, O 0 1.1748432955649424e-11
a O 0 4.1814676721152466e-11
candidate O 0 1.8243113963922752e-10
gene O 0 2.8428539904090666e-13
for O 0 4.735128847181691e-13
an O 0 7.03320951825348e-12
autosomal O 0 1.843467423157108e-08
form O 0 2.433651502542489e-07
of O 1 0.9943988919258118
EDMD B-Disease 1 1.0
. O 0 0.0002257421874674037

In O 0 2.3176307095695847e-08
contrast O 0 2.9101167697831443e-08
, O 0 4.425117339224016e-08
lamin O 0 0.00014522003766614944
B1 O 0 1.8992985133081675e-05
was O 0 1.544598688951737e-07
absent O 0 5.379820677831049e-08
from O 0 2.865008896790755e-09
cardiomyocyte O 0 8.839186307341151e-07
nuclei O 0 5.130299314259901e-07
, O 0 5.349670706422671e-10
showing O 0 1.0495565527790518e-09
that O 0 2.4371056284167025e-09
lamin O 0 5.812331437482499e-06
B1 O 0 2.438274577798438e-07
is O 0 1.6431616484124945e-11
not O 0 5.416549500592005e-11
essential O 0 7.97773444527472e-11
for O 0 1.697793294841432e-11
localization O 0 4.338700065886769e-08
of O 0 5.691982440936272e-09
emerin O 0 1.7315171874088264e-07
to O 0 1.8413800262351288e-08
the O 0 7.749716424143571e-09
nuclear O 0 2.040205981757026e-05
lamina O 1 0.9996975660324097
. O 0 6.261983571675955e-07

Lamin O 1 0.7091391086578369
B1 O 0 0.00045327297993935645
is O 0 3.634011702668971e-10
also O 0 1.6838102093186258e-11
almost O 0 3.2893679446921453e-10
completely O 0 8.770799198032364e-09
absent O 0 2.2302979019173108e-08
from O 0 8.04856803426901e-09
skeletal O 0 2.3101328849861602e-07
muscle O 0 1.5193457159057289e-07
nuclei O 0 7.674166408833116e-05
. O 0 1.2547325241030194e-06

In O 0 3.392564451587532e-07
EDMD B-Disease 1 1.0
, O 0 1.7964333354214546e-09
the O 0 2.843791035989085e-10
additional O 0 8.672973450529753e-11
absence O 0 5.42056488583853e-09
of O 0 1.553030415379908e-08
lamin O 0 2.3081400286173448e-05
B1 O 0 5.082854386273539e-06
from O 0 4.8179352063471015e-08
heart O 0 0.0002275452861795202
and O 0 1.775614180132834e-07
skeletal O 0 1.1635804185061716e-05
muscle O 0 2.1211276362009812e-06
nuclei O 0 0.08711158484220505
which O 0 4.005744642654463e-07
already O 0 2.103439555867226e-08
lack O 0 3.1451282467287456e-08
emerin O 0 2.3144234972960476e-08
may O 0 5.147279824591067e-10
offer O 0 2.185747242922087e-11
an O 0 2.561529981182087e-12
alternative O 0 4.455296409577869e-10
explanation O 0 5.387116308597228e-10
of O 0 1.5819870413658066e-10
why O 0 1.165296747984712e-10
these O 0 1.2405268652593282e-11
tissues O 0 4.3957543160999535e-10
are O 0 5.725346845925072e-12
particularly O 0 2.5760388613904617e-11
affected O 0 4.4291489920134097e-10
. O 0 1.086159828744826e-09
. O 0 2.5527803870772914e-08

Genetic O 0 1.5928452512525837e-06
mapping O 0 1.424706539410181e-07
of O 0 1.7494934922979155e-07
the O 0 3.6613371889870905e-08
copper B-Disease 0 2.5757438493201334e-07
toxicosis I-Disease 0 1.917337067425251e-05
locus O 0 1.512074199183644e-08
in O 0 2.4799078346404713e-09
Bedlington O 0 1.2944863669872575e-07
terriers O 0 6.7035719197861e-09
to O 0 3.0840709985824333e-09
dog O 0 8.094708014994012e-09
chromosome O 0 5.458769436472721e-08
10 O 0 1.753504896839786e-08
, O 0 2.362160597332852e-12
in O 0 6.067609522458772e-12
a O 0 4.307149359394913e-10
region O 0 9.8956071781231e-08
syntenic O 0 1.1251084970353986e-06
to O 0 1.3427086109629727e-08
human O 0 5.766354504999072e-09
chromosome O 0 4.676905973610701e-06
region O 0 2.5864712824841263e-06
2p13 O 0 3.828025728580542e-05
- O 0 1.1916174571524607e-06
p16 O 0 2.840016577465576e-07
. O 0 1.5713011336515592e-08

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 0 0.0004436724411789328
accumulation I-Disease 0 1.5185957636276726e-05
is O 0 4.4083795641691736e-11
recognized O 0 4.841507837000103e-12
as O 0 9.487858415591077e-12
an O 0 2.8251405659318607e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 1.4330943258755724e-06
man O 0 3.3928083666978637e-06
, O 0 1.3006049015551469e-10
mouse O 0 3.995556951963408e-08
, O 0 1.3888070249379325e-08
rat O 0 6.953536626497225e-07
and O 0 7.268640800361936e-09
dog O 0 2.7186808893020498e-06
. O 0 1.9174044041392335e-07

The O 0 7.483143349418242e-08
major O 0 5.099174131828477e-07
cause O 1 0.8499345779418945
of O 1 0.9528321027755737
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 1.0
in O 0 1.145276655734051e-05
man O 0 5.377058641897747e-06
is O 0 8.766642273227987e-11
a O 0 7.700837745261424e-10
dysfunctional O 0 1.6225259003022074e-07
ATP7B O 0 0.0005295186419971287
gene O 0 8.45336423083154e-09
, O 0 4.75089523277461e-10
causing O 0 4.919862112728879e-05
Wilson B-Disease 0 0.0002908865571953356
disease I-Disease 1 0.9987590312957764
( O 0 1.0204910250166677e-09
WD B-Disease 0 5.5723248806316406e-06
) O 0 1.5137328057690524e-09
. O 0 2.364157758449892e-08

Mutations O 0 2.7134046831633896e-07
in O 0 1.1647394160263502e-09
the O 0 1.9844931031798296e-08
ATP7B O 0 0.14981301128864288
genes O 0 6.119548423555443e-09
have O 0 1.8215429165024943e-11
also O 0 2.7904284785607025e-12
been O 0 2.659118151365769e-12
demonstrated O 0 3.024645638116663e-12
in O 0 1.0269235982407476e-11
mouse O 0 2.9665159217984183e-09
and O 0 7.454933559358778e-09
rat O 0 5.94009122778516e-07
. O 0 2.5893385213748843e-08

The O 0 1.324006007052958e-06
ATP7B O 0 0.07348693162202835
gene O 0 7.620187147949764e-09
has O 0 1.4534445869074375e-10
been O 0 7.82749212668854e-11
excluded O 0 2.910885421592013e-10
in O 0 1.622810566481725e-11
the O 0 4.162155689546587e-11
much O 0 4.5794829039991214e-10
rarer O 0 1.6573176253587008e-06
human O 0 6.458899974859378e-07
copper B-Disease 0 0.0006711636087857187
overload I-Disease 1 0.9999923706054688
disease O 1 0.999996542930603
non B-Disease 0 5.001739964427543e-07
- I-Disease 0 6.531870155868091e-08
Indian I-Disease 0 9.908711184891672e-09
childhood I-Disease 0 5.713565656151331e-07
cirrhosis I-Disease 1 0.7319731116294861
, O 0 6.77119679770577e-11
indicating O 0 4.453038382479235e-09
genetic O 0 9.052393323827346e-08
heterogeneity O 0 2.2505537344841287e-07
. O 0 2.518183883637448e-08

By O 0 3.449530106003351e-10
investigating O 0 1.9794576644471817e-08
the O 0 9.772223030779514e-09
common O 0 5.293988124321913e-06
autosomal O 1 0.9999978542327881
recessive O 1 0.9999996423721313
copper B-Disease 1 0.9999942779541016
toxicosis I-Disease 1 0.9999988079071045
( O 0 4.039194934080115e-08
CT B-Disease 0 0.0012993878917768598
) O 0 4.778267226335231e-10
in O 0 4.799039832192875e-09
Bedlington O 0 3.5922475944971666e-06
terriers O 0 1.2553294936878956e-07
, O 0 1.3773934770533458e-10
we O 0 1.9374769150148907e-11
have O 0 1.745775019771495e-13
identified O 0 1.895751079988156e-13
a O 0 3.6484639772240215e-14
new O 0 2.548593389280207e-14
locus O 0 1.1596371649394421e-12
involved O 0 8.839503564880835e-13
in O 0 5.676830533429822e-11
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.599891250720248e-05

We O 0 4.437710998672628e-08
examined O 0 8.915480798066255e-09
whether O 0 5.949781223257844e-10
the O 0 1.5834550337601172e-09
WD B-Disease 0 1.7249425354748382e-06
gene O 0 3.6614049570005136e-09
ATP7B O 0 8.201835589716211e-05
was O 0 5.7607067560638825e-08
also O 0 1.165172264228076e-10
causative O 0 4.4760875561600244e-10
for O 0 1.1221007456541088e-10
CT B-Disease 0 6.763655591157658e-08
by O 0 4.353182744831763e-11
investigating O 0 1.5126792041186832e-09
the O 0 1.0880549794478611e-09
chromosomal O 0 7.924681710846926e-08
co O 0 4.23921076020406e-09
- O 0 5.299119809620834e-09
localization O 0 5.065570363171901e-08
of O 0 1.0980862441556383e-07
ATP7B O 0 9.002800652524456e-06
and O 0 1.0621774571006881e-09
C04107 O 0 5.904319166916139e-08
, O 0 1.215303725710104e-11
using O 0 2.0850141058126326e-11
fluorescence O 0 2.211927752071574e-09
in O 0 2.141548494094536e-09
situ O 0 2.8319613321059478e-08
hybridization O 0 1.7214818459621029e-09
( O 0 1.235384849973542e-10
FISH O 0 1.575202013270882e-08
) O 0 4.083061666548815e-11
. O 0 1.2634570056846428e-09

C04107 O 0 0.0003315926587674767
is O 0 1.2049714559481117e-09
an O 0 4.095634942302695e-11
anonymous O 0 1.5589644852820328e-10
microsatellite O 0 8.930716433042107e-08
marker O 0 4.3210764744117114e-08
closely O 0 1.1408941569257536e-09
linked O 0 1.3735939319303725e-07
to O 0 1.9472142867016373e-06
CT B-Disease 1 0.9998595714569092
. O 0 3.7641971175617073e-06

However O 0 1.7396089333487907e-06
, O 0 4.8071957081674555e-08
BAC O 0 6.187542021507397e-05
clones O 0 8.271150164773644e-08
containing O 0 4.0553246871688486e-10
ATP7B O 0 9.193329788104165e-06
and O 0 1.92350180228118e-09
C04107 O 0 3.6041785733686993e-07
mapped O 0 2.759022565967939e-09
to O 0 1.9907777648597857e-09
the O 0 8.492566649920263e-10
canine O 0 1.3948704413735413e-08
chromosome O 0 1.2489645939695038e-07
regions O 0 3.788469982168863e-08
CFA22q11 O 0 4.956279440193612e-07
and O 0 9.536109679686433e-10
CFA10q26 O 0 7.212738069029001e-07
, O 0 2.6940910613504343e-10
respectively O 0 1.0296076213833771e-09
, O 0 3.467180015315208e-11
demonstrating O 0 3.666418904590962e-11
that O 0 1.7009050418126392e-11
WD B-Disease 0 5.909208411480904e-08
cannot O 0 8.661112715913077e-09
be O 0 7.126281231784048e-10
homologous O 0 3.092775757718158e-10
to O 0 1.6170043082297525e-08
CT B-Disease 0 7.368600199697539e-05
. O 0 1.0737299760421593e-07

The O 0 2.3458683244825806e-06
copper O 0 8.317485367115296e-07
transport O 0 5.145930259686793e-08
genes O 0 1.6237844402411383e-09
CTR1 O 0 9.25810468288546e-07
and O 0 3.4961283867929183e-10
CTR2 O 0 5.8025948419526685e-06
were O 0 6.0997812356689e-10
also O 0 1.896577513094133e-11
excluded O 0 1.5174436707177108e-10
as O 0 2.5771790951312212e-11
candidate O 0 3.523530356375204e-09
genes O 0 1.3602095838560757e-10
for O 0 1.4822695848515366e-10
CT B-Disease 0 1.574230736878235e-05
since O 0 5.9455221190773955e-08
they O 0 6.019464093842686e-11
both O 0 7.318906765363398e-12
mapped O 0 1.7953989406294113e-09
to O 0 6.781518013809773e-09
canine O 0 4.2235959085701325e-07
chromosome O 0 1.3933121408626903e-05
region O 0 1.3944568308943417e-05
CFA11q22 O 0 0.0008318994659930468
. O 0 1.2392066537358915e-06

2 O 0 3.475206540315412e-05
- O 0 2.7183905331185088e-06
22 O 0 2.1358300728024915e-06
. O 0 3.6670119385462385e-08

5 O 0 8.069954492384568e-05
. O 0 6.359516646625707e-07

A O 0 1.5335608622990549e-06
transcribed O 0 8.229664949510607e-09
sequence O 0 3.138700965799046e-10
identified O 0 3.0913827053780096e-11
from O 0 1.862020607146242e-11
the O 0 7.185622930006019e-11
C04107 O 0 1.0538396821857532e-08
- O 0 9.1848967320729e-10
containing O 0 3.764004732897952e-11
BAC O 0 1.7281649888900574e-07
was O 0 5.824427606881954e-10
found O 0 2.1156227811292005e-12
to O 0 7.217582868174199e-12
be O 0 1.2233226584501544e-11
homologous O 0 5.930219856842278e-12
to O 0 1.0039049452847948e-10
a O 0 6.668651741925657e-10
gene O 0 1.7252280160029443e-10
expressed O 0 6.459161677740966e-11
from O 0 6.902485250037671e-10
human O 0 1.4470417086798193e-09
chromosome O 0 3.539875024216599e-07
2p13 O 0 1.241321456291189e-06
- O 0 3.2182825293602946e-08
p16 O 0 3.5497709216514295e-09
, O 0 1.5521862224351923e-12
a O 0 1.5018939217292804e-11
region O 0 2.5003881187757315e-09
devoid O 0 2.2756740936102915e-09
of O 0 7.304602062108145e-11
any O 0 1.918890879526458e-10
positional O 0 5.139887804261889e-08
candidate O 0 1.4266822745412355e-06
genes O 0 2.371772644949033e-08
. O 0 3.681221993900863e-09

Molecular O 0 2.3805197812976076e-08
analysis O 0 4.618823726265653e-11
of O 0 5.378953393808672e-10
the O 0 1.9518071603386034e-09
APC B-Disease 0 1.6208510089654737e-09
gene O 0 3.2238849177052e-12
in O 0 1.816455731488975e-12
205 O 0 2.0482737034255294e-11
families O 0 2.2570743017646944e-12
: O 0 9.345587454953619e-13
extended O 0 3.6112466350601835e-09
genotype O 0 5.103061084810179e-08
- O 0 4.180429158395782e-08
phenotype O 0 6.42018349594764e-09
correlations O 0 1.6784953427162463e-09
in O 0 4.966098365866145e-11
FAP B-Disease 0 2.087170714037967e-11
and O 0 3.368941681614751e-13
evidence O 0 7.220981083043421e-13
for O 0 5.912752790637396e-14
the O 0 2.570643350963131e-12
role O 0 6.1209167075138016e-12
of O 0 1.176534841773602e-10
APC B-Disease 0 6.189295187475352e-10
amino O 0 8.475785628903054e-10
acid O 0 5.822517468168087e-10
changes O 0 5.147515191872287e-10
in O 0 2.07975426746998e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 1.2062954738212284e-05

BACKGROUND O 0 7.04354690128639e-08
/ O 0 6.887880488193332e-08
AIMS O 0 1.284491020214773e-07
The O 0 2.5088758848212933e-10
development O 0 1.0856343379828104e-08
of O 0 6.825119953646208e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.5248845509094906e-11
a O 0 3.0188646721329704e-12
variable O 0 8.138988615014053e-12
range O 0 3.906263854047687e-11
of O 0 2.3060961126808444e-11
extracolonic O 0 4.3227251467214955e-07
manifestations O 0 2.4602829853392905e-06
in O 0 2.0645127278839936e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 4.0235836884505716e-09
FAP B-Disease 0 8.676601659374228e-10
) O 0 3.2705808954104285e-14
is O 0 1.2405676732738478e-14
the O 0 1.8432343596320316e-13
result O 0 5.479914265416053e-12
of O 0 1.4249219859596707e-10
the O 0 8.493522551944466e-10
dominant O 0 1.3654921815486887e-07
inheritance O 0 3.0483619411825202e-05
of O 0 0.00022793222160544246
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 5.250005319368256e-09
APC B-Disease 0 1.3697030176729186e-08
) O 0 1.1857827220129735e-10
gene O 0 7.346676600405999e-10
mutations O 0 4.044035861738848e-08
. O 0 6.041418743052418e-08

In O 0 3.4119715941471895e-09
this O 0 1.8720854033649204e-10
study O 0 1.0389336092819779e-11
, O 0 1.8474756230055234e-13
direct O 0 2.003563460972746e-11
mutation O 0 1.5047870935425145e-11
analysis O 0 2.435851867432781e-12
of O 0 1.4116963154009454e-10
the O 0 8.889225466823802e-10
APC B-Disease 0 4.400227293643866e-09
gene O 0 6.229061710882888e-11
was O 0 9.094144881593991e-10
performed O 0 5.957144499912914e-12
to O 0 5.790872295574623e-11
determine O 0 1.992676162965168e-10
genotype O 0 3.828565908747805e-09
- O 0 4.103818174172602e-09
phenotype O 0 1.6161433302741557e-09
correlations O 0 2.5343966925106542e-09
for O 0 6.555000292562951e-11
nine O 0 4.3352543777075425e-10
extracolonic O 0 2.0314066873083902e-08
manifestations O 0 3.8626142284670095e-09
and O 0 3.850104696861978e-12
to O 0 3.8472728475236195e-11
investigate O 0 3.266346568220335e-11
the O 0 1.4561270592072795e-11
incidence O 0 4.9598276596896085e-09
of O 0 2.611700578025733e-10
APC B-Disease 0 2.902354578893096e-09
mutations O 0 2.7492625953584593e-09
in O 0 3.10586534268964e-09
non O 1 0.9999997615814209
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.4297782147186808e-05

METHODS O 0 3.880223630403634e-06
The O 0 5.223349575089742e-08
APC B-Disease 0 1.702647445256389e-08
gene O 0 1.0656429211275409e-10
was O 0 3.900689216074227e-10
analysed O 0 3.730967965132059e-11
in O 0 9.28241641537375e-13
190 O 0 8.065956236258387e-11
unrelated O 0 1.8248716426860767e-10
FAP B-Disease 0 1.3181968017139667e-10
and O 0 2.4979449064765902e-11
15 O 0 3.0850790722070087e-07
non O 1 0.9994712471961975
- O 1 1.0
FAP O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.500656215431718e-08
using O 0 3.92400861803921e-10
denaturing O 0 2.640177569901425e-07
gradient O 0 2.4054585878729995e-08
gel O 0 1.6028599558737255e-09
electrophoresis O 0 2.1811297212792624e-10
, O 0 1.2105010570306884e-11
the O 0 6.407124136798004e-11
protein O 0 5.309271772224733e-11
truncation O 0 1.1509436737000556e-09
test O 0 8.67350219424523e-11
, O 0 5.440046742070936e-13
and O 0 1.553400528868376e-12
direct O 0 3.6200462627533625e-09
sequencing O 0 7.506986143823724e-09
. O 0 1.57301034420243e-08

RESULTS O 0 2.0779381884494796e-05
Chain O 0 2.9818457392138953e-07
terminating O 0 7.098099530367108e-08
signals O 0 2.7142179614969564e-09
were O 0 2.213115628257878e-11
only O 0 2.1988088433344544e-12
identified O 0 2.202536113563025e-12
in O 0 4.675056457410787e-13
patients O 0 1.239166538477554e-12
belonging O 0 7.826229356418246e-13
to O 0 5.89805149164846e-11
the O 0 5.343623321607538e-10
FAP B-Disease 0 2.245239771880847e-09
group O 0 6.477619135525359e-11
( O 0 7.101068344450567e-11
105 O 0 1.2487443257214181e-07
patients O 0 1.3290989420156052e-09
) O 0 2.1520338289171548e-10
. O 0 1.3534202203402401e-08

Amino O 0 2.3728274811674055e-07
acid O 0 2.0500070530005132e-09
changes O 0 1.9252028790606168e-11
were O 0 3.684068241444072e-12
identified O 0 2.5774432501485256e-12
in O 0 6.203586906325387e-13
four O 0 8.018366244415265e-13
patients O 0 6.558995425780256e-13
, O 0 1.1419150672785372e-13
three O 0 3.954630026226091e-12
of O 0 2.679864108401375e-10
whom O 0 3.7288142018532255e-10
belonged O 0 6.337472213679973e-10
to O 0 4.720599466878639e-10
the O 0 1.251297843118948e-09
non O 0 1.613656053223167e-07
- O 0 1.724727241025903e-07
FAP O 0 3.009264659681321e-08
group O 0 1.1545495670617356e-09
of O 0 3.742906483239494e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999998807907104
. O 0 8.102224455797113e-06

Genotype O 0 9.016462172439788e-06
- O 0 1.7893131598611944e-06
phenotype O 0 1.2132888116411777e-07
correlations O 0 3.8830780368925844e-08
identified O 0 3.581215046732922e-10
significant O 0 6.205936459169337e-11
differences O 0 1.0419033413811007e-09
in O 0 8.358681108378008e-11
the O 0 4.397271990974616e-10
nature O 0 8.036732390692691e-11
of O 0 4.7261288632638454e-11
certain O 0 1.264333776562765e-10
extracolonic O 0 5.504773525899509e-07
manifestations O 0 3.5548271881680193e-08
in O 0 2.380176888916452e-10
FAP B-Disease 0 1.0602929645386894e-09
patients O 0 5.406111756173226e-12
belonging O 0 2.9710923391684796e-12
to O 0 1.674107935611957e-10
three O 0 3.857039687638064e-10
mutation O 0 3.5330479875028686e-08
subgroups O 0 3.076077348396211e-07
. O 0 1.8891899600248507e-08

CONCLUSIONS O 0 1.9711931145138806e-06
Extended O 0 4.662582853143249e-08
genotype O 0 4.0095123665651045e-08
- O 0 1.5711513867699978e-08
phenotype O 0 6.158751730822587e-09
correlations O 0 1.9671191342496286e-09
made O 0 8.204299045688757e-11
in O 0 3.192233977156178e-11
this O 0 5.761995047759427e-11
study O 0 4.464114841673528e-11
may O 0 3.2313740572220695e-10
have O 0 1.081231111588199e-11
the O 0 2.7078134873237403e-11
potential O 0 2.0905933234560692e-11
to O 0 1.828613788168454e-10
determine O 0 6.333206736819363e-10
the O 0 7.706372345817059e-11
most O 0 4.552116062567224e-12
appropriate O 0 1.6473612751699562e-10
surveillance O 0 1.1675932443111492e-09
and O 0 2.2675705757535525e-10
prophylactic O 0 4.494864242587937e-06
treatment O 0 1.535030769161949e-08
regimens O 0 3.4980275620544177e-11
for O 0 3.2130851798650717e-13
those O 0 6.493706397256438e-13
patients O 0 8.690600322713848e-13
with O 0 1.4565422706922654e-13
mutations O 0 1.9161916497978382e-10
associated O 0 1.3310288982104623e-10
with O 0 7.24888638697907e-12
life O 0 1.9465467016033244e-09
threatening O 0 4.323603377542895e-07
conditions O 0 3.644376920419745e-05
. O 0 1.7291360165927472e-07

This O 0 1.2231285317909624e-08
study O 0 2.967923684593643e-10
also O 0 3.422275754883658e-13
provided O 0 1.4559589699234682e-13
evidence O 0 3.0983876488782647e-12
for O 0 1.7702263266361484e-12
the O 0 2.6752475235092277e-10
pathological O 0 2.407203396614932e-07
nature O 0 1.082996803347669e-09
of O 0 2.7043065564669178e-09
amino O 0 5.684905879377311e-10
acid O 0 6.337010083345973e-11
changes O 0 3.602985097772571e-12
in O 0 2.0888037827182515e-11
APC O 0 3.652976809931374e-10
associated O 0 1.8792753811447405e-11
with O 0 7.009150204684289e-14
both O 0 3.707075011544214e-12
FAP B-Disease 0 5.478582032480972e-10
and O 0 3.227463019062071e-10
non O 1 0.99897301197052
- O 1 1.0
FAP O 1 0.9999986886978149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.178385885708849e-07
. O 0 1.6827138571429145e-09
. O 0 4.404316911177375e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 0.02174338884651661
cancer B-Disease 1 1.0
risk O 0 0.004030486103147268
of O 0 3.323538521726732e-06
the O 0 2.982426110520464e-07
APC O 0 2.940766385961524e-08
I1307K O 0 2.0368700859307864e-07
polymorphism O 0 4.9158003889715474e-08
. O 0 4.609360715335242e-08

Germ O 0 1.732595956127625e-05
- O 0 1.0322651178285014e-07
line O 0 2.0113660070819606e-08
and O 0 3.6432490357896086e-10
somatic O 0 1.162693585854413e-08
truncating O 0 6.520343731608591e-08
mutations O 0 3.364382994419657e-09
of O 0 6.329016755124428e-10
the O 0 1.1895165963338172e-09
APC B-Disease 0 4.565171574100191e-10
gene O 0 1.3247014596373674e-11
are O 0 5.460359269772452e-13
thought O 0 8.05712614682097e-12
to O 0 1.5574101730475576e-10
initiate O 0 3.1186064575194905e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.999996542930603
formation O 0 1.7577665857970715e-05
in O 0 5.1969509513583034e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.00011792234727181494
sporadic O 1 0.9994882345199585
colorectal O 1 1.0
carcinogenesis O 1 0.9999967813491821
, O 0 2.4266334719413862e-08
respectively O 0 5.813623360495512e-08
. O 0 2.760592821005048e-08

Recently O 0 2.2428275769925676e-07
, O 0 1.0202905187384204e-09
an O 0 1.2969539886498183e-09
isoleucine O 0 6.900305606905022e-07
- O 0 1.4275600790369936e-07
- O 0 1.3330505055364483e-07
> O 0 6.945147390524653e-08
lysine O 0 2.9345692098559084e-08
polymorphism O 0 4.522143770557818e-10
at O 0 1.1335496985509508e-09
codon O 0 6.589677137291972e-10
1307 O 0 9.096248199114143e-09
( O 0 2.7464660753984127e-11
I1307K O 0 4.4738474258565475e-08
) O 0 2.900153424703622e-12
of O 0 9.4082665269557e-11
the O 0 5.441912476200628e-10
APC B-Disease 0 5.196159502673936e-09
gene O 0 6.080658893070634e-11
has O 0 2.992465433435121e-12
been O 0 2.3529381568132557e-12
identified O 0 2.4791000415719244e-12
in O 0 1.9485049424644574e-12
6 O 0 7.483707542554896e-10
% O 0 1.5233356243093965e-11
- O 0 6.167420740776919e-11
7 O 0 4.040819234774062e-09
% O 0 2.910412189027767e-11
of O 0 7.1464466289139494e-12
the O 0 3.1383520782135577e-11
Ashkenazi O 0 1.891709455748014e-09
Jewish O 0 4.5110304380813204e-10
population O 0 9.263442443674386e-12
. O 0 3.628353451023969e-10

To O 0 3.27394822363658e-08
assess O 0 1.1445350622807382e-07
the O 0 1.015084460931348e-09
risk O 0 3.574624596325293e-09
of O 0 6.159133619787482e-11
this O 0 5.615197976732711e-12
common O 0 3.4121391823127567e-10
APC B-Disease 0 3.6741301112641622e-09
allelic O 0 6.5604601751090286e-09
variant O 0 3.0313742627186e-08
in O 0 9.774966969189336e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 3.371477248492738e-07
we O 0 1.0693945284856454e-08
have O 0 1.7535323887374332e-11
analyzed O 0 2.5613016915726483e-11
a O 0 4.3630060501953505e-12
large O 0 6.244891756490567e-12
cohort O 0 3.8268122004581073e-10
of O 0 1.4816448068444288e-10
unselected O 0 6.127458505034156e-07
Ashkenazi O 0 1.2649699954181415e-07
Jewish O 0 2.4299030343399863e-08
subjects O 0 9.307786541512542e-09
with O 0 1.05446193443548e-10
adenomatous B-Disease 0 1.0290475984220393e-05
polyps I-Disease 0 4.938491429129499e-07
and O 0 1.5757352367362643e-10
. O 0 3.192145658914569e-09
or O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 3.0125479888454265e-09
for O 0 1.8656227951385773e-10
the O 0 1.1056749293913981e-08
APC O 0 2.3918023117630582e-08
I1307K O 0 3.477365169146651e-07
polymorphism O 0 9.289026081660268e-08
. O 0 3.6711970352598655e-08

The O 0 1.968081448922021e-07
APC O 0 2.8958698550241024e-08
I1307K O 0 5.802932889764634e-08
allele O 0 3.9253336692191e-10
was O 0 4.1368550252052216e-10
identified O 0 1.2821093145487517e-11
in O 0 1.8535482176895712e-11
48 O 0 3.1726912208540625e-09
( O 0 8.153500444252337e-12
10 O 0 8.973070064755007e-10
. O 0 2.4192401554268272e-11
1 O 0 3.365578393754731e-08
% O 0 2.1979640330016537e-10
) O 0 4.4078816117953945e-12
of O 0 6.86374013181279e-11
476 O 0 5.813775683094491e-09
patients O 0 1.6425522053609143e-09
. O 0 5.264283675643355e-09

Compared O 0 1.947229710808074e-09
with O 0 1.1059616764064195e-12
the O 0 4.1788923016428114e-11
frequency O 0 8.02284141898646e-11
in O 0 4.176561169393772e-13
two O 0 1.083881180879813e-13
separate O 0 4.183577312702469e-13
population O 0 2.4872167042958027e-13
control O 0 1.611306227333742e-11
groups O 0 3.3559930550687567e-13
, O 0 1.4647985949189923e-11
the O 0 7.758156894688284e-10
APC O 0 9.142864243472104e-09
I1307K O 0 5.2764299596219644e-08
allele O 0 6.141411268423269e-10
is O 0 1.582148474732481e-12
associated O 0 1.6867858021810123e-12
with O 0 4.941590553094767e-14
an O 0 5.7299681492650745e-12
estimated O 0 1.4015094640384973e-10
relative O 0 3.5508136431161574e-09
risk O 0 1.790017734037974e-08
of O 0 2.523246500629739e-08
1 O 0 0.0002859671658370644
. O 0 3.247863560318365e-07

5 O 0 1.445071120542707e-05
- O 0 2.1679279598174617e-06
1 O 0 1.4043912415218074e-05
. O 0 6.403455898862376e-08

7 O 0 1.870188680186402e-05
for O 0 1.0693317165078042e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 0 0.0014516236260533333
( O 0 1.6512187173134407e-09
both O 0 2.663142151249076e-09
P O 0 1.8569517123978585e-05
= O 0 2.91462010082455e-09
. O 0 1.2010632766124019e-10
01 O 0 1.079338618481529e-09
) O 0 4.343172696485986e-11
. O 0 1.684261508039242e-09

Furthermore O 0 1.2922008352234116e-07
, O 0 4.008139653510767e-10
compared O 0 3.6380132240054763e-10
with O 0 1.3929780939836434e-11
noncarriers O 0 2.182648358939332e-06
, O 0 1.898468715566537e-09
APC O 0 4.1840266362669354e-08
I1307K O 0 1.4618848354075453e-07
carriers O 0 3.7104583294755855e-11
had O 0 5.5358474748690156e-11
increased O 0 3.459926442572758e-11
numbers O 0 2.218359176908713e-12
of O 0 1.1544432770849156e-10
adenomas B-Disease 0 5.3246429160935804e-05
and O 0 1.505891759734368e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 3.8308782677631825e-05
patient O 0 2.0559580207191175e-06
( O 0 2.2617133166313863e-10
P O 0 1.0269956192132668e-06
= O 0 3.669324011301711e-10
. O 0 1.463957947922534e-11
03 O 0 4.6169124079398216e-11
) O 0 5.800118415069666e-13
, O 0 1.2041447483221446e-12
as O 0 1.298751904632578e-12
well O 0 5.017354262094875e-13
as O 0 1.856455744339569e-12
a O 0 5.042513975817009e-11
younger O 0 1.163772966883414e-10
age O 0 2.3852497754717206e-09
at O 0 1.1652355524915947e-08
diagnosis O 0 1.4992309615990962e-06
. O 0 7.910920807319144e-09

We O 0 2.988187830510469e-08
conclude O 0 1.0310844800187624e-07
that O 0 7.91396045918269e-11
the O 0 8.860076561312269e-10
APC O 0 6.5085870026848625e-09
I1307K O 0 4.6679037524199885e-08
variant O 0 2.6841011635525547e-09
leads O 0 2.3751112188108436e-10
to O 0 1.1942306865631025e-10
increased O 0 8.8786213936487e-09
adenoma B-Disease 1 1.0
formation O 0 2.8001855056913882e-08
and O 0 1.0972264069541993e-10
directly O 0 2.2566504220833394e-10
contributes O 0 1.371319204024335e-11
to O 0 9.538669853981219e-11
3 O 0 8.17858614166056e-10
% O 0 1.731398184545707e-11
- O 0 1.1475011912898125e-11
4 O 0 2.2384184783508232e-10
% O 0 3.0894709533713094e-12
of O 0 3.914494054423068e-13
all O 0 1.6186241800011936e-12
Ashkenazi O 0 2.0210460149883147e-07
Jewish O 0 2.539924389566295e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.2598043731013604e-07

The O 0 5.798131397227735e-08
estimated O 0 1.1818281464570646e-08
relative O 0 3.805162762660075e-08
risk O 0 3.2945119965432923e-09
for O 0 3.18654581887845e-11
carriers O 0 5.2809628198202674e-11
may O 0 1.6408832070879953e-09
justify O 0 7.181461536553968e-10
specific O 0 1.0998134694628625e-11
clinical O 0 3.1197613936662094e-11
screening O 0 5.084358281615131e-12
for O 0 4.4089303605568397e-13
the O 0 1.3670753765127053e-11
360 O 0 1.0158142382810098e-10
, O 0 8.585605316968614e-12
000 O 0 4.002805031877443e-11
Americans O 0 3.766356530040399e-13
expected O 0 1.740033256369955e-10
to O 0 1.1084653334103578e-10
harbor O 0 1.974170604768233e-09
this O 0 6.029319838535274e-12
allele O 0 1.9166989176366833e-11
, O 0 1.5195709274218316e-12
and O 0 3.5055133709022135e-12
genetic O 0 1.613311220727276e-11
testing O 0 1.0255998524402732e-12
in O 0 1.6847463636844584e-13
the O 0 2.936679979054224e-12
setting O 0 3.812690788085327e-11
of O 0 4.867138983510877e-11
long O 0 3.2758129542287406e-10
- O 0 1.3337284610059896e-09
term O 0 5.723229534737584e-08
- O 0 8.426625619506467e-09
outcome O 0 8.387035954626754e-09
studies O 0 7.206399539605446e-12
may O 0 1.0150854115598129e-11
impact O 0 1.306534880285426e-10
significantly O 0 4.402561426530838e-09
on O 0 0.000519519264344126
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 4.0737955231406886e-08
in O 0 2.02770959745191e-12
this O 0 3.805975066356604e-12
population O 0 3.68031776928901e-12
. O 0 2.729354520170091e-10

Localization O 0 3.4818922358681448e-06
of O 0 1.0445467779618411e-07
human O 0 4.850499557562671e-09
BRCA1 O 0 6.0101550403146575e-09
and O 0 1.9642152487842068e-11
its O 0 1.431639182203348e-11
loss O 0 3.7716222506256614e-11
in O 0 2.0014857826655685e-11
high O 0 2.156284395482544e-08
- O 0 4.640243744802319e-08
grade O 0 4.0453790006722556e-07
, O 0 1.023354290197176e-09
non B-Disease 0 0.42187008261680603
- I-Disease 1 0.9999653100967407
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.0019700617995113134

Although O 0 2.120368547409157e-09
the O 0 2.9743729701436905e-10
link O 0 3.615779897714333e-10
between O 0 2.0588708515845155e-09
the O 0 3.1431357516709113e-09
BRCA1 O 0 2.1417987383642867e-08
tumour B-Disease 1 1.0
- O 0 9.319031768484365e-09
suppressor O 0 7.060599216401897e-09
gene O 0 9.291920011200716e-11
and O 0 5.959867044325051e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 1.7910035410295677e-07
established O 0 1.6660392510026156e-10
, O 0 1.9792224499950994e-13
the O 0 1.1974410178694495e-12
role O 0 1.682993696662527e-12
, O 0 1.7605816977905864e-13
if O 0 2.3743251288677047e-12
any O 0 6.773457489339663e-11
, O 0 2.2631146956442194e-11
of O 0 3.956195926413386e-10
BRCA1 O 0 1.3130665443839007e-08
in O 0 6.382443906716162e-09
non B-Disease 1 0.9297398924827576
- I-Disease 1 0.999996542930603
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 5.315014561801945e-08
unclear O 0 9.349657403845413e-08
. O 0 1.4639126355575627e-08

BRCA1 O 0 9.842682629823685e-06
mutations O 0 5.704217187485483e-07
are O 0 9.954752300256331e-11
rare O 0 1.0715113241133167e-09
in O 0 5.079403120333836e-09
sporadic B-Disease 0 0.0006231664447113872
cancers I-Disease 1 1.0
, O 0 1.03896287129146e-08
but O 0 4.6103787454399026e-09
loss O 0 5.0540762686068774e-08
of O 0 5.5370172447055666e-08
BRCA1 O 0 4.385865892686525e-09
resulting O 0 1.3995253844711897e-09
from O 0 4.056330271673403e-10
reduced O 0 7.782389177535265e-10
expression O 0 3.215326269123686e-11
or O 0 1.4396081549072903e-10
incorrect O 0 1.3425619505014197e-09
subcellular O 0 1.4627431710323435e-08
localization O 0 1.2534723481394394e-08
is O 0 1.664815334201375e-11
postulated O 0 7.205963603595933e-11
to O 0 1.5399110805947025e-11
be O 0 4.478081100378617e-12
important O 0 1.0052874331589745e-12
in O 0 4.517701490680537e-11
non B-Disease 0 1.2886562217317987e-05
- I-Disease 1 0.790916383266449
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.8773708939552307

Epigenetic O 0 0.0003140230546705425
loss O 0 0.00013251019117888063
, O 0 2.649866992499028e-09
however O 0 1.1205443239958868e-09
, O 0 4.127960126498742e-12
has O 0 4.5053655359401923e-13
not O 0 3.7582475109418367e-13
received O 0 1.6329442138751649e-12
general O 0 9.159646652268094e-11
acceptance O 0 6.661443618938279e-10
due O 0 4.413087228982704e-09
to O 0 1.6553110271377847e-10
controversy O 0 1.1419384882138672e-10
regarding O 0 5.547601614197539e-11
the O 0 8.671981188701494e-11
subcellular O 0 1.3519625419178283e-08
localization O 0 1.3594225301005736e-08
of O 0 9.674303136364415e-09
BRCA1 O 0 1.1621963391661438e-09
proteins O 0 6.299648303009775e-12
, O 0 8.651716495999828e-13
reports O 0 1.765189231762998e-12
of O 0 7.135958490778194e-12
which O 0 3.2423974529599553e-12
have O 0 1.0083739399036062e-11
ranged O 0 1.0153871521367819e-08
from O 0 7.893853903873094e-10
exclusively O 0 1.382705477892543e-10
nuclear O 0 1.4152732319416828e-07
, O 0 8.21059192857021e-11
to O 0 6.15361761546751e-10
conditionally O 0 1.2298991691750416e-07
nuclear O 0 2.0992075633330387e-07
, O 0 5.877355546690666e-11
to O 0 1.2836056662024475e-09
the O 0 9.709482107211898e-09
ER O 0 3.937488600058714e-06
/ O 0 2.1416600048951295e-08
golgi O 0 3.091929556831019e-08
, O 0 1.5111665391254192e-11
to O 0 2.2112517372718798e-10
cytoplasmic O 0 7.745814656345829e-09
invaginations O 0 3.0682542728754925e-08
into O 0 5.535259472999599e-10
the O 0 9.827715308219354e-10
nucleus O 0 2.2390782561387823e-08
. O 0 8.301016762857216e-09

In O 0 7.057111783836945e-09
an O 0 1.356331297275304e-10
attempt O 0 7.163994730774448e-09
to O 0 1.579554820274609e-09
resolve O 0 2.8080371805572213e-08
this O 0 1.2228985879492171e-10
issue O 0 2.223810469104137e-09
, O 0 5.624805482495887e-11
we O 0 1.3042417146280627e-10
have O 0 4.212447057838631e-11
comprehensively O 0 1.0397915417570402e-08
characterized O 0 7.203163621127828e-10
19 O 0 1.9825861841127335e-08
anti O 0 1.6174670491864163e-08
- O 0 4.68817624721396e-08
BRCA1 O 0 1.886369727088777e-09
antibodies O 0 3.9045672250992425e-10
. O 0 1.695303564197559e-09

These O 0 4.682510734710377e-08
reagents O 0 4.6100556261308157e-08
detect O 0 1.0640256675742421e-07
a O 0 1.1634146090955255e-08
220 O 0 4.134372399988706e-09
- O 0 3.199179809953989e-09
kD O 0 1.3481746385934912e-08
protein O 0 2.435933399436152e-10
localized O 0 1.5287159316201837e-09
in O 0 5.958511462011984e-11
discrete O 0 1.1124737575585186e-08
nuclear O 0 2.0553541162371403e-06
foci O 0 1.3772957174751355e-07
in O 0 1.1784168085782198e-10
all O 0 7.303486981857787e-11
epithelial O 0 1.7021725140509147e-09
cell O 0 1.4009916560198121e-09
lines O 0 2.7247239187122574e-11
, O 0 4.645509779806212e-13
including O 0 6.518409808231249e-14
those O 0 8.153030117349913e-13
derived O 0 2.6294083230182785e-11
from O 0 1.90023663471095e-09
breast B-Disease 0 9.205571132042678e-07
malignancies I-Disease 0 1.1196003697477863e-06
. O 0 4.718767954159375e-08

Immunohistochemical O 0 1.983976108022034e-05
staining O 0 3.7940312722639646e-06
of O 0 5.69377618830913e-07
human O 0 3.5961170397058595e-07
breast O 0 1.0749491593742277e-05
specimens O 0 4.890127858203641e-09
also O 0 9.911315101973628e-10
revealed O 0 5.958042947895592e-08
BRCA1 O 0 2.5293644512203173e-07
nuclear O 0 0.0003670527075883001
foci O 0 2.1122772523085587e-05
in O 0 1.7866202739469372e-08
benign O 1 1.0
breast O 1 1.0
, O 0 3.452648343227338e-06
invasive B-Disease 1 0.999916672706604
lobular I-Disease 1 0.9999998807907104
cancers I-Disease 1 1.0
and O 0 0.00025683300918899477
low B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
grade I-Disease 1 0.9999918937683105
ductal I-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
. O 0 0.0001881635980680585

Conversely O 0 3.720548988894734e-07
, O 0 2.2448414238596115e-09
BRCA1 O 0 1.125599613516215e-09
expression O 0 1.156814991021271e-10
was O 0 3.581338281488655e-10
reduced O 0 1.0679258866108654e-10
or O 0 4.0599506395677665e-11
undetectable O 0 7.09217545802332e-11
in O 0 3.8185600514939466e-13
the O 0 9.257062347570177e-13
majority O 0 3.195050831978491e-13
of O 0 5.427604893304405e-11
high O 0 2.404486849627574e-07
- O 0 5.996422260068357e-06
grade O 0 1.4950481272535399e-05
, O 0 7.679854263642483e-08
ductal B-Disease 1 0.9931471943855286
carcinomas I-Disease 1 1.0
, O 0 1.4359834432653429e-09
suggesting O 0 1.37937650190878e-09
that O 0 1.789968173682155e-10
absence O 0 1.3918885599650821e-08
of O 0 9.191857941459602e-09
BRCA1 O 0 2.471568505413302e-09
may O 0 2.315340585923309e-09
contribute O 0 4.7061413793736406e-11
to O 0 1.004027971873711e-09
the O 0 1.239052638268845e-09
pathogenesis O 0 2.492066641934798e-08
of O 0 7.577048710682988e-11
a O 0 3.699998987749531e-11
significant O 0 4.433239608747641e-10
percentage O 0 8.555494446227385e-08
of O 0 2.472211235726718e-08
sporadic B-Disease 1 0.9999192953109741
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.492457835818641e-06
. O 0 1.0169782171942643e-06

